"","Gene Symbol","logFC","AveExpr","t","P.Value","adj.P.Val","B","Direction","Checked","Protein FDR Confidence: Combined","Master","Accession","Description","Exp. q_value: Combined","Sum PEP Score","Coverage [%]","No Peptides","No Isoforms","No PSMs","No Unique Peptides","No AAs","MW [kDa]","calc. pI","Score Sequest HT: Sequest HT","No Peptides (by Search Engine): Sequest HT","Biological Process","Cellular Component","Molecular Function","Pfam IDs","Entrez Gene ID","Gene ID","Ensembl Gene ID","Reactome Pathways","WikiPathways","No Protein Pathway Groups","No Razor Peptides","Abundances (Grouped): 2G11_Control_DMSO_1","Abundances (Grouped): 2G11_Control_DMSO_2","Abundances (Grouped): 2G11_Control_DMSO_3","Abundances (Grouped): SI8_AD_Abeta42_1","Abundances (Grouped): SI8_AD_Abeta42_2","Abundances (Grouped): SI8_AD_Abeta42_3","Abundances (Grouped): SI8_AD_Abeta42_Losma_1","Abundances (Grouped): SI8_AD_Abeta42_Losma_2","Abundances (Grouped): SI8_AD_Abeta42_Losma_3","Found in Sample: [S1] F1: 126, Sample, 2G11_Control_DMSO_1","Found in Sample: [S2] F1: 127N, Sample, 2G11_Control_DMSO_2","Found in Sample: [S3] F1: 127C, Sample, 2G11_Control_DMSO_3","Found in Sample: [S10] F1: 131, Sample, 2G11_Losma","Found in Sample: [S4] F1: 128N, Sample, SI8_AD_Abeta42_1","Found in Sample: [S5] F1: 128C, Sample, SI8_AD_Abeta42_2","Found in Sample: [S6] F1: 129N, Sample, SI8_AD_Abeta42_3","Found in Sample: [S7] F1: 129C, Sample, SI8_AD_Abeta42_Losma_1","Found in Sample: [S8] F1: 130N, Sample, SI8_AD_Abeta42_Losma_2","Found in Sample: [S9] F1: 130C, Sample, SI8_AD_Abeta42_Losma_3","No Protein Groups","Modifications","missing","ENSEMBL"
"1","SDC2",1.95878264866551,6.52559685902118,23.8726174222529,7.28090804237767e-10,1.18824419251604e-06,13.3402111203568,"UP",FALSE,"High","Master Protein","P34741","Syndecan-2 [OS=Homo sapiens]",0,7.564,4,1,1,2,1,201,22.1,4.86,7.52,1,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf01034","6383","B3KQA3; hsa:6383; P34741; Q6PIS6; Q9H6V1","ENSG00000169439","Cell surface interactions at the vascular wall; RSV-host interactions; Respiratory syncytial virus (RSV) attachment and entry; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; EPHB-mediated forward signaling; A tetrasaccharide linker sequence is required for GAG synthesis; HS-GAG biosynthesis; HS-GAG degradation; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective EXT2 causes exostoses 2; Defective EXT1 causes exostoses 1, TRPS2 and CHDS; Defective B3GALT6 causes EDSP2 and SEMDJL1; Attachment and Entry; Retinoid metabolism and transport; Syndecan interactions","miRNA targets in ECM and membrane receptors",18,0,39.1,43.2,42.3,153.4,197.3,170.5,111.1,106.3,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S187(100)]",0,"ENSG00000169439"
"2","GTF2I",-1.70687008119693,6.25555617754193,-20.736749490899,2.74439567661611e-09,1.59677901213236e-06,12.0820435420211,"DOWN",FALSE,"High","Master Protein","P78347","General transcription factor II-I [OS=Homo sapiens]",0,49.377,8,7,10,25,7,998,112.3,6.39,30.19,7,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02946","2969","hsa:2969; O14743; O15359; O43546; O43588; O43589; P78347; Q75M85; Q75M86; Q75M87; Q75M88; Q86U51; Q9BSZ4","ENSG00000263001",NA,"B cell receptor signaling pathway; 7q11.23 copy number variation syndrome; Genetic causes of porto-sinusoidal vascular disease",3,0,175.8,167,171.5,51.1,42.6,55,55.1,55.6,55.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S210(100); S674(100); S823(100); S831(99.6)]",0,"ENSG00000263001"
"3","RPL18A",-1.60097456777882,6.29356334024462,-19.4653636132608,4.96995365962575e-09,1.59677901213236e-06,11.5043958315669,"DOWN",FALSE,"High","Master Protein","Q02543","Large ribosomal subunit protein eL20 [OS=Homo sapiens]",0,50.071,10,2,2,7,2,176,20.7,10.71,26.67,2,"protein metabolism;other metabolic processes","cytosol;translational apparatus;other cell component","other molecular function","Pf01775","6142","hsa:6142; Q02543","ENSG00000105640","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","VEGFA-VEGFR2 signaling; Cytoplasmic ribosomal proteins",15,0,175.7,156.8,154.1,50.4,36.4,58.5,65.1,63.8,60.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(100)]",0,"ENSG00000105640"
"4","RPL12",-1.80486902946637,6.24546821199367,-18.8421476645528,6.74083449842543e-09,1.59677901213236e-06,11.2048487436647,"DOWN",FALSE,"High","Master Protein","P30050","Large ribosomal subunit protein uL11 [OS=Homo sapiens]",0,7.136,10,2,2,3,2,165,17.8,9.42,7.09,2,"protein metabolism;other metabolic processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00298, Pf03946","6136","hsa:6136; P30050; Q5VVV2; Q6PB27","ENSG00000197958","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,171.7,169.8,138,40.8,33.5,44.3,69.5,64.6,63.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S38(100); S126(100)]",0,"ENSG00000197958"
"5","ACTL6A",-1.43245723107553,6.40926345394252,-18.6534586879814,7.40647404626386e-09,1.59677901213236e-06,11.1118925756262,"DOWN",FALSE,"High","Master Protein","O96019","Actin-like protein 6A [OS=Homo sapiens]",0.006,1.808,2,1,1,2,1,429,47.4,5.6,4.55,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00022","86","B3KMN1; D3DNR9; hsa:86; O96019; Q8TAE5; Q9BVS8; Q9H0W6","ENSG00000136518","UCH proteinases; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines; HATs acetylate histones; DNA Damage Recognition in GG-NER","Androgen receptor network in prostate cancer; Gastric cancer network 1; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome",10,0,165.2,154.2,139.4,52.4,46,57.9,79.8,77.8,74.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100)]",0,"ENSG00000136518"
"6","SRSF6",-1.29235929654608,6.35616979316684,-18.5114785128013,7.95509929986902e-09,1.59677901213236e-06,11.041232909846,"DOWN",FALSE,"High","Master Protein","Q13247","Serine/arginine-rich splicing factor 6 [OS=Homo sapiens]",0,51.706,8,6,9,46,5,344,39.6,11.43,114.78,6,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076","6431","B7Z6J3; E1P5W6; hsa:6431; Q13244; Q13245; Q13247; Q96J06; Q9UJB8; Q9Y3N7","ENSG00000124193","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",7,0,165.1,153.4,152.6,61.9,54.8,61.2,61.4,62.8,64.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(100); S303(100); S314(100); S316(100)]",0,"ENSG00000124193"
"7","MCM6",-1.84419786001721,6.14713940397995,-18.5082561759663,7.96805948851246e-09,1.59677901213236e-06,11.0396220482214,"DOWN",FALSE,"High","Master Protein","Q14566","DNA replication licensing factor MCM6 [OS=Homo sapiens]",0,11.186,2,1,1,2,1,821,92.8,5.41,7.11,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00493, Pf14551, Pf17207, Pf17855, Pf18263","4175","B2R6H2; hsa:4175; Q13504; Q14566; Q99859","ENSG00000076003","Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA","Cell cycle; Retinoblastoma gene in cancer; Ciliary landscape; G1 to S cell cycle control; DNA replication",11,0,178.7,175.2,167.2,44.6,36.4,46.8,51.4,55.6,49.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S762(100)]",0,"ENSG00000076003"
"8","RNPS1",-1.67175820190365,6.30033940168392,-18.3796253603489,8.50490345446221e-09,1.59677901213236e-06,10.9750559300881,"DOWN",FALSE,"High","Master Protein","Q15287-2","Isoform 2 of RNA-binding protein with serine-rich domain 1 [OS=Homo sapiens]",0,37.872,13,8,12,61,8,282,31.7,11.9,91.82,8,NA,NA,NA,NA,NA,"Q15287-2",NA,NA,NA,0,0,169.7,167.4,155.7,48.8,40.1,49.1,69.1,57,64.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S4(100); S29(100); S132(100); S134(100); S228(100)]; Met-loss [N-Term]",0,"ENSG00000205937"
"9","NUF2",-2.29003370158384,6.20755859607081,-18.3113902844318,8.80576661102406e-09,1.59677901213236e-06,10.9405958123512,"DOWN",FALSE,"High","Master Protein","Q9BZD4","Kinetochore protein Nuf2 [OS=Homo sapiens]",0,4.066,2,1,1,1,1,464,54.3,8.27,2.58,1,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","cytosol;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf03800","83540","hsa:83540; Q8WU69; Q96HJ4; Q96Q78; Q9BZD4","ENSG00000143228","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal",NA,6,0,163.9,148.5,158,23,21,31.1,74.3,95.6,87.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S247(100)]",0,"ENSG00000143228"
"10","PTDSS1",-1.49977166364578,6.25348155560688,-18.0675962811958,9.98042437474683e-09,1.62880525795868e-06,10.8162713103559,"DOWN",FALSE,"High","Master Protein","P48651","Phosphatidylserine synthase 1 [OS=Homo sapiens]",0.004,2.094,2,1,1,2,1,473,55.5,8.43,4.09,1,"other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf03034","9791","B4DE85; E5RFC5; hsa:9791; P48651; Q9BUQ5","ENSG00000156471","Synthesis of PS","Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids",3,0,169.3,155.7,150.4,55.5,39.6,56.8,63.3,59.6,54.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S442(100)]",0,"ENSG00000156471"
"11","SH3BP2",1.4488471272871,6.5913075817775,17.6007570656533,1.27424599073559e-08,1.86645795891954e-06,10.572822144075,"UP",FALSE,"High","Master Protein","P78314","SH3 domain-binding protein 2 [OS=Homo sapiens]",0,4.573,3,2,2,2,2,561,62.2,7.78,4.98,2,"signal transduction",NA,"other molecular function","Pf00017, Pf00169","6452","A6NNC2; B2R5R6; B4DT04; D3DVR0; D6R919; hsa:6452; O00500; O15373; P78314; P78315","ENSG00000087266",NA,"B cell receptor signaling pathway",1,0,55.4,48.5,53.4,134.4,160.4,147.4,115.8,121.8,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S225(100); S427(100)]",0,"ENSG00000087266"
"12","LMNB1",-1.16728891796312,6.4311052035533,-17.3279853698318,1.47396759273019e-08,1.86645795891954e-06,10.4271980359885,"DOWN",FALSE,"High","Master Protein","P20700","Lamin-B1 [OS=Homo sapiens]",0,78.278,19,8,11,11,6,586,66.4,5.16,32.3,8,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;nucleus","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00038, Pf00932","4001","B2R6J6; hsa:4001; P20700; Q3SYN7; Q96EI6","ENSG00000113368","RHOD GTPase cycle; RHOF GTPase cycle; Meiotic synapsis; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina; Breakdown of the nuclear lamina; Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Fas ligand pathway and stress induction of heat shock proteins; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome",14,2,148.4,141.1,138.9,56.7,51.3,65.1,76.9,78.1,79.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S278(100); S302(100); S375(100); S393(100)]",0,"ENSG00000113368"
"13","PHIP",-1.60085047254415,6.28549399427586,-17.3119203555795,1.4867618545315e-08,1.86645795891954e-06,10.4185418065949,"DOWN",FALSE,"High","Master Protein","Q8WWQ0","PH-interacting protein [OS=Homo sapiens]",0,34.67,2,3,3,12,3,1821,206.6,8.85,12.41,3,"cell organization and biogenesis;signal transduction;other biological processes","nucleus","signal transduction activity or receptor binding;other molecular function","Pf00400, Pf00439","55023","A7J992; B2RPK4; hsa:55023; Q05CQ9; Q5VVH4; Q66I29; Q69YV1; Q8NBZ5; Q8WWQ0; Q96H52; Q96ME2; Q9H261","ENSG00000146247","RHOBTB2 GTPase cycle",NA,1,0,171.7,161.1,162.7,53.8,39.5,56.2,63.2,53.7,64.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1783(100)]",0,"ENSG00000146247"
"14","EPB41L3",1.8353420102455,6.47654669115608,16.8140811692363,1.95081293285186e-08,2.16617508337524e-06,10.1457868724828,"UP",FALSE,"High","Master Protein","Q9Y2J2-4","Isoform 4 of Band 4.1-like protein 3 [OS=Homo sapiens]",0,210.29,13,10,14,55,9,883,98.4,5.34,203.7,10,NA,NA,NA,NA,NA,"Q9Y2J2-4",NA,NA,NA,0,0,46.7,49.7,50.5,176.9,199.1,184.7,85.7,92.6,74.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T401(100); S448(100); S478(100); T487(100); T510(100); S591(99.4); S793(100)]",0,"ENSG00000082397"
"15","SMARCA5",-1.25608874230906,6.4097807051545,-16.7772876431476,1.99096974574931e-08,2.16617508337524e-06,10.1252755588298,"DOWN",FALSE,"High","Master Protein","O60264","SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 [OS=Homo sapiens]",0,15.12,4,2,2,2,2,1052,121.8,8.09,6.34,2,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf09110, Pf09111","8467","hsa:8467; O60264","ENSG00000153147","Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; NoRC negatively regulates rRNA expression","10q11.21q11.23 copy number variation syndrome",5,0,154.9,153.7,143,60.6,53.7,60.3,72.5,76.2,68.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S116(100)]",0,"ENSG00000153147"
"16","SRSF5",-1.70848869936725,6.19222229015463,-16.5122255194434,2.30864712078721e-08,2.16833717005634e-06,9.97603625968254,"DOWN",FALSE,"High","Master Protein","Q13243","Serine/arginine-rich splicing factor 5 [OS=Homo sapiens]",0,9.704,4,1,1,3,1,272,31.2,11.59,7.92,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus",NA,"Pf00076","6430","hsa:6430; O14797; Q13243; Q16662; Q49AD6; Q6FGE0","ENSG00000100650","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway","mRNA processing",6,0,179.1,167.6,160.8,49.1,45.7,47.5,59.1,49,53.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100)]",0,"ENSG00000100650"
"17","HNRNPU",-1.16925267413137,6.40541233492189,-16.4733352655551,2.35978303317336e-08,2.16833717005634e-06,9.95391922267724,"DOWN",FALSE,"High","Master Protein","Q00839","Heterogeneous nuclear ribonucleoprotein U [OS=Homo sapiens]",0,83.946,13,9,9,13,9,825,90.5,6,38.89,9,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00622, Pf02037, Pf13671","3192","hsa:3192; O75507; Q00839; Q8N174; Q96HY9; Q9BQ09","ENSG00000153187","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing; lncRNA in canonical Wnt signaling and colorectal cancer",4,0,159.4,148.6,139.9,62.2,52.2,69.2,67.6,69.6,70,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100); S192(99.4)]",0,"ENSG00000153187"
"18","CIR1",-1.34607638562538,6.3174743531746,-16.3167365738405,2.57868535727826e-08,2.16833717005634e-06,9.86428091475996,"DOWN",FALSE,"High","Master Protein","Q86X95","Corepressor interacting with RBPJ 1 [OS=Homo sapiens]",0,3.701,2,1,1,2,1,450,52.3,9.86,5.12,1,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf10197","9541","A6NFI6; A8K8M4; hsa:9541; O95367; Q12804; Q4G1B9; Q6PJI4; Q86X95; Q8IWI2","ENSG00000138433",NA,"Notch signaling pathway",1,0,172.5,155.6,147.3,56.3,58.3,61.5,62.6,58.2,58.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S394(100)]",0,"ENSG00000138433"
"19","NUP88",-1.09143473753008,6.46509724857962,-16.2614303585465,2.66126154273106e-08,2.16833717005634e-06,9.83239922198468,"DOWN",FALSE,"High","Master Protein","Q99567","Nuclear pore complex protein Nup88 [OS=Homo sapiens]",0,41.262,5,2,4,7,2,741,83.5,5.69,32.5,2,"other metabolic processes;transport","cytosol;nucleus","other molecular function","Pf10168","4927","D3DTM2; hsa:4927; Q99567; Q9BWE5","ENSG00000108559","Viral Messenger RNA Synthesis; HCMV Early Events; SUMOylation of DNA damage response and repair proteins; HCMV Late Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses","Ciliary landscape",29,0,145.5,136.1,138,65.1,51.5,62.7,82.5,81.5,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(99.4); S517(100)]",0,"ENSG00000108559"
"20","RPL11",-1.23608551629816,6.39167943400946,-16.2364599685158,2.69949440657307e-08,2.16833717005634e-06,9.81796622253724,"DOWN",FALSE,"High","Master Protein","P62913","Large ribosomal subunit protein uL5 [OS=Homo sapiens]",0,26.719,17,3,4,4,3,178,20.2,9.6,10.1,3,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00281, Pf00673","6135","hsa:6135; P25121; P39026; P62913; Q8TDH2; Q9Y674","ENSG00000142676","L13a-mediated translational silencing of Ceruloplasmin expression; GTP hydrolysis and joining of the 60S ribosomal subunit; Regulation of expression of SLITs and ROBOs; Formation of a pool of free 40S subunits; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","MET in type 1 papillary renal cell carcinoma; Cytoplasmic ribosomal proteins",15,0,155.1,146.6,149.7,58.2,50.3,66.8,71.5,70.8,65.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T47(100)]",0,"ENSG00000142676"
"21","RPL4",-2.07736510714028,6.0498832334411,-16.1069579222217,2.90773047732386e-08,2.16833717005634e-06,9.74272514506391,"DOWN",FALSE,"High","Master Protein","P36578","Large ribosomal subunit protein uL4 [OS=Homo sapiens]",0,19.875,7,3,3,4,3,427,47.7,11.06,7.65,3,"protein metabolism;other metabolic processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf00573, Pf14374","6124","A8K502; hsa:6124; P36578; P39029; Q4VBR0; Q969Z9","ENSG00000174444","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,188.6,177.4,163,42.8,23.8,47.3,49.5,49.1,46,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100)]",0,"ENSG00000174444"
"22","RPL13",-1.24043766151218,6.40583791220975,-16.0978644355266,2.92300353806615e-08,2.16833717005634e-06,9.73741719811509,"DOWN",FALSE,"High","Master Protein","P26373","Large ribosomal subunit protein eL13 [OS=Homo sapiens]",0,21.574,15,4,5,6,4,211,24.2,11.65,10.69,4,"protein metabolism;other metabolic processes;developmental processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf01294","6137","B4DLX3; F5H1S2; hsa:6137; P26373; Q3KQT8; Q567Q8; Q9BPX0","ENSG00000167526","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,159.9,147.5,137.7,60.2,46.4,63.5,70.1,75,75.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100)]",0,"ENSG00000167526"
"23","CSRP1",1.99762454291752,6.48518987089963,15.99879205677,3.0952477484095e-08,2.19628014148013e-06,9.6793768410906,"UP",FALSE,"High","Master Protein","P21291","Cysteine and glycine-rich protein 1 [OS=Homo sapiens]",0,45.601,19,2,2,5,2,193,20.6,8.57,19.52,2,"cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00412","1465","A8K268; hsa:1465; P21291; Q5U0J2","ENSG00000159176","MTF1 activates gene expression","MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling",3,0,42.8,45.3,41.9,160.4,203.8,185.8,82.2,108.2,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S192(100)]",0,"ENSG00000159176"
"24","PRPF40A",-1.75003568378753,6.21614699366874,-15.4351560335647,4.31475085054724e-08,2.86870419835143e-06,9.3416467847444,"DOWN",FALSE,"High","Master Protein","O75400","Pre-mRNA-processing factor 40 homolog A [OS=Homo sapiens]",0,25.484,3,3,3,5,3,957,108.7,7.56,11.39,3,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus",NA,"Pf00397, Pf01846","55660","hsa:55660; O43856; O75400; O75404; Q8TBQ1; Q9H782; Q9NWU9; Q9P0Q2; Q9Y5A8","ENSG00000196504","mRNA Splicing - Major Pathway","mRNA processing",2,0,171.2,163.8,167.2,52.7,34.5,48.9,63.4,55.9,51.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S888(100); S938(100)]",0,"ENSG00000196504"
"25","ZC3H11A",-1.41365348843084,6.35829015587755,-15.3891653794167,4.43549677622866e-08,2.86870419835143e-06,9.31350950315615,"DOWN",FALSE,"High","Master Protein","O75152","Zinc finger CCCH domain-containing protein 11A [OS=Homo sapiens]",0,24.641,2,1,1,3,1,810,89.1,8.37,11.12,1,"other metabolic processes;transport","nucleus","other molecular function","Pf15663","9877","hsa:9877; O75152; Q6AHY4; Q6AHY9; Q6AW79; Q6AWA1; Q6PJK4; Q86XZ7","ENSG00000058673","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,3,0,169.8,146.3,157.7,56.3,45.6,61.2,73,63.4,62.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S108(100)]",0,"ENSG00000058673"
"26","POU3F2",-1.22836567439023,6.44204951056651,-15.3394428021495,4.57023953168733e-08,2.86870419835143e-06,9.28298825408286,"DOWN",FALSE,"High","Master Protein","P20265","POU domain, class 3, transcription factor 2 [OS=Homo sapiens]",0,33.283,11,2,3,5,2,443,46.9,7.87,20.37,2,"cell cycle OR cell proliferation;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf00157","5454","hsa:5454; P20265; Q14960; Q86V54; Q9UJL0","ENSG00000184486","EGR2 and SOX10-mediated initiation of Schwann cell myelination","MECP2 and associated Rett syndrome; Sudden infant death syndrome (SIDS) susceptibility pathways",3,0,151.1,146,138.3,59.8,51.3,59.2,83.2,73.8,84.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S341(99.6)]",0,"ENSG00000184486"
"27","RPS8",-1.06969476699457,6.45395507338458,-14.5694559675741,7.35100223113416e-08,4.44327245970776e-06,8.79654943422339,"DOWN",FALSE,"High","Master Protein","P62241","Small ribosomal subunit protein eS8 [OS=Homo sapiens]",0,59.476,17,4,6,8,4,208,24.2,10.32,27.02,4,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf01201","6202","hsa:6202; P09058; P62241; Q6IRL7","ENSG00000142937","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,152.4,133.6,138.6,66.7,55.9,63.2,77.8,76.1,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T130(100); S160(99.7)]",0,"ENSG00000142937"
"28","PEG10",-1.06526078173654,6.46405434130766,-14.4361239799564,8.00033014618946e-08,4.56044103909771e-06,8.7095892534009,"DOWN",FALSE,"High","Master Protein","Q86TG7-5","Isoform 5 of Retrotransposon-derived protein PEG10 [OS=Homo sapiens]",0,6.053,4,2,2,6,2,401,45,7.93,5.52,2,NA,NA,NA,NA,NA,"Q86TG7-5",NA,NA,NA,0,0,151.8,143.9,139.5,70.1,58.3,65.3,74.2,73.3,80.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(100); S392(99.5)]",0,"ENSG00000242265"
"29","POLDIP2",-1.74849487288128,6.26766258068973,-14.4159955961123,8.10372488565157e-08,4.56044103909771e-06,8.69638895029877,"DOWN",FALSE,"High","Master Protein","Q9Y2S7","Polymerase delta-interacting protein 2 [OS=Homo sapiens]",0,9.85,3,1,1,2,1,368,42,8.63,6.65,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytoskeleton;mitochondrion;nucleus;other cell component","nucleic acid binding activity","Pf04379, Pf08755","26073","B2R846; hsa:26073; Q96JE4; Q9Y2S7","ENSG00000004142",NA,NA,0,0,184,150.8,138.6,41.8,29.3,49.6,72.4,62.6,71.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T292(100)]",0,"ENSG00000004142"
"30","PRPF38B",-1.05433241865086,6.4315163435896,-14.315512784491,8.64235342702035e-08,4.70144026429907e-06,8.63020491271311,"DOWN",FALSE,"High","Master Protein","Q5VTL8","Pre-mRNA-splicing factor 38B [OS=Homo sapiens]",0,11.939,4,2,2,11,2,546,64.4,10.54,13.41,2,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf03371","55119","hsa:55119; Q05DD6; Q32Q58; Q5VTL8; Q5VTL9; Q6PK39; Q7Z6E2; Q86WF3; Q8IWG9; Q9NW40","ENSG00000134186",NA,NA,0,0,148.6,139.8,145.2,72.5,60.3,64.1,72.4,70.9,70.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S491(100); S527(100); S529(100)]",0,"ENSG00000134186"
"31","VDAC1",-1.35324405048086,6.4143655626607,-14.1465787081593,9.63887435550442e-08,5.07440095102684e-06,8.51784541081643,"DOWN",FALSE,"High","Master Protein","P21796","Voltage-dependent anion-selective channel protein 1 [OS=Homo sapiens]",0,118.315,31,8,10,21,7,283,30.8,8.54,71.68,8,"cell-cell signaling;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;mitochondrion;other cell component","transporter activity;other molecular function","Pf01459","7416","B3KVK4; D3DQ93; P21796; Q5FVE7; Q9UIQ5; Q9UPL0","ENSG00000213585","Ub-specific processing proteases; Pyruvate metabolism; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy; Mitochondrial calcium ion transport","Alzheimer's disease and miRNA effects; Alzheimer's disease; Arsenic metabolism and reactive oxygen species generation; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes",10,1,160.8,141.2,141.7,56.9,39.4,59.7,85.9,71.8,77.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S104(100)]",0,"ENSG00000213585"
"32","DCX",1.3655509491985,6.59619849330168,13.926598061951,1.11307717851056e-07,5.67669361040387e-06,8.36944772076105,"UP",FALSE,"High","Master Protein","O43602","Neuronal migration protein doublecortin [OS=Homo sapiens]",0,53.355,11,5,7,13,3,365,40.5,9.28,35.27,5,"cell organization and biogenesis;developmental processes;signal transduction","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf03607","1641","A6NFY6; A9Z1V8; D3DUY8; D3DUY9; D3DUZ0; hsa:1641; O43602; O43911; Q5JYZ5","ENSG00000077279","Neurofascin interactions","PAFAH1B1 copy number variation; Cell lineage map for neuronal differentiation",3,0,54.7,53.4,62.1,144.3,187.9,127.6,106.2,109,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S206(100); S332(100); S339(99.3)]",0,"ENSG00000077279"
"33","SCML2",-1.36159568689051,6.34570110792082,-13.7034398431966,1.29079119309761e-07,6.29867093964429e-06,8.21643640159241,"DOWN",FALSE,"High","Master Protein","Q9UQR0","Sex comb on midleg-like protein 2 [OS=Homo sapiens]",0,3.311,2,1,1,1,1,700,77.2,8.54,2.37,1,"other biological processes","nucleus","other molecular function","Pf00536, Pf02820, Pf12140, Pf17208","10389","hsa:10389; Q5JXE6; Q86U98; Q8IWD0; Q8NDP2; Q9UGC5; Q9UQR0","ENSG00000102098",NA,NA,0,0,169.8,144.1,137.2,53.1,41.8,62.2,73.1,71.1,63.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S499(100)]",0,"ENSG00000102098"
"34","HNRNPH1",-1.05529890110719,6.44586047609557,-13.6788337627088,1.31222311242589e-07,6.29867093964429e-06,8.19940983581841,"DOWN",FALSE,"High","Master Protein","P31943","Heterogeneous nuclear ribonucleoprotein H [OS=Homo sapiens]",0,119.899,17,5,8,21,2,449,49.2,6.3,74.66,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08080","3187","B3KW86; D3DWQ2; P31943; Q6IBM4","ENSG00000169045; ENSG00000284254","mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA","MECP2 and associated Rett syndrome; mRNA processing; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells",6,4,149.2,137.1,141.6,70.1,50.5,70.8,76.3,74.8,74.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(100); S63(100); S104(100); S161(100)]",0,"ENSG00000169045"
"35","HNRNPH2",-2.09391382143142,6.10764403431705,-13.5831549475567,1.39935627895187e-07,6.52499842071272e-06,8.13290661103077,"DOWN",FALSE,"High","Master Protein","P55795","Heterogeneous nuclear ribonucleoprotein H2 [OS=Homo sapiens]",0,99.979,12,4,7,20,1,449,49.2,6.3,70.04,4,"other biological processes","cytosol;nucleus;other cell component",NA,"Pf00076, Pf08080","3188","A1L400; P55795; Q9HHA7","ENSG00000126945","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",3,0,169.2,177.8,161.7,40.2,25,37.1,59.7,48.4,63.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S104(100); S161(100)]",0,"ENSG00000126945"
"36","DEK",-1.67044324760855,6.21700282881095,-13.4416603748629,1.54009825591246e-07,6.98177876013646e-06,8.03368396644415,"DOWN",FALSE,"High","Master Protein","P35659","Protein DEK [OS=Homo sapiens]",0,32.194,5,3,3,4,3,375,42.6,8.56,9.28,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytoskeleton;nucleus","nucleic acid binding activity;other molecular function","Pf08766","7913","B2R6K6; B4DN37; hsa:7913; P35659; Q5TGV4; Q5TGV5","ENSG00000124795","B-WICH complex positively regulates rRNA expression; Transcriptional regulation of granulopoiesis; Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","IL-18 signaling pathway; 10q11.21q11.23 copy number variation syndrome",5,0,168.4,159.3,167.9,53.8,44.1,42.5,57.7,50.5,62.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S307(100)]",0,"ENSG00000124795"
"37","STARD3NL",-1.29671618280335,6.35549827270068,-13.3333906393551,1.65830807559622e-07,7.31448318749467e-06,7.95704578051395,"DOWN",FALSE,"High","Master Protein","O95772","STARD3 N-terminal-like protein [OS=Homo sapiens]",0.008,1.654,3,1,1,2,1,234,26.6,4.81,4.2,1,"cell organization and biogenesis;transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf10457","83930","A4D1X0; hsa:83930; O95772","ENSG00000010270","Pregnenolone biosynthesis",NA,1,0,157.4,148.5,150.4,55.8,50.1,64.6,70.5,59.1,69.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000010270"
"38","HSPD1",-1.090373532918,6.46523188484022,-13.2501003372551,1.75603651278601e-07,7.50038646596839e-06,7.89766201612142,"DOWN",FALSE,"High","Master Protein","P10809","60 kDa heat shock protein, mitochondrial [OS=Homo sapiens]",0,284.395,45,20,21,39,20,573,61,5.87,146.68,20,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00118","3329","B2R5M6; B7Z712; hsa:3329; P10809; Q38L19; Q9UCR6","ENSG00000144381","Mitochondrial protein import; Mitochondrial protein degradation; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation","Apoptosis-related network due to altered Notch3 in ovarian cancer; 8p23.1 copy number variation syndrome; Sudden infant death syndrome (SIDS) susceptibility pathways",6,0,146.4,142.3,138.9,65,55.8,64.2,86.2,74.2,77.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100)]",0,"ENSG00000144381"
"39","PRPF38A",-0.950710243828559,6.4343378341843,-13.2204248665545,1.79237176576451e-07,7.50038646596839e-06,7.87641364718736,"DOWN",FALSE,"High","Master Protein","Q8NAV1","Pre-mRNA-splicing factor 38A [OS=Homo sapiens]",0,6.04,3,2,2,9,2,312,37.5,9.96,18,2,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf03371, Pf12871","84950","hsa:84950; Q8NAV1; Q96JW1; Q9BVZ8","ENSG00000134748","mRNA Splicing - Major Pathway","MECP2 and associated Rett syndrome",2,0,142.1,139.4,129.7,64.1,63.4,72.3,73,73.3,76.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100)]",0,"ENSG00000134748"
"40","BIN1",1.24405187667043,6.58853848432059,13.0889176256688,1.96364564833929e-07,8.01167424522432e-06,7.78167297969306,"UP",FALSE,"High","Master Protein","O00499","Myc box-dependent-interacting protein 1 [OS=Homo sapiens]",0,52.068,7,3,4,9,3,593,64.7,5.06,34.16,3,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf03114, Pf14604","274","hsa:274; O00297; O00499; O00545; O43867; O60552; O60553; O60554; O60555; O75514; O75515; O75516; O75517; O75518; Q659B7; Q92944; Q99688","ENSG00000136717","Clathrin-mediated endocytosis","VEGFA-VEGFR2 signaling; IL-18 signaling pathway",3,0,63.7,60,64.6,145.5,189.9,131,92.4,95.4,100.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); S331(99.2)]",0,"ENSG00000136717"
"41","CDK7",-1.30849868928282,6.43817727762386,-13.0414699214075,2.02979325174659e-07,8.07956728500105e-06,7.74725702201765,"DOWN",FALSE,"High","Master Protein","P50613","Cyclin-dependent kinase 7 [OS=Homo sapiens]",0,7.42,5,2,2,5,2,346,39,8.47,9.45,2,"cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","1022","hsa:1022; P50613; Q9BS60; Q9UE19","ENSG00000134058; ENSG00000277273","RUNX1 regulates transcription of genes involved in differentiation of HSCs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; NoRC negatively regulates rRNA expression; Cyclin D associated events in G1; Cyclin A/B1/B2 associated events during G2/M transition; RNA Polymerase I Transcription Initiation; RNA Polymerase I Promoter Escape; RNA Polymerase I Transcription Termination; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Formation of Incision Complex in GG-NER; Cyclin E associated events during G1/S transition ; Cyclin A:Cdk2-associated events at S phase entry","MicroRNAs in cardiomyocyte hypertrophy; Cell cycle; Cardiac hypertrophic response; Eukaryotic transcription initiation; G1 to S cell cycle control; Nucleotide excision repair; DNA repair pathways, full network; Pleural mesothelioma; Nucleotide excision repair in xeroderma pigmentosum",43,0,159.6,147.9,164,57.2,46.1,72.2,74.8,69.6,69.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100); T170(100)]",0,"ENSG00000134058"
"42","DPYSL3",1.53558190875404,6.61015798927443,12.9865749950495,2.10939528752592e-07,8.19650740295786e-06,7.70728321650952,"UP",FALSE,"High","Master Protein","Q14195-2","Isoform LCRMP-4 of Dihydropyrimidinase-related protein 3 [OS=Homo sapiens]",0,243.83,18,11,22,112,9,684,73.9,6.35,269.98,11,NA,NA,NA,NA,NA,"Q14195-2",NA,NA,NA,0,0,52,51.9,53.3,155.6,141.1,159.5,102.6,127,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(99.4); S102(100); T621(97.9); T623(100); T628(100); S636(100); S653(99.4)]",0,"ENSG00000113657"
"43","CHTF18",-2.50250585708986,5.84920837074355,-12.7826853056452,2.43652058592433e-07,9.05011535669436e-06,7.55732924052118,"DOWN",FALSE,"High","Master Protein","Q8WVB6","Chromosome transmission fidelity protein 18 homolog [OS=Homo sapiens]",0,14.861,2,1,1,2,1,975,107.3,7.21,7.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00004","63922","B7ZBA2; D3DU68; hsa:63922; Q7Z6Y4; Q7Z6Y6; Q8WVB6; Q9BR83; Q9BRG5; Q9H7K3","ENSG00000127586","Polymerase switching on the C-strand of the telomere","Gastric cancer network 2; 7q11.23 copy number variation syndrome",3,0,193.3,191,191.2,43.4,28,29.9,38.8,42.9,37.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S871(100)]",0,"ENSG00000127586"
"44","PHB2",-1.23803361081886,6.40130430162399,-12.7806919772657,2.43998208146171e-07,9.05011535669436e-06,7.55585154779602,"DOWN",FALSE,"High","Master Protein","Q99623","Prohibitin-2 [OS=Homo sapiens]",0,33.259,9,3,3,4,3,299,33.3,9.83,11.28,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;mitochondrion;nucleus;other cell component","other molecular function","Pf01145","11331","B4DP75; hsa:11331; Q2YDA4; Q7KYU3; Q92978; Q99623","ENSG00000215021","Processing of SMDT1; Cellular response to mitochondrial stress",NA,2,0,158.9,145.9,140.4,56.3,59,59.3,79.1,65.8,70.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S293(100)]",0,"ENSG00000215021"
"45","WDR3",-0.950915393880852,6.49766897485941,-12.7420622057909,2.50814260863955e-07,9.09619719399942e-06,7.52716948985706,"DOWN",FALSE,"High","Master Protein","Q9UNX4","WD repeat-containing protein 3 [OS=Homo sapiens]",0,15.2,3,1,1,3,1,943,106,6.64,14.08,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","other membranes;nucleus;other cell component","nucleic acid binding activity","Pf00400, Pf04003, Pf12894","10885","hsa:10885; Q9UNX4","ENSG00000065183","Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol",NA,2,0,150.1,124.7,136.9,68.8,61.2,68.5,84.6,83.4,80.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S241(99.4)]",0,"ENSG00000065183"
"46","RFTN1",0.906724188575821,6.63628364128207,12.7086658212237,2.56875727290517e-07,9.11350406387226e-06,7.50230385958177,"UP",FALSE,"High","Master Protein","Q14699","Raftlin [OS=Homo sapiens]",0,56.292,12,4,4,7,4,578,63.1,5.67,22.6,4,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","nucleic acid binding activity","Pf15250","23180","hsa:23180; Q0D2G0; Q14699; Q496Y2; Q4QQI7; Q5JB48; Q7Z7P2","ENSG00000131378",NA,NA,0,0,71.9,66.6,70.2,132.1,139.3,131,104.3,101.8,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(100); S220(100); S238(99.4); S555(100)]",0,"ENSG00000131378"
"47","MRPL1",-1.9850073626686,6.2775487499136,-12.5821957859209,2.81332429077305e-07,9.76881966498215e-06,7.40755205017651,"DOWN",FALSE,"High","Master Protein","Q9BYD6","Large ribosomal subunit protein uL1m [OS=Homo sapiens]",0,4.52,4,1,1,1,1,325,36.9,8.78,2.57,1,"protein metabolism;other metabolic processes","other membranes;mitochondrion;translational apparatus","other molecular function","Pf00687","65008","A6NG03; hsa:65008; Q4W5B8; Q6IAG4; Q96BW3; Q9BYD6; Q9H793; Q9NRL5","ENSG00000169288","Mitochondrial translation initiation; Mitochondrial translation elongation; Mitochondrial translation termination",NA,3,0,185.2,177.2,153.4,42.3,35.7,33.2,72.9,55.6,73.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(100)]",0,"ENSG00000169288"
"48","RPS20",-0.885167155330821,6.50277390318545,-12.4852737561926,3.01807608395694e-07,1.02614586854536e-05,7.33430210761098,"DOWN",FALSE,"High","Master Protein","P60866","Small ribosomal subunit protein uS10 [OS=Homo sapiens]",0,26.467,33,4,5,5,4,119,13.4,9.94,9.86,4,"protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00338","6224","B2R4F4; B4DW28; hsa:6224; P17075; P60866; Q5M8S9","ENSG00000008988","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,140.6,129.5,125.2,69.5,56.7,74.9,83.9,85,88.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S93(100)]",0,"ENSG00000008988"
"49","UTP6",-1.01923038008131,6.43680299394205,-12.3797425757794,3.25981181201341e-07,1.06791447655345e-05,7.25390981498907,"DOWN",FALSE,"High","Master Protein","Q9NYH9","U3 small nucleolar RNA-associated protein 6 homolog [OS=Homo sapiens]",0,24.708,3,2,2,2,2,597,70.1,7.28,7.44,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf08640","55813","hsa:55813; Q8IX96; Q96BL2; Q9NQ91; Q9NYH9","ENSG00000108651","Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol","NF1 copy number variation syndrome",3,0,150.8,140.1,139.3,68.7,67.4,63.3,71.2,74,70.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S286(100)]",0,"ENSG00000108651"
"50","HSPB1",1.04694026367032,6.64332575534039,12.3747361196756,3.27179680316622e-07,1.06791447655345e-05,7.25007934648693,"UP",FALSE,"High","Master Protein","P04792","Heat shock protein beta-1 [OS=Homo sapiens]",0,5.993,5,1,1,4,1,205,22.8,6.4,12.79,1,"protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00011","3315","B2R4N8; hsa:3315; P04792; Q6FI47; Q96C20; Q96EI7; Q9UC31; Q9UC34; Q9UC35; Q9UC36","ENSG00000106211","AUF1 (hnRNP D0) binds and destabilizes mRNA; MAPK6/MAPK4 signaling; Extra-nuclear estrogen signaling; VEGFA-VEGFR2 Pathway","Apoptosis-related network due to altered Notch3 in ovarian cancer; Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling; p38 MAPK signaling pathway; Extracellular vesicles in the crosstalk of cardiac cells; Ferroptosis; IL-18 signaling pathway; Intracellular trafficking proteins involved in CMT neuropathy; GDNF signaling; Macrophage-stimulating protein (MSP) signaling network map; 7q11.23 distal copy number variation; HDAC6 interactions in the central nervous system",18,0,59.3,62.3,66.9,127.5,150.6,124.9,110.7,116.4,133.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(99.7)]",0,"ENSG00000106211"
"51","NSUN2",-1.09259279691853,6.40945430348914,-12.2783930541142,3.51212154551271e-07,1.11983618035542e-05,7.17607098786185,"DOWN",FALSE,"High","Master Protein","Q08J23","RNA cytosine C(5)-methyltransferase NSUN2 [OS=Homo sapiens]",0,52.822,7,2,3,11,2,767,86.4,6.77,48.26,2,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;cytoskeleton;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01189","54888","A8K529; B2RNR4; B3KP09; B4DQW2; G3V1R4; hsa:54888; Q08J23; Q9BVN4; Q9H858; Q9NXD9","ENSG00000037474","tRNA modification in the nucleus and cytosol",NA,1,0,143.8,141.3,146.9,65.5,53.8,68.6,66,77.2,68.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S456(100); S743(100)]",0,"ENSG00000037474"
"52","NIBAN2",1.22445643801301,6.60993692034396,12.2222008125161,3.66119992179819e-07,1.11983618035542e-05,7.13264417176922,"UP",FALSE,"High","Master Protein","Q96TA1","Protein Niban 2 [OS=Homo sapiens]",0,35.76,3,1,3,8,1,746,84.1,6.19,24.94,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function",NA,"64855","hsa:64855; Q4LE55; Q5VVW6; Q5VVW7; Q96TA1; Q9BUS2; Q9NT35","ENSG00000136830",NA,NA,0,0,55.6,53,63.9,124.6,142.1,146.8,103.6,118.2,131.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S691(99); S692(100)]",0,"ENSG00000136830"
"53","ARFGAP2",0.932018532105691,6.63706185071407,12.2148063923996,3.68132945048947e-07,1.11983618035542e-05,7.12691514015222,"UP",FALSE,"High","Master Protein","Q8N6H7","ADP-ribosylation factor GTPase-activating protein 2 [OS=Homo sapiens]",0,16.171,4,2,3,6,2,521,56.7,7.99,16.6,2,"cell organization and biogenesis;transport","plasma membrane;other membranes;cytosol;ER/Golgi","enzyme regulator activity;other molecular function","Pf01412","84364","B4DX29; B7Z9M7; D3DQQ9; hsa:84364; Q3LIF2; Q8N3I1; Q8N6H7; Q96SX7","ENSG00000149182","COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; CDC42 GTPase cycle","IL-18 signaling pathway; 5q35 copy number variation",5,0,61.3,63.1,63.5,113.2,137.2,121.1,119.9,133.8,133,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S368(100); S432(100)]",0,"ENSG00000149182"
"54","KLC1",0.888833792878822,6.62629005363114,12.2060440568242,3.70534030264662e-07,1.11983618035542e-05,7.12012191919457,"UP",FALSE,"High","Master Protein","Q07866-6","Isoform N of Kinesin light chain 1 [OS=Homo sapiens]",0,84.952,12,8,10,19,7,628,71,6.67,58.62,8,NA,NA,NA,NA,NA,"Q07866-6",NA,NA,NA,0,1,62.4,59.9,63.3,113.8,129.8,113.7,128.1,131.5,134.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S460(100); S521(100); S524(100); S546(99.5); S552(100); S559(100); S591(100); S622(100)]",0,"ENSG00000126214"
"55","ZNF318",-1.07911527311544,6.45617057414301,-12.1011638299837,4.00648433891499e-07,1.18883317111078e-05,7.03844200669188,"DOWN",FALSE,"High","Master Protein","Q5VUA4","Zinc finger protein 318 [OS=Homo sapiens]",0,23.783,2,4,4,8,4,2279,251,7.2,18.05,4,"cell cycle OR cell proliferation;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function",NA,"24149","hsa:24149; O94796; Q4G0E4; Q5VUA4; Q8NEM6; Q9UNU8; Q9Y2W9","ENSG00000171467",NA,"Androgen receptor signaling pathway",1,0,145.3,144.6,150,64.8,65.6,64.5,78.4,69.6,71.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S709(100); S1761(100); S2101(100)]",0,"ENSG00000171467"
"56","CHCHD3",-1.88461191122184,6.26133388119218,-12.0681647840449,4.10671694435595e-07,1.19681465235516e-05,7.01260090524861,"DOWN",FALSE,"High","Master Protein","Q9NX63","MICOS complex subunit MIC19 [OS=Homo sapiens]",0,30.401,7,1,1,4,1,227,26.1,8.28,17.74,1,"cell organization and biogenesis","other membranes;mitochondrion;nucleus","other molecular function","Pf05300","54927","hsa:54927; Q9NX63","ENSG00000106554","Cristae formation; Mitochondrial protein import",NA,2,0,149.5,152.7,135.1,27,27.4,36.4,104.5,68.2,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100)]",0,"ENSG00000106554"
"57","SYNPO",1.01629956053515,6.61241067175809,12.0048638126111,4.30678699070433e-07,1.2331011173385e-05,6.96283929567412,"UP",FALSE,"High","Master Protein","Q8N3V7-2","Isoform 2 of Synaptopodin [OS=Homo sapiens]",0,125.655,20,10,11,23,10,903,96.3,9.77,76.28,10,NA,NA,NA,NA,NA,"Q8N3V7-2",NA,NA,NA,0,0,62,65.7,65.4,127.9,148.3,125.7,115.5,111,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100); S281(100); S441(100); S510(100); S589(100); S610(100); S646(98.8); S738(99.3); S784(100); S854(99.3)]",0,"ENSG00000171992"
"58","SF3A3",-1.81238780007244,6.34193408810322,-11.7171528040092,5.36144498512869e-07,1.50859969236725e-05,6.73344116971244,"DOWN",FALSE,"High","Master Protein","Q12874","Splicing factor 3A subunit 3 [OS=Homo sapiens]",0,7.898,2,1,1,2,1,501,58.8,5.38,4.34,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf11931, Pf12108, Pf13297, Pf16837","10946","D3DPT5; hsa:10946; Q12874; Q15460; Q5VT87","ENSG00000183431","mRNA Splicing - Major Pathway","Exercise-induced circadian regulation; mRNA processing",3,0,159.6,170.7,144.5,36.7,36,41.2,76.5,65.5,97.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100)]",0,"ENSG00000183431"
"59","VDAC2",-1.43296605076418,6.37183074811115,-11.65053911989,5.64417605255273e-07,1.55607046422544e-05,6.67956114588038,"DOWN",FALSE,"High","Master Protein","P45880","Voltage-dependent anion-selective channel protein 2 [OS=Homo sapiens]",0,96.669,23,7,7,17,6,294,31.5,7.56,57.11,7,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;cytoskeleton;mitochondrion;other cell component","transporter activity;other molecular function","Pf01459","7417","hsa:7417; P45880; Q5VWK1; Q5VWK3; Q6IB40; Q7L3J5; Q9BWK8; Q9Y5I6","ENSG00000165637","Ub-specific processing proteases; Mitochondrial calcium ion transport","Alzheimer's disease and miRNA effects; Ferroptosis; Alzheimer's disease",5,0,169.4,144.5,145.9,53.1,34.8,65.6,78.4,64.8,71.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S115(100)]",0,"ENSG00000165637"
"60","ARL3",3.25869817808432,6.20071613947052,11.5928272275738,5.90238734366438e-07,1.55607046422544e-05,6.63264375608067,"UP",FALSE,"High","Master Protein","P36405","ADP-ribosylation factor-like protein 3 [OS=Homo sapiens]",0,5.344,4,1,1,3,1,182,20.4,7.24,7.49,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00025","403","B2R6C7; hsa:403; P36405; Q53X83; Q5JSM2","ENSG00000138175","Trafficking of myristoylated proteins to the cilium","Genes related to primary cilium development (based on CRISPR); Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome",5,0,7.3,13.6,10.7,206.6,183.3,222.2,76.5,184.7,94.8,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S5(100)]",0,"ENSG00000138175"
"61","KIF1A",-0.894529469428083,6.52790814418591,-11.5853062519117,5.93698155213414e-07,1.55607046422544e-05,6.62651317814387,"DOWN",FALSE,"High","Master Protein","Q12756","Kinesin-like protein KIF1A [OS=Homo sapiens]",0,31.514,3,4,4,7,4,1690,190.9,6.21,24.36,4,"transport;other biological processes","other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00225, Pf00498, Pf12423, Pf12473, Pf16183","547","B0I1S5; F5H045; hsa:547; O95068; Q12756; Q13355; Q14752; Q2NKJ6; Q4LE42; Q53T78; Q59GH1; Q63Z40; Q6P1R9; Q7KZ57","ENSG00000130294","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins","2q37 copy number variation syndrome",3,0,132.2,126.4,131,64.4,58.7,75.7,91.2,86.6,93.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1310(100); S1337(100); S1370(100); S1548(100)]",0,"ENSG00000130294"
"62","PNISR",-0.743104247500383,6.55777996030611,-11.5728580067988,5.99472973115618e-07,1.55607046422544e-05,6.61635792724726,"DOWN",FALSE,"High","Master Protein","Q8TF01","Arginine/serine-rich protein PNISR [OS=Homo sapiens]",0,13.941,3,3,3,4,3,805,92.5,10.02,11.79,3,NA,"plasma membrane;other membranes;cytosol;nucleus;other cell component",NA,"Pf15996","25957","A8K540; E1P5D2; hsa:25957; Q5T064; Q5T065; Q6P2B4; Q6P2N4; Q6PJ93; Q6PK36; Q7Z640; Q8N2L1; Q8TF00; Q8TF01; Q96K10; Q96SI3; Q96SM5; Q9P076; Q9P0C0; Q9Y4N3","ENSG00000132424",NA,NA,0,0,132.2,129.3,125.5,77,67.1,78.2,85.1,89.7,91.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S211(100); S563(100); S726(100)]",0,"ENSG00000132424"
"63","PELP1",-1.00782377872612,6.45841477241468,-11.5572134370591,6.06818184391835e-07,1.55607046422544e-05,6.60358041625559,"DOWN",FALSE,"High","Master Protein","Q8IZL8","Proline-, glutamic acid- and leucine-rich protein 1 [OS=Homo sapiens]",0,80.12,9,4,5,29,4,1130,119.6,4.34,127.13,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf08166, Pf08167","27043","hsa:27043; O15450; Q5EGN3; Q6NTE6; Q8IZL8; Q96FT1; Q9BU60","ENSG00000141456","Major pathway of rRNA processing in the nucleolus and cytosol; PTK6 Expression",NA,2,0,142.5,136.5,143.2,67,52.1,76.8,78.1,77.5,72.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S481(100); T745(99.6); S1033(100); S1043(100)]",0,"ENSG00000141456"
"64","SLC6A11",-1.1377903980386,6.46948954299457,-11.5500303768124,6.10223711460959e-07,1.55607046422544e-05,6.59770824472015,"DOWN",FALSE,"High","Master Protein","P48066","Sodium- and chloride-dependent GABA transporter 3 [OS=Homo sapiens]",0,20.311,7,3,4,5,3,632,70.6,6.89,15.05,3,"transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf00209","6538","B2R6U6; hsa:6538; P48066; Q8IYC9","ENSG00000132164","Na+/Cl- dependent neurotransmitter transporters; Creatine metabolism; Reuptake of GABA","Nuclear receptors meta-pathway; NRF2 pathway; GABA receptor signaling",6,0,153.3,144.2,129.5,59.5,53.1,64.4,73.7,86.9,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S603(100); S618(100)]",0,"ENSG00000132164"
"65","HNRNPF",-1.06698219524308,6.43560004678047,-11.4715555646735,6.4882701840527e-07,1.60538703412444e-05,6.53332860368149,"DOWN",FALSE,"High","Master Protein","P52597","Heterogeneous nuclear ribonucleoprotein F [OS=Homo sapiens]",0,42.156,15,5,6,9,4,415,45.6,5.58,19.09,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf08080","3185","B3KM84; hsa:3185; P52597; Q5T0N2; Q96AU2","ENSG00000169813","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA","MECP2 and associated Rett syndrome",5,1,163.7,130.4,143.5,62.2,55.5,76.3,72.8,68.5,73.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(100); S161(100)]",0,"ENSG00000169813"
"66","APRT",-0.807517665724794,6.48540074811929,-11.4577009648055,6.55916771062148e-07,1.60538703412444e-05,6.52191923658527,"DOWN",FALSE,"High","Master Protein","P07741","Adenine phosphoribosyltransferase [OS=Homo sapiens]",0,10.816,9,2,2,3,2,180,19.6,6.02,7.88,2,"other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cell component","other molecular function","Pf00156","353","G5E9J2; hsa:353; P07741; Q3KP55; Q68DF9","ENSG00000198931","Neutrophil degranulation; Purine salvage; Defective APRT disrupts adenine salvage",NA,3,0,142.1,129.2,128.3,74.7,69.9,72.2,78.3,76.1,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100)]",0,"ENSG00000198931"
"67","POGZ",-0.973699391204285,6.46250767957553,-11.4515833472701,6.59074333862362e-07,1.60538703412444e-05,6.51687718395205,"DOWN",FALSE,"High","Master Protein","Q7Z3K3","Pogo transposable element with ZNF domain [OS=Homo sapiens]",0,55.568,4,3,6,10,3,1410,155.2,7.4,28.94,3,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03184, Pf03221","23126","B4DTP8; B4DYL9; B7ZBY5; E9PM80; hsa:23126; O75049; Q3LIC4; Q5SZS1; Q5SZS2; Q5SZS3; Q5SZS4; Q7Z3K3; Q8TDZ7; Q9Y4X7","ENSG00000143442",NA,NA,0,0,142.1,142.2,140.6,69.5,66.5,68,80.2,70.8,70,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S425(100); S1364(100); T1368(99.4)]",0,"ENSG00000143442"
"68","ENAH",1.26921275184529,6.60542823647447,11.3021487342064,7.41627808501594e-07,1.77902528811725e-05,6.39292013246391,"UP",FALSE,"High","Master Protein","Q8N8S7-2","Isoform 2 of Protein enabled homolog [OS=Homo sapiens]",0,39.559,11,4,6,8,4,570,63.9,6.43,28.41,4,NA,NA,NA,NA,NA,"Q8N8S7-2",NA,NA,NA,0,0,47.9,50.2,52.6,132.5,111.9,123.6,145.5,150.2,131.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S125(100); T464(99.1); T489(99.5); T493(100); S508(100)]",0,"ENSG00000154380"
"69","SLC12A7",-1.20141906724413,6.45665713714136,-11.2844043959716,7.52161426961339e-07,1.77902528811725e-05,6.37809882040781,"DOWN",FALSE,"High","Master Protein","Q9Y666","Solute carrier family 12 member 7 [OS=Homo sapiens]",0,11.812,2,1,1,1,1,1083,119,6.71,3.3,1,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522","10723","A6NDS8; hsa:10723; Q4G0F3; Q96I81; Q9H7I3; Q9H7I7; Q9UFW2; Q9Y666","ENSG00000113504","Cation-coupled Chloride cotransporters",NA,1,0,146.7,144.2,138.7,68.1,46,58.3,91.2,75.7,82.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T30(100)]",0,"ENSG00000113504"
"70","METTL16",-1.19977210485025,6.29610093976376,-11.2615063012294,7.65997818570321e-07,1.78586919986681e-05,6.35894037936782,"DOWN",FALSE,"High","Master Protein","Q86W50","RNA N6-adenosine-methyltransferase METTL16 [OS=Homo sapiens]",0,4.72,2,1,1,2,1,562,63.6,7.85,4.54,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05971","79066","D3DTI8; hsa:79066; Q86TE5; Q86W50; Q96T16; Q9BVG7","ENSG00000127804",NA,NA,0,0,156.4,159.6,153.2,65.1,51.5,75.5,52.9,59.2,55.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000127804"
"71","SRSF8",-1.02518350461328,6.37910231790833,-11.1143450706312,8.61871178313146e-07,1.98108980705219e-05,6.23493584980324,"DOWN",FALSE,"High","Master Protein","Q9BRL6","Serine/arginine-rich splicing factor 8 [OS=Homo sapiens]",0,6.713,7,1,1,6,1,282,32.3,11.72,7.76,1,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus",NA,"Pf00076","10929","B2R6B8; hsa:10929; Q6PF01; Q96TA3; Q9BRL6","ENSG00000263465","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA",NA,2,0,154.9,148,140,66.7,66.4,71.5,59.3,66.7,63,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S158(100); S173(100); S327(100)]",0,"ENSG00000263465"
"72","TPPP",1.29408308212084,6.61624583654846,11.0803173290355,8.85867052813142e-07,1.99937069319517e-05,6.20604448175574,"UP",FALSE,"High","Master Protein","O94811","Tubulin polymerization-promoting protein [OS=Homo sapiens]",0,57.18,24,5,6,14,5,219,23.7,9.44,26.83,5,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf05517","11076","hsa:11076; O94811","ENSG00000171368",NA,"Microtubule cytoskeleton regulation; Glial cell differentiation; HDAC6 interactions in the central nervous system; Sudden infant death syndrome (SIDS) susceptibility pathways",4,0,60.1,57.2,60.7,153.6,167.5,125.1,101.6,110.6,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T14(100); S18(100); S32(100); S160(99.6)]",0,"ENSG00000171368"
"73","RPL18",-1.16607951279471,6.38447890971921,-11.0685619245186,8.94326351735585e-07,1.99937069319517e-05,6.19604431372378,"DOWN",FALSE,"High","Master Protein","Q07020","Large ribosomal subunit protein eL18 [OS=Homo sapiens]",0,50.565,17,3,4,5,3,188,21.6,11.72,15.93,3,"protein metabolism;other metabolic processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf17135","6141","F8VWC5; hsa:6141; Q07020; Q8WTZ6","ENSG00000063177","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,156.1,138.9,139.4,61.1,41.9,73.6,72.4,64,74.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100)]; Met-loss [N-Term]",0,"ENSG00000063177"
"74","NKTR",-1.03441119764363,6.51136451687721,-10.9665166786479,9.71596852518395e-07,2.14276495041895e-05,6.10881868018088,"DOWN",FALSE,"High","Master Protein","P30414","NK-tumor recognition protein [OS=Homo sapiens]",0,39.273,5,5,5,8,5,1462,165.6,9.99,17.3,5,"protein metabolism;other metabolic processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00160","4820","hsa:4820; P30414","ENSG00000114857",NA,NA,0,0,139,138.5,129.7,63.1,46.7,74.4,95,86.4,87.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S379(100); S463(100); S613(99); T1155(100); S1462(100)]",0,"ENSG00000114857"
"75","RBM39",-0.75424799249599,6.50635776396954,-10.9134406693494,1.0146590687048e-06,2.20789813350164e-05,6.06315275736838,"DOWN",FALSE,"High","Master Protein","Q14498","RNA-binding protein 39 [OS=Homo sapiens]",0,41.304,8,4,4,16,4,530,59.3,10.1,58.35,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf00076, Pf15519","9584","A2RRD3; A5D8W2; B0BLV3; E1P5S0; E1P5S1; hsa:9584; Q14498; Q14499","ENSG00000131051","mRNA Splicing - Major Pathway","VEGFA-VEGFR2 signaling; mRNA processing",3,0,135.8,128.3,125.8,77.7,63.5,82.3,78.6,84.2,79.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S97(100); S117(100); S129(100); S136(100)]",0,"ENSG00000131051"
"76","PROX1",-0.753663773029473,6.50494710653529,-10.7913615993956,1.12186889174415e-06,2.4090658306927e-05,5.95733402602626,"DOWN",FALSE,"High","Master Protein","Q92786","Prospero homeobox protein 1 [OS=Homo sapiens]",0,25.283,6,3,4,10,3,737,83.2,7.18,24.03,3,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05044","5629","A6NK29; A8K2B1; hsa:5629; Q5SW76; Q8TB91; Q92786","ENSG00000117707",NA,"PTF1A related regulatory pathway; Epithelial to mesenchymal transition in colorectal cancer",2,0,137.3,131.5,127,77.9,69.6,77.9,76.9,76.8,83.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100); S511(100)]",0,"ENSG00000117707"
"77","SCAF8",-0.791354207714663,6.51861783527168,-10.7707777135204,1.14114056268754e-06,2.41862519260528e-05,5.93938326648876,"DOWN",FALSE,"High","Master Protein","Q9UPN6","SR-related and CTD-associated factor 8 [OS=Homo sapiens]",0,42.761,2,2,2,4,2,1271,140.4,8.29,16.58,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf04818","22828","B7Z888; hsa:22828; Q5TBU6; Q6NSK3; Q9BQN8; Q9BX43; Q9UPN6","ENSG00000213079",NA,NA,0,0,134.4,129.7,129.1,78,66.5,72.5,77.7,86.5,86,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S617(99.5)]",0,"ENSG00000213079"
"78","TMX1",-0.708600561857479,6.54558099819067,-10.717674578974,1.19255568320251e-06,2.49519342946988e-05,5.89292725181487,"DOWN",FALSE,"High","Master Protein","Q9H3N1","Thioredoxin-related transmembrane protein 1 [OS=Homo sapiens]",0,83.578,11,3,3,19,3,280,31.8,4.98,99.62,3,"stress response;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf00085","81542","B2R7A4; hsa:81542; Q8N487; Q8NBN5; Q9H3N1; Q9Y4T6","ENSG00000139921",NA,NA,0,0,128.5,123.6,119.3,78.3,62.8,78,89.6,91.2,91.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S247(100); S270(100)]",0,"ENSG00000139921"
"79","RFC1",-1.0290407584618,6.5002872869549,-10.6790339005353,1.23156386027176e-06,2.5372519754201e-05,5.85899049594618,"DOWN",FALSE,"High","Master Protein","P35251","Replication factor C subunit 1 [OS=Homo sapiens]",0,21.463,4,4,4,4,4,1148,128.2,9.36,10.69,4,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00004, Pf00533, Pf08519","5981","A8K6E7; hsa:5981; P35251; Q5XKF5; Q6PKU0; Q86V41; Q86V46","ENSG00000035928","Termination of translesion DNA synthesis; HDR through Homologous Recombination (HRR); Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; Recognition of DNA damage by PCNA-containing replication complex; PCNA-Dependent Long Patch Base Excision Repair; Dual Incision in GG-NER; Polymerase switching on the C-strand of the telomere; Polymerase switching; Translesion Synthesis by POLH; Gap-filling DNA repair synthesis and ligation in GG-NER","miRNA regulation of DNA damage response; DNA replication; Male infertility; Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; DNA mismatch repair; DNA damage response",22,0,146.3,137.3,134,65.8,54.6,66.9,75.1,92.3,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(100); S190(100); S368(100)]",0,"ENSG00000035928"
"80","RPS3A",-0.978055598160028,6.46027757241,-10.6672361538907,1.24375096834319e-06,2.5372519754201e-05,5.84860653863439,"DOWN",FALSE,"High","Master Protein","P61247","Small ribosomal subunit protein eS1 [OS=Homo sapiens]",0,41.777,20,5,5,5,5,264,29.9,9.73,14.89,5,"protein metabolism;other metabolic processes;other biological processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01015","6189","B2R4D4; D3DP05; hsa:6189; P33443; P49241; P61247","ENSG00000145425; ENSG00000292158","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,150.2,136,137,67.1,52.7,79.5,72.9,81.5,75.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100)]",0,"ENSG00000145425"
"81","NASP",-1.07478371756279,6.41360290284501,-10.6186999474033,1.29529847898366e-06,2.59919910829316e-05,5.80577591863226,"DOWN",FALSE,"High","Master Protein","P49321","Nuclear autoantigenic sperm protein [OS=Homo sapiens]",0,4.128,2,2,2,2,2,788,85.2,4.3,4.67,2,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf10516","4678","A8K6H2; B4DQP3; D3DQ07; F5H3J2; hsa:4678; P49321; Q53GW5; Q5T622; Q5T625; Q96A69; Q9BTW2","ENSG00000132780",NA,NA,0,0,130.6,149.4,155,65.4,60,69.6,65.7,73.7,66,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S421(100); S726(100)]",0,"ENSG00000132780"
"82","RBM14",-0.959516455874751,6.46147197029671,-10.608916377477,1.30597014019632e-06,2.59919910829316e-05,5.79712078582311,"DOWN",FALSE,"High","Master Protein","Q96PK6","RNA-binding protein 14 [OS=Homo sapiens]",0,16.669,4,3,3,13,3,669,69.4,9.67,31.37,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf00076","100526737; 10432","B0LM41; B3KMN4; D6RGD8; hsa:100526737; hsa:10432; O75932; Q2PYN1; Q53GV1; Q68DQ9; Q96PK5; Q96PK6","ENSG00000239306","RUNX2 regulates bone development","Ciliary landscape",2,0,157.4,137.2,135,68.9,56.3,83.6,75.4,68.8,74.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T206(100); S582(100); S618(100)]",0,"ENSG00000239306"
"83","CBX8",-0.763127147392233,6.49847174181999,-10.5935931445156,1.3228785405144e-06,2.60112985315603e-05,5.78355028614678,"DOWN",FALSE,"High","Master Protein","Q9HC52","Chromobox protein homolog 8 [OS=Homo sapiens]",0,17.307,7,2,2,3,2,389,43.4,9.91,9.07,2,"cell organization and biogenesis;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00385, Pf17218","57332","hsa:57332; Q96H39; Q9HC52; Q9NR07","ENSG00000141570","SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription",NA,8,0,132.3,135,129.3,77,71.4,75.9,82.6,76.5,76.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S191(99.6); S311(100)]",0,"ENSG00000141570"
"84","HNRNPL",-0.934482183528466,6.47929122284595,-10.4379976290361,1.50884245461871e-06,2.91400593828919e-05,5.64473141527465,"DOWN",FALSE,"High","Master Protein","P14866","Heterogeneous nuclear ribonucleoprotein L [OS=Homo sapiens]",0,20.902,2,1,2,8,1,589,64.1,8.22,15.24,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf11835, Pf13893","3191","A6ND69; A6NIT8; hsa:3191; P14866; Q9H3P3","ENSG00000104824; ENSG00000282947","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing; Hippocampal synaptogenesis and neurogenesis",4,0,144,139.1,132.9,64.5,60.8,81.1,78.3,71.4,82.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S185(100)]",0,"ENSG00000104824"
"85","CDK11B",-1.36345806547853,6.37227495860533,-10.428715049109,1.52080928711982e-06,2.91400593828919e-05,5.63639045942741,"DOWN",FALSE,"High","Master Protein","P21127","Cyclin-dependent kinase 11B [OS=Homo sapiens]",0,48.701,7,4,5,14,4,795,92.6,5.54,39.49,4,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","984","B7ZVY7; hsa:984; J3KTL7; J3QR29; J3QR44; O95265; P21127; Q12817; Q12818; Q12819; Q12820; Q12822; Q8N530; Q9NZS5; Q9UBJ0; Q9UBQ1; Q9UBR0; Q9UNY2; Q9UP57; Q9UP58; Q9UP59","ENSG00000248333","Recruitment of mitotic centrosome proteins and complexes","1p36 copy number variation syndrome",2,0,159.6,153.7,151.2,60.9,35.3,68.8,73.9,70.3,62.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100); S283(100); S589(100); S752(99.5)]",0,"ENSG00000248333"
"86","LAS1L",-0.715890196301006,6.52618128652136,-10.4171616126859,1.53584917580774e-06,2.91400593828919e-05,5.62599960891265,"DOWN",FALSE,"High","Master Protein","Q9Y4W2","Ribosomal biogenesis protein LAS1L [OS=Homo sapiens]",0,43.736,6,2,2,3,2,734,83,4.73,14.31,2,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","other molecular function","Pf04031","81887","A9X410; hsa:81887; Q5JXQ0; Q8TEN5; Q9H9V5; Q9Y4W2","ENSG00000001497","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,126.4,124.2,125.3,74,66,81.2,86.4,83.2,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S523(100); S617(100)]",0,"ENSG00000001497"
"87","ZKSCAN8",-1.14051639492545,6.40864807252328,-10.4038182668164,1.55342228327916e-06,2.91400593828919e-05,5.6139859782619,"DOWN",FALSE,"High","Master Protein","Q15776","Zinc finger protein with KRAB and SCAN domains 8 [OS=Homo sapiens]",0,20.392,3,1,1,2,1,578,65.8,7.39,8.19,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352, Pf02023","7745","A1L3D4; B4DYF1; hsa:7745; Q15776; Q4VAR1; Q4VAR2; Q4VAR3; Q9H4T1","ENSG00000198315","Generic Transcription Pathway",NA,1,0,152.4,137.6,164.9,70,52,73.4,63.3,67.5,66.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100)]",0,"ENSG00000198315"
"88","DCLK1",1.11148891828651,6.59906111020914,10.3797555862345,1.58567237901966e-06,2.93875289775274e-05,5.59228597816724,"UP",FALSE,"High","Master Protein","O15075","Serine/threonine-protein kinase DCLK1 [OS=Homo sapiens]",0,342.64,31,23,55,98,3,740,82.2,8.66,273.34,23,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","kinase activity;other molecular function","Pf00069, Pf03607","9201","B7Z3E9; hsa:9201; O15075; Q5VZY8; Q5VZZ0; Q5VZZ1","ENSG00000133083",NA,"Orexin receptor pathway",1,26,65.5,67.3,70.8,149.8,186.7,126.9,90.4,88.2,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100); S36(100); T46(100); S77(100); S172(100); S212(99.5); S298(100); S307(100); S313(99.3); S332(99.3); T336(99.2); S337(100); S352(100); S353(100); S355(98.5); S364(99.5); S735(100); S738(100)]",0,"ENSG00000133083"
"89","ZSCAN18",0.745129649339223,6.64327843604435,10.3673181968212,1.60262872487741e-06,2.93875289775274e-05,5.5810519754968,"UP",FALSE,"High","Master Protein","Q8TBC5","Zinc finger and SCAN domain-containing protein 18 [OS=Homo sapiens]",0,28.922,7,3,3,4,3,510,54.8,4.82,16.92,3,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf02023","65982","B4DG23; E9PBI0; hsa:65982; Q8TBC5; Q9BRK7; Q9H9A0","ENSG00000121413",NA,NA,0,0,78.4,75.3,81,129.1,138.7,137.5,96.8,91.7,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S10(99.4); S14(99.6)]",0,"ENSG00000121413"
"90","H2AX",-0.950363694862675,6.46406194945394,-10.3350783241354,1.64751493775233e-06,2.9874937537909e-05,5.551874761241,"DOWN",FALSE,"High","Master Protein","P16104","Histone H2AX [OS=Homo sapiens]",0,29.395,29,7,7,15,4,143,15.1,10.74,29.14,7,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00125, Pf16211","3014","hsa:3014; P16104; Q4ZGJ7; Q6IAS5","ENSG00000188486","RMTs methylate histone arginines; Amyloid fiber formation; Meiotic synapsis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Transcriptional regulation by small RNAs; Deposition of new CENPA-containing nucleosomes at the centromere; B-WICH complex positively regulates rRNA expression; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the beta-catenin:TCF transactivating complex; Oxidative Stress Induced Senescence; NoRC negatively regulates rRNA expression; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Chromatin modifications during the maternal to zygotic transition (MZT); RNA Polymerase I Promoter Escape; Meiotic recombination; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; SIRT1 negatively regulates rRNA expression; PRC2 methylates histones and DNA; Assembly of the ORC complex at the origin of replication; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Defective pyroptosis; Packaging Of Telomere Ends; Condensation of Prophase Chromosomes; DNA Damage/Telomere Stress Induced Senescence; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; DNA methylation; Nonhomologous End-Joining (NHEJ); RNA Polymerase I Promoter Opening; Transcriptional regulation of granulopoiesis; Replacement of protamines by nucleosomes in the male pronucleus","miRNA regulation of DNA damage response; miRNAs involved in DNA damage response; Proteasome degradation; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; DNA repair pathways, full network; 5q35 copy number variation; DNA damage response",47,3,141.1,129.8,125.6,64.6,55.1,70.7,79.6,76.5,92.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100)]",0,"ENSG00000188486"
"91","XRCC1",-1.15424766406957,6.43264443741711,-10.2901135502808,1.71243449247948e-06,3.07109130958957e-05,5.51104417351563,"DOWN",FALSE,"High","Master Protein","P18887","DNA repair protein XRCC1 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,633,69.5,6.28,10.08,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00533, Pf01834","7515","hsa:7515; P18887; Q6IBS4; Q9HCB1","ENSG00000073050","Gap-filling DNA repair synthesis and ligation in TC-NER; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway; HDR through MMEJ (alt-NHEJ); Resolution of AP sites via the single-nucleotide replacement pathway; Gap-filling DNA repair synthesis and ligation in GG-NER","Base excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",8,0,161.5,142.5,140.1,64.2,63.6,59.7,81.2,71.6,65.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T453(100)]",0,"ENSG00000073050"
"92","PPIG",-0.982908895919021,6.48279553748315,-10.2704890945103,1.74164237840184e-06,3.08952213212153e-05,5.49317369428459,"DOWN",FALSE,"High","Master Protein","Q13427","Peptidyl-prolyl cis-trans isomerase G [OS=Homo sapiens]",0,61.559,11,12,15,33,12,754,88.6,10.29,55.55,12,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","other molecular function","Pf00160","9360","D3DPC5; D3DPC6; hsa:9360; O00706; Q13427; Q53R40; Q53SN4; Q96DG9","ENSG00000138398","mRNA Splicing - Major Pathway; SARS-CoV-1 activates/modulates innate immune responses",NA,2,0,139.3,138.3,131.8,66.5,63.4,63.8,91.3,76.6,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S290(100); T358(100); S397(100); S415(100); T552(100); S687(100); S696(100); S717(100)]",0,"ENSG00000138398"
"93","BCL10",1.17347505704442,6.61625222815939,10.206786487038,1.84027968565246e-06,3.19779332973537e-05,5.43495253391585,"UP",FALSE,"High","Master Protein","O95999","B-cell lymphoma/leukemia 10 [OS=Homo sapiens]",0,9.991,5,1,1,1,1,233,26.2,5.74,3.58,1,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00619","8915","hsa:8915; O95999; Q5VUF1","ENSG00000142867","FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Activation of NF-kappaB in B cells; CLEC7A (Dectin-1) signaling","B cell receptor signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Modulators of TCR signaling and T cell activation; T-cell receptor signaling pathway",9,0,59.6,57.4,59.2,131.4,176.1,119.5,103.5,120.7,130.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000142867"
"94","RPS3",-0.957051674631256,6.53297065992761,-10.2057926452331,1.84186625609758e-06,3.19779332973537e-05,5.43404163041635,"DOWN",FALSE,"High","Master Protein","P23396","Small ribosomal subunit protein uS3 [OS=Homo sapiens]",0,36.532,12,3,4,10,3,243,26.7,9.66,31.23,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;translational apparatus;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00189, Pf07650","6188","B2R7N5; hsa:6188; J3KN86; P23396; Q498B5; Q8NI95","ENSG00000149273","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,130.4,118.2,121,65.2,41,68.5,101.6,106.6,100.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T221(100)]",0,"ENSG00000149273"
"95","DNAJC19",-1.63431286987432,6.3674067127832,-10.1833114140413,1.87815872438855e-06,3.22647898758117e-05,5.41341525258599,"DOWN",FALSE,"High","Master Protein","Q96DA6","Mitochondrial import inner membrane translocase subunit TIM14 [OS=Homo sapiens]",0,10.119,12,1,1,1,1,116,12.5,10.1,3.54,1,"protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","other membranes;mitochondrion;other cell component","other molecular function","Pf00226","131118","B2R4B1; C9JBV1; hsa:131118; Q96DA6","ENSG00000205981","Mitochondrial protein import",NA,1,0,183.5,149.3,177.5,57.7,50.3,45.2,76,55.7,63.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100)]",0,"ENSG00000205981"
"96","INTS3",-0.933612683914166,6.44561028810238,-10.1211541537987,1.98264439100737e-06,3.32354725818304e-05,5.35617366153416,"DOWN",FALSE,"High","Master Protein","Q68E01","Integrator complex subunit 3 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1043,118,5.8,8.97,1,"cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component",NA,"Pf10189","65123","A8K1W0; B4DQC8; B4E3U9; D3DV57; hsa:65123; Q4G0E5; Q5VUQ5; Q5VUQ6; Q5VUR0; Q5VUR1; Q68DJ1; Q68E01; Q69YR5; Q6AI57; Q6DKG7; Q6MZQ4; Q6MZZ9; Q8NC46; Q8TB23; Q9H6S9","ENSG00000143624; ENSG00000262826","RNA polymerase II transcribes snRNA genes",NA,1,0,147.5,133.1,143.7,69.2,58.7,83.9,74.5,71.1,67.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S502(100)]",0,"ENSG00000143624"
"97","SRSF7",-0.736240723690291,6.44671036270554,-10.1204517578693,1.98386091339745e-06,3.32354725818304e-05,5.35552502181107,"DOWN",FALSE,"High","Master Protein","Q16629","Serine/arginine-rich splicing factor 7 [OS=Homo sapiens]",0,16.464,18,8,14,32,8,238,27.4,11.82,34.67,8,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","6432","B4DLU6; G5E9M3; hsa:6432; Q16629; Q564D3","ENSG00000115875","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",7,0,147.2,132.3,133.5,81.4,75.4,82.4,65.9,70.3,65.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S167(100); S171(100); S181(100); S183(100); S196(100); S215(100); S233(100)]",0,"ENSG00000115875"
"98","CLIP2",0.79498034888634,6.67162854289502,10.1050178066363,2.01079938636792e-06,3.32354725818304e-05,5.34126212480449,"UP",FALSE,"High","Master Protein","Q9UDT6","CAP-Gly domain-containing linker protein 2 [OS=Homo sapiens]",0,105.094,13,8,12,20,8,1046,115.8,6.73,62.68,8,"cell organization and biogenesis","cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf01302","7461","hsa:7461; O14527; O43611; Q9UDT6","ENSG00000106665",NA,"7q11.23 copy number variation syndrome",1,0,71.4,72.3,76.8,133.1,125.7,129.2,105.3,111.2,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100); S48(99.5); T177(98); S195(99.7); S202(100); S923(100)]",0,"ENSG00000106665"
"99","AHSG",-1.2940564919892,6.36409509529343,-10.101994871211,2.0161224176478e-06,3.32354725818304e-05,5.33846628007092,"DOWN",FALSE,"High","Master Protein","P02765","Alpha-2-HS-glycoprotein [OS=Homo sapiens]",0,6.885,4,1,1,2,1,367,39.3,5.72,5,1,"stress response;transport;developmental processes;other biological processes","extracellular matrix;ER/Golgi;other cell component","enzyme regulator activity","Pf00031","197","A8K9N6; B2R7G1; hsa:197; O14961; O14962; P02765; Q9P152","ENSG00000145192","Neutrophil degranulation; Platelet degranulation ; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,4,0,151.8,164.7,139.2,55.7,65.6,52.6,69.8,62.7,68.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000145192"
"100","PLXDC2",0.938280847969041,6.60441959250048,10.0357042542343,2.13682112748889e-06,3.45448653401863e-05,5.27696748097482,"UP",FALSE,"High","Master Protein","Q6UX71","Plexin domain-containing protein 2 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,529,59.5,6.46,4.14,1,NA,"other membranes",NA,"Pf01437","84898","hsa:84898; Q6UX71; Q96E59; Q96PD9; Q96SU9","ENSG00000120594",NA,NA,0,0,61.9,57.5,56.3,114.5,114.7,117.5,118.7,150.8,141.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S506(100)]",0,"ENSG00000120594"
"101","WFS1",0.820915215469334,6.60825001301339,10.0351373364806,2.13788688686202e-06,3.45448653401863e-05,5.27643998618337,"UP",FALSE,"High","Master Protein","O76024","Wolframin [OS=Homo sapiens]",0,12.385,2,2,2,6,2,890,100.2,8.05,18.44,2,"protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf19913, Pf19914, Pf20023, Pf20053","7466","B2R797; D3DVT1; hsa:7466; O76024; Q8N6I3; Q9UNW6","ENSG00000109501","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; XBP1(S) activates chaperone genes","CAMKK2 pathway",4,0,62.7,55.7,56.4,104.6,98.7,113.1,142,140.9,158.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100); S235(100)]",0,"ENSG00000109501"
"102","IGF2BP3",-1.40208844410543,6.37134395637764,-9.96586400934321,2.27260488609065e-06,3.63616781774504e-05,5.2117839049664,"DOWN",FALSE,"High","Master Protein","O00425","Insulin-like growth factor 2 mRNA-binding protein 3 [OS=Homo sapiens]",0,4.329,2,1,1,2,1,579,63.7,8.87,4.82,1,"protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf00076","10643","A0A4Z5; hsa:10643; O00425; Q63HM0; Q6MZZ2; Q86VB1","ENSG00000136231","Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA",NA,1,0,155,156.8,148.1,48.5,63.3,52,68.2,63.9,78.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S184(100)]",0,"ENSG00000136231"
"103","ADGRG1",0.847789917533327,6.65437637464516,9.88668831312779,2.43807608761154e-06,3.85200302598267e-05,5.13739631741215,"UP",FALSE,"High","Master Protein","Q9Y653","Adhesion G-protein coupled receptor G1 [OS=Homo sapiens]",0,59.309,3,4,8,16,4,693,77.7,8.48,45.54,4,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00002, Pf01825, Pf18587, Pf18619","9289","A6NIT7; A6NJV9; B0M0K4; B4DR54; hsa:9289; O95966; Q6ZMP1; Q8NGB3; Q96HB4; Q9Y653","ENSG00000205336",NA,"GPCRs, other",1,0,71.4,71.3,68.6,128.2,120.8,139.1,105.7,115.4,107.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S678(100)]",0,"ENSG00000205336"
"104","GTF3C2",-0.687589643582568,6.5769969157275,-9.87905762837243,2.45470781067523e-06,3.85200302598267e-05,5.13019932664836,"DOWN",FALSE,"High","Master Protein","Q8WUA4","General transcription factor 3C polypeptide 2 [OS=Homo sapiens]",0,5.003,2,2,2,2,2,911,100.6,7.31,2.7,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf00400","2976","D6W557; hsa:2976; Q16632; Q8WUA4; Q9BWI7","ENSG00000115207","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter",NA,3,0,118.7,122.1,119.5,75.9,62.4,79.3,94.3,101.9,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S167(100); S220(99.7)]",0,"ENSG00000115207"
"105","NEDD4L",0.948767466582028,6.64669226924092,9.81666694490764,2.59544942572071e-06,4.03406996454876e-05,5.07117023921443,"UP",FALSE,"High","Master Protein","Q96PU5","E3 ubiquitin-protein ligase NEDD4-like [OS=Homo sapiens]",0,54.193,5,3,3,6,3,975,111.9,5.82,23.04,3,"protein metabolism;other metabolic processes;transport;other biological processes","cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00168, Pf00397, Pf00632","23327","hsa:23327; O43165; Q3LSM7; Q7Z5F1; Q7Z5F2; Q7Z5N3; Q8N5A7; Q8WUU9; Q96PU5; Q9BW58; Q9H2W4; Q9NT88","ENSG00000049759","Antigen processing: Ubiquitination & Proteasome degradation; Stimuli-sensing channels; Budding and maturation of HIV virion; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity","TGF-beta signaling pathway",6,0,76,74,73.2,149.9,147.2,137.6,94.7,97.9,87.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S303(99.6); S448(99.5); S479(100); S487(100)]",0,"ENSG00000049759"
"106","EML3",0.916990456953068,6.63102491976127,9.76467390741177,2.71949724989592e-06,4.1869995394624e-05,5.02172610152134,"UP",FALSE,"High","Master Protein","Q32P44","Echinoderm microtubule-associated protein-like 3 [OS=Homo sapiens]",0,19.723,4,4,4,8,4,896,95.1,7.12,17.58,4,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00400, Pf03451","256364","hsa:256364; Q32P44; Q6ZQW7; Q8NA55","ENSG00000149499",NA,NA,0,0,64.4,56.6,61.5,121.3,114.3,117,117.6,139.6,152.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S176(100); S889(100)]",0,"ENSG00000149499"
"107","CLASRP",-0.950428020726807,6.47623790233043,-9.74526778574616,2.76744909150698e-06,4.2151007851811e-05,5.00321215350893,"DOWN",FALSE,"High","Master Protein","Q8N2M8","CLK4-associating serine/arginine rich protein [OS=Homo sapiens]",0,20.907,5,3,3,8,3,674,77.1,10.4,19.51,3,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf09750","11129","A0A0A0MQS2; B4DDT8; F8WAG9; hsa:11129; O96026; Q6UW71; Q8N2M8; Q96DX2","ENSG00000104859",NA,"mRNA processing",1,0,139.9,138.3,131.5,70.4,66,63.2,82.6,71.3,84.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S285(100); S501(99.7); S547(100)]",0,"ENSG00000104859"
"108","ADAM22",0.803232472551449,6.65088277570627,9.73650477191723,2.78940493136985e-06,4.2151007851811e-05,4.99484142463544,"UP",FALSE,"High","Master Protein","Q9P0K1","Disintegrin and metalloproteinase domain-containing protein 22 [OS=Homo sapiens]",0,21.785,3,2,2,6,2,906,100.4,7.2,19.49,2,"cell adhesion;protein metabolism;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00200, Pf01421, Pf01562, Pf07974, Pf08516","53616","hsa:53616; O75075; O75076; Q9P0K1; Q9P0K2; Q9UIA1; Q9UKK2","ENSG00000008277","LGI-ADAM interactions",NA,1,0,67.2,68.1,64.4,120.7,122.1,115.5,128.7,126.7,122,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S834(100); S857(100)]",0,"ENSG00000008277"
"109","HNRNPC",-0.744725032471969,6.51144871273399,-9.62780610908934,3.07820205694192e-06,4.60883096965983e-05,4.89045778682324,"DOWN",FALSE,"High","Master Protein","P07910","Heterogeneous nuclear ribonucleoproteins C1/C2 [OS=Homo sapiens]",0,65.048,15,4,8,18,4,306,33.7,5.08,53.46,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","3183","D3DS19; D3DS22; hsa:3183; P07910; P22628; Q53EX2; Q59FD3; Q5FWE8; Q86SF8; Q86U45; Q96HK7; Q96HM4; Q96IY5; Q9BTS3","ENSG00000092199","SUMOylation of RNA binding proteins; mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle","mRNA processing",6,0,130.1,131.7,126.1,78.4,68.3,76,86.8,81.1,76.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100)]",0,"ENSG00000092199"
"110","SPAG1",1.19125077111839,6.57181740453987,9.58338471453724,3.20551369646714e-06,4.75581668421307e-05,4.84750404426237,"UP",FALSE,"High","Master Protein","Q07617","Sperm-associated antigen 1 [OS=Homo sapiens]",0,5.488,2,1,1,4,1,926,103.6,6.86,7.19,1,"cell organization and biogenesis;other biological processes","cytosol;other cell component","other molecular function","Pf00515, Pf13877","6674","A6NP70; B3KQ58; G3XAM3; hsa:6674; Q07617; Q7Z5G1","ENSG00000104450",NA,"Ciliopathies",1,0,60.9,64.7,65.9,149.6,189.3,124.2,99.5,85.6,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S418(100)]",0,"ENSG00000104450"
"111","SUGP2",-0.813466168976869,6.50502196268878,-9.56343416777367,3.26455799309216e-06,4.76889224770261e-05,4.82815635552173,"DOWN",FALSE,"High","Master Protein","Q8IX01","SURP and G-patch domain-containing protein 2 [OS=Homo sapiens]",0,18.549,2,1,1,3,1,1082,120.1,7.28,10.35,1,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf01585, Pf01805","10147","C9JI71; hsa:10147; O15071; O60369; Q5JPH7; Q8IX01; Q8WUF7","ENSG00000064607",NA,"mRNA processing",1,0,136.2,137,141.3,79.9,61.1,89.1,76.3,73.2,76.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S277(99.3)]",0,"ENSG00000064607"
"112","NPM1",-1.00248817039117,6.55989997213962,-9.56069098923325,3.27276918959983e-06,4.76889224770261e-05,4.82549333192299,"DOWN",FALSE,"High","Master Protein","P06748","Nucleophosmin [OS=Homo sapiens]",0,99.947,33,8,8,18,8,294,32.6,4.78,83.27,8,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;cytoskeleton;translational apparatus;nucleus;other cell component","enzyme regulator activity;translation activity;nucleic acid binding activity;other molecular function","Pf03066, Pf16276","4869","A8K3N7; B5BU00; D3DQL6; hsa:4869; P06748; P08693; Q12826; Q13440; Q13441; Q14115; Q5EU94; Q5EU95; Q5EU96; Q5EU97; Q5EU98; Q5EU99; Q6V962; Q8WTW5; Q96AT6; Q96DC4; Q96EA5; Q9BYG9; Q9UDJ7","ENSG00000181163","TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; PKR-mediated signaling; Nuclear import of Rev protein; Deposition of new CENPA-containing nucleosomes at the centromere; SUMOylation of transcription cofactors; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation; Nuclear events stimulated by ALK signaling in cancer; SARS-CoV-1-host interactions",NA,10,0,128.4,139.2,132.8,61.5,59.3,65.7,84.1,102.4,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100); S125(100); S137(100); S227(100); S243(100)]",0,"ENSG00000181163"
"113","TCF12",-0.932715036475983,6.56901297097618,-9.53465711458785,3.35183187434884e-06,4.84087576897106e-05,4.80018714204339,"DOWN",FALSE,"High","Master Protein","Q99081","Transcription factor 12 [OS=Homo sapiens]",0,5.164,2,1,1,2,1,682,72.9,7.02,3.18,1,"other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00010","6938","B4E1W1; hsa:6938; Q7Z3D9; Q86TC1; Q86VM2; Q99081","ENSG00000140262","RUNX1 regulates transcription of genes involved in differentiation of HSCs; NGF-stimulated transcription; Myogenesis",NA,3,0,134.5,134,113.6,60,65.8,61,104,102.9,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S559(99.3)]",0,"ENSG00000140262"
"114","MCMBP",-0.957466259986516,6.42676588679326,-9.50206065544669,3.45378562786533e-06,4.94436679357563e-05,4.76841733034774,"DOWN",FALSE,"High","Master Protein","Q9BTE3","Mini-chromosome maintenance complex-binding protein [OS=Homo sapiens]",0,6.274,2,1,1,1,1,642,72.9,5.87,2.79,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf09739","79892","B3KSP7; hsa:79892; Q6IA56; Q9BTE3; Q9BVT9; Q9H916","ENSG00000197771",NA,NA,0,0,145.5,131.5,140.8,74.5,51.8,76.9,77.1,68.5,66.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100)]",0,"ENSG00000197771"
"115","DENND4C",0.773955910878246,6.64813482925962,9.44365352250937,3.64506353727292e-06,5.17282060246035e-05,4.71125518123122,"UP",FALSE,"High","Master Protein","Q5VZ89","DENN domain-containing protein 4C [OS=Homo sapiens]",0,22.322,2,2,3,4,2,1909,212.6,6.83,10.45,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity","Pf02141, Pf03455, Pf03456","55667","A2A3R1; A2A3R2; A2A3R3; A2A3R9; hsa:55667; Q5VZ89; Q6AI48; Q6ZUB3; Q8NCY7; Q9H6N4; Q9NUT1; Q9NWA5; Q9NWT3; R4GN35; R4GNB2","ENSG00000137145","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,69.6,63.7,68.3,115,133.9,113.1,117.5,127.1,134.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1126(99.3); S1325(100)]",0,"ENSG00000137145"
"116","RCOR2",-1.43659757180512,6.33790601770693,-9.42642157091257,3.70368894959267e-06,5.21070721184072e-05,4.69433231786097,"DOWN",FALSE,"High","Master Protein","Q8IZ40","REST corepressor 2 [OS=Homo sapiens]",0,13.744,4,1,1,1,1,523,58,9.01,3.47,1,"other biological processes","nucleus;other cell component","other molecular function","Pf00249, Pf01448, Pf20878","283248","hsa:283248; Q8IZ40; Q96FP3","ENSG00000167771",NA,NA,0,0,155.4,161.1,164,49.8,66.6,52.6,68,63.8,58.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(100)]",0,"ENSG00000167771"
"117","PACS1",0.962547490039825,6.63915507194579,9.355342181369,3.9566525708458e-06,5.51365959649188e-05,4.62424554752626,"UP",FALSE,"High","Master Protein","Q6VY07","Phosphofurin acidic cluster sorting protein 1 [OS=Homo sapiens]",0,29.706,5,2,3,8,2,963,104.8,7.74,13.4,2,"other biological processes","cytosol;ER/Golgi","other molecular function","Pf10254","55690","hsa:55690; Q6PJY6; Q6PKB6; Q6VY07; Q7Z590; Q7Z5W4; Q8N8K6; Q96MW0; Q9NW92; Q9ULP5","ENSG00000175115","Nef mediated downregulation of MHC class I complex cell surface expression",NA,1,0,62.2,68,58.3,127.6,136.9,115.2,118.8,132.4,123,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S519(100); S781(97)]",0,"ENSG00000175115"
"118","SLU7",-0.711992834817972,6.54250135908666,-9.34726016369144,3.98659211020859e-06,5.51365959649188e-05,4.6162474886236,"DOWN",FALSE,"High","Master Protein","O95391","Pre-mRNA-splicing factor SLU7 [OS=Homo sapiens]",0,17.82,5,2,2,4,2,586,68.3,7.14,12.36,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf11708","10569","D3DQK2; hsa:10569; O95391; Q3LUJ0; Q3LUJ1; Q6RXQ5; Q96FM9","ENSG00000164609","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,4,0,126.9,123.2,119.9,82.4,59.2,76.4,88.5,92.1,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100); S466(100)]",0,"ENSG00000164609"
"119","ZNRF2",0.806261142978586,6.63607188787201,9.31383762116172,4.11306336054564e-06,5.6407726087483e-05,4.58310914432743,"UP",FALSE,"High","Master Protein","Q8NHG8","E3 ubiquitin-protein ligase ZNRF2 [OS=Homo sapiens]",0,28.804,11,2,2,4,2,242,24.1,7.09,8.38,2,"protein metabolism;other metabolic processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13639","223082","Q8NHG8","ENSG00000180233","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,76.4,71.4,79,129.1,161,128.8,99.8,100.2,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(100); S135(100)]",0,"ENSG00000180233"
"120","PGRMC1",-1.30677570834002,6.34827505312272,-9.21763785323808,4.50224347593549e-06,6.12305112727227e-05,4.48715732599955,"DOWN",FALSE,"High","Master Protein","O00264","Membrane-associated progesterone receptor component 1 [OS=Homo sapiens]",0,115.061,22,5,6,41,5,195,21.7,4.7,157.87,5,"cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;mitochondrion;ER/Golgi;other cell component","other molecular function","Pf00173","10857","B7Z1L3; hsa:10857; O00264; Q9UGJ9","ENSG00000101856","Neutrophil degranulation","Primary ovarian insufficiency",2,0,160.2,151.5,155.3,58.7,67.9,50.5,71.2,60,60.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S181(100)]",0,"ENSG00000101856"
"121","NUP35",-0.814967523792105,6.52847913495084,-9.20860114359032,4.5408217264792e-06,6.12448021290418e-05,4.47810014882229,"DOWN",FALSE,"High","Master Protein","Q8NFH5","Nucleoporin NUP35 [OS=Homo sapiens]",0,26.566,9,2,4,6,2,326,34.8,9.09,14.23,2,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf05172","129401","B4DP57; B4DYB4; hsa:129401; Q4ZFZ9; Q53S95; Q8NFH5; Q8TDJ1","ENSG00000163002","HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation",NA,29,0,126.1,121.2,116.9,60,65.8,70.3,97,91.3,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T265(100); T273(100)]",0,"ENSG00000163002"
"122","SLC47A2",1.08576060613969,6.62399025600668,9.19246549351807,4.61060806141532e-06,6.16763307887689e-05,4.46190915605858,"UP",FALSE,"High","Master Protein","Q86VL8","Multidrug and toxin extrusion protein 2 [OS=Homo sapiens]",0,5.163,2,1,1,2,1,602,65,8.28,4.98,1,"transport","plasma membrane;other membranes","transporter activity","Pf01554","146802","A0JBX9; A0P8Z7; Q63HJ9; Q86VL8; Q8IV44; Q96NA1","ENSG00000180638","Transport of bile salts and organic acids, metal ions and amine compounds","Proximal tubule transport",2,0,63.3,56,60.5,128.8,146.4,119.8,120.8,137.8,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S515(99.6)]",0,"ENSG00000180638"
"123","GAP43",1.20927577494322,6.59085274695731,9.08805615823105,5.0915372285691e-06,6.75560061546729e-05,4.35655570303444,"UP",FALSE,"High","Master Protein","P17677","Neuromodulin [OS=Homo sapiens]",0,109.862,46,7,9,12,7,238,24.8,4.72,47.26,7,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00612, Pf06614, Pf10580","2596","A8K0Y4; hsa:2596; P17677","ENSG00000172020","L1CAM interactions","Glial cell differentiation; Spinal cord injury",3,0,53.8,58.1,53.7,129.4,178.3,109.2,124.3,120.1,118,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T107(100); S151(99.2); T181(99.3)]",0,"ENSG00000172020"
"124","FTH1",-0.686199430254514,6.54023873723229,-9.05778958366771,5.24101459452587e-06,6.89785146634373e-05,4.3258243043475,"DOWN",FALSE,"High","Master Protein","P02794","Ferritin heavy chain [OS=Homo sapiens]",0,7.866,14,2,2,10,2,183,21.2,5.55,10.32,2,"transport;other biological processes","non-structural extracellular;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf00210","2495","B3KNR5; hsa:2495; P02794; Q3KRA8; Q3SWW1","ENSG00000167996","Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Iron uptake and transport; Scavenging by Class A Receptors","Iron metabolism in placenta; Nuclear receptors meta-pathway; NRF2 pathway; Ferroptosis; Iron metabolism disorders",9,0,127.8,132.3,125,86.9,67.5,76,85.7,85.5,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S179(100)]",0,"ENSG00000167996"
"125","RFX4",-1.02505020427737,6.41614456860457,-9.00121173084336,5.53346953749866e-06,7.15882474092538e-05,4.26814506467537,"DOWN",FALSE,"High","Master Protein","Q33E94","Transcription factor RFX4 [OS=Homo sapiens]",0,43.754,3,1,3,7,1,735,83.3,6.86,31.83,1,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02257","5992","A8K5Y0; B2RDW4; hsa:5992; Q33DW6; Q33DW7; Q33E94; Q33E95; Q6YM53; Q8MHQ1; Q8NC78; Q8NDF9; Q8SNA1; Q96S80; Q9BXI0","ENSG00000111783",NA,NA,0,0,153.7,152.2,132.7,77.2,57.3,69.4,76,66.4,61,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S514(100)]",0,"ENSG00000111783"
"126","PEA15",1.44554065287452,6.58357078349761,8.99805026769835,5.55032969950059e-06,7.15882474092538e-05,4.26491308406591,"UP",FALSE,"High","Master Protein","Q15121","Astrocytic phosphoprotein PEA-15 [OS=Homo sapiens]",0,36.172,10,2,2,14,2,130,15,5.02,41.72,2,"transport;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf01335","8682","B1AKZ3; hsa:8682; O00511; Q15121","ENSG00000162734","RAF/MAP kinase cascade; RAF-independent MAPK1/3 activation","Apoptosis modulation and signaling",3,0,50.6,53.9,55.5,139.2,216.3,117.1,113.9,102.4,119.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S116(100)]",0,"ENSG00000162734"
"127","QKI",-0.895416080875909,6.50821708200894,-8.99420745995591,5.57089915500934e-06,7.15882474092538e-05,4.26098327847235,"DOWN",FALSE,"High","Master Protein","Q96PU8","KH domain-containing RNA-binding protein QKI [OS=Homo sapiens]",0,34.523,9,2,3,3,2,341,37.6,8.56,11.14,2,"RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf16544, Pf16551","9444","hsa:9444; Q2I375; Q5MJQ1; Q969L9; Q96EJ3; Q96KA3; Q96PU6; Q96PU7; Q96PU8; Q9P0X6; Q9P0X7; Q9P0X8; Q9P0X9; Q9P0Y0; Q9P0Y1","ENSG00000112531","Signaling by BRAF and RAF1 fusions","VEGFA-VEGFR2 signaling; Exercise-induced circadian regulation",3,0,149.2,126.8,134,69.1,69.7,67.7,90.1,75.7,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S69(100); S188(100)]",0,"ENSG00000112531"
"128","RBM4",-0.917389809803725,6.47828841113076,-8.95780959616678,5.76991274882131e-06,7.35663875474717e-05,4.22369145187618,"DOWN",FALSE,"High","Master Protein","Q9BWF3","RNA-binding protein 4 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,364,40.3,7.08,4.3,1,"cell-cell signaling;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf00098","5936","B3KUN0; B4E1U0; E7EQS3; hsa:5936; O02916; Q4VC48; Q6P1P2; Q8WU85; Q9BWF3","ENSG00000173933","Circadian Clock",NA,1,0,142.5,138.5,121.4,70.1,68.3,62.1,75.3,85,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S86(100)]",0,"ENSG00000173933"
"129","ERBIN",0.716545452994383,6.66068708986004,8.93368211632602,5.90611276668953e-06,7.47191940716071e-05,4.1989014300788,"UP",FALSE,"High","Master Protein","Q96RT1","Erbin [OS=Homo sapiens]",0,112.694,9,9,12,22,9,1412,158.2,5.5,54.4,9,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","extracellular matrix;plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity","Pf00595, Pf13855","55914","A0AVR1; B4E3F1; B7ZLV9; E7EQW9; E9PCR8; hsa:55914; Q1RMD0; Q86W38; Q96RT1; Q9NR18; Q9NW48; Q9ULJ5","ENSG00000112851","Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants; RHOG GTPase cycle; RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle","Nucleotide-binding oligomerization domain (NOD) pathway; Nod-like receptor (NLR) signaling pathway; Pathways affected in adenoid cystic carcinoma",26,0,76.7,75,74.2,128.9,129.1,125.1,106.7,113.6,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S852(99); S872(100); S1015(100); S1079(99.3); S1179(100)]",0,"ENSG00000112851"
"130","SORBS2",0.736691220540198,6.63651113914943,8.88525049053194,6.19024134271113e-06,7.77113374715735e-05,4.14897067425874,"UP",FALSE,"High","Master Protein","O94875-10","Isoform 10 of Sorbin and SH3 domain-containing protein 2 [OS=Homo sapiens]",0,30.799,6,4,4,6,4,824,91.2,9.17,15.74,4,NA,NA,NA,NA,NA,"O94875-10",NA,NA,NA,0,0,79,77.2,81.1,133.1,146.1,127.6,87.5,100.9,91.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S136(100); S510(100); S529(99.5); S553(98.8)]",0,"ENSG00000154556"
"131","SOX6",0.842473392505872,6.68112091431496,8.86201996864991,6.33179887845256e-06,7.88816470964472e-05,4.12494057166571,"UP",FALSE,"High","Master Protein","P35712","Transcription factor SOX-6 [OS=Homo sapiens]",0,3.757,2,1,1,1,1,828,91.9,7.78,2.47,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","55553","hsa:55553; P35712; Q86VX7; Q9BXQ3; Q9BXQ4; Q9BXQ5; Q9H0I8","ENSG00000110693","Deactivation of the beta-catenin transactivating complex","NOTCH1 regulation of endothelial cell calcification; Endochondral ossification; Endochondral ossification with skeletal dysplasias",4,0,67.8,66.5,72.1,132.2,113.4,127.5,125.1,116.5,121.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S442(98.7)]",0,"ENSG00000110693"
"132","PHF6",-1.0132276871683,6.41225663195765,-8.8532656103426,6.38605913316531e-06,7.89549129191348e-05,4.11587130002771,"DOWN",FALSE,"High","Master Protein","Q8IWS0","PHD finger protein 6 [OS=Homo sapiens]",0,19.593,9,2,2,5,2,365,41.3,8.68,7.47,2,"developmental processes;other biological processes","nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf13771","84295","A8K230; B4E0G4; D3DTG3; E9PC97; hsa:84295; Q5JRC7; Q5JRC8; Q8IWS0; Q96JK3; Q9BRU0","ENSG00000156531",NA,"Mesodermal commitment pathway",1,0,150,139.1,139.4,63.9,52.1,84.3,63.8,71.7,73.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S155(99.1); S204(99.5)]",0,"ENSG00000156531"
"133","TSG101",-0.997939393046546,6.4537310031456,-8.82415181513426,6.57019602034532e-06,8.0620751166944e-05,4.08565654176415,"DOWN",FALSE,"High","Master Protein","Q99816","Tumor susceptibility gene 101 protein [OS=Homo sapiens]",0,7.665,3,1,1,1,1,390,43.9,6.46,3.36,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf05743, Pf09454","7251","hsa:7251; Q99816; Q9BUM5","ENSG00000074319","HCMV Late Events; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy","Ebola virus infection in host; 7q11.23 copy number variation syndrome",7,0,151.2,140.2,118.8,63.2,66.1,61.7,87.1,74.3,77.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T220(100)]",0,"ENSG00000074319"
"134","HSP90B1",-0.755016825746289,6.52377586292368,-8.79308703874587,6.77309307748122e-06,8.2490208227234e-05,4.05332571222472,"DOWN",FALSE,"High","Master Protein","P14625","Endoplasmin [OS=Homo sapiens]",0,130.019,17,12,12,15,11,803,92.4,4.84,47.27,12,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00183, Pf13589","7184","hsa:7184; P14625; Q96A97","ENSG00000166598","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Interleukin-4 and Interleukin-13 signaling; Trafficking and processing of endosomal TLR; Scavenging by Class A Receptors; ATF6 (ATF6-alpha) activates chaperone genes","Photodynamic therapy-induced unfolded protein response; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; PI3K-Akt signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways",11,0,131.4,126.6,125.4,73,68.4,76.2,90.7,77.5,87.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T675(100); S680(100)]",0,"ENSG00000166598"
"135","GIGYF2",0.595221564166327,6.66533587986304,8.78300989523592,6.84037414909935e-06,8.26925230468899e-05,4.04281755442612,"UP",FALSE,"High","Master Protein","Q6Y7W6","GRB10-interacting GYF protein 2 [OS=Homo sapiens]",0,58.669,6,5,7,11,5,1299,150,5.54,40.25,5,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf02213","26058","A6H8W4; B9EG55; E9PBB0; hsa:26058; O75137; Q6Y7W6; Q7Z2Z8; Q7Z3I2; Q96HU4; Q9NV82","ENSG00000204120",NA,"VEGFA-VEGFR2 signaling",1,0,72.6,73.3,73.5,109.1,121.4,117.5,118.3,127.4,120.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(99.5); S160(100); S201(100)]",0,"ENSG00000204120"
"136","MYRIP",1.24161038978221,6.62756725065563,8.76759867247872,6.94468549440553e-06,8.33362259328663e-05,4.02672786975332,"UP",FALSE,"High","Master Protein","Q8NFW9","Rab effector MyRIP [OS=Homo sapiens]",0,9.832,2,1,1,1,1,859,95.6,5.6,3.44,1,"transport;other biological processes","cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf02318, Pf04698","25924","B3KWM3; B3KWW4; B7Z2H1; B7Z9V3; G3XAI8; hsa:25924; Q32M41; Q32M42; Q569F7; Q8IUF5; Q8NFW9; Q9Y3V4","ENSG00000170011","Insulin processing","Deregulation of Rab and Rab effector genes in bladder cancer",2,0,67.5,66.1,52.3,144.2,139.6,142.6,103.8,121.6,105.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100)]",0,"ENSG00000170011"
"137","PITPNC1",1.14778163812427,6.63733394153548,8.72943906605906,7.21052765522825e-06,8.58947527980475e-05,3.98678758129207,"UP",FALSE,"High","Master Protein","Q9UKF7","Cytoplasmic phosphatidylinositol transfer protein 1 [OS=Homo sapiens]",0,34.158,11,3,4,9,3,332,38.4,6.4,26.24,3,"cell organization and biogenesis;transport;signal transduction","cytosol;nucleus;other cell component","transporter activity;other molecular function","Pf02121","26207","A8K473; hsa:26207; J3QR20; Q96I07; Q9UKF7","ENSG00000154217",NA,NA,0,0,64.8,71.6,67.4,153.2,135.5,163.3,89.6,110.3,90.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100); S299(100)]",0,"ENSG00000154217"
"138","MAPT",0.868253724994862,6.6551496544705,8.65693497610555,7.7467953575792e-06,9.16142755331106e-05,3.9105023759717,"UP",FALSE,"High","Master Protein","P10636","Microtubule-associated protein tau [OS=Homo sapiens]",0,262.68,23,17,29,81,2,758,78.9,6.71,262.14,17,"cell-cell signaling;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00418","4137","hsa:4137; P10636; P18518; Q14799; Q15549; Q15550; Q15551; Q1RMF6; Q53YB1; Q5CZI7; Q5XWF0; Q6QT54; Q9UDJ3; Q9UMH0; Q9UQ96","ENSG00000186868; ENSG00000276155; ENSG00000277956","Caspase-mediated cleavage of cytoskeletal proteins","IL-5 signaling pathway; Microtubule cytoskeleton regulation; Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; Copper homeostasis; MAPK signaling pathway; IL-2 signaling pathway; Inclusion body myositis; Alzheimer's disease; DYRK1A involvement regarding cell proliferation in brain development; Neurogenesis regulation in the olfactory epithelium; HDAC6 interactions in the central nervous system",14,17,66.5,75.6,76.5,133.1,161.1,123.2,109.3,103,98.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S411(100); S438(100); T498(100); S516(99.2); S519(100); T529(99.6); T534(100); T548(100); S552(99.6); S579(99.8); S673(100); S713(100); S717(100); S733(99.5)]",0,"ENSG00000186868"
"139","TFAP4",-1.04655789615568,6.52777916707888,-8.61032917444956,8.11443449789872e-06,9.52716338170554e-05,3.86118881656815,"DOWN",FALSE,"High","Master Protein","Q01664","Transcription factor AP-4 [OS=Homo sapiens]",0,18.064,3,1,1,4,1,338,38.7,5.87,9.07,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00010","7023","hsa:7023; O60409; Q01664","ENSG00000090447",NA,"DYRK1A involvement regarding cell proliferation in brain development",1,0,136.1,134.5,120.6,55,62.7,59.5,108.2,88.4,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S124(100)]",0,"ENSG00000090447"
"140","FXR2",1.04700937024695,6.63796525858345,8.5934648356036,8.25212573588419e-06,9.61962085783071e-05,3.84329087345231,"UP",FALSE,"High","Master Protein","P51116","RNA-binding protein FXR2 [OS=Homo sapiens]",0,15.2,3,1,2,4,1,673,74.2,6.23,16.64,1,"developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf05641, Pf12235, Pf16096, Pf17904, Pf18336","9513","B2R9M2; D3DTQ1; hsa:9513; P51116; Q86V09; Q8WUM2","ENSG00000129245",NA,"VEGFA-VEGFR2 signaling",1,0,69,65.5,67.7,135.6,135.2,149.3,101.1,120.4,90.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S603(100)]",0,"ENSG00000129245"
"141","FOXK2",-0.678592083982946,6.51744358042866,-8.57025848001895,8.44578625975148e-06,9.77554835171235e-05,3.81861528630884,"DOWN",FALSE,"High","Master Protein","Q01167","Forkhead box protein K2 [OS=Homo sapiens]",0,17.187,4,2,2,2,2,660,69,9.54,6.35,2,"other metabolic processes;stress response;other biological processes","mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250, Pf00498","3607","A6NEP5; hsa:3607; Q01167; Q13622; Q13623; Q13624","ENSG00000141568","UCH proteinases",NA,1,0,133,130.2,130.3,84.7,69.8,85.8,72.5,78.9,82,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(100); S398(100)]",0,"ENSG00000141568"
"142","GFAP",1.03711519456003,6.64210473819421,8.54651250331402,8.64910049208959e-06,9.94037465006353e-05,3.79330947797961,"UP",FALSE,"High","Master Protein","P14136","Glial fibrillary acidic protein [OS=Homo sapiens]",0,761.054,77,44,78,298,42,432,49.9,5.52,761.77,44,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00038, Pf04732","2670","A7REI1; B2RD44; D3DX59; E9PAX3; hsa:2670; P14136; Q53H98; Q5D055; Q6ZQS3; Q7Z5J6; Q7Z5J7; Q96KS4; Q96P18; Q9UFD0","ENSG00000131095","Nuclear signaling by ERBB4; Chaperone Mediated Autophagy","Neural crest differentiation; Spinal cord injury; Neuroinflammation and glutamatergic signaling; Cell lineage map for neuronal differentiation",6,3,67.7,69.6,72.2,142.3,126.3,168,100.8,103,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S8(99.6); S13(100); S16(99.7); S38(100); S82(100); S291(100); S305(100); S323(100); S337(100); S385(100); S398(100); S400(100); S424(100)]",0,"ENSG00000131095"
"143","METTL2B",-0.842514857976594,6.42313650453078,-8.52046154002582,8.87831812282618e-06,0.000101324581653513,3.76548138284391,"DOWN",FALSE,"High","Master Protein","Q6P1Q9","tRNA N(3)-methylcytidine methyltransferase METTL2B [OS=Homo sapiens]",0,10.132,3,1,1,1,1,378,43.4,5.86,4.29,1,"RNA metabolism OR transcription;other metabolic processes","other cell component","other molecular function","Pf08242","55798","B4DZ68; hsa:55798; Q0IJ54; Q3B7J1; Q6P1Q9","ENSG00000165055",NA,NA,0,0,144.1,138,133,76.1,69.5,75.3,61,68.2,74.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T154(100)]",0,"ENSG00000165055"
"144","ARHGEF6",-0.984487025668259,6.55807626972395,-8.50624450708631,9.0062028753147e-06,0.000102070299253567,3.75026533444353,"DOWN",FALSE,"High","Master Protein","Q15052","Rho guanine nucleotide exchange factor 6 [OS=Homo sapiens]",0,66.098,5,4,5,38,3,776,87.4,6.05,102.24,4,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00169, Pf00307, Pf00621, Pf07653, Pf16523, Pf16614, Pf16615","9459","A6NMW9; A8K6S7; B1AL37; hsa:9459; Q15052; Q15396; Q5JQ66; Q7Z3W1; Q86XH0","ENSG00000129675","CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOU GTPase cycle; G beta:gamma signalling through CDC42; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Pancreatic adenocarcinoma pathway; Regulation of actin cytoskeleton",9,2,120.9,130.6,117,56.2,52.7,62.5,117.2,94,123.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S225(100); S488(100); S640(100); S684(100)]",0,"ENSG00000129675"
"145","NUP155",-0.92243749121167,6.50246622493808,-8.48350643551373,9.21493699947664e-06,0.000103715704711351,3.72588654959099,"DOWN",FALSE,"High","Master Protein","O75694","Nuclear pore complex protein Nup155 [OS=Homo sapiens]",0,21.931,3,2,2,3,2,1391,155.1,6.16,11.12,2,"cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","other membranes;cytosol;nucleus","other molecular function","Pf08801","9631","hsa:9631; O75694; Q9UBE9; Q9UFL5","ENSG00000113569","HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Postmitotic nuclear pore complex (NPC) reformation",NA,29,0,148.2,129.4,117.2,63.9,65.6,63.4,82,86.5,100,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S992(100)]; Met-loss [N-Term]",0,"ENSG00000113569"
"146","CHD4",-0.643036690744337,6.50332449876945,-8.46523334163279,9.38651266364007e-06,0.00010492321004836,3.70625653342651,"DOWN",FALSE,"High","Master Protein","Q14839","Chromodomain-helicase-DNA-binding protein 4 [OS=Homo sapiens]",0,41.94,4,3,5,12,3,1912,217.9,5.86,21.38,3,"cell organization and biogenesis;DNA metabolism;stress response;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf00385, Pf00628, Pf06461, Pf06465, Pf08073, Pf08074","1108","Q14839; Q8IXZ5","ENSG00000111642","Potential therapeutics for SARS; NGF-stimulated transcription; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation","Rett syndrome; Effect of progerin on genes involved in progeria",9,0,134.4,129.1,132.6,83.2,80.4,85.8,70.4,78.2,73,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1535(100)]",0,"ENSG00000111642"
"147","FUBP3",-0.808844498509754,6.58595979189964,-8.4114297717292,9.91228496296013e-06,0.000110046592241843,3.64825808609029,"DOWN",FALSE,"High","Master Protein","Q96I24","Far upstream element-binding protein 3 [OS=Homo sapiens]",0,26.071,6,2,2,4,2,572,61.6,8.38,12.73,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","translational apparatus;nucleus;other cell component","nucleic acid binding activity","Pf00013","8939","A3KFK8; A3KFL0; hsa:8939; Q92946; Q96I24; Q9BVB6","ENSG00000107164",NA,NA,0,0,108,102.8,108.8,62.2,50.3,59.8,116.8,124.1,158.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T76(100); S569(100)]",0,"ENSG00000107164"
"148","ATP2A2",-0.770228386212204,6.54361586628418,-8.39345269471863,1.00950574674143e-05,0.000111318471532569,3.62881272359682,"DOWN",FALSE,"High","Master Protein","P16615","Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 [OS=Homo sapiens]",0,62.164,6,4,4,8,4,1042,114.7,5.34,28.19,4,"cell adhesion;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","transporter activity;nucleic acid binding activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf13246","488","A6NDN7; B4DF05; hsa:488; P16614; P16615; Q86VJ2","ENSG00000174437","Ion homeostasis; Ion transport by P-type ATPases; Pre-NOTCH Processing in Golgi; Reduction of cytosolic Ca++ levels","Alzheimer's disease and miRNA effects; Arrhythmogenic right ventricular cardiomyopathy; Endothelin pathways; Myometrial relaxation and contraction pathways; Alzheimer's disease; Calcium regulation in cardiac cells",10,0,131.3,123.6,126.7,74.2,59.7,81.9,97.8,84.3,86.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S663(100)]",0,"ENSG00000174437"
"149","SORBS1",0.993155054828062,6.65945084410341,8.36689390673182,1.0371847575594e-05,0.000112958800213265,3.60002333836056,"UP",FALSE,"High","Master Protein","Q9BX66-12","Isoform 12 of Sorbin and SH3 domain-containing protein 1 [OS=Homo sapiens]",0,126.445,10,12,14,28,12,1294,143.7,8.6,65.08,12,NA,NA,NA,NA,NA,"Q9BX66-12",NA,NA,NA,0,0,66.1,66.6,68.5,146.3,128.9,127.3,119,110.3,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S204(100); T286(100); S345(100); S1205(99.3)]",0,"ENSG00000095637"
"150","RAP1GAP",1.02612389238592,6.64548505656778,8.36591159405492,1.03822426666604e-05,0.000112958800213265,3.59895711675309,"UP",FALSE,"High","Master Protein","P47736-4","Isoform 4 of Rap1 GTPase-activating protein 1 [OS=Homo sapiens]",0,50.775,7,4,4,9,4,727,80.6,6.18,33.41,4,NA,NA,NA,NA,NA,"P47736-4",NA,NA,NA,0,0,71.8,66.1,77.2,152.6,132.5,152,92,104.5,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T9(100); S548(100); S579(100)]",0,"ENSG00000076864"
"151","TNS1",0.578048377429863,6.64740921823543,8.33181815205471,1.07501709440372e-05,0.000116187278017673,3.56188903672083,"UP",FALSE,"High","Master Protein","Q9HBL0","Tensin-1 [OS=Homo sapiens]",0,73.254,5,6,6,8,6,1839,196.9,8.16,36.64,6,"cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00017, Pf00130, Pf08416, Pf10409","7145","A0A804HI61; hsa:7145; Q4ZG71; Q6IPI5; Q9HBL0","ENSG00000079308",NA,"Integrin-mediated cell adhesion",1,0,81.8,76.7,78.2,119.8,124.4,123.1,106.2,102.5,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T985(99.3); S1032(100); S1281(100); S1373(99.5); S1418(100); S1485(100)]",0,"ENSG00000079308"
"152","CENPA",-0.810122775265564,6.4842128758606,-8.24585214751579,1.17426465091898e-05,0.000125848060066403,3.46788108070693,"DOWN",FALSE,"High","Master Protein","P49450","Histone H3-like centromeric protein A [OS=Homo sapiens]",0,22.025,10,2,3,9,2,140,16,11.71,11.18,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00125","1058","D6W544; hsa:1058; P49450; Q53T74; Q9BVW2","ENSG00000115163","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Deposition of new CENPA-containing nucleosomes at the centromere; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2q37 copy number variation syndrome",8,0,142,133.3,134.6,77.3,77.3,69.3,74.9,68.2,81.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100)]",0,"ENSG00000115163"
"153","SRRM1",-0.631610264216392,6.5382138178302,-8.24127234931253,1.17982556312253e-05,0.000125848060066403,3.46285097043616,"DOWN",FALSE,"High","Master Protein","Q8IYB3","Serine/arginine repetitive matrix protein 1 [OS=Homo sapiens]",0,614.082,36,52,80,270,51,904,102.3,11.84,696.14,52,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf01480","10250","hsa:10250; O60585; Q5VVN4; Q8IYB3","ENSG00000133226","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle","mRNA processing",7,1,129.8,126.1,123,81.6,80.3,77.7,84.3,78.8,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100); S211(100); T220(100); S234(100); S260(100); S380(100); S389(100); S391(99.7); S393(100); S402(100); T406(100); S431(100); S450(100); S452(100); S463(100); S465(100); S551(100); S562(100); S583(100); S597(100); S605(100); S607(100); T614(100); S616(100); S626(100); S628(100); S636(100); S638(100); S646(100); S653(100); S675(100); S695(98.4); S696(99.5); S713(100); S715(100); S725(100); T727(100); S738(100); S740(100); S756(100); T846(100); S874(100); S901(100)]",0,"ENSG00000133226"
"154","MYH9",0.955873929890974,6.63802744100839,8.21358960224496,1.21405656750676e-05,0.000128658462218899,3.43239891215253,"UP",FALSE,"High","Master Protein","P35579","Myosin-9 [OS=Homo sapiens]",0,61.891,2,4,4,17,4,1960,226.4,5.6,58.8,4,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00063, Pf01576, Pf02736","4627","A8K6E4; hsa:4627; O60805; P35579; Q60FE2; Q86T83","ENSG00000100345","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Signaling by ALK fusions and activated point mutants; RHO GTPases activate CIT; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs; CD163 mediating an anti-inflammatory response","Primary focal segmental glomerulosclerosis (FSGS); VEGFA-VEGFR2 signaling; Nephrotic syndrome; HDAC6 interactions in the central nervous system",17,0,67.1,66.4,66.9,140.3,135.3,120.1,113.2,121.3,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1943(100)]",0,"ENSG00000100345"
"155","POP1",-1.062840081874,6.38985221095278,-8.17980135469308,1.25731344908298e-05,0.00013238293863893,3.395120041724,"DOWN",FALSE,"High","Master Protein","Q99575","Ribonucleases P/MRP protein subunit POP1 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1024,114.6,9.22,8.18,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf06978, Pf08170","10940","A8K5W9; Q15037; Q99575","ENSG00000104356","tRNA processing in the nucleus",NA,1,0,140,158.5,130.1,59.5,71.9,62.3,67,62.7,75.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S367(100)]",0,"ENSG00000104356"
"156","MATR3",-1.36365617322114,6.30967024929068,-8.1478574330791,1.2997593820456e-05,0.000134764970996327,3.35976380536736,"DOWN",FALSE,"High","Master Protein","P43243","Matrin-3 [OS=Homo sapiens]",0,75.888,8,9,14,44,9,847,94.6,6.25,113.75,9,"stress response;developmental processes;other biological processes","other membranes;nucleus","nucleic acid binding activity;other molecular function",NA,"9782","B7ZAV5; D3DQC3; hsa:9782; P43243; Q9UHW0; Q9UQ27","ENSG00000015479",NA,NA,0,0,167.4,153.9,154.2,57.2,71.1,46.5,65.5,53.7,62.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100); S598(100); S604(99.4); S615(100); S621(99.6); S705(98.9)]",0,"ENSG00000015479"
"157","F2R",0.88144290168217,6.67096124626582,8.14494201107929,1.30371044793824e-05,0.000134764970996327,3.35653150292386,"UP",FALSE,"High","Master Protein","P25116","Proteinase-activated receptor 1 [OS=Homo sapiens]",0,14.069,4,1,1,1,1,425,47.4,8.27,3.93,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00001","2149","hsa:2149; P25116; Q53XV0; Q96RF7; Q9BUN4","ENSG00000181104","G alpha (q) signalling events; Peptide ligand-binding receptors; Thrombin signalling through proteinase activated receptors (PARs); Common Pathway of Fibrin Clot Formation","GPCRs, other; Apoptosis-related network due to altered Notch3 in ovarian cancer; IL1 and megakaryocytes in obesity; Dengue-2 interactions with complement and coagulation cascades; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; GPCRs, class A rhodopsin-like; Regulation of actin cytoskeleton; Complement and coagulation cascades",13,0,67.9,70.4,72.2,133.8,153.1,117.9,107.8,123.5,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S418(100)]",0,"ENSG00000181104"
"158","TMEM192",-1.55701055646508,6.3259464817936,-8.14310952495535,1.30620059220323e-05,0.000134764970996327,3.35449937456757,"DOWN",FALSE,"High","Master Protein","Q8IY95","Transmembrane protein 192 [OS=Homo sapiens]",0,11.727,4,1,1,2,1,271,30.9,7.99,5.9,1,NA,"other membranes;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf14802","201931","hsa:201931; Q7Z3A1; Q8IY95; Q8N928","ENSG00000170088",NA,NA,0,0,149.7,143.4,141.7,30.9,39.2,56.7,89.6,61.5,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S230(99.7)]",0,"ENSG00000170088"
"159","BNIP3L",0.781198988078112,6.65672263547982,8.13814893857029,1.3129675483098e-05,0.000134764970996327,3.34899654094817,"UP",FALSE,"High","Master Protein","O60238","BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like [OS=Homo sapiens]",0,2.831,4,2,3,3,2,219,23.9,5.85,4.2,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;mitochondrion;ER/Golgi;nucleus","other molecular function","Pf06553","665","B0AZS9; hsa:665; O60238; Q5JW63; Q8NF87","ENSG00000104765","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","Apoptosis; Photodynamic therapy-induced HIF-1 survival signaling",3,0,70.3,67.1,79.7,117.1,143.4,128.4,100.4,119.2,111.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S168(100)]",0,"ENSG00000104765"
"160","FSCN1",-0.629599088971442,6.59711760205612,-8.11103241922359,1.35064082891673e-05,0.000136562589981789,3.31886907410649,"DOWN",FALSE,"High","Master Protein","Q16658","Fascin [OS=Homo sapiens]",0,13.023,4,3,3,3,3,493,54.5,7.24,6.15,3,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf06268","6624","A6NI89; B2RE97; hsa:6624; Q16658; Q96IC5; Q96IH1; Q9BRF1","ENSG00000075618","Interleukin-4 and Interleukin-13 signaling","VEGFA-VEGFR2 signaling; Urotensin-II-mediated signaling pathway",3,0,115.8,102.5,106.5,71.6,58.5,72.1,109.8,113.5,128.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000075618"
"161","HDAC1",-0.867097206459853,6.32744365241305,-8.10911519900711,1.35334872912531e-05,0.000136562589981789,3.31673597043442,"DOWN",FALSE,"High","Master Protein","Q13547","Histone deacetylase 1 [OS=Homo sapiens]",0,13.136,4,1,1,2,1,482,55.1,5.48,3.3,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00850","3065","hsa:3065; Q13547; Q92534","ENSG00000116478","Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Formation of the beta-catenin:TCF transactivating complex; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Estrogen-dependent gene expression; MECP2 regulates transcription of neuronal ligands; Factors involved in megakaryocyte development and platelet production; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Downregulation of SMAD2/3:SMAD4 transcriptional activity; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; G1/S-Specific Transcription; Regulation of TP53 Activity through Acetylation; Transcription of E2F targets under negative control by DREAM complex; Nuclear events stimulated by ALK signaling in cancer; Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1; MECP2 regulates neuronal receptors and channels; Repression of WNT target genes; Loss of MECP2 binding ability to 5mC-DNA","Androgen receptor signaling pathway; Energy metabolism; Cell cycle; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Neural crest differentiation; Retinoblastoma gene in cancer; Notch signaling; Apoptosis-related network due to altered Notch3 in ovarian cancer; Initiation of transcription and translation elongation at the HIV-1 LTR; MECP2 and associated Rett syndrome; IL6 signaling pathway; TGF-beta signaling pathway; Valproic acid pathway; VEGFA-VEGFR2 signaling; Ethanol effects on histone modifications; Rett syndrome; Effect of progerin on genes involved in progeria; Ciliary landscape; Transcription co-factors SKI and SKIL protein partners; Overlap between signal transduction pathways contributing to LMNA laminopathies; Opioid receptor pathways; 15q11q13 copy number variation; Notch signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways",56,0,154.8,148.1,119.2,69.4,75.5,74,57.9,61.7,59.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S423(99.4)]",0,"ENSG00000116478"
"162","API5",-0.618874333999657,6.58171074233033,-8.10753537889387,1.35558453290746e-05,0.000136562589981789,3.31497796069758,"DOWN",FALSE,"High","Master Protein","Q9BZZ5","Apoptosis inhibitor 5 [OS=Homo sapiens]",0,27.084,4,3,3,7,3,524,59,7.34,15.62,3,"other biological processes","nucleus;other cell component","other molecular function","Pf05918","8539","B4DGR0; B4DRJ2; B4E283; D3DR21; G3V1C3; hsa:8539; O15441; Q9BZZ5; Q9Y4J7","ENSG00000166181",NA,NA,0,0,120.7,120.9,120,78.1,73.1,78.1,87.5,100.3,96.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S464(100); S470(100)]",0,"ENSG00000166181"
"163","CAMK2D",-0.969164930004952,6.50216580575204,-8.04088397117584,1.45368297254941e-05,0.000145546663263843,3.24056260519706,"DOWN",FALSE,"High","Master Protein","Q13557-8","Isoform Delta 6 of Calcium/calmodulin-dependent protein kinase type II subunit delta [OS=Homo sapiens]",0,91.705,12,8,12,35,1,478,54.1,7.25,89.11,8,NA,NA,NA,NA,NA,"Q13557-8",NA,NA,NA,0,0,143.1,129,135.6,67,71.5,59,87.4,78,90.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T287(100); S315(100); S319(100); T336(99.6); T337(97.6); S472(100)]",0,"ENSG00000145349"
"164","FRMD8",0.843790223640264,6.5719811708189,8.01327707505914,1.49656041990188e-05,0.000148926012517065,3.20959836332949,"UP",FALSE,"High","Master Protein","Q9BZ67","FERM domain-containing protein 8 [OS=Homo sapiens]",0,19.272,6,2,2,7,2,464,51.2,6.23,23.03,2,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus",NA,"Pf00373","83786","B4E2P1; hsa:83786; Q86V56; Q8NCB5; Q9BZ67","ENSG00000126391",NA,NA,0,0,61.3,47.4,50.4,95.1,93.7,99.1,153.7,165,184.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S439(100); S446(100)]",0,"ENSG00000126391"
"165","PDLIM5",0.89736133457954,6.63003701925835,8.00691861060517,1.50663022240178e-05,0.000149019425633921,3.2024548289332,"UP",FALSE,"High","Master Protein","Q96HC4","PDZ and LIM domain protein 5 [OS=Homo sapiens]",0,14.622,3,1,1,2,1,596,63.9,8.21,3.66,1,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00412, Pf00595","10611","A8K6F9; D6RB78; E9PBF5; hsa:10611; O60705; Q56VN4; Q5UW38; Q8WVK0; Q96HC4","ENSG00000163110","Neurexins and neuroligins","Extracellular vesicles in the crosstalk of cardiac cells",2,0,65.5,69,81.4,138.2,161.6,122.5,96.2,106.8,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S111(99.6)]",0,"ENSG00000163110"
"166","KCNN3",1.06892616908911,6.62636301379967,7.94084178813435,1.61576193727502e-05,0.000157509516777587,3.12795687410023,"UP",FALSE,"High","Master Protein","Q9UGI6","Small conductance calcium-activated potassium channel protein 3 [OS=Homo sapiens]",0,17.758,3,2,2,2,2,731,81.3,8.95,8.23,2,"transport","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf02888, Pf03530, Pf07885","3782","B1ANX0; hsa:3782; O43517; Q86VF9; Q8WXG7; Q9UGI6","ENSG00000143603","Ca2+ activated K+ channels","Estradiol regulation in porto-sinusoidal vascular disease; Genetic causes of porto-sinusoidal vascular disease",3,0,67.8,64.7,66.2,140.3,136.4,139.9,118.6,106.9,86.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100); S167(100)]",0,"ENSG00000143603"
"167","BUD13",-0.509045648851094,6.55755468828439,-7.93988466841385,1.61740471188485e-05,0.000157509516777587,3.12687424103127,"DOWN",FALSE,"High","Master Protein","Q9BRD0","BUD13 homolog [OS=Homo sapiens]",0,19.361,4,2,2,4,2,619,70.5,9.86,14.22,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf09736","84811","A8K0S0; hsa:84811; Q96LS7; Q9BRD0","ENSG00000137656","mRNA Splicing - Major Pathway",NA,1,0,124.3,119.7,116,84,76.8,90.2,85.1,87.7,85.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(100); S325(100)]",0,"ENSG00000137656"
"168","SYT6",-0.903807930979481,6.53540845302235,-7.93754885092801,1.62142149623987e-05,0.000157509516777587,3.12423168760426,"DOWN",FALSE,"High","Master Protein","Q5T7P8","Synaptotagmin-6 [OS=Homo sapiens]",0,5.739,2,1,1,1,1,510,57.3,8.19,3.23,1,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi","other molecular function","Pf00168","148281","B1AMB8; B3KPK1; hsa:148281; Q5T7P8","ENSG00000134207",NA,NA,0,0,92.9,100.8,95.5,59.1,34.4,49,157.5,140.1,150.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100)]",0,"ENSG00000134207"
"169","ESF1",-0.712948198898203,6.57208705164908,-7.90916381735245,1.67111260816731e-05,0.000161376081451423,3.09207092704994,"DOWN",FALSE,"High","Master Protein","Q9H501","ESF1 homolog [OS=Homo sapiens]",0,15.073,2,1,1,1,1,851,98.7,5.11,4.33,1,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf08159","51575","hsa:51575; Q86X92; Q9H501; Q9H9Q5; Q9HA35; Q9NX93; Q9P1S6","ENSG00000089048",NA,NA,0,0,126.7,115.4,126.5,78.5,68.5,69.5,96,89.1,103.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(100)]",0,"ENSG00000089048"
"170","PABPN1",-0.68872062380435,6.60493860437655,-7.90345406806992,1.68130735419172e-05,0.000161405506002405,3.08559088796091,"DOWN",FALSE,"High","Master Protein","Q86U42","Polyadenylate-binding protein 2 [OS=Homo sapiens]",0,31.836,22,2,2,5,2,306,32.7,5.06,18.21,2,"RNA metabolism OR transcription;other metabolic processes;transport;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","8106","D3DS49; hsa:8106; O43484; Q86U42","ENSG00000100836","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs; Inhibition of Host mRNA Processing and RNA Silencing; Z-decay: degradation of maternal mRNAs by zygotically expressed factors","mRNA processing",7,0,120.5,126.7,132,72.2,80.1,78,93.6,94.4,98.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100); S150(100)]",0,"ENSG00000100836"
"171","AHNAK2",1.67876863310038,6.52744162320602,7.89513645428238,1.69627995730605e-05,0.000161890578381489,3.07614468433366,"UP",FALSE,"High","Master Protein","Q8IVF2","Protein AHNAK2 [OS=Homo sapiens]",0,30.408,4,3,4,8,3,5795,616.2,5.36,20.86,3,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component",NA,NA,"113146","hsa:113146; Q5BKX7; Q7Z343; Q7Z358; Q7Z394; Q7Z3G0; Q86WQ6; Q8IVF2; Q8IYY1; Q8N3G4; Q96EX9","ENSG00000185567",NA,NA,0,0,50.5,41.3,55.6,142.4,162.8,180.6,127.3,112.3,74.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S294(100); S842(100); S1007(100); S1337(100); S1502(100); S1667(100); S1832(100); S1997(100); S2162(100); S2492(100); S2822(100); S2987(100); S3152(100); S3482(100); S3812(100); S3977(100); S4142(100); S4307(100)]",0,"ENSG00000185567"
"172","TRIP10",0.677377566316337,6.64612291461816,7.88099007973813,1.72207987004537e-05,0.000163397345808956,3.06006116583851,"UP",FALSE,"High","Master Protein","Q15642","Cdc42-interacting protein 4 [OS=Homo sapiens]",0,12.69,3,1,1,1,1,601,68.3,5.73,4.3,1,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00018, Pf00611","9322","B2R8A6; B7WP22; D6W645; hsa:9322; O15184; Q15642; Q53G22; Q5TZN1; Q6FI24; Q8NFL1; Q8TCY1; Q8TDX3; Q96RJ1","ENSG00000125733","RHOQ GTPase cycle; Clathrin-mediated endocytosis","Angiopoietin-like protein 8 regulatory pathway",3,0,70.3,73.6,74.3,109.8,121.5,130.3,104.4,115.1,123.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S296(100)]",0,"ENSG00000125733"
"173","SORBS3",0.768569427374645,6.64941628219645,7.8749475373625,1.73323026448854e-05,0.000163504727840768,3.05318439210456,"UP",FALSE,"High","Master Protein","O60504","Vinexin [OS=Homo sapiens]",0,28.582,3,2,3,7,2,671,75.3,9.45,21.99,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf00018, Pf02208, Pf14604","10174","hsa:10174; O60504; Q5BJE4; Q6NX54; Q96FY4; Q9UQE4","ENSG00000120896","Smooth Muscle Contraction",NA,1,0,72.2,67.6,78.4,123.9,118.9,138.6,98.8,108.2,116.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S530(99.6); S545(100)]",0,"ENSG00000120896"
"174","DCLK2",0.678429233828709,6.66759823125369,7.86429095963471,1.75308727366685e-05,0.000164427496012891,3.04104664997628,"UP",FALSE,"High","Master Protein","Q8N568","Serine/threonine-protein kinase DCLK2 [OS=Homo sapiens]",0,216.21,27,16,27,64,14,766,83.6,8.34,190.19,16,"cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf03607","166614","C9J5Q9; hsa:166614; Q59GC8; Q8N399; Q8N568","ENSG00000170390",NA,NA,0,0,77.3,79.1,77.5,130,128.2,125.7,97.5,114.3,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100); S34(99.5); T61(100); S166(100); S182(99.6); S223(100); S308(100); S317(99.5); S347(100); S355(100); S360(100); S362(100); S375(100); S682(99.5)]",0,"ENSG00000170390"
"175","SPECC1",0.533058627522821,6.65966031247355,7.85872353205527,1.76355988417831e-05,0.000164464556055943,3.03470036147284,"UP",FALSE,"High","Master Protein","Q5M775","Cytospin-B [OS=Homo sapiens]",0,87.326,12,8,10,16,8,1068,118.5,6.7,53.56,8,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf00307","92521","B4DHH0; B7WNS8; hsa:92521; Q5IBP1; Q5IBP2; Q5IBP3; Q5IBP4; Q5M772; Q5M773; Q5M774; Q5M775; Q86XT8; Q8N4U4; Q8WU84; Q9HCQ3","ENSG00000128487",NA,NA,0,0,77.1,79,81.6,118.7,122.5,117.6,108.8,111,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S55(99.4); S218(100); S315(100); S360(99.3); S810(100); S847(100); S914(100)]",0,"ENSG00000128487"
"176","URI1",1.53506726442813,6.43398482450922,7.80752701022747,1.86312381748621e-05,0.000171699600839193,2.97617897764884,"UP",FALSE,"High","Master Protein","O94763","Unconventional prefoldin RPB5 interactor 1 [OS=Homo sapiens]",0,26.88,5,2,2,3,2,535,59.8,5.05,13.06,2,"other biological processes","cytosol;mitochondrion;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf02996","8725","A8K805; H7BY42; hsa:8725; O94763; Q8TC23; Q9UNU3","ENSG00000105176",NA,NA,0,0,33.2,32.5,52.5,95.4,143,99.9,144.2,163.5,183.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S442(99.3)]",0,"ENSG00000105176"
"177","MAP4",0.743096788046719,6.68575587494744,7.80463592680153,1.86892613325757e-05,0.000171699600839193,2.97286548032784,"UP",FALSE,"High","Master Protein","P27816","Microtubule-associated protein 4 [OS=Homo sapiens]",0,279.764,21,21,33,142,21,1152,120.9,5.43,402.78,21,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00418","4134","P27816; Q13082; Q59FT2; Q68D74; Q6ZUW9; Q86V26; Q96A76; Q96NS9","ENSG00000047849",NA,"Splicing factor NOVA regulated synaptic proteins; 2q37 copy number variation syndrome",2,0,71.4,78.5,78.5,136.6,129.5,124.7,105.4,115.8,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S280(100); S358(100); S384(100); T451(100); S507(100); T521(100); S696(100); S740(100); S787(98.9); S801(99.4); S825(100); S868(99.6); S941(99.7); S1073(100)]",0,"ENSG00000047849"
"178","ZNF326",-0.997036154688849,6.48977438092955,-7.80275881571779,1.8727039797412e-05,0.000171699600839193,2.97071360241043,"DOWN",FALSE,"High","Master Protein","Q5BKZ1","DBIRD complex subunit ZNF326 [OS=Homo sapiens]",0,3.826,2,2,2,4,2,582,65.6,5.15,4.42,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04988","284695","A8MYX1; B4DLN0; B4E179; hsa:284695; Q5BKZ1; Q5VW93; Q5VW94; Q5VW96; Q5VW97; Q6NSA2; Q7Z638; Q7Z6C2","ENSG00000162664",NA,NA,0,0,136.4,144.2,132.1,76.8,41.6,77.2,80.5,89.8,77.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100)]",0,"ENSG00000162664"
"179","EPB41L1",0.847318744056829,6.65265410823524,7.75465829348785,1.97240608010645e-05,0.000179830543169482,2.9154366562471,"UP",FALSE,"High","Master Protein","Q9H4G0","Band 4.1-like protein 1 [OS=Homo sapiens]",0,185.922,21,19,29,48,19,881,98.4,5.62,128.15,19,"cell organization and biogenesis","plasma membrane;other membranes;cytosol;cytoskeleton","cytoskeletal activity;other molecular function","Pf00373, Pf04382, Pf05902, Pf08736, Pf09379, Pf09380","2036","hsa:2036; O15046; Q4VXM6; Q4VXM7; Q4VXM8; Q4VXN4; Q6ZT61; Q8IUU7; Q96CV5; Q96L65; Q9H4G0","ENSG00000088367","Trafficking of AMPA receptors; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Neurexins and neuroligins","Splicing factor NOVA regulated synaptic proteins",5,0,74.8,78.7,79.5,145.4,139.8,137.9,92,103.8,83.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); T78(99.1); S86(100); S378(100); T475(100); T489(99.6); S510(100); S546(99.5); S667(100); T686(99.5); S759(100); S784(100); S870(100)]",0,"ENSG00000088367"
"180","PRKDC",-0.618507738924901,6.49239772621758,-7.7439373120193,1.99540777443861e-05,0.0001809169715491,2.90308047696844,"DOWN",FALSE,"High","Master Protein","P78527","DNA-dependent protein kinase catalytic subunit [OS=Homo sapiens]",0,139.061,4,9,13,22,9,4128,468.8,7.12,76.58,9,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00454, Pf02259, Pf02260, Pf08163, Pf19704, Pf20502","5591","hsa:5591; P78527; P78528; Q13327; Q13337; Q14175; Q59H99; Q7Z611; Q96SE6; Q9UME3","ENSG00000253729","E3 ubiquitin ligases ubiquitinate target proteins; Cytosolic sensors of pathogen-associated DNA ; Nonhomologous End-Joining (NHEJ); IRF3-mediated induction of type I IFN","miRNA regulation of DNA damage response; Cell cycle; Retinoblastoma gene in cancer; Fas ligand pathway and stress induction of heat shock proteins; Pathways affected in adenoid cystic carcinoma; Non-homologous end joining; Osteoblast differentiation and related diseases; DNA repair pathways, full network; DNA damage response",13,0,129.8,124.8,118.1,76.5,77.7,83.4,75.7,76.2,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S511(100); S2612(100); S3205(100); S3731(100)]",0,"ENSG00000253729"
"181","NKAP",-1.2386341357822,6.38089935338242,-7.7370259578674,2.01039081916709e-05,0.000181268387672967,2.8951080687851,"DOWN",FALSE,"High","Master Protein","Q8N5F7","NF-kappa-B-activating protein [OS=Homo sapiens]",0,27.521,8,2,2,7,2,415,47.1,10.11,18.83,2,"cell cycle OR cell proliferation;signal transduction;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf06047, Pf15692","79576","hsa:79576; Q6IPW6; Q8N5F7; Q96BQ2; Q9H638","ENSG00000101882","mRNA Splicing - Major Pathway",NA,1,0,146.6,146.2,143.8,70.1,34.6,66.1,73.1,82.6,63,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S149(100)]; Met-loss [N-Term]",0,"ENSG00000101882"
"182","YWHAZ",0.558264932228762,6.67314529593922,7.71776333657166,2.05280078410065e-05,0.000184075323057816,2.87285953961651,"UP",FALSE,"High","Master Protein","P63104","14-3-3 protein zeta/delta [OS=Homo sapiens]",0,135.574,50,10,11,18,6,245,27.7,4.79,56.6,10,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00244","7534","A8K1N0; B7Z465; hsa:7534; P29213; P29312; P63104; Q32P43; Q5XJ08; Q6GPI2; Q6IN74; Q6NUR9; Q6P3U9; Q86V33","ENSG00000164924","Deactivation of the beta-catenin transactivating complex; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; Negative regulation of NOTCH4 signaling; Interleukin-3, Interleukin-5 and GM-CSF signaling; TP53 Regulates Metabolic Genes; NOTCH4 Activation and Transmission of Signal to the Nucleus; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Rap1 signalling; KSRP (KHSRP) binds and destabilizes mRNA; GP1b-IX-V activation signalling; Activation of BAD and translocation to mitochondria","Cell cycle; Prolactin signaling pathway; Pathogenic Escherichia coli infection; Myometrial relaxation and contraction pathways; Hepatitis B infection; GDNF signaling; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways",23,1,76.7,78.5,79.1,123.9,116,116.8,109.1,114.2,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S45(100)]",0,"ENSG00000164924"
"183","DDX41",-2.3429540463067,6.01989116634216,-7.71208475836696,2.06548844233007e-05,0.000184200936496321,2.86629266377013,"DOWN",FALSE,"High","Master Protein","Q9UJV9","Probable ATP-dependent RNA helicase DDX41 [OS=Homo sapiens]",0,8.22,3,2,2,2,2,622,69.8,6.84,2.67,2,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf00270, Pf00271","51428","B2RDC8; Q96BK6; Q96K05; Q9NT96; Q9NW04; Q9UJV9","ENSG00000183258","mRNA Splicing - Major Pathway; Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN","5q35 copy number variation",5,0,181.9,190.8,163.6,19.2,30.8,56.5,51.4,50.6,52.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S405(100)]",0,"ENSG00000183258"
"184","EPB41L2",0.7002733325807,6.6621687453399,7.70353688654734,2.08474834373794e-05,0.000184908113966322,2.85640072231281,"UP",FALSE,"High","Master Protein","O43491-4","Isoform 4 of Band 4.1-like protein 2 [OS=Homo sapiens]",0,154.779,12,13,15,51,1,852,95.5,5.77,121.71,13,NA,NA,NA,NA,NA,"O43491-4",NA,NA,NA,0,12,69.2,68.4,68.6,118.3,103.9,122,114.4,138.5,132.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S87(100); S499(100); T510(100); S550(100); S598(100); S613(99.6); S648(99.7)]",0,"ENSG00000079819"
"185","YTHDC1",-0.68069292607913,6.45773653457145,-7.69509444348913,2.10396288999678e-05,0.000185603645214851,2.84662260522256,"DOWN",FALSE,"High","Master Protein","Q96MU7","YTH domain-containing protein 1 [OS=Homo sapiens]",0,11.468,5,3,4,8,3,727,84.6,6.23,17,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","plasma membrane;other membranes;nucleus","nucleic acid binding activity;other molecular function","Pf04146","91746","hsa:91746; Q4W5Q3; Q7Z622; Q8TF35; Q96MU7","ENSG00000083896; ENSG00000275272",NA,NA,0,0,143.5,136.5,126,76.1,74.5,94.7,67.4,64.2,71.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(99.4); S294(100); S308(100)]",0,"ENSG00000083896"
"186","RNF20",-0.727966220335772,6.51643187000466,-7.68126764085106,2.1358499747728e-05,0.000187403610689743,2.83059068413906,"DOWN",FALSE,"High","Master Protein","Q5VTR2","E3 ubiquitin-protein ligase BRE1A [OS=Homo sapiens]",0,31.15,3,2,3,6,2,975,113.6,5.94,16.15,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00097","56254","A7MCT5; hsa:56254; Q2TB34; Q5VTR2; Q69YL5; Q6P527; Q8N3J4; Q96JD3; Q9H9Y7; Q9HA51; Q9NUR4; Q9NWQ3; Q9NX83","ENSG00000155827","E3 ubiquitin ligases ubiquitinate target proteins; RHOBTB1 GTPase cycle","ATM signaling in development and disease",3,0,130,137.3,125.7,73.3,76.7,80.8,73.5,80.3,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000155827"
"187","WDTC1",-0.92042669523974,6.50468097207433,-7.64890361862879,2.21256470380083e-05,0.000193096555968072,2.79297960276183,"DOWN",FALSE,"High","Master Protein","Q8N5D0","WD and tetratricopeptide repeats protein 1 [OS=Homo sapiens]",0.003,2.216,2,1,1,1,1,677,75.9,7.27,2.58,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00400","23038","D3DPL5; hsa:23038; Q5SSC5; Q8N5D0; Q9NV87; Q9UPW4","ENSG00000142784","Neddylation",NA,1,0,139.7,139.7,125.2,61.5,72.4,66.2,88.9,73.7,90.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S511(100)]",0,"ENSG00000142784"
"188","EYA4",-0.590490023813989,6.56643509433768,-7.62981019580476,2.2592272130839e-05,0.000196120149561325,2.77073421320605,"DOWN",FALSE,"High","Master Protein","O95677","Eyes absent homolog 4 [OS=Homo sapiens]",0,33.064,2,2,2,7,2,639,69.5,5.2,21.49,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf00702","2070","B7Z7F7; hsa:2070; O95464; O95677; O95679; Q8IW39; Q9NTR7","ENSG00000112319","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks",NA,1,0,127.9,120.4,128.5,81.3,81.4,84.9,85.5,80.9,89.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S361(100)]",0,"ENSG00000112319"
"189","DHX57",0.673663660524856,6.65017743020559,7.61377021804383,2.2992562696907e-05,0.000198538954081229,2.75201387665051,"UP",FALSE,"High","Master Protein","Q6P158","Putative ATP-dependent RNA helicase DHX57 [OS=Homo sapiens]",0,31.689,2,2,2,4,2,1386,155.5,7.71,12.45,2,NA,NA,"other molecular function","Pf00270, Pf00271, Pf04408, Pf05773, Pf07717, Pf18044, Pf21010","90957","A2RRC7; hsa:90957; Q53SI4; Q6P158; Q6P9G1; Q7Z6H3; Q8NG17; Q96M33","ENSG00000163214",NA,NA,0,0,77.7,72.9,78.5,129.1,126.9,122.5,95.6,111.7,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(100); S132(100)]",0,"ENSG00000163214"
"190","GAB1",0.779282318568425,6.59151200039026,7.5437437146791,2.48328942996271e-05,0.000213301492089429,2.66993684457757,"UP",FALSE,"High","Master Protein","Q13480-2","Isoform 2 of GRB2-associated-binding protein 1 [OS=Homo sapiens]",0,198.627,27,13,17,32,13,724,80,6.38,112.45,13,NA,NA,NA,NA,NA,"Q13480-2",NA,NA,NA,0,0,78.7,79.6,83.9,138.3,177.1,127.3,79.1,91,75.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100); S266(100); S274(100); S383(99.4); S402(100); S454(100); T503(99.4); S531(100); S547(100); S713(100)]",0,"ENSG00000109458"
"191","DPYSL2",1.0838328195879,6.59374182879845,7.50877039193391,2.58115624207406e-05,0.000220546962673553,2.62873149638485,"UP",FALSE,"High","Master Protein","Q16555","Dihydropyrimidinase-related protein 2 [OS=Homo sapiens]",0,279.019,36,18,30,71,15,572,62.3,6.38,225.7,18,"cell organization and biogenesis;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton","other molecular function","Pf01979","1808","A8K5H2; B4DR31; D3DSS7; hsa:1808; O00424; Q16555","ENSG00000092964","Recycling pathway of L1; CRMPs in Sema3A signaling","Microtubule cytoskeleton regulation; Brain-derived neurotrophic factor (BDNF) signaling pathway",4,3,62.2,64.7,64.4,138.4,195.1,108.4,100.3,105.9,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T509(100); T514(99.8); S518(99.2); S522(100); S542(100); T569(100)]",0,"ENSG00000092964"
"192","PSMD1",-0.60427227230271,6.61557991979233,-7.48232968080639,2.65793253368527e-05,0.000225924265363248,2.59748420436225,"DOWN",FALSE,"High","Master Protein","Q99460","26S proteasome non-ATPase regulatory subunit 1 [OS=Homo sapiens]",0,56.743,5,4,4,9,4,953,105.8,5.39,36.02,4,"protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf01851, Pf13646, Pf18004, Pf21505","5707","B8ZZH9; hsa:5707; Q24JU0; Q53TI2; Q6GMU5; Q6P2P4; Q6PJM7; Q6PKG9; Q86VU1; Q8IV79; Q99460","ENSG00000173692","Neutrophil degranulation; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Cross-presentation of soluble exogenous antigens (endosomes); Regulation of ornithine decarboxylase (ODC); Somitogenesis","Proteasome degradation; Alzheimer's disease and miRNA effects; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",64,0,111.7,109.7,109.5,78.7,57.6,75.8,118.1,114.5,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T273(100); T311(100); S315(100)]",0,"ENSG00000173692"
"193","ABCF1",0.599593847496291,6.65966750357213,7.46767067997678,2.70156655379925e-05,0.000228443347968931,2.58012501657554,"UP",FALSE,"High","Master Protein","Q8NE71","ATP-binding cassette sub-family F member 1 [OS=Homo sapiens]",0,105.238,6,5,7,16,5,845,95.9,6.8,69.1,5,"protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00005","23","A2BF75; hsa:23; O14897; Q69YP6; Q8NE71","ENSG00000204574; ENSG00000206490; ENSG00000225989; ENSG00000231129; ENSG00000232169; ENSG00000236149; ENSG00000236342","ABC-family proteins mediated transport","IL-18 signaling pathway",2,0,70.4,69.9,73.2,107.7,128.6,105.7,121.7,124.1,135.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S109(100); S166(100); S228(100)]",0,"ENSG00000204574"
"194","EPS15L1",0.52208219463201,6.64619393827084,7.43499708822288,2.80165493953442e-05,0.000235685611408257,2.54134186914229,"UP",FALSE,"High","Master Protein","Q9UBC2","Epidermal growth factor receptor substrate 15-like 1 [OS=Homo sapiens]",0,113.758,13,6,6,15,6,864,94.2,5.11,51.31,6,"transport","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf12763","58513","A2RRF3; A5PL29; B4DKA3; hsa:58513; Q9UBC2","ENSG00000127527","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation","EGF/EGFR signaling pathway",4,0,80.4,86.2,85.7,120.6,126.3,129.1,97.8,98,92.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S229(100); S255(100); T366(100)]",0,"ENSG00000127527"
"195","BRAT1",-0.797778960271017,6.49704532489978,-7.42441993054519,2.83491487373634e-05,0.000237260567894241,2.5287599040735,"DOWN",FALSE,"High","Master Protein","Q6PJG6","BRCA1-associated ATM activator 1 [OS=Homo sapiens]",0,22.932,2,1,1,2,1,821,88.1,5.27,7.14,1,"cell cycle OR cell proliferation;other metabolic processes;stress response;other biological processes","nucleus;other cell component",NA,"Pf02985","221927","A4D200; C9JY24; hsa:221927; Q6PJG6; Q8IW85; Q8IZ43; Q8WVR8; Q96IV9; Q9H7J8; Q9UFA3","ENSG00000106009",NA,NA,0,0,136.1,138,113.1,86.1,54.7,71.2,84.8,84.7,80.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S742(100)]",0,"ENSG00000106009"
"196","FEZ1",-1.5274118912978,6.50033429381654,-7.41761449441122,2.85654165713211e-05,0.000237850815532633,2.52065755758022,"DOWN",FALSE,"High","Master Protein","Q99689","Fasciculation and elongation protein zeta-1 [OS=Homo sapiens]",0,8.513,3,1,1,1,1,392,45.1,4.3,3.51,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf07763","9638","hsa:9638; O00679; O00728; Q6IBI7; Q99689","ENSG00000149557",NA,"Prader-Willi and Angelman syndrome",1,0,106.9,134,169,52.4,34.4,41.8,131.8,104.8,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S58(100)]",0,"ENSG00000149557"
"197","TAOK2",0.593497340945023,6.6366989969825,7.40866948647522,2.885241256023e-05,0.00023902100151419,2.50999955566077,"UP",FALSE,"High","Master Protein","Q9UL54-2","Isoform 2 of Serine/threonine-protein kinase TAO2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1049,119.2,7.47,5.95,1,NA,NA,NA,NA,NA,"Q9UL54-2",NA,NA,NA,0,0,70.8,71.7,81.3,118.5,114.7,116,105.2,114.7,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1011(100)]",0,"ENSG00000149930"
"198","PDAP1",0.680675300524408,6.63154430543194,7.39683364536468,2.92369927511136e-05,0.000240983697827361,2.49588253046695,"UP",FALSE,"High","Master Protein","Q13442","28 kDa heat- and acid-stable phosphoprotein [OS=Homo sapiens]",0,30.781,23,3,5,8,3,181,20.6,8.87,25.02,3,"signal transduction","non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component",NA,"Pf10252","11333","D6W5S5; hsa:11333; Q13442; Q92906","ENSG00000106244","Neutrophil degranulation",NA,1,0,68.5,67.4,68.5,109.1,135.1,103.1,117.8,124.8,132.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T18(99.7); S63(100); S176(100)]",0,"ENSG00000106244"
"199","LEMD2",-0.893853445497826,6.52586490777736,-7.36276645030045,3.03754114337831e-05,0.000249108901808714,2.45515641994825,"DOWN",FALSE,"High","Master Protein","Q8NC56","LEM domain-containing protein 2 [OS=Homo sapiens]",0,8.484,6,3,3,8,3,503,56.9,9,6.76,3,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytoskeleton;nucleus;other cell component",NA,"Pf03020, Pf09402","221496","B4DVH5; E7EVT2; Q5T972; Q5T974; Q8NC56","ENSG00000161904","Sealing of the nuclear envelope (NE) by ESCRT-III; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina",NA,4,0,129.5,126.7,120.3,55.9,70,64.9,96,86.7,106,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S499(99.6)]",0,"ENSG00000161904"
"200","SNX24",-0.644696578397674,6.5938212061408,-7.3497344426548,3.0823579116496e-05,0.000251520405590607,2.43954054005348,"DOWN",FALSE,"High","Master Protein","Q9Y343","Sorting nexin-24 [OS=Homo sapiens]",0,9.584,10,1,1,1,1,169,19.8,7.24,3.53,1,"transport","other membranes","other molecular function","Pf00787","28966","hsa:28966; Q6UY33; Q9Y343","ENSG00000064652",NA,NA,0,0,120.8,115.7,127.6,87.9,63.9,75.6,101.1,94.5,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S116(100)]",0,"ENSG00000064652"
"201","GPRC5B",1.00545850204098,6.61940440457223,7.33365836405488,3.13863691249366e-05,0.000254030740346962,2.42024907286253,"UP",FALSE,"High","Master Protein","Q9NZH0","G-protein coupled receptor family C group 5 member B [OS=Homo sapiens]",0,7.351,5,2,3,5,2,403,44.8,8.24,7.65,2,"signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00003","51704","D2DFB0; hsa:51704; O75205; Q8NBZ8; Q9NZH0","ENSG00000167191",NA,"GPCRs, class C metabotropic glutamate, pheromone",1,0,60.6,66,72,124.4,125.3,160.3,105.9,119.8,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S354(100); S360(100); S362(100)]",0,"ENSG00000167191"
"202","APPL1",0.81718999146467,6.62427398544335,7.33207135527955,3.14425303615725e-05,0.000254030740346962,2.41834296789081,"UP",FALSE,"High","Master Protein","Q9UKG1","DCC-interacting protein 13-alpha [OS=Homo sapiens]",0,30.401,3,1,1,3,1,709,79.6,5.41,15.28,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00640, Pf16746","26060","hsa:26060; Q9P2B9; Q9UKG1","ENSG00000157500","Caspase activation via Dependence Receptors in the absence of ligand","Follicle stimulating hormone (FSH) signaling pathway; Chromosomal and microsatellite instability in colorectal cancer",3,0,64,77.6,65.7,118.5,133.3,123.7,99.8,127.3,113.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S401(100)]",0,"ENSG00000157500"
"203","PWWP2A",-0.862687624749944,6.51770612458674,-7.32455885893089,3.17098711895943e-05,0.000254228241448562,2.40931585623103,"DOWN",FALSE,"High","Master Protein","Q96N64","PWWP domain-containing protein 2A [OS=Homo sapiens]",0,9.303,2,1,1,1,1,755,81.9,9,3.64,1,"cell organization and biogenesis;other biological processes","nucleus","other molecular function","Pf00855","114825","G5EA07; hsa:114825; Q2HJJ2; Q8IYR3; Q96N64; Q96PV3","ENSG00000170234",NA,NA,0,0,136.1,127.3,138.4,64.8,80.6,66.1,82.2,91.4,78.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S81(100)]",0,"ENSG00000170234"
"204","HRH1",1.00776791111162,6.65346595336533,7.322640602895,3.17785301810703e-05,0.000254228241448562,2.40700977105913,"UP",FALSE,"High","Master Protein","P35367","Histamine H1 receptor [OS=Homo sapiens]",0,10.777,4,2,2,3,2,487,55.7,9.22,8.08,2,"cell-cell signaling;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00001","3269","A8K047; hsa:3269; P35367; Q6P9E5","ENSG00000196639","G alpha (q) signalling events; Histamine receptors","IL-4 signaling pathway; GPCRs, class A rhodopsin-like; Monoamine GPCRs",5,0,62.2,60.6,59.5,129.3,96.9,139.2,125.9,152.6,123,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100); S380(100)]",0,"ENSG00000196639"
"205","FTSJ3",-0.815119135734783,6.53070177800398,-7.31606638539121,3.20150668940115e-05,0.000254871166687935,2.39910304319135,"DOWN",FALSE,"High","Master Protein","Q8IY81","pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 [OS=Homo sapiens]",0,20.237,5,2,5,8,2,847,96.5,8.4,18.44,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf01728, Pf07780, Pf11861","117246","B2RCA5; D3DU22; hsa:117246; Q8IY81; Q8N3A3; Q8WXX1; Q9BWM4; Q9NXT6","ENSG00000108592","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,139.3,123.6,122.5,67.2,69.9,68.8,93.4,78.1,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S333(99.6); S335(99.7); S584(100)]",0,"ENSG00000108592"
"206","CLU",-0.746338500257528,6.48946301727028,-7.30011964959022,3.25968173610096e-05,0.000258242747248386,2.37990254610074,"DOWN",FALSE,"High","Master Protein","P10909","Clusterin [OS=Homo sapiens]",0,176.695,23,9,12,23,9,449,52.5,6.27,78.28,9,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf01093","1191","B2R9Q1; B3KSE6; hsa:1191; P10909; P11380; P11381; Q2TU75; Q5HYC1; Q7Z5B9","ENSG00000120885","Regulation of Complement cascade; Platelet degranulation ; Antimicrobial peptides; Terminal pathway of complement","Dengue-2 interactions with complement and coagulation cascades; Male infertility; Complement system in neuronal development and plasticity; Complement and coagulation cascades",8,0,134.8,135.7,143.5,79.9,77.7,83.2,79.2,67.1,64.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S396(99.4)]",0,"ENSG00000120885"
"207","NEDD1",0.594718410113583,6.58923807267236,7.28045271052357,3.33301713229288e-05,0.000262777002893815,2.35618065372368,"UP",FALSE,"High","Master Protein","Q8NHV4","Protein NEDD1 [OS=Homo sapiens]",0,10.595,3,2,2,3,2,660,71.9,7.97,8.15,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf00400","121441","B0AZN0; B4E145; G3V3F1; hsa:121441; Q8NA30; Q8NHV4","ENSG00000139350","Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2",NA,7,0,60.4,56.4,58.6,97.1,76.6,92.1,145.6,186.3,167.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S397(100); S493(100)]",0,"ENSG00000139350"
"208","FKBP3",0.844897965555639,6.65574426586694,7.27254857943313,3.36299448846138e-05,0.000263865721402355,2.34663370866106,"UP",FALSE,"High","Master Protein","Q00688","Peptidyl-prolyl cis-trans isomerase FKBP3 [OS=Homo sapiens]",0,6.959,6,1,1,1,1,224,25.2,9.28,3,1,NA,"nucleus","other molecular function","Pf00254, Pf18410","2287","B2R4Q9; hsa:2287; Q00688; Q14317","ENSG00000100442",NA,NA,0,0,72.2,64.1,68.8,133.1,136.2,113.4,113.3,128.3,107.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(99.7)]",0,"ENSG00000100442"
"209","MTDH",-0.545596159828738,6.62775000909768,-7.25501784635657,3.43053367864681e-05,0.00026787707959577,2.32543242753814,"DOWN",FALSE,"High","Master Protein","Q86UE4","Protein LYRIC [OS=Homo sapiens]",0,58.702,11,5,5,10,5,582,63.8,9.32,34.21,5,"signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15686","92140","hsa:92140; Q05DH2; Q52QU9; Q6PK07; Q86UE4; Q8TCX3","ENSG00000147649",NA,"Gastric cancer network 2; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; CCL18 signaling pathway",3,0,109.1,117.9,112.5,83.7,68.2,76.3,103.9,114.4,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); S308(100); S426(100); S494(99.3); S568(100)]",0,"ENSG00000147649"
"210","TRAF4",-1.55466104006323,6.34545840014979,-7.23140127072466,3.52386200166646e-05,0.000273854418415222,2.29681227865676,"DOWN",FALSE,"High","Master Protein","Q9BUZ4","TNF receptor-associated factor 4 [OS=Homo sapiens]",0,10.917,3,1,1,2,1,470,53.5,8.15,6.75,1,"protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00097, Pf02176, Pf21355","9618","hsa:9618; O75615; Q14848; Q2KJU4; Q2PJN8; Q9BUZ4","ENSG00000076604",NA,"Small cell lung cancer; p53 transcriptional gene network",2,0,131.4,131.5,128.1,35.8,35.7,40.3,95.5,70.8,138.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S426(100)]",0,"ENSG00000076604"
"211","PHF12",-0.484027195036633,6.59929225526817,-7.20034794701928,3.6508052627108e-05,0.000281274902905652,2.25907677114905,"NONE",FALSE,"High","Master Protein","Q96QT6","PHD finger protein 12 [OS=Homo sapiens]",0,27.978,4,3,3,5,3,1004,109.6,7.74,21.22,3,"other biological processes","nucleus;other cell component","other molecular function","Pf00628, Pf16737","57649","hsa:57649; Q0VAI5; Q2TAK2; Q6ZML2; Q96QT6; Q9BV34; Q9H7U9; Q9P205","ENSG00000109118",NA,NA,0,0,118,121.1,121.4,85,82.9,90.5,87.2,92.3,92.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S131(100); T671(100); T880(99.6)]",0,"ENSG00000109118"
"212","NIPBL",-0.508561350053842,6.55730805008352,-7.19962573785179,3.65381614068617e-05,0.000281274902905652,2.25819775833599,"DOWN",FALSE,"High","Master Protein","Q6KC79","Nipped-B-like protein [OS=Homo sapiens]",0,81.097,4,8,8,13,8,2804,315.9,7.91,45.11,8,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf12765, Pf12830","25836","hsa:25836; Q6KC79; Q6KCD6; Q6N080; Q6ZT92; Q7Z2E6; Q8N4M5; Q9Y6Y3; Q9Y6Y4","ENSG00000164190","Cohesin Loading onto Chromatin","Cohesin complex - Cornelia de Lange syndrome; NIPBL role in DNA damage - Cornelia de Lange syndrome",3,0,126.4,120.3,115.7,86.2,80.6,84.9,87.8,87,81.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S280(100); S318(100); T713(100); T746(100); S2658(100)]",0,"ENSG00000164190"
"213","ATP1A2",-0.616025832572813,6.56176948112241,-7.19456381803542,3.67499513288808e-05,0.000281577091871988,2.25203502798846,"DOWN",FALSE,"High","Master Protein","P50993","Sodium/potassium-transporting ATPase subunit alpha-2 [OS=Homo sapiens]",0,75.252,8,6,7,10,6,1020,112.2,5.66,36.51,6,"other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf13246","477","D3DVE4; hsa:477; P50993; Q07059; Q5JW74; Q86UZ5; Q9UQ25","ENSG00000018625","Potential therapeutics for SARS; Ion homeostasis; Ion transport by P-type ATPases","Synaptic vesicle pathway",4,0,134.8,127.2,119.8,80.8,67.2,94.7,85.1,81.9,88.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S439(100)]",0,"ENSG00000018625"
"214","ZKSCAN1",-0.507349522352039,6.58646410370716,-7.17692753433859,3.7498341686766e-05,0.000285383040692797,2.23053899274337,"DOWN",FALSE,"High","Master Protein","P17029","Zinc finger protein with KRAB and SCAN domains 1 [OS=Homo sapiens]",0,40.618,9,3,3,7,3,563,63.6,7.05,24.15,3,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352, Pf02023","7586","A4D294; hsa:7586; P17029; P52745; Q2M1U1; Q8TBW5; Q8TEK7","ENSG00000106261","Generic Transcription Pathway",NA,1,0,122.2,117.3,117.8,86.7,78.6,83.9,89.6,96.6,87.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100); S208(100); S359(99.2)]",0,"ENSG00000106261"
"215","JCAD",0.513993689099125,6.646795898337,7.17464470876121,3.7596417738328e-05,0.000285383040692797,2.2277537889147,"UP",FALSE,"High","Master Protein","Q9P266","Junctional cadherin 5-associated protein [OS=Homo sapiens]",0,42.994,8,6,6,7,6,1359,148.3,7.09,20.86,6,"cell adhesion;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf15351","57608","hsa:57608; Q5HYA7; Q5T992; Q86WZ9; Q9BYJ2; Q9P266","ENSG00000165757",NA,NA,0,0,75.7,79.5,73,107.8,113.5,118,116.4,111.9,120,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S375(98.6); S694(99.3); S770(100); S1044(100); S1281(100); S1304(100)]",0,"ENSG00000165757"
"216","TAF12",-0.498042266884642,6.58740831493162,-7.11036001193787,4.04760307751947e-05,0.00030581889919036,2.14905995873547,"NONE",FALSE,"High","Master Protein","Q16514","Transcription initiation factor TFIID subunit 12 [OS=Homo sapiens]",0,28.857,13,2,2,3,2,161,17.9,7.99,11.61,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03847","6883","D3DPM5; hsa:6883; Q15775; Q16514; Q5T077","ENSG00000120656","Regulation of TP53 Activity through Phosphorylation; RNA Polymerase II Pre-transcription Events; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; HATs acetylate histones","Eukaryotic transcription initiation",11,0,113.6,125.2,118.4,86.3,79.9,84.8,92.6,89.5,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100)]",0,"ENSG00000120656"
"217","FLNA",0.529988178321656,6.66501694345565,7.10423007496533,4.07628926198946e-05,0.000306567008090636,2.14152950776662,"UP",FALSE,"High","Master Protein","P21333","Filamin-A [OS=Homo sapiens]",0,167.252,7,11,15,26,11,2647,280.6,6.06,77.22,11,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00307, Pf00630","2316","E9KL45; hsa:2316; P21333; Q5HY53; Q5HY55; Q8NF52","ENSG00000196924","OAS antiviral response; Platelet degranulation ; RHO GTPases activate PAKs; GP1b-IX-V activation signalling; Cell-extracellular matrix interactions","Androgen receptor signaling pathway; Prolactin signaling pathway; Focal adhesion; Hypothesized pathways in pathogenesis of cardiovascular disease; MAPK signaling pathway; IL-4 signaling pathway; Ebola virus infection in host; Joubert syndrome; NPHP1 deletion syndrome",14,0,76.5,77.8,77.1,116.1,106.5,121.3,110.4,121.9,115.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S968(100); S1084(100); S1459(100); S2152(100); S2180(100)]",0,"ENSG00000196924"
"218","TFE3",0.618416519950419,6.66700679998515,7.0887058607733,4.14993095411976e-05,0.00030936722619528,2.12243773448512,"UP",FALSE,"High","Master Protein","P19532","Transcription factor E3 [OS=Homo sapiens]",0,25.406,3,1,2,4,1,575,61.5,5.58,16.25,1,"cell organization and biogenesis;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00010, Pf11851, Pf15951","7030","A8MZL6; hsa:7030; P19532; Q5JU74; Q92757; Q92758; Q99964","ENSG00000068323; ENSG00000292217",NA,"MET in type 1 papillary renal cell carcinoma; Type 2 papillary renal cell carcinoma; TGF-beta receptor signaling in skeletal dysplasias; Autophagy in pancreatic ductal adenocarcinoma; TGF-beta receptor signaling",5,0,76.3,77.1,83.8,128.2,136,116.9,106.3,109.9,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S556(100)]",0,"ENSG00000068323"
"219","ARHGAP12",0.542135716122633,6.65987690038653,7.08179531234389,4.18317628677374e-05,0.00030936722619528,2.11392953124041,"UP",FALSE,"High","Master Protein","Q8IWW6","Rho GTPase-activating protein 12 [OS=Homo sapiens]",0,137.194,15,8,13,35,8,846,96.2,7.61,107.48,8,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other cell component","enzyme regulator activity","Pf00018, Pf00169, Pf00397, Pf00620, Pf16618","94134","B1ANY0; B1ANY1; B1ANY2; hsa:94134; Q504X1; Q86UB3; Q8IWW6; Q8IWW7; Q8N3L1; Q9NT76","ENSG00000165322","RAC1 GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle; RHOV GTPase cycle",NA,4,0,78.7,82.3,85.6,127.2,127.7,119.8,97.2,106.4,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S103(100); S165(100); S176(100); S201(100); S215(100); T231(99); S240(100); S303(100); S592(100)]",0,"ENSG00000165322"
"220","SLC20A2",-0.683029345778786,6.52485676769562,-7.08112423287994,4.18642010831685e-05,0.00030936722619528,2.11310299010505,"DOWN",FALSE,"High","Master Protein","Q08357","Sodium-dependent phosphate transporter 2 [OS=Homo sapiens]",0,28.112,4,3,3,4,3,652,70.3,6.54,13.41,3,"transport;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function","Pf01384","6575","hsa:6575; Q08357","ENSG00000168575","Sodium-coupled phosphate cotransporters; Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)","Proximal tubule transport",3,0,131,126.5,129.4,77.2,86,74.3,85.3,77.7,78.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S256(100)]",0,"ENSG00000168575"
"221","CBY1",0.554159012446754,6.60530564841272,7.0805190278287,4.18934785472775e-05,0.00030936722619528,2.11235753605708,"UP",FALSE,"High","Master Protein","Q9Y3M2","Protein chibby homolog 1 [OS=Homo sapiens]",0,10.338,10,1,1,1,1,126,14.5,9.13,4.11,1,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus","other molecular function","Pf14645","25776","B2R4S2; hsa:25776; Q66GT6; Q9UIK9; Q9Y3M2","ENSG00000100211","Deactivation of the beta-catenin transactivating complex","Genes related to primary cilium development (based on CRISPR)",2,0,92.1,84.4,92.8,127.1,136.9,143.7,82.2,77.7,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(100)]",0,"ENSG00000100211"
"222","MPST",0.491361332344095,6.65514432395558,7.06265481392358,4.27677810290454e-05,0.000314400984862171,2.09033309988907,"NONE",FALSE,"High","Master Protein","P25325-2","Isoform 2 of 3-mercaptopyruvate sulfurtransferase [OS=Homo sapiens]",0,32.178,5,2,3,4,2,317,35.2,6.61,18.77,2,NA,NA,NA,NA,NA,"P25325-2",NA,NA,NA,0,0,77.7,77.9,82,115.8,110.7,119.9,109.6,106.5,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S15(100)]",0,"ENSG00000128309"
"223","FRMD5",-0.760779535488051,6.50442022565004,-7.05611733382103,4.30926748854009e-05,0.000315368813511095,2.0822632939543,"DOWN",FALSE,"High","Master Protein","Q7Z6J6","FERM domain-containing protein 5 [OS=Homo sapiens]",0,7.949,2,1,1,3,1,570,65,8.35,5.71,1,"cell organization and biogenesis;other biological processes","other membranes;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00373, Pf08736, Pf09379, Pf09380","84978","hsa:84978; Q7Z6J6; Q8NBG4","ENSG00000171877",NA,NA,0,0,127.9,125.3,130.3,72.7,59.2,89.3,75.2,82.6,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(100)]",0,"ENSG00000171877"
"224","NDRG2",0.583286701551961,6.61115989530946,7.04772029369639,4.35139242622142e-05,0.000317030019624703,2.07189029007655,"UP",FALSE,"High","Master Protein","Q9UN36","Protein NDRG2 [OS=Homo sapiens]",0,168.096,13,5,19,95,5,371,40.8,5.21,376.28,5,"cell-cell signaling;cell cycle OR cell proliferation;signal transduction;other biological processes","cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf03096","57447","B3KUE3; B4DE86; B7WP11; B7WPD5; D3DS07; D3DS10; hsa:57447; Q567T1; Q68DW2; Q86U08; Q86U46; Q96FD3; Q96FT0; Q96JU0; Q96PN0; Q9BQH5; Q9ULH2; Q9UN36","ENSG00000165795",NA,NA,0,0,82.6,88.3,88.9,125.2,162.4,127.8,78.4,83.1,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S332(100); S338(100); S350(99.6); S352(98.5)]",0,"ENSG00000165795"
"225","RSRC2",-0.491193862432027,6.54861527303704,-7.0071167536139,4.56149749532961e-05,0.000330860618327907,2.02160844595466,"NONE",FALSE,"High","Master Protein","Q7L4I2","Arginine/serine-rich coiled-coil protein 2 [OS=Homo sapiens]",0,38.469,10,6,8,14,6,434,50.5,11.33,37.36,6,NA,NA,NA,"Pf15477","65117","hsa:65117; Q6N040; Q6NW16; Q7L4I2; Q9H864","ENSG00000111011",NA,NA,0,0,124.2,124,115.6,91.5,80.6,83.5,82.6,84.8,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S4(99.1); S17(99.4); S30(99.6); T220(100); S222(100)]; Met-loss [N-Term]",0,"ENSG00000111011"
"226","MID1",1.53893017292408,6.49942269754999,7.00064410548415,4.59599745128966e-05,0.000331887957544457,2.0135739967052,"UP",FALSE,"High","Master Protein","O15344","E3 ubiquitin-protein ligase Midline-1 [OS=Homo sapiens]",0,18.865,2,2,2,2,2,667,75.2,6.8,6.21,2,"cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf00041, Pf00622, Pf00643, Pf13445, Pf18568","4281","B2RCG2; hsa:4281; O15344; O75361; Q9BZX5","ENSG00000101871","Interferon gamma signaling",NA,1,0,51.7,47.6,67.1,201,112.2,199.1,94,89.5,76.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S96(99.6)]",0,"ENSG00000101871"
"227","MLLT1",-0.698550175925226,6.55345385960917,-6.96385966428653,4.7975246045798e-05,0.000344914544258777,1.96781433402855,"DOWN",FALSE,"High","Master Protein","Q03111","Protein ENL [OS=Homo sapiens]",0,18.037,6,4,6,7,4,559,62,8.59,12.24,4,"other biological processes","cytosol;nucleus","other molecular function","Pf03366, Pf17793","4298","hsa:4298; Q03111; Q14768","ENSG00000130382","Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events",NA,3,0,128.4,129.2,127.9,79.1,78.3,73.5,95.6,82.4,80.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S292(100); S475(100)]",0,"ENSG00000130382"
"228","ZHX3",0.528304775127705,6.65944710986425,6.92439596686296,5.02445658243995e-05,0.000359645313269386,1.91853307424473,"UP",FALSE,"High","Master Protein","Q9H4I2","Zinc fingers and homeoboxes protein 3 [OS=Homo sapiens]",0,23.074,2,1,2,6,1,956,104.6,6.07,14.36,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf11569, Pf18387","23051","E1P5W5; F5H820; hsa:23051; O43145; Q6NUJ7; Q9H4I2","ENSG00000174306",NA,NA,0,0,79.8,73.8,82.4,112.9,122.6,120.9,103.2,112.1,116.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S946(99.4)]",0,"ENSG00000174306"
"229","RABEP1",0.6387597494306,6.64776261713414,6.92035960721319,5.04831638827485e-05,0.000359775211601072,1.91348153021372,"UP",FALSE,"High","Master Protein","Q15276","Rab GTPase-binding effector protein 1 [OS=Homo sapiens]",0,48.558,4,3,6,10,3,862,99.2,5.01,38.43,3,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf03528, Pf09311","9135","B2RAG7; hsa:9135; O95369; Q15276; Q8IVX3","ENSG00000029725","TBC/RABGAPs","GDNF signaling",2,0,76.1,82.5,84,130.3,147.3,118.2,92.1,102,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S407(99.7)]",0,"ENSG00000029725"
"230","PALLD",1.00475804188966,6.62585313057865,6.87427553253355,5.32962583348237e-05,0.000378171711314923,1.85566110236621,"UP",FALSE,"High","Master Protein","Q8WX93","Palladin [OS=Homo sapiens]",0,23.9,2,2,2,6,2,1383,150.5,7.09,20.33,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf07679","23022","B3KTG2; B5MD56; B7ZMM5; hsa:23022; Q7L3E0; Q7Z3W0; Q86WE8; Q8N1M2; Q8WX93; Q9UGA0; Q9UQF5; Q9Y2J6; Q9Y3E9","ENSG00000129116",NA,NA,0,0,68.1,75.9,68.3,152.5,123.7,147,83.2,96.8,109.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S893(100); S1121(100)]",0,"ENSG00000129116"
"231","UCHL3",0.653981861339781,6.60241411647376,6.86723628114897,5.37407383971448e-05,0.00037967482711749,1.84680549639215,"UP",FALSE,"High","Master Protein","P15374","Ubiquitin carboxyl-terminal hydrolase isozyme L3 [OS=Homo sapiens]",0,11.031,6,1,1,1,1,230,26.2,4.92,3.41,1,"protein metabolism;other metabolic processes","cytosol;nucleus;other cell component","other molecular function","Pf01088","7347","B2R970; hsa:7347; P15374; Q5TBK8; Q6IBE9","ENSG00000118939","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; UCH proteinases; Neddylation","Proteasome degradation",4,0,82,82.2,78.7,129.6,156.3,120,85.6,84.3,95.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100)]",0,"ENSG00000118939"
"232","PIK3C2A",-0.547093045184814,6.61317983957868,-6.84428335219102,5.52182403951083e-05,0.000388201938903865,1.81788630349362,"DOWN",FALSE,"High","Master Protein","O00443","Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha [OS=Homo sapiens]",0,20.785,2,2,2,2,2,1686,190.6,8.02,7.08,2,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00168, Pf00454, Pf00613, Pf00787, Pf00792, Pf00794","5286","B0LPH2; B4E2G4; hsa:5286; O00443; Q14CQ9","ENSG00000011405","Golgi Associated Vesicle Biogenesis; Clathrin-mediated endocytosis; Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane; Synthesis of PIPs at the late endosome membrane","Glioblastoma signaling pathways; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Microglia pathogen phagocytosis pathway; Osteoblast differentiation and related diseases; Insulin signaling; Regulation of actin cytoskeleton; DNA damage response (only ATM dependent)",14,0,113.3,109.9,110.8,77.5,66.6,79,101.4,106.2,122.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S259(100); S1553(99.2)]",0,"ENSG00000011405"
"233","SET",0.699158942544508,6.65341421079581,6.84114841927115,5.54234385812503e-05,0.000388201938903865,1.81393129840545,"UP",FALSE,"High","Master Protein","Q01105","Protein SET [OS=Homo sapiens]",0,10.169,3,1,1,5,1,290,33.5,4.32,16.57,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00956","6418","A5A5H4; A6NGV1; B4DUE2; hsa:6418; Q01105; Q15541; Q5VXV1; Q5VXV2; Q6FHZ5","ENSG00000119335","HuR (ELAVL1) binds and stabilizes mRNA; Condensation of Prophase Chromosomes","Histone modifications; VEGFA-VEGFR2 signaling",4,0,67.6,74.9,77.7,130,128,110.9,113.7,107.7,117.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100)]",0,"ENSG00000119335"
"234","NOC2L",-0.875084461121981,6.50173435951993,-6.81232660513614,5.73492477865476e-05,0.000398924041017626,1.77751131941191,"DOWN",FALSE,"High","Master Protein","Q9Y3T9","Nucleolar complex protein 2 homolog [OS=Homo sapiens]",0,19.727,2,2,2,5,2,749,84.9,5.62,11.91,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf03715","26155","hsa:26155; Q5SVA3; Q9BTN6; Q9Y3T9","ENSG00000188976","Regulation of TP53 Activity through Phosphorylation","1p36 copy number variation syndrome",2,0,141,123.3,112,64.8,70.8,58.6,92.6,85.3,100.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(100); S56(100)]",0,"ENSG00000188976"
"235","HDGF",0.99917667437699,6.641278430619,6.81027651863429,5.74889708269432e-05,0.000398924041017626,1.77491674455461,"UP",FALSE,"High","Master Protein","P51858","Hepatoma-derived growth factor [OS=Homo sapiens]",0,106.436,20,7,9,24,7,240,26.8,4.73,82.51,7,"cell organization and biogenesis;signal transduction;other biological processes","nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00855","3068","B3KU21; D3DVC9; P51858; Q5SZ07; Q5SZ08; Q5SZ09","ENSG00000143321","XBP1(S) activates chaperone genes","IL-18 signaling pathway",2,0,57.6,64.3,63.4,135.1,149.1,98.4,123.8,133.9,123.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S103(100); S133(99.6); S165(100)]",0,"ENSG00000143321"
"236","SYNM",0.801967404208611,6.6343641684786,6.80737222268622,5.76875451471566e-05,0.000398924041017626,1.77124017016498,"UP",FALSE,"High","Master Protein","O15061","Synemin [OS=Homo sapiens]",0,242.4,13,14,21,62,14,1565,172.8,5.15,221.07,14,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00038","23336","A7E2Y2; hsa:23336; O15061; Q2TBJ4; Q5NJJ9; Q8TE61; Q8TE62","ENSG00000182253",NA,NA,0,0,74.5,72.7,72.4,131.1,142.4,123.6,117.7,98.3,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S566(100); S592(100); T598(100); S653(100); S777(100); S1049(100); T1094(100); S1163(99.3); S1432(100); S1540(100)]",0,"ENSG00000182253"
"237","TRA2A",-0.609340455279972,6.40324924270511,-6.79384968188592,5.86219708267661e-05,0.000403675343414693,1.7541076800037,"DOWN",FALSE,"High","Master Protein","Q13595","Transformer-2 protein homolog alpha [OS=Homo sapiens]",0,21.595,13,6,8,27,6,282,32.7,11.27,60.44,6,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf00076","29896","B4DQI6; B4DUA9; E9PD75; hsa:29896; Q13595","ENSG00000164548",NA,"Orexin receptor pathway",1,0,149.7,130.9,128.1,93.4,69.8,96.5,58.7,62.6,61.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(99.6); T88(100); S260(99.7); S262(100); S278(100)]",0,"ENSG00000164548"
"238","BICD1",0.481143783170081,6.64223121010888,6.74644198122474,6.20299077698165e-05,0.000425347938993027,1.69385922772287,"NONE",FALSE,"High","Master Protein","Q96G01","Protein bicaudal D homolog 1 [OS=Homo sapiens]",0,18.071,4,3,4,5,2,975,110.7,5.81,13.2,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf09730","636","A8K2C3; F8W113; hsa:636; O43892; O43893; Q96G01","ENSG00000151746","COPI-independent Golgi-to-ER retrograde traffic",NA,1,1,71.1,68.9,72.1,98.6,109,101.5,130.7,134.3,135.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S548(100); S560(100); S610(100)]",0,"ENSG00000151746"
"239","RFX3",-0.976928784007487,6.44936011835935,-6.73832345146242,6.2634783643048e-05,0.000426723395323446,1.68351280084914,"DOWN",FALSE,"High","Master Protein","P48380","Transcription factor RFX3 [OS=Homo sapiens]",0,28.782,2,1,2,11,1,749,83.5,6,23.25,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","non-structural extracellular;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02257, Pf04589","5991","A8K0H5; D3DRH8; D3DRH9; hsa:5991; P48380; Q5JTL7; Q5JTL8; Q6NW13; Q8WTU4; Q95HL5; Q95HL6","ENSG00000080298",NA,"Alstrom syndrome",1,0,149.6,150.2,141.1,78.8,44.1,94.2,71.7,66.7,66.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S155(100)]",0,"ENSG00000080298"
"240","MVB12A",1.08399420836906,6.56738869768637,6.73308715904482,6.30283100781868e-05,0.000426723395323446,1.67683506068132,"UP",FALSE,"High","Master Protein","Q96EY5","Multivesicular body subunit 12A [OS=Homo sapiens]",0,32.328,5,1,2,5,1,273,28.8,8.91,17.7,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf10240","93343","hsa:93343; Q96EY5; Q96I18","ENSG00000141971","Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy; HCMV Late Events","7q11.23 copy number variation syndrome",6,0,52,58,49.6,117.2,107.4,117.2,108,176.8,157.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(100)]",0,"ENSG00000141971"
"241","CBS",-0.700879247150003,6.59219709902639,-6.73278618551277,6.30510107199335e-05,0.000426723395323446,1.67645112784122,"DOWN",FALSE,"High","Master Protein","P35520","Cystathionine beta-synthase [OS=Homo sapiens]",0.003,2.422,2,1,1,1,1,551,60.5,6.65,2.05,1,"DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00291, Pf00571","102724560; 875","B2R993; D3DSK4; hsa:102724560; hsa:875; P35520; Q99425; Q9BWC5","ENSG00000160200","Metabolism of ingested SeMet, Sec, MeSec into H2Se; Cysteine formation from homocysteine","Selenium micronutrient network; Vitamin B12 metabolism; Folate-alcohol and cancer pathway hypotheses; Folate metabolism; Trans-sulfuration pathway; Trans-sulfuration, one-carbon metabolism and related pathways; Vitamin D receptor pathway; Amino acid metabolism; Methionine metabolism leading to sulfur amino acids and related disorders; Ferroptosis; Ciliary landscape",13,0,116.8,129.1,129.7,75.8,74.3,74.4,94.1,106.9,86.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100)]",0,"ENSG00000160200"
"242","KANK2",-0.815287806212538,6.47068952094581,-6.72980444134068,6.32763858261483e-05,0.000426723395323446,1.67264687588428,"DOWN",FALSE,"High","Master Protein","Q63ZY3","KN motif and ankyrin repeat domain-containing protein 2 [OS=Homo sapiens]",0,10.197,2,1,1,2,1,851,91.1,5.63,7.13,1,"cell organization and biogenesis;developmental processes;other biological processes","mitochondrion;other cell component",NA,"Pf12075, Pf12796","25959","B0I1P4; hsa:25959; Q3KQZ3; Q63ZY3; Q6GUF5; Q9H8S4; Q9NUP0; Q9P210","ENSG00000197256",NA,NA,0,0,132.8,151.1,118.8,69,72.3,77.4,73,66.8,84.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S375(100)]",0,"ENSG00000197256"
"243","KLC2",0.647567777570931,6.67015759415014,6.72220111773362,6.38550488523225e-05,0.000428853661427944,1.66294100878218,"UP",FALSE,"High","Master Protein","Q9H0B6","Kinesin light chain 2 [OS=Homo sapiens]",0,21.275,3,2,4,10,2,622,68.9,7.15,24.28,2,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity","Pf13424","64837","A8MXL7; B2RDY4; hsa:64837; Q9H0B6; Q9H9C8; Q9HA20","ENSG00000174996","MHC class II antigen presentation; COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; RHO GTPases activate KTN1","Alzheimer's disease and miRNA effects; Alzheimer's disease",6,0,72.6,76.4,72.4,111.8,145.6,113.7,109.7,115.7,128.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S582(99.7); S610(99.6)]",0,"ENSG00000174996"
"244","ARPP19",1.11225589342159,6.62351834455505,6.71665257244899,6.42809527229845e-05,0.000429392263645199,1.65585342472246,"UP",FALSE,"High","Master Protein","P56211","cAMP-regulated phosphoprotein 19 [OS=Homo sapiens]",0,2.786,7,1,1,1,1,112,12.3,9.09,2.68,1,"cell cycle OR cell proliferation;other biological processes","nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf04667","10776","B2R497; hsa:10776; P56211; Q6IAM2; Q86TA6; Q9UD70","ENSG00000128989","MASTL Facilitates Mitotic Progression",NA,1,0,62,54,64.2,138.4,126.1,130.6,98,159,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S104(100)]",0,"ENSG00000128989"
"245","ABLIM1",0.524561731391044,6.65603127349651,6.711790893561,6.46566669384062e-05,0.000429392263645199,1.64963996462585,"UP",FALSE,"High","Master Protein","O14639","Actin-binding LIM protein 1 [OS=Homo sapiens]",0,118.535,14,9,12,36,9,778,87.6,8.59,101.55,9,"cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00412, Pf02209, Pf16182","3983","A6NI16; A6NJ06; A8MXA9; B3KVH2; hsa:3983; O14639; Q15039; Q5JVV1; Q5JVV2; Q5T6N2; Q5T6N3; Q5T6N5; Q68CQ9; Q9BUP1","ENSG00000099204","DCC mediated attractive signaling","Male infertility",2,0,77.5,78,82.5,115.7,134.6,112.2,104.3,111.5,109.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(99.6); S352(91.9); S367(98.1); S431(100); S452(100); S655(100); S706(100)]",0,"ENSG00000099204"
"246","NMT1",0.527513221509175,6.66480930813653,6.71091552096838,6.47245691524014e-05,0.000429392263645199,1.64852087228087,"UP",FALSE,"High","Master Protein","P30419","Glycylpeptide N-tetradecanoyltransferase 1 [OS=Homo sapiens]",0,15.852,2,1,1,2,1,496,56.8,7.8,6.7,1,"protein metabolism;other metabolic processes;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;other cell component","other molecular function","Pf01233, Pf02799","4836","A8K7C1; hsa:4836; P30419; Q9UE09","ENSG00000136448","Inactivation, recovery and regulation of the phototransduction cascade; Late Phase of HIV Life Cycle; Activation, myristolyation of BID and translocation to mitochondria",NA,3,0,68.7,71.1,72,106,100.1,108.2,121.4,151.4,149.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100)]",0,"ENSG00000136448"
"247","RALY",-0.606465085047627,6.53675603390418,-6.6842670583576,6.68291552251201e-05,0.000441559438572454,1.61440562061886,"DOWN",FALSE,"High","Master Protein","Q9UKM9-2","Isoform 1 of RNA-binding protein Raly [OS=Homo sapiens]",0,25.904,17,3,3,7,3,290,30.3,9.63,25.09,3,NA,NA,NA,NA,NA,"Q9UKM9-2",NA,NA,NA,0,0,126.2,130.3,119.5,77.3,67.6,96.3,79.8,82.2,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100); S119(100); T270(99.1)]",0,"ENSG00000125970"
"248","MIGA2",-0.767060780150486,6.58001763309267,-6.68014453157754,6.71613137801194e-05,0.000441964774553044,1.60911977681096,"DOWN",FALSE,"High","Master Protein","Q7L4E1","Mitoguardin 2 [OS=Homo sapiens]",0,14.817,2,1,1,3,1,593,65.5,5.83,8.34,1,"cell organization and biogenesis;developmental processes","plasma membrane;other membranes;mitochondrion","other molecular function","Pf10265","84895","hsa:84895; Q7L4E1; Q8NBM3; Q8TEJ6; Q969E6","ENSG00000148343","Synthesis of PA",NA,1,0,124.3,136.7,137.9,66.6,79.6,80.4,93.8,80.2,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100)]",0,"ENSG00000148343"
"249","MZT2B",0.587395129007927,6.6370321266276,6.67442677820366,6.76249700126755e-05,0.000442602283360746,1.60178491394838,"UP",FALSE,"High","Master Protein","Q6NZ67","Mitotic-spindle organizing protein 2B [OS=Homo sapiens]",0,3.074,6,1,1,2,1,158,16.2,10.15,2.05,1,NA,"cytosol;cytoskeleton;nucleus",NA,"Pf12926","80097","hsa:80097; Q6NZ67; Q96CG4","ENSG00000152082; ENSG00000292119","Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes",NA,2,0,80.9,83.7,80.4,118.5,159.1,119.5,97.1,95.5,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S152(100)]",0,"ENSG00000152082"
"250","TLE3",0.624786688358062,6.62393059417646,6.67227208884868,6.78005948775653e-05,0.000442602283360746,1.59901973119324,"UP",FALSE,"High","Master Protein","Q04726","Transducin-like enhancer protein 3 [OS=Homo sapiens]",0,30.401,4,2,2,4,2,772,83.4,7.2,16.96,2,"cell-cell signaling;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf00400, Pf03920","7090","B4DPT0; E9PD64; F8W964; hsa:7090; Q04726; Q6PI57; Q8IVV6; Q8WVR2; Q9HCM5","ENSG00000140332","Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex; Estrogen-dependent gene expression; Repression of WNT target genes","White fat cell differentiation",5,0,71,80.1,81.9,122,142.7,114.6,103.6,96.3,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S286(99.3)]",0,"ENSG00000140332"
"251","AHNAK",0.524256709335104,6.64553682707024,6.6393191345878,7.05490830387799e-05,0.000458709575774059,1.55665509073836,"UP",FALSE,"High","Master Protein","Q09666","Neuroblast differentiation-associated protein AHNAK [OS=Homo sapiens]",0,445.002,6,32,45,73,32,5890,628.7,6.15,248.6,32,"other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function",NA,"79026","A1A586; hsa:79026; Q09666","ENSG00000124942",NA,NA,0,0,74.8,81.6,79.8,115.3,132.4,111.1,107.1,109.9,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S135(100); S210(100); S216(100); S379(100); S511(100); S559(100); S570(100); S2150(100); S3326(100); S4425(100); S4520(100); S4908(100); S4995(99.3); S5110(100); S5400(100); S5448(100); S5731(100); S5749(100); S5752(100); S5782(100); T5794(98.1); S5830(100); S5841(100); S5867(100)]",0,"ENSG00000124942"
"252","SERBP1",1.30728079308827,6.52823194536688,6.61693144236203,7.2485181760138e-05,0.000469427843779941,1.5277927207546,"UP",FALSE,"High","Master Protein","Q8NC51","SERPINE1 mRNA-binding protein 1 [OS=Homo sapiens]",0,4.857,7,2,2,3,2,408,44.9,8.65,2.32,2,"cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf04774, Pf16174","26135","hsa:26135; Q5VU19; Q5VU20; Q5VU22; Q8NC51; Q8WUH0; Q96SE2; Q9BTY3; Q9BUM4; Q9Y367; Q9Y4S3","ENSG00000142864",NA,"Apoptosis-related network due to altered Notch3 in ovarian cancer",1,0,42.9,41.8,50.9,108.8,151.4,104.4,103.1,182.7,178.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S74(100)]",0,"ENSG00000142864"
"253","GLYR1",1.2801633879845,6.58145655586573,6.57349488495282,7.64079677258347e-05,0.00049287669299827,1.47160749964173,"UP",FALSE,"High","Master Protein","Q49A26","Cytokine-like nuclear factor N-PAC [OS=Homo sapiens]",0,11.694,5,2,2,3,2,553,60.5,9.17,6.63,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00855, Pf03446, Pf14833","84656","B4DL47; C9JJ40; C9JJ60; hsa:84656; Q49A26; Q5U632; Q6P1Q2; Q6V3W7; Q9BTI1; Q9BXK2","ENSG00000140632",NA,NA,0,0,56.5,47.8,46.7,104.9,101.7,168,120.8,154,161.3,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S5(100)]",0,"ENSG00000140632"
"254","HNRNPUL2",-0.551208444251431,6.56531901217433,-6.56969648233078,7.67617910946517e-05,0.000493209618371935,1.46668253058329,"DOWN",FALSE,"High","Master Protein","Q1KMD3","Heterogeneous nuclear ribonucleoprotein U-like protein 2 [OS=Homo sapiens]",0,84.395,6,6,7,20,6,747,85.1,4.91,51.31,6,NA,"nucleus;other cell component",NA,"Pf00622, Pf02037, Pf13671","221092","hsa:221092; Q1KMD3; Q8N3B3","ENSG00000214753",NA,NA,0,0,116.5,116.3,121.2,86,65.7,87,96.3,92.9,85.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S161(100); S185(100); S193(100)]",0,"ENSG00000214753"
"255","ANP32A",0.618611345340743,6.64379288176702,6.56071956832098,7.76050751463312e-05,0.00049667248093652,1.4550356439122,"UP",FALSE,"High","Master Protein","P39687","Acidic leucine-rich nuclear phosphoprotein 32 family member A [OS=Homo sapiens]",0,5.92,8,2,2,3,2,249,28.6,4.09,2.57,2,"transport;signal transduction;other biological processes","ER/Golgi;nucleus;other cell component","other molecular function","Pf14580","8125","B2R6T4; hsa:8125; P39687; Q53FK4; Q5J8L8; Q7M4N6","ENSG00000140350","HuR (ELAVL1) binds and stabilizes mRNA","IL-18 signaling pathway",2,0,76.4,81.5,75.4,119.7,147.9,112.3,100.7,105,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T15(100)]",0,"ENSG00000140350"
"256","GLCCI1",0.544368215884258,6.66461553880586,6.50668923295625,8.28975715005736e-05,0.000528472018316157,1.38471168722378,"UP",FALSE,"High","Master Protein","Q86VQ1","Glucocorticoid-induced transcript 1 protein [OS=Homo sapiens]",0,32.827,8,3,3,4,3,547,58,9.44,16.47,3,NA,"other cell component",NA,"Pf15388","113263","A4D103; hsa:113263; Q86VQ1; Q96FD0","ENSG00000106415",NA,NA,0,0,71,82.9,78.6,108.2,120.2,124.7,107.8,113.4,121.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S223(100); S303(100)]",0,"ENSG00000106415"
"257","SLMAP",-0.509231821469966,6.5784377254164,-6.49164819343539,8.44395996341023e-05,0.000536207885614222,1.36506639809925,"DOWN",FALSE,"High","Master Protein","Q14BN4","Sarcolemmal membrane-associated protein [OS=Homo sapiens]",0,10.739,2,1,1,1,1,828,95.1,5.47,3.15,1,"other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi",NA,"Pf00498","7871","hsa:7871; Q14BN4; Q14C95; Q6AI54; Q6UXC9; Q6ZVQ8; Q8NCW9; Q9H297; Q9HCH1; Q9Y681","ENSG00000163681",NA,NA,0,0,115.2,116.1,120.4,80.3,80.9,83.9,85.7,97,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100)]",0,"ENSG00000163681"
"258","TPD52",1.73401411277636,6.50902112220951,6.48304544374662,8.53355170977238e-05,0.000539796759315834,1.35381681084685,"UP",FALSE,"High","Master Protein","P55327","Tumor protein D52 [OS=Homo sapiens]",0.006,1.773,5,1,1,1,1,224,24.3,4.83,2.65,1,"transport;other biological processes","ER/Golgi;other cell component","other molecular function","Pf04201","7163","B7Z414; C9J502; D0UFD1; D0UFD2; D0UFD3; D0UFD4; D0UFD5; E5RKB4; hsa:7163; P55327; Q13056; Q53EK8; Q6FGP3; Q6FGS3; Q86YZ2; Q9UCX8","ENSG00000076554","Golgi Associated Vesicle Biogenesis",NA,1,0,30.8,43.5,48.1,143.6,178,93.3,161.4,167,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S176(100)]",0,"ENSG00000076554"
"259","SLC43A2",-1.29306046761656,6.05961169722947,-6.46501856234185,8.72464799514578e-05,0.000548516860560203,1.33021179941377,"DOWN",FALSE,"High","Master Protein","Q8N370","Large neutral amino acids transporter small subunit 4 [OS=Homo sapiens]",0,21.372,4,2,2,5,2,569,62.7,7.94,16.42,2,"transport;other biological processes","plasma membrane;other membranes","transporter activity",NA,"124935","B7Z6X9; C9JNU8; D3DTH9; hsa:124935; Q5CD75; Q6IPM1; Q8N370; Q8NBX1; Q8NC21; Q8WZ00","ENSG00000167703; ENSG00000278550","Amino acid transport across the plasma membrane",NA,1,0,64.8,72.8,61.7,25.2,14.4,28.2,175.3,161.7,145.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S274(100); S297(100)]",0,"ENSG00000167703"
"260","NES",-0.724091284457978,6.57503363570151,-6.46371674740099,8.73862645500324e-05,0.000548516860560203,1.32850549355712,"DOWN",FALSE,"High","Master Protein","P48681","Nestin [OS=Homo sapiens]",0,1080.398,46,58,86,285,57,1621,177.3,4.36,1120.31,58,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytoskeleton;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00038","10763","hsa:10763; O00552; P48681; Q3LIF5; Q5SYZ6","ENSG00000132688",NA,"Cell lineage map for neuronal differentiation",1,1,114.3,125.2,120.2,61.8,69.6,77.4,108.5,90.9,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T315(100); S325(100); T338(100); S398(100); S459(100); S471(100); S548(100); S564(100); S578(100); S588(100); S680(100); S702(100); S746(100); S768(100); S814(100); S828(100); S842(100); T851(100); S905(100); S913(100); S931(100); S934(100); S965(100); S1016(100); S1030(100); S1175(100); S1347(100); S1418(100); S1442(100); S1498(99.3); S1502(100); S1521(100); S1577(100); S1617(99.1); S1618(99.5)]",0,"ENSG00000132688"
"261","ATAT1",0.75067244592648,6.65187292540973,6.45556661715466,8.82669323385541e-05,0.000551921967726131,1.31781790893896,"UP",FALSE,"High","Master Protein","Q5SQI0-4","Isoform 4 of Alpha-tubulin N-acetyltransferase 1 [OS=Homo sapiens]",0,37.601,11,3,4,9,3,333,37.5,10.05,27.35,3,NA,NA,NA,NA,NA,"Q5SQI0-4",NA,NA,NA,0,0,76.7,77,77.5,142.1,139.5,119.4,104.8,90,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S315(100); S324(99.4)]",0,"ENSG00000137343"
"262","EIF4G3",-0.514687385725217,6.61045560437136,-6.42110681769558,9.20982257718881e-05,0.000572949900832602,1.27253203005395,"DOWN",FALSE,"High","Master Protein","O43432","Eukaryotic translation initiation factor 4 gamma 3 [OS=Homo sapiens]",0,76.459,3,4,4,7,4,1585,176.5,5.38,26.74,4,"protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity","Pf02020, Pf02847, Pf02854","8672","B9EGQ7; hsa:8672; O43432; Q15597; Q504Z1; Q5SWC3; Q8NEN1","ENSG00000075151","ISG15 antiviral mechanism","Translation factors; Translation inhibitors in chronically activated PDGFRA cells",3,0,117.1,121.7,117.1,84.8,69.1,92.6,92.2,102.6,94.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S495(100); S1156(100); S1409(100)]",0,"ENSG00000075151"
"263","SDC3",1.25269135488279,6.62919421844477,6.4190546863161,9.23319999503519e-05,0.000572949900832602,1.26983021255074,"UP",FALSE,"High","Master Protein","O75056","Syndecan-3 [OS=Homo sapiens]",0,5.549,4,2,2,2,2,442,45.5,4.69,5.04,2,"other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf01034","9672","hsa:9672; O75056; Q5T1Z6; Q5T1Z7; Q96CT3; Q96PR8","ENSG00000162512","Cell surface interactions at the vascular wall; RSV-host interactions; Respiratory syncytial virus (RSV) attachment and entry; A tetrasaccharide linker sequence is required for GAG synthesis; HS-GAG biosynthesis; HS-GAG degradation; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective EXT2 causes exostoses 2; Defective EXT1 causes exostoses 1, TRPS2 and CHDS; Defective B3GALT6 causes EDSP2 and SEMDJL1; Attachment and Entry; Retinoid metabolism and transport; Syndecan interactions",NA,14,0,45.7,52.3,64.4,142.6,93,149.3,120.1,161.2,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100)]",0,"ENSG00000162512"
"264","WRAP53",0.572713841728943,6.66442855733695,6.41406382939142,9.29032338979707e-05,0.000574310900460182,1.26325695758679,"UP",FALSE,"High","Master Protein","Q9BUR4","Telomerase Cajal body protein 1 [OS=Homo sapiens]",0,42.376,12,3,5,13,3,548,59.3,4.58,37.54,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400","55135","B3KPR9; D3DTQ4; hsa:55135; Q08ET9; Q9BUR4; Q9NW09","ENSG00000141499","Association of TriC/CCT with target proteins during biosynthesis; Telomere Extension By Telomerase",NA,2,0,80.6,84.5,81.2,122.2,115.5,138.3,102.8,102.8,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S85(99.5); S90(100); S491(100)]",0,"ENSG00000141499"
"265","MTCL1",-0.634600629048708,6.55751669957911,-6.3802600816057,9.68745050891227e-05,0.000596600725680937,1.21864806726277,"DOWN",FALSE,"High","Master Protein","Q9Y4B5","Microtubule cross-linking factor 1 [OS=Homo sapiens]",0,38.439,3,3,3,5,3,1905,209.4,6.43,15.88,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf11365, Pf14818","23255","E9PAY7; hsa:23255; Q6ZMQ9; Q8IWA9; Q9Y4B5","ENSG00000168502",NA,NA,0,0,124.3,125.5,123.1,73.3,77.7,84.5,79.2,87.1,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100); S306(100); S1514(100)]",0,"ENSG00000168502"
"266","CD99",1.13773659241747,6.56746996119232,6.37132951428403,9.79541085220478e-05,0.000600981598150308,1.2068374452367,"UP",FALSE,"High","Master Protein","P14209","CD99 antigen [OS=Homo sapiens]",0,35.437,16,2,3,4,2,185,18.8,4.75,13.93,2,"cell adhesion;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf12301","4267","A6NIW1; hsa:4267; O00518; P14209; Q6ICV7","ENSG00000002586; ENSG00000292348","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Cell surface interactions at the vascular wall",NA,2,0,61.8,57.4,65.8,132.3,214.3,105.4,98.3,108.3,94.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S168(100); T181(100)]",0,"ENSG00000002586"
"267","DDX54",-0.700950274416056,6.53695470685603,-6.35998627175212,9.93441996014042e-05,0.000604626368990242,1.19182070744851,"DOWN",FALSE,"High","Master Protein","Q8TDD1","ATP-dependent RNA helicase DDX54 [OS=Homo sapiens]",0,19.797,2,2,2,7,2,881,98.5,10.02,12,2,"RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","ER/Golgi;nucleus","signal transduction activity or receptor binding;other molecular function","Pf00270, Pf00271, Pf08147","79039","hsa:79039; Q86YT8; Q8TDD1; Q9BRZ1","ENSG00000123064",NA,NA,0,0,128.9,128.6,128.6,74.2,82.3,75.6,81.9,75.7,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S782(100)]",0,"ENSG00000123064"
"268","GTF3C1",-0.60741791437462,6.4839518097892,-6.35867435396811,9.95063454864113e-05,0.000604626368990242,1.19008281651536,"DOWN",FALSE,"High","Master Protein","Q12789","General transcription factor 3C polypeptide 1 [OS=Homo sapiens]",0,48.618,4,5,5,8,5,2109,238.7,7.3,28.37,5,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04182","2975","B2RP21; hsa:2975; Q12789; Q12838; Q6DKN9; Q9Y4W9","ENSG00000077235","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter",NA,3,0,132.6,124.7,122.8,77.9,93.9,77.2,74.8,74.5,74,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S667(100); S739(100); S1068(100); S1856(98.9)]",0,"ENSG00000077235"
"269","SHISA6",-0.432602546762499,6.58478072332571,-6.35743637324944,9.96596159671416e-05,0.000604626368990242,1.18844265846769,"NONE",FALSE,"High","Master Protein","Q6ZSJ9","Protein shisa-6 [OS=Homo sapiens]",0,27.053,9,3,3,3,3,500,55.7,9.35,10.38,3,"cell-cell signaling;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf13908","388336","B3KXV5; Q4PL63; Q6ZSJ9","ENSG00000188803",NA,NA,0,0,124.5,116.1,116.1,89,80,94,90.6,88.4,84.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S391(100); S425(100)]",0,"ENSG00000188803"
"270","CDK16",0.867454089407699,6.53382697196122,6.33119958613605,0.000102968764025624,0.000615993323135968,1.15363417609294,"UP",FALSE,"High","Master Protein","Q00536","Cyclin-dependent kinase 16 [OS=Homo sapiens]",0,16.562,4,2,2,3,1,496,55.7,7.62,10.35,2,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5127","A8K280; B7Z7C8; hsa:5127; J3KN74; J3KQP7; Q00536","ENSG00000102225",NA,NA,0,0,56.3,46,50.2,101.5,66.6,110.3,138,177.4,188.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100); S153(100)]",0,"ENSG00000102225"
"271","UGP2",0.736348129378969,6.60874459419883,6.33003966591171,0.00010311778039863,0.000615993323135968,1.15209317421593,"UP",FALSE,"High","Master Protein","Q16851","UTP--glucose-1-phosphate uridylyltransferase [OS=Homo sapiens]",0.003,2.473,3,1,1,1,1,508,56.9,8.15,1.74,1,"other metabolic processes;developmental processes","cytosol;other cell component","other molecular function","Pf01704","7360","hsa:7360; Q07131; Q0P6K2; Q16851; Q86Y81; Q9BU15","ENSG00000169764","Glycogen synthesis; Formation of the active cofactor, UDP-glucuronate","Exercise-induced circadian regulation; Glycogen synthesis and degradation; Glucuronidation",5,0,65.6,70,56.7,106.6,117,105.5,127,147.7,122.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100)]",0,"ENSG00000169764"
"272","RBM12B",-0.645350241814586,6.51492143555478,-6.32587872713872,0.000103654265272069,0.000615993323135968,1.14656371018489,"DOWN",FALSE,"High","Master Protein","Q8IXT5","RNA-binding protein 12B [OS=Homo sapiens]",0,30.173,4,4,4,9,4,1001,118,6.81,24.31,4,"other biological processes","nucleus;other cell component",NA,"Pf00076","389677","A8MYB5; hsa:389677; Q8IXT5","ENSG00000183808",NA,NA,0,0,134.7,125.4,120,73.1,68.2,95,74.5,85,83.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S250(100); S254(100); S280(100); S591(100); S638(99.7)]",0,"ENSG00000183808"
"273","SLC39A7",-1.03882236175612,6.41881672099698,-6.32483601016095,0.000103789179509735,0.000615993323135968,1.14517768141737,"DOWN",FALSE,"High","Master Protein","Q92504","Zinc transporter SLC39A7 [OS=Homo sapiens]",0,19.346,3,3,6,14,3,469,50.1,6.87,13.18,3,"transport;other biological processes","other membranes;ER/Golgi;nucleus","transporter activity","Pf02535","7922","B0UXF6; hsa:7922; Q5STP8; Q92504; Q9UIQ0","ENSG00000112473; ENSG00000206288; ENSG00000224399; ENSG00000226614; ENSG00000227402; ENSG00000229802","Zinc influx into cells by the SLC39 gene family","Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis",4,0,152.3,136.8,135.9,66.1,77.4,52.2,83.3,64.3,68.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S275(100); S276(99.5)]",0,"ENSG00000112473"
"274","RETREG3",0.681913452751558,6.62742514132492,6.32417853034776,0.00010387434670289,0.000615993323135968,1.14430365310964,"UP",FALSE,"High","Master Protein","Q86VR2","Reticulophagy regulator 3 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,466,51.4,4.97,11.03,1,"cell organization and biogenesis;other metabolic processes;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function",NA,"162427","B3KR75; hsa:162427; Q86VR2","ENSG00000141699",NA,NA,0,0,69.5,72.3,75.9,112.5,136.4,119.1,105.8,99.5,131.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(100)]",0,"ENSG00000141699"
"275","MAPKAP1",0.735942704793771,6.65949912004459,6.32076244115782,0.000104318072095853,0.000615993323135968,1.1397615018883,"UP",FALSE,"High","Master Protein","Q9BPZ7","Target of rapamycin complex 2 subunit MAPKAP1 [OS=Homo sapiens]",0.006,1.827,2,1,1,2,1,522,59.1,7.55,5.25,1,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf05422, Pf16978, Pf16979","79109","A8K1Z5; B1AMA4; B7Z309; hsa:79109; Q00426; Q5JSV5; Q5JSV6; Q5JSV9; Q658R0; Q699U1; Q699U2; Q699U3; Q699U4; Q6GVJ0; Q6GVJ1; Q6GVJ2; Q9BPZ7","ENSG00000119487","PIP3 activates AKT signaling; CD28 dependent PI3K/Akt signaling; Constitutive Signaling by AKT1 E17K in Cancer; Regulation of TP53 Degradation; VEGFR2 mediated vascular permeability","Target of rapamycin signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Head and neck squamous cell carcinoma; ADHD and autism (ASD) linked metabolic pathways and SNP; Interferon type I signaling pathways",13,0,71.2,69.2,66.7,109.2,107.1,137.3,110.1,135.3,130.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S510(100)]",0,"ENSG00000119487"
"276","STOML2",-0.59917148322341,6.58144484434609,-6.31924239576857,0.000104516174335251,0.000615993323135968,1.13773989288826,"DOWN",FALSE,"High","Master Protein","Q9UJZ1","Stomatin-like protein 2, mitochondrial [OS=Homo sapiens]",0,25.765,4,1,1,3,1,356,38.5,7.39,10.21,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;mitochondrion","signal transduction activity or receptor binding;other molecular function","Pf01145, Pf16200","30968","B4E1K7; D3DRN3; hsa:30968; O60376; Q53G29; Q96FY2; Q9P042; Q9UJZ1","ENSG00000165283","Processing of SMDT1; Cellular response to mitochondrial stress",NA,2,0,126.4,119.9,111.6,83.7,64.2,83.3,104.5,94.8,88.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T327(100)]",0,"ENSG00000165283"
"277","TAGLN3",0.612608785498109,6.65856800233864,6.31896179703695,0.000104552788301877,0.000615993323135968,1.13736667213434,"UP",FALSE,"High","Master Protein","Q9UI15","Transgelin-3 [OS=Homo sapiens]",0,7.423,5,2,2,2,2,199,22.5,7.33,5.25,2,"cell organization and biogenesis;developmental processes;other biological processes","cytoskeleton;nucleus","cytoskeletal activity","Pf00307, Pf00402","29114","D3DN64; hsa:29114; Q96A74; Q9UI15","ENSG00000144834",NA,NA,0,0,75,67.2,72.8,103.8,136.5,110.5,116.1,128.6,129.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S163(100)]",0,"ENSG00000144834"
"278","EDF1",1.0970666680304,6.52102896601649,6.30721883241019,0.000106097590009054,0.000622846283794157,1.12173802269805,"UP",FALSE,"High","Master Protein","O60869","Endothelial differentiation-related factor 1 [OS=Homo sapiens]",0.004,2.055,4,1,1,2,1,148,16.4,9.95,4.82,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01381, Pf08523","8721","hsa:8721; O60869; Q5T5T2; Q9UIM1","ENSG00000107223",NA,NA,0,0,45,49.3,49,93.6,125.7,102.7,114.9,209,166.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S53(100)]",0,"ENSG00000107223"
"279","SRSF1",-0.749970000758403,6.52079168565471,-6.28733255566785,0.000108770294457919,0.000635328781324193,1.09522919322013,"DOWN",FALSE,"High","Master Protein","Q07955","Serine/arginine-rich splicing factor 1 [OS=Homo sapiens]",0,53.241,13,5,6,29,5,248,27.7,10.36,59.74,5,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","6426","B2R6Z7; D3DTZ3; hsa:6426; Q07955; Q13809","ENSG00000136450","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",7,0,133.5,133.7,128.3,72.7,83.3,72.2,87.1,70.1,85.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(100); S205(99); S234(100); S238(100)]",0,"ENSG00000136450"
"280","DTNA",0.541978199910821,6.64331374316986,6.285629952942,0.000109002486991896,0.000635328781324193,1.09295711379041,"UP",FALSE,"High","Master Protein","Q9Y4J8","Dystrobrevin alpha [OS=Homo sapiens]",0,62.835,9,4,5,13,3,743,83.8,6.89,31.05,4,"cell-cell signaling;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00569, Pf09068, Pf09069","1837","A8K541; A8MSZ0; A8MUY4; B4DGS6; B4DIR0; B4DIU8; hsa:1837; M0QYX6; M0R397; O15332; O15333; O75697; Q13197; Q13198; Q13199; Q13498; Q13499; Q13500; Q59GK7; Q9BS59; Q9Y4J8","ENSG00000134769",NA,"13q12.12 copy number variation",1,0,80.1,81,91.5,123.3,144.5,119.3,96.3,98.1,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S564(99); S623(98.8); S641(100); S662(100)]",0,"ENSG00000134769"
"281","PRKACG",-2.4122935718282,6.11432170081025,-6.26200998879019,0.000112279606897648,0.000651057515514995,1.06139657196348,"DOWN",FALSE,"High","Master Protein","P22612","cAMP-dependent protein kinase catalytic subunit gamma [OS=Homo sapiens]",0,6.233,5,1,1,3,1,351,40.4,8.59,5.8,1,"cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5568","hsa:5568; O60850; P22612; Q5VZ02; Q86YI1","ENSG00000165059","FCGR3A-mediated IL10 synthesis; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; MAPK6/MAPK4 signaling; Triglyceride catabolism; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; RET signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; CD209 (DC-SIGN) signaling; Rap1 signalling; HDL assembly; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; ROBO receptors bind AKAP5; PKA-mediated phosphorylation of key metabolic factors","AMP-activated protein kinase signaling; Dopamine metabolism; Polycystic kidney disease pathway; Common pathways underlying drug addiction; G protein signaling pathways; MAPK signaling pathway; Cannabinoid receptor signaling; Chemokine signaling pathway; Lipid metabolism pathway; Ras signaling; Hedgehog signaling pathway; Thermogenesis; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; GPR143 in melanocytes and retinal pigment epithelium cells; Vasopressin-regulated water reabsorption; Cardiomyocyte signaling pathways converging on titin; ADHD and autism (ASD) linked metabolic pathways and SNP",44,0,188,179.3,181.7,53.2,14.3,44,75.7,54,38.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T198(100)]",0,"ENSG00000165059"
"282","HMGN3",0.772107186064845,6.65669934394655,6.26045607913878,0.0001124989089309,0.000651057515514995,1.05931762940077,"UP",FALSE,"High","Master Protein","Q15651","High mobility group nucleosome-binding domain-containing protein 3 [OS=Homo sapiens]",0,11.271,10,3,3,13,3,99,10.7,9.66,12.37,3,"cell organization and biogenesis","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01101","9324","B2RD37; hsa:9324; Q15651; Q5HYD3; Q7RTT0; Q969M5; Q9BZT7","ENSG00000118418",NA,NA,0,0,63.9,74.8,73.9,124.5,145.8,110.5,126.3,106.3,113.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100)]",0,"ENSG00000118418"
"283","GDAP1",-0.583147747430074,6.58218253018369,-6.25574988504925,0.000113165922872332,0.000652603484549988,1.05301932393583,"DOWN",FALSE,"High","Master Protein","Q8TB36","Ganglioside-induced differentiation-associated protein 1 [OS=Homo sapiens]",0,43.814,4,3,3,14,3,358,41.3,8.34,40.25,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;mitochondrion;other cytoplasmic organelle",NA,"Pf13410, Pf13417","54332","A8K957; E7FJF3; E7FJF4; hsa:54332; Q8TB36","ENSG00000104381","Class I peroxisomal membrane protein import","Intracellular trafficking proteins involved in CMT neuropathy",2,0,122.8,118.5,114.2,79.5,69.2,83.3,98.5,85.5,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100)]",0,"ENSG00000104381"
"284","TUBB",-0.423705915608803,6.56203301866643,-6.24237422763667,0.000115085145204518,0.000661334355541457,1.03510232853364,"NONE",FALSE,"High","Master Protein","P07437","Tubulin beta chain [OS=Homo sapiens]",0,312.663,42,14,24,66,2,444,49.6,4.89,176.1,14,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;other biological processes","non-structural extracellular;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00091, Pf03953","203068","hsa:203068; P05218; P07437; Q8WUC1; Q9CY33","ENSG00000183311; ENSG00000196230; ENSG00000224156; ENSG00000227739; ENSG00000229684; ENSG00000232421; ENSG00000232575; ENSG00000235067","Potential therapeutics for SARS; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Opioid receptor pathways; Alzheimer's disease; HDAC6 interactions in the central nervous system",15,4,117.3,113.8,115.6,87,75.7,94.4,89.5,85.8,86.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T55(100); S75(100); S172(100); T285(100); T312(100)]",0,"ENSG00000196230"
"285","MCOLN1",-0.453664886997311,6.53654453653442,-6.23304714622424,0.000116444282163754,0.000666796731548232,1.02259417798138,"NONE",FALSE,"High","Master Protein","Q9GZU1","Mucolipin-1 [OS=Homo sapiens]",0,11.767,3,1,1,1,1,580,65,7.24,4.1,1,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf08016, Pf21381","57192","D6W647; hsa:57192; Q7Z4F7; Q9GZU1; Q9H292; Q9H4B3; Q9H4B5","ENSG00000090674","Transferrin endocytosis and recycling; TRP channels","Iron metabolism in placenta",3,0,117.9,129,114.8,85.7,81.9,94.7,81.4,78.4,81.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S557(100)]",0,"ENSG00000090674"
"286","PHRF1",-0.409638094679577,6.59195654181552,-6.22944819039801,0.000116973354866406,0.000667484318678234,1.01776462487397,"NONE",FALSE,"High","Master Protein","Q9P1Y6","PHD and RING finger domain-containing protein 1 [OS=Homo sapiens]",0,113.516,8,9,9,16,9,1649,178.6,8.95,57.02,9,"protein metabolism;other metabolic processes",NA,"other molecular function","Pf00628, Pf13639","57661","A6H8W1; B7ZM64; B9EGP0; C9JS82; hsa:57661; Q6PJP2; Q8IVY2; Q8N2Y7; Q9BSM2; Q9P1Y6","ENSG00000070047; ENSG00000274780",NA,NA,0,0,119,116.8,115.8,87.7,83.2,94.4,88.6,87.1,91.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S867(100); S915(100); S973(100); S991(100); S1034(100); S1124(99.6); S1202(100); S1229(100)]",0,"ENSG00000070047"
"287","LLGL1",0.655213695336203,6.67540871582345,6.22139423853601,0.000118166791034162,0.000671944958075793,1.00695041807107,"UP",FALSE,"High","Master Protein","Q15334","Lethal(2) giant larvae protein homolog 1 [OS=Homo sapiens]",0,43.438,8,6,7,14,6,1064,115.3,6.29,31.47,6,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf08366","3996","A7MBM7; hsa:3996; O00188; Q15334; Q58F11; Q86UK6","ENSG00000131899",NA,"Smith-Magenis and Potocki-Lupski syndrome copy number variation",1,0,81.3,77.4,76.1,132.7,122.8,123,96.3,117.7,107,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S420(100); S655(100); S659(100); S663(100); S682(99.5); S961(100); S967(100)]",0,"ENSG00000131899"
"288","CLDN12",1.20677970896691,6.55241397430578,6.21751616063731,0.000118746138348985,0.000672894783977583,1.00174010937406,"UP",FALSE,"High","Master Protein","P56749","Claudin-12 [OS=Homo sapiens]",0,9.571,7,1,2,2,1,244,27.1,8.46,7.03,1,"cell adhesion;other biological processes","plasma membrane;other membranes;other cell component","other molecular function",NA,"9069","D6W5Q4; hsa:9069; P56749; Q7LDZ0","ENSG00000157224","Tight junction interactions","Epithelial to mesenchymal transition in colorectal cancer; IL-18 signaling pathway",3,0,51.8,63,63.8,112,210.9,125.9,84.8,110.4,121.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(99.5)]",0,"ENSG00000157224"
"289","BRD8",-0.441860801097287,6.62837716302498,-6.2061983721021,0.000120454547508061,0.00068021391533964,0.98652268150097,"NONE",FALSE,"High","Master Protein","Q9H0E9-2","Isoform 2 of Bromodomain-containing protein 8 [OS=Homo sapiens]",0,33.778,4,3,5,8,3,951,102.8,4.69,19.26,3,NA,NA,NA,NA,NA,"Q9H0E9-2",NA,NA,NA,0,0,110.5,112.4,117.3,81.1,77.5,91.8,100.9,99,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T264(100); S268(100); S460(100)]",0,"ENSG00000112983"
"290","VAPB",1.67870416391474,6.40722385373961,6.19543034331835,0.00012210467620394,0.000687154591602862,0.972028309275204,"UP",FALSE,"High","Master Protein","O95292","Vesicle-associated membrane protein-associated protein B/C [OS=Homo sapiens]",0,4.312,5,1,2,2,1,243,27.2,7.3,2.12,1,"cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf00635","9217","A2A2F2; hsa:9217; O95292; O95293; Q9P0H0","ENSG00000124164","Sphingolipid de novo biosynthesis; RHOC GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RHOD GTPase cycle","Ciliary landscape",7,0,36,34.9,36.7,108.3,94.2,144.6,92.5,181.1,220.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S158(100)]",0,"ENSG00000124164"
"291","PRPF3",-0.844223970791862,6.48411211335384,-6.1821256199937,0.000124177387501755,0.000696417513411902,0.954097661083802,"DOWN",FALSE,"High","Master Protein","O43395","U4/U6 small nuclear ribonucleoprotein Prp3 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,683,77.5,9.5,8.37,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus","other molecular function","Pf01480, Pf06544, Pf08572","9129","B4DSY9; hsa:9129; O43395; O43446; Q5VT54","ENSG00000117360","mRNA Splicing - Major Pathway","mRNA processing",2,0,128.5,132.4,133.7,78.3,48.2,87.1,81.9,88.5,70.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S619(100)]",0,"ENSG00000117360"
"292","CRIP2",0.828436260821655,6.61333661004029,6.17569422198648,0.000125192936530225,0.000698080153419391,0.945421503446196,"UP",FALSE,"High","Master Protein","P52943","Cysteine-rich protein 2 [OS=Homo sapiens]",0,25.337,8,1,1,4,1,208,22.5,8.72,12.72,1,"other biological processes","other cell component","other molecular function","Pf00412","1397","A1A4U1; B7Z6C0; E9PD13; hsa:1397; P52943","ENSG00000182809",NA,"VEGFA-VEGFR2 signaling",1,0,64.2,64.1,63.5,115.1,123.2,112.1,103.1,157.8,132,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S115(100)]",0,"ENSG00000182809"
"293","ACSS2",-0.68345889839959,6.50481608330877,-6.17483468128636,0.000125329341269535,0.000698080153419391,0.944261530043995,"DOWN",FALSE,"High","Master Protein","Q9NR19","Acetyl-coenzyme A synthetase, cytoplasmic [OS=Homo sapiens]",0,19.206,4,2,2,6,2,701,78.5,6.46,10.99,2,"other metabolic processes","cytosol;mitochondrion;other cell component","other molecular function","Pf00501, Pf13193, Pf16177","55902","A6NE90; hsa:55902; Q5QPH2; Q5QPH3; Q8N238; Q96EL0; Q9NQP7; Q9NR19; Q9UJ15","ENSG00000131069","Transcriptional activation of mitochondrial biogenesis; Ethanol oxidation","Fatty acid beta-oxidation; Fatty acid biosynthesis; Lipid metabolism pathway; Ethanol effects on histone modifications; Fluoroacetic acid toxicity; Amino acid conjugation of benzoic acid",8,0,132.2,125.3,136.4,81.4,85.4,74.6,71.6,72.6,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S267(100)]",0,"ENSG00000131069"
"294","NAP1L1",0.872928232313046,6.68478168516874,6.1633908572052,0.000127160815434502,0.000705872281595605,0.928808203444582,"UP",FALSE,"High","Master Protein","P55209","Nucleosome assembly protein 1-like 1 [OS=Homo sapiens]",0,27.422,4,1,2,5,1,391,45.3,4.46,17.93,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00956","4673","B3KNT8; B3KV44; hsa:4673; P55209","ENSG00000187109",NA,"VEGFA-VEGFR2 signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies",2,0,65.7,64.2,81.2,135.5,116.1,135.8,127.5,116.4,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T62(100); S69(100)]",0,"ENSG00000187109"
"295","SRSF2",-0.812443246429857,6.48920022626935,-6.14818348515907,0.000129639533805951,0.000717192268377329,0.908245129474897,"DOWN",FALSE,"High","Master Protein","Q01130","Serine/arginine-rich splicing factor 2 [OS=Homo sapiens]",0,48.076,18,6,9,21,5,221,25.5,11.85,47.58,6,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00076","6427","B3KWD5; B4DN89; H0YG49; hsa:6427; Q01130","ENSG00000161547","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Minor Pathway","mRNA processing",7,1,142,135.9,127.9,67.4,87.3,66.6,82.3,67,82.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(99.7); S191(100); S208(100)]",0,"ENSG00000161547"
"296","SNAP23",0.618895622903328,6.65635022936439,6.08369993391402,0.000140745812208735,0.000776003937583298,0.820701236198287,"UP",FALSE,"High","Master Protein","O00161","Synaptosomal-associated protein 23 [OS=Homo sapiens]",0,20.752,8,1,1,3,1,211,23.3,5.01,11.55,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport","plasma membrane;other membranes;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00835","8773","hsa:8773; O00161; O00162; Q13602; Q6IAE3","ENSG00000092531","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; ER-Phagosome pathway; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RAC3 GTPase cycle; RHOB GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; Neutrophil degranulation; trans-Golgi Network Vesicle Budding","Insulin signaling",13,0,76,79.2,86.9,127.2,127.5,128.1,111.3,96.4,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S110(100)]",0,"ENSG00000092531"
"297","RTN1",0.726206728878055,6.54616112304086,6.07360505030852,0.000142575724032531,0.000783446402764613,0.806944766885779,"UP",FALSE,"High","Master Protein","Q16799","Reticulon-1 [OS=Homo sapiens]",0,20.124,2,1,1,5,1,776,83.6,4.69,18.76,1,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;ER/Golgi;other cell component",NA,"Pf02453","6252","hsa:6252; Q16799; Q16800; Q16801; Q5BKZ4; Q9BQ59","ENSG00000139970",NA,NA,0,0,81,87.8,96.1,135.4,143.2,179.5,69.6,71.7,61.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S352(100)]",0,"ENSG00000139970"
"298","GLI3",-0.674124481239427,6.5645957102871,-6.06105758316165,0.00014488614474733,0.000793470430294101,0.789826644115875,"DOWN",FALSE,"High","Master Protein","P10071","Transcriptional activator GLI3 [OS=Homo sapiens]",0,19.696,2,2,2,3,2,1580,169.8,7.4,10.12,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","2737","A4D1W1; hsa:2737; O75219; P10071; Q17RW4; Q75MT0; Q75MU9; Q9UDT5; Q9UJ39","ENSG00000106571","GLI3 is processed to GLI3R by the proteasome; RUNX2 regulates osteoblast differentiation; GLI proteins bind promoters of Hh responsive genes to promote transcription","Ectoderm differentiation; Ectoderm differentiation; Tgif disruption of Shh signaling; Tumor suppressor activity of SMARCB1; Hedgehog signaling pathway; Hedgehog signaling pathway; Endochondral ossification; Osteoblast differentiation and related diseases; Ciliopathies; Endochondral ossification with skeletal dysplasias; Genes controlling nephrogenesis; GDNF/RET signaling axis; Development of ureteric collection system; Bardet-Biedl syndrome; 11p11.2 copy number variation syndrome",20,0,128.9,120.2,126,80.8,85.8,65.5,90.4,85.6,93.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S445(100); S664(100)]",0,"ENSG00000106571"
"299","SLTM",-0.603078998809293,6.54254011864787,-6.04825974253353,0.000147284409485456,0.000803906877191518,0.772344688399786,"DOWN",FALSE,"High","Master Protein","Q9NWH9","SAFB-like transcription modulator [OS=Homo sapiens]",0,73.246,4,4,4,10,4,1034,117.1,7.87,37.39,4,"other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf02037","79811","A8K5V8; B2RTX3; hsa:79811; Q2VPK7; Q52MB3; Q658J7; Q6ZNF2; Q86TK6; Q9H7C3; Q9H8U9; Q9NWH9","ENSG00000137776",NA,NA,0,0,124.3,127.1,129.8,88.8,68.5,89.7,84.4,87.3,71.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S289(100); S344(99.4); S553(100)]",0,"ENSG00000137776"
"300","KSR1",-0.412962038083873,6.60285778983719,-6.01248603768486,0.000154218747743521,0.000838949987724753,0.723358108880582,"NONE",FALSE,"High","Master Protein","Q8IVT5","Kinase suppressor of Ras 1 [OS=Homo sapiens]",0,63.385,5,5,5,7,5,923,102.1,8.66,25.96,5,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","kinase activity;other molecular function","Pf07714, Pf20406","8844","F8WEA9; H7BYU0; hsa:8844; Q13476; Q8IVT5","ENSG00000141068","Signaling by BRAF and RAF1 fusions; RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants","TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Clear cell renal cell carcinoma pathways; Ras signaling; MAPK pathway in congenital thyroid cancer",14,0,117.1,111.6,114.1,89,83.8,84.2,92.2,96.7,96.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T288(100); S334(100); S406(100); T425(100)]",0,"ENSG00000141068"
"301","DST",0.531663977092086,6.65540325452009,6.00260203654853,0.000156196272070918,0.000841207090480202,0.709792436040962,"UP",FALSE,"High","Master Protein","Q03001-11","Isoform 6 of Dystonin [OS=Homo sapiens]",0,20.163,16,2,3,3,2,224,25.4,10.67,10.8,2,NA,NA,NA,NA,NA,"Q03001-11",NA,NA,NA,0,0,75.8,81,85.3,116.7,123.5,124.4,113.1,103.8,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S157(100); S170(100)]",0,"ENSG00000151914"
"302","METTL3",-1.78995336694624,6.02957719773515,-6.00127003836982,0.000156464857111822,0.000841207090480202,0.707963255288341,"DOWN",FALSE,"High","Master Protein","Q86U44","N6-adenosine-methyltransferase catalytic subunit [OS=Homo sapiens]",0,7.156,3,1,1,1,1,580,64.4,6.42,3.07,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05063","56339","hsa:56339; O14736; Q86U44; Q86V05; Q9HB32","ENSG00000165819","Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",2,0,177.3,177.1,123.6,23.3,26.9,75.8,60.6,46.3,41.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S243(100)]",0,"ENSG00000165819"
"303","APOE",-0.970988617519342,6.50983754999656,-5.99969097547122,0.000156783906941299,0.000841207090480202,0.705794473482204,"DOWN",FALSE,"High","Master Protein","P02649","Apolipoprotein E [OS=Homo sapiens]",0,25.177,14,5,5,5,5,317,36.1,5.73,10.37,5,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;enzyme regulator activity;cytoskeletal activity;other molecular function","Pf01442","348","B2RC15; C0JYY5; hsa:348; P02649; Q9P2S4","ENSG00000130203","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Amyloid fiber formation; Retinoid metabolism and transport; Nuclear signaling by ERBB4; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Chylomicron clearance; Scavenging by Class A Receptors; Chylomicron assembly; Chylomicron remodeling; HDL remodeling; Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","Vitamin B12 metabolism; Alzheimer's disease and miRNA effects; Apoptosis-related network due to altered Notch3 in ovarian cancer; ApoE and miR-146 in inflammation and atherosclerosis; Statin inhibition of cholesterol production; Familial hyperlipidemia type 3; Alzheimer's disease; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes; HDAC6 interactions in the central nervous system",22,0,138.5,126.8,131,55.9,60.2,73.9,74.8,86.9,113.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000130203"
"304","NRBP1",-0.527613707324948,6.58750754757056,-5.99951218974412,0.000156820074884742,0.000841207090480202,0.705548896542306,"DOWN",FALSE,"High","Master Protein","Q9UHY1","Nuclear receptor-binding protein [OS=Homo sapiens]",0,10.526,2,1,1,1,1,535,59.8,5.08,3.68,1,"transport","other membranes;nucleus;other cell component","kinase activity;other molecular function","Pf07714","29959","B3KV40; D6W558; hsa:29959; Q53FZ5; Q96SU3; Q9UHY1","ENSG00000115216","Nuclear Receptor transcription pathway",NA,1,0,135.9,105.8,117.1,81.6,72.6,89.4,88,95.6,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T433(100)]",0,"ENSG00000115216"
"305","ANP32B",0.998792519729482,6.61805264662156,5.9975831748814,0.00015721088394391,0.000841207090480202,0.702898955300432,"UP",FALSE,"High","Master Protein","Q92688","Acidic leucine-rich nuclear phosphoprotein 32 family member B [OS=Homo sapiens]",0,4.088,4,1,1,9,1,251,28.8,4.06,17.23,1,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf12799","10541","B2R9C7; hsa:10541; O00655; P78458; P78459; Q92688","ENSG00000136938",NA,NA,0,0,54.9,64.7,66.8,130.7,172.6,97.7,107.2,121.7,136.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T244(100)]",0,"ENSG00000136938"
"306","SEC16A",0.472987610663732,6.6524466711706,5.98494302100545,0.000159797896376912,0.00085225544734353,0.685522127704365,"NONE",FALSE,"High","Master Protein","O15027","Protein transport protein Sec16A [OS=Homo sapiens]",0,72.178,4,5,7,12,5,2357,251.7,5.8,43.16,5,"cell organization and biogenesis;other metabolic processes;stress response;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cell component",NA,"Pf12931, Pf12932","9919","A1YCA4; hsa:9919; J3KNL6; O15027; Q4G0D7; Q5SXP0; Q5SXP1; Q8N347; Q96HP1","ENSG00000148396","COPII-mediated vesicle transport",NA,1,0,78,77.1,89.1,118.8,119.2,114.3,104.6,110.1,105.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1069(100); S1964(100); T2054(100); S2081(99.5)]",0,"ENSG00000148396"
"307","DBF4",-0.80814601277504,6.49795083512089,-5.96774923141261,0.000163390966316994,0.000868579990323562,0.661849875794873,"DOWN",FALSE,"High","Master Protein","Q9UBU7","Protein DBF4 homolog A [OS=Homo sapiens]",0,6.049,2,1,1,1,1,674,76.8,7.9,2.43,1,"cell cycle OR cell proliferation;DNA metabolism;other metabolic processes;other biological processes","nucleus","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf07535","10926","A4D1D8; A8K954; hsa:10926; O75226; Q75MS6; Q75N01; Q9UBU7; Q9Y2M6","ENSG00000006634","Activation of ATR in response to replication stress; Activation of the pre-replicative complex","Cell cycle; DNA replication",4,0,128.6,146.3,116.8,65.4,57.8,92.2,87.3,73.1,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S359(100)]",0,"ENSG00000006634"
"308","MPZL1",0.632000184785085,6.65970122988087,5.96296557114833,0.000164406078090002,0.00087113869948988,0.655256516236019,"UP",FALSE,"High","Master Protein","O95297","Myelin protein zero-like protein 1 [OS=Homo sapiens]",0,9.373,4,1,1,2,1,269,29.1,8.72,6.11,1,"cell-cell signaling;signal transduction","plasma membrane;other membranes","other molecular function","Pf07686","9019","B2REB9; B2REC0; hsa:9019; O95297; Q5R332; Q8IX11; Q9BWZ3; Q9NYK4; Q9UL20","ENSG00000197965",NA,NA,0,0,76.9,74.1,78.6,126.6,114.2,125,120.6,106.4,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(100)]",0,"ENSG00000197965"
"309","CSNK1E",0.427087473942841,6.63841261337704,5.9250875044958,0.000172688593103536,0.00091206402571188,0.602937115739863,"NONE",FALSE,"High","Master Protein","P49674","Casein kinase I isoform epsilon [OS=Homo sapiens]",0,16.914,6,2,3,4,2,416,47.3,9.66,11.41,2,"cell-cell signaling;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","102800317; 1454","hsa:102800317; hsa:1454; P49674","ENSG00000213923","Major pathway of rRNA processing in the nucleolus and cytosol; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Circadian Clock; WNT mediated activation of DVL","Alzheimer's disease and miRNA effects; Melatonin metabolism and effects; Wnt signaling pathway; Wnt signaling pathway and pluripotency; Hedgehog signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Pleural mesothelioma; Alzheimer's disease",20,0,81.2,86.2,79.4,114.8,118.8,114.5,99.1,106.4,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(99.5); S389(100)]",0,"ENSG00000213923"
"310","SATB2",-0.626808669114554,6.57038510989516,-5.91636796188019,0.000174658341086961,0.000919491653722326,0.590865046218473,"DOWN",FALSE,"High","Master Protein","Q9UPW6","DNA-binding protein SATB2 [OS=Homo sapiens]",0,23.75,3,1,2,2,1,733,82.5,6.9,6.84,1,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf02376, Pf16534, Pf16557","23314","A8K5Z8; hsa:23314; Q3ZB87; Q4V763; Q9UPW6","ENSG00000119042","SUMOylation of chromatin organization proteins; RUNX2 regulates osteoblast differentiation","Rett syndrome; Transcription co-factors SKI and SKIL protein partners",4,0,130.7,113.4,122.4,75,88.1,72,89.5,89.8,97.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S594(99.3)]",0,"ENSG00000119042"
"311","FARP2",-0.427930988524232,6.61131735754977,-5.90833252114306,0.000176495039133403,0.00092194933115385,0.579730773756841,"NONE",FALSE,"High","Master Protein","O94887","FERM, ARHGEF and pleckstrin domain-containing protein 2 [OS=Homo sapiens]",0,32.472,4,3,4,5,3,1054,119.8,8.79,13.96,3,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity","Pf00169, Pf00373, Pf00621, Pf08736, Pf09379, Pf09380","9855","B7Z6J8; F5GZ84; hsa:9855; O94887; Q53QM5; Q8WU27; Q9UFE7","ENSG00000006607","RAC1 GTPase cycle; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion","2q37 copy number variation syndrome; TAR syndrome",4,0,114.4,114.4,115.4,85.2,77.5,92.2,100,97.9,91.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T22(100); S439(100)]",0,"ENSG00000006607"
"312","ARHGAP35",-0.393908256733542,6.60893797338871,-5.90766647688955,0.000176648213091754,0.00092194933115385,0.578807470690988,"NONE",FALSE,"High","Master Protein","Q9NRY4","Rho GTPase-activating protein 35 [OS=Homo sapiens]",0,60.376,6,5,5,11,5,1499,170.4,6.64,31.61,5,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00071, Pf00620, Pf16512, Pf19518","2909","A7E2A4; hsa:2909; Q14452; Q9C0E1; Q9NRY4","ENSG00000160007","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RND2 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; Sema4D mediated inhibition of cell attachment and migration; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","Focal adhesion; Regulation of actin cytoskeleton",18,0,110.8,116.6,111.4,87.6,81,89.7,95.2,99.7,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S970(98.6); S975(100); S1179(100)]",0,"ENSG00000160007"
"313","ANKS1A",0.509755057573772,6.66733088796979,5.90692050383324,0.000176819939124482,0.00092194933115385,0.577773293370138,"UP",FALSE,"High","Master Protein","Q92625","Ankyrin repeat and SAM domain-containing protein 1A [OS=Homo sapiens]",0,31.494,4,3,3,6,3,1134,123,6.38,19.82,3,"developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding","Pf00023, Pf00536, Pf00640","23294","A2RUC1; B4DQW8; hsa:23294; Q5JYI9; Q5SYR2; Q86WQ7; Q92625","ENSG00000064999",NA,NA,0,0,79.8,80.6,89.2,124,130.9,117.2,104.8,108,96.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S626(99.3); S647(100)]",0,"ENSG00000064999"
"314","EPS8",0.723931054295109,6.61856935311822,5.90071301242689,0.00017825593817271,0.000926476723241598,0.569164564072015,"UP",FALSE,"High","Master Protein","Q12929","Epidermal growth factor receptor kinase substrate 8 [OS=Homo sapiens]",0,13.164,4,2,2,3,2,822,91.8,7.5,5.02,2,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","cytoskeletal activity;other molecular function","Pf00018, Pf08416, Pf18016","2059","A6NMC3; A8K6W2; A8KA66; B4DX66; hsa:2059; Q12929; Q8N6J0","ENSG00000151491","Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea","EGF/EGFR signaling pathway; IL-18 signaling pathway",4,0,80.3,81.5,63.3,126.9,131.3,120.7,105.5,99,105.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S659(100)]",0,"ENSG00000151491"
"315","SCFD1",-0.448848736030084,6.63360893178335,-5.89632300493741,0.000179279090689841,0.000927583775031688,0.56307314668479,"NONE",FALSE,"High","Master Protein","Q8WVM8","Sec1 family domain-containing protein 1 [OS=Homo sapiens]",0,30.401,3,1,1,3,1,642,72.3,6.27,16.59,1,"stress response;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi","other molecular function","Pf00995","23256","A8K2Z5; B7Z4U7; B7Z594; hsa:23256; O60754; O94990; Q7Z529; Q8WVM8; Q9BZI3; Q9UNL3; Q9Y6A8","ENSG00000092108","COPII-mediated vesicle transport; RHOA GTPase cycle",NA,2,0,99.3,117.6,113.7,84.7,72.4,83.8,105.6,106.5,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S303(100)]",0,"ENSG00000092108"
"316","SLC4A4",-0.476891617447068,6.60372857996595,-5.89400010564337,0.000179823037956379,0.000927583775031688,0.559848892614374,"NONE",FALSE,"High","Master Protein","Q9Y6R1","Electrogenic sodium bicarbonate cotransporter 1 [OS=Homo sapiens]",0,89.122,5,6,11,23,6,1079,121.4,6.8,68.79,6,"transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00955, Pf07565","8671","C4B714; hsa:8671; O15153; Q8NEJ2; Q9H262; Q9NRZ1; Q9UIC0; Q9UIC1; Q9UP50; Q9Y6R1","ENSG00000080493","Bicarbonate transporters; Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)","Proximal tubule transport",3,0,111.1,112.6,102.6,82.2,73.6,75.1,101.6,103.3,114.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S245(100); T254(99.8); S1069(100)]",0,"ENSG00000080493"
"317","NSMF",1.13802572358043,6.58710319745078,5.8925051309317,0.000180174054341327,0.000927583775031688,0.557773426618823,"UP",FALSE,"High","Master Protein","Q6X4W1","NMDA receptor synaptonuclear signaling and neuronal migration factor [OS=Homo sapiens]",0,14.394,4,1,1,1,1,530,60.1,9.07,4.14,1,"other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","other molecular function",NA,"26012","hsa:26012; Q2TB96; Q6X4V7; Q6X4V8; Q6X4V9; Q6X4W1; Q8N2M2; Q96SY1; Q9NPM4; Q9NPP3; Q9NPS3","ENSG00000165802",NA,"IL-18 signaling pathway; Neuroinflammation and glutamatergic signaling",2,0,72,66.3,69.3,174.3,206.6,117.6,100.3,77.5,78.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100)]",0,"ENSG00000165802"
"318","KCNIP3",0.771772897837059,6.63175652977725,5.87515762477071,0.000184301733749575,0.000945850407167629,0.533667273168881,"UP",FALSE,"High","Master Protein","Q9Y2W7","Calsenilin [OS=Homo sapiens]",0,10.16,7,1,1,2,1,256,29.2,5.4,6.89,1,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus","transporter activity;nucleic acid binding activity;other molecular function","Pf13499, Pf13833","30818","H7BY46; hsa:30818; Q3YAC3; Q3YAC4; Q53TJ5; Q96T40; Q9UJ84; Q9UJ85; Q9Y2W7","ENSG00000115041","Regulation of NPAS4 gene transcription; Phase 1 - inactivation of fast Na+ channels","Thyroid stimulating hormone (TSH) signaling pathway",3,0,71,78.4,76.3,120.4,177.9,122,111.8,98.2,87.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000115041"
"319","SPTBN1",0.40369208589984,6.63237649868225,5.86614687945553,0.000186485936393276,0.00095299709151063,0.521129410052145,"NONE",FALSE,"High","Master Protein","Q01082","Spectrin beta chain, non-erythrocytic 1 [OS=Homo sapiens]",0,262.899,6,15,27,76,15,2364,274.4,5.57,219.28,15,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00307, Pf00435","6711","B2RP63; hsa:6711; O60837; Q01082; Q16057; Q53R99; Q59ER3; Q8IX99","ENSG00000115306","Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; COPI-mediated anterograde transport; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Interaction between L1 and Ankyrins; Signaling by FLT3 fusion proteins","TGF-beta signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways",12,0,90.1,90.3,86.9,122.6,126.5,119.7,90.6,94.7,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2102(100); S2138(100); S2161(99.3); T2187(100); T2195(100); S2316(99.5); T2328(100); S2358(100)]",0,"ENSG00000115306"
"320","PPP1R3D",0.602628403442662,6.63935721675116,5.86369348017557,0.00018708546710338,0.00095299709151063,0.517713710128172,"UP",FALSE,"High","Master Protein","O95685","Protein phosphatase 1 regulatory subunit 3D [OS=Homo sapiens]",0,21.821,6,1,1,3,1,299,32.5,8.07,12.58,1,"other metabolic processes;other biological processes","other cell component","other molecular function","Pf03370","5509","hsa:5509; O95685; Q6DK02","ENSG00000132825",NA,NA,0,0,70.5,74.4,67.3,97,131.4,113.8,122.1,119.7,132.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(100)]",0,"ENSG00000132825"
"321","CCNL1",-0.411737781192185,6.60458140432246,-5.86222170410029,0.000187446119102275,0.00095299709151063,0.515664255325772,"NONE",FALSE,"High","Master Protein","Q9UK58","Cyclin-L1 [OS=Homo sapiens]",0,28.12,11,3,3,6,3,526,59.6,10.7,16.17,3,"other biological processes","nucleus;other cell component","enzyme regulator activity","Pf00134, Pf02984","57018","B3KMY3; C9JPL0; hsa:57018; Q6NVY9; Q6UWS7; Q8NI48; Q96QT0; Q9NZF3; Q9UK58","ENSG00000163660",NA,NA,0,0,121.3,108.2,106.8,88.1,77.2,85.6,99,97.8,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100); S338(99.2); S352(100)]",0,"ENSG00000163660"
"322","ACTB",-0.404648032172318,6.58926624591069,-5.85294275987556,0.000189737229403772,0.000961649560207938,0.502736345678788,"NONE",FALSE,"High","Master Protein","P60709","Actin, cytoplasmic 1 [OS=Homo sapiens]",0,328.803,46,14,22,125,6,375,41.7,5.48,365.96,14,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00022","60","hsa:60; P02570; P60709; P70514; P99021; Q11211; Q64316; Q75MN2; Q96B34; Q96HG5","ENSG00000075624","UCH proteinases; Clathrin-mediated endocytosis; DNA Damage Recognition in GG-NER; RHOF GTPase cycle; Adherens junctions interactions; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHO GTPases Activate WASPs and WAVEs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; B-WICH complex positively regulates rRNA expression; Signaling by BRAF and RAF1 fusions; EPHB-mediated forward signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; EPH-ephrin mediated repulsion of cells; HATs acetylate histones; Interaction between L1 and Ankyrins; Prefoldin mediated transfer of substrate  to CCT/TriC; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Formation of annular gap junctions; Folding of actin by CCT/TriC; Cell-extracellular matrix interactions","Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; Ebola virus infection in host; Acute viral myocarditis; Thermogenesis; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Overlap between signal transduction pathways contributing to LMNA laminopathies; Pleural mesothelioma; Regulation of actin cytoskeleton; Network map of SARS-CoV-2 signaling pathway",47,11,116.9,112.2,116.8,90.4,79.1,91.9,95,89.2,88.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T66(100); S233(98.7)]",0,"ENSG00000075624"
"323","PTOV1",-0.452209190783702,6.59207961582235,-5.83158336066257,0.000195126846501344,0.000985904066533107,0.472931771516703,"NONE",FALSE,"High","Master Protein","Q86YD1","Prostate tumor-overexpressed gene 1 protein [OS=Homo sapiens]",0,6.909,2,1,1,1,1,416,46.8,10.54,3.28,1,"other biological processes","plasma membrane;other membranes;nucleus;other cell component",NA,"Pf11232","53635","hsa:53635; Q6UXX7; Q86YD1; Q96BU3; Q9HBN4; Q9NYL1","ENSG00000104960",NA,NA,0,0,126.6,111.4,118.1,92,81.5,84.4,86.9,89.3,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100)]",0,"ENSG00000104960"
"324","RALBP1",0.435564140538784,6.6466067695317,5.79231101756712,0.000205472432880831,0.00103497225451085,0.417965819819128,"NONE",FALSE,"High","Master Protein","Q15311","RalA-binding protein 1 [OS=Homo sapiens]",0,14.935,4,4,4,8,4,655,76,5.88,12.49,4,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus","transporter activity;enzyme regulator activity;other molecular function","Pf00620, Pf20924","10928","D3DUI0; hsa:10928; Q15311","ENSG00000017797","CDC42 GTPase cycle; RAC1 GTPase cycle","RalA downstream regulated genes; Ras signaling; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway",6,0,86.8,85,92.8,123.1,121.6,125.2,95.6,97.2,88.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S29(99.7); S645(100)]",0,"ENSG00000017797"
"325","SH3BP4",-0.523094336028624,6.62109066427064,-5.77954016188785,0.000208962970225125,0.00104709861567325,0.400045228491827,"DOWN",FALSE,"High","Master Protein","Q9P0V3","SH3 domain-binding protein 4 [OS=Homo sapiens]",0,25.509,3,2,4,6,2,963,107.4,7.71,18.23,2,"transport;other biological processes","other membranes;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf00791, Pf07653","23677","hsa:23677; O95082; Q309A3; Q53QD0; Q53TD1; Q9P0V3","ENSG00000130147","Amino acids regulate mTORC1","2q37 copy number variation syndrome",2,0,108,109.3,106.1,79.1,73.6,67.1,114,106.9,123.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S246(100); S279(100)]",0,"ENSG00000130147"
"326","TOPORS",-0.573275315755103,6.54148405935025,-5.77881500068325,0.000209163081317084,0.00104709861567325,0.399026968831779,"DOWN",FALSE,"High","Master Protein","Q9NS56","E3 ubiquitin-protein ligase Topors [OS=Homo sapiens]",0,13.09,2,2,2,2,2,1045,119.1,9.51,6.42,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00097","10210","hsa:10210; O43273; Q6P987; Q9NS55; Q9NS56; Q9UNR9","ENSG00000197579","SUMOylation of SUMOylation proteins; SUMOylation of transcription cofactors; SUMOylation of immune response proteins","Ciliopathies",4,0,134.9,114.2,127.6,81.5,72.1,94.8,74.6,83.8,87.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S98(100); S736(99.7)]",0,"ENSG00000197579"
"327","SIPA1L1",0.465947187091589,6.6770380382014,5.77307292810884,0.000210754945710251,0.00105184119693923,0.390961448637547,"NONE",FALSE,"High","Master Protein","O43166","Signal-induced proliferation-associated 1-like protein 1 [OS=Homo sapiens]",0,138.525,10,14,16,32,14,1804,199.9,8.19,99.77,14,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","signal transduction activity or receptor binding;enzyme regulator activity","Pf00595, Pf02145, Pf11881, Pf21022","26037","hsa:26037; J3KP19; O43166; O95321; Q9UDU4; Q9UNU4","ENSG00000197555","Neurexins and neuroligins",NA,1,0,81.4,78.1,87.6,121.2,109.1,121.6,110,110.8,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S208(99.8); T239(100); S255(100); S310(100); S1181(100); S1270(100); S1393(100); S1433(99.5); S1528(100); S1549(100); S1585(100)]",0,"ENSG00000197555"
"328","ALAD",0.853923812984383,6.67915770358619,5.77050358604892,0.000211471466661586,0.00105219949265765,0.387350966782923,"UP",FALSE,"High","Master Protein","P13716","Delta-aminolevulinic acid dehydratase [OS=Homo sapiens]",0.003,2.304,2,1,1,2,1,330,36.3,6.79,4.95,1,"cell organization and biogenesis;other metabolic processes;stress response;other biological processes","non-structural extracellular;cytosol;other cell component","other molecular function","Pf00490","210","A8K375; B2R6F2; hsa:210; P13716; Q16870; Q16871; Q9BVQ9","ENSG00000148218","Neutrophil degranulation; Heme biosynthesis","Hemesynthesis defects and porphyrias; Heme biosynthesis",4,0,62.8,69.8,83.4,136.4,121.2,135.3,118.2,122.2,93.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100)]",0,"ENSG00000148218"
"329","VPS13D",0.469982433268637,6.65348901777641,5.76575618877176,0.00021280231015447,0.00105560294885135,0.380677418008566,"NONE",FALSE,"High","Master Protein","Q5THJ4","Intermembrane lipid transfer protein VPS13D [OS=Homo sapiens]",0,31.41,2,4,4,4,4,4388,491.6,6.58,13.77,4,"cell organization and biogenesis;transport;other biological processes","other membranes",NA,"Pf00627, Pf06650, Pf12624, Pf16908, Pf16909, Pf16910","55187","hsa:55187; J3KP14; Q58F10; Q5THJ4; Q6MZK9; Q6ZV12; Q709C4; Q709C5; Q86UB4; Q9NSJ3; Q9UIM0","ENSG00000048707",NA,NA,0,0,75.6,71,77.6,101.9,107.6,114.1,119.2,116.7,142.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1038(100); S1042(100); S1709(99.4); S2093(100)]",0,"ENSG00000048707"
"330","ITSN1",0.452714022585417,6.66465659986136,5.75706801623693,0.000215261324087079,0.00106456509366701,0.368456050615269,"NONE",FALSE,"High","Master Protein","Q15811","Intersectin-1 [OS=Homo sapiens]",0,64.282,5,5,6,11,5,1721,195.3,7.77,36.48,5,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf00168, Pf00621, Pf07653, Pf12763, Pf14604, Pf16617, Pf16652","6453","A7Y322; A8CTX8; A8CTY3; A8CTY7; A8D7D0; A8DCP3; B4DTM2; E7ERJ1; E9PE44; E9PG01; E9PHV2; hsa:6453; O95216; Q0PW94; Q0PW95; Q0PW97; Q14BD3; Q15811; Q1ED40; Q20BK3; Q9UET5; Q9UK60; Q9UNK1; Q9UNK2; Q9UQ92","ENSG00000205726","Cargo recognition for clathrin-mediated endocytosis; CDC42 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOQ GTPase cycle; RHOG GTPase cycle; EPHB-mediated forward signaling",NA,8,0,85.8,85,87.3,119.9,115,128.4,104,99.9,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S559(100); S904(100); S986(100); S1137(100)]",0,"ENSG00000205726"
"331","SLC1A2",-0.658788346172712,6.61580657115491,-5.7490181667441,0.000217567035765566,0.00107271722770212,0.357123168072575,"DOWN",FALSE,"High","Master Protein","P43004","Excitatory amino acid transporter 2 [OS=Homo sapiens]",0,16.108,5,2,3,5,2,574,62.1,6.54,11.55,2,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00375","6506","B4DQE9; hsa:6506; P43004; Q14417; Q541G6; U3KQQ4","ENSG00000110436","Glutamate Neurotransmitter Release Cycle; Transport of inorganic cations/anions and amino acids/oligopeptides; Astrocytic Glutamate-Glutamine Uptake And Metabolism","Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; Cell lineage map for neuronal differentiation",6,0,126.1,130.9,111.4,73.3,71.1,80.8,91.8,118.4,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S521(100); S534(100)]",0,"ENSG00000110436"
"332","SALL2",-0.412177682419674,6.54678950017703,-5.74640313467199,0.000218321776711471,0.00107319620359374,0.353439675932194,"NONE",FALSE,"High","Master Protein","Q9Y467","Sal-like protein 2 [OS=Homo sapiens]",0,49.876,5,2,3,8,2,1007,105.3,6.34,29.31,2,"developmental processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf13912","6297","B2RMX6; B9EGK8; hsa:6297; Q8N656; Q9Y467; Q9Y4G1","ENSG00000165821",NA,NA,0,0,128.1,114.8,123.6,92.1,83.8,98.9,79.1,80.1,75.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S806(100); S873(96.7)]",0,"ENSG00000165821"
"333","CARHSP1",0.62795709722704,6.62545295018551,5.73875450645415,0.000220545545517617,0.00108087186271697,0.342660447551404,"UP",FALSE,"High","Master Protein","Q9Y2V2","Calcium-regulated heat-stable protein 1 [OS=Homo sapiens]",0,42.399,18,5,6,25,5,147,15.9,8.21,52.29,5,"signal transduction;other biological processes","cytosol;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00313","23589","B2R4C3; D3DUF5; hsa:23589; Q2YDX5; Q9BQ53; Q9Y2V2","ENSG00000153048",NA,NA,0,0,76.4,77.2,81.9,111.8,171,118.5,97.5,96.4,102.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S32(100); S41(100); S52(100)]",0,"ENSG00000153048"
"334","PPIB",-0.543752256758401,6.56656936482458,-5.73399891804277,0.000221940493582851,0.00108390574275599,0.335954257410159,"DOWN",FALSE,"High","Master Protein","P23284","Peptidyl-prolyl cis-trans isomerase B [OS=Homo sapiens]",0,29.474,24,6,6,6,5,216,23.7,9.41,10.54,6,"protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00160","5479","A8K534; hsa:5479; P23284; Q6IBH5; Q9BVK5","ENSG00000166794","Collagen biosynthesis and modifying enzymes; SARS-CoV-1 activates/modulates innate immune responses","Prolactin signaling pathway; Type I collagen synthesis in the context of osteogenesis imperfecta",4,1,118.7,115.7,114.6,85.6,60.1,91.7,97.6,93.5,89.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S189(100)]",0,"ENSG00000166794"
"335","DMWD",0.498974062717961,6.63148663069586,5.73212455916565,0.000222492906754446,0.00108390574275599,0.333310221916218,"NONE",FALSE,"High","Master Protein","Q09019","Dystrophia myotonica WD repeat-containing protein [OS=Homo sapiens]",0,27.412,9,3,4,5,3,674,70.4,7.24,16.84,3,NA,"nucleus;other cell component","enzyme regulator activity","Pf00400","1762","hsa:1762; Q09019","ENSG00000185800",NA,NA,0,0,83,78.3,89.1,115.6,138.6,119.6,93.4,103.8,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S495(99.6); S545(100)]",0,"ENSG00000185800"
"336","EIF4B",0.754590401170771,6.62152222527793,5.72686354280665,0.00022405137434521,0.00108824953253388,0.325886221483472,"UP",FALSE,"High","Master Protein","P23588","Eukaryotic translation initiation factor 4B [OS=Homo sapiens]",0,50.064,8,3,7,13,3,611,69.1,5.73,48.16,3,"protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus","nucleic acid binding activity","Pf00076","1975","B4DS13; hsa:1975; P23588; Q4G0E3; Q53HQ2; Q6GPH5; Q6IB46; Q8WYK5","ENSG00000063046","Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Z-decay: degradation of maternal mRNAs by zygotically expressed factors","Translation factors; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Pleural mesothelioma; Interferon type I signaling pathways",16,0,67.8,69.4,67.3,113.7,162.5,100.2,108,123.2,122.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100); S497(99.2); S597(100)]",0,"ENSG00000063046"
"337","INVS",-0.623993580096338,6.53910075989426,-5.72142393736239,0.000225675127824016,0.0010928837050706,0.318206131113441,"DOWN",FALSE,"High","Master Protein","Q9Y283","Inversin [OS=Homo sapiens]",0.01,1.564,2,1,1,1,1,1065,117.8,9.35,2.16,1,"cell-cell signaling;signal transduction;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00612, Pf12796","27130","A2A2Y2; hsa:27130; Q2NKL0; Q5W0T6; Q8IVX8; Q9BRB9; Q9Y283; Q9Y488; Q9Y498","ENSG00000119509",NA,"Wnt signaling in kidney disease; Wnt signaling; Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome; NPHP1 deletion syndrome",6,0,123.3,127.5,121.3,71.4,73,92.2,77.4,82.6,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S614(100)]",0,"ENSG00000119509"
"338","PEX11G",-0.733085994935432,6.52206229394178,-5.71041453162775,0.000229000451594911,0.00110570632249377,0.302649442602668,"DOWN",FALSE,"High","Master Protein","Q96HA9","Peroxisomal membrane protein 11C [OS=Homo sapiens]",0,3.568,5,1,1,1,1,241,26.6,9.13,2.18,1,"cell organization and biogenesis","other membranes;other cytoplasmic organelle;other cell component",NA,"Pf05648","92960","hsa:92960; Q8NDM0; Q96HA9","ENSG00000104883",NA,NA,0,0,111.1,118.8,121.3,73.1,49.8,83.6,84.3,95.9,107.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100)]",0,"ENSG00000104883"
"339","MYH14",-0.7863937098985,6.47446994804027,-5.70508190045589,0.000230630094293073,0.00110842691811171,0.295108134262167,"DOWN",FALSE,"High","Master Protein","Q7Z406","Myosin-14 [OS=Homo sapiens]",0,30.401,2,1,1,2,1,1995,227.7,5.6,10.4,1,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00063, Pf01576, Pf02736","79784","B0I1S2; C3TTN4; hsa:79784; Q5CZ75; Q6XYE4; Q76B62; Q7Z406; Q8WV23; Q96I22; Q9BT27; Q9BW35; Q9H882","ENSG00000105357","RHO GTPases activate CIT; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs",NA,6,0,148.6,138.4,121.8,73.7,59.2,95.2,64.2,78.4,80.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1969(100)]",0,"ENSG00000105357"
"340","ALYREF",1.25847953379205,6.57750809625582,5.70362360650258,0.000231077919867966,0.00110842691811171,0.293045147690321,"UP",FALSE,"High","Master Protein","Q86V81","THO complex subunit 4 [OS=Homo sapiens]",0,12.842,7,1,1,1,1,257,26.9,11.15,4.24,1,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf13865","10189","hsa:10189; O43672; Q86V81",NA,"mRNA Splicing - Major Pathway; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,7,0,55.2,60.9,56.7,130,112.1,184.8,81.2,132.4,125.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S239(100)]",0,"ENSG00000183684"
"341","CTNND2",0.515126632275972,6.66884275054623,5.70192262119469,0.000231601457767214,0.00110842691811171,0.290638459184309,"UP",FALSE,"High","Master Protein","Q9UQB3","Catenin delta-2 [OS=Homo sapiens]",0,213.461,17,16,29,60,15,1225,132.6,7.74,186.45,16,"cell adhesion;cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00514","1501","B0FTZ7; hsa:1501; O00379; O15390; O43206; O43840; Q13589; Q9UM66; Q9UPM3; Q9UQB3","ENSG00000169862",NA,"Ectoderm differentiation; Ectoderm differentiation",2,0,83.9,83.5,85.7,124.4,115,132,94.9,109.4,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S201(100); S267(100); S276(99.6); S285(100); S299(99.2); S305(99.2); S327(100); S415(100); S438(100); S461(99.4); S474(99.6); S534(100); S537(100); S1060(99.2); S1065(100); S1082(100)]",0,"ENSG00000169862"
"342","DBNL",0.396522723622318,6.66321912375776,5.68469726504051,0.000236975780295702,0.00113083179369177,0.26624379923326,"NONE",FALSE,"High","Master Protein","Q9UJU6","Drebrin-like protein [OS=Homo sapiens]",0,82.414,10,5,7,35,1,430,48.2,5.05,98.05,5,"cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00241, Pf14604","28988","A4D2I9; B4DDP6; B4DEM2; C9J7P1; hsa:28988; P84070; Q6IAI8; Q96F30; Q96K74; Q9HBN8; Q9NR72; Q9UJU6","ENSG00000136279","Neutrophil degranulation; Caspase-mediated cleavage of cytoskeletal proteins; Neurexins and neuroligins","T-cell receptor signaling pathway",4,5,80.9,81.5,83.4,112.6,114,112,105.4,117.4,111.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S232(100); S269(100); S283(100); T291(100)]",0,"ENSG00000136279"
"343","IRF2BP1",-0.45759272676625,6.59422646410376,-5.67132742471009,0.000241239806791015,0.00114782322064996,0.247280644597982,"NONE",FALSE,"High","Master Protein","Q8IU81","Interferon regulatory factor 2-binding protein 1 [OS=Homo sapiens]",0,47.419,10,5,5,10,5,584,61.6,8.18,31.84,5,"protein metabolism;other metabolic processes;other biological processes","nucleus","other molecular function","Pf11261","26145","Q53EL7; Q6DC95; Q8IU81; Q9BRZ9; Q9Y4P4","ENSG00000170604",NA,NA,0,0,112,111.4,110.5,79.4,79.3,82.9,93.6,98.2,109.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S125(100); S384(100); S453(100)]",0,"ENSG00000170604"
"344","C7orf50",-0.492354285117557,6.57426002616689,-5.66893593720647,0.000242011201014218,0.00114814616295118,0.243886024947516,"NONE",FALSE,"High","Master Protein","Q9BRJ6","Uncharacterized protein C7orf50 [OS=Homo sapiens]",0,39.305,18,2,2,5,2,194,22.1,9.64,16.34,2,NA,NA,NA,"Pf10180","84310","Q9BRJ6","ENSG00000146540",NA,NA,0,0,111,118.7,120.9,78.4,81.2,89.3,84.3,92.9,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100); S175(100)]",0,"ENSG00000146540"
"345","DCP1B",0.591497853872933,6.66548801839131,5.65971648267732,0.000245009980674427,0.00115900373466859,0.230791865875506,"UP",FALSE,"High","Master Protein","Q8IZD4","mRNA-decapping enzyme 1B [OS=Homo sapiens]",0,20.604,8,3,3,4,3,617,67.7,8.56,12.6,3,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf06058, Pf16741","196513","B4DRD1; hsa:196513; Q86XH9; Q8IZD4; Q96BP8; Q96MZ8","ENSG00000151065; ENSG00000284850","mRNA decay by 5' to 3' exoribonuclease",NA,1,0,70.3,79.3,92.8,124.7,135.2,119.4,108.5,99.1,105.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S275(100); S448(100); S511(100)]",0,"ENSG00000151065"
"346","HSPA5",-0.517164247611769,6.56399850204767,-5.61983920258672,0.000258449632274714,0.0012190456643709,0.174017599509716,"DOWN",FALSE,"High","Master Protein","P11021","Endoplasmic reticulum chaperone BiP [OS=Homo sapiens]",0,100.841,21,11,12,14,9,654,72.3,5.16,41.53,11,"protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","translation activity;other molecular function","Pf00012","3309","B0QZ61; hsa:3309; P11021; Q2EF78; Q9NPF1; Q9UK02","ENSG00000044574","Regulation of HSF1-mediated heat shock response; Platelet degranulation ; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; ATF6B (ATF6-beta) activates chaperones; IRE1alpha activates chaperones; PERK regulates gene expression; ATF6 (ATF6-alpha) activates chaperone genes","Parkin-ubiquitin proteasomal system pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Photodynamic therapy-induced unfolded protein response; Prion disease pathway; Unfolded protein response; Orexin receptor pathway",14,0,120.2,115.9,123.3,85.5,72.8,91,97.1,83.4,82.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T648(100)]",0,"ENSG00000044574"
"347","XPR1",0.497697547797137,6.65601220685841,5.60662107962891,0.000263078021116657,0.0012341673510179,0.155149280529461,"NONE",FALSE,"High","Master Protein","Q9UBH6","Solute carrier family 53 member 1 [OS=Homo sapiens]",0,9.139,4,3,4,6,3,696,81.5,8.44,14.31,3,"stress response;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","transporter activity;other molecular function","Pf03105, Pf03124","9213","hsa:9213; O95719; Q7L8K9; Q8IW20; Q9NT19; Q9UBH6; Q9UFB9","ENSG00000143324",NA,NA,0,0,81.1,79.4,75.2,115.2,111.8,118.4,110.4,122.5,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S666(100); S676(100); T690(100)]",0,"ENSG00000143324"
"348","RCC1",-0.412342117609638,6.57469829901305,-5.60565139012151,0.000263421059824543,0.0012341673510179,0.153764121176858,"NONE",FALSE,"High","Master Protein","P18754","Regulator of chromosome condensation [OS=Homo sapiens]",0,28.103,3,2,2,10,2,421,44.9,7.52,29.81,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00415","1104","hsa:1104; P18754; Q16269; Q6NT97","ENSG00000180198","Rev-mediated nuclear export of HIV RNA; Nuclear import of Rev protein; Postmitotic nuclear pore complex (NPC) reformation","22q11.2 copy number variation syndrome",4,0,114,116.8,125.2,88,88.2,93.6,84.5,82.6,87.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100)]",0,"ENSG00000180198"
"349","TACC2",-0.378596251491722,6.65058075135114,-5.60423139707246,0.000263924268079195,0.0012341673510179,0.15173548396219,"NONE",FALSE,"High","Master Protein","O95359-3","Isoform 3 of Transforming acidic coiled-coil-containing protein 2 [OS=Homo sapiens]",0,76.878,4,5,10,13,5,2871,300.9,4.78,41.02,5,NA,NA,NA,NA,NA,"O95359-3",NA,NA,NA,0,0,100.2,106.7,109.8,86.2,72.8,84.3,111.4,115.3,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2088(100); S2226(100); S2317(99); S2321(100); S2569(100); T2625(100)]",0,"ENSG00000138162"
"350","EGLN1",0.54187971405615,6.64796078535514,5.57371220166504,0.000274993532369925,0.00128225555665062,0.108066383119342,"UP",FALSE,"High","Master Protein","Q9GZT9","Egl nine homolog 1 [OS=Homo sapiens]",0,12.052,4,1,1,2,1,426,46,8.53,8.23,1,"protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf01753, Pf13640","54583","hsa:54583; Q8N3M8; Q9BZS8; Q9BZT0; Q9GZT9","ENSG00000135766","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Photodynamic therapy-induced HIF-1 survival signaling; Hereditary leiomyomatosis and renal cell carcinoma pathway; Type 2 papillary renal cell carcinoma; Markers of kidney cell lineage",5,0,87.1,83.4,76,122.5,140.3,115.2,104.3,100.9,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S125(100)]",0,"ENSG00000135766"
"351","CTTNBP2NL",0.468140391795047,6.69209412700372,5.56556949916184,0.000278030643588067,0.00129272367617016,0.0963930359695224,"NONE",FALSE,"High","Master Protein","Q9P2B4","CTTNBP2 N-terminal-like protein [OS=Homo sapiens]",0,44.668,5,2,3,5,2,639,70.1,8.06,17.88,2,"protein metabolism;other metabolic processes;other biological processes","cytoskeleton;other cell component","other molecular function","Pf09727","55917","B3KMS5; hsa:55917; Q96B40; Q9P2B4","ENSG00000143079",NA,NA,0,0,73.8,84.8,86.6,122.7,113.4,115.4,113.3,111.5,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S488(100); S557(98.8); S560(98.8); S568(100)]",0,"ENSG00000143079"
"352","VIM",0.536427264622897,6.64403460000874,5.55715600519126,0.00028120672784863,0.00130377664729819,0.0843216683365817,"UP",FALSE,"High","Master Protein","P08670","Vimentin [OS=Homo sapiens]",0,898.126,77,42,81,267,40,466,53.6,5.12,819.87,42,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00038, Pf04732","7431","B0YJC2; D3DRU4; hsa:7431; P08670; Q15867; Q15868; Q15869; Q548L2; Q6LER9; Q8N850; Q96ML2; Q9NTM3","ENSG00000026025","Aggrephagy; Interleukin-4 and Interleukin-13 signaling; Chaperone Mediated Autophagy; Late endosomal microautophagy; Striated Muscle Contraction; RHOBTB1 GTPase cycle; Caspase-mediated cleavage of cytoskeletal proteins","Allograft rejection; Spinal cord injury; Primary focal segmental glomerulosclerosis (FSGS); Mammary gland development pathway - Puberty (Stage 2 of 4); Apoptosis-related network due to altered Notch3 in ovarian cancer; Striated muscle contraction pathway; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Ciliary landscape; Burn wound healing; CCL18 signaling pathway; TROP2 regulatory signaling; Macrophage-stimulating protein (MSP) signaling network map; HDAC6 interactions in the central nervous system; T-cell receptor signaling pathway",21,0,75.8,73.8,75.2,107.4,108.4,122.4,103,129.7,121.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100); S10(99.6); S26(99.5); T33(99); S39(100); S42(99.5); S51(100); S73(100); S83(100); S205(99.2); S214(100); S339(100); S419(100); S420(99.6); S430(100); S438(99.6); T446(100); S459(99.4)]",0,"ENSG00000026025"
"353","ATP2B1",0.63839372550721,6.6304754016106,5.55500452235854,0.000282025166448892,0.00130386705848326,0.0812331990643118,"UP",FALSE,"High","Master Protein","P20020","Plasma membrane calcium-transporting ATPase 1 [OS=Homo sapiens]",0,79.67,8,5,8,12,2,1220,134.6,5.91,38.05,5,"transport;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf12424, Pf13246","490","hsa:490; P20020; Q12992; Q12993; Q13819; Q13820; Q13821; Q16504; Q93082","ENSG00000070961","Sensory processing of sound by inner hair cells of the cochlea; Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels","Vitamin D receptor pathway; Splicing factor NOVA regulated synaptic proteins; Vitamin D-sensitive calcium signaling in depression; Calcium regulation in cardiac cells",8,3,74.8,76.1,84.9,112.9,117.2,147.9,94.4,98.5,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1127(99.7); S1155(100); S1178(99); S1182(100); S1211(98.9)]",0,"ENSG00000070961"
"354","COL4A1",-0.733508179302491,6.4829738415467,-5.55045540090618,0.000283764138497938,0.00130820077409219,0.0747007536582514,"DOWN",FALSE,"High","Master Protein","P02462","Collagen alpha-1(IV) chain [OS=Homo sapiens]",0,13.768,2,2,2,2,2,1669,160.5,8.28,2.88,2,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","non-structural extracellular;extracellular matrix;ER/Golgi","extracellular structural activity;other molecular function","Pf01391, Pf01413","1282","A7E2W4; B1AM70; F5H5K0; P02462; Q1P9S9; Q5VWF6; Q86X41; Q8NF88; Q9NYC5","ENSG00000187498","Collagen degradation; Signaling by PDGF; Integrin cell surface interactions; ECM proteoglycans; NCAM1 interactions; Collagen chain trimerization; Non-integrin membrane-ECM interactions; Laminin interactions; Anchoring fibril formation; Crosslinking of collagen fibrils; Scavenging by Class A Receptors","Spinal cord injury; miRNA targets in ECM and membrane receptors; Focal adhesion; Overview of nanoparticle effects; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; Small cell lung cancer; Pleural mesothelioma; Macrophage-stimulating protein (MSP) signaling network map",24,0,118.1,125.5,142.3,78.8,61,89.1,66.6,83,82,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S656(100)]",0,"ENSG00000187498"
"355","MSH6",-0.409243896242198,6.56971897969967,-5.54583682922671,0.000285541473228651,0.00130965886553958,0.0680655945062414,"NONE",FALSE,"High","Master Protein","P52701","DNA mismatch repair protein Msh6 [OS=Homo sapiens]",0,14.508,2,2,2,2,2,1360,152.7,6.9,5.6,2,"cell cycle OR cell proliferation;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00488, Pf00855, Pf01624, Pf05188, Pf05190, Pf05192","2956","B4DF41; B4E3I4; F5H2F9; hsa:2956; O43706; O43917; P52701; Q8TCX4; Q9BTB5","ENSG00000116062","Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha); Defective Mismatch Repair Associated With MSH2; Defective Mismatch Repair Associated With MSH6","Glioblastoma signaling pathways; Retinoblastoma gene in cancer; Chromosomal and microsatellite instability in colorectal cancer ; DNA repair pathways, full network; DNA mismatch repair",8,0,113.8,111.4,105.8,90.3,71.2,85.7,95.3,97.6,90.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(99.6); S227(100)]",0,"ENSG00000116062"
"356","CNN3",1.08261684142719,6.54799209369881,5.54546420366675,0.00028568538978682,0.00130965886553958,0.0675301399092296,"UP",FALSE,"High","Master Protein","Q15417","Calponin-3 [OS=Homo sapiens]",0,11.054,3,1,2,2,1,329,36.4,6.05,5.86,1,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton","cytoskeletal activity;other molecular function","Pf00307, Pf00402","1266","B4DFK6; B4DP09; F8WA86; hsa:1266; Q15417; Q6FHA7","ENSG00000117519",NA,NA,0,0,54.7,61.3,53.2,124.7,166.1,93.2,97.7,130.8,146.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100)]",0,"ENSG00000117519"
"357","HSPA8",-0.439375829642151,6.58485563667407,-5.53769984475591,0.000288701996151967,0.00131772595801495,0.0563684755185996,"NONE",FALSE,"High","Master Protein","P11142","Heat shock cognate 71 kDa protein [OS=Homo sapiens]",0,120.609,20,12,12,18,10,646,70.9,5.52,54.26,12,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00012","3312","hsa:3312; P11142; Q9H3R6","ENSG00000109971","AUF1 (hnRNP D0) binds and destabilizes mRNA; Neutrophil degranulation; Golgi Associated Vesicle Biogenesis; Late endosomal microautophagy; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; PKR-mediated signaling; Regulation of HSF1-mediated heat shock response; Lysosome Vesicle Biogenesis; Clathrin-mediated endocytosis; mRNA Splicing - Major Pathway; CHL1 interactions; Interleukin-4 and Interleukin-13 signaling; GABA synthesis, release, reuptake and degradation; Lipophagy; Chaperone Mediated Autophagy; Protein methylation; Attenuation phase; Respiratory syncytial virus genome transcription","Parkin-ubiquitin proteasomal system pathway; MAPK signaling pathway; Exercise-induced circadian regulation; Measles virus infection; Opioid receptor pathways; Extrafollicular and follicular B cell activation by SARS-CoV-2; 1p36 copy number variation syndrome; HDAC6 interactions in the central nervous system",27,1,123.1,115.5,117.2,92.5,69.9,97.9,87.6,88.6,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S254(100)]",0,"ENSG00000109971"
"358","MYO18A",0.721792520075921,6.65805357214083,5.53678423212167,0.000289059983437103,0.00131772595801495,0.0550516750059096,"UP",FALSE,"High","Master Protein","Q92614","Unconventional myosin-XVIIIa [OS=Homo sapiens]",0,26.855,2,4,4,4,4,2054,233,6.3,12.85,4,"cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;other biological processes","other membranes;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00063, Pf00595, Pf01576","399687","hsa:399687; Q5H9U3; Q5QD01; Q5W9F9; Q5W9G1; Q8IXP8; Q92614","ENSG00000196535","Signaling by cytosolic FGFR1 fusion mutants; Signaling by FGFR1 in disease; Signaling by FLT3 fusion proteins",NA,3,0,75.9,72.9,71.4,135,99.3,130.8,103.3,122,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100); S987(100); S1640(100); S1998(100)]",0,"ENSG00000196535"
"359","PRPF4B",-0.407010907520966,6.58382728397784,-5.51935904963735,0.000295964764464466,0.00133906439897281,0.0299688780394698,"NONE",FALSE,"High","Master Protein","Q13523","Serine/threonine-protein kinase PRP4 homolog [OS=Homo sapiens]",0,74.942,12,15,16,29,15,1007,116.9,10.26,70.22,15,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","8899","A8K5C9; hsa:8899; Q13523; Q5D0F6; Q5TAY8; Q8IVC3; Q8TDP2; Q96QT7; Q9UEE6","ENSG00000112739","mRNA Splicing - Major Pathway","mRNA processing",2,0,121.1,113.8,117.2,92.3,75.1,96.8,86,92.1,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S239(100); S241(99.5); S257(100); S277(100); S294(100); S356(100); S368(100); S387(100); S431(100); S437(100); S569(100)]",0,"ENSG00000112739"
"360","MAVS",0.382318897201666,6.65212698819022,5.51931895415761,0.00029598085562988,0.00133906439897281,0.0299111129368042,"NONE",FALSE,"High","Master Protein","Q7Z434","Mitochondrial antiviral-signaling protein [OS=Homo sapiens]",0,65.544,14,3,5,16,3,540,56.5,5.52,45.35,3,"stress response;signal transduction;other biological processes","other membranes;mitochondrion;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf16739","57506","A8K6X0; B2BD33; B2BD34; F5H6C8; hsa:57506; M1P2Z0; Q2HWT5; Q3I0Y2; Q5T7I6; Q7Z434; Q86VY7; Q9H1H3; Q9H4Y1; Q9H8D3; Q9ULE9","ENSG00000088888","SARS-CoV-2 activates/modulates innate and adaptive immune responses; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses; PKR-mediated signaling; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; Ovarian tumor domain proteases","Novel intracellular components of RIG-I-like receptor pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; Lung pathology of COVID-19; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",24,0,73.1,76.2,76.3,97.9,106.4,102.2,127.8,126.4,135.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S165(100); S222(100)]",0,"ENSG00000088888"
"361","RRM2",1.4092857137223,6.58590569517412,5.51876725987368,0.00029620235786102,0.00133906439897281,0.0291162702112535,"UP",FALSE,"High","Master Protein","P31350","Ribonucleoside-diphosphate reductase subunit M2 [OS=Homo sapiens]",0,7.902,5,1,1,1,1,389,44.8,5.38,2.96,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus","other molecular function","Pf00268","6241","B2R9B5; hsa:6241; J3KP43; P31350; Q5WRU7","ENSG00000171848","Transcriptional Regulation by E2F6; Interconversion of nucleotide di- and triphosphates; G1/S-Specific Transcription","Fluoropyrimidine activity; Retinoblastoma gene in cancer; Hepatitis C and hepatocellular carcinoma; Pyrimidine metabolism; Orexin receptor pathway",8,0,59.5,43.7,71.2,145,257.9,112.5,85.1,116.9,93.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(100)]",0,"ENSG00000171848"
"362","CCDC167",-0.50347190558454,6.55864260151311,-5.5106093698407,0.000299498611644973,0.00135022578509557,0.0173579375551673,"DOWN",FALSE,"High","Master Protein","Q9P0B6","Coiled-coil domain-containing protein 167 [OS=Homo sapiens]",0.004,2.104,7,1,1,2,1,97,11.5,9.5,4.77,1,NA,"other membranes",NA,"Pf15188","154467","hsa:154467; Q5T7F7; Q9BTQ9; Q9P0B6","ENSG00000198937",NA,NA,0,0,113.6,117,124.8,78.2,83.2,89.4,91.9,80.9,89.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100)]",0,"ENSG00000198937"
"363","ZC3H18",-0.396604502015434,6.60547003461527,-5.50634227617972,0.000301238466337868,0.00135432831146942,0.0112038435002395,"NONE",FALSE,"High","Master Protein","Q86VM9","Zinc finger CCCH domain-containing protein 18 [OS=Homo sapiens]",0,75.081,11,9,9,17,9,953,106.3,8.32,45.02,9,"other biological processes","nucleus;other cell component","other molecular function","Pf18044","124245","hsa:124245; Q86VM9; Q96DG4; Q96MP7","ENSG00000158545",NA,NA,0,0,113.6,116.3,111.4,87.7,86.2,86.4,97.4,91.9,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100); T162(100); S534(99.7); T796(99); S842(100); S868(100); S893(100)]",0,"ENSG00000158545"
"364","PANK2",0.614951248195537,6.61452426067295,5.49868642785201,0.000304387365504005,0.001360651268795,0.000155973697371969,"UP",FALSE,"High","Master Protein","Q9BZ23","Pantothenate kinase 2, mitochondrial [OS=Homo sapiens]",0,20.437,3,1,1,2,1,570,62.6,9.28,6.77,1,"other metabolic processes;developmental processes;other biological processes","cytosol;mitochondrion;nucleus","kinase activity;other molecular function","Pf03630","80025","B1AK33; B2Z3X0; D3DVZ0; hsa:80025; Q5T7I2; Q5T7I4; Q7RTX5; Q8N7Q4; Q8TCR5; Q9BYW5; Q9BZ23; Q9HAF2","ENSG00000125779","Coenzyme A biosynthesis","Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Iron metabolism disorders",3,0,72.7,72.4,81.8,116.6,100.1,139.1,103.1,105.5,102.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100)]",0,"ENSG00000125779"
"365","RSL1D1",-0.454355389569363,6.57226733586151,-5.49811696354902,0.000304623000909039,0.001360651268795,-0.000666129593131615,"NONE",FALSE,"High","Master Protein","O76021","Ribosomal L1 domain-containing protein 1 [OS=Homo sapiens]",0,37.719,6,2,3,12,2,490,54.9,10.13,40.94,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity","Pf00687","26156","B4DJ58; D3DUG7; hsa:26156; O76021; Q2M1T7; Q6PL22; Q8IWS7; Q8WUZ1; Q9HDA9; Q9Y3Z9","ENSG00000171490",NA,NA,0,0,113.2,107.2,110,75.3,82.6,82.4,92.3,100,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S361(100); S427(100)]",0,"ENSG00000171490"
"366","SH3BP5L",0.633159756513783,6.65996209697835,5.49685457742705,0.000305146056604761,0.001360651268795,-0.00248872798398025,"UP",FALSE,"High","Master Protein","Q7L8J4","SH3 domain-binding protein 5-like [OS=Homo sapiens]",0,25.172,18,4,4,4,4,393,43.5,5.77,9.55,4,"signal transduction","other cell component","enzyme regulator activity","Pf05276","80851","B4DQ94; hsa:80851; Q7L8J4; Q96FI5; Q9BQH8; Q9C0E3","ENSG00000175137",NA,NA,0,0,65.8,89.8,85.2,123,133.5,127.4,94.4,103.9,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S350(100); S362(100)]",0,"ENSG00000175137"
"367","PRKCA",0.547504818082984,6.65968337610006,5.49007789667621,0.000307970466088129,0.00136950354402133,-0.0122765583535625,"UP",FALSE,"High","Master Protein","P17252","Protein kinase C alpha type [OS=Homo sapiens]",0,39.133,9,4,4,5,3,672,76.7,7.05,15.33,4,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00069, Pf00130, Pf00168, Pf00433","5578","B5BU22; hsa:5578; P17252; Q15137; Q32M72; Q96RE4","ENSG00000154229","G alpha (z) signalling events; Disinhibition of SNARE formation; RET signaling; Regulation of KIT signaling; SHC1 events in ERBB2 signaling; Ca2+ pathway; WNT5A-dependent internalization of FZD4; Inactivation, recovery and regulation of the phototransduction cascade; Syndecan interactions; HuR (ELAVL1) binds and stabilizes mRNA; VEGFR2 mediated cell proliferation; Trafficking of GluR2-containing AMPA receptors; Depolymerization of the Nuclear Lamina; Acetylcholine regulates insulin secretion; EGFR Transactivation by Gastrin; RHO GTPases Activate NADPH Oxidases; Calmodulin induced events; ROBO receptors bind AKAP5","Target of rapamycin signaling; Thyroxine (thyroid hormone) production; Follicle stimulating hormone (FSH) signaling pathway; Microtubule cytoskeleton regulation; Endothelin pathways; Glioblastoma signaling pathways; Pathogenic Escherichia coli infection; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Spinal cord injury; Alpha 6 beta 4 signaling pathway; T cell receptor and co-stimulatory signaling; Common pathways underlying drug addiction; Cardiac hypertrophic response; Complement system; Myometrial relaxation and contraction pathways; Transcriptional activation by NRF2 in response to phytochemicals; Kit receptor signaling pathway; Focal adhesion; Melatonin metabolism and effects; G protein signaling pathways; Wnt signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; PDGFR-beta pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Ras signaling; Non-small cell lung cancer; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; NRF2-ARE regulation; EGF/EGFR signaling pathway; Hippo signaling regulation pathways; Fragile X syndrome; Overview of interferons-mediated signaling pathway; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; Hippocampal synaptogenesis and neurogenesis; Chronic hyperglycemia impairment of neuron function; TROP2 regulatory signaling; Cardiomyocyte signaling pathways converging on titin; Calcium regulation in cardiac cells; Osteoarthritic chondrocyte hypertrophy; ErbB signaling pathway",75,1,74.7,70,79.8,111.1,95.8,128.8,116.2,121.4,121.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S226(100); S319(100); T497(100)]",0,"ENSG00000154229"
"368","AKAP10",-0.498206458267431,6.60407818612287,-5.4830439025103,0.000310931893570005,0.00137675134714573,-0.0224428935866614,"NONE",FALSE,"High","Master Protein","O43572","A-kinase anchor protein 10, mitochondrial [OS=Homo sapiens]",0,7.975,2,1,1,1,1,662,73.8,6.39,3.36,1,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;other cell component","other molecular function","Pf00615","11216","B2R650; hsa:11216; O43572; Q96AJ7","ENSG00000108599","Factors involved in megakaryocyte development and platelet production","G protein signaling pathways; TAR syndrome",3,0,100.7,111.3,112.8,82,63.5,82.3,113.8,99.3,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S187(100)]",0,"ENSG00000108599"
"369","GTF3C3",-0.463224462588873,6.59647380631619,-5.4822040469854,0.000311287528858317,0.00137675134714573,-0.0236572159365736,"NONE",FALSE,"High","Master Protein","Q9Y5Q9","General transcription factor 3C polypeptide 3 [OS=Homo sapiens]",0,22.671,6,2,2,4,2,886,101.2,5.07,10.86,2,"RNA metabolism OR transcription;other metabolic processes","other membranes;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf13181","9330","hsa:9330; Q4ZG48; Q86XJ8; Q8WX84; Q96B44; Q9H5I8; Q9NT97; Q9Y5Q9","ENSG00000119041","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Initiation From Type 1 Promoter; RNA Polymerase III Transcription Initiation From Type 2 Promoter",NA,3,0,117.3,112.7,105.7,87.6,79.8,74.1,98.1,98.5,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S43(100)]",0,"ENSG00000119041"
"370","CAPZB",0.468973209494436,6.65284678182274,5.46487936749969,0.000318722102932128,0.00140582289725739,-0.0487286769309012,"NONE",FALSE,"High","Master Protein","P47756-1","Isoform 2 of F-actin-capping protein subunit beta [OS=Homo sapiens]",0,5.947,3,1,1,5,1,277,31.3,5.59,13.36,1,NA,NA,NA,NA,NA,"P47756-1",NA,NA,NA,0,0,68.8,68.7,72.2,90.9,113,101,134.1,144,149.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100)]",0,"ENSG00000077549"
"371","TBC1D10A",1.01987497794845,6.56944878307569,5.4572693460051,0.000322047983574705,0.00140955979552656,-0.0597549404577986,"UP",FALSE,"High","Master Protein","Q9BXI6","TBC1 domain family member 10A [OS=Homo sapiens]",0,16.618,6,2,2,2,2,508,57.1,8.44,6.45,2,"protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00566","83874","B3KXT8; hsa:83874; O76053; Q20WK7; Q543A2; Q9BXI6","ENSG00000099992","TBC/RABGAPs","Deregulation of Rab and Rab effector genes in bladder cancer",2,0,62.8,53.1,53.1,99.6,107.6,144.8,121.1,107,167.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(100); S407(99.2)]",0,"ENSG00000099992"
"372","SQSTM1",-0.403559143265519,6.60526377100956,-5.4562009678794,0.000322517887463866,0.00140955979552656,-0.0613035828046824,"NONE",FALSE,"High","Master Protein","Q13501","Sequestosome-1 [OS=Homo sapiens]",0,32.737,11,2,2,4,2,440,47.7,5.22,10.51,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00564, Pf00569, Pf16577","8878","A6NFN7; B2R661; B3KUW5; hsa:8878; Q13446; Q13501; Q9BUV7; Q9BVS6; Q9UEU1","ENSG00000161011; ENSG00000284099","Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Signaling by ALK fusions and activated point mutants; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; Nuclear events mediated by NFE2L2; PINK1-PRKN Mediated Mitophagy; NRIF signals cell death from the nucleus; Pexophagy","IL-1 signaling pathway; RANKL/RANK signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Nuclear receptors meta-pathway; NRF2 pathway; Interleukin-1 induced activation of NF-kB; Clear cell renal cell carcinoma pathways; CAMKK2 pathway; 7q11.23 copy number variation syndrome; Opioid receptor pathways; Clock-controlled autophagy in bone metabolism; Autophagy in pancreatic ductal adenocarcinoma; HDAC6 interactions in the central nervous system",24,0,108.9,111.7,122.6,87.9,84,89.6,90.9,94.4,97.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S272(100)]",0,"ENSG00000161011"
"373","CANX",-0.452623896184293,6.58423219977183,-5.45508898743428,0.000323007752247342,0.00140955979552656,-0.0629155990914558,"NONE",FALSE,"High","Master Protein","P27824","Calnexin [OS=Homo sapiens]",0,263.04,13,10,21,113,10,592,67.5,4.6,452.09,10,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;nucleus;other cell component","other molecular function","Pf00262","821","B2R5V8; B4DGP8; B4E2T8; D3DWQ3; D6R9K3; hsa:821; P27824","ENSG00000127022; ENSG00000283777","MHC class II antigen presentation; Antigen Presentation: Folding, assembly and peptide loading of class I MHC; Interleukin-35 Signalling; Interleukin-27 signaling; Assembly of Viral Components at the Budding Site; Maturation of spike protein; Calnexin/calreticulin cycle; Maturation of spike protein","15q11q13 copy number variation",9,0,116.7,116.6,112.3,86.2,83.3,82.4,97.1,86.4,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S564(100); S583(100)]",0,"ENSG00000127022"
"374","ADGRB1",-0.560429270896201,6.60857686907037,-5.4532684345873,0.000323811495490299,0.00140955979552656,-0.0655551959676863,"DOWN",FALSE,"High","Master Protein","O14514","Adhesion G protein-coupled receptor B1 [OS=Homo sapiens]",0,35.014,2,2,2,4,2,1584,173.4,7.88,15.71,2,"cell adhesion;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","other molecular function","Pf00002, Pf00090, Pf01825, Pf02793, Pf16489, Pf19188","575","hsa:575; O14514","ENSG00000181790",NA,"p53 transcriptional gene network",1,0,103.9,115.7,104.5,70.9,72.1,71.3,123.7,103.8,112.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1278(100); S1469(100)]",0,"ENSG00000181790"
"375","H1-5",-0.486730957208389,6.47595410346502,-5.45309580374488,0.000323887820663273,0.00140955979552656,-0.0658055155747794,"NONE",FALSE,"High","Master Protein","P16401","Histone H1.5 [OS=Homo sapiens]",0,64.807,31,7,8,13,3,226,22.6,10.92,32.35,7,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","3009","hsa:3009; P16401; Q14529; Q3MJ42","ENSG00000184357","Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF)",NA,2,0,105.8,110,104.5,72.4,73,79.6,79.4,92.4,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100); S107(100); S116(100); T138(100)]; Met-loss [N-Term]",0,"ENSG00000184357"
"376","ITPKB",0.432496983258382,6.63969086961802,5.4431128813587,0.000328334646525559,0.00142511208279179,-0.0802881959929547,"NONE",FALSE,"High","Master Protein","P27987","Inositol-trisphosphate 3-kinase B [OS=Homo sapiens]",0,250.122,18,14,23,49,14,946,102.3,8.43,167.63,14,"cell cycle OR cell proliferation;other metabolic processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf03770","3707","hsa:3707; P27987; Q5VWL9; Q5VWM0; Q96BZ2; Q96JS1; Q9UH47","ENSG00000143772","Synthesis of IP3 and IP4 in the cytosol","CCL18 signaling pathway",2,0,90.4,83.7,87.3,122.2,132.9,115.5,97.7,92.4,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T33(100); S43(100); S65(100); S120(100); S174(100); S176(100); S204(100); S269(100); S562(100); S588(100)]",0,"ENSG00000143772"
"377","CSTF2",0.616038104921676,6.62268444706715,5.43916650939623,0.000330110601269201,0.00142901989727145,-0.0860172603022438,"UP",FALSE,"High","Master Protein","P33240","Cleavage stimulation factor subunit 2 [OS=Homo sapiens]",0,30.401,7,1,1,3,1,577,60.9,6.83,8.87,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf14304, Pf14327","1478","hsa:1478; P33240; Q5H951; Q6LA74; Q8N502","ENSG00000101811","tRNA processing in the nucleus; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs","mRNA processing",6,0,88.4,76.4,77.4,123.4,109.4,143.2,94.3,98.1,93.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S524(98.3)]",0,"ENSG00000101811"
"378","CKB",0.433357718910384,6.66336026074922,5.42794989100623,0.000335214973569394,0.0014449423538934,-0.102312769423547,"NONE",FALSE,"High","Master Protein","P12277","Creatine kinase B-type [OS=Homo sapiens]",0,265.996,46,16,22,47,16,381,42.6,5.59,150.03,16,"other metabolic processes","non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion","kinase activity;other molecular function","Pf00217, Pf02807","1152","A8K236; B2R5R4; hsa:1152; P12277; Q2LE07; Q6FG40; Q9UC66","ENSG00000166165","RND3 GTPase cycle; Creatine metabolism",NA,2,0,85,84.2,89.6,121.9,110.1,126.9,95.9,104.6,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T35(100); S164(99.5); T322(100)]; Met-loss [N-Term]",0,"ENSG00000166165"
"379","STX7",0.656486145152621,6.6816516052592,5.42719937373347,0.000335559529488724,0.0014449423538934,-0.103403755798157,"UP",FALSE,"High","Master Protein","O15400","Syntaxin-7 [OS=Homo sapiens]",0,22.334,5,1,1,3,1,261,29.8,5.55,10.54,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf05739, Pf14523","8417","E1P579; hsa:8417; O15400; Q5SZW2; Q96ES9","ENSG00000079950",NA,NA,0,0,78.8,76.5,70.3,117,106.9,139.5,110.1,129,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T79(99.6)]",0,"ENSG00000079950"
"380","LBR",-0.408524729867691,6.59663750476031,-5.41540853907927,0.000341022878895469,0.00146460352199317,-0.120553901548749,"NONE",FALSE,"High","Master Protein","Q14739","Delta(14)-sterol reductase LBR [OS=Homo sapiens]",0,20.417,4,4,4,11,4,615,70.7,9.36,15.81,4,"other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01222, Pf09465","3930","B2R5P3; hsa:3930; Q14739; Q14740; Q53GU7; Q59FE6","ENSG00000143815","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Regulation of MECP2 expression and activity; Initiation of Nuclear Envelope (NE) Reformation; Cholesterol biosynthesis","Gastric cancer network 2; Envelope proteins and their potential roles in EDMD physiopathology; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders; Cholesterol metabolism; Enterocyte cholesterol metabolism",18,0,112.4,106,111.8,84.4,75.9,88.2,105.1,96.6,95.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S86(99.7); S99(100); S516(100)]",0,"ENSG00000143815"
"381","CRMP1",0.473682191289599,6.68221519052853,5.40458226905507,0.000346123573284716,0.00148260806194398,-0.136318357282626,"NONE",FALSE,"High","Master Protein","Q14194","Dihydropyrimidinase-related protein 1 [OS=Homo sapiens]",0,104.816,16,8,11,25,5,572,62.1,7.03,77.76,8,"other metabolic processes;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf01979","1400","A0EJG6; hsa:1400; Q13024; Q14194; Q4W5F1; Q96TC8","ENSG00000072832","CRMPs in Sema3A signaling",NA,1,0,80.6,81.6,81.6,123.5,115.6,112.4,109.3,120.4,106.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T509(100); T514(100); S518(98.4); S542(99.5)]",0,"ENSG00000072832"
"382","OPTN",0.676478185683139,6.68750752796462,5.39017249089798,0.000353040218722553,0.00150827653653195,-0.157326561408945,"UP",FALSE,"High","Master Protein","Q96CV9","Optineurin [OS=Homo sapiens]",0,6.539,2,1,1,2,1,577,65.9,5.17,3.1,1,"cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf11577, Pf16516, Pf18414","10133","B3KP00; D3DRS4; D3DRS8; hsa:10133; Q5T672; Q5T673; Q5T674; Q5T675; Q7LDL9; Q8N562; Q96CV9; Q9UET9; Q9UEV4; Q9Y218","ENSG00000123240","Regulation of PLK1 Activity at G2/M Transition; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; TBC/RABGAPs; TNFR1-induced proapoptotic signaling","HDAC6 interactions in the central nervous system",6,0,72.4,68.8,73.9,129.9,134.7,97.3,124.3,123.3,126.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(100)]",0,"ENSG00000123240"
"383","IFT43",0.80422560701489,6.60981752521373,5.38572515232182,0.000355204817187286,0.00151356204086071,-0.163816320609768,"UP",FALSE,"High","Master Protein","Q96FT9","Intraflagellar transport protein 43 homolog [OS=Homo sapiens]",0,7.618,5,1,1,3,1,208,23.5,4.75,7.68,1,"cell organization and biogenesis;transport","cytoskeleton;other cell component",NA,"Pf15305","112752","B3KPT6; B4DZI9; G3V385; hsa:112752; O95418; Q96FT9; Q9ULA9","ENSG00000119650","Intraflagellar transport","Ciliary landscape; Intraflagellar transport proteins binding to dynein; Genes related to primary cilium development (based on CRISPR); Ciliopathies; Bardet-Biedl syndrome",6,0,57.4,74.4,68.8,114.5,167.4,100.8,116,109.9,123.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S78(100)]",0,"ENSG00000119650"
"384","IP6K1",1.21975537991595,6.56851778049233,5.37203308426034,0.000361959033248758,0.00153832589130722,-0.183813961620897,"UP",FALSE,"High","Master Protein","Q92551","Inositol hexakisphosphate kinase 1 [OS=Homo sapiens]",0,4.179,2,1,1,2,1,441,50.2,7.24,2.76,1,"other metabolic processes;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf03770","9807","A8K157; A8MUX4; hsa:9807; Q7L3I7; Q92551; Q96E38","ENSG00000176095","Synthesis of pyrophosphates in the cytosol; Synthesis of IPs in the nucleus",NA,2,0,36.7,54.3,75.6,111.8,191.9,128.6,93,120.5,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(99.1)]",0,"ENSG00000176095"
"385","FNBP1L",0.473103607602826,6.68592960537726,5.36818735117981,0.000363880846027997,0.00154059461729683,-0.189435526505887,"NONE",FALSE,"High","Master Protein","Q5T0N5","Formin-binding protein 1-like [OS=Homo sapiens]",0,12.619,2,1,1,5,1,605,70,6.64,16.12,1,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00018, Pf00611","54874","hsa:54874; J3QSS4; Q5T0N5; Q5T0N6; Q6B097; Q6P653; Q6R4Q4; Q9NXG1","ENSG00000137942","CDC42 GTPase cycle; RHOJ GTPase cycle; Clathrin-mediated endocytosis",NA,3,0,78,80.5,88.4,127.1,111.1,115.7,109.2,113.8,108.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S295(100)]",0,"ENSG00000137942"
"386","AGFG1",0.512342478155614,6.66020596689113,5.36562455003585,0.000365167631447493,0.00154059461729683,-0.193182904739867,"UP",FALSE,"High","Master Protein","P52594","Arf-GAP domain and FG repeat-containing protein 1 [OS=Homo sapiens]",0,26.633,4,2,2,5,2,562,58.2,8.63,18.86,2,"cell organization and biogenesis;other metabolic processes;transport","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf01412","3267","B3KUL1; E9PHX7; hsa:3267; P52594; Q15277; Q4VAS0; Q4VAS1; Q4VAS3; Q53QT8; Q53R11","ENSG00000173744","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,79.3,85.1,89.1,118.5,112.8,139.4,98.5,95.4,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T177(100); S181(100)]",0,"ENSG00000173744"
"387","NUMBL",1.24073443004089,6.54105981812422,5.36531214088835,0.000365324826528109,0.00154059461729683,-0.193639779016714,"UP",FALSE,"High","Master Protein","Q9Y6R0","Numb-like protein [OS=Homo sapiens]",0,16.815,3,2,2,4,2,609,64.9,8.85,8.89,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","other cell component",NA,"Pf00640, Pf06311","9253","hsa:9253; Q7Z4J9; Q9Y6R0","ENSG00000105245",NA,"Notch signaling; Neurogenesis regulation in the olfactory epithelium; Notch signaling pathway",3,0,58.1,52.7,58.8,128.9,219.9,100.6,90.4,97.1,137.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S324(100)]",0,"ENSG00000105245"
"388","CLUH",-0.488461420598401,6.58069249035046,-5.36169628586728,0.000367149519241912,0.0015442990087701,-0.198928691811949,"NONE",FALSE,"High","Master Protein","O75153","Clustered mitochondria protein homolog [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1309,146.6,6.13,5.04,1,"cell organization and biogenesis","other cell component","nucleic acid binding activity","Pf12807, Pf13236, Pf13374, Pf13424, Pf15044","23277","hsa:23277; O75153; Q6AHY2; Q6P3X7; Q6ZUG8; Q8N4U7; Q9BTA3; Q9H979","ENSG00000132361",NA,"Translation factors",1,0,117.8,106.2,124.1,88.9,76.2,80.8,91.2,100.4,87.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S664(100)]",0,"ENSG00000132361"
"389","PCGF6",-0.602648417331324,6.51819116337404,-5.3219504264175,0.000387864927489834,0.00162723794772085,-0.257186769957274,"DOWN",FALSE,"High","Master Protein","Q9BYE7","Polycomb group RING finger protein 6 [OS=Homo sapiens]",0,12.902,4,1,1,2,1,350,39,4.97,7.1,1,"cell organization and biogenesis;other biological processes","nucleus","other molecular function","Pf13923, Pf16207","84108","A8K3R4; hsa:84108; Q5SYD1; Q5SYD6; Q96ID9; Q96SJ1; Q9BYE7","ENSG00000156374","Transcriptional Regulation by E2F6",NA,1,0,114.3,138.5,126.7,75.2,70.9,100.9,77.3,74,82.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S115(100)]",0,"ENSG00000156374"
"390","PHACTR4",0.600120499658591,6.67858405525618,5.32007896938628,0.000388870784693007,0.00162727466825381,-0.259935389293282,"UP",FALSE,"High","Master Protein","Q8IZ21","Phosphatase and actin regulator 4 [OS=Homo sapiens]",0,10.987,4,2,2,2,2,702,78.2,6.62,3.52,2,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf02755","65979","A2APK6; B9ZVW0; D3DPM3; hsa:65979; Q68DD4; Q6NUN6; Q8IZ21; Q8N384; Q9H395; Q9H6X0; Q9H8W6","ENSG00000204138",NA,NA,0,0,71.8,81.7,97,113.5,148.2,137.2,98.4,100.1,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S118(100); S176(98.9)]",0,"ENSG00000204138"
"391","PAWR",0.844423904145706,6.60128479350635,5.29852819685988,0.000400657804829227,0.00167231083754808,-0.291622793156473,"UP",FALSE,"High","Master Protein","Q96IZ0","PRKC apoptosis WT1 regulator protein [OS=Homo sapiens]",0,10.904,4,1,2,5,1,340,36.5,5.41,7.4,1,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function",NA,"5074","hsa:5074; O75796; Q6FHY9; Q8N700; Q96IZ0","ENSG00000177425",NA,NA,0,0,67,60.7,53.4,106.6,136.6,98.5,110.3,161,153.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(100)]",0,"ENSG00000177425"
"392","MCRS1",-0.770143800528956,6.48220958647091,-5.29506597515393,0.000402586949318259,0.00167569569389802,-0.296719625407559,"DOWN",FALSE,"High","Master Protein","Q96EZ8","Microspherule protein 1 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,462,51.8,9.38,6.99,1,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity","Pf00498, Pf13325","10445","hsa:10445; O14742; O75497; Q6VN53; Q7Z372; Q96EZ8","ENSG00000187778","UCH proteinases; Formation of WDR5-containing histone-modifying complexes; HATs acetylate histones; DNA Damage Recognition in GG-NER","3q29 copy number variation syndrome; 8p23.1 copy number variation syndrome",6,0,165.9,102.6,125.2,79.7,58.3,81.1,84.6,81.3,72,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S282(100)]",0,"ENSG00000187778"
"393","FABP7",-0.495243456706032,6.59824742925401,-5.29176929971189,0.000404433125433032,0.00167569569389802,-0.301574326505114,"NONE",FALSE,"High","Master Protein","O15540","Fatty acid-binding protein, brain [OS=Homo sapiens]",0,46.762,31,3,3,8,3,132,14.9,5.59,29.73,3,"cell cycle OR cell proliferation;transport;developmental processes;other biological processes","cytosol;nucleus","other molecular function","Pf00061","2173","B2R4L1; hsa:2173; O14951; O15540; Q6IAU7; Q9H047","ENSG00000164434","Triglyceride catabolism; NOTCH3 Intracellular Domain Regulates Transcription","PPAR signaling pathway; Fatty acid transporters; Cell lineage map for neuronal differentiation",5,0,113.9,117.2,121.3,93.6,71.8,82.5,88,103.2,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000164434"
"394","OSBPL1A",-0.457752607918875,6.60114668434074,-5.29156277661929,0.000404549082963125,0.00167569569389802,-0.301878504575205,"NONE",FALSE,"High","Master Protein","Q9BXW6","Oxysterol-binding protein-related protein 1 [OS=Homo sapiens]",0,24.41,4,2,2,3,2,950,108.4,6.38,9.31,2,"other metabolic processes;transport","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf01237, Pf12796","114876","B7Z7D3; hsa:114876; Q9BXW6; Q9BZF5; Q9NW87","ENSG00000141447","MHC class II antigen presentation; Synthesis of bile acids and bile salts",NA,2,0,115,105,125.6,88.3,81.2,81.8,98.2,93.6,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S465(100); S499(100)]",0,"ENSG00000141447"
"395","UBA6",1.39231936721463,6.46997769988461,5.28684536204895,0.000407207538174301,0.00168243722101382,-0.308828201642896,"UP",FALSE,"High","Master Protein","A0AVT1","Ubiquitin-like modifier-activating enzyme 6 [OS=Homo sapiens]",0,23.225,2,1,2,3,1,1052,117.9,6.14,6.77,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;other cell component","other molecular function","Pf00899, Pf09358, Pf10585, Pf16190, Pf16191","55236","A0AVT1; A6N8M7; B2RAV3; hsa:55236; Q4W5K0; Q6UV21; Q86T78; Q86TC7; Q8N5T3; Q8N9E4; Q9H3T7; Q9NVC9","ENSG00000033178","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation",NA,2,0,40.3,44.1,38.5,110.7,166.4,90.8,95.5,188.7,181.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100)]",0,"ENSG00000033178"
"396","SRRM2",-0.334564983621859,6.58066971009979,-5.28434632131755,0.000408623445348308,0.00168402389598091,-0.312511063363518,"NONE",FALSE,"High","Master Protein","Q9UQ35","Serine/arginine repetitive matrix protein 2 [OS=Homo sapiens]",0,1249.598,37,112,196,571,112,2752,299.4,12.06,1330.17,112,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf08312","23524","A6NKB9; D3DU97; hsa:23524; O15038; O94803; Q6NSL3; Q6PIM3; Q6PK40; Q8IW17; Q96GY7; Q9P0G1; Q9UHA8; Q9UQ35; Q9UQ36; Q9UQ37; Q9UQ38; Q9UQ40","ENSG00000167978","mRNA Splicing - Major Pathway",NA,1,0,119.1,112.5,113.7,93.3,89.4,93.7,85.6,86.4,86.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S24(100); S222(100); T252(100); S295(100); S297(100); S323(99.3); S333(100); S351(100); S353(100); S377(100); S398(99.2); S404(100); S440(98.2); S456(99.7); S486(100); S510(100); S746(99.7); S774(100); S780(100); S783(100); S790(100); T792(100); S819(99.3); S820(99.7); T848(100); T866(100); S876(99.7); T903(99.1); S908(100); S914(100); S954(100); S972(99); S974(98.6); T983(100); S994(100); T1003(100); S1014(100); T1043(99.5); S1083(100); S1103(99.6); S1110(99.5); S1112(98.8); S1124(100); S1132(100); S1179(100); T1208(100); S1219(99.7); S1320(100); S1329(100); S1401(98.4); S1404(99.4); T1413(99.4); S1421(99.4); T1434(100); S1443(99.5); T1472(100); S1482(99.6); T1492(100); S1499(100); T1511(100); S1519(100); T1531(100); S1542(99.3); S1552(100); S1601(99.7); S1616(99.7); S1620(99.2); S1672(99.6); S1675(99.7); S1691(99.2); S1694(100); S1727(99.6); S1731(100); S1762(100); S1764(100); S1854(99.8); S1857(99.7); T1880(100); S1925(100); T1927(100); S1948(100); T1950(100); S1960(100); T1962(100); S1975(100); S2020(100); T2022(100); S2032(100); T2034(100); S2044(100); S2046(100); S2067(100); S2071(100); S2102(99); T2104(100); S2132(100); S2272(100); S2310(100); S2382(99.4); T2409(99.7); S2426(100); S2449(100); S2581(100); S2688(100); S2694(100); S2702(100)]",0,"ENSG00000167978"
"397","ESYT2",0.792717406117533,6.64404463178478,5.28095746878842,0.000410551953742186,0.00168770979472858,-0.317506659161428,"UP",FALSE,"High","Master Protein","A0FGR8","Extended synaptotagmin-2 [OS=Homo sapiens]",0,22.548,3,2,4,6,2,921,102.3,9.26,18.41,2,"cell organization and biogenesis;transport","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf00168, Pf17047","57488","A0FGR8; A4D229; hsa:57488; Q69YJ2; Q6UKI4; Q6ZTU0; Q6ZVU1; Q9BQS0; Q9NW47; Q9ULJ2","ENSG00000117868","Glycosphingolipid transport",NA,1,0,58.2,65.5,77.9,126.6,87.4,134.4,115.3,122.5,136.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S676(100); S761(100)]",0,"ENSG00000117868"
"398","PTPN21",0.462293775178725,6.61823108368945,5.27161286576417,0.000415920532541332,0.00170241989550448,-0.331290186127097,"NONE",FALSE,"High","Master Protein","Q16825","Tyrosine-protein phosphatase non-receptor type 21 [OS=Homo sapiens]",0,37.252,2,2,2,3,2,1174,133.2,7.9,10.91,2,"protein metabolism;other metabolic processes","cytoskeleton;other cell component","other molecular function","Pf00102, Pf00373, Pf09379, Pf09380","11099","hsa:11099; Q16825","ENSG00000070778",NA,NA,0,0,96.2,90,88.2,123.3,124.4,139.8,81.7,81.1,87.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S590(99.5); S673(100)]",0,"ENSG00000070778"
"399","ARL6IP4",-0.549814606501977,6.58341963955094,-5.2711012515246,0.000416216628864147,0.00170241989550448,-0.332045186270133,"DOWN",FALSE,"High","Master Protein","Q66PJ3","ADP-ribosylation factor-like protein 6-interacting protein 4 [OS=Homo sapiens]",0,15.2,7,1,1,2,1,237,26.4,10.86,9.78,1,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf10500","51329","A4UCR8; B3V0L0; B3V0L1; hsa:51329; Q4F966; Q504R8; Q66PJ3; Q96BI2; Q9NR05; Q9P2R9","ENSG00000182196",NA,NA,0,0,113.5,119.1,121.4,73.9,89.4,78.2,96.5,87.6,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100)]",0,"ENSG00000182196"
"400","DNAJB11",-0.608527586212364,6.57119174604374,-5.26904845161316,0.000417406962946226,0.0017030204088206,-0.335074919044037,"DOWN",FALSE,"High","Master Protein","Q9UBS4","DnaJ homolog subfamily B member 11 [OS=Homo sapiens]",0,50.622,4,1,2,9,1,358,40.5,6.18,36.5,1,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00226, Pf01556","51726","hsa:51726; Q542Y5; Q542Y9; Q6IAQ8; Q96JC6; Q9UBS4","ENSG00000090520","XBP1(S) activates chaperone genes","Photodynamic therapy-induced unfolded protein response",2,0,113.4,124,115,77.5,68.4,78,109.3,83.8,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T188(100)]",0,"ENSG00000090520"
"401","EFNB3",0.589050914489765,6.64030315475169,5.26154811900244,0.000421787265758089,0.00171660054293567,-0.346149739530772,"UP",FALSE,"High","Master Protein","Q15768","Ephrin-B3 [OS=Homo sapiens]",0,35.513,7,2,3,11,2,340,35.8,8.6,26.52,2,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00812","1949","B2RBW2; D3DTQ6; hsa:1949; O00680; Q15768; Q8TBH7; Q92875","ENSG00000108947","EPHB-mediated forward signaling; Ephrin signaling; EPH-ephrin mediated repulsion of cells",NA,4,0,71.8,74.3,74.8,95.3,136.9,123.2,118.3,111.3,116.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(100); S274(100)]",0,"ENSG00000108947"
"402","DDX51",0.475135866051144,6.65256216461699,5.25823928676548,0.000423735336231501,0.00171989555760342,-0.351038011470592,"NONE",FALSE,"High","Master Protein","Q8N8A6","ATP-dependent RNA helicase DDX51 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,666,72.4,8.16,4.39,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00270, Pf00271","317781","A8MPT9; hsa:317781; Q5CZ71; Q8IXK5; Q8N8A6; Q96ED1","ENSG00000185163; ENSG00000288503",NA,NA,0,0,80.2,79.3,71.4,115.2,103.5,112.3,116,126.6,111.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(100)]",0,"ENSG00000185163"
"403","AJM1",0.763590356035167,6.62884834908533,5.25556955354646,0.000425314178648081,0.00171989555760342,-0.354983243525369,"UP",FALSE,"High","Master Protein","C9J069","Apical junction component 1 homolog [OS=Homo sapiens]",0,33.187,3,2,2,3,2,976,106.6,9.03,11.62,2,"cell organization and biogenesis","plasma membrane;other membranes;other cell component",NA,NA,"389813","C9J069","ENSG00000232434",NA,NA,0,0,77.6,86.4,82.1,143.2,117.3,165.9,81.8,96.9,77.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S109(100)]",0,"ENSG00000232434"
"404","SUB1",-0.742652337598272,6.47625555775718,-5.25482021821851,0.00042575845911261,0.00171989555760342,-0.356090764183996,"DOWN",FALSE,"High","Master Protein","P53999","Activated RNA polymerase II transcriptional coactivator p15 [OS=Homo sapiens]",0,44.446,40,4,8,9,4,127,14.4,9.6,24.63,4,"RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02229","10923","hsa:10923; P53999; Q96L29","ENSG00000113387",NA,NA,0,0,117.9,113,111.5,62.4,70.4,62.6,78.7,91,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S15(100); S56(99.1); S118(100)]",0,"ENSG00000113387"
"405","ACOX1",-0.730084215874653,6.54579348928442,-5.23217678835009,0.00043942148738396,0.00177070584545833,-0.389595238825243,"DOWN",FALSE,"High","Master Protein","Q15067","Peroxisomal acyl-coenzyme A oxidase 1 [OS=Homo sapiens]",0,3.501,4,2,2,2,2,660,74.4,8.16,1.87,2,"cell organization and biogenesis;other metabolic processes;other biological processes","other membranes;cytosol;other cytoplasmic organelle","other molecular function","Pf01756, Pf02770, Pf14749","51","A8K6X8; A8KAA0; B4DK61; F5GYQ8; hsa:51; Q12863; Q15067; Q15068; Q15101; Q16131; Q7Z3W5; Q9UD31","ENSG00000161533","TYSND1 cleaves peroxisomal proteins","Estrogen receptor pathway; Nuclear receptors meta-pathway; PPAR signaling pathway; Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Omega-3 / omega-6 fatty acid synthesis",8,0,120.6,116.7,134.8,73.4,58.2,88.5,104.8,78.3,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100)]",0,"ENSG00000161533"
"406","HADHB",-0.396926345236165,6.58362153100597,-5.20728138126046,0.000454988386803564,0.00182891883562418,-0.426515384690962,"NONE",FALSE,"High","Master Protein","P55084","Trifunctional enzyme subunit beta, mitochondrial [OS=Homo sapiens]",0,8.788,4,3,3,4,2,474,51.3,9.41,8.88,3,"other metabolic processes;other biological processes","other membranes;mitochondrion;ER/Golgi","nucleic acid binding activity;other molecular function","Pf00108, Pf02803","3032","B2RB16; B4E2W0; hsa:3032; O14969; P55084; Q53TA6; Q96C77; Q9H3F5; Q9T2V8","ENSG00000138029","Acyl chain remodeling of CL; mitochondrial fatty acid beta-oxidation of unsaturated fatty acids; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA; Beta oxidation of octanoyl-CoA to hexanoyl-CoA; Beta oxidation of hexanoyl-CoA to butanoyl-CoA; Beta oxidation of myristoyl-CoA to lauroyl-CoA; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA; Beta oxidation of palmitoyl-CoA to myristoyl-CoA","Fatty acid beta-oxidation; Valproic acid pathway; Female steroid hormones in cardiomyocyte energy metabolism; Sudden infant death syndrome (SIDS) susceptibility pathways",12,0,120.2,110.9,106.5,85,76.6,93.4,89.3,98.8,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S197(100)]",0,"ENSG00000138029"
"407","PNKP",-0.674971646632917,6.52741358279094,-5.19236650943542,0.000464597186130698,0.00186295481023415,-0.448676176028901,"DOWN",FALSE,"High","Master Protein","Q96T60","Bifunctional polynucleotide phosphatase/kinase [OS=Homo sapiens]",0,15.2,4,1,1,2,1,521,57,8.46,8.69,1,"DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf08645, Pf13671, Pf17913","11284","hsa:11284; Q96T60; Q9BUL2; Q9P1V2; Q9UKU8; Q9UNF8; Q9UNI0","ENSG00000039650","APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway","Base excision repair; DNA repair pathways, full network",3,0,121,122.6,130.3,85.8,52.4,93.4,83.2,92.6,78.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T118(100)]",0,"ENSG00000039650"
"408","GYG2",0.597920807139707,6.69263443359497,5.18880171920142,0.000466925864728467,0.00186770345891387,-0.453977451965785,"UP",FALSE,"High","Master Protein","O15488","Glycogenin-2 [OS=Homo sapiens]",0,5.593,2,2,2,2,2,501,55.1,5.1,5.07,2,"other metabolic processes","cytosol;other cell component","other molecular function","Pf01501","8908","B7WNN6; hsa:8908; O15485; O15486; O15487; O15488; O15489; O15490","ENSG00000056998","Glycogen synthesis; Glycogen storage disease type 0 (liver GYS2); Glycogen storage disease type IV (GBE1); Glycogen breakdown (glycogenolysis)","Glycogen synthesis and degradation; Disorders of galactose metabolism",6,0,80.6,87.7,82.9,131,118.7,138.1,88.2,102.4,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S468(100)]",0,"ENSG00000056998"
"409","DNMT3A",-0.467388219911104,6.53081387927848,-5.18459345309592,0.000469691016850324,0.00187417051222427,-0.460237960624315,"NONE",FALSE,"High","Master Protein","Q9Y6K1","DNA (cytosine-5)-methyltransferase 3A [OS=Homo sapiens]",0,49.687,5,3,4,6,3,912,101.8,6.57,22.72,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00145, Pf00855, Pf17980, Pf21255","1788","E9PEB8; hsa:1788; Q86TE8; Q86XF5; Q8IZV0; Q8WXU9; Q9Y6K1","ENSG00000119772","RMTs methylate histone arginines; PRC2 methylates histones and DNA; Defective pyroptosis; DNA methylation; SUMOylation of DNA methylation proteins","One-carbon metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Hematopoietic stem cell gene regulation by GABP alpha/beta complex; One-carbon metabolism and related pathways; MTHFR deficiency; Opioid receptor pathways; Spina bifida",12,0,127.1,119.9,125.2,86,102,86.5,75.4,79.1,75.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100); S243(100)]",0,"ENSG00000119772"
"410","PPP1R12A",0.42880518495414,6.65994067267063,5.16943117321516,0.000479800369242558,0.00190983951854599,-0.482815119934279,"NONE",FALSE,"High","Master Protein","O14974","Protein phosphatase 1 regulatory subunit 12A [OS=Homo sapiens]",0,49.685,3,3,4,5,3,1030,115.2,5.4,22.26,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00023, Pf15898","4659","B4DZ09; F8VWB4; hsa:4659; O14974; Q2NKL4; Q569H0; Q86WU3; Q8NFR6; Q9BYH0","ENSG00000058272","Regulation of PLK1 Activity at G2/M Transition; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs","Focal adhesion; Hippo-Merlin signaling dysregulation; Regulation of actin cytoskeleton",8,0,73.7,77.5,72.5,99.6,117,100.4,122.7,132.8,133.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S445(100)]",0,"ENSG00000058272"
"411","PXN",0.494898832738043,6.64177742300883,5.15268568929107,0.000491237158901898,0.00195060594483673,-0.507787367790514,"NONE",FALSE,"High","Master Protein","P49023","Paxillin [OS=Homo sapiens]",0,70.586,12,4,5,9,4,591,64.5,6.19,27.01,4,"cell adhesion;cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00412, Pf03535","5829","B2RAI3; B7ZMB4; hsa:5829; O14970; O14971; O60360; P49023; Q5HYA4","ENSG00000089159","VEGFA-VEGFR2 Pathway; GAB1 signalosome; Smooth Muscle Contraction; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases; Localization of the PINCH-ILK-PARVIN complex to focal adhesions; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Integrin-mediated cell adhesion; Prolactin signaling pathway; Androgen receptor network in prostate cancer; Oncostatin M signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; 3q29 copy number variation syndrome; Regulation of actin cytoskeleton; GDNF signaling; HDAC6 interactions in the central nervous system",21,0,85,86.1,86.6,126.4,144,114.6,99.7,93.1,87.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(99.4); S303(99.6)]",0,"ENSG00000089159"
"412","LUC7L",-0.566601798812155,6.61383209004944,-5.13972378570605,0.000500290503454938,0.00198173325640403,-0.527144342674494,"DOWN",FALSE,"High","Master Protein","Q9NQ29","Putative RNA-binding protein Luc7-like 1 [OS=Homo sapiens]",0,8.218,3,1,1,2,1,371,43.7,9.92,7.05,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf03194","55692","B8ZZ13; hsa:55692; Q96S32; Q9NPH4; Q9NQ29","ENSG00000007392",NA,"VEGFA-VEGFR2 signaling",1,0,122.6,128.6,130.2,92.4,92.6,73.4,95,87.8,85.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(100)]",0,"ENSG00000007392"
"413","ANKRD6",0.594308552537296,6.64823038983184,5.13727316423473,0.000502022181504822,0.00198377772449363,-0.530806696573199,"UP",FALSE,"High","Master Protein","Q9Y2G4","Ankyrin repeat domain-containing protein 6 [OS=Homo sapiens]",0,22.202,6,2,2,3,2,727,79.9,9.32,6.85,2,"other biological processes","nucleus;other cell component",NA,"Pf12796","22881","B3KUC3; hsa:22881; Q5JUJ4; Q5JUJ5; Q8IUQ8; Q9NU24; Q9UFQ9; Q9Y2G4","ENSG00000135299",NA,NA,0,0,70.9,83.5,85.5,129.8,104.7,131.8,106.2,100,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(99.7)]",0,"ENSG00000135299"
"414","PAICS",-0.494161338176532,6.63195394867079,-5.12169882621904,0.000513178744927611,0.00202296548725087,-0.554101661551003,"NONE",FALSE,"High","Master Protein","P22234","Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase [OS=Homo sapiens]",0,12.241,4,2,2,3,2,425,47,7.23,8.38,2,"other metabolic processes","cytosol;other cell component","other molecular function","Pf00731, Pf01259","10606","E9PDH9; hsa:10606; P22234; Q68CQ5","ENSG00000128050","Purine ribonucleoside monophosphate biosynthesis","Metabolic reprogramming in colon cancer",2,0,115.3,110.5,110.1,83.7,60.3,92.9,105.2,114.8,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S107(100)]",0,"ENSG00000128050"
"415","PDE4B",-0.421522545772586,6.6194984550017,-5.1161206640742,0.000517239020604834,0.00203144586867344,-0.562453370950164,"NONE",FALSE,"High","Master Protein","Q07343-3","Isoform PDE4B3 of 3',5'-cyclic-AMP phosphodiesterase 4B [OS=Homo sapiens]",0,20.958,8,4,4,4,4,721,82,5.58,9.81,4,NA,NA,NA,NA,NA,"Q07343-3",NA,NA,NA,0,0,118.8,108,109,87.2,79.9,82.7,94.7,109.9,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S182(100); S275(100); S717(99.6)]",0,"ENSG00000184588"
"416","SPTAN1",0.534546768292588,6.65950286070266,5.11532696783334,0.000517819535152054,0.00203144586867344,-0.563642060664929,"UP",FALSE,"High","Master Protein","Q13813","Spectrin alpha chain, non-erythrocytic 1 [OS=Homo sapiens]",0,166.924,7,13,17,27,13,2472,284.4,5.35,83.27,13,"cell organization and biogenesis","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00018, Pf00435, Pf08726, Pf13499","6709","hsa:6709; Q13186; Q13813; Q15324; Q16606; Q59EF1; Q5VXV5; Q5VXV6; Q7Z6M5; Q9P0V0","ENSG00000197694","Neutrophil degranulation; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Interaction between L1 and Ankyrins; COPI-mediated anterograde transport; RHOV GTPase cycle; RHOU GTPase cycle; Nephrin family interactions; RAF/MAP kinase cascade; NCAM signaling for neurite out-growth; Caspase-mediated cleavage of cytoskeletal proteins","Fas ligand pathway and stress induction of heat shock proteins",12,0,81.3,82.5,85.2,120.8,113.5,136.9,109,99.6,91.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1031(100); S1186(99.3); S1190(100); S1217(100); S1323(100)]",0,"ENSG00000197694"
"417","ZNF282",-0.638333766697591,6.61198705775767,-5.10650968500186,0.000524315732331723,0.00205199826178746,-0.576853338717518,"DOWN",FALSE,"High","Master Protein","Q9UDV7","Zinc finger protein 282 [OS=Homo sapiens]",0,6.077,3,1,1,1,1,671,74.2,5.9,2.83,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352","8427","B4DRI5; hsa:8427; O43691; Q6DKK0; Q9UDV7","ENSG00000170265","Generic Transcription Pathway",NA,1,0,135.2,109.6,108.3,68.4,78.9,71.3,113.6,95.1,112.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(99.2)]",0,"ENSG00000170265"
"418","TJP1",0.33851332034279,6.67093348082183,5.1004428627525,0.000528836204985195,0.0020647384845355,-0.58594984109131,"NONE",FALSE,"High","Master Protein","Q07157","Tight junction protein ZO-1 [OS=Homo sapiens]",0,147.687,9,11,13,24,3,1748,195.3,6.7,74.71,11,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00595, Pf00625, Pf00791, Pf07653","7082","B4E3K1; hsa:7082; Q07157; Q2NKP3; Q4ZGJ6","ENSG00000104067; ENSG00000277401","RUNX1 regulates expression of components of tight junctions; Signaling by Hippo; Regulation of gap junction activity; SARS-CoV-2 targets PDZ proteins in cell-cell junction; Apoptotic cleavage of cell adhesion  proteins","Epithelial to mesenchymal transition in colorectal cancer; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Disruption of postsynaptic signaling by CNV; 1q21.1 copy number variation syndrome; 15q11q13 copy number variation",11,8,84.8,82.3,86.2,106.9,111.9,116.4,106.5,111.5,115.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100); S212(100); T589(100); S617(100); S912(100); S968(100); S1051(100); S1278(100); S1617(100)]",0,"ENSG00000104067"
"419","NADK",0.779325441520077,6.59900866550804,5.09242792577404,0.000534872392898815,0.00208332158761543,-0.597975247119373,"UP",FALSE,"High","Master Protein","O95544","NAD kinase [OS=Homo sapiens]",0,10.552,3,1,1,1,1,446,49.2,6.47,3.67,1,"other metabolic processes;other biological processes","cytosol","kinase activity;other molecular function","Pf01513, Pf20143","65220","A6NNN3; A8K296; B7Z434; F5GXR5; hsa:65220; O95544; Q5QPS4; Q9H2P2; Q9H931","ENSG00000008130","Nicotinate metabolism","NAD+ metabolism; 1p36 copy number variation syndrome",3,0,56.3,60.5,60.7,85.8,95.1,130.4,122,167.3,162.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100)]",0,"ENSG00000008130"
"420","PHKB",-0.439111720705172,6.6360461935612,-5.07896906363136,0.000545175205550534,0.00211367827484627,-0.618188875466864,"NONE",FALSE,"High","Master Protein","Q93100","Phosphorylase b kinase regulatory subunit beta [OS=Homo sapiens]",0,22.336,3,2,2,6,2,1093,124.8,6.95,20.39,2,"other metabolic processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00723, Pf19292","5257","hsa:5257; Q8N4T5; Q93100","ENSG00000102893","Glycogen breakdown (glycogenolysis)","Glycogen synthesis and degradation",2,0,97.6,108.5,96.2,69.6,64.9,85.1,117.2,129.9,129.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S701(98.8)]",0,"ENSG00000102893"
"421","SNX17",0.46389331597838,6.66141519340665,5.07886399615438,0.00054525646673424,0.00211367827484627,-0.618346774509701,"NONE",FALSE,"High","Master Protein","Q15036","Sorting nexin-17 [OS=Homo sapiens]",0,47.144,8,3,3,6,3,470,52.9,7.46,19.15,3,"other metabolic processes;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00787, Pf18116, Pf21271, Pf21273","9784","B4DQM7; hsa:9784; Q15036; Q53HN7; Q6IAS3","ENSG00000115234",NA,NA,0,0,86,74.6,85.6,117,109.8,123.6,102.3,115.1,104.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S336(99.6); S409(100); S421(99.6)]",0,"ENSG00000115234"
"422","CCDC9",-0.71236195706738,6.53581319563717,-5.07680618534675,0.000546850635745473,0.00211483468610571,-0.621439636225535,"DOWN",FALSE,"High","Master Protein","Q9Y3X0","Coiled-coil domain-containing protein 9 [OS=Homo sapiens]",0,18.171,6,2,2,3,2,531,59.7,5.4,8.69,2,NA,"nucleus","nucleic acid binding activity","Pf15266","26093","hsa:26093; Q9Y3X0","ENSG00000105321",NA,"IL-18 signaling pathway",1,0,125.6,138.2,116.7,67.4,86.6,72,91,74.5,95.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S386(100)]",0,"ENSG00000105321"
"423","MIA3",1.01078542846699,6.61679880704448,5.06518187460592,0.000555950177883435,0.00214494253027368,-0.638921977213269,"UP",FALSE,"High","Master Protein","Q5JRA6","Transport and Golgi organization protein 1 homolog [OS=Homo sapiens]",0,28.846,3,2,2,4,2,1907,213.6,4.84,17.03,2,"cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf07653","375056","A8K2S0; A8MT05; A8MT13; B7Z430; hsa:375056; Q14083; Q3S4X3; Q5JRA5; Q5JRA6; Q5JRB0; Q5JRB1; Q5JRB2; Q6UVY8; Q86Y60; Q8N8M5; Q92580","ENSG00000154305","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo concentration in the ER","Type I collagen synthesis in the context of osteogenesis imperfecta",4,0,69.9,61.2,75,149.9,163.7,118.6,123.1,79.6,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(100); S1906(100)]",0,"ENSG00000154305"
"424","SMC3",-0.73086574630554,6.48429329082718,-5.04299927349821,0.000573768019750656,0.00220846558545535,-0.672336007595045,"DOWN",FALSE,"High","Master Protein","Q9UQE7","Structural maintenance of chromosomes protein 3 [OS=Homo sapiens]",0,15.2,2,1,3,4,1,1217,141.5,7.18,15.41,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf02463, Pf06470","9126","A8K156; hsa:9126; O60464; Q5T482; Q9UQE7","ENSG00000108055","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; SUMOylation of DNA damage response and repair proteins; Meiotic synapsis; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin","Cell cycle; Retinoblastoma gene in cancer; MECP2 and associated Rett syndrome; Prion disease pathway; Regulation of sister chromatid separation at the metaphase-anaphase transition; Cohesin complex - Cornelia de Lange syndrome; SMC1/SMC3 role in DNA damage - Cornelia de Lange Syndrome; 10q22q23 copy number variation",15,0,124.9,134.8,144.3,80,65.3,93.8,61.2,79.2,78.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1067(100)]",0,"ENSG00000108055"
"425","NOS1AP",0.395531486857968,6.62805975466408,5.02270109563391,0.000590608780530248,0.00226793771723615,-0.702971901594445,"NONE",FALSE,"High","Master Protein","O75052","Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein [OS=Homo sapiens]",0,57.52,7,2,8,14,2,506,56.1,6.3,41.18,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","other molecular function","Pf00640","9722","B7ZLF5; hsa:9722; O43564; O75052; Q3T551; Q5VU95","ENSG00000198929",NA,"Sudden infant death syndrome (SIDS) susceptibility pathways",1,0,85.4,88,88.7,119.1,132.8,112,93.3,97.9,91.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(99.5); S371(100); S374(100)]",0,"ENSG00000198929"
"426","DGCR8",-0.432916487174304,6.59883470770927,-5.02082474317502,0.000592192045277673,0.00226867938472573,-0.705806778855953,"NONE",FALSE,"High","Master Protein","Q8WYQ5","Microprocessor complex subunit DGCR8 [OS=Homo sapiens]",0,13.658,3,1,1,1,1,773,86,5.95,3.74,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00035","54487","B2R8G1; hsa:54487; Q6DCB2; Q6MZE9; Q6Y2L0; Q8WYQ5; Q96G39; Q96GP8; Q9H6L8; Q9H6T7; Q9NRW2","ENSG00000128191","Transcriptional Regulation by MECP2; MicroRNA (miRNA) biogenesis","miRNA biogenesis; exRNA mechanism of action and biogenesis; DDX1 as a regulatory component of the Drosha microprocessor; 22q11.2 copy number variation syndrome",6,0,118.9,117.8,125.1,82.6,85.4,102,90.5,86,85.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S377(100)]",0,"ENSG00000128191"
"427","PHACTR2",0.637229670384259,6.67296134768356,5.00337325771481,0.000607137176482893,0.00231959115079461,-0.73219685089508,"UP",FALSE,"High","Master Protein","O75167","Phosphatase and actin regulator 2 [OS=Homo sapiens]",0,15.033,5,2,2,2,2,634,69.7,8.16,3.67,2,"cell organization and biogenesis","plasma membrane;other membranes","enzyme regulator activity;cytoskeletal activity","Pf02755","9749","A6NKP5; A7MCZ5; A8MZC0; B2RWP7; B4DN76; B4DPB5; B4DTH7; hsa:9749; O75167; Q5TFA0; Q68DM2","ENSG00000112419","Platelet degranulation",NA,1,0,74.3,84.9,83.1,140.7,108.2,130.7,108.7,97.7,98.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T25(99.5); S237(99.1)]",0,"ENSG00000112419"
"428","SPG21",-0.511894381868937,6.61625722788623,-5.00200698802468,0.000608324149840742,0.00231959115079461,-0.734264715942044,"DOWN",FALSE,"High","Master Protein","Q9NZD8","Maspardin [OS=Homo sapiens]",0,4.28,3,1,1,2,1,308,34.9,6.28,4.49,1,"signal transduction","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding","Pf00561","51324","B4DW44; Q6ZMB6; Q9NZD8","ENSG00000090487",NA,NA,0,0,114.9,114.8,103.5,79.6,73.9,75.3,103.5,98.2,125.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S304(100)]",0,"ENSG00000090487"
"429","PLEKHA6",0.551312908625608,6.63037881043805,5.00034238937816,0.000609773660387034,0.00231969840035347,-0.73678445780956,"UP",FALSE,"High","Master Protein","Q9Y2H5","Pleckstrin homology domain-containing family A member 6 [OS=Homo sapiens]",0,30.401,3,2,2,2,2,1048,117.1,9.1,9.56,2,NA,NA,NA,"Pf00169","22874","A7MD51; hsa:22874; Q5VTI6; Q9Y2H5","ENSG00000143850","Synthesis of PIPs at the plasma membrane",NA,1,0,91.9,82.9,77.5,131.4,130.1,119.1,101.6,88.4,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S777(100); S867(100)]",0,"ENSG00000143850"
"430","LARP1",0.404392228479845,6.66963057458239,4.99136880549829,0.000617651693111399,0.00233978714128215,-0.750374649033129,"NONE",FALSE,"High","Master Protein","Q6PKG0","La-related protein 1 [OS=Homo sapiens]",0,146.662,13,10,15,30,10,1096,123.4,8.82,99.2,10,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf05383, Pf21071","23367","hsa:23367; O94836; Q6PKG0; Q8N4M2; Q8NB73; Q9UFD7","ENSG00000155506","SARS-CoV-2 activates/modulates innate and adaptive immune responses","Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Network map of SARS-CoV-2 signaling pathway",4,0,81.8,84.8,85.4,115,130.8,108.2,104.4,105.2,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S215(100); S517(100); T526(100); S548(100); S766(100); S774(100); T785(100); T788(100); S850(98.6)]",0,"ENSG00000155506"
"431","PLEKHA5",0.406195285329582,6.66555602323031,4.99106339538051,0.000617921726649881,0.00233978714128215,-0.750837380277386,"NONE",FALSE,"High","Master Protein","Q9HAU0","Pleckstrin homology domain-containing family A member 5 [OS=Homo sapiens]",0,61.556,8,6,6,10,6,1116,127.4,7.53,36.05,6,"developmental processes","cytosol;nucleus;other cell component","other molecular function","Pf00169, Pf00397","54477","A0JP03; B4DGS1; E9PHQ3; F5H0I0; hsa:54477; Q6NSF8; Q86ST7; Q8N3K6; Q96DY9; Q9BVR4; Q9C0H7; Q9H924; Q9HAU0; Q9NVK8","ENSG00000052126","Synthesis of PIPs at the plasma membrane",NA,1,0,90.4,87.1,91.5,122.1,115.9,128,102.1,92.6,94.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S410(100); T438(100); T460(100); S809(100); S855(100); S933(100)]",0,"ENSG00000052126"
"432","NOPCHAP1",0.53605042740069,6.64048921663233,4.97651561480241,0.000630931901426703,0.00238352051650088,-0.772894010907329,"UP",FALSE,"High","Master Protein","Q8N5I9","NOP protein chaperone 1 [OS=Homo sapiens]",0,12.556,6,1,1,1,1,185,20.1,5.22,4.01,1,"cell organization and biogenesis","nucleus","other molecular function","Pf15370","121053","Q8N5I9","ENSG00000151131",NA,NA,0,0,72.2,70.5,67.3,97,129.5,98.5,130,129,135.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100)]",0,"ENSG00000151131"
"433","PKM",-0.510780736879676,6.56784038641242,-4.97301189145305,0.0006341089107161,0.00238999016694844,-0.778210596177813,"DOWN",FALSE,"High","Master Protein","P14618","Pyruvate kinase PKM [OS=Homo sapiens]",0,197.92,35,15,16,25,15,531,57.9,7.84,83.51,15,"cell organization and biogenesis;other metabolic processes;other biological processes","non-structural extracellular;cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00224, Pf02887","5315","A6NFK3; B2R5N8; B3KRY0; B4DFX8; B4DUU6; hsa:5315; P14618; P14786; Q53GK4; Q96E76; Q9BWB5; Q9UCV6; Q9UPF2","ENSG00000067225","Neutrophil degranulation","Photodynamic therapy-induced HIF-1 survival signaling; Amino acid metabolism; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Glucose metabolism in triple-negative breast cancer cells; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",10,0,121.6,118.7,114.5,86.9,63.6,96.1,82.8,97.7,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S127(100)]",0,"ENSG00000067225"
"434","RMDN3",-0.418701091508249,6.60172767246615,-4.96141988274127,0.000644742589817818,0.00242446983083567,-0.795812625297961,"NONE",FALSE,"High","Master Protein","Q96TC7","Regulator of microtubule dynamics protein 3 [OS=Homo sapiens]",0,46.289,13,2,2,8,2,470,52.1,5.1,28.22,2,"other biological processes","other membranes;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity","Pf21033","55177","A9UMZ9; B3KRR3; hsa:55177; Q6ZWE9; Q96H23; Q96SD6; Q96TC7; Q9H6G1; Q9NVQ6","ENSG00000137824",NA,NA,0,0,113.6,105.7,100.2,74.2,75.7,86,104.4,102,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S212(100)]",0,"ENSG00000137824"
"435","CXADR",0.523047483065058,6.65053612170799,4.95361850360977,0.000652006337118002,0.00244614791304961,-0.807669265951566,"UP",FALSE,"High","Master Protein","P78310","Coxsackievirus and adenovirus receptor [OS=Homo sapiens]",0,4.546,3,1,1,5,1,365,40,7.56,14.78,1,"cell adhesion;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf07686, Pf13927","1525","B2R8V8; B7WPI3; D3YHP0; hsa:1525; O00694; P78310; Q8WWT6; Q8WWT7; Q8WWT8; Q9UKV4","ENSG00000154639","Cell surface interactions at the vascular wall; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","Acute viral myocarditis; 15q11q13 copy number variation",4,0,87.1,80,75.6,122,123.2,117.2,111,109.1,93.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S332(100)]",0,"ENSG00000154639"
"436","SNCAIP",0.439859281338747,6.67267447620409,4.94996727726385,0.00065543597342342,0.00245337501978675,-0.813221360079715,"NONE",FALSE,"High","Master Protein","Q9Y6H5","Synphilin-1 [OS=Homo sapiens]",0,32.504,7,5,7,9,5,919,100.3,6.34,24.77,5,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf12796, Pf16700","9627","D3DSZ1; hsa:9627; Q05BS1; Q1PSC2; Q49AC6; Q504U9; Q6L984; Q6L985; Q6L986; Q9HC59; Q9Y6H5","ENSG00000064692","Amyloid fiber formation","Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway; HDAC6 interactions in the central nervous system",4,0,85.6,91.8,90.6,121.6,136.6,123.6,95.6,104.9,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S566(99.6); S676(99.5); S801(100)]",0,"ENSG00000064692"
"437","SF3B2",-0.342034108471609,6.59406079588719,-4.94717646831826,0.000658070423295953,0.00245759938402516,-0.817466345473,"NONE",FALSE,"High","Master Protein","Q13435","Splicing factor 3B subunit 2 [OS=Homo sapiens]",0,46.416,6,3,5,8,3,895,100.2,5.67,23.22,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf02037, Pf04037, Pf04046","10992","A8K485; B4DT19; hsa:10992; Q13435; Q7L4T5; Q7Z627; Q969K1; Q96CM6; Q9BWD2","ENSG00000087365","mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing",3,0,109.7,116.6,116.1,94.8,83.5,93.6,87.4,93.8,87,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S309(99.5); T780(99.5)]",0,"ENSG00000087365"
"438","ZNF687",-0.490372350766267,6.60163184989195,-4.93465032863095,0.000670035075940658,0.00249656905008026,-0.836532690456234,"NONE",FALSE,"High","Master Protein","Q8N1G0","Zinc finger protein 687 [OS=Homo sapiens]",0,41.293,3,2,2,3,2,1237,129.4,8.19,11.81,2,"other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf16622","57592","D3DV17; hsa:57592; Q68DQ8; Q8N1G0; Q9H937; Q9P2A7","ENSG00000143373",NA,NA,0,0,122.1,115.2,112.7,86.9,65.2,94.2,104,89.9,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100); S1191(100)]",0,"ENSG00000143373"
"439","AKAP12",0.486497294130189,6.65953494814014,4.93009585330575,0.000674442902267498,0.00250726837471653,-0.843470577591101,"NONE",FALSE,"High","Master Protein","Q02952","A-kinase anchor protein 12 [OS=Homo sapiens]",0,131.223,10,10,13,21,10,1782,191.4,4.41,60.89,10,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf03832, Pf10522","9590","hsa:9590; O00310; O00498; Q02952; Q4LE68; Q5SZ80; Q5TGN1; Q68D82; Q99970","ENSG00000131016","RHOD GTPase cycle; RHOF GTPase cycle","G protein signaling pathways",3,0,79.8,81.2,85.3,117.7,142.6,106.1,108.7,102.7,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T21(98.8); S283(99.4); S598(99.4); S612(100); S696(100); S698(99.7); S1331(100); S1395(100)]",0,"ENSG00000131016"
"440","NUCKS1",0.869052428397711,6.58193509216798,4.91376231247589,0.000690507342971721,0.00256115450847693,-0.868375353713688,"UP",FALSE,"High","Master Protein","Q9H1E3","Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 [OS=Homo sapiens]",0,108.788,35,8,11,25,8,243,27.3,5.08,63.8,8,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function",NA,"64710","hsa:64710; Q54AC0; Q5PXE7; Q9H1D6; Q9H1E3; Q9H723","ENSG00000069275",NA,NA,0,0,60.6,75.1,69.5,121,202.2,100.6,102.7,107.4,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S61(100); S79(100); S113(100); S214(100); T222(99.4)]",0,"ENSG00000069275"
"441","BAG3",0.440469233287993,6.64226110719865,4.90926141944614,0.000695005651010248,0.00257199370169779,-0.875244656425312,"NONE",FALSE,"High","Master Protein","O95817","BAG family molecular chaperone regulator 3 [OS=Homo sapiens]",0,92.916,14,5,10,26,5,575,61.6,6.95,82.38,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00397, Pf02179","9531","A8K5L8; hsa:9531; O95817; Q3B763; Q9NT20; Q9P120","ENSG00000151929","Regulation of HSF1-mediated heat shock response","Cell interactions of the pancreatic cancer microenvironment",2,0,85,89.9,91.6,121,138.1,121.5,97.3,95.2,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100); S264(100); S279(100); T285(99.3); S289(100); S377(100); S386(100)]",0,"ENSG00000151929"
"442","DDX24",-0.424040200088682,6.59130773639428,-4.90354609017291,0.000700762907382306,0.00258743227341159,-0.883971491676268,"NONE",FALSE,"High","Master Protein","Q9GZR7","ATP-dependent RNA helicase DDX24 [OS=Homo sapiens]",0,16.484,5,2,2,2,2,859,96.3,9.06,6.77,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00270, Pf00271","57062","E7EMJ4; hsa:57062; Q4V9L5; Q9GZR7","ENSG00000089737; ENSG00000273761",NA,NA,0,0,115.8,115.8,101.9,89.4,66.5,90.5,96.3,102.4,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(100); S287(100)]",0,"ENSG00000089737"
"443","PLEC",0.484517560079042,6.66625874854175,4.89286698198457,0.000711657466456454,0.0026182191131116,-0.900289740559118,"NONE",FALSE,"High","Master Protein","Q15149","Plectin [OS=Homo sapiens]",0,289.56,5,17,35,94,17,4684,531.5,5.96,279.59,17,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00681, Pf03501, Pf17902, Pf18373, Pf21019, Pf21020, Pf21097","5339","hsa:5339; Q15148; Q15149; Q16640; Q6S376; Q6S377; Q6S378; Q6S379; Q6S380; Q6S381; Q6S382; Q6S383","ENSG00000178209","Assembly of collagen fibrils and other multimeric structures; Caspase-mediated cleavage of cytoskeletal proteins; Type I hemidesmosome assembly","Envelope proteins and their potential roles in EDMD physiopathology",4,0,82.4,79,82.1,117.1,108.4,125.4,95.6,116.4,114.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S149(100); S720(100); S1047(100); S1435(100); S1721(100); S1732(100); T4030(100); S4386(99.7); S4389(100); S4396(100); S4613(100); S4616(100); T4623(99.6); S4675(99.4)]",0,"ENSG00000178209"
"444","SRSF11",-0.613051376194696,6.57595714506139,-4.89164972472711,0.000712910731523636,0.0026182191131116,-0.902150777835756,"DOWN",FALSE,"High","Master Protein","Q05519","Serine/arginine-rich splicing factor 11 [OS=Homo sapiens]",0,48.857,11,6,6,16,6,484,53.5,10.52,35.16,6,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00076","9295","hsa:9295; Q05519; Q5T758; Q8IWE6","ENSG00000116754","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,5,0,121.1,124.2,114.5,79.4,85.2,66.4,105.8,87.5,91.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(99.7); T325(100); S414(99.4); S449(100); S456(100)]",0,"ENSG00000116754"
"445","PPME1",-0.350115922635614,6.65486474122675,-4.89067701364646,0.000713913912582514,0.0026182191131116,-0.903638081446837,"NONE",FALSE,"High","Master Protein","Q9Y570","Protein phosphatase methylesterase 1 [OS=Homo sapiens]",0,15.15,3,1,2,2,1,386,42.3,5.97,5.7,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes","nucleus","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf12697","51400","B3KMU6; B5MEE7; hsa:51400; J3QT22; Q8WYG8; Q9NVT5; Q9UI18; Q9Y570","ENSG00000214517","Cyclin A/B1/B2 associated events during G2/M transition",NA,1,0,113.2,102.4,102.8,84.7,82.7,82.9,109.6,113.6,114.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S243(99.6)]",0,"ENSG00000214517"
"446","NAB2",-0.487912887337793,6.56543463753139,-4.86804968032608,0.000737681030899304,0.00268888277676364,-0.938272877583349,"NONE",FALSE,"High","Master Protein","Q15742","NGFI-A-binding protein 2 [OS=Homo sapiens]",0,66.635,17,3,4,5,3,525,56.6,6.96,21.54,3,"developmental processes;other biological processes","nucleus","other molecular function","Pf04904, Pf04905","4665","B2RAK3; hsa:4665; O76006; Q14797; Q15742","ENSG00000166886","NGF-stimulated transcription; EGR2 and SOX10-mediated initiation of Schwann cell myelination",NA,2,0,131.6,101.5,115.4,80.2,84.3,80.8,86.3,92.4,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100); S171(100); S205(99.4)]",0,"ENSG00000166886"
"447","RAD23A",0.613205770926281,6.65978311742382,4.86785119719829,0.00073789321626826,0.00268888277676364,-0.93857700132207,"UP",FALSE,"High","Master Protein","P54725","UV excision repair protein RAD23 homolog A [OS=Homo sapiens]",0,30.401,8,1,1,4,1,363,39.6,4.58,22.42,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00240, Pf00627, Pf09280","5886","hsa:5886; K7ESE3; P54725; Q59EU8; Q5M7Z1","ENSG00000179262","Josephin domain DUBs; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER","Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum",6,0,70,71.1,67.7,125.9,100.2,100.4,126.4,153.1,121.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S123(100)]",0,"ENSG00000179262"
"448","PLEKHA7",0.466977469151115,6.63732992991297,4.86763474662637,0.000738124683817471,0.00268888277676364,-0.938908661696659,"NONE",FALSE,"High","Master Protein","Q6IQ23","Pleckstrin homology domain-containing family A member 7 [OS=Homo sapiens]",0,69.163,6,5,9,11,5,1121,127.1,9.35,37.45,5,"cell adhesion;cell organization and biogenesis","other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00169","144100","B4DK33; B4DWC3; hsa:144100; Q6IQ23; Q86VZ7","ENSG00000166689",NA,NA,0,0,90.9,89,94.5,132.2,138.9,121.8,93.4,85.2,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S536(100); S612(100); S903(99.5); S907(99.5); S986(100)]",0,"ENSG00000166689"
"449","ADAR",-0.614114136330863,6.58689678153725,-4.86393479165137,0.000742093359366151,0.00269731929284089,-0.944578986615955,"DOWN",FALSE,"High","Master Protein","P55265","Double-stranded RNA-specific adenosine deaminase [OS=Homo sapiens]",0,25.324,3,3,3,3,3,1226,136,8.65,9.52,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00035, Pf02137, Pf02295","103","B1AQQ9; B1AQR0; D3DV76; hsa:103; O15223; O43859; O43860; P55265; Q9BYM3; Q9BYM4","ENSG00000160710","PKR-mediated signaling; Interferon alpha/beta signaling; C6 deamination of adenosine; Formation of editosomes by ADAR proteins","Measles virus infection; Cytosolic DNA-sensing pathway",6,0,115.5,105.8,125.5,74.7,70.7,75.2,109,85.6,111.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T601(99.4); S825(100)]",0,"ENSG00000160710"
"450","TAB2",0.526057048359125,6.62377418124025,4.85861185142892,0.000747842948725148,0.0027121770940432,-0.952739915542455,"UP",FALSE,"High","Master Protein","Q9NYJ8","TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [OS=Homo sapiens]",0,27.67,5,2,2,2,2,693,76.4,8.54,8.32,2,"stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf02845","23118","B2RCC4; E1P5A0; hsa:23118; O94838; Q6I9W8; Q76N06; Q9NYJ8; Q9UFP7","ENSG00000055208","SARS-CoV-2 activates/modulates innate and adaptive immune responses; FCERI mediated NF-kB activation; Downstream TCR signaling; CLEC7A (Dectin-1) signaling; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Nuclear signaling by ERBB4; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TAK1-dependent IKK and NF-kappa-B activation  ; TNFR1-induced NF-kappa-B signaling pathway; TICAM1,TRAF6-dependent induction of TAK1 complex; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; Alpha-protein kinase 1 signaling pathway","IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; MAPK signaling pathway; TLR4 signaling and tolerance; Exercise-induced circadian regulation; miRNA role in immune response in sepsis; Measles virus infection; Hepatitis B infection; Toll-like receptor signaling pathway",27,0,84.9,67.6,76.2,113.2,110,118.4,97.9,117.9,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S372(100); S582(100)]",0,"ENSG00000055208"
"451","PPHLN1",-0.336373942294825,6.5980031292837,-4.84928425027961,0.000758033297722593,0.00274167309115771,-0.967050066753435,"NONE",FALSE,"High","Master Protein","Q8NEY8","Periphilin-1 [OS=Homo sapiens]",0,42.589,11,6,6,13,6,458,52.7,9.11,25.67,6,"cell organization and biogenesis;other biological processes","cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf11488","51535","E9PAX8; hsa:51535; Q86YT2; Q8IXN3; Q8NEY8; Q8TB09; Q96NB9; Q9NXL4; Q9P0P6; Q9P0R9","ENSG00000134283",NA,NA,0,0,113.6,110.3,115.7,91.5,86.3,92.9,95.2,90.7,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S121(100); S133(100); S155(100); T200(99.4); S205(99.6)]",0,"ENSG00000134283"
"452","MIEF1",-0.550796741098543,6.57345663351898,-4.84712106818152,0.000760417692772459,0.00274167309115771,-0.970370475755734,"DOWN",FALSE,"High","Master Protein","Q9NQG6","Mitochondrial dynamics protein MIEF1 [OS=Homo sapiens]",0,5.38,2,1,1,1,1,463,51.3,7.64,2.68,1,"cell organization and biogenesis;stress response;other biological processes","other membranes;mitochondrion","other molecular function","Pf20266, Pf21297","54471","hsa:54471; Q7L890; Q9BUI3; Q9NQG6","ENSG00000100335",NA,NA,0,0,122.4,120.8,113.8,73.8,67.4,98.8,85,89.5,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(99.6)]",0,"ENSG00000100335"
"453","CTNNA2",0.467429832118039,6.63640727835498,4.84657951834781,0.000761015876405909,0.00274167309115771,-0.971201836805809,"NONE",FALSE,"High","Master Protein","P26232","Catenin alpha-2 [OS=Homo sapiens]",0,145.347,11,8,11,18,8,953,105.2,5.71,84.05,8,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf01044","1496","B3KXE5; B7Z2W7; B7Z352; B7Z898; hsa:1496; P26232; Q4ZFW1; Q53R26; Q53R33; Q53T67; Q53T71; Q53TM8; Q7Z3L1; Q7Z3Y0","ENSG00000066032","Myogenesis","Arrhythmogenic right ventricular cardiomyopathy; Ectoderm differentiation; Ectoderm differentiation; Endometrial cancer; Pleural mesothelioma",6,0,89.8,87.3,89,124.8,110.8,139.3,89.6,94.2,85.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S262(100); T535(100); T657(100); S901(100); S939(100)]",0,"ENSG00000066032"
"454","CDK12",-0.332291042146699,6.61561433497962,-4.8445882216396,0.00076321974454445,0.00274355643853864,-0.974259126559816,"NONE",FALSE,"High","Master Protein","Q9NYV4","Cyclin-dependent kinase 12 [OS=Homo sapiens]",0,30.762,4,6,6,12,5,1490,164.1,9.44,30.61,6,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","51755","A7E2B2; B4DYX4; B9EIQ6; hsa:51755; O94978; Q9NYV4","ENSG00000167258","TP53 Regulates Transcription of DNA Repair Genes","17q12 copy number variation syndrome",2,0,106.8,109.7,106.3,88.4,74.3,93.8,101.9,102.9,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S293(100); S423(100); T692(100); T893(100); S1083(99.7)]",0,"ENSG00000167258"
"455","AQP4",-0.429671466616585,6.59561279857569,-4.83987404166671,0.000768464391739359,0.00275633821388711,-0.981499107891892,"NONE",FALSE,"High","Master Protein","P55087","Aquaporin-4 [OS=Homo sapiens]",0,49.961,9,5,8,17,5,323,34.8,7.66,40.12,5,"cell organization and biogenesis;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00230","361","hsa:361; P55087; P78564","ENSG00000171885","Passive transport by Aquaporins; Vasopressin regulates renal water homeostasis via Aquaporins","Spinal cord injury; Vasopressin-regulated water reabsorption; Cell lineage map for neuronal differentiation; Sudden infant death syndrome (SIDS) susceptibility pathways",6,0,121.3,125.2,122.6,83.1,102.3,95.3,84.3,83.7,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S316(100); S321(99.6)]",0,"ENSG00000171885"
"456","CCDC92",0.483865403958955,6.61624479889211,4.83173712698647,0.000777607721397613,0.00278301710815988,-0.994002884912156,"NONE",FALSE,"High","Master Protein","Q53HC0","Coiled-coil domain-containing protein 92 [OS=Homo sapiens]",0,4.671,5,1,1,1,1,331,36.9,8.9,2.76,1,"stress response;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf14916","80212","B3KNQ0; hsa:80212; Q53HC0; Q9H697","ENSG00000119242; ENSG00000275035",NA,NA,0,0,76.1,84.4,74.4,116.2,101.2,120.5,111.5,97.4,109.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S211(100)]",0,"ENSG00000119242"
"457","CCDC9B",0.462824350242004,6.61448445010688,4.80493377036876,0.000808557352070255,0.00288321991646783,-1.03525527141932,"NONE",FALSE,"High","Master Protein","Q6ZUT6","Coiled-coil domain-containing protein 9B [OS=Homo sapiens]",0,17.565,3,2,2,2,2,534,57.3,9.13,6.51,2,NA,NA,NA,"Pf15266","388115","B9EIQ8; hsa:388115; Q68DG9; Q6ZTM3; Q6ZU22; Q6ZUT6","ENSG00000188549",NA,NA,0,0,90,90.6,83.6,117.3,131.7,129.8,80.6,98.3,85.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S201(100)]",0,"ENSG00000188549"
"458","PPAN",-0.511689456211199,6.59918108804785,-4.80444065899565,0.000809138922636192,0.00288321991646783,-1.03601513121683,"DOWN",FALSE,"High","Master Protein","Q9NQ55","Suppressor of SWI4 1 homolog [OS=Homo sapiens]",0,23.311,3,1,1,4,1,473,53.2,10.13,14.15,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf04427","56342; 692312","C9J3F9; hsa:56342; hsa:692312; Q9BW97; Q9H170; Q9NQ55","ENSG00000130810",NA,NA,0,0,121.9,113.8,106.1,73.4,82.9,80.8,100.6,92.1,111.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S359(100)]",0,"ENSG00000130810"
"459","KIF26B",0.476817424231866,6.62211807185034,4.80104261781449,0.00081315870350775,0.00289123094580533,-1.04125224836388,"NONE",FALSE,"High","Master Protein","Q2KJY2","Kinesin-like protein KIF26B [OS=Homo sapiens]",0,64.183,3,5,8,13,5,2108,223.7,8.44,38,5,"developmental processes;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00225","55083","hsa:55083; Q2KJY2; Q6ZQR9; Q6ZUZ0; Q8IUN3; Q8IVR1; Q9NWB4","ENSG00000162849","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins",NA,2,0,90.1,87.2,88.2,127.8,143.5,117.5,95.8,85.2,81.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1006(100); S1021(100); S1742(100); S1773(100); S1958(99.2)]",0,"ENSG00000162849"
"460","CTNNB1",0.384890097783133,6.65795377091611,4.78647010304882,0.000830640951431834,0.00294219218275616,-1.06372959447999,"NONE",FALSE,"High","Master Protein","P35222","Catenin beta-1 [OS=Homo sapiens]",0,88.231,7,6,8,22,6,781,85.4,5.86,76.03,6,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00514","1499","A8K1L7; hsa:1499; P35222; Q8NEW9; Q8NI94; Q9H391","ENSG00000168036","Deactivation of the beta-catenin transactivating complex; InlA-mediated entry of Listeria monocytogenes into host cells; RHO GTPases activate IQGAPs; Formation of paraxial mesoderm; Somitogenesis; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1); Formation of axial mesoderm; Myogenesis; Transcriptional Regulation by VENTX; Ca2+ pathway; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; Cardiogenesis; Germ layer formation at gastrulation; Formation of definitive endoderm; VEGFR2 mediated vascular permeability; Adherens junctions interactions; Regulation of CDH11 function; Regulation of CDH19 Expression and Function; CDH11 homotypic and heterotypic interactions; Binding of TCF/LEF:CTNNB1 to target gene promoters; RUNX3 regulates WNT signaling; Specification of the neural plate border; Formation of the nephric duct; Apoptotic cleavage of cell adhesion  proteins; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production","Androgen receptor signaling pathway; MicroRNAs in cardiomyocyte hypertrophy; Heart development; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Alzheimer's disease and miRNA effects; Neural crest differentiation; Arrhythmogenic right ventricular cardiomyopathy; Pathogenic Escherichia coli infection; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Gastric cancer network 2; Brain-derived neurotrophic factor (BDNF) signaling pathway; Polycystic kidney disease pathway; Primary focal segmental glomerulosclerosis (FSGS); Endoderm differentiation; Ectoderm differentiation; Extracellular vesicle-mediated signaling in recipient cells; Focal adhesion; Ectoderm differentiation; RAC1/PAK1/p38/MMP2 pathway; Wnt signaling pathway; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling; Embryonic stem cell pluripotency pathways; H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity; OSX and miRNAs in tooth development; miRNA regulation of prostate cancer signaling pathways; Wnt signaling pathway and pluripotency; PTF1A related regulatory pathway; Wnt signaling in kidney disease; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Ciliary landscape; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; Osteoblast differentiation and related diseases; TGF-beta receptor signaling in skeletal dysplasias; Genes controlling nephrogenesis; GDNF/RET signaling axis; Mammalian disorder of sexual development; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; 1q21.1 copy number variation syndrome; 7q11.23 copy number variation syndrome; Development of ureteric collection system; Pleural mesothelioma; Alzheimer's disease; Urotensin-II-mediated signaling pathway; Markers of kidney cell lineage; TROP2 regulatory signaling; 8p23.1 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; ADHD and autism (ASD) linked metabolic pathways and SNP; HDAC6 interactions in the central nervous system; Wnt/Beta-catenin signaling inhibitors in current and past clinical trials; TGF-beta receptor signaling; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response (only ATM dependent)",103,0,84.2,79.9,83.2,103.9,108.2,124.2,107.8,114.1,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S191(100); S552(100); S675(100)]",0,"ENSG00000168036"
"461","SNRNP200",-0.689515302433302,6.4945286517797,-4.78609420694984,0.000831097179075116,0.00294219218275616,-1.06430977943378,"DOWN",FALSE,"High","Master Protein","O75643","U5 small nuclear ribonucleoprotein 200 kDa helicase [OS=Homo sapiens]",0,22.926,2,2,2,2,2,2136,244.4,6.06,5.98,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00270, Pf00271, Pf02889, Pf18149, Pf21188","23020","hsa:23020; O75643; O94884; Q6NZY0; Q6PX59; Q8NBE6; Q96IF2; Q9H7S0","ENSG00000144028","mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","2q11.2 copy number variation syndrome",3,0,135,121.6,129.2,84.9,52.4,98,79.4,85.1,68.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S225(100)]",0,"ENSG00000144028"
"462","RABGAP1",-0.427235295070533,6.60315319130608,-4.78252400744575,0.000835443715830307,0.00295117780137459,-1.06982124494975,"NONE",FALSE,"High","Master Protein","Q9Y3P9","Rab GTPase-activating protein 1 [OS=Homo sapiens]",0,15.489,2,2,2,3,2,1069,121.7,5.25,10.62,2,"cell cycle OR cell proliferation;other biological processes","cytosol;cytoskeleton","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00566, Pf00640, Pf12473","23637","B9A6L2; hsa:23637; Q05CW2; Q6ZMY1; Q9HA28; Q9P0E2; Q9UG67; Q9Y3P9","ENSG00000011454","TBC/RABGAPs",NA,1,0,128.5,110.4,111.6,99.2,72,86,93,93.9,93.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S491(100); T996(100)]",0,"ENSG00000011454"
"463","MTMR3",-0.414577610965513,6.62148109840345,-4.77025653675403,0.000850564651231658,0.00299810261514053,-1.08877233450866,"NONE",FALSE,"High","Master Protein","Q13615","Myotubularin-related protein 3 [OS=Homo sapiens]",0,50.31,5,3,3,5,3,1198,133.5,5.8,24.77,3,"protein metabolism;other metabolic processes;stress response;other biological processes","other membranes;cytosol;other cell component","other molecular function","Pf01363, Pf06602","8897","A5PL26; A7MD32; hsa:8897; Q13615; Q9NYN5; Q9NYN6; Q9UDX6; Q9UEG3","ENSG00000100330","Synthesis of PIPs at the plasma membrane; Macroautophagy",NA,2,0,107.4,112.6,111.8,82.4,86.3,82.3,107.6,96.4,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S613(100); S633(100); S647(100)]",0,"ENSG00000100330"
"464","GRK5",0.817130693967985,6.67597008739273,4.75971290290326,0.00086379428129976,0.00303817298939916,-1.10507682512903,"UP",FALSE,"High","Master Protein","P34947","G protein-coupled receptor kinase 5 [OS=Homo sapiens]",0,7.73,2,1,2,3,1,590,67.7,8.1,7.98,1,"cell-cell signaling;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00615","2869","D3DRD0; hsa:2869; P34947; Q5T059","ENSG00000198873","G alpha (q) signalling events; G alpha (s) signalling events","Myometrial relaxation and contraction pathways; Chemokine signaling pathway; Comprehensive IL-17A signaling; Calcium regulation in cardiac cells",6,0,79,65.5,70.9,134.5,93.3,151.2,112.7,124.4,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S484(99.6)]",0,"ENSG00000198873"
"465","PJA2",0.714442517613704,6.61165266092132,4.75627843902585,0.000868150960701245,0.00304692982336437,-1.11039109489514,"UP",FALSE,"High","Master Protein","O43164","E3 ubiquitin-protein ligase Praja-2 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,708,78.2,4.39,10.36,1,"protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf13639","9867","A8K6U4; D3DSZ5; O43164; Q68D49; Q8N1G5","ENSG00000198961","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,65.2,65.9,67.3,102,134.5,107.7,99.7,133.3,158,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100)]",0,"ENSG00000198961"
"466","SCAF4",-0.764183795667624,6.55056568116488,-4.74762937280071,0.000879226681574847,0.00307710886286013,-1.12378122926203,"DOWN",FALSE,"High","Master Protein","O95104","SR-related and CTD-associated factor 4 [OS=Homo sapiens]",0,80.572,3,1,3,29,1,1147,125.8,9.55,34.25,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076, Pf04818","57466","C9JLZ0; hsa:57466; O95104; Q0P5W8; Q6P1M5; Q8N3I8; Q9UFM1; Q9ULP8","ENSG00000156304",NA,NA,0,0,132,116.9,134.6,75.9,49.8,97.2,98.2,92.9,78.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(100)]",0,"ENSG00000156304"
"467","NAV2",0.331419663004055,6.65946038197844,4.74662643563929,0.000880520734654215,0.00307710886286013,-1.12533459531317,"NONE",FALSE,"High","Master Protein","Q8IVL1","Neuron navigator 2 [OS=Homo sapiens]",0,32.148,2,5,6,8,5,2488,268,9.03,19.57,5,"cell organization and biogenesis;developmental processes;other biological processes","extracellular matrix;nucleus","other molecular function","Pf00307","89797","A6NEC1; hsa:89797; Q8IVK3; Q8IVK4; Q8IVK5; Q8IVK6; Q8IVK7; Q8IVK8; Q8IVL1; Q8NHC9; Q8NHD0; Q8TDE9; Q8TDF0; Q8TEB3; Q96B30; Q9NUZ6; Q9NVM7; Q9P2C8","ENSG00000166833",NA,NA,0,0,79.5,80.1,83.2,101.6,108.8,109.6,113.4,114.8,128.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S311(100); S458(100); S1104(100); S1319(99.7); S1977(99.6)]",0,"ENSG00000166833"
"468","LIMCH1",0.297600565206642,6.66561529198656,4.74467878213272,0.000883039529835951,0.00307931733481255,-1.12835154522482,"NONE",FALSE,"High","Master Protein","Q9UPQ0","LIM and calponin homology domains-containing protein 1 [OS=Homo sapiens]",0,180.04,14,14,17,42,14,1083,121.8,6.47,126.38,14,"cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00412, Pf15949","22998","A8MXC3; E9PHM7; hsa:22998; Q503B5; Q5CZB1; Q5CZB6; Q5H9S8; Q68E07; Q6PJ44; Q7Z3G5; Q8N3S9; Q8N6M2; Q9UPQ0","ENSG00000064042",NA,NA,0,0,77.1,81,80.1,101,98.9,103.4,122.2,129.4,128.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100); S192(100); S201(100); S217(100); S231(100); S377(100); S471(99.6); S493(100); S670(100); S718(100); S875(100); S973(100)]",0,"ENSG00000064042"
"469","UBXN1",0.385593691438952,6.66710597313061,4.74250198246926,0.000885863768732826,0.0030825792549509,-1.13172405762607,"NONE",FALSE,"High","Master Protein","Q04323","UBX domain-containing protein 1 [OS=Homo sapiens]",0,30.222,10,2,2,3,2,297,33.3,5.25,13.36,2,"protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00627, Pf00789","51035","hsa:51035; Q04323; Q9BV93; Q9BVV5","ENSG00000162191","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; N-glycan trimming in the ER and Calnexin/Calreticulin cycle",NA,2,0,86.4,81.2,76.1,114.5,103.2,111.5,112.6,118,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S200(100)]",0,"ENSG00000162191"
"470","SEC62",-0.641618593818683,6.56987138427057,-4.72868977073637,0.000904010205676973,0.00313903118226558,-1.15313831341147,"DOWN",FALSE,"High","Master Protein","Q99442","Translocation protein SEC62 [OS=Homo sapiens]",0,33.302,9,5,5,12,5,399,45.8,7.12,26.08,5,"transport;other biological processes","other membranes;ER/Golgi","other molecular function","Pf03839","7095","D3DNQ0; hsa:7095; O00682; O00729; Q99442","ENSG00000008952",NA,NA,0,0,118.9,124.6,122,90.5,57.5,83.2,102.4,97.3,79.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(100); T158(100); S309(100)]",0,"ENSG00000008952"
"471","CPNE3",-0.504000224617886,6.57706992857449,-4.72444152783281,0.000909670963834303,0.003151980919273,-1.1597299407705,"DOWN",FALSE,"High","Master Protein","O75131","Copine-3 [OS=Homo sapiens]",0,35.047,9,3,3,5,3,537,60.1,5.85,15.6,3,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00168, Pf07002","8895","A8KA47; hsa:8895; O75131; Q8IYA1","ENSG00000085719","Neutrophil degranulation; Glycerophospholipid biosynthesis",NA,2,0,114.1,110.3,121.8,80.8,62.6,100.3,96.5,93,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100); S243(99.7)]",0,"ENSG00000085719"
"472","ZC3HAV1",0.426435981298044,6.65195345392266,4.72211587377731,0.000912785890052123,0.00315607324695988,-1.16333949257978,"NONE",FALSE,"High","Master Protein","Q7Z2W4","Zinc finger CCCH-type antiviral protein 1 [OS=Homo sapiens]",0,15.174,3,2,2,2,2,902,101.4,8.4,6.52,2,"stress response;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00644, Pf02825, Pf18606, Pf18633","56829","A4D1R2; A4D1S4; hsa:56829; Q7Z2W4; Q8IW57; Q8TAJ3; Q96N79; Q9H8R9; Q9P0Y7","ENSG00000105939","Signaling by BRAF and RAF1 fusions",NA,1,0,90.4,86.6,78.1,117.4,121.3,118.2,99.6,95.7,110.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S275(100); S378(99.6)]",0,"ENSG00000105939"
"473","RIN1",0.458041345934812,6.62936538952764,4.71932158986563,0.000916543543535142,0.00316236588382527,-1.16767735597773,"NONE",FALSE,"High","Master Protein","Q13671","Ras and Rab interactor 1 [OS=Homo sapiens]",0,23.49,3,2,3,5,2,783,84,8.02,13.07,2,"transport;signal transduction","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00788, Pf02204","9610","hsa:9610; O15010; Q00427; Q13671; Q96CC8","ENSG00000174791","RAB GEFs exchange GTP for GDP on RABs","Ras signaling; EGF/EGFR signaling pathway",3,0,71.7,72.9,66.3,93.2,93.9,110.5,119.4,139.7,154.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S337(99.4); S351(100)]",0,"ENSG00000174791"
"474","EPN1",0.434205558604964,6.66374909275634,4.71612921889766,0.000920856734717047,0.00316438501872899,-1.17263450808255,"NONE",FALSE,"High","Master Protein","Q9Y6I3","Epsin-1 [OS=Homo sapiens]",0,47.334,11,3,5,6,3,576,60.3,4.83,24.64,3,"transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle","other molecular function","Pf01417","29924","hsa:29924; Q86ST3; Q9HA18; Q9Y6I3","ENSG00000063245","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation","VEGFA-VEGFR2 signaling; EGF/EGFR signaling pathway",5,0,82,75.8,81.2,117,96.1,119.1,112.3,121.7,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S435(100); T470(100)]",0,"ENSG00000063245"
"475","GMPS",-0.341632479844567,6.61853722791395,-4.71601853333202,0.000921006669054088,0.00316438501872899,-1.17280640674595,"NONE",FALSE,"High","Master Protein","P49915","GMP synthase [glutamine-hydrolyzing] [OS=Homo sapiens]",0,5.437,2,1,1,1,1,693,76.7,6.87,2.9,1,"other metabolic processes","cytosol","other molecular function","Pf00117, Pf00958, Pf02540","8833","A8K639; B4DXV7; F8W720; hsa:8833; P49915","ENSG00000163655","Purine ribonucleoside monophosphate biosynthesis; Azathioprine ADME",NA,2,0,113.4,109,106.4,83.5,88.3,91,98.2,102.1,100,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S332(99.1)]",0,"ENSG00000163655"
"476","SURF6",-0.495717070788501,6.63323069701675,-4.70547954418308,0.000935402718488894,0.00320709503481906,-1.18918143892379,"NONE",FALSE,"High","Master Protein","O75683","Surfeit locus protein 6 [OS=Homo sapiens]",0,3.129,2,1,1,1,1,361,41.4,10.64,2.78,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf04935","6838","hsa:6838; O75683; Q5T8U1; Q9BRK9; Q9BTZ5; Q9UK24","ENSG00000148296; ENSG00000281309",NA,NA,0,0,112.2,118.4,118.4,77,76.9,92.5,88.9,106.8,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000148296"
"477","ERC1",0.448971812813334,6.64852877139849,4.69890893988313,0.000944499342857798,0.00323149460701033,-1.19939817275438,"NONE",FALSE,"High","Master Protein","Q8IUD2","ELKS/Rab6-interacting/CAST family member 1 [OS=Homo sapiens]",0,28.653,3,3,4,15,3,1116,128,5.97,15.28,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf09457, Pf10174","23085","A2RU77; A7E295; D3DUP7; D3DUP8; hsa:23085; Q6NVK2; Q8IUD2; Q8IUD3; Q8IUD4; Q8IUD5; Q8NAS1; Q9NXN5; Q9UIK7; Q9UPS1","ENSG00000082805",NA,"Cell lineage map for neuronal differentiation",1,0,82.6,83.1,86.6,116.9,141.4,109.9,93.9,107,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S37(99.4)]",0,"ENSG00000082805"
"478","SLC1A3",-0.431580657402963,6.58269211486967,-4.68849618145514,0.000959108955015557,0.00327461467486483,-1.21560108359732,"NONE",FALSE,"High","Master Protein","P43003","Excitatory amino acid transporter 1 [OS=Homo sapiens]",0,63.48,3,1,4,33,1,542,59.5,8.41,123.08,1,"cell-cell signaling;other metabolic processes;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00375","6507","B2R5T3; hsa:6507; P43003; Q4JCQ8","ENSG00000079215","Glutamate Neurotransmitter Release Cycle; Transport of inorganic cations/anions and amino acids/oligopeptides; Astrocytic Glutamate-Glutamine Uptake And Metabolism; Defective SLC1A3 causes episodic ataxia 6 (EA6)","Synaptic vesicle pathway; Neuroinflammation and glutamatergic signaling; Cell lineage map for neuronal differentiation; Sudden infant death syndrome (SIDS) susceptibility pathways",8,0,108.2,107.1,97.7,81.5,59.6,89.6,105.8,110,104.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S512(100)]",0,"ENSG00000079215"
"479","ZBTB40",-0.555791659542567,6.55504778103116,-4.66238272815574,0.000996817635083866,0.00339625549155923,-1.25629958896655,"DOWN",FALSE,"High","Master Protein","Q9NUA8","Zinc finger and BTB domain-containing protein 40 [OS=Homo sapiens]",0,7.152,3,2,2,3,2,1239,138,6.57,2.99,2,"stress response;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf00651, Pf12874","9923","hsa:9923; O75066; Q5TFU5; Q8N1R1; Q9NUA8","ENSG00000184677",NA,NA,0,0,126.9,124.6,126.6,84,93.9,81.2,72.2,86.8,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S728(100)]",0,"ENSG00000184677"
"480","AMPD2",0.575956072618117,6.63008257511647,4.66015014060791,0.00100011410737934,0.00340038796508976,-1.25978339412112,"UP",FALSE,"High","Master Protein","Q01433","AMP deaminase 2 [OS=Homo sapiens]",0,41.668,5,4,4,10,4,825,94.8,6.55,33.92,4,"other metabolic processes;other biological processes","cytosol","other molecular function","Pf19326","271","A0A5F9UK94; B4DK50; B4DZI5; E9PNG0; hsa:271; Q01433; Q14856; Q14857; Q16686; Q16687; Q16688; Q16729; Q5T693; Q5T695; Q96IA1; Q9UDX8; Q9UDX9; Q9UMU4","ENSG00000116337","Purine salvage",NA,1,0,69.2,68.2,64.9,103.3,120.3,92.1,119.4,131.5,166.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); S46(100); S114(100)]",0,"ENSG00000116337"
"481","ZNF423",-0.338852750602721,6.59117859339612,-4.61837026362405,0.00106399456470404,0.00360480395390431,-1.32510137807931,"NONE",FALSE,"High","Master Protein","Q2M1K9","Zinc finger protein 423 [OS=Homo sapiens]",0,11.026,2,2,2,2,2,1284,144.5,6.89,5.46,2,"developmental processes;signal transduction;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf13912","23090","hsa:23090; O94860; Q2M1K9; Q76N04; Q9NZ13","ENSG00000102935",NA,"Differentiation of white and brown adipocyte; White fat cell differentiation; Joubert syndrome; Ciliopathies; TGF-beta receptor signaling in skeletal dysplasias; TGF-beta receptor signaling",6,0,120.4,118.4,106.6,95.7,79.9,96.8,88.6,90.2,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T383(99.6)]",0,"ENSG00000102935"
"482","ABI2",0.311505152275141,6.65400220347838,4.61795296713717,0.00106465410893497,0.00360480395390431,-1.32575494982874,"NONE",FALSE,"High","Master Protein","Q9NYB9","Abl interactor 2 [OS=Homo sapiens]",0,58.658,14,5,8,39,5,513,55.6,6.16,52.68,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00018, Pf07815","10152","B4DSN1; hsa:10152; Q13147; Q13249; Q13801; Q9BV70; Q9NYB9","ENSG00000138443","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway","Regulation of actin cytoskeleton",8,0,86.1,88.8,90.8,109.1,122.7,115.5,101.8,98.8,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(100); S196(100); S216(100); S227(100); T361(100)]",0,"ENSG00000138443"
"483","CRKL",0.347234330670362,6.65080151375549,4.61345005275715,0.00107179880894763,0.00362148168986032,-1.33280891277129,"NONE",FALSE,"High","Master Protein","P46109","Crk-like protein [OS=Homo sapiens]",0,30.371,14,2,3,5,2,303,33.8,6.74,14.93,2,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00017, Pf00018, Pf07653","1399","A8KA44; D3DX35; hsa:1399; P46109","ENSG00000099942","Downstream signal transduction; Regulation of signaling by CBL; Erythropoietin activates RAS; Frs2-mediated activation; MET activates RAP1 and RAC1; MET receptor recycling","Androgen receptor network in prostate cancer; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; MAPK signaling pathway; Chemokine signaling pathway; MET in type 1 papillary renal cell carcinoma; EGF/EGFR signaling pathway; 22q11.2 copy number variation syndrome; IL-2 signaling pathway; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway",22,0,81.3,83.8,92.2,107.7,125.8,113.3,103.8,102.6,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(99.1); S107(100)]",0,"ENSG00000099942"
"484","ZFP36L1",0.536831969096676,6.66489786796051,4.6084467554521,0.00107979739677267,0.00364096973457229,-1.34064991069206,"UP",FALSE,"High","Master Protein","Q07352","mRNA decay activator protein ZFP36L1 [OS=Homo sapiens]",0,6.607,6,2,2,2,2,338,36.3,7.96,3.06,2,"cell adhesion;cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00642, Pf04553","677","hsa:677; Q07352; Q13851","ENSG00000185650","Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA","Modulators of TCR signaling and T cell activation",2,0,88.5,84.1,74.4,117.3,107.4,139.9,98.1,104.8,107.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S90(100)]",0,"ENSG00000185650"
"485","MARK2",0.365037507174645,6.62352943318349,4.60013432982858,0.0010932270407475,0.00367865264020603,-1.35368422829781,"NONE",FALSE,"High","Master Protein","Q7KZI7","Serine/threonine-protein kinase MARK2 [OS=Homo sapiens]",0,40.931,5,3,3,11,2,788,87.9,9.72,25.87,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;mitochondrion;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00627, Pf02149","2011","hsa:2011; Q15449; Q15524; Q5XGA3; Q68A18; Q7KZI7; Q96HB3; Q96RG0","ENSG00000072518",NA,"Microtubule cytoskeleton regulation; Complement system in neuronal development and plasticity; Neurogenesis regulation in the olfactory epithelium",3,0,90.7,91.5,86.2,118.8,128.1,116.2,87.4,90.1,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T208(100); S456(100); S486(100)]",0,"ENSG00000072518"
"486","NADK2",-0.494689312216586,6.52347334748242,-4.59562335445011,0.00110058937593017,0.00369294024514572,-1.36076151855576,"NONE",FALSE,"High","Master Protein","Q4G0N4","NAD kinase 2, mitochondrial [OS=Homo sapiens]",0,13.249,4,1,1,1,1,442,49.4,8.18,3.43,1,"other metabolic processes","mitochondrion","kinase activity;other molecular function","Pf01513","133686","B5MC93; hsa:133686; Q4G0N4; Q6UTX5; Q96NM0","ENSG00000152620","Mitochondrial protein degradation; Nicotinate metabolism",NA,2,0,111.5,124.4,95.6,80,68.5,79.7,100.4,93.4,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S367(100)]",0,"ENSG00000152620"
"487","NAF1",-0.746487146871551,6.55165072600646,-4.59476350462464,0.00110199871285905,0.00369294024514572,-1.36211084765956,"DOWN",FALSE,"High","Master Protein","Q96HR8","H/ACA ribonucleoprotein complex non-core subunit NAF1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,494,53.7,4.87,4.17,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04410","92345","D3DP28; E9PAZ2; hsa:92345; Q96HR8","ENSG00000145414",NA,NA,0,0,119.2,141.5,120,89.4,52.6,77.4,94.7,103,74.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S315(100)]",0,"ENSG00000145414"
"488","PRRT3",-1.13647621866798,6.52337011314736,-4.58113631063913,0.0011245927760438,0.00376093321824483,-1.38350857199389,"DOWN",FALSE,"High","Master Protein","Q5FWE3","Proline-rich transmembrane protein 3 [OS=Homo sapiens]",0,7.936,2,2,2,2,2,981,102.1,7.78,5.06,2,NA,"other membranes",NA,NA,"285368","hsa:285368; Q49AD0; Q5FWE3; Q6UXY6; Q8NBC9","ENSG00000163704",NA,NA,0,0,126.7,163.7,93,45.2,62,49.9,127.5,84.8,124.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S815(100); S976(99.6)]",0,"ENSG00000163704"
"489","RGMA",0.806762483119849,6.5718588000513,4.57793709407965,0.00112996827700841,0.00377118247050658,-1.38853561996695,"UP",FALSE,"High","Master Protein","Q96B86","Repulsive guidance molecule A [OS=Homo sapiens]",0,7.423,2,1,1,1,1,450,49.3,7.42,3.43,1,"cell organization and biogenesis;protein metabolism;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf06534, Pf06535","56963","B2RTW1; B7Z5S8; F5GXQ7; F5GZU6; G3V518; hsa:56963; Q0JV97; Q8NC80; Q96B86; Q9H0E6; Q9NPM3","ENSG00000182175","Netrin-1 signaling","Spinal cord injury; Ectoderm differentiation; Netrin-UNC5B signaling pathway",4,0,83.6,80.1,83.8,162,150.9,125.8,91.4,66,66.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S141(100)]",0,"ENSG00000182175"
"490","EML1",0.612370856135429,6.67687826704329,4.5747124870843,0.00113541412876402,0.00378069616841777,-1.39360393551365,"UP",FALSE,"High","Master Protein","O00423","Echinoderm microtubule-associated protein-like 1 [OS=Homo sapiens]",0,13.517,2,1,1,1,1,815,89.8,7.06,4.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00400, Pf03451","2009","hsa:2009; O00423; Q86U15; Q8N536; Q8N5C4; Q8WWL6","ENSG00000066629",NA,NA,0,0,86.8,82.1,90.6,134.7,112.2,153.2,84.2,103.4,90.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(100)]",0,"ENSG00000066629"
"491","DPY19L3",-0.592184778386756,6.58594935936643,-4.57211903323847,0.00113981433293289,0.00378069616841777,-1.39768122617257,"DOWN",FALSE,"High","Master Protein","Q6ZPD9","Probable C-mannosyltransferase DPY19L3 [OS=Homo sapiens]",0,11.53,2,1,1,1,1,716,83.1,8.72,4.38,1,NA,"other membranes;ER/Golgi;nucleus","other molecular function","Pf10034","147991","hsa:147991; Q68DC7; Q6ZPD9; Q6ZTB7; Q6ZTS2","ENSG00000178904",NA,NA,0,0,112.5,123.9,93.9,79.9,54.3,76.1,99,125.6,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000178904"
"492","TEX2",0.752869838839278,6.60611045555812,4.57097446766536,0.0011417620391516,0.00378069616841777,-1.39948093428645,"UP",FALSE,"High","Master Protein","Q8IWB9","Testis-expressed protein 2 [OS=Homo sapiens]",0,12.73,2,2,2,4,2,1127,125.2,6.01,11.36,2,"other metabolic processes;transport;signal transduction","other membranes;ER/Golgi;nucleus","other molecular function",NA,"55852","hsa:55852; Q6AHZ5; Q8IWB9; Q8N3L0; Q9C0C5","ENSG00000136478","RHOA GTPase cycle",NA,1,0,60.6,63.2,63.7,102.3,153,85.7,141.7,126.4,139.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(100); S266(99.5)]",0,"ENSG00000136478"
"493","FKBP15",0.778072133177802,6.62017926274698,4.57078470468115,0.0011420853008762,0.00378069616841777,-1.39977933320841,"UP",FALSE,"High","Master Protein","Q5T1M5","FK506-binding protein 15 [OS=Homo sapiens]",0,85.256,8,5,6,11,5,1219,133.5,5.2,44.68,5,"transport","other membranes;cytoskeleton;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00254","23307","hsa:23307; Q05DK8; Q5T1M2; Q5T1M5; Q6DD85; Q9Y4D0","ENSG00000119321",NA,"TYROBP causal network in microglia",1,0,76.9,69.5,81.3,142.2,170,107,96,108.9,81,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S311(100); S956(100); S1114(100); S1164(100)]",0,"ENSG00000119321"
"494","RANBP2",-0.452130700827365,6.61297013087513,-4.56551680471626,0.00115109818278399,0.00380281828806371,-1.40806491130823,"NONE",FALSE,"High","Master Protein","P49792","E3 SUMO-protein ligase RanBP2 [OS=Homo sapiens]",0,24.793,2,4,4,8,4,3224,358,6.2,15.43,4,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00160, Pf00638, Pf00641, Pf12185","5903","hsa:5903; P49792; Q13074; Q15280; Q53TE2; Q59FH7","ENSG00000153201","tRNA processing in the nucleus; HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Signaling by ALK fusions and activated point mutants",NA,35,0,115.8,114,114,84.3,65.1,101.5,98.1,94.8,102.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S788(99.7); S1456(100); T2293(100); S2668(100)]",0,"ENSG00000153201"
"495","SLC3A2",-0.76634383137486,6.58449142328173,-4.55305366990598,0.00117272421845994,0.00386643621116488,-1.42768204030678,"DOWN",FALSE,"High","Master Protein","P08195","Amino acid transporter heavy chain SLC3A2 [OS=Homo sapiens]",0,2.928,2,1,1,2,1,630,68,5.01,2.2,1,"other metabolic processes;transport;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","transporter activity;nucleic acid binding activity;other molecular function","Pf00128, Pf16028","6520","hsa:6520; J3KPF3; P08195; Q13543","ENSG00000168003","Tryptophan catabolism; Basigin interactions; Amino acid transport across the plasma membrane; Defective SLC7A7 causes lysinuric protein intolerance (LPI)","mRNA, protein, and metabolite inducation pathway by cyclosporin A; Ferroptosis; Proximal tubule transport; Pleural mesothelioma",8,0,114.8,104.9,122.8,76.4,63.5,57.6,128.4,91.8,120.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S165(100)]",0,"ENSG00000168003"
"496","UFD1",1.00065637085751,6.56887026079981,4.54749005256441,0.00118251742139023,0.00389086377360657,-1.43644584872966,"UP",FALSE,"High","Master Protein","Q92890-1","Isoform Long of Ubiquitin recognition factor in ER-associated degradation protein 1 [OS=Homo sapiens]",0,21.313,3,1,1,4,1,343,38.7,6.34,14.14,1,NA,NA,NA,NA,NA,"Q92890-1",NA,NA,NA,0,0,52,49.5,56.7,99.6,108.5,122.5,99.3,209.1,158.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100)]",0,"ENSG00000070010"
"497","SMAD5",0.551300757675953,6.61923173836033,4.5321066019809,0.0012100513997594,0.00397344845957211,-1.46069902890812,"UP",FALSE,"High","Master Protein","Q99717","Mothers against decapentaplegic homolog 5 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,465,52.2,7.71,9.9,1,"developmental processes;signal transduction;other biological processes","cytosol;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03165, Pf03166","4090","hsa:4090; O14688; Q15798; Q99717; Q9UQA1","ENSG00000113658","Signaling by BMP","Differentiation of white and brown adipocyte; BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Neovascularization processes; Osteoblast differentiation and related diseases; TGF-beta receptor signaling in skeletal dysplasias; Network map of SARS-CoV-2 signaling pathway; Clock-controlled autophagy in bone metabolism; Markers of kidney cell lineage; 10q11.21q11.23 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; TGF-beta receptor signaling",14,0,78.7,77.9,89.4,128.2,137.5,112.2,88.5,109.5,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S133(100)]",0,"ENSG00000113658"
"498","MEX3D",-0.489866640498628,6.53629670005386,-4.5279514833568,0.0012176048379446,0.00399022308338472,-1.4672552142936,"NONE",FALSE,"High","Master Protein","Q86XN8","RNA-binding protein MEX3D [OS=Homo sapiens]",0,7.336,2,1,1,2,1,651,64.8,5.35,2.98,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf13920","399664","A0PJL8; A1L023; E9PAL6; hsa:399664; Q71M49; Q86XN8","ENSG00000181588",NA,NA,0,0,120.7,113.9,121.1,85,66.3,100.6,76.1,85,90.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S514(99.4)]",0,"ENSG00000181588"
"499","TBC1D22A",0.507506591775579,6.64764722728675,4.52240831433278,0.00122775974015784,0.00401543866921361,-1.47600506499495,"UP",FALSE,"High","Master Protein","Q8WUA7","TBC1 domain family member 22A [OS=Homo sapiens]",0,29.63,6,1,1,2,1,517,59.1,5.97,8.57,1,NA,NA,"enzyme regulator activity;other molecular function","Pf00566","25771","B0QYI2; B0QYI3; B9A6M3; hsa:25771; Q5TE47; Q6ZUH2; Q8WUA7; Q92680; Q9BVD6; Q9UGG0; Q9UGT2; Q9UGU6; Q9UH25; Q9Y4W5","ENSG00000054611",NA,NA,0,0,79.9,79.4,85.1,125.7,123.3,112.9,94.3,97.9,122.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S167(100)]",0,"ENSG00000054611"
"500","EIF2A",0.442057040253458,6.64633704057239,4.51995547113679,0.00123228198332408,0.00402021011029745,-1.47987814242236,"NONE",FALSE,"High","Master Protein","Q9BY44","Eukaryotic translation initiation factor 2A [OS=Homo sapiens]",0,21.711,3,1,1,3,1,585,64.9,8.87,12.48,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;translational apparatus;other cell component","translation activity;nucleic acid binding activity","Pf08662","83939","A8MPS6; B4DF96; B4DQ14; D3DNI9; hsa:83939; Q5QTR2; Q7Z4E9; Q8NFM1; Q96EW9; Q96K81; Q9BY44","ENSG00000144895",NA,"Photodynamic therapy-induced unfolded protein response; VEGFA-VEGFR2 signaling; 7q11.23 copy number variation syndrome",3,0,77.3,81.7,83.2,120.6,126.1,99.6,107,107.9,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S506(100)]",0,"ENSG00000144895"
"501","AGAP2",0.502823495334243,6.62050784007869,4.51894755592592,0.0012341453831244,0.00402021011029745,-1.48146988416436,"UP",FALSE,"High","Master Protein","Q99490","Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 [OS=Homo sapiens]",0,21.973,3,2,2,2,2,1192,124.6,9.89,7.44,2,"cell organization and biogenesis;transport;other biological processes","cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00023, Pf00071, Pf01412","116986","A8K9F7; hsa:116986; O00578; Q548E0; Q8IWU3; Q99490","ENSG00000135439","Netrin-1 signaling","Prolactin signaling pathway; Fragile X syndrome; Netrin-UNC5B signaling pathway; 15q25 copy number variation",5,0,67.3,64.4,80.8,97.2,105,109.9,110.5,137.2,144.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S638(100)]",0,"ENSG00000135439"
"502","ZEB1",0.431296393500743,6.62710616713152,4.51237007402617,0.00124637944000423,0.0040519745937986,-1.49186057667496,"NONE",FALSE,"High","Master Protein","P37275","Zinc finger E-box-binding homeobox 1 [OS=Homo sapiens]",0,30.044,4,2,3,4,2,1124,124,4.94,13.35,2,"cell cycle OR cell proliferation;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf05605","6935","B4DJV0; B4DUW9; E9PCM7; F5H4I8; hsa:6935; P37275; Q12924; Q13800; Q2KJ05; Q5T968; Q5VZ84; Q8NB68","ENSG00000148516","Interleukin-4 and Interleukin-13 signaling","Hypoxia-mediated EMT and stemness; TGF-beta signaling pathway; Clear cell renal cell carcinoma pathways; Epithelial to mesenchymal transition in colorectal cancer; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; CCL18 signaling pathway; Hypertrophy model",8,0,83.1,80.5,85.8,117,130.6,108.4,106.7,93,100.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(100); S887(99.3)]",0,"ENSG00000148516"
"503","CCNY",0.399852930092995,6.6410156588944,4.50989950922069,0.00125100793261619,0.00405524548774108,-1.49576487860068,"NONE",FALSE,"High","Master Protein","Q8ND76","Cyclin-Y [OS=Homo sapiens]",0,51.916,13,4,5,9,2,341,39.3,7.2,33.91,4,"cell-cell signaling;cell cycle OR cell proliferation;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00134","219771","B7ZKX9; D3DRY9; hsa:219771; Q2M3V4; Q2TU96; Q6NT86; Q7Z4U7; Q8ND76; Q8TEX2; Q8TEX3; Q96M99; Q96P45","ENSG00000108100",NA,NA,0,0,77.2,84.1,81.6,108.6,104.9,119.7,117.5,101,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S100(99.5); S326(100)]",0,"ENSG00000108100"
"504","LARP4B",0.529998878634981,6.6483465674521,4.50866980268813,0.00125331854288924,0.00405524548774108,-1.49770851460098,"UP",FALSE,"High","Master Protein","Q92615","La-related protein 4B [OS=Homo sapiens]",0,5.447,2,1,1,2,1,738,80.5,6.92,6.23,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf05383","23185","A7MD20; hsa:23185; Q5T3R3; Q5T3R4; Q5T3R5; Q68CY4; Q92615","ENSG00000107929",NA,NA,0,0,65.1,82.1,89.5,114.1,114.3,122.3,100,113.2,119.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S601(99.8)]",0,"ENSG00000107929"
"505","TCEAL5",0.874882186800209,6.60729520424627,4.50786136933099,0.00125484005594929,0.00405524548774108,-1.49898640670372,"UP",FALSE,"High","Master Protein","Q5H9L2","Transcription elongation factor A protein-like 5 [OS=Homo sapiens]",0,10.342,8,1,1,2,1,206,23.3,4.81,6.58,1,NA,"nucleus",NA,"Pf04538","340543","A2RUJ4; hsa:340543; Q5H9L2","ENSG00000204065",NA,NA,0,0,65.1,69.1,67.9,133.4,185.3,90.3,117.7,101.3,106.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(100)]",0,"ENSG00000204065"
"506","SORT1",0.557254783535692,6.64543719905153,4.50354254706501,0.00126300164410758,0.00407355470984895,-1.50581461991774,"UP",FALSE,"High","Master Protein","Q99523","Sortilin [OS=Homo sapiens]",0,6.453,2,2,2,7,1,831,92,5.74,12.64,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf15901, Pf15902","6272","B4DWI3; C0JYZ0; hsa:6272; Q8IZ49; Q99523","ENSG00000134243","Golgi Associated Vesicle Biogenesis","Brain-derived neurotrophic factor (BDNF) signaling pathway; Neural crest cell migration in cancer; Cholesterol metabolism; Fatty acids and lipoproteins transport in hepatocytes",5,1,78.8,80.2,96.7,124.3,112.6,145.4,84.7,97.8,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S825(100)]",0,"ENSG00000134243"
"507","OSBPL6",-0.33579953640671,6.63856786149731,-4.49982296788848,0.0012700760441096,0.00408829211831728,-1.51169735516932,"NONE",FALSE,"High","Master Protein","Q9BZF3","Oxysterol-binding protein-related protein 6 [OS=Homo sapiens]",0,16.892,3,3,3,5,3,934,106.2,6.93,8.42,3,"other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf01237, Pf15409","114880","B4DTW1; C4AMC0; C4AME4; D3DPF6; D3DPF7; hsa:114880; Q4ZG68; Q53T68; Q59H61; Q7Z4Q1; Q86V84; Q8N9T0; Q96SR1; Q9BZF3","ENSG00000079156","Synthesis of bile acids and bile salts",NA,1,0,106.7,102.5,99.2,83,76.5,84.6,105.7,114.8,123.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(100); S44(100); S190(100)]",0,"ENSG00000079156"
"508","PGD",0.398300558681973,6.69267195527645,4.49720884837269,0.00127507313502496,0.00409629794559201,-1.51583281756496,"NONE",FALSE,"High","Master Protein","P52209","6-phosphogluconate dehydrogenase, decarboxylating [OS=Homo sapiens]",0,39.807,6,3,3,3,3,483,53.1,7.23,11.07,3,"other metabolic processes","cytosol","other molecular function","Pf00393, Pf03446","5226","A8K2Y9; B4DQJ8; hsa:5226; P52209; Q9BWD8","ENSG00000142657","NFE2L2 regulates pentose phosphate pathway genes; Pentose phosphate pathway","Pentose phosphate metabolism; Nuclear receptors meta-pathway; NRF2 pathway; VEGFA-VEGFR2 signaling; Metabolic reprogramming in colon cancer",7,0,76.4,84,79.1,115,97.6,113.4,122.6,130.7,115.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100)]",0,"ENSG00000142657"
"509","RAVER1",-0.428518632592179,6.62670275160851,-4.49482548448735,0.00127964733855224,0.00410041358763211,-1.51960400554349,"NONE",FALSE,"High","Master Protein","Q8IY67-2","Isoform 2 of Ribonucleoprotein PTB-binding 1 [OS=Homo sapiens]",0,44.152,6,3,3,10,3,739,77.8,8.84,40.2,3,NA,NA,NA,NA,NA,"Q8IY67-2",NA,NA,NA,0,0,113.1,100.8,105.8,84.5,82.3,69.6,111,108.9,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100); T463(100); S567(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000161847"
"510","REEP3",0.499969202033683,6.6697567042138,4.49392544661054,0.00128137924613504,0.00410041358763211,-1.5210283242378,"NONE",FALSE,"High","Master Protein","Q6NUK4","Receptor expression-enhancing protein 3 [OS=Homo sapiens]",0,7.707,11,1,1,1,1,255,29.2,9.57,3.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","other membranes;cytoskeleton;ER/Golgi","cytoskeletal activity","Pf03134","221035","hsa:221035; Q5JQR5; Q5QGT2; Q6NUK4; Q6PEW8; Q6PJY4","ENSG00000165476",NA,NA,0,0,78.5,79.8,72.3,98.4,125.3,121.7,105.7,128,130.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S150(99.1)]",0,"ENSG00000165476"
"511","NRBP2",0.410220980715625,6.66570058983676,4.48406365463875,0.00130051999079923,0.00415351981405939,-1.53664159580522,"NONE",FALSE,"High","Master Protein","Q9NSY0","Nuclear receptor-binding protein 2 [OS=Homo sapiens]",0,28.722,7,3,3,5,3,501,57.8,6.49,19.65,3,"developmental processes;other biological processes","other cell component","kinase activity;other molecular function","Pf00069","340371","B4DF59; hsa:340371; Q2HIX8; Q597G7; Q8NCX8; Q8WYS5; Q9NSY0","ENSG00000185189",NA,NA,0,0,86.1,78.6,88,118.4,101.8,124.6,102.3,112.3,106,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); T411(100)]",0,"ENSG00000185189"
"512","DDX23",-0.348825442718579,6.59611781908342,-4.47227116644868,0.001323807840834,0.00421963749265839,-1.55532810919741,"NONE",FALSE,"High","Master Protein","Q9BUQ8","Probable ATP-dependent RNA helicase DDX23 [OS=Homo sapiens]",0,25.973,3,4,5,20,4,820,95.5,9.55,23.65,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf00270, Pf00271","9416","B2R600; B4DH15; hsa:9416; O43188; Q9BUQ8","ENSG00000174243","mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway",NA,2,0,115.2,111.1,109.5,91.1,92.1,83.8,93.4,91.4,96.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100); S39(100); S109(100)]",0,"ENSG00000174243"
"513","TNIP1",-0.425644043253061,6.5893207769069,-4.46784508444694,0.00133266252962157,0.00423958138078442,-1.56234637185593,"NONE",FALSE,"High","Master Protein","Q15025","TNFAIP3-interacting protein 1 [OS=Homo sapiens]",0,8.509,2,1,1,1,1,636,71.8,6.62,2.75,1,"cell adhesion;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus","other molecular function",NA,"10318","A4F1W8; A4F1W9; A4F1X2; A4F1X4; A4F1X5; A4F1X6; A4F1X7; A4F1X9; B7Z699; E7EPY1; E7ET96; hsa:10318; O76008; Q05KP3; Q05KP4; Q15025; Q6N077; Q96EL9; Q99833; Q9H1J3","ENSG00000145901","Ovarian tumor domain proteases","RAC1/PAK1/p38/MMP2 pathway",2,0,120,109.6,116.1,82.1,76,98.3,84.2,93.5,101.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100)]",0,"ENSG00000145901"
"514","PHC3",-0.339758668845103,6.60821186213645,-4.46396367097331,0.00134047937740576,0.00425615242008989,-1.5685030568357,"NONE",FALSE,"High","Master Protein","Q8NDX5","Polyhomeotic-like protein 3 [OS=Homo sapiens]",0,44.226,3,3,5,6,3,983,106.1,6.62,20.7,3,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00536, Pf21319","80012","A2RRP9; hsa:80012; Q5HYF0; Q6NSG2; Q8NDX5; Q8NFT7; Q8NFZ1; Q8TBM2; Q9H971; Q9H9I4","ENSG00000173889","SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; Oxidative Stress Induced Senescence; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6",NA,9,0,113.9,107.3,111.3,87.5,87.5,90.6,96.3,91.2,102.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100); T609(100); S616(100)]",0,"ENSG00000173889"
"515","PLEKHO2",0.656365400201809,6.63438694881752,4.45755277343406,0.00135349728852999,0.0042880991945902,-1.57867625528068,"UP",FALSE,"High","Master Protein","Q8TD55","Pleckstrin homology domain-containing family O member 2 [OS=Homo sapiens]",0,27.697,10,3,3,8,3,490,53.3,5.43,10.23,3,"other biological processes","non-structural extracellular;other cell component",NA,"Pf00169","80301","hsa:80301; Q7L4H4; Q8TD55; Q8WYS8","ENSG00000241839","Neutrophil degranulation",NA,1,0,79.4,75.8,73.6,124.8,167.7,100.8,112.6,95.9,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T311(100); S390(99.7)]",0,"ENSG00000241839"
"516","TFIP11",-0.414300336958652,6.62757608754741,-4.45642750765159,0.00135579606887779,0.0042880991945902,-1.58046244106452,"NONE",FALSE,"High","Master Protein","Q9UBB9","Tuftelin-interacting protein 11 [OS=Homo sapiens]",0,20.658,3,1,2,2,1,837,96.8,5.67,6.18,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","extracellular matrix;nucleus;other cell component","nucleic acid binding activity","Pf01585, Pf07842, Pf12457","24144","hsa:24144; O95908; Q20WL0; Q5H8V8; Q9UBB9; Q9UGV7; Q9Y2Q8","ENSG00000100109","mRNA Splicing - Major Pathway",NA,1,0,109.3,100.2,122.1,88.9,66.5,92.8,101.2,104.9,106.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S210(100)]",0,"ENSG00000100109"
"517","MPRIP",0.39218549279965,6.65787192266408,4.44385554839591,0.00138176297630999,0.00436177403740407,-1.60042955957509,"NONE",FALSE,"High","Master Protein","Q6WCQ1","Myosin phosphatase Rho-interacting protein [OS=Homo sapiens]",0,25.628,4,2,2,3,2,1025,116.5,6.21,7.5,2,NA,"cytosol;cytoskeleton","cytoskeletal activity","Pf00169","23164","hsa:23164; Q3KQZ5; Q5FB94; Q6DHW2; Q6WCQ1; Q7Z5Y2; Q8N390; Q96G40","ENSG00000133030","Signaling by BRAF and RAF1 fusions","Smith-Magenis and Potocki-Lupski syndrome copy number variation",2,0,80.5,82.1,85.7,110.7,128.4,106.1,107.4,116.2,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100); S977(100)]",0,"ENSG00000133030"
"518","PCDH8",-0.51624899190128,6.51090495388118,-4.43978285652754,0.00139028785961545,0.00438021194380776,-1.60690226902101,"DOWN",FALSE,"High","Master Protein","O95206","Protocadherin-8 [OS=Homo sapiens]",0,9.267,2,1,2,2,1,1070,112.9,5.54,4.9,1,"cell adhesion;cell-cell signaling;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00028, Pf08266","5100","B4DMV7; hsa:5100; O95206; Q5TAN1; Q5TAN2; Q8IYE9; Q96SF1","ENSG00000136099",NA,NA,0,0,145,120.4,122.8,94,76.7,94.6,83.9,64.2,68.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S800(100)]",0,"ENSG00000136099"
"519","GAS2L1",0.486334996391499,6.64946520411259,4.43792077141882,0.00139420413731455,0.00438408699826079,-1.60986238025471,"NONE",FALSE,"High","Master Protein","Q99501","GAS2-like protein 1 [OS=Homo sapiens]",0,57.349,13,5,7,10,5,681,72.7,10.05,28.42,5,"cell organization and biogenesis;stress response;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf02187","10634","B5MCR7; hsa:10634; Q53EN7; Q92640; Q99501; Q9BUY9","ENSG00000185340",NA,"Ectoderm differentiation",1,0,80.5,73.6,85.8,112.1,138.8,107.2,109.2,99.3,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S297(99.9); S306(95.4); T334(100); S492(99.5); S620(100)]",0,"ENSG00000185340"
"520","MFF",-0.525027735606394,6.62031304957262,-4.43499350032172,0.00140038438852863,0.00439505254245908,-1.61451668964088,"DOWN",FALSE,"High","Master Protein","Q9GZY8-5","Isoform 5 of Mitochondrial fission factor [OS=Homo sapiens]",0,10.805,8,2,3,5,1,238,27.1,6.62,12.09,2,NA,NA,NA,NA,NA,"Q9GZY8-5",NA,NA,NA,0,1,107.8,108.5,102.5,69.9,84.9,64.9,121.8,112.4,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S129(100); S146(100)]",0,"ENSG00000168958"
"521","GLIPR2",0.562886676346518,6.64083294761141,4.43152302513963,0.00140774921046481,0.00440127120071519,-1.62003610505824,"UP",FALSE,"High","Master Protein","Q9H4G4","Golgi-associated plant pathogenesis-related protein 1 [OS=Homo sapiens]",0,3.195,6,1,1,2,1,154,17.2,9.41,4.46,1,"other biological processes","non-structural extracellular;other membranes;ER/Golgi","other molecular function","Pf00188","152007","hsa:152007; Q5VZR1; Q8N2S6; Q8WWC9; Q8WX36; Q9H4G4","ENSG00000122694",NA,NA,0,0,75.1,77.8,94.4,114.6,121.1,139.5,95.5,89,111.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S55(100)]",0,"ENSG00000122694"
"522","RBBP6",-0.299810194182288,6.63203827869737,-4.43151817189805,0.00140775953846405,0.00440127120071519,-1.62004382469299,"NONE",FALSE,"High","Master Protein","Q7Z6E9","E3 ubiquitin-protein ligase RBBP6 [OS=Homo sapiens]",0,89.919,4,9,9,18,9,1792,201.4,9.64,55.65,9,"protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf04564, Pf08783, Pf13696","5930","Q147T5; Q15290; Q6DKH4; Q6P4C2; Q6YNC9; Q7Z6E8; Q7Z6E9; Q8N0V2; Q96PH3; Q9H3I8; Q9H5M5; Q9NPX4","ENSG00000122257","RHOBTB1 GTPase cycle; Antigen processing: Ubiquitination & Proteasome degradation",NA,2,0,106.6,107.6,107.5,91.9,80.1,91.5,105.6,102.3,99.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S730(100); S772(100); S861(100); S1179(100); S1277(100); T1468(100)]",0,"ENSG00000122257"
"523","VANGL2",0.522479509501907,6.62141102318628,4.42671748645778,0.00141801521325166,0.00442485817978339,-1.62768133756606,"UP",FALSE,"High","Master Protein","Q9ULK5","Vang-like protein 2 [OS=Homo sapiens]",0,12.079,6,2,5,7,2,521,59.7,9.22,16.5,2,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf06638","57216","D3DVE9; hsa:57216; Q5T212; Q9ULK5","ENSG00000162738","Asymmetric localization of PCP proteins; RND2 GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle","Wnt signaling; Development of ureteric collection system",7,0,87.7,92.6,85.4,131.8,109.1,145,81.2,91.5,82.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S58(99.4); S517(100)]",0,"ENSG00000162738"
"524","CBARP",-0.609949401516539,6.60366020484858,-4.41913647533196,0.00143437239379204,0.00446386250451512,-1.63974812322684,"DOWN",FALSE,"High","Master Protein","Q8N350","Voltage-dependent calcium channel beta subunit-associated regulatory protein [OS=Homo sapiens]",0,117.135,18,8,9,14,5,705,73.9,6.4,48.4,8,"other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","other molecular function",NA,"255057","hsa:255057; K7EJP2; O43385; Q8N350","ENSG00000099625",NA,NA,0,3,101.6,106.4,108,61.1,72,66.7,127.6,99.8,139.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S299(100); S322(100); S328(99.4); S341(100); S399(100); S507(100); S528(100); S541(100); S699(98.5)]",0,"ENSG00000099625"
"525","NONO",-0.299825100404851,6.63682419670148,-4.41839397932526,0.00143598518068041,0.00446386250451512,-1.64093035709567,"NONE",FALSE,"High","Master Protein","Q15233","Non-POU domain-containing octamer-binding protein [OS=Homo sapiens]",0,34.841,14,3,4,6,3,471,54.2,8.95,22.98,3,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08075","4841","B7Z4C2; D3DVV4; F5GYZ3; hsa:4841; O00201; P30807; Q12786; Q15233; Q9BQC5","ENSG00000147140",NA,"mRNA processing",1,0,105.8,110.2,109,90.3,89.1,89.4,98.6,103.8,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T428(100); T450(100)]",0,"ENSG00000147140"
"526","ACBD5",-0.524153281667229,6.58244885580303,-4.41392089804935,0.00144574206061379,0.00448564837057357,-1.64805407433188,"DOWN",FALSE,"High","Master Protein","Q5T8D3","Acyl-CoA-binding domain-containing protein 5 [OS=Homo sapiens]",0,5.123,2,1,1,3,1,534,60.1,5.33,4.94,1,"other metabolic processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00887","91452","B3KQ56; D3DRW0; hsa:91452; Q5T8D3; Q5T8D4; Q5T8E1; Q5T8E2; Q86UV1; Q8N6E3; Q9UFB5","ENSG00000107897","RHOA GTPase cycle; RHOC GTPase cycle; Peroxisomal lipid metabolism; Class I peroxisomal membrane protein import",NA,4,0,107.7,123.2,106,87.9,64.8,76.3,112.3,100.4,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100)]",0,"ENSG00000107897"
"527","MACF1",-0.285402424628503,6.66526077221085,-4.40739589191852,0.00146010111987001,0.00452160346798456,-1.65845020201268,"NONE",FALSE,"High","Master Protein","Q9UPN3","Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4/5 [OS=Homo sapiens]",0,107.817,2,7,8,14,4,7388,837.8,5.39,59.11,7,"cell-cell signaling;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00435, Pf00681, Pf02187, Pf13499, Pf17902, Pf18373, Pf21019, Pf21020, Pf21097","23499","B1ALC5; E9PJT0; hsa:23499; O75053; Q5VW20; Q8WXY1; Q8WXY2; Q96PK2; Q9H540; Q9UKP0; Q9ULG9; Q9UPN3","ENSG00000127603",NA,"Mesodermal commitment pathway; Mesodermal commitment pathway",2,2,97.6,100.8,101,84.3,74.8,88.9,119.8,116.8,125.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(100); S280(100); S3927(100); S4167(100); S5592(98.8); S6967(100); S7330(100)]",0,"ENSG00000127603"
"528","NAPA",0.856696251365181,6.60306591299706,4.39230881974716,0.00149388498441682,0.00461746267910653,-1.68250875062041,"UP",FALSE,"High","Master Protein","P54920","Alpha-soluble NSF attachment protein [OS=Homo sapiens]",0,26.022,6,1,1,2,1,295,33.2,5.36,7.5,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf14938","8775","A8K879; hsa:8775; P54920; Q96IK3; Q9BVJ3","ENSG00000105402","COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Golgi Associated Vesicle Biogenesis; Intra-Golgi traffic; COPII-mediated vesicle transport; Retrograde transport at the Trans-Golgi-Network","Synaptic vesicle pathway; VEGFA-VEGFR2 signaling",8,0,59.5,95.2,57,128.6,138.2,117.8,107.5,118.2,94.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S195(100)]",0,"ENSG00000105402"
"529","BCAS3",0.535460317122895,6.59656841028893,4.38535137884394,0.00150974314510307,0.00465765749113083,-1.69361311932633,"UP",FALSE,"High","Master Protein","Q9H6U6","BCAS3 microtubule associated cell migration factor [OS=Homo sapiens]",0,15.2,2,1,1,1,1,928,101.2,6.7,4.8,1,"cell-cell signaling;other metabolic processes;stress response;developmental processes;other biological processes","cytoskeleton;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf12490, Pf21034","54828","hsa:54828; Q17RM0; Q6KF21; Q8IXI6; Q8NDR8; Q8TDL9; Q8TDM1; Q8WY55; Q9BVF0; Q9H6U6; Q9H957; Q9H9Y9; Q9NXP4","ENSG00000141376",NA,"Ectoderm differentiation",1,0,75.3,75.7,104.5,115.3,145.4,125.2,86.6,88.4,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S869(100)]",0,"ENSG00000141376"
"530","MYH10",0.548306218414854,6.65141392357176,4.37706432160594,0.00152886537648327,0.00470775149890696,-1.70684758556963,"UP",FALSE,"High","Master Protein","P35580","Myosin-10 [OS=Homo sapiens]",0,69.537,3,6,10,17,6,1976,228.9,5.54,63.44,6,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00063, Pf00612, Pf01576, Pf02736","4628","B2RWP9; D3DTS1; F8VTL3; hsa:4628; P35580; Q12989; Q149N3; Q149N4; Q16087; Q4LE45; Q6PK16; Q9BWG0","ENSG00000133026","Sema4D induced cell migration and growth-cone collapse; EPHA-mediated growth cone collapse; RHO GTPases activate PAKs; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs","Regulation of actin cytoskeleton",7,0,73.6,80.7,83.4,116.1,108.1,132.4,90.3,113.8,118.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1935(100); S1956(100); S1975(100)]",0,"ENSG00000133026"
"531","ANKLE2",-0.597399264992782,6.52440504098442,-4.37134784090509,0.00154220574018626,0.00473988656870805,-1.71598187224789,"DOWN",FALSE,"High","Master Protein","Q86XL3","Ankyrin repeat and LEM domain-containing protein 2 [OS=Homo sapiens]",0,11.916,4,2,2,2,2,938,104.1,7.09,5.74,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","other membranes;ER/Golgi","enzyme regulator activity;other molecular function","Pf00023, Pf01693, Pf03020","23141","A8KAG3; B3KN97; B3KSF8; hsa:23141; O75176; Q6P6A5; Q86XL3; Q8TAZ9; Q96DH4","ENSG00000176915","RHOG GTPase cycle; RAC2 GTPase cycle; Initiation of Nuclear Envelope (NE) Reformation",NA,3,0,121.6,127.7,117.6,71.4,85.3,83.4,74.1,79.1,100.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T47(99.3); S662(100)]",0,"ENSG00000176915"
"532","ZRSR2",-0.584575066893378,6.51265406654468,-4.36243848144546,0.00156324404914229,0.00479551557932373,-1.7302262055073,"DOWN",FALSE,"High","Master Protein","Q15696","U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 [OS=Homo sapiens]",0,4.322,2,1,1,1,1,482,58,9.72,2.81,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076, Pf00642","8233","hsa:8233; Q14D69; Q15696","ENSG00000169249","mRNA Splicing - Minor Pathway",NA,1,0,127.5,109.5,125.4,84.9,57.6,96.9,75.5,81.3,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100)]",0,"ENSG00000169249"
"533","DLGAP4",0.313776868695274,6.66075858822269,4.34894080432441,0.00159569912794239,0.00488589301463785,-1.75182531922737,"NONE",FALSE,"High","Master Protein","Q9Y2H0","Disks large-associated protein 4 [OS=Homo sapiens]",0,71.846,6,4,5,12,4,992,107.9,7.08,42.68,4,"other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf03359","22839","E1P5T5; hsa:22839; Q5QPG4; Q5T2Y4; Q5T2Y5; Q9H137; Q9H138; Q9H1L7; Q9Y2H0","ENSG00000080845","Neurexins and neuroligins",NA,1,0,83.2,81.3,86.7,101.2,112.1,115.2,108.5,111.8,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S665(99.5); S744(100); S973(100)]",0,"ENSG00000080845"
"534","KIF21A",0.356671051519911,6.66011562704429,4.33577178441145,0.00162805347456745,0.00497562410204884,-1.77292043820093,"NONE",FALSE,"High","Master Protein","Q7Z4S6","Kinesin-like protein KIF21A [OS=Homo sapiens]",0,75.88,4,5,7,22,5,1674,187.1,6.42,71.37,5,"other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00225, Pf00400","55605","A8MX28; B0I1R9; B9EGE4; F5H0C3; F5H219; hsa:55605; Q2UVF1; Q6UKL9; Q7Z4S6; Q7Z668; Q86WZ5; Q8IVZ8; Q9C0F5; Q9NXU4; Q9Y590","ENSG00000139116","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins",NA,2,0,77.6,75,79.8,103.4,104.3,101.1,116.1,123.3,147.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S853(100); S1212(100); S1229(100); S1239(100); S1662(100)]",0,"ENSG00000139116"
"535","CASP3",0.867513252936795,6.62292918564912,4.3237633713685,0.00165816310439119,0.00505817231096528,-1.79217521015979,"UP",FALSE,"High","Master Protein","P42574","Caspase-3 [OS=Homo sapiens]",0,15.2,7,1,1,1,1,277,31.6,6.54,4.1,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00656","836","A8K5M2; D3DP53; hsa:836; P42574; Q96AN1; Q96KP2","ENSG00000164305","Degradation of the extracellular matrix; Caspase-mediated cleavage of cytoskeletal proteins; Other interleukin signaling; Apoptosis induced DNA fragmentation; Signaling by Hippo; Activation of caspases through apoptosome-mediated cleavage; SMAC (DIABLO) binds to IAPs ; SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ; Caspase activation via Dependence Receptors in the absence of ligand; Pyroptosis; NADE modulates death signalling; Apoptotic cleavage of cell adhesion  proteins; Stimulation of the cell death response by PAK-2p34","miRNA regulation of DNA damage response; Prolactin signaling pathway; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; AGE/RAGE pathway; Allograft rejection; Corticotropin-releasing hormone signaling pathway; Parkinson's disease pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Spinal cord injury; Amyotrophic lateral sclerosis (ALS); Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Copper homeostasis; Hepatitis C and hepatocellular carcinoma; MAPK signaling pathway; Apoptosis modulation by HSP70; ERK pathway in Huntington's disease; Oxidative damage response; miRNA regulation of p53 pathway in prostate cancer; Prion disease pathway; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; MTHFR deficiency; Acute viral myocarditis; Nonalcoholic fatty liver disease; Measles virus infection; Small cell lung cancer; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Host-pathogen interaction of human coronaviruses - apoptosis; Peroxiredoxin 2 induced ovarian failure; Complement system in neuronal development and plasticity; Orexin receptor pathway; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; Urotensin-II-mediated signaling pathway; DYRK1A involvement regarding cell proliferation in brain development; IL-26 signaling pathways; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response",60,0,68.5,79.8,63.8,113.6,104.6,187.7,92.2,109.7,118,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100)]",0,"ENSG00000164305"
"536","WASHC2C",0.329179569024761,6.6848154361358,4.31564647057373,0.00167884926728182,0.0051117201570969,-1.80520029600212,"NONE",FALSE,"High","Master Protein","Q9Y4E1-1","Isoform 5 of WASH complex subunit 2C [OS=Homo sapiens]",0,86.9,8,6,7,17,1,1318,144.6,4.79,57.18,6,NA,NA,NA,NA,NA,"Q9Y4E1-1",NA,NA,NA,0,0,80.6,94.5,91.9,112.1,115.4,121.7,105,102.6,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S333(99.7); S498(100); S539(100); S726(100)]",0,"ENSG00000172661"
"537","SKP1",0.563160536483035,6.63895339577683,4.30922065342086,0.00169541961854445,0.00515256018149821,-1.81551749465594,"UP",FALSE,"High","Master Protein","P63208","S-phase kinase-associated protein 1 [OS=Homo sapiens]",0.003,2.269,6,2,2,2,1,163,18.6,4.54,2.27,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf01466, Pf03931","6500","D3DQ97; D3DQ98; hsa:6500; P34991; P63208; Q8TAY2","ENSG00000113558","Regulation of PLK1 Activity at G2/M Transition; Circadian Clock; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; SCF-beta-TrCP mediated degradation of Emi1; Vpu mediated degradation of CD4; Degradation of beta-catenin by the destruction complex; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; NIK-->noncanonical NF-kB signaling; Orc1 removal from chromatin; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Neddylation; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SCF(Skp2)-mediated degradation of p27/p21; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Cyclin D associated events in G1; Regulation of BACH1 activity; MAP3K8 (TPL2)-dependent MAPK1/3 activation; NOTCH1 Intracellular Domain Regulates Transcription; Prolactin receptor signaling; Iron uptake and transport; Nuclear events stimulated by ALK signaling in cancer; Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling","Cell cycle; TNF-alpha signaling pathway; TGF-beta signaling pathway; Breast cancer pathway; Small cell lung cancer; Notch signaling pathway",39,0,60.7,80.7,77.2,116.3,121.5,96.9,121.8,111.5,133.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T131(100)]",0,"ENSG00000113558"
"538","SFSWAP",0.400276375286171,6.67250795621468,4.29834696260139,0.00172385586156385,0.00522908277661815,-1.83298772220235,"NONE",FALSE,"High","Master Protein","Q12872","Splicing factor, suppressor of white-apricot homolog [OS=Homo sapiens]",0,30.828,2,2,2,3,2,951,104.8,8.05,12.39,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf01805, Pf09750","6433","B2RN45; B7ZM97; F5H6B8; hsa:6433; Q12872; Q6PJF7","ENSG00000061936",NA,"mRNA processing",1,0,83.6,73,83.4,117.2,96,112.6,116.3,121.7,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S909(100)]",0,"ENSG00000061936"
"539","TOMM22",-0.682779904665661,6.54651038084931,-4.29715367426893,0.00172700711801298,0.00522908277661815,-1.8349058053823,"DOWN",FALSE,"High","Master Protein","Q9NS69","Mitochondrial import receptor subunit TOM22 homolog [OS=Homo sapiens]",0,30.401,33,2,2,2,2,142,15.5,4.34,9.71,2,"cell organization and biogenesis;transport;other biological processes","other membranes;mitochondrion","transporter activity","Pf04281","56993","hsa:56993; Q9NS69","ENSG00000100216","Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy",NA,2,0,116.6,135.1,119.1,72.5,87.1,66.1,105.9,89.2,77.4,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S15(100)]",0,"ENSG00000100216"
"540","PHLDB1",0.332441500410734,6.64982751723048,4.29552155481747,0.00173132713533097,0.0052324553423336,-1.83752954560447,"NONE",FALSE,"High","Master Protein","Q86UU1","Pleckstrin homology-like domain family B member 1 [OS=Homo sapiens]",0,56.966,10,10,11,18,10,1377,151.1,8.63,50.32,10,"other biological processes","plasma membrane;other membranes;cytosol;other cell component",NA,"Pf00169, Pf00498","23187","B0YJ63; B0YJ64; hsa:23187; O75133; Q4KMF8; Q86UU1; Q8TEQ2","ENSG00000019144",NA,NA,0,0,87.2,83.3,80.1,104,117.9,109.4,105.4,113.9,111.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S381(100); S430(100); S443(100); S461(100); S470(100); S520(99.5); S539(100); S563(100)]",0,"ENSG00000019144"
"541","RNFT2",0.359258248654542,6.62204385942006,4.28090268944971,0.00177053592790187,0.00534106217067624,-1.86104489214503,"NONE",FALSE,"High","Master Protein","Q96EX2","E3 ubiquitin-protein ligase RNFT2 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,444,48.9,7.84,9.18,1,"other biological processes","other membranes","other molecular function","Pf13639","84900","E9PAM7; hsa:84900; Q96EX2; Q96SU5","ENSG00000135119",NA,NA,0,0,68,64.8,72.2,96.5,73.6,94.9,133.4,163.9,160.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(99.4)]",0,"ENSG00000135119"
"542","SLC4A10",0.743351593404185,6.61532727559822,4.26485450423291,0.00181466372093751,0.00545877779841496,-1.88688941757164,"UP",FALSE,"High","Master Protein","Q6U841","Sodium-driven chloride bicarbonate exchanger [OS=Homo sapiens]",0,14.989,2,1,1,1,1,1118,125.9,6.49,3.63,1,"transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf00955, Pf07565","57282","B7Z1R0; B7Z2J0; B7ZLC5; B9EG69; F8W675; hsa:57282; Q4ZFX6; Q6U841; Q8TCP2; Q9HCQ6","ENSG00000144290","Bicarbonate transporters",NA,1,0,69.6,51.4,65.7,112.4,96.9,111.1,174,119,123.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(100)]",0,"ENSG00000144290"
"543","VIPAS39",0.488753650631673,6.64729691371548,4.26428613853861,0.00181624776013439,0.00545877779841496,-1.88780530649643,"NONE",FALSE,"High","Master Protein","Q9H9C1","Spermatogenesis-defective protein 39 homolog [OS=Homo sapiens]",0,31.7,7,2,2,3,2,493,57,7.4,8.91,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf04840","63894","B4DPI6; hsa:63894; O95434; Q9H7E1; Q9H9C1; Q9H9I9","ENSG00000151445",NA,NA,0,0,77,77.9,72.7,104.9,111.1,117.1,102.3,139.6,117.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T21(100); S121(100)]",0,"ENSG00000151445"
"544","ATXN2L",0.27631997690048,6.66162085145471,4.26227314845143,0.00182186976566502,0.00546560929699505,-1.89104944046164,"NONE",FALSE,"High","Master Protein","Q8WWM7","Ataxin-2-like protein [OS=Homo sapiens]",0,101.926,10,7,9,21,7,1075,113.3,8.59,53.76,7,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity","Pf06741, Pf07145, Pf14438","11273","A8K1R6; B9EGM2; E9PAR9; hsa:11273; O95135; Q63ZY4; Q6NVJ8; Q6PJW6; Q8IU61; Q8IU95; Q8WWM3; Q8WWM4; Q8WWM5; Q8WWM6; Q8WWM7; Q99703","ENSG00000168488",NA,"16p11.2 distal deletion syndrome",1,0,83.4,85.5,87.2,103.6,107.4,114.2,107.8,109.9,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S111(100); S339(100); S449(100); S559(98.9); S594(100)]",0,"ENSG00000168488"
"545","ELAVL1",0.611261725031772,6.59898829664883,4.24577420663737,0.00186864947268883,0.00559566227418014,-1.91765760912799,"UP",FALSE,"High","Master Protein","Q15717","ELAV-like protein 1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,326,36.1,9.17,4.69,1,"cell organization and biogenesis;transport;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","1994","B4DVB8; hsa:1994; Q15717; Q53XN6; Q9BTT1","ENSG00000066044","HuR (ELAVL1) binds and stabilizes mRNA","AMP-activated protein kinase signaling; Endoderm differentiation; Pre-implantation embryo; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Gastrin signaling pathway; IL-18 signaling pathway; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; 1p36 copy number variation syndrome",10,0,70,94.8,81.3,110,162.6,130.3,99.7,87.3,81.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100)]",0,"ENSG00000066044"
"546","SCAF1",-0.275321764013161,6.61502619245347,-4.23551768856758,0.00189836960082598,0.00567354435461315,-1.93421504295764,"NONE",FALSE,"High","Master Protein","Q9H7N4","Splicing factor, arginine/serine-rich 19 [OS=Homo sapiens]",0,52.513,6,6,9,17,6,1312,139.2,9.25,43.44,6,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function",NA,"58506","hsa:58506; Q7Z5V7; Q8WVA1; Q9H7N4; Q9NR59","ENSG00000126461",NA,NA,0,0,107.4,106.6,107.1,88.8,89,92.1,98,97.5,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S498(100); S500(100); S719(100); S725(100); S734(99.6); S874(100); S965(99.7); T976(100)]",0,"ENSG00000126461"
"547","KIF5C",1.2735390164913,6.61615766472828,4.23440944569682,0.00190161076101311,0.00567354435461315,-1.93600487248263,"UP",FALSE,"High","Master Protein","O60282","Kinesin heavy chain isoform 5C [OS=Homo sapiens]",0,18.768,3,1,1,2,1,957,109.4,6.19,6.69,1,"cell organization and biogenesis;transport;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf00225","3800","hsa:3800; O60282; O95079; Q2YDC5","ENSG00000168280","Insulin processing","Alzheimer's disease and miRNA effects; Alzheimer's disease",3,0,32.5,43.1,77.7,137.9,78.6,131.2,136.6,208.4,154,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T396(100)]",0,"ENSG00000168280"
"548","DENR",0.7366454934994,6.6739865537265,4.23219717084612,0.00190809829556503,0.00568251171233966,-1.93957817143278,"UP",FALSE,"High","Master Protein","O43583","Density-regulated protein [OS=Homo sapiens]",0,32.385,13,2,2,3,2,198,22.1,5.3,12.46,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes",NA,"nucleic acid binding activity","Pf01253, Pf21023","8562","hsa:8562; O43583; Q9H3U6; Q9UKZ0","ENSG00000139726",NA,NA,0,0,73.2,69.7,76,145.4,126.1,103.2,124.4,121.1,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S73(100)]",0,"ENSG00000139726"
"549","USP42",0.377604012099753,6.6560522325016,4.22748618208173,0.00192199153696256,0.00571346118091602,-1.947189383929,"NONE",FALSE,"High","Master Protein","Q9H9J4","Ubiquitin carboxyl-terminal hydrolase 42 [OS=Homo sapiens]",0,23.567,3,2,2,2,2,1324,145.3,8.63,6.73,2,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf00443","84132","A2RUE3; B5MDA5; hsa:84132; Q0VIN8; Q3C166; Q6P9B4; Q9H9J4","ENSG00000106346","Ub-specific processing proteases",NA,1,0,86.6,85.3,94.3,120.1,110.1,125.3,99.1,102.9,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S754(99.2); S856(100)]",0,"ENSG00000106346"
"550","ALG3",0.568999368733611,6.61186223943443,4.21854123231096,0.00194866667894121,0.00577037279667319,-1.96164841174253,"UP",FALSE,"High","Master Protein","Q92685","Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase [OS=Homo sapiens]",0,23.3,3,1,1,2,1,438,50.1,9.44,8.13,1,"protein metabolism;other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf05208","10195","A8JZZ6; hsa:10195; Q92685; Q9BT71","ENSG00000214160","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein; Defective ALG3 causes CDG-1d","N-glycan biosynthesis",3,0,65.7,67.6,62,93.7,76.8,121,125,139.7,176.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100)]",0,"ENSG00000214160"
"551","ZNF316",-0.530756377298219,6.60495501385788,-4.21844009814715,0.00194897050600281,0.00577037279667319,-1.9618119442488,"DOWN",FALSE,"High","Master Protein","A6NFI3","Zinc finger protein 316 [OS=Homo sapiens]",0,10.962,3,2,2,2,2,1004,108.4,5.31,5.97,2,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352","100131017","A6NFI3","ENSG00000205903",NA,NA,0,0,114.6,114.5,110,85,84.4,64.5,110.9,95.2,104.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S10(100); S112(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000205903"
"552","POLR2A",-0.325571221109063,6.59701896085346,-4.21732966113024,0.00195230977745309,0.00577037279667319,-1.96360758531144,"NONE",FALSE,"High","Master Protein","P24928","DNA-directed RNA polymerase II subunit RPB1 [OS=Homo sapiens]",0,16.757,2,2,4,8,2,1970,217,7.37,15.53,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00623, Pf04983, Pf04990, Pf04992, Pf04997, Pf04998, Pf05000, Pf05001","5430","A6NN93; B9EH88; hsa:5430; P24928; Q6NX41",NA,"Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Viral Messenger RNA Synthesis; Transcriptional regulation by small RNAs; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; MicroRNA (miRNA) biogenesis; PIWI-interacting RNA (piRNA) biogenesis; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM; Inhibition of DNA recombination at telomere","Pyrimidine metabolism; Eukaryotic transcription initiation; mRNA processing",44,0,117.2,116.1,103.3,91.8,77.4,98.9,89.6,94.7,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T1877(98.7); S1920(99.6); S1934(99.6); S3842(99.4)]",0,"ENSG00000181222"
"553","NPDC1",0.425329908507234,6.64956824360358,4.21634379801296,0.00195527950769624,0.00577037279667319,-1.96520190628363,"NONE",FALSE,"High","Master Protein","Q9NQX5","Neural proliferation differentiation and control protein 1 [OS=Homo sapiens]",0,6.875,10,2,2,2,2,325,34.5,7.01,2.13,2,NA,"plasma membrane;other membranes",NA,"Pf06809","56654","hsa:56654; Q5SPY8; Q9BTD6; Q9BXT3; Q9NQS2; Q9NQX5; Q9Y434","ENSG00000107281","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell",NA,1,0,94.6,84.4,82.4,116.3,129.4,122,102.9,102.2,86.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S229(100); S312(100)]",0,"ENSG00000107281"
"554","EIF4G1",0.584803301473542,6.5998639546345,4.21247586003142,0.00196697720098894,0.00579441659208296,-1.97145818709669,"UP",FALSE,"High","Master Protein","Q04637","Eukaryotic translation initiation factor 4 gamma 1 [OS=Homo sapiens]",0,74.462,4,7,9,22,7,1599,175.4,5.33,55.11,7,"protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02020, Pf02847, Pf02854","1981","D3DNT2; D3DNT4; D3DNT5; E9PFM1; G5E9S1; hsa:1981; O43177; O95066; Q04637; Q5HYG0; Q6ZN21; Q8N102","ENSG00000114867","ISG15 antiviral mechanism; AUF1 (hnRNP D0) binds and destabilizes mRNA; Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Z-decay: degradation of maternal mRNAs by zygotically expressed factors","Translation factors; VEGFA-VEGFR2 signaling; Acute viral myocarditis; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Pleural mesothelioma",20,0,60.6,61.3,63.3,91.3,119.7,78.5,139.8,142.2,184.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1077(100); S1147(100); S1187(100); S1209(100); S1231(100); S1238(100)]",0,"ENSG00000114867"
"555","PACS2",0.525356235473927,6.64771932277289,4.19690199280169,0.00201483135120987,0.00592469327058471,-1.9966664545273,"UP",FALSE,"High","Master Protein","Q86VP3","Phosphofurin acidic cluster sorting protein 2 [OS=Homo sapiens]",0,66.136,7,4,4,7,4,889,97.6,6.6,28.59,4,"cell organization and biogenesis;other metabolic processes;other biological processes","mitochondrion;ER/Golgi","other molecular function","Pf10254","23241","A2VDJ9; G8JLK3; hsa:23241; O60342; Q6P191; Q86VP3; Q96FL7","ENSG00000179364",NA,NA,0,0,79.7,76.8,80.9,121.5,142.7,99.1,99.7,105.3,120.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100); S366(100); S390(100)]",0,"ENSG00000179364"
"556","STIP1",0.555186529251386,6.66756697745102,4.19267353779765,0.00202803570485947,0.005952795450235,-2.00351569696785,"UP",FALSE,"High","Master Protein","P31948","Stress-induced-phosphoprotein 1 [OS=Homo sapiens]",0,27.307,5,2,3,5,2,543,62.6,6.8,13.82,2,"other biological processes","cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00515, Pf13181, Pf17830","10963","B4DM70; F5H0T1; G3XAD8; hsa:10963; P31948; Q3ZCU9; Q5TZU9","ENSG00000168439","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; RND1 GTPase cycle","VEGFA-VEGFR2 signaling",3,0,80.8,57.4,76,100.5,102.3,124.2,137.2,127.8,129,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S481(100)]",0,"ENSG00000168439"
"557","UBR4",-0.360666033059802,6.59234446712975,-4.18892592782667,0.00203981501898701,0.00596610533430295,-2.00958783070241,"NONE",FALSE,"High","Master Protein","Q5T4S7","E3 ubiquitin-protein ligase UBR4 [OS=Homo sapiens]",0,54.089,2,6,7,14,6,5183,573.5,6.04,37.56,6,"protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","other molecular function","Pf02207, Pf13764, Pf19423","23352","A8MPT2; A8MQ33; A8MQB1; O60646; O75050; Q4QRK5; Q5T4S7; Q5T4S8; Q5T4S9; Q5TBN8; Q5TBP2; Q6DKH8; Q6P4A4; Q7L8P7; Q8IXJ4; Q8TDN5; Q8WV67; Q9HA46; Q9P2N9; Q9UG82","ENSG00000127481","Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation",NA,2,0,115.7,107.3,117.1,82.9,88.2,97.2,90.2,87.3,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100); S2885(99.2)]",0,"ENSG00000127481"
"558","TP53BP2",0.323701406709425,6.6709596494629,4.1889048090288,0.0020398816032727,0.00596610533430295,-2.00962205351089,"NONE",FALSE,"High","Master Protein","Q13625","Apoptosis-stimulating of p53 protein 2 [OS=Homo sapiens]",0,20.969,4,3,3,7,3,1128,125.5,6.07,19.62,3,"cell cycle OR cell proliferation;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00018, Pf00023, Pf21801","7159","B4DG66; hsa:7159; Q12892; Q13625; Q86X75; Q96KQ3","ENSG00000143514","TP53 Regulates Transcription of Death Receptors and Ligands; Activation of PUMA and translocation to mitochondria; TP53 Regulates Transcription of Genes Involved in Cytochrome C Release; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain; Regulation of TP53 Activity through Association with Co-factors",NA,5,0,89.6,88.7,90.3,117.6,111.4,118.7,99.5,110.1,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S480(100); S556(99.3); S698(100)]",0,"ENSG00000143514"
"559","PDLIM4",0.478893661579963,6.65099776861979,4.18764302566964,0.00204386398430248,0.00596705907402798,-2.01166685659191,"NONE",FALSE,"High","Master Protein","P50479","PDZ and LIM domain protein 4 [OS=Homo sapiens]",0,28.128,5,1,1,6,1,330,35.4,7.91,23.5,1,"cell-cell signaling;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00412, Pf00595, Pf15936","8572","B2R8U1; hsa:8572; P50479; Q53Y39; Q96AT8; Q9BTW8; Q9Y292","ENSG00000131435",NA,NA,0,0,72.4,75.1,70.1,107.4,120.8,91.7,136.4,120.6,131.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S112(99.7)]",0,"ENSG00000131435"
"560","PLIN3",0.429330618280813,6.66900612059656,4.18160588855165,0.00206303221600574,0.00601226531521674,-2.02145302672625,"NONE",FALSE,"High","Master Protein","O60664","Perilipin-3 [OS=Homo sapiens]",0,39.009,7,2,3,5,2,434,47,5.44,19.2,2,"cell organization and biogenesis;stress response;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf03036","10226","A8K4Y9; hsa:10226; K7EQF4; O60664; Q53G77; Q9BS03; Q9UBD7; Q9UP92","ENSG00000105355","Late endosomal microautophagy; Triglyceride catabolism; Retrograde transport at the Trans-Golgi-Network; RHOBTB3 ATPase cycle; Lipophagy; Chaperone Mediated Autophagy",NA,6,0,80.4,78.6,77.7,110.6,99.8,118.4,105.3,135.3,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100); S217(99.5)]",0,"ENSG00000105355"
"561","SMARCC1",-0.720067012215339,6.51990814991781,-4.17614125659039,0.00208054665598911,0.00605249936287742,-2.03031485867725,"DOWN",FALSE,"High","Master Protein","Q92922","SWI/SNF complex subunit SMARCC1 [OS=Homo sapiens]",0,28.028,2,3,3,6,3,1105,122.8,5.76,15.41,3,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf00249, Pf04433, Pf16495, Pf16496, Pf16498","6599","hsa:6599; Q17RS0; Q6P172; Q8IWH2; Q92922","ENSG00000173473","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines","Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome",6,0,127.3,129.5,115.7,77.9,83.4,61.2,83.3,74.2,108.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S310(100); S328(100); S330(100)]",0,"ENSG00000173473"
"562","PLEKHG2",-0.592202142119509,6.63957179006528,-4.17259998650743,0.00209198051808486,0.00607493275002579,-2.03605949985394,"DOWN",FALSE,"High","Master Protein","Q9H7P9","Pleckstrin homology domain-containing family G member 2 [OS=Homo sapiens]",0,11.031,2,2,3,5,2,1386,147.9,5.86,11.11,2,"cell organization and biogenesis","cytosol","enzyme regulator activity;other molecular function","Pf00169, Pf00621","64857","B8ZZK6; C9J0Y4; hsa:64857; Q6DHV6; Q96BU2; Q96D18; Q9H699; Q9H7P9","ENSG00000090924","G alpha (12/13) signalling events; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK",NA,4,0,105.3,116.6,106,62.4,87.9,65,120.6,108.4,135.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T1257(100); S1261(100); S1318(99.3)]",0,"ENSG00000090924"
"563","PML",-0.315391929252736,6.59767402904485,-4.1694785959333,0.00210211378526068,0.0060935163366704,-2.04112422949053,"NONE",FALSE,"High","Master Protein","P29590","Protein PML [OS=Homo sapiens]",0,24.314,5,4,5,9,4,882,97.5,6.21,20.87,4,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf00097, Pf00643, Pf12126","5371","E9PBR7; hsa:5371; P29590; P29591; P29592; P29593; Q00755; Q15959; Q59FP9; Q8WUA0; Q96S41; Q9BPW2; Q9BWP7; Q9BZX6; Q9BZX7; Q9BZX8; Q9BZX9; Q9BZY0; Q9BZY2; Q9BZY3","ENSG00000140464","HCMV Early Events; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Interferon gamma signaling; Regulation of TP53 Activity through Acetylation; Regulation of PTEN localization; Regulation of RUNX1 Expression and Activity","miRNA regulation of DNA damage response; Wnt/beta-catenin signaling pathway in leukemia; TGF-beta signaling pathway; p53 transcriptional gene network; Acute myeloid leukemia; DNA damage response",13,0,116.6,112.2,113.5,92.7,90.4,94.5,93.4,83.5,91.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S40(100); S403(100); S505(100); S518(100); S527(100)]",0,"ENSG00000140464"
"564","CXorf38",0.466574063291242,6.64433708453249,4.16583024994114,0.00211402356716804,0.0061171745773373,-2.04704543259252,"NONE",FALSE,"High","Master Protein","Q8TB03","Uncharacterized protein CXorf38 [OS=Homo sapiens]",0,9.078,4,1,1,1,1,319,36.6,6.3,3.6,1,NA,NA,NA,"Pf15112","159013","B3KW28; D3DWB5; hsa:159013; Q5JPF5; Q8N941; Q8TB03","ENSG00000185753",NA,NA,0,0,67.1,90.8,81.1,112.8,113.8,114.5,102.2,112.7,120.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T314(100)]",0,"ENSG00000185753"
"565","FBXO42",0.749669654993755,6.6254948262762,4.16121529883638,0.00212919103787271,0.00615015889169605,-2.05453764222279,"UP",FALSE,"High","Master Protein","Q6P3S6","F-box only protein 42 [OS=Homo sapiens]",0,3.219,4,1,1,1,1,717,77.8,7.43,2.24,1,NA,"other cell component","other molecular function","Pf12937, Pf13415, Pf13854","54455","B3KP30; hsa:54455; Q5TEU8; Q6P3S6; Q86XI0; Q8N3N4; Q8N5F8; Q9BRM0; Q9P2L4","ENSG00000037637; ENSG00000291375",NA,NA,0,0,91.5,56.6,75.1,127.4,113.8,137.2,86.7,118,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100)]",0,"ENSG00000037637"
"566","TNKS1BP1",0.349044712784685,6.64912451449148,4.15797668064304,0.00213990372047276,0.0061701817523172,-2.05979690426972,"NONE",FALSE,"High","Master Protein","Q9C0C2","182 kDa tankyrase-1-binding protein [OS=Homo sapiens]",0,229.802,15,18,22,40,18,1729,181.7,4.86,127.28,18,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf15327","85456","A7E2F8; hsa:85456; Q6PJ35; Q6ZV74; Q9C0C2","ENSG00000149115","Deadenylation of mRNA; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain; M-decay: degradation of maternal mRNAs by maternally stored factors","Ciliary landscape",4,0,74.6,78.5,80.6,99.9,115.7,96.3,119.1,123.9,129.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S178(100); S221(100); T239(100); S429(100); S494(100); S601(100); S672(100); S691(100); S872(100); S893(100); S1138(100); S1158(100); S1473(100); S1620(99.5); S1652(100); S1666(100)]",0,"ENSG00000149115"
"567","GOLGA4",-0.389906756910541,6.63738640607905,-4.15592404513836,0.00214672290064963,0.00617892729075872,-2.06313085452102,"NONE",FALSE,"High","Master Protein","Q13439","Golgin subfamily A member 4 [OS=Homo sapiens]",0,25.662,2,4,4,6,4,2230,261,5.39,15.33,4,"cell organization and biogenesis;transport","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01465","2803","F8W8Q7; hsa:2803; Q13270; Q13439; Q13654; Q14436; Q59EW8","ENSG00000144674","Retrograde transport at the Trans-Golgi-Network; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB",NA,2,0,103.9,95.3,100.5,75.7,70.7,80.8,130.5,110.2,126.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(99.7); S71(100); S89(100); S266(100)]",0,"ENSG00000144674"
"568","EEA1",1.00441101747449,6.567146540932,4.15229832015488,0.00215882430799552,0.006202819138466,-2.06902105717413,"UP",FALSE,"High","Master Protein","Q15075","Early endosome antigen 1 [OS=Homo sapiens]",0,10.758,3,1,1,2,1,1411,162.4,5.68,6.2,1,"cell-cell signaling;cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf01363","8411","hsa:8411; Q14221; Q15075","ENSG00000102189","Toll Like Receptor 9 (TLR9) Cascade","VEGFA-VEGFR2 signaling",2,0,34.3,70.1,58,117.7,110.4,95.7,175.5,124.3,140.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S15(100)]",0,"ENSG00000102189"
"569","ATXN2",0.299082679652853,6.65865919302021,4.14923595132,0.0021691015909513,0.00622139507281638,-2.0739972417467,"NONE",FALSE,"High","Master Protein","Q99700","Ataxin-2 [OS=Homo sapiens]",0,54.917,5,5,6,8,5,1313,140.2,9.57,25.54,5,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;ER/Golgi;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity","Pf06741, Pf07145, Pf14438","6311","A6NLD4; hsa:6311; Q24JQ7; Q6ZQZ7; Q99493; Q99700","ENSG00000204842",NA,"Parkinson's disease pathway; EGF/EGFR signaling pathway",2,0,89.9,88.1,93.5,116.9,114.3,116.6,97.5,105.4,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S667(99.5); T741(100); S772(99.4); S784(100); S889(99.7)]",0,"ENSG00000204842"
"570","MINK1",0.345963976938257,6.66485412297158,4.14480777910093,0.00218405402958646,0.00624285438746163,-2.08119470240726,"NONE",FALSE,"High","Master Protein","Q8N4C8-3","Isoform 2 of Misshapen-like kinase 1 [OS=Homo sapiens]",0,70.229,7,6,6,11,4,1303,146.6,7.46,42.22,6,NA,NA,NA,NA,NA,"Q8N4C8-3",NA,NA,NA,0,0,84.2,87.9,85.5,114,129.2,104.5,105.1,109.3,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T181(100); S601(100); S641(100); S696(100); T780(100)]",0,"ENSG00000141503"
"571","TWF1",0.522555808581409,6.67149382792631,4.14475468200777,0.00218423397992683,0.00624285438746163,-2.08128101908858,"UP",FALSE,"High","Master Protein","Q12792","Twinfilin-1 [OS=Homo sapiens]",0,22.984,5,1,2,3,1,350,40.3,6.96,6.9,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00241","5756","A8K5A8; B3KXS6; B4DLX9; hsa:5756; Q12792; Q59G07; Q5U0B1; Q6FHJ1; Q6FHL6; Q6NUK9; Q86XL6; Q8TCD3","ENSG00000151239","Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; RHOBTB2 GTPase cycle",NA,3,0,92.5,77.3,89,136.1,121.9,120.7,101.3,87,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S143(99.4)]",0,"ENSG00000151239"
"572","GPSM1",-0.402135995311386,6.62306837350459,-4.1390194624516,0.00220376364184101,0.00628766129979811,-2.09060632856178,"NONE",FALSE,"High","Master Protein","Q86YR5","G-protein-signaling modulator 1 [OS=Homo sapiens]",0,36.39,8,3,4,8,3,675,74.5,6.54,19.29,3,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf02188, Pf13424","26086","A9Z1X4; B1B0W3; hsa:26086; Q86SR5; Q86YR5; Q969T1; Q9UFS8","ENSG00000160360","G alpha (i) signalling events",NA,1,0,100,92.9,104.7,71.8,77.6,73.5,109.8,123.1,136.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S471(100); S492(99.8); S545(98.6)]",0,"ENSG00000160360"
"573","QSOX2",-0.370800432693343,6.58476653085196,-4.13288960860447,0.00222484124294045,0.00633672060816548,-2.10057749145813,"NONE",FALSE,"High","Master Protein","Q6ZRP7","Sulfhydryl oxidase 2 [OS=Homo sapiens]",0,16.9,6,2,2,3,2,698,77.5,7.72,7.32,2,"protein metabolism;other metabolic processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus","other molecular function","Pf00085, Pf04777, Pf18108, Pf18371","169714","A2CEE0; A6NLB0; hsa:169714; Q5TB37; Q6ZRP7; Q7Z7B6; Q86VV7; Q8N3G2","ENSG00000165661",NA,NA,0,0,114,115.5,103.6,81.4,82.2,94.5,101.1,91.8,89.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100); S578(99.6)]; Met-loss [N-Term]",0,"ENSG00000165661"
"574","PCNP",0.665388101313662,6.63126538453153,4.13038353152434,0.00223351966864976,0.0063503555735826,-2.1046552602101,"UP",FALSE,"High","Master Protein","Q8WW12","PEST proteolytic signal-containing nuclear protein [OS=Homo sapiens]",0,60.58,17,2,3,9,2,178,18.9,7.49,38.34,2,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes","nucleus",NA,"Pf15473","57092","B2RBE7; D3DN52; hsa:57092; Q53GF3; Q6AI44; Q8WW12; Q96CU3; Q9NS81","ENSG00000081154",NA,NA,0,0,66.3,73.2,68.5,110.7,142.8,97.8,106.7,157.1,112.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S87(100); S119(100)]",0,"ENSG00000081154"
"575","GNG12",-0.432419623255006,6.62815955497026,-4.12895935162918,0.00223846746529132,0.00635335461453118,-2.10697293876659,"NONE",FALSE,"High","Master Protein","Q9UBI6","Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [OS=Homo sapiens]",0,26.83,32,2,3,4,2,72,8,8.97,10.81,2,"signal transduction","plasma membrane;other membranes","other molecular function","Pf00631","55970","hsa:55970; Q69YP5; Q9BRV5; Q9UBI6","ENSG00000172380","G alpha (z) signalling events; G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; ADP signalling through P2Y purinoceptor 12; G alpha (s) signalling events; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation","Myometrial relaxation and contraction pathways; G protein signaling pathways; MAPK signaling pathway; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Regulation of actin cytoskeleton; Calcium regulation in cardiac cells",37,0,105.5,98,120.4,74.3,78.8,86.3,113.9,99.5,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100); S49(100)]",0,"ENSG00000172380"
"576","PABIR1",0.282596311894405,6.66879799098679,4.11845222488133,0.00227533038567921,0.00644676942609109,-2.12407917863064,"NONE",FALSE,"High","Master Protein","Q96E09","PPP2R1A-PPP2R2A-interacting phosphatase regulator 1 [OS=Homo sapiens]",0,15.2,9,1,1,1,1,287,30.5,6.79,4.56,1,"cell cycle OR cell proliferation;signal transduction;other biological processes","nucleus;other cell component","enzyme regulator activity",NA,"116224","hsa:116224; Q96E09","ENSG00000187866",NA,NA,0,0,89.2,82.9,81.8,104.4,106.9,110.8,112.3,115.5,114.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100)]",0,"ENSG00000187866"
"577","PTPRZ1",0.475546349257985,6.6549234693037,4.11458211230762,0.00228906928671224,0.00647445593745992,-2.13038313390899,"NONE",FALSE,"High","Master Protein","P23471","Receptor-type tyrosine-protein phosphatase zeta [OS=Homo sapiens]",0,77.513,4,7,11,28,7,2315,254.4,4.88,75.82,7,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00041, Pf00102, Pf00194","5803","A4D0W5; C9JFM0; hsa:5803; O76043; P23471; Q9UDR6","ENSG00000106278","Other interleukin signaling; MDK and PTN in ALK signaling","Spinal cord injury; VEGFA-VEGFR2 signaling; IL-18 signaling pathway",5,0,75.5,79.9,72.8,113.7,83.8,125,117.5,129.4,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1451(100); S1683(98.8); T1687(98.8); S2055(99.6); S2196(100)]",0,"ENSG00000106278"
"578","TMEM132A",0.742260334292958,6.56137077329372,4.11118597472314,0.00230119775251054,0.00649749953650034,-2.13591644510645,"UP",FALSE,"High","Master Protein","Q24JP5","Transmembrane protein 132A [OS=Homo sapiens]",0,28.839,3,3,3,3,2,1023,110,5.62,10.7,3,"other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf15705, Pf15706, Pf16070","54972","hsa:54972; Q24JP5; Q69YU7; Q86VZ8; Q86W97; Q9H8K3; Q9HCI9; Q9NWY0","ENSG00000006118","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,93,73.4,60.8,109.7,180.1,120.1,86,97.8,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S485(100); S529(100)]",0,"ENSG00000006118"
"579","DPF3",0.475036346378998,6.67981860782971,4.10969449171223,0.0023065456433583,0.00650135145070941,-2.13834692592931,"NONE",FALSE,"High","Master Protein","Q92784-3","Isoform 3 of Zinc finger protein DPF3 [OS=Homo sapiens]",0,3.72,2,1,1,2,1,412,46.4,7.28,2.27,1,NA,NA,NA,NA,NA,"Q92784-3",NA,NA,NA,0,0,78.1,74.8,78.1,115.5,117.4,101.5,137.6,115.3,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S403(100)]",0,"ENSG00000205683"
"580","NAP1L4",0.397726071371812,6.67116740641538,4.09929154505414,0.00234421356087205,0.00659084768004114,-2.15530630734248,"NONE",FALSE,"High","Master Protein","Q99733","Nucleosome assembly protein 1-like 4 [OS=Homo sapiens]",0,54.118,11,2,4,10,2,375,42.8,4.69,21.11,2,"cell organization and biogenesis","nucleus;other cell component","other molecular function","Pf00956","4676","B2R6J4; F5HFY4; hsa:4676; Q99733","ENSG00000205531; ENSG00000273562",NA,NA,0,0,71.8,90.3,87.1,119,104.8,114.3,110,113.8,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(99.5); S125(100)]",0,"ENSG00000205531"
"581","FNBP1",0.4047048618586,6.65865524098665,4.09870022448291,0.00234637408217151,0.00659084768004114,-2.1562706743871,"NONE",FALSE,"High","Master Protein","Q96RU3","Formin-binding protein 1 [OS=Homo sapiens]",0,9.056,2,1,1,1,1,617,71.3,5.72,3.75,1,"transport;signal transduction","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf00018, Pf00611","23048","B7ZL12; E9PGQ4; hsa:23048; O60301; Q3MIN8; Q5TC87; Q5TC88; Q6P658; Q7LGG2; Q96RU3; Q9H8H8; Q9NWD1","ENSG00000187239","RND2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; RHOJ GTPase cycle; Clathrin-mediated endocytosis",NA,5,0,76.9,84.3,98.3,118.8,113.2,121.9,102.5,94.8,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S296(100)]",0,"ENSG00000187239"
"582","DENND1A",0.296623101990659,6.65506623479359,4.09182222216523,0.00237165938915348,0.00665042632834791,-2.16749070184265,"NONE",FALSE,"High","Master Protein","Q8TEH3","DENN domain-containing protein 1A [OS=Homo sapiens]",0,11.441,2,2,2,3,2,1009,110.5,6.96,7.67,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf02141, Pf03455, Pf03456","57706","A8MZA3; B1AM80; B7Z3C8; B7Z669; D3PFD3; hsa:57706; Q05C88; Q5VWF0; Q6PJZ5; Q8IVD6; Q8TEH3; Q9H796","ENSG00000119522","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,89.1,86.2,84.5,109.8,111.9,111.5,100.6,106.3,113.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S473(100); S523(100)]",0,"ENSG00000119522"
"583","MAP1B",0.447650354730984,6.66931564398284,4.08570608306673,0.00239438553030717,0.0067026366817518,-2.17747238274622,"NONE",FALSE,"High","Master Protein","P46821","Microtubule-associated protein 1B [OS=Homo sapiens]",0,2115.584,38,81,202,879,80,2468,270.5,4.81,3122.64,81,"cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00414","4131","A2BDK5; hsa:4131; P46821","ENSG00000131711","RSV-host interactions","Microtubule cytoskeleton regulation; Fragile X syndrome; Neurogenesis regulation in the olfactory epithelium; HDAC6 interactions in the central nervous system",5,1,80.2,85.3,87,124.8,131.4,105.6,111.6,105.9,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(99.9); S91(100); S343(100); T527(100); S541(100); S544(100); S561(100); S614(100); T704(100); S831(100); S832(100); S891(100); S970(99.7); S995(100); S1016(100); T1067(100); S1154(100); T1206(98.9); S1208(100); S1247(100); S1256(98.6); S1260(100); S1265(100); T1282(100); S1298(100); S1312(100); S1326(100); S1339(100); S1378(100); S1389(100); S1396(100); S1400(100); S1421(100); S1427(100); S1438(100); S1443(100); S1501(100); S1620(100); S1653(100); S1772(100); S1779(100); S1782(100); S1785(100); T1788(100); S1793(99.6); S1819(99.3); S1852(99.7); S1915(99.6); S1917(100); T1932(100); T1949(100); S1965(99.6); T2034(100); S2087(99.5); S2209(100); S2211(100); S2271(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000131711"
"584","YWHAE",0.375178002008774,6.67841882186831,4.08132145259795,0.00241081917554671,0.00673708372344561,-2.1846307860063,"NONE",FALSE,"High","Master Protein","P62258","14-3-3 protein epsilon [OS=Homo sapiens]",0,132.739,43,11,13,19,8,255,29.2,4.74,54.85,11,"stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;nucleus;other cell component","other molecular function","Pf00244","7531","B3KY71; D3DTH5; hsa:7531; P29360; P42655; P62258; Q4VJB6; Q53XZ5; Q63631; Q7M4R4","ENSG00000108953; ENSG00000274474","Regulation of HSF1-mediated heat shock response; RAB GEFs exchange GTP for GDP on RABs; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; TP53 Regulates Metabolic Genes; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; HSF1 activation; NADE modulates death signalling; Activation of BAD and translocation to mitochondria","Cell cycle; Myometrial relaxation and contraction pathways; VEGFA-VEGFR2 signaling; Calcium regulation in cardiac cells; 17p13.3 (YWHAE) copy number variation; Sudden infant death syndrome (SIDS) susceptibility pathways",26,4,86,82.8,87.6,123.3,111.6,110.3,110.2,112.5,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S210(99.4)]",0,"ENSG00000108953"
"585","REEP4",-0.335047773117635,6.65753931139786,-4.07494724402397,0.00243492241201087,0.00679280919043031,-2.19504123831301,"NONE",FALSE,"High","Master Protein","Q9H6H4","Receptor expression-enhancing protein 4 [OS=Homo sapiens]",0.007,1.717,3,1,1,1,1,257,29.4,9.73,1.95,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","other membranes;cytoskeleton;ER/Golgi","cytoskeletal activity","Pf03134","80346","D3DSQ9; hsa:80346; Q86VL1; Q9H6H4; Q9H6I5; Q9HBP4","ENSG00000168476",NA,NA,0,0,107.3,92.4,108.7,83.5,80.2,81.7,118.6,118,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S152(100)]",0,"ENSG00000168476"
"586","HTATSF1",-0.493920803757257,6.5843308466213,-4.07303116507781,0.00244221742265933,0.00680153384604101,-2.19817149414799,"NONE",FALSE,"High","Master Protein","O43719","17S U2 SnRNP complex component HTATSF1 [OS=Homo sapiens]",0,22.782,4,3,3,4,3,755,85.8,4.4,8.98,3,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf00076","27336","D3DWG9; hsa:27336; O43719; Q59G06; Q99730","ENSG00000102241","mRNA Splicing - Major Pathway",NA,1,0,122.5,126.6,114.8,94.8,88.9,73.9,93.7,94.3,78.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S498(100); S642(100)]",0,"ENSG00000102241"
"587","MTA1",-0.395721893209002,6.59919177934254,-4.0704531773737,0.0024520688992793,0.00681437319393034,-2.20238374153948,"NONE",FALSE,"High","Master Protein","Q13330","Metastasis-associated protein MTA1 [OS=Homo sapiens]",0,24.127,4,3,4,7,3,715,80.7,9.26,16.25,3,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00249, Pf00320, Pf01426, Pf01448, Pf17226","9112","A5PLK4; hsa:9112; Q13330; Q86SW2; Q8NFI8; Q96GI8","ENSG00000182979","Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; SUMOylation of transcription factors","Effect of progerin on genes involved in progeria; TAR syndrome",8,0,115.9,105.9,109.3,82.6,78.5,91.3,92.3,92.9,113,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S449(100); S522(100); S639(100)]",0,"ENSG00000182979"
"588","SOWAHC",0.745027086583621,6.65867632829491,4.06964168872806,0.0024551785772249,0.00681437319393034,-2.20370980909086,"UP",FALSE,"High","Master Protein","Q53LP3","Ankyrin repeat domain-containing protein SOWAHC [OS=Homo sapiens]",0,5.561,2,1,1,1,1,525,55.6,7.03,2.86,1,NA,NA,NA,"Pf12796","65124","hsa:65124; Q53LP3; Q8NE15; Q9H6U1","ENSG00000198142","RHOA GTPase cycle; RHOB GTPase cycle; RHOF GTPase cycle",NA,3,0,77.6,64,67.3,132.5,81.3,133.2,127.3,131.8,105.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(99.5)]",0,"ENSG00000198142"
"589","HCN4",0.545483235019652,6.61463283236431,4.06296712234609,0.00248091435603001,0.00687411244319351,-2.21461961065603,"UP",FALSE,"High","Master Protein","Q9Y3Q4","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 [OS=Homo sapiens]",0,22.324,3,2,2,3,2,1203,129,8.91,11.79,2,"cell-cell signaling;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00027, Pf00520, Pf08412","10021","hsa:10021; Q9UMQ7; Q9Y3Q4","ENSG00000138622","HCN channels","Genes targeted by miRNAs in adipocytes",2,0,85.9,76.3,100.4,127.8,122.2,139.5,76.7,98.4,82.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S917(100); T1071(100)]",0,"ENSG00000138622"
"590","RER1",-0.550459513078791,6.57483722703446,-4.05763444364901,0.00250168056779294,0.0069199028587086,-2.22333960368506,"DOWN",FALSE,"High","Master Protein","O15258","Protein RER1 [OS=Homo sapiens]",0,9.646,9,1,1,1,1,196,22.9,9.54,3.47,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding","Pf03248","11079","hsa:11079; O15258; O95322","ENSG00000157916",NA,"1p36 copy number variation syndrome",1,0,113.5,116.7,115.3,89.2,57.8,86.9,110,96.8,83.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100)]",0,"ENSG00000157916"
"591","PACSIN3",0.289724706697839,6.64401166390787,4.04787377011356,0.0025401663805393,0.00701446959905268,-2.23930839104277,"NONE",FALSE,"High","Master Protein","Q9UKS6","Protein kinase C and casein kinase substrate in neurons protein 3 [OS=Homo sapiens]",0,60.801,15,4,4,6,4,424,48.5,6.18,28.46,4,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00611, Pf14604","29763","A6NH84; hsa:29763; Q9H331; Q9NWV9; Q9UKS6","ENSG00000165912","Clathrin-mediated endocytosis",NA,1,0,82.7,88.1,87.5,102.8,114.8,114.8,105.4,108.1,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S319(100); S354(100)]",0,"ENSG00000165912"
"592","CACNB2",0.311694478313005,6.65576283053862,4.03205161250633,0.00260388449376378,0.00717827617199744,-2.26521620723909,"NONE",FALSE,"High","Master Protein","Q08289","Voltage-dependent L-type calcium channel subunit beta-2 [OS=Homo sapiens]",0,10.508,2,1,1,1,1,660,73.5,8.1,3.91,1,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;cytoskeletal activity","Pf00625, Pf12052","783","A6PVM5; A6PVM7; A6PVM8; hsa:783; O00304; Q08289; Q5QJ99; Q5QJA0; Q5VVG9; Q5VVH0; Q5VWV6; Q6TME1; Q6TME2; Q6TME3; Q8WX81; Q96NZ3; Q96NZ4; Q96NZ5; Q9BWU2; Q9HD32; Q9Y340; Q9Y341","ENSG00000165995","Sensory processing of sound by inner hair cells of the cochlea; Adrenaline,noradrenaline inhibits insulin secretion; NCAM1 interactions; Presynaptic depolarization and calcium channel opening; Phase 0 - rapid depolarisation; Phase 2 - plateau phase","Arrhythmogenic right ventricular cardiomyopathy; MAPK signaling pathway; Opioid receptor pathways; Affected pathways in Duchenne muscular dystrophy",11,0,81,85.1,91.2,107.2,114.2,113.6,111.6,107.4,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S514(100)]",0,"ENSG00000165995"
"593","YWHAB",0.397362128952127,6.66262514597999,4.02951418181854,0.00261425889999422,0.00718979620221714,-2.26937364109282,"NONE",FALSE,"High","Master Protein","P31946","14-3-3 protein beta/alpha [OS=Homo sapiens]",0,65.413,30,7,8,10,3,246,28.1,4.83,33.57,7,"signal transduction;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00244","7529","A8K9K2; E1P616; hsa:7529; P31946","ENSG00000166913","Signaling by BRAF and RAF1 fusions; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Signaling by Hippo; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Rap1 signalling; Negative regulation of MAPK pathway; Frs2-mediated activation; ARMS-mediated activation; Activation of BAD and translocation to mitochondria ; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA","Cell cycle; IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Hepatitis B infection; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways",33,0,76.3,86.8,94.7,114.2,105,129.6,104.5,102.7,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100)]",0,"ENSG00000166913"
"594","EVL",0.589624578565223,6.63049326192519,4.02873185755656,0.00261746625143718,0.00718979620221714,-2.270655575716,"UP",FALSE,"High","Master Protein","Q9UI08","Ena/VASP-like protein [OS=Homo sapiens]",0,7.499,3,1,1,2,1,416,44.6,8.84,4.71,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00568, Pf08776","51466","A8K105; B7Z3I5; hsa:51466; O95884; Q7Z522; Q8TBV1; Q9UF25; Q9UI08; Q9UIC2","ENSG00000196405","Generation of second messenger molecules; RHO GTPases Activate Formins; Signaling by ROBO receptors",NA,3,0,72.4,71.4,66.7,108.2,141.5,90.3,118.2,115.5,148.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S331(100)]",0,"ENSG00000196405"
"595","SUPT7L",-0.389164113041404,6.58147898340431,-4.02780297030085,0.00262127986539167,0.00718979620221714,-2.27217775834209,"NONE",FALSE,"High","Master Protein","O94864","STAGA complex 65 subunit gamma [OS=Homo sapiens]",0,39.133,6,1,2,6,1,414,46.2,5.12,14.16,1,"other biological processes","nucleus;other cell component","other molecular function","Pf07524","9913","B4E3W3; hsa:9913; O94864; Q6IB21; Q9H2T6","ENSG00000119760","HATs acetylate histones",NA,1,0,103.9,103.6,117.2,87.2,86.2,76.2,102.6,95.3,93.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S108(99.3)]",0,"ENSG00000119760"
"596","ADGRB3",-1.08869352425844,6.58105997033022,-4.02621388403712,0.00262781756194214,0.00719563466625768,-2.27478203739063,"DOWN",FALSE,"High","Master Protein","O60242","Adhesion G protein-coupled receptor B3 [OS=Homo sapiens]",0,10.927,2,1,1,1,1,1522,171.4,7.06,4.21,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","enzyme regulator activity;other molecular function","Pf00002, Pf00090, Pf01825, Pf02793, Pf16489, Pf19188","577","B7Z1K0; hsa:577; O60242; O60297; Q2NKN6; Q5VY37; Q9BX54","ENSG00000135298",NA,NA,0,0,150,165.5,89.8,45.7,63,62.3,140.8,86.6,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1220(100)]",0,"ENSG00000135298"
"597","MAP1A",0.338835051293271,6.67543212168231,4.02167915983044,0.00264656865904622,0.00723484095739268,-2.28221529258703,"NONE",FALSE,"High","Master Protein","P78559","Microtubule-associated protein 1A [OS=Homo sapiens]",0,665.628,18,34,48,139,34,2803,305.3,4.92,495.19,34,"cell organization and biogenesis;transport;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function",NA,"4130","hsa:4130; O95643; P78559; Q12973; Q15882; Q9UJT4","ENSG00000166963",NA,NA,0,0,79.1,81.5,81.1,110.3,106.1,101.2,127.8,119,116.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(100); T504(100); S605(100); S612(100); T616(100); S644(100); S667(100); S844(99.4); S896(100); S909(100); S986(100); S1069(100); S1144(99.3); S1146(100); S1172(100); S1218(100); S1311(99.4); S1326(100); S1654(99.7); S1675(99.7); S1776(100); S1791(100); S1797(100); S1801(100); S1818(100); S2022(100); S2106(100); S2449(100); S2617(100); S2629(100); S2664(100)]",0,"ENSG00000166963"
"598","SNX27",-0.536884929881191,6.61268720316295,-4.01676963763412,0.00266702863966838,0.00727857983267358,-2.29026542399396,"DOWN",FALSE,"High","Master Protein","Q96L92","Sorting nexin-27 [OS=Homo sapiens]",0,7.444,2,1,1,1,1,541,61.2,6.49,3.49,1,"transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf00595, Pf00787, Pf00788","81609","hsa:81609; Q32Q36; Q4AEJ5; Q5VWB0; Q5VWB1; Q5VWB2; Q6IPP6; Q86UB1; Q96D79; Q96L92; Q9H3K8","ENSG00000143376",NA,NA,0,0,117.2,121,126.7,71.1,96,89.1,91,84.3,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100)]",0,"ENSG00000143376"
"599","PAG1",-0.330032761220233,6.6292483008718,-4.01529297495447,0.00267321505473332,0.0072793367632171,-2.29268721410154,"NONE",FALSE,"High","Master Protein","Q9NWQ8","Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 [OS=Homo sapiens]",0,63.653,17,5,9,21,5,432,47,4.65,42.89,5,"signal transduction;other biological processes","plasma membrane;other membranes","other molecular function","Pf15347","55824","A8K1A3; hsa:55824; Q2M1Z9; Q5BKU4; Q9NWQ8; Q9NYK0","ENSG00000076641","Phosphorylation of CD3 and TCR zeta chains; GAB1 signalosome",NA,2,0,113,117.7,110.8,91.2,98.3,88.7,97.5,97,90.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(99.5); S239(100); S249(99.3); S288(99.4); S298(100)]",0,"ENSG00000076641"
"600","CLCN6",-0.302249243026798,6.57551796907244,-4.01457540275783,0.00267622675118276,0.0072793367632171,-2.29386414829885,"NONE",FALSE,"High","Master Protein","P51797","H(+)/Cl(-) exchange transporter 6 [OS=Homo sapiens]",0,5.03,3,2,2,2,2,869,97.2,6.81,4.46,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00571, Pf00654","1185","A8K1T4; B4DGT7; F8W9R3; hsa:1185; O60818; O60819; O60820; O60821; P51797; P78520; P78521; Q17R81; Q5SNW2; Q5SNW3; Q5SNX1; Q5SNX2; Q5SNX3; Q99427; Q99428; Q99429","ENSG00000011021","Signaling by BRAF and RAF1 fusions; Stimuli-sensing channels",NA,2,0,120.5,119.1,120.9,94.8,105.6,99.6,75.4,81.3,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T25(100); S683(99.6)]",0,"ENSG00000011021"
"601","SYAP1",0.522831542373708,6.67941351503941,3.99980284715283,0.00273902915930224,0.00743776304156615,-2.31810583959111,"UP",FALSE,"High","Master Protein","Q96A49","Synapse-associated protein 1 [OS=Homo sapiens]",0,14.768,6,2,2,4,2,352,39.9,4.53,10.62,2,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf03909","94056","hsa:94056; Q68CP1; Q96A49; Q96C60; Q96JQ6; Q96T20","ENSG00000169895",NA,NA,0,0,72.2,73.1,75.3,106.7,97.3,122.8,142.6,133.6,109.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T248(100)]",0,"ENSG00000169895"
"602","VCPIP1",0.704027025916077,6.66075565305482,3.99745137077083,0.00274916837257783,0.00745289499011133,-2.32196676042027,"UP",FALSE,"High","Master Protein","Q96JH7","Deubiquitinating protein VCPIP1 [OS=Homo sapiens]",0,8.894,2,2,2,2,2,1222,134.2,7.2,5.68,2,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","ER/Golgi;nucleus;other cell component","other molecular function","Pf02338, Pf19437, Pf21403","80124","hsa:80124; Q504T4; Q86T93; Q86W01; Q8N3A9; Q96JH7; Q9H5R8","ENSG00000175073","Ovarian tumor domain proteases","Alstrom syndrome",2,0,77.1,74.9,78.4,131.2,89.6,161.5,91.1,111.1,112.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S768(100); S998(99.6)]",0,"ENSG00000175073"
"603","DCAF8",0.54525923557766,6.65052056839771,3.96565314436761,0.00289022733098795,0.00782230680625594,-2.37423436209523,"UP",FALSE,"High","Master Protein","Q5TAQ9","DDB1- and CUL4-associated factor 8 [OS=Homo sapiens]",0,30.401,4,1,1,6,1,597,66.8,5.39,26.12,1,"protein metabolism;other metabolic processes","cytosol;mitochondrion;nucleus;other cell component",NA,"Pf00400","50717","D3DVE6; hsa:50717; Q12839; Q4QQI6; Q53F14; Q5TAQ9; Q66K50; Q68CS7; Q96E00","ENSG00000132716","Neddylation",NA,1,0,72,80.3,73.5,121.8,85.6,125.8,101.2,122.2,130.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S99(100)]",0,"ENSG00000132716"
"604","SFT2D1",0.660009378772056,6.71260766887125,3.95472733272387,0.00294043729761176,0.0079450226319576,-2.39221796875614,"UP",FALSE,"High","Master Protein","Q8WV19","Vesicle transport protein SFT2A [OS=Homo sapiens]",0,15.2,17,1,1,2,1,159,17.8,8.65,9.07,1,"transport","other membranes",NA,"Pf04178","113402","hsa:113402; Q5TI64; Q8WV19; Q9UIC7","ENSG00000198818",NA,NA,0,0,85.6,53.7,84.3,125.9,117.6,119.1,137.4,117.1,118.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(100)]",0,"ENSG00000198818"
"605","GAPDH",-0.390033590557033,6.59355253730389,-3.95184081506506,0.00295385513901908,0.00795969196251934,-2.39697117995148,"NONE",FALSE,"High","Master Protein","P04406","Glyceraldehyde-3-phosphate dehydrogenase [OS=Homo sapiens]",0,127.293,30,10,14,28,10,335,36,8.46,81.62,10,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00044, Pf02800","2597","E7EUT4; hsa:2597; P00354; P04406; Q53X65","ENSG00000111640","Glycolysis; Gluconeogenesis","Cori cycle; Alzheimer's disease and miRNA effects; HIF1A and PPARG regulation of glycolysis; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; 7q11.23 copy number variation syndrome; Glycolysis in senescence; Alzheimer's disease; Sildenafil treatment; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; Sudden infant death syndrome (SIDS) susceptibility pathways",16,0,117.5,112.2,116.9,92.2,66.9,104.7,87.4,92.6,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T153(99.5); T211(99.7)]",0,"ENSG00000111640"
"606","PGK1",-0.73264987066266,6.56795987684293,-3.95046214997044,0.00296028652347681,0.00795969196251934,-2.39924172473808,"DOWN",FALSE,"High","Master Protein","P00558","Phosphoglycerate kinase 1 [OS=Homo sapiens]",0,27.961,7,2,2,4,2,417,44.6,8.1,10.88,2,"protein metabolism;other metabolic processes;stress response;other biological processes","non-structural extracellular;other membranes;cytosol","kinase activity;other molecular function","Pf00162","5230","A8K4W6; B7Z7A9; hsa:5230; P00558; Q5J7W1; Q6IBT6; Q8NI87","ENSG00000102144","Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism","Cori cycle; Photodynamic therapy-induced HIF-1 survival signaling; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; Glycolysis in senescence; Warburg effect modulated by deubiquitinating enzymes and their substrates; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",13,0,129.8,112.4,138.7,78,49.9,98.8,76.3,93,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000102144"
"607","GATAD2A",-0.399496133068964,6.61631705313251,-3.95041683288428,0.00296049817478507,0.00795969196251934,-2.39931636149275,"NONE",FALSE,"High","Master Protein","Q86YP4","Transcriptional repressor p66-alpha [OS=Homo sapiens]",0,30.401,8,2,2,2,2,633,68,9.94,10.14,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00320, Pf16563","54815","B5MC40; hsa:54815; Q7L3J2; Q86YP4; Q96F28; Q9NPU2; Q9NXS1","ENSG00000167491","Regulation of PTEN gene transcription; Potential therapeutics for SARS; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation",NA,6,0,117.7,104.4,118.8,86.1,71.9,100,98.8,103.5,88.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T49(100); S100(100)]",0,"ENSG00000167491"
"608","ANK2",0.267920696645819,6.66308060178826,3.93882615456632,0.00301515831215213,0.00809331967998728,-2.41841305983873,"NONE",FALSE,"High","Master Protein","Q01484","Ankyrin-2 [OS=Homo sapiens]",0,340.352,5,15,34,90,15,3957,433.4,5.14,342.48,15,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00023, Pf00531, Pf00791, Pf17809","287","hsa:287; Q01484; Q01485; Q08AC7; Q08AC8; Q7Z3L5","ENSG00000145362","Interaction between L1 and Ankyrins; COPI-mediated anterograde transport",NA,2,0,89,89.7,94.1,115.2,108.7,117.2,100.5,104.2,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S31(100); S901(100); S1461(100); S1755(99.5); S3793(100); S3795(99.6); T3803(100); T3814(100); S3818(99.5); S3823(100); S3845(99.7); S3909(98.4); S3947(99.5)]",0,"ENSG00000145362"
"609","SSBP4",0.505882615828164,6.54373274274513,3.92687054959487,0.00307265318902577,0.00823410509768482,-2.43812549092779,"UP",FALSE,"High","Master Protein","Q9BWG4","Single-stranded DNA-binding protein 4 [OS=Homo sapiens]",0,3.891,4,1,1,1,1,385,39.4,6.8,1.95,1,"other biological processes","nucleus","nucleic acid binding activity","Pf04503","170463","hsa:170463; Q9BWG4; Q9BWW5","ENSG00000130511",NA,NA,0,0,83.3,73.6,88,101.8,150.2,122.7,77.6,91.6,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S342(99.4)]",0,"ENSG00000130511"
"610","PPP1R1C",0.9296776346718,6.55849952459823,3.92520926966074,0.00308073313989524,0.00824222374476889,-2.44086577053401,"UP",FALSE,"High","Master Protein","Q8WVI7","Protein phosphatase 1 regulatory subunit 1C [OS=Homo sapiens]",0,8.947,14,1,1,1,1,109,12.3,6.8,2.82,1,"cell cycle OR cell proliferation;signal transduction;other biological processes","other cell component","enzyme regulator activity","Pf05395","151242","hsa:151242; Q5HYJ5; Q8TD54; Q8WVI7","ENSG00000150722",NA,NA,0,0,56.3,63.3,77.9,131.1,207.2,85.2,100,95,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100)]",0,"ENSG00000150722"
"611","EXOC7",0.412700841197826,6.67205070531468,3.91632100352107,0.0031243441912409,0.00834522049117045,-2.45553172817016,"NONE",FALSE,"High","Master Protein","Q9UPT5","Exocyst complex component 7 [OS=Homo sapiens]",0,45.203,4,3,3,6,3,735,83.3,6.79,22.46,3,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf03081, Pf20669","23265","B5MC69; B8XXP2; hsa:23265; Q8ND93; Q8WV91; Q96FF0; Q9H8C3; Q9H9X3; Q9HA32; Q9UPT5","ENSG00000182473","VxPx cargo-targeting to cilium; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Insulin processing","Angiopoietin-like protein 8 regulatory pathway; Ciliary landscape",5,0,87.5,83.5,87.1,127.1,105.7,120.6,111.3,104.4,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S250(100); S283(100)]",0,"ENSG00000182473"
"612","ARHGEF26",0.37708558902137,6.67422291584668,3.91401816217512,0.00313574885108227,0.00836199693621937,-2.45933280636631,"NONE",FALSE,"High","Master Protein","Q96DR7","Rho guanine nucleotide exchange factor 26 [OS=Homo sapiens]",0,75.663,9,5,6,13,5,871,97.3,8.95,54.25,5,"cell organization and biogenesis;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00018, Pf00169, Pf00621","26084","B3KVP8; E9PBD0; hsa:26084; Q68CL1; Q6AZ96; Q6Q8Q8; Q96AW8; Q96DR6; Q96DR7; Q9H9D7; Q9H9R2; Q9UFW5","ENSG00000114790; ENSG00000277101","NRAGE signals death through JNK; G alpha (12/13) signalling events; CDC42 GTPase cycle; RHOG GTPase cycle","MECP2 and associated Rett syndrome",5,0,76.1,82.5,86.9,111.9,102.6,115.8,105.5,130.8,113.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S222(100); S333(100); S392(100); S422(99.7)]",0,"ENSG00000114790"
"613","NOP58",-0.435392885223919,6.57729443037894,-3.90762299334747,0.00316765064711127,0.00843328850911191,-2.46989150529955,"NONE",FALSE,"High","Master Protein","Q9Y2X3","Nucleolar protein 58 [OS=Homo sapiens]",0,71.014,7,4,4,9,4,529,59.5,8.92,37.44,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01798, Pf08156","51602","hsa:51602; Q53SA4; Q6PK08; Q9P036; Q9UFN3; Q9Y2X3","ENSG00000055044","SUMOylation of RNA binding proteins; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol",NA,3,0,119.1,111.8,118.2,89.6,63.7,104.6,89.8,93.4,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S502(100); S514(100)]",0,"ENSG00000055044"
"614","HARS2",-0.373621572173565,6.60479940076054,-3.90324434213249,0.00318968988071962,0.00847813336373685,-2.47712322279521,"NONE",FALSE,"High","Master Protein","P49590","Histidine--tRNA ligase, mitochondrial [OS=Homo sapiens]",0,3.664,2,1,1,2,1,506,56.9,8.24,2.9,1,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","cytosol;mitochondrion","other molecular function","Pf03129, Pf13393","23438","B4DDY8; hsa:23438; P49590","ENSG00000112855","Mitochondrial tRNA aminoacylation","Primary ovarian insufficiency",2,0,111.5,102.9,116.8,83.2,74.1,98.8,104.9,96.1,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100)]",0,"ENSG00000112855"
"615","C2CD2L",0.446781559413768,6.59199313508555,3.89356829220498,0.00323896639111076,0.00859511081348416,-2.49311086335694,"NONE",FALSE,"High","Master Protein","O14523","Phospholipid transfer protein C2CD2L [OS=Homo sapiens]",0,15.2,3,1,1,1,1,706,76.1,7.69,5.43,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","transporter activity;other molecular function","Pf00168, Pf18696","9854","hsa:9854; O14523; Q86UT7; Q86V04; Q8N522; Q8TBN4; Q96G10","ENSG00000172375",NA,NA,0,0,86,88.1,91.5,110.6,131.6,137.6,75.6,96,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S662(100)]",0,"ENSG00000172375"
"616","RPRD1B",-0.367546124329511,6.62121967088721,-3.87606301914404,0.0033301581910355,0.00882275676586027,-2.52205831191773,"NONE",FALSE,"High","Master Protein","Q9NQG5","Regulation of nuclear pre-mRNA domain-containing protein 1B [OS=Homo sapiens]",0,20.543,4,1,3,4,1,326,36.9,5.97,8.8,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf04818, Pf16566","58490","hsa:58490; Q1WDE7; Q6PKF4; Q9NQG5","ENSG00000101413","RNA polymerase II transcribes snRNA genes","Modulators of TCR signaling and T cell activation",2,0,101.9,111.2,121.7,92.2,84.4,84.9,105.2,93.7,95.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S134(99.6)]",0,"ENSG00000101413"
"617","BCAN",0.326472936956105,6.61581961607907,3.86773434313975,0.0033744888480343,0.00892571442462233,-2.53584156155462,"NONE",FALSE,"High","Master Protein","Q96GW7","Brevican core protein [OS=Homo sapiens]",0,32.935,3,1,3,8,1,911,99.1,4.64,19.2,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","non-structural extracellular;extracellular matrix;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00008, Pf00059, Pf00084, Pf00193, Pf07686","63827","D3DVC2; hsa:63827; Q5SZ10; Q5T3I5; Q8TBB9; Q96GW7; Q9HBK1; Q9HBK4","ENSG00000132692","ECM proteoglycans; Degradation of the extracellular matrix; A tetrasaccharide linker sequence is required for GAG synthesis; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective B3GALT6 causes EDSP2 and SEMDJL1; Chondroitin sulfate biosynthesis; Dermatan sulfate biosynthesis; CS/DS degradation; Defective CHST3 causes SEDCJD; Defective CHST14 causes EDS, musculocontractural type; Defective CHSY1 causes TPBS","Spinal cord injury",13,0,89.3,84.6,98.1,119.7,126.2,110.9,87.5,94.1,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S419(98.7)]",0,"ENSG00000132692"
"618","TBCK",0.58355625381862,6.72646758561156,3.86206990577992,0.00340499253637323,0.00899182495042252,-2.54521959798748,"UP",FALSE,"High","Master Protein","Q8TEA7","TBC domain-containing protein kinase-like protein [OS=Homo sapiens]",0,14.077,2,1,1,4,1,893,100.6,6.58,7.12,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf00566, Pf00581","93627","B9A6J1; hsa:93627; Q4W5B3; Q4W5E1; Q6NUP4; Q8N7M8; Q8TEA7; Q8WW57; Q96GV6; Q9P080","ENSG00000145348",NA,NA,0,0,79.1,87.8,70.3,132.7,92.6,131,119,130.4,110.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S890(100)]",0,"ENSG00000145348"
"619","GGA3",0.40288049684878,6.67754464453798,3.85994232907316,0.00341652449476004,0.00900770270670176,-2.54874281874443,"NONE",FALSE,"High","Master Protein","Q9NZ52","ADP-ribosylation factor-binding protein GGA3 [OS=Homo sapiens]",0,7.161,2,1,1,1,1,723,78.3,5.58,3.51,1,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00790, Pf02883, Pf03127, Pf18308","23163","B7Z7E2; B7Z7M9; hsa:23163; J3KRN0; Q15017; Q6IS16; Q9NZ52; Q9UJY3","ENSG00000125447","Amyloid fiber formation; TBC/RABGAPs; MET receptor recycling",NA,3,0,69.4,80,84.8,103.9,113.2,104.3,135.4,115.9,126.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100)]",0,"ENSG00000125447"
"620","SIN3A",-0.635398346268461,6.56394226249983,-3.83453348172187,0.00355745984458698,0.00936415236510636,-2.59085307764555,"DOWN",FALSE,"High","Master Protein","Q96ST3","Paired amphipathic helix protein Sin3a [OS=Homo sapiens]",0,8.084,2,1,1,1,1,1273,145.1,7.25,3.45,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02671, Pf08295, Pf16879","25942","B2RNS5; Q8N8N4; Q8NC83; Q8WV18; Q96L98; Q96ST3; Q9UFQ1","ENSG00000169375","Cytoprotection by HMOX1; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; SUMOylation of transcription cofactors; NoRC negatively regulates rRNA expression; MECP2 regulates transcription of neuronal ligands; Factors involved in megakaryocyte development and platelet production; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Regulation of lipid metabolism by PPARalpha; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; MECP2 regulates neuronal receptors and channels; Loss of MECP2 binding ability to 5mC-DNA","Androgen receptor signaling pathway; Retinoblastoma gene in cancer; MECP2 and associated Rett syndrome; TGF-beta signaling pathway; Transcription co-factors SKI and SKIL protein partners; Hedgehog signaling pathway; 15q11q13 copy number variation",19,0,97.8,136.9,127.2,88.5,81.8,61.1,85.2,93.4,103.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S832(100)]",0,"ENSG00000169375"
"621","RPRD2",0.311586741728261,6.64239354722932,3.81110529268038,0.00369282096496897,0.00970372760838971,-2.62973521865764,"NONE",FALSE,"High","Master Protein","Q5VT52","Regulation of nuclear pre-mRNA domain-containing protein 2 [OS=Homo sapiens]",0,63.658,7,5,5,7,5,1461,155.9,7.42,25.27,5,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf04818","23248","A8K6N8; B3KPT1; B4E2Q6; hsa:23248; O75048; Q5VT51; Q5VT52; Q5VT53; Q6MZL4; Q86XD2; Q9P0D7","ENSG00000163125","RNA polymerase II transcribes snRNA genes",NA,1,0,87.8,88.5,91.4,103.6,118.5,125.2,99.9,94.6,100.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S593(100); S614(100); T723(100); T732(100); S769(97.2)]",0,"ENSG00000163125"
"622","ZBTB21",0.309068493149093,6.6488972951857,3.81016639775429,0.00369835696839363,0.00970372760838971,-2.63129451082183,"NONE",FALSE,"High","Master Protein","Q9ULJ3","Zinc finger and BTB domain-containing protein 21 [OS=Homo sapiens]",0,13.089,3,2,2,2,2,1066,118.8,8.29,5.24,2,"other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf00651, Pf18450","49854","hsa:49854; Q5R2W1; Q5R2W2; Q6P4R0; Q9ULJ3","ENSG00000173276",NA,NA,0,0,91.6,79.7,82.6,104.2,105.3,116.9,104.4,110.6,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S345(100); S411(100)]",0,"ENSG00000173276"
"623","SNN",0.363640418608867,6.65822663943383,3.80621280306618,0.00372176422194015,0.00974946903724933,-2.63786143764021,"NONE",FALSE,"High","Master Protein","O75324","Stannin [OS=Homo sapiens]",0,18.973,32,2,2,2,2,88,9.5,5.31,6.41,2,"other biological processes","other membranes;mitochondrion;other cell component","other molecular function","Pf09049, Pf09050, Pf09051","8303","D3DUG4; hsa:8303; O75324; Q6FGI0","ENSG00000184602",NA,NA,0,0,90.2,85.5,86.1,120.2,105.2,121.6,108.7,101.8,93.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(100); S66(100)]",0,"ENSG00000184602"
"624","GNAS",-0.270267731339924,6.62854921507482,-3.80520782527868,0.00372773892675501,0.0097494710392054,-2.639530938755,"NONE",FALSE,"High","Master Protein","Q5JWF2","Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas [OS=Homo sapiens]",0,14.713,2,2,2,3,1,1037,111,5.03,8.18,2,"cell adhesion;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00503","2778","A2A2S3; E1P5G3; O75684; O75685; Q5JW67; Q5JWF1; Q5JWF2; Q9NY42","ENSG00000087460","Vasopressin regulates renal water homeostasis via Aquaporins; G alpha (i) signalling events; G alpha (z) signalling events; G alpha (s) signalling events; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Prostacyclin signalling through prostacyclin receptor; Glucagon-type ligand receptors; PKA activation in glucagon signalling; Hedgehog 'off' state","Thyroid stimulating hormone (TSH) signaling pathway; Endothelin pathways; Corticotropin-releasing hormone signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; G protein signaling pathways; Thermogenesis; Hippo signaling regulation pathways; Purinergic signaling; GPR143 in melanocytes and retinal pigment epithelium cells; Vasopressin-regulated water reabsorption; Prostaglandin and leukotriene metabolism in senescence ; Primary ovarian insufficiency; Prostaglandin and leukotriene metabolism in senescence ; Calcium regulation in cardiac cells; Estrogen signaling pathway; Serotonin receptor 4/6/7 and NR3C signaling",29,0,103.3,97.1,101.9,82.4,83,89.5,111.3,109.3,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S995(100)]",0,"ENSG00000087460"
"625","ABHD2",-0.462433052588721,6.53214236145304,-3.79427356495477,0.00379339826439055,0.00990532154797661,-2.65770131567546,"NONE",FALSE,"High","Master Protein","P08910","Monoacylglycerol lipase ABHD2 [OS=Homo sapiens]",0,8.801,3,1,1,3,1,425,48.3,6.7,10.22,1,"other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","other molecular function","Pf00561","11057","P08910; Q53G48; Q53GU0; Q5FVD9; Q8TC79","ENSG00000140526",NA,"Glucocorticoid receptor pathway; Nuclear receptors meta-pathway",2,0,122.6,97.2,121.7,86.1,65.1,94.2,90.3,94.6,78.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S415(100)]",0,"ENSG00000140526"
"626","KHDRBS1",-0.266254231017429,6.63098858439162,-3.79018522737641,0.00381825890707578,0.00994380205379877,-2.66449807468934,"NONE",FALSE,"High","Master Protein","Q07666","KH domain-containing, RNA-binding, signal transduction-associated protein 1 [OS=Homo sapiens]",0,54.37,12,2,2,10,2,443,48.2,8.66,37.05,2,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf16274, Pf16568","10657","D3DPP3; hsa:10657; Q07666; Q6PJX7; Q8NB97; Q99760","ENSG00000121774","PTK6 Regulates Proteins Involved in RNA Processing","Leptin signaling pathway; Primary ovarian insufficiency",3,0,103.4,107,109.2,91.7,90.2,90.1,101,97.6,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(99.5); S58(100)]",0,"ENSG00000121774"
"627","STK10",0.369446175802794,6.65936491805474,3.7898473685611,0.0038203210096396,0.00994380205379877,-2.66505982500653,"NONE",FALSE,"High","Master Protein","O94804","Serine/threonine-protein kinase 10 [OS=Homo sapiens]",0,21.781,3,2,2,2,2,968,112.1,6.95,6.23,2,"cell adhesion;cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;other cell component","kinase activity;other molecular function","Pf00069, Pf12474","6793","A6ND35; B2R8F5; B3KMY1; hsa:6793; O94804; Q6NSK0; Q9UIW4","ENSG00000072786","RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; Neutrophil degranulation",NA,4,0,91.2,71.3,78.7,109.1,110,102.9,116,118.3,120.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S438(100); T952(100)]",0,"ENSG00000072786"
"628","FARP1",0.366087751852168,6.64642365254352,3.78537578790179,0.00384772331052015,0.00999917904899504,-2.67249560462031,"NONE",FALSE,"High","Master Protein","Q9Y4F1","FERM, ARHGEF and pleckstrin domain-containing protein 1 [OS=Homo sapiens]",0,187.075,12,7,11,38,7,1045,118.6,8.15,167.53,7,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00169, Pf00373, Pf00621, Pf08736, Pf09379, Pf09380","10160","hsa:10160; Q5JVI9; Q6IQ29; Q9Y4F1","ENSG00000152767","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOF GTPase cycle",NA,4,0,85,86.5,91.8,114.1,104.9,131.4,91.6,105.2,98.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(99.6); S403(100); S427(100); S510(100); S872(99.6); S889(100)]",0,"ENSG00000152767"
"629","SALL1",-0.512179064751277,6.51677597736375,-3.78272751417305,0.00386404928505687,0.0100256413882557,-2.67690027112881,"NONE",FALSE,"High","Master Protein","Q9NSC2","Sal-like protein 1 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1324,140.3,7.02,4.05,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf12874","6299","hsa:6299; Q99881; Q9NSC2; Q9NSC3; Q9P1R0","ENSG00000103449","Formation of the ureteric bud; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation","GDNF/RET signaling axis; Development of ureteric collection system; Markers of kidney cell lineage",5,0,128.2,136.4,116.4,108.1,62.5,91.8,73.7,80.7,71.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S586(99.3)]",0,"ENSG00000103449"
"630","PDCD4",0.811287720988215,6.59049091586148,3.77250645227683,0.00392774376979364,0.0101657434217959,-2.69390612509348,"NONE",FALSE,"High","Master Protein","Q53EL6","Programmed cell death protein 4 [OS=Homo sapiens]",0,25.333,5,4,5,11,4,469,51.7,5.21,29.82,4,"developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf02847","27250","B2RCV4; B5ME91; hsa:27250; O15501; Q53EL6; Q5VZS6; Q6PJI5; Q8TAR5; Q99834","ENSG00000150593","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Translation inhibitors in chronically activated PDGFRA cells; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways",4,0,63.3,65.6,66.8,114.6,200.2,82.7,119.3,104.9,125.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S94(100); S457(100)]",0,"ENSG00000150593"
"631","MPDZ",0.3982717212192,6.6661643400435,3.77206730025165,0.00393050496271641,0.0101657434217959,-2.69463699971076,"NONE",FALSE,"High","Master Protein","O75970","Multiple PDZ domain protein [OS=Homo sapiens]",0,77.568,6,5,6,13,5,2070,221.5,5.06,39.95,5,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component",NA,"Pf00595, Pf09045, Pf16667","8777","A6NLC2; B2RTS3; B7ZMI4; hsa:8777; O43798; O75970; Q4LE30; Q5CZ80; Q5JTX3; Q5JTX6; Q5JTX7; Q5JUC3; Q5JUC4; Q5VZ62; Q8N790","ENSG00000107186",NA,NA,0,0,78.4,86.9,82.8,110.3,93.4,131.3,107.7,111.9,110.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S230(100); S354(99.1); S1595(100); S1818(100)]",0,"ENSG00000107186"
"632","WDR20",0.446750572599039,6.66267411284652,3.7658599898855,0.00396975209570002,0.0102510054116811,-2.70496959215738,"NONE",FALSE,"High","Master Protein","Q8TBZ3","WD repeat-containing protein 20 [OS=Homo sapiens]",0,19.265,4,2,2,3,2,569,62.9,8,10.63,2,NA,"nucleus;other cell component","enzyme regulator activity","Pf00400","91833","B4DN18; E7EUY8; F8W9S4; G3V2F8; G3V5R0; H0YJJ1; hsa:91833; Q86TU2; Q8NCN7; Q8TBZ3; Q8WXX2; Q9UF86","ENSG00000140153","Ub-specific processing proteases",NA,1,0,75,90,86.4,106.9,128.6,125,92.7,119.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S434(99.6); S465(100)]",0,"ENSG00000140153"
"633","PDZRN3",-0.303385018305301,6.58845374848059,-3.76220384678217,0.00399306086357566,0.0102949057335789,-2.71105716467006,"NONE",FALSE,"High","Master Protein","Q9UPQ7","E3 ubiquitin-protein ligase PDZRN3 [OS=Homo sapiens]",0,21.09,3,2,2,3,2,1066,119.5,6.02,6.25,2,"cell organization and biogenesis;protein metabolism;other metabolic processes","other cell component","other molecular function","Pf00595, Pf13923","23024","A7MCZ6; Q8N2N7; Q96CC2; Q9NSQ2; Q9UPQ7","ENSG00000121440",NA,NA,0,0,109.9,110.5,110.9,96,83.3,91.6,83.6,97.5,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S774(99.7); S848(99.4)]",0,"ENSG00000121440"
"634","ZFP91",0.274861171392045,6.65575031789679,3.7489652353813,0.00407866671511332,0.010481510944918,-2.73310972604115,"NONE",FALSE,"High","Master Protein","Q96JP5","E3 ubiquitin-protein ligase ZFP91 [OS=Homo sapiens]",0,22.19,5,3,3,3,3,570,63.4,7.36,9.34,3,"protein metabolism;other metabolic processes;signal transduction;other biological processes","nucleus","other molecular function","Pf00096","80829","A6NHC4; A8MSG7; Q86V47; Q96JP4; Q96JP5; Q96QA3","ENSG00000186660",NA,NA,0,0,88.8,90.6,88.5,110.7,115.9,112.1,101.5,97.4,109.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(99.5); S103(100)]",0,"ENSG00000186660"
"635","ADD1",0.298560804599796,6.64435830483276,3.74808402719999,0.00408443275453278,0.010481510944918,-2.73457817079693,"NONE",FALSE,"High","Master Protein","P35611","Alpha-adducin [OS=Homo sapiens]",0,182.37,14,9,11,36,9,737,80.9,5.83,113.72,9,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00596","118","A2A3N8; A2A3P0; B4DI79; D3DVR3; D3DVR4; D3DVR5; hsa:118; P35611; Q13734; Q14729; Q16156; Q86XM2; Q9UJB6","ENSG00000087274","XBP1(S) activates chaperone genes; Caspase-mediated cleavage of cytoskeletal proteins; Miscellaneous transport and binding events",NA,3,0,92.8,94.2,91.1,118.4,124,115.4,99.6,90.4,90.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T11(99.7); S355(100); S431(100); S465(100); S481(99.4); S586(100)]",0,"ENSG00000087274"
"636","CFL1",0.316681993459605,6.68089166610609,3.74804222822506,0.00408470647118128,0.010481510944918,-2.73464782627751,"NONE",FALSE,"High","Master Protein","P23528","Cofilin-1 [OS=Homo sapiens]",0,66.252,38,7,9,16,7,166,18.5,8.09,37.98,7,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity","Pf00241","1072","B3KUQ1; hsa:1072; P23528; Q53Y87; Q9UCA2","ENSG00000172757","Platelet degranulation ; Regulation of actin dynamics for phagocytic cup formation; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; EPHB-mediated forward signaling; Sema3A PAK dependent Axon repulsion; RHO GTPases Activate ROCKs","Brain-derived neurotrophic factor (BDNF) signaling pathway; VEGFA-VEGFR2 signaling; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; 7q11.23 copy number variation syndrome; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Regulation of actin cytoskeleton; G13 signaling pathway",15,0,86.9,83.7,80.9,114.9,107.4,102.7,120,114.3,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S3(100); T25(100); S156(100)]; Met-loss+Acetyl [N-Term]",0,"ENSG00000172757"
"637","RAB11FIP2",-0.365483824950267,6.64909741781564,-3.74474555887474,0.00410635502272355,0.010520520246601,-2.74014201060147,"NONE",FALSE,"High","Master Protein","Q7L804","Rab11 family-interacting protein 2 [OS=Homo sapiens]",0,4.701,3,2,2,3,2,512,58.2,9.32,6.42,2,"cell-cell signaling;transport;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00168, Pf09457","22841","A6NEI4; hsa:22841; Q3I768; Q7L804; Q9Y2F0","ENSG00000107560","Vasopressin regulates renal water homeostasis via Aquaporins",NA,1,0,101.4,97.4,100.5,73.3,83,76.1,128.9,115,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S277(100); T317(100)]",0,"ENSG00000107560"
"638","SRGAP1",0.46861360966428,6.65444227544284,3.73705535505593,0.00415732338592459,0.0106144327568734,-2.75296209318118,"NONE",FALSE,"High","Master Protein","Q7Z6B7","SLIT-ROBO Rho GTPase-activating protein 1 [OS=Homo sapiens]",0,12.06,2,2,2,4,2,1085,124.2,6.83,7.38,2,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00018, Pf00611, Pf00620","57522","hsa:57522; Q7Z6B7; Q9H8A3; Q9P2P2","ENSG00000196935","RAC1 GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; Inactivation of CDC42 and RAC1",NA,4,0,84.9,87.1,89.7,132.7,99.4,133.8,92.5,103,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S906(100); S932(100)]",0,"ENSG00000196935"
"639","SPHK2",0.356832400234339,6.62790962345399,3.73636761778271,0.00416191365809832,0.0106144327568734,-2.75410884794861,"NONE",FALSE,"High","Master Protein","Q9NRA0","Sphingosine kinase 2 [OS=Homo sapiens]",0,28.354,7,2,2,4,2,654,69.2,6.95,17.04,2,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00781, Pf19279","56848","A0T4C8; B4DU87; hsa:56848; Q9BRN1; Q9H0Q2; Q9NRA0; Q9NWU7","ENSG00000063176","Sphingolipid de novo biosynthesis","Sphingolipid pathway; S1P receptor signal transduction; Metabolism of sphingolipids in ER and Golgi apparatus; Sphingolipid metabolism: integrated pathway; Biosynthesis and turnover of 1-deoxy-sphingoid bases; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids",7,0,85.4,76.1,91.8,117.2,106.1,111.8,96.7,110.4,102.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(99.4); S484(100)]",0,"ENSG00000063176"
"640","TRPS1",-0.384269836880934,6.58574262502459,-3.73627643531876,0.00416252264975429,0.0106144327568734,-2.75426089154126,"NONE",FALSE,"High","Master Protein","Q9UHF7","Zinc finger transcription factor Trps1 [OS=Homo sapiens]",0,21.864,3,2,2,3,2,1281,141.4,7.58,9.27,2,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00320","7227","B4E1Z5; hsa:7227; Q08AU2; Q9NWE1; Q9UHF7; Q9UHH6","ENSG00000104447",NA,NA,0,0,120.5,109.9,124.4,94.2,85.5,92.5,84.6,77.5,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100); S1066(100)]",0,"ENSG00000104447"
"641","TOMM70",0.307077427265915,6.63166381631113,3.73342421405324,0.00418161931487783,0.010646494105898,-2.75901723548458,"NONE",FALSE,"High","Master Protein","O94826","Mitochondrial import receptor subunit TOM70 [OS=Homo sapiens]",0,36.564,4,1,2,6,1,608,67.4,7.12,23.77,1,"cell organization and biogenesis;transport;other biological processes","other membranes;mitochondrion","transporter activity;other molecular function","Pf00515, Pf13181","9868","D3DN48; hsa:9868; O94826","ENSG00000154174","Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Mitochondrial protein import; DDX58/IFIH1-mediated induction of interferon-alpha/beta; SARS-CoV-1 activates/modulates innate immune responses; PINK1-PRKN Mediated Mitophagy","Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",9,0,87.5,85.2,93.7,108.9,113,122,92.9,94.4,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S91(100)]",0,"ENSG00000154174"
"642","EPN2",0.729250975681222,6.62923834857221,3.72727263951431,0.00422311926815096,0.010735405990066,-2.76927795156805,"NONE",FALSE,"High","Master Protein","O95208-2","Isoform 2 of Epsin-2 [OS=Homo sapiens]",0,39.396,6,2,4,9,2,584,62.3,7.53,37.52,2,NA,NA,NA,NA,NA,"O95208-2",NA,NA,NA,0,0,68.1,73.6,85.1,108.4,137.6,144.8,76.7,109.4,127,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(99.7); S192(100)]",0,"ENSG00000072134"
"643","CDK14",0.569206151958219,6.6483267787416,3.71270222634756,0.00432314378781812,0.0109725826776348,-2.79359408239434,"NONE",FALSE,"High","Master Protein","O94921","Cyclin-dependent kinase 14 [OS=Homo sapiens]",0,4.787,4,2,2,3,2,469,53,8.92,6.87,2,"cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5218","A4D1E6; A6NK51; A8WFP6; B4DHG5; B4DNM2; hsa:5218; O94921; Q75N06; Q75N22; Q8N764; Q9H3D7; Q9UDR0","ENSG00000058091",NA,NA,0,0,88.3,77.1,70,118.8,132.4,113.4,89.3,129.8,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S24(100); S134(100)]",0,"ENSG00000058091"
"644","DYNC1LI2",0.297658907536715,6.65656794113996,3.70307378805844,0.00439060004782827,0.0111264895621984,-2.80967257780242,"NONE",FALSE,"High","Master Protein","O43237","Cytoplasmic dynein 1 light intermediate chain 2 [OS=Homo sapiens]",0,58.649,14,3,4,14,3,492,54.1,6.38,47.64,3,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf05783","1783","A8K6V1; B4DZP4; hsa:1783; O43237; Q8TAT3","ENSG00000135720","HCMV Early Events; Separation of Sister Chromatids; MHC class II antigen presentation; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Intraflagellar transport proteins binding to dynein; Vasopressin-regulated water reabsorption",14,0,87.6,84.4,91.7,113.5,102.9,119.6,102.7,110.4,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S194(100); S407(100)]",0,"ENSG00000135720"
"645","SEC22B",0.333952253442055,6.65118350181483,3.70084939670011,0.0044063400158596,0.011149064970361,-2.81338818841369,"NONE",FALSE,"High","Master Protein","O75396","Vesicle-trafficking protein SEC22b [OS=Homo sapiens]",0,27.309,7,1,1,3,1,215,24.7,8.51,12.99,1,"cell organization and biogenesis;transport;other biological processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf00957, Pf13774","9554","A8K1G0; hsa:9554; O75396","ENSG00000265808","COPI-dependent Golgi-to-ER retrograde traffic; ER-Phagosome pathway; COPII-mediated vesicle transport; Cargo concentration in the ER",NA,4,0,71.2,86.4,73.2,97.6,95.2,107.3,124.1,123.8,140.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(100)]",0,"ENSG00000265808"
"646","CIC",0.257241530801518,6.64989719637899,3.69885894115565,0.00442047467762482,0.0111630134338189,-2.81671338450697,"NONE",FALSE,"High","Master Protein","Q96RK0","Protein capicua homolog [OS=Homo sapiens]",0,67.123,7,7,7,15,7,1608,163.7,8.56,28.08,7,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","23152","hsa:23152; Q7LGI1; Q96RK0; Q9UEG5; Q9Y6T1","ENSG00000079432",NA,NA,0,0,89.7,83.5,85.5,107.1,109.8,104.9,106.8,107,112.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100); S496(100); S904(100); S1246(99.4)]",0,"ENSG00000079432"
"647","SOX5",-0.37119358841656,6.55967084165977,-3.69814825497221,0.00442553289931422,0.0111630134338189,-2.81790071586077,"NONE",FALSE,"High","Master Protein","P35711","Transcription factor SOX-5 [OS=Homo sapiens]",0,32.038,3,3,3,3,3,763,84,6.6,10.85,3,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","6660","B7Z8V0; F5H5B0; hsa:6660; P35711; Q86UK8; Q8J017; Q8J018; Q8J019; Q8J020; Q8N1D9; Q8N7E0; Q8TEA4","ENSG00000134532",NA,"Neural crest differentiation; Male infertility; Endochondral ossification; Endochondral ossification with skeletal dysplasias",4,0,118.5,110.6,110.6,80.2,101.9,87.5,90.9,83.8,87.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T131(100); S382(100)]",0,"ENSG00000134532"
"648","PNPLA2",-0.325096380799479,6.64973552971648,-3.69338164073753,0.00445961554018906,0.0112263502455133,-2.82586530321781,"NONE",FALSE,"High","Master Protein","Q96AD5","Patatin-like phospholipase domain-containing protein 2 [OS=Homo sapiens]",0,14.22,3,1,1,1,1,504,55.3,7.08,4.14,1,"cell organization and biogenesis;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01734","57104","hsa:57104; O60643; Q5EFF5; Q6XYE5; Q96AD5; Q96ET6; Q9NQ61; Q9NQ62","ENSG00000177666","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Acyl chain remodeling of DAG and TAG","Fatty acid beta-oxidation; Triacylglyceride synthesis; Lipid metabolism pathway; Thermogenesis; Glycerolipids and glycerophospholipids; Familial partial lipodystrophy; 5q35 copy number variation",10,0,120.6,95.2,116.5,90.8,78.5,94.9,101.8,102.6,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S404(100)]",0,"ENSG00000177666"
"649","FASN",-0.358580444692585,6.58155988050152,-3.69203070652575,0.00446932494788901,0.0112263502455133,-2.82812293664302,"NONE",FALSE,"High","Master Protein","P49327","Fatty acid synthase [OS=Homo sapiens]",0,67.126,3,5,6,8,5,2511,273.3,6.44,24.49,5,"other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf00107, Pf00109, Pf00550, Pf00698, Pf00975, Pf02801, Pf08242, Pf08659, Pf16197, Pf21089, Pf21149","2194","hsa:2194; P49327; Q13479; Q16702; Q4LE83; Q6P4U5; Q6SS02; Q969R1; Q96C68; Q96IT0","ENSG00000169710","ChREBP activates metabolic gene expression; Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; NR1H2 & NR1H3 regulate gene expression linked to lipogenesis; Vitamin B5 (pantothenate) metabolism","AMP-activated protein kinase signaling; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Liver X receptor pathway; Nuclear receptors meta-pathway; Fatty acid biosynthesis; Angiopoietin-like protein 8 regulatory pathway; Lipid metabolism pathway; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Omega-9 fatty acid synthesis; FOXA2 pathway",18,0,121.1,107.4,117.7,89.6,73.5,107.3,83.2,92.7,86.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100); T2204(100)]",0,"ENSG00000169710"
"650","SSR3",-0.363655333265694,6.63850421805388,-3.69175916911928,0.00447127920317625,0.0112263502455133,-2.82857673857378,"NONE",FALSE,"High","Master Protein","Q9UNL2","Translocon-associated protein subunit gamma [OS=Homo sapiens]",0,18.218,8,1,1,2,1,185,21.1,9.61,6.67,1,"other biological processes","other membranes;ER/Golgi",NA,"Pf07074","6747","B2R7D0; B4E2P2; D3DNK5; hsa:6747; Q549M4; Q9UNL2","ENSG00000114850","SRP-dependent cotranslational protein targeting to membrane","VEGFA-VEGFR2 signaling",2,0,111.3,103.6,113,74,85.3,97.5,107.5,105.6,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100)]",0,"ENSG00000114850"
"651","SPAST",0.552808299088072,6.68131620316621,3.6752458126495,0.00459182146871341,0.0115112943731802,-2.85618577410826,"NONE",FALSE,"High","Master Protein","Q9UBP0","Spastin [OS=Homo sapiens]",0,14.715,2,1,2,3,1,616,67.2,9.64,10.14,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00004, Pf09336, Pf17862","6683","A7E2A7; hsa:6683; Q9UBP0; Q9UPR9","ENSG00000021574","Sealing of the nuclear envelope (NE) by ESCRT-III",NA,1,0,74.5,87.6,78,127,103.3,128.1,107.1,132.8,94.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(100)]",0,"ENSG00000021574"
"652","CCM2",0.420589970560399,6.66231882777478,3.66597074880138,0.00466101191998078,0.0116668273825286,-2.87170268242116,"NONE",FALSE,"High","Master Protein","Q9BSQ5","Cerebral cavernous malformations 2 protein [OS=Homo sapiens]",0,6.068,2,1,1,2,1,444,48.8,5.54,5.89,1,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","mitochondrion;other cell component",NA,"Pf16545","83605","A4D2L4; B3KUV0; D3DVL4; E9PDJ3; F5H0E1; F5H551; hsa:83605; Q71RE5; Q8TAT4; Q9BSQ5","ENSG00000136280",NA,NA,0,0,76.3,81.4,81,94.1,113.2,126.3,121.6,107.1,120.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S384(100)]",0,"ENSG00000136280"
"653","ACIN1",-0.537065888995208,6.55831590254003,-3.66025618304685,0.00470418335055103,0.0117568563983144,-2.88126642342066,"NONE",FALSE,"High","Master Protein","Q9UKV3","Apoptotic chromatin condensation inducer in the nucleus [OS=Homo sapiens]",0,99.137,10,11,12,39,11,1341,151.8,6.43,95.06,11,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02037, Pf16294","22985","B2RTT4; D3DS45; hsa:22985; O75158; Q9UG91; Q9UKV1; Q9UKV2; Q9UKV3","ENSG00000100813","mRNA Splicing - Major Pathway; Apoptotic cleavage of cellular proteins",NA,2,0,123.4,121.2,120.5,76.5,109.4,72.9,89.3,77.4,91.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100); S365(100); S386(99.6); S388(100); T414(100); S490(100); S710(100); S729(100); S825(100); S990(100); S1004(100)]",0,"ENSG00000100813"
"654","DAB2IP",-0.241291031589246,6.60609989049171,-3.6576012729056,0.00472438217229482,0.0117892839528825,-2.8857104946722,"NONE",FALSE,"High","Master Protein","Q5VWQ8","Disabled homolog 2-interacting protein [OS=Homo sapiens]",0,14.885,2,3,3,4,3,1189,131.5,8.72,8.67,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00168, Pf00616, Pf12004","153090","A6H8V2; A6NHI9; B0QZB1; G3XA90; hsa:153090; Q5VWQ8; Q8TDL2; Q96SE1; Q9C0C0","ENSG00000136848","Regulation of RAS by GAPs","Ebola virus infection in host",2,0,111.2,117.5,109.7,97.8,92.2,101,87.9,89.8,85.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S702(99.6); S747(100); S978(100)]",0,"ENSG00000136848"
"655","HECTD4",-0.365114931715831,6.59717981557177,-3.65050709145015,0.00477880122814274,0.0119068757317999,-2.89758823181067,"NONE",FALSE,"High","Master Protein","Q9Y4D8","Probable E3 ubiquitin-protein ligase HECTD4 [OS=Homo sapiens]",0,63.639,2,4,6,13,4,3996,439.1,6.19,32.72,4,"protein metabolism;other metabolic processes;other biological processes","other membranes","other molecular function","Pf00632",NA,"L8B0P6; Q3MJD5; Q6P0A0; Q7L530; Q8NB70; Q8WU73; Q96NT9; Q9NZS4; Q9UFT6; Q9Y4D8",NA,NA,NA,0,0,114.5,111.5,107.7,89.8,66,103.1,95.3,92.7,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1107(99.4); S1139(99.4); T2080(100)]",0,"ENSG00000173064"
"656","JMY",0.480530463454123,6.67514299349782,3.64001188342426,0.00486051331543262,0.0120920087359543,-2.91516753767505,"NONE",FALSE,"High","Master Protein","Q8N9B5","Junction-mediating and -regulatory protein [OS=Homo sapiens]",0,33.19,4,3,3,6,3,988,111.4,6.18,15.28,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","other membranes;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf15871, Pf15920","133746","A1L4P5; B5MDS2; B5MDT0; hsa:133746; Q8N9B5","ENSG00000152409","Regulation of TP53 Activity through Methylation",NA,1,0,79.8,81.6,96.1,123.6,103.8,138.2,88.4,108.7,108.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100); S142(100); S713(100)]",0,"ENSG00000152409"
"657","ARHGEF11",0.287216567428756,6.64918181705846,3.63185743481589,0.00492500772483191,0.0122338091429614,-2.92883201989626,"NONE",FALSE,"High","Master Protein","O15085","Rho guanine nucleotide exchange factor 11 [OS=Homo sapiens]",0,18.524,2,2,2,2,2,1522,167.6,5.5,5.66,2,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity","Pf00595, Pf00621, Pf09128, Pf17838","9826","D3DVD0; hsa:9826; O15085; Q5VY40; Q6PFW2","ENSG00000132694","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle; Sema4D induced cell migration and growth-cone collapse",NA,8,0,94.7,90.6,85.2,117,115.1,111.4,95,102.6,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T668(100); S1480(99.3)]",0,"ENSG00000132694"
"658","SIRT6",-0.351826756215115,6.57982067808315,-3.63014587851256,0.00493865770482654,0.0122490719973813,-2.93170074062425,"NONE",FALSE,"High","Master Protein","Q8N6T7","NAD-dependent protein deacylase sirtuin-6 [OS=Homo sapiens]",0,6.249,3,1,1,1,1,355,39.1,9.19,2.91,1,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02146","51548","B2RCD0; hsa:51548; O75291; Q6IAF5; Q6PK99; Q8N6T7; Q8NCD2; Q9BSI5; Q9BWP3; Q9NRC7; Q9UQD1","ENSG00000077463","Pre-NOTCH Transcription and Translation; Processing of DNA double-strand break ends","SREBF and miR33 in cholesterol and lipid homeostasis; NAD+ metabolism; NAD+ biosynthetic pathways; Thermogenesis; Thyroid hormones production and peripheral downstream signaling effects; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction; 10q11.21q11.23 copy number variation syndrome",9,0,116.2,111.5,107,89.9,85.2,88.8,80.7,99,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T294(100)]",0,"ENSG00000077463"
"659","WWC3",-0.267040106104361,6.60118040855066,-3.62483549162965,0.00498126097412147,0.0123288282490137,-2.94060284885203,"NONE",FALSE,"High","Master Protein","Q9ULE0","Protein WWC3 [OS=Homo sapiens]",0,9.072,3,2,2,2,2,1216,136.6,6.42,2.5,2,"other biological processes","cytosol;other cell component","other molecular function","Pf00397","55841","A8KA96; hsa:55841; Q659C1; Q9BTQ1; Q9ULE0; T2C6S4","ENSG00000047644",NA,NA,0,0,104.5,114.4,109.1,91.6,83.5,100.8,90.7,90.6,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1051(100)]",0,"ENSG00000047644"
"660","CXCR4",0.347623829721994,6.64259703500007,3.62425723900528,0.00498592318893938,0.0123288282490137,-2.94157233699928,"NONE",FALSE,"High","Master Protein","P61073","C-X-C chemokine receptor type 4 [OS=Homo sapiens]",0,22.003,9,2,4,6,2,352,39.7,8.21,11.79,2,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00001, Pf12109","7852","B2R5N0; hsa:7852; O60835; P30991; P56438; P61073; Q53S69; Q9BXA0; Q9UKN2","ENSG00000121966","G alpha (i) signalling events; Chemokine receptors bind chemokines; Signaling by ROBO receptors; Formation of definitive endoderm; Specification of primordial germ cells; Binding and entry of HIV virion","Peptide GPCRs; Cardiac progenitor differentiation; Hematopoietic stem cell differentiation; Amplification and expansion of oncogenic pathways as metastatic traits; Chemokine signaling pathway; Acute viral myocarditis; Neovascularization processes; Selective expression of chemokine receptors during T-cell polarization; GPCRs, class A rhodopsin-like; Genes controlling nephrogenesis; CCL18 signaling pathway; Extrafollicular and follicular B cell activation by SARS-CoV-2; 2q37 copy number variation syndrome; Cell interactions of the pancreatic cancer microenvironment; TAR syndrome; 5q35 copy number variation; IL-19 signaling pathway",23,0,84.3,87.9,92.7,106.4,109.3,133.8,93.9,99.5,100.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T318(99.7)]",0,"ENSG00000121966"
"661","SPRY2",1.15616035145352,6.52651422016242,3.62304941366208,0.00499567609134539,0.0123342562497363,-2.94359743767982,"NONE",FALSE,"High","Master Protein","O43597","Protein sprouty homolog 2 [OS=Homo sapiens]",0,16.193,5,1,2,3,1,315,34.7,8.35,3.44,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","enzyme regulator activity;other molecular function","Pf05210","10253","B2R9J9; hsa:10253; O43597; Q5T6Z7","ENSG00000136158","EGFR downregulation; Spry regulation of FGF signaling","Glioblastoma signaling pathways; Androgen receptor network in prostate cancer; Ectoderm differentiation; EGF/EGFR signaling pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development",8,0,93.8,37.1,68,157.3,153.6,110.2,95.1,105.7,80,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(99.7)]",0,"ENSG00000136158"
"662","SMAP2",0.621857245633324,6.65384608440713,3.61967907432273,0.0050229962345385,0.0123829756114303,-2.94924890332549,"NONE",FALSE,"High","Master Protein","Q8WU79","Stromal membrane-associated protein 2 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,429,46.8,8.87,7.06,1,NA,"cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01412","64744","B2R7T1; B7Z5B5; B7Z8V2; D3DPV2; hsa:64744; Q5QPL2; Q8WU79; Q96C93; Q9NST2; Q9UJL8","ENSG00000084070",NA,NA,0,0,78.3,55.8,100.1,125,119.3,120.8,100.2,118.1,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(100)]",0,"ENSG00000084070"
"663","USP8",0.256054304783321,6.66309335786834,3.58870398123385,0.00528150415885048,0.0130006256217858,-3.00122838341412,"NONE",FALSE,"High","Master Protein","P40818","Ubiquitin carboxyl-terminal hydrolase 8 [OS=Homo sapiens]",0,76.617,4,5,7,11,5,1118,127.4,8.51,49.73,5,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00443, Pf00581, Pf08969, Pf20625","9101","B4DKA8; hsa:9101; P40818; Q2TB31; Q7Z3U2; Q86VA0; Q8IWI7","ENSG00000138592","Negative regulation of MET activity; Ub-specific processing proteases; Downregulation of ERBB2:ERBB3 signaling; Regulation of FZD by ubiquitination","EGF/EGFR signaling pathway; Male infertility",6,0,88.6,90.3,93,110.4,120.1,110.5,97,105.4,105.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S392(100); T577(100)]",0,"ENSG00000138592"
"664","RBM5",-0.299071334452727,6.58988694582346,-3.58144118926396,0.00534410170262069,0.0131140376085785,-3.01342627855322,"NONE",FALSE,"High","Master Protein","P52756","RNA-binding protein 5 [OS=Homo sapiens]",0,20.671,3,2,2,3,2,815,92.1,6.28,7.16,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076, Pf00641, Pf01585, Pf17780","10181","B2RA45; B4DM16; B4DMF9; B4DZ63; hsa:10181; P52756; Q93021; Q9BU14; Q9HDA6; Q9UKY8; Q9UL24","ENSG00000003756","mRNA Splicing - Major Pathway","mRNA processing",2,0,100.2,115.3,122.4,97.2,81.8,98.1,87.4,89.4,87.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100); S624(100)]",0,"ENSG00000003756"
"665","SH3KBP1",-0.6621436882885,6.57498909178288,-3.5806982125605,0.00535054884299012,0.0131140376085785,-3.01467432517966,"NONE",FALSE,"High","Master Protein","Q96B97","SH3 domain-containing kinase-binding protein 1 [OS=Homo sapiens]",0,9.927,4,2,2,2,2,665,73.1,6.62,4.51,2,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf14604","30011","B7Z1D5; hsa:30011; Q5JPT4; Q5JPT5; Q8IWX6; Q8IX98; Q96B97; Q96RN4; Q9NYR0","ENSG00000147010","Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Reelin signalling pathway","EGF/EGFR signaling pathway",9,0,102.2,119.3,112.6,65.9,78.9,61.7,105.2,87.4,145.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(99.5); S230(100)]",0,"ENSG00000147010"
"666","NAGK",0.259888954632715,6.65146815629618,3.58056743868612,0.00535168446526547,0.0131140376085785,-3.01489400222718,"NONE",FALSE,"High","Master Protein","Q9UJ70","N-acetyl-D-glucosamine kinase [OS=Homo sapiens]",0,30.401,5,1,1,7,1,344,37.4,6.24,30.7,1,"other metabolic processes;stress response;other biological processes","cytosol","kinase activity;other molecular function","Pf01869","55577","B4DLZ5; hsa:55577; Q53HD5; Q6IA84; Q9BS29; Q9BVP0; Q9NV37; Q9UJ70","ENSG00000124357","Synthesis of UDP-N-acetyl-glucosamine",NA,1,0,92.5,89.3,100.5,111.5,116.7,123.4,91.2,96.8,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(100)]",0,"ENSG00000124357"
"667","DBN1",0.377652359584621,6.63782601614298,3.55743408040937,0.00555657842792809,0.0135957061384987,-3.05377297702435,"NONE",FALSE,"High","Master Protein","Q16643","Drebrin [OS=Homo sapiens]",0,172.705,15,5,15,69,5,649,71.4,4.45,268.54,5,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00241","1627","A8MV58; B2RBG0; hsa:1627; Q16643; Q9UFZ5","ENSG00000113758","RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle; RHOD GTPase cycle; RHOH GTPase cycle","5q35 copy number variation",5,0,80.6,86,93.3,110.6,140.6,110.2,104.8,91.7,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S142(100); S337(100); T346(100); S381(100); S601(100)]",0,"ENSG00000113758"
"668","EIF3J",0.418778308585086,6.6296478956029,3.5472701170804,0.00564917047275556,0.0138015661849357,-3.07086674650294,"NONE",FALSE,"High","Master Protein","O75822","Eukaryotic translation initiation factor 3 subunit J [OS=Homo sapiens]",0,6.224,5,2,2,2,2,258,29,4.83,2.92,2,"cell organization and biogenesis;protein metabolism;other metabolic processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf08597","8669","B4DUI3; F5H425; hsa:8669; O75822; Q9BUD2; Q9H8Q2; Q9UI65","ENSG00000104131","L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit","Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell",8,0,79.2,79.8,85.1,107.1,144,99.4,101,112.5,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T109(100)]",0,"ENSG00000104131"
"669","TAGLN2",0.478917851826439,6.6654540306819,3.54600971945584,0.00566076398898645,0.0138092179821015,-3.07298697599506,"NONE",FALSE,"High","Master Protein","P37802","Transgelin-2 [OS=Homo sapiens]",0,14.607,13,2,2,2,2,199,22.4,8.25,6.29,2,"cell organization and biogenesis;other biological processes","non-structural extracellular;cytosol;cytoskeleton","cytoskeletal activity","Pf00307, Pf00402","8407","E9KL39; hsa:8407; P37802; Q5JRQ6; Q5JRQ7; Q6FGI1; Q9BUH5; Q9H4P0","ENSG00000158710","Platelet degranulation",NA,1,0,75.3,63.8,87.5,119.1,107.3,97.1,132,120.5,123.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S163(100)]",0,"ENSG00000158710"
"670","VASH1",0.33178848416531,6.66488127546087,3.54359486180183,0.00568304585121185,0.0138428818345936,-3.07704952794086,"NONE",FALSE,"High","Master Protein","Q7L8A9","Tubulinyl-Tyr carboxypeptidase 1 [OS=Homo sapiens]",0.002,2.684,3,1,1,1,1,365,40.9,9.48,2.38,1,"cell cycle OR cell proliferation;protein metabolism;stress response;developmental processes;other biological processes","non-structural extracellular;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf14822","22846","hsa:22846; Q7L8A9; Q96H02; Q9UBF4; Q9Y629","ENSG00000071246","Carboxyterminal post-translational modifications of tubulin",NA,1,0,89.9,89.2,82.9,117.6,117.4,107.9,95.1,109.8,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(100)]",0,"ENSG00000071246"
"671","PSMA3",0.325688165517867,6.67005660411555,3.54109598762787,0.00570619911746964,0.01387856476857,-3.08125383611013,"NONE",FALSE,"High","Master Protein","P25788","Proteasome subunit alpha type-3 [OS=Homo sapiens]",0,23.949,5,1,2,65,1,255,28.4,5.33,107.36,1,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00227, Pf10584","5684","B2RCK6; hsa:5684; P25788; Q86U83; Q8N1D8; Q9BS70","ENSG00000100567","FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; Cross-presentation of soluble exogenous antigens (endosomes); Regulation of ornithine decarboxylase (ODC); Somitogenesis","Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease",62,0,83.8,86,87.3,117.6,121.6,99.4,108.5,110.2,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S250(100)]",0,"ENSG00000100567"
"672","EIF4ENIF1",-0.284714140404603,6.62095622456913,-3.53839618702286,0.00573132449242666,0.0138909687770199,-3.08579667033907,"NONE",FALSE,"High","Master Protein","Q9NRA8","Eukaryotic translation initiation factor 4E transporter [OS=Homo sapiens]",0,34.031,6,4,4,10,4,985,108.1,8.32,21.87,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf10477","56478","B1AKL2; B1AKL3; B2RBF1; hsa:56478; Q8NCF2; Q9H708; Q9NRA8","ENSG00000184708",NA,"Primary ovarian insufficiency; 10q11.21q11.23 copy number variation syndrome",2,0,110.9,107.3,111.2,84.8,98.3,94.6,93.7,96.7,100.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S78(99.7); S564(100); S951(100)]",0,"ENSG00000184708"
"673","PRKAR2B",0.401388831672421,6.63003380273042,3.5380152775558,0.0057348786438676,0.0138909687770199,-3.08643764900447,"NONE",FALSE,"High","Master Protein","P31323","cAMP-dependent protein kinase type II-beta regulatory subunit [OS=Homo sapiens]",0,16.205,9,2,2,3,2,418,46.3,4.92,12.03,2,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00027, Pf02197","5577","A4D0R9; hsa:5577; P31323","ENSG00000005249","FCGR3A-mediated IL10 synthesis; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase","Myometrial relaxation and contraction pathways; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Calcium regulation in cardiac cells; ADHD and autism (ASD) linked metabolic pathways and SNP; Sudden infant death syndrome (SIDS) susceptibility pathways",27,0,79.6,85.1,83,102.4,101.6,135.3,96.3,106.5,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(100)]",0,"ENSG00000005249"
"674","G3BP1",0.326073699426834,6.66537426390115,3.53780582944293,0.00573683391894083,0.0138909687770199,-3.08679010373916,"NONE",FALSE,"High","Master Protein","Q13283","Ras GTPase-activating protein-binding protein 1 [OS=Homo sapiens]",0,28.716,4,1,1,4,1,466,52.1,5.52,18.19,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00076, Pf02136","10146","hsa:10146; Q13283; Q5HYE9","ENSG00000145907","SARS-CoV-2 activates/modulates innate and adaptive immune responses","7q11.23 distal copy number variation; HDAC6 interactions in the central nervous system",3,0,83.1,90.2,102,121.9,114.6,120.9,98.1,101.2,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S232(99.5)]",0,"ENSG00000145907"
"675","RALGAPA1",0.371711547046298,6.65642439692618,3.52609938771191,0.00584722887417338,0.014137300033557,-3.10649407686521,"NONE",FALSE,"High","Master Protein","Q6GYQ0","Ral GTPase-activating protein subunit alpha-1 [OS=Homo sapiens]",0,74.666,4,5,6,15,5,2036,229.7,6.19,50.38,5,"other biological processes","nucleus;other cell component","enzyme regulator activity;other molecular function","Pf02145, Pf20412","253959","A6NMA4; B9EK38; C5NU19; hsa:253959; O94960; Q6GYP9; Q6GYQ0; Q6ZT23; Q86YF3; Q86YF5; Q8ND69","ENSG00000174373","RHOH GTPase cycle",NA,1,0,84.7,82.9,80.8,108.4,132.2,101.5,102.2,107.9,123.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S740(100); T754(100); S773(100); S797(100); S860(100)]",0,"ENSG00000174373"
"676","USP16",0.366345337814471,6.63568594351989,3.52253400639698,0.00588128897176263,0.0141986147957346,-3.11249702266777,"NONE",FALSE,"High","Master Protein","Q9Y5T5","Ubiquitin carboxyl-terminal hydrolase 16 [OS=Homo sapiens]",0,14.464,2,1,1,1,1,823,93.5,6.93,4.31,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","translation activity;other molecular function","Pf00443, Pf02148","10600","A8MU43; B3KN13; B4DFV8; B4DY37; D3DSD9; hsa:10600; Q53GP7; Q53HA0; Q5VKN8; Q8NEL3; Q9H3E6; Q9Y5T5","ENSG00000156256; ENSG00000291527","Ub-specific processing proteases",NA,1,0,80.8,72.4,90.2,102.9,106.5,116.8,104.1,123.9,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S552(99.1)]",0,"ENSG00000156256"
"677","NECTIN2",0.965479882019697,6.59109557575164,3.51457184763858,0.00595809905471675,0.0143628030388445,-3.12590569287512,"NONE",FALSE,"High","Master Protein","Q92692","Nectin-2 [OS=Homo sapiens]",0,33.757,9,2,2,3,2,538,57.7,4.82,11.3,2,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf07686, Pf08205","5819","A8K5L5; hsa:5819; O75455; Q6IBI6; Q92692; Q96J29","ENSG00000130202","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Nectin/Necl  trans heterodimerization","Monoamine transport",4,0,54.7,87.2,81.1,157.2,85.5,196.2,98.3,88.3,77.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T410(100); S433(100)]",0,"ENSG00000130202"
"678","SDCCAG8",0.551421828654572,6.6466962042289,3.51353301436233,0.00596819727883179,0.0143659261932942,-3.1276554406758,"NONE",FALSE,"High","Master Protein","Q86SQ7","Serologically defined colon cancer antigen 8 [OS=Homo sapiens]",0,7.774,2,1,1,1,1,713,82.6,5.81,2.55,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;other cell component",NA,"Pf15964","10806","O60527; Q3ZCR6; Q86SQ7; Q8N5F2; Q9P0F1","ENSG00000054282; ENSG00000276111","Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2","Ciliopathies; 16p11.2 distal deletion syndrome; Bardet-Biedl syndrome",10,0,93.9,67.5,74.1,112.8,153.1,102.7,114.6,99.9,112.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S92(100)]",0,"ENSG00000054282"
"679","MORC2",-0.37992646162632,6.57235201539297,-3.49726386242833,0.00612868954479639,0.0147305174331483,-3.15506714230759,"NONE",FALSE,"High","Master Protein","Q9Y6X9","ATPase MORC2 [OS=Homo sapiens]",0,30.824,2,2,2,5,2,1032,117.8,8.38,17.3,2,"cell organization and biogenesis;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf07496, Pf13589, Pf17942","22880","B2RNB1; hsa:22880; Q9UF28; Q9Y6V2; Q9Y6X9","ENSG00000133422","Fatty acyl-CoA biosynthesis",NA,1,0,120.6,111.9,107.5,80.1,72.9,108.2,84.6,94.6,90.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S615(100); S743(100)]",0,"ENSG00000133422"
"680","BCL7C",0.537046849779067,6.62247050791736,3.49546067036068,0.00614675200716406,0.0147338573975718,-3.15810634042984,"NONE",FALSE,"High","Master Protein","Q8WUZ0","B-cell CLL/lymphoma 7 protein family member C [OS=Homo sapiens]",0,15.2,15,1,1,1,1,217,23.5,5.2,5.13,1,"cell organization and biogenesis;other biological processes","nucleus;other cell component",NA,"Pf04714","9274","hsa:9274; O43770; Q6PD89; Q8WUZ0","ENSG00000099385",NA,NA,0,0,73.1,88.7,85.2,102,117.4,157.7,90.5,93,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(98.4); S126(98.5)]",0,"ENSG00000099385"
"681","RWDD2B",-0.393555671487345,6.59364467286276,-3.49468050498019,0.00615458402452639,0.0147338573975718,-3.15942133606382,"NONE",FALSE,"High","Master Protein","P57060","RWD domain-containing protein 2B [OS=Homo sapiens]",0,9.592,7,1,1,2,1,319,36.3,5.87,6.23,1,NA,NA,NA,"Pf05773, Pf06544","10069","hsa:10069; P57060","ENSG00000156253; ENSG00000291523",NA,NA,0,0,111.1,105.7,109.1,86.1,74.1,86.8,108.4,107,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(97.9)]",0,"ENSG00000156253"
"682","EDC4",0.359761212625271,6.62503014997971,3.49442378874682,0.00615716344677937,0.0147338573975718,-3.15985404834955,"NONE",FALSE,"High","Master Protein","Q6P2E9","Enhancer of mRNA-decapping protein 4 [OS=Homo sapiens]",0,81.999,7,4,6,15,4,1401,151.6,5.86,80.67,4,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus;other cell component",NA,"Pf16529, Pf21289","23644","A6NGM1; A8K4T4; hsa:23644; Q13025; Q13826; Q6P2E9; Q6ZR12; Q7Z6H7","ENSG00000038358","mRNA decay by 5' to 3' exoribonuclease",NA,1,0,84.4,94.6,106.6,119.2,119.7,138.1,78.8,82.4,89.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S723(99.3); S729(99.4); S844(100); S879(100)]",0,"ENSG00000038358"
"683","HDGFL2",-0.435057361380212,6.55066487506418,-3.49141489086621,0.0061874800623286,0.0147819359339758,-3.16492604878418,"NONE",FALSE,"High","Master Protein","Q7Z4V5","Hepatoma-derived growth factor-related protein 2 [OS=Homo sapiens]",0,15.959,10,4,4,6,4,671,74.3,7.49,5.82,4,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf00855, Pf11467","84717","I3L080; K7EQZ6; Q7Z4V5; Q96GI5; Q9BW08","ENSG00000167674",NA,NA,0,0,113.6,122.6,111.1,84,95.3,81.7,82.1,78.2,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S369(99.3); S625(100); S652(100); S664(100)]",0,"ENSG00000167674"
"684","TXLNA",0.394804712185987,6.66580885620533,3.49028237970668,0.00619893102325022,0.0147819359339758,-3.1668352298794,"NONE",FALSE,"High","Master Protein","P40222","Alpha-taxilin [OS=Homo sapiens]",0,15.2,3,1,2,3,1,546,61.9,6.52,12.94,1,"transport;other biological processes","non-structural extracellular;cytosol;other cell component","other molecular function","Pf09728","200081","D3DPP6; hsa:200081; P40222; Q5TFJ6; Q66K62; Q86T54; Q86T85; Q86T86; Q86Y86; Q86YW3; Q8N2Y3","ENSG00000084652","Other interleukin signaling",NA,1,0,66.2,89.1,86.7,107.4,115.4,105.8,110,119.8,125.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S515(99.5)]",0,"ENSG00000084652"
"685","ZDHHC5",0.246886293634906,6.66737993371191,3.48973951894018,0.00620442776640528,0.0147819359339758,-3.16775040945574,"NONE",FALSE,"High","Master Protein","Q9C0B5","Palmitoyltransferase ZDHHC5 [OS=Homo sapiens]",0,30.48,7,3,3,6,3,715,77.5,9.01,12.28,3,"protein metabolism;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","other molecular function","Pf01529","25921","hsa:25921; Q2TGF0; Q6ZMF0; Q8TAK8; Q9C0B5; Q9H923; Q9UFI7","ENSG00000156599","Maturation of spike protein",NA,1,0,86.3,83.8,83.7,106.9,95.4,109.7,117.3,112.6,119.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S380(100); S590(98.8)]",0,"ENSG00000156599"
"686","NOLC1",-0.30201495692628,6.60342065418421,-3.48487050571423,0.0062539561676154,0.0148782164220821,-3.17595961948997,"NONE",FALSE,"High","Master Protein","Q14978","Nucleolar and coiled-body phosphoprotein 1 [OS=Homo sapiens]",0,49.288,7,6,6,16,6,699,73.6,9.47,30.14,6,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf05022","9221","hsa:9221; Q14978; Q15030; Q5VV70; Q9BUV3","ENSG00000166197",NA,NA,0,0,110.3,110.8,110.6,87.7,100.7,88.7,96.3,89.4,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S538(100); S563(100); S623(100); S698(100)]",0,"ENSG00000166197"
"687","PSEN1",0.654907425849827,6.63894558640726,3.47821446491156,0.00632232840896798,0.0150189810239239,-3.18718410061535,"NONE",FALSE,"High","Master Protein","P49768","Presenilin-1 [OS=Homo sapiens]",0,26.739,4,1,2,4,1,467,52.6,5.31,11.64,1,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;other molecular function","Pf01080","5663","B2R6D3; hsa:5663; O95465; P49768; Q14762; Q15719; Q15720; Q96P33; Q9UIF0","ENSG00000080815","Degradation of the extracellular matrix; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; Neutrophil degranulation; Nuclear signaling by ERBB4; EPH-ephrin mediated repulsion of cells; NOTCH4 Activation and Transmission of Signal to the Nucleus; NRIF signals cell death from the nucleus; Regulated proteolysis of p75NTR; Noncanonical activation of NOTCH3","Alzheimer's disease and miRNA effects; Notch signaling; Canonical and non-canonical Notch signaling; Inclusion body myositis; Alzheimer's disease; DYRK1A involvement regarding cell proliferation in brain development; Neurogenesis regulation in the olfactory epithelium; TROP2 regulatory signaling; Notch signaling pathway",22,0,71.8,72.5,76.4,101.8,105.8,154.5,90.9,113,142.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S366(99.6)]",0,"ENSG00000080815"
"688","ZNF608",-0.223925706870401,6.62430090384782,-3.46739003537236,0.00643518307133408,0.0152648528668855,-3.2054436308143,"NONE",FALSE,"High","Master Protein","Q9ULD9","Zinc finger protein 608 [OS=Homo sapiens]",0,30.7,3,5,5,7,5,1512,162.1,8.79,21.12,5,"other biological processes","nucleus","other molecular function",NA,"57507","A7E2W9; hsa:57507; Q3SYM6; Q68D12; Q8IY05; Q9ULD9; Q9Y5A1","ENSG00000168916",NA,NA,0,0,109.5,106.1,107.9,94,89.6,97.8,96.1,93.9,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T481(100); S627(100); S964(100); S1430(100)]",0,"ENSG00000168916"
"689","GAPVD1",0.293245390137614,6.65315450987146,3.46057726146965,0.00650728404788683,0.0154134797767073,-3.21693949905208,"NONE",FALSE,"High","Master Protein","Q14C86","GTPase-activating protein and VPS9 domain-containing protein 1 [OS=Homo sapiens]",0,62.249,4,4,4,8,4,1478,164.9,5.22,29.8,4,"transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00616, Pf02204, Pf18151","26130","A8MYK3; B0QZ62; B0QZ63; B0QZ64; hsa:26130; Q14C76; Q14C86; Q2Q1W1; Q8ND92; Q8WU86; Q96CZ4; Q9NXQ1; Q9P207; Q9Y4N0","ENSG00000165219","RAB GEFs exchange GTP for GDP on RABs; Clathrin-mediated endocytosis",NA,2,0,89.1,81.6,91.3,116.4,103.8,111.4,98,107.9,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S569(99.5); S902(100)]",0,"ENSG00000165219"
"690","DENND2B",0.348696500744095,6.67174660484474,3.45439079323698,0.0065734837740096,0.0155477181437445,-3.22738086046153,"NONE",FALSE,"High","Master Protein","P78524","DENN domain-containing protein 2B [OS=Homo sapiens]",0,23.668,4,3,4,6,3,1137,126.4,9.25,10.56,3,"other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","enzyme regulator activity","Pf02141, Pf03455, Pf03456","6764","B2R6X7; B3KXQ6; hsa:6764; P78523; P78524; Q16492; Q7KYY2; Q7KZ12; Q8NE12; Q9BQQ6","ENSG00000166444","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,80.6,86.1,82.6,110.3,100.8,118.5,98.9,123.9,122.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S48(100); T364(100); S368(99.3); S622(100)]",0,"ENSG00000166444"
"691","TTLL12",-0.331801146125948,6.63041432048214,-3.45101145250075,0.0066099402207473,0.0156113204634726,-3.23308534655824,"NONE",FALSE,"High","Master Protein","Q14166","Tubulin--tyrosine ligase-like protein 12 [OS=Homo sapiens]",0,30.401,4,1,1,6,1,644,74.4,5.53,27.05,1,"protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf03133","23170","hsa:23170; Q14166; Q20WK5; Q9UGU3","ENSG00000100304","Carboxyterminal post-translational modifications of tubulin",NA,1,0,97.7,110.4,118.2,88.5,86.1,87.9,93.9,111,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(99.5)]",0,"ENSG00000100304"
"692","MICAL3",0.278915716243082,6.66303957972714,3.4476152478544,0.00664679019003417,0.0156703632878359,-3.23881894991731,"NONE",FALSE,"High","Master Protein","Q7RTP6","[F-actin]-monooxygenase MICAL3 [OS=Homo sapiens]",0,56.657,5,7,7,13,7,2002,224.2,5.55,30.22,7,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf00412, Pf01494, Pf12130","57553","B2RXJ5; E9PEF0; O94909; Q5U4P4; Q6ICK4; Q7RTP6; Q96DF2; Q9P2I3","ENSG00000243156",NA,NA,0,0,88.7,84,86.6,109,118.6,102.4,112.2,105.8,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S685(99.5); S977(100); S1221(100); S1310(100); S1649(100); S1792(100)]",0,"ENSG00000243156"
"693","SEC61B",-0.584004321725773,6.60836984285642,-3.44693990933273,0.00665414323435679,0.0156703632878359,-3.23995915966368,"NONE",FALSE,"High","Master Protein","P60468","Protein transport protein Sec61 subunit beta [OS=Homo sapiens]",0,26.137,26,2,3,5,2,96,10,11.56,17.33,2,"protein metabolism;other metabolic processes;stress response;transport","other membranes;cytosol;ER/Golgi","translation activity;other molecular function","Pf03911","10952","hsa:10952; P38390; P38391; P60468; Q6IBC1","ENSG00000106803","ER-Phagosome pathway; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; SRP-dependent cotranslational protein targeting to membrane",NA,3,0,101.3,116.7,131.2,66.7,104,67.3,99,94.1,113.3,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S17(96.9)]",0,"ENSG00000106803"
"694","RRAGC",-0.270128888919619,6.67049447699129,-3.44137226378333,0.00671508620086976,0.0157910960804315,-3.24936027993977,"NONE",FALSE,"High","Master Protein","Q9HB90","Ras-related GTP-binding protein C [OS=Homo sapiens]",0,25.581,4,1,2,7,1,399,44.2,5.1,24.24,1,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf04670","64121","hsa:64121; Q9H202; Q9H8Q8; Q9HB90","ENSG00000116954","Regulation of PTEN gene transcription; Macroautophagy; Amino acids regulate mTORC1; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Energy dependent regulation of mTOR by LKB1-AMPK","Target of rapamycin signaling; Orexin receptor pathway; 2q37 copy number variation syndrome",10,0,109.8,103,96.3,90.7,75,91.2,119,111.3,116.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(99.6)]",0,"ENSG00000116954"
"695","MTFR1L",-0.610992827967146,6.61899463474861,-3.43741579067393,0.00675874540949846,0.0158683931655807,-3.25604193528415,"NONE",FALSE,"High","Master Protein","Q9H019","Mitochondrial fission regulator 1-like [OS=Homo sapiens]",0,39.157,14,4,8,30,4,292,31.9,6.1,47.54,4,"cell organization and biogenesis;other metabolic processes","mitochondrion",NA,"Pf05308","56181","A6NCB4; B7WNV5; D3DPJ4; hsa:56181; Q63HP1; Q7Z2S7; Q9H019; Q9NUI7","ENSG00000117640",NA,NA,0,0,101.7,108.4,113.6,65.1,78.7,63.3,139.3,94.4,128.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(100); S103(100); S238(99.7)]",0,"ENSG00000117640"
"696","GBF1",0.666264606296344,6.67073452526848,3.43663438044615,0.0067674029676741,0.0158683931655807,-3.25736167539183,"NONE",FALSE,"High","Master Protein","Q92538-1","Isoform 4 of Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 [OS=Homo sapiens]",0,39.342,3,3,3,3,3,1859,206.3,5.73,12.64,3,NA,NA,NA,NA,NA,"Q92538-1",NA,NA,NA,0,0,80.7,71.9,87.1,125.3,90.8,184.9,93.4,111.6,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1298(100); T1337(100); S1784(99.5)]",0,"ENSG00000107862"
"697","MFHAS1",0.437701638360202,6.65810858043898,3.43444915192028,0.00679167515528346,0.0159024589001759,-3.26105253080182,"NONE",FALSE,"High","Master Protein","Q9Y4C4","Malignant fibrous histiocytoma-amplified sequence 1 [OS=Homo sapiens]",0,27.034,2,1,1,2,1,1052,116.9,7.88,8.05,1,"stress response;signal transduction;other biological processes","other cell component","other molecular function","Pf13855","9258","hsa:9258; Q96CI0; Q9Y4C4","ENSG00000147324",NA,"8p23.1 copy number variation syndrome",1,0,85.5,82.4,95.2,123.3,113.3,128.7,101.4,108.8,81.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1038(100)]",0,"ENSG00000147324"
"698","IL17RA",0.473780104585629,6.64673643169839,3.4226945008493,0.00692379779130749,0.0161885931166387,-3.28091058740285,"NONE",FALSE,"High","Master Protein","Q96F46","Interleukin-17 receptor A [OS=Homo sapiens]",0,32.903,5,2,2,3,2,866,96.1,5.21,11.96,2,"protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes","signal transduction activity or receptor binding;other molecular function","Pf08357, Pf16556, Pf16578","23765","hsa:23765; O43844; Q20WK1; Q96F46","ENSG00000177663","SARS-CoV-2 activates/modulates innate and adaptive immune responses; Interleukin-17 signaling","IL-17 signaling pathway; Comprehensive IL-17A signaling; COVID-19 and endothelial cell senescence",5,0,78.2,94.8,70,98.4,119,133.3,106.7,109.4,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S629(100); S708(100)]",0,"ENSG00000177663"
"699","C1orf198",0.384428171821854,6.68302674642102,3.40996453752494,0.00706989476282732,0.016506535411923,-3.30242456039729,"NONE",FALSE,"High","Master Protein","Q9H425","Uncharacterized protein C1orf198 [OS=Homo sapiens]",0,23.878,10,4,4,6,4,327,36.3,5.72,16.81,4,NA,"cytosol",NA,"Pf15797","84886","A8K8R8; B3KTW1; G5EA08; hsa:84886; Q9H425","ENSG00000119280",NA,NA,0,0,80.4,85.6,92.4,106,125.2,124.3,112.8,93.6,116.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S175(99.6); S289(100)]",0,"ENSG00000119280"
"700","TUBA1A",-0.36376295732898,6.5923621138063,-3.37960376859589,0.00743138275655286,0.017325738083849,-3.35376811795239,"NONE",FALSE,"High","Master Protein","Q71U36","Tubulin alpha-1A chain [OS=Homo sapiens]",0,322.324,44,15,21,54,15,451,50.1,5.06,194.19,15,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00091, Pf03953","7846","A8K0B8; G3V1U9; hsa:7846; P04687; P05209; Q71U36","ENSG00000167552","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Recycling pathway of L1; MHC class II antigen presentation; Recruitment of mitotic centrosome proteins and complexes; Formation of tubulin folding intermediates by CCT/TriC; Prefoldin mediated transfer of substrate  to CCT/TriC; COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; Intraflagellar transport; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; Sealing of the nuclear envelope (NE) by ESCRT-III; PKR-mediated signaling; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Hedgehog 'off' state","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease; PAFAH1B1 copy number variation",42,0,114.2,113.2,108.7,95.1,66.1,99.8,97.9,96.9,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S48(100); T73(100); S158(100); S287(100); T334(100)]",0,"ENSG00000167552"
"701","UCKL1",-0.379715919287744,6.44767269942476,-3.37796434923601,0.00745143928034489,0.017347715985054,-3.35654183925874,"NONE",FALSE,"High","Master Protein","Q9NWZ5","Uridine-cytidine kinase-like 1 [OS=Homo sapiens]",0,7.134,3,1,1,2,1,548,61.1,7.36,2.31,1,"other metabolic processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00485, Pf14681","54963","B7Z8N2; hsa:54963; Q5JWV0; Q70AQ5; Q8N524; Q9H3Z2; Q9NWZ5","ENSG00000198276","Pyrimidine salvage","Pyrimidine metabolism",2,0,128,108.9,125.9,84.6,112.4,91.8,66.8,63.6,68,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(99.4)]",0,"ENSG00000198276"
"702","GSK3B",-0.427877324541301,6.59079529135094,-3.37567454044683,0.0074795465268508,0.0173883474812258,-3.36041616126703,"NONE",FALSE,"High","Master Protein","P49841","Glycogen synthase kinase-3 beta [OS=Homo sapiens]",0,61.632,13,3,3,11,3,420,46.7,8.78,43.33,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069","2932","D3DN89; hsa:2932; P49841; Q9BWH3; Q9UL47","ENSG00000082701","Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Ubiquitin-dependent degradation of Cyclin D; Regulation of RUNX2 expression and activity; Regulation of HSF1-mediated heat shock response; Constitutive Signaling by AKT1 E17K in Cancer; B-WICH complex positively regulates rRNA expression; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; CRMPs in Sema3A signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; AKT phosphorylates targets in the cytosol; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Maturation of nucleoprotein; Maturation of nucleoprotein","IL-5 signaling pathway; Androgen receptor signaling pathway; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; Cell cycle; Leptin signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; Neural crest differentiation; IL-17 signaling pathway; B cell receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac progenitor differentiation; T cell receptor and co-stimulatory signaling; Cardiac hypertrophic response; Focal adhesion; Copper homeostasis; Melatonin metabolism and effects; Wnt signaling pathway; IL6 signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Regulation of apoptosis by parathyroid hormone-related protein; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Wnt signaling pathway and pluripotency; PI3K/AKT/mTOR - vitamin D3 signaling; Endometrial cancer; PI3K-Akt signaling pathway; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; Acute viral myocarditis; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; NRF2-ARE regulation; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Influence of laminopathies on Wnt signaling; MAP3K1 role in promoting and blocking gonadal determination; Overlap between signal transduction pathways contributing to LMNA laminopathies; Glycogen synthesis and degradation; Pleural mesothelioma; CCL18 signaling pathway; Alzheimer's disease; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Neurogenesis regulation in the olfactory epithelium; Sildenafil treatment; Macrophage-stimulating protein (MSP) signaling network map; HDAC6 interactions in the central nervous system; Notch signaling pathway; ErbB signaling pathway; DNA damage response (only ATM dependent)",95,0,111.8,112.4,115.6,76.5,101.8,81.4,87.7,91,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(99.4); S215(100); T390(98.7)]",0,"ENSG00000082701"
"703","LHFPL3",-1.14986131737475,6.44381437173689,-3.37062831886388,0.00754187695760712,0.0174878465245755,-3.36895515588391,"NONE",FALSE,"High","Master Protein","Q86UP9","LHFPL tetraspan subfamily member 3 protein [OS=Homo sapiens]",0,4.824,4,1,1,6,1,236,25.8,5.95,11.65,1,"other biological processes","plasma membrane;other membranes",NA,"Pf10242","375612","A1L383; A4D0Q5; hsa:375612; Q86UP9","ENSG00000187416",NA,NA,0,0,111.7,117,90,40.1,68.3,30.6,170.7,86.6,146.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S234(100)]",0,"ENSG00000187416"
"704","DCAF5",-0.234606374827568,6.58988610415933,-3.37047517771621,0.00754377693216984,0.0174878465245755,-3.3692143130527,"NONE",FALSE,"High","Master Protein","Q96JK2","DDB1- and CUL4-associated factor 5 [OS=Homo sapiens]",0,38.387,5,4,4,8,4,942,103.9,5.76,21.77,4,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf00400","8816","B2RN31; G3V4J7; hsa:8816; O60559; Q8N3V3; Q8N3V5; Q96JK2","ENSG00000139990","Neddylation",NA,1,0,104.9,108,110.6,91.2,94.7,96.3,91,94,88.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S648(100); S794(100)]",0,"ENSG00000139990"
"705","PGRMC2",-0.463783432387572,6.59122485708416,-3.36635722593688,0.0075950534087086,0.0175817406567552,-3.37618342984856,"NONE",FALSE,"High","Master Protein","O15173","Membrane-associated progesterone receptor component 2 [OS=Homo sapiens]",0,32.159,12,2,2,5,2,223,23.8,4.88,23.86,2,"transport;signal transduction;other biological processes","ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf00173","10424","hsa:10424; O15173; Q569H1","ENSG00000164040","RHOA GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Heme signaling","Ciliary landscape",7,0,100.7,97.2,84.3,64.9,65.3,66.1,152,114.8,128.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S104(100)]",0,"ENSG00000164040"
"706","MTFR1",0.243387484970339,6.64963461935281,3.35284266695365,0.00776588642362493,0.0179512523745405,-3.39906049886692,"NONE",FALSE,"High","Master Protein","Q15390","Mitochondrial fission regulator 1 [OS=Homo sapiens]",0,12.967,8,2,2,2,2,333,37,9.01,6.44,2,"cell organization and biogenesis;other metabolic processes","plasma membrane;other membranes;cytosol;mitochondrion",NA,"Pf05308","9650","E7EP84; hsa:9650; Q15390; Q6IB94; Q7Z669; Q86XH5; Q8IVD7","ENSG00000066855",NA,NA,0,0,79.8,75.9,75.5,91.5,93.7,96.4,131.3,129.7,146.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100); S290(100)]",0,"ENSG00000066855"
"707","RTN4",0.574539944671264,6.67144386044705,3.35199945745557,0.00777667612058831,0.0179512523745405,-3.40048812831904,"NONE",FALSE,"High","Master Protein","Q9NQC3","Reticulon-4 [OS=Homo sapiens]",0,201.37,14,10,16,53,10,1192,129.9,4.5,206.21,10,"cell adhesion;cell organization and biogenesis;stress response;developmental processes;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","other molecular function","Pf02453","57142","O94962; Q7L7Q5; Q7L7Q6; Q7L7Q8; Q8IUA4; Q96B16; Q9BXG5; Q9H212; Q9H3I3; Q9NQC3; Q9UQ42; Q9Y293; Q9Y2Y7; Q9Y5U6","ENSG00000115310","Axonal growth inhibition (RHOA activation)","Alzheimer's disease and miRNA effects; Spinal cord injury; 22q11.2 copy number variation syndrome; Alzheimer's disease; Neurogenesis regulation in the olfactory epithelium; 13q12.12 copy number variation",7,0,74.6,75.7,85.3,124.1,85.3,144.1,111.7,125.2,96.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S107(100); S111(100); S181(100); S863(99.5); T890(100); S983(100)]",0,"ENSG00000115310"
"708","KLHL9",0.364846135412683,6.61589529862441,3.35030531278667,0.0077984013056733,0.0179759758910435,-3.40335656102479,"NONE",FALSE,"High","Master Protein","Q9P2J3","Kelch-like protein 9 [OS=Homo sapiens]",0,10.005,3,1,1,1,1,617,69.4,6.35,3.8,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","other molecular function","Pf00651, Pf01344, Pf07707","55958","hsa:55958; Q8TCQ2; Q9P2J3","ENSG00000198642","Neddylation; Antigen processing: Ubiquitination & Proteasome degradation",NA,2,0,65.7,80.3,71.3,96.5,96.4,94.4,123.6,156.4,124,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S603(100)]",0,"ENSG00000198642"
"709","GIT1",0.281088804574997,6.66350433298444,3.34788346952973,0.00782956741871217,0.0180223611104912,-3.40745730879647,"NONE",FALSE,"High","Master Protein","Q9Y2X7","ARF GTPase-activating protein GIT1 [OS=Homo sapiens]",0,59.845,8,4,5,10,4,761,84.3,6.8,30.4,4,"transport;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;mitochondrion;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf01412, Pf08518, Pf12205, Pf12796, Pf16559","28964","B4DGU9; B4DSV3; hsa:28964; Q86SS0; Q9BRJ4; Q9Y2X7","ENSG00000108262","RHOJ GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; Ephrin signaling; Activation of RAC1 downstream of NMDARs","CAMKK2 pathway; Regulation of actin cytoskeleton",12,0,72.1,80.9,82.1,91.2,101,105.6,120.7,130,144.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(99.6); S410(100); S592(100)]",0,"ENSG00000108262"
"710","CRELD2",0.920597288322423,6.56548203958055,3.34470153356144,0.00787071104129142,0.0180915498864614,-3.41284545451162,"NONE",FALSE,"High","Master Protein","Q6UXH1","Protein disulfide isomerase CRELD2 [OS=Homo sapiens]",0,4.965,3,2,2,4,2,353,38.2,4.59,6.41,2,NA,"non-structural extracellular;ER/Golgi","other molecular function","Pf07645","79174","A5GZA2; A5GZA3; A5GZA4; A5GZA5; A5GZA6; hsa:79174; Q4W0V0; Q6UXH1; Q86UC0; Q9BU47","ENSG00000184164",NA,NA,0,0,68.1,61.2,70.1,107.1,220.8,105.3,132.3,79.1,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(99.6)]",0,"ENSG00000184164"
"711","BCLAF1",-0.447084588205672,6.5552509611783,-3.34244162329945,0.00790006836502779,0.0181334902555912,-3.41667254572725,"NONE",FALSE,"High","Master Protein","Q9NYF8","Bcl-2-associated transcription factor 1 [OS=Homo sapiens]",0,368.127,19,28,32,107,28,920,106.1,9.98,298.68,28,"stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15440","9774","A2RU75; B7ZM58; E1P586; hsa:9774; Q14673; Q86WU6; Q86WY0; Q9NYF8","ENSG00000029363",NA,"Interactome of polycomb repressive complex 2 (PRC2)",1,0,118.8,118.8,116.9,86.2,108.2,74,91.3,77.3,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S153(100); S177(100); S183(99.6); S222(100); S285(100); S290(100); S397(100); S496(100); S512(100); S531(100); S648(100); S658(100); S690(100); S884(99.5)]",0,"ENSG00000029363"
"712","PFKFB3",0.547161252654173,6.62912948748443,3.34155630965444,0.00791159988460313,0.0181344536680791,-3.41817185710575,"NONE",FALSE,"High","Master Protein","Q16875","6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 [OS=Homo sapiens]",0,14.773,3,1,1,1,1,520,59.6,8.21,4.89,1,"other metabolic processes","cytosol;nucleus","kinase activity;other molecular function","Pf00300, Pf01591","5209","B7Z955; hsa:5209; O43622; O75902; Q16875; Q5VX15; Q5VX18; Q5VX19","ENSG00000170525","Regulation of glycolysis by fructose 2,6-bisphosphate metabolism","AMP-activated protein kinase signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway",3,0,85.6,76.7,60.5,112.6,103.4,113.3,100.8,138,126,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S461(100)]",0,"ENSG00000170525"
"713","SRSF4",-0.293308954265463,6.58471650260374,-3.33786109790905,0.00795991968806955,0.0181910178430428,-3.42443019007945,"NONE",FALSE,"High","Master Protein","Q08170","Serine/arginine-rich splicing factor 4 [OS=Homo sapiens]",0,14.257,5,3,5,7,2,494,56.6,11.52,10.41,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076","6429","hsa:6429; Q08170; Q5VXP1; Q9BUA4; Q9UEB5","ENSG00000116350","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination","mRNA processing",6,0,117.2,113.2,112,99,98.6,88.6,89.5,89.2,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S269(100); S456(100)]",0,"ENSG00000116350"
"714","FAM76B",-0.663375239774838,6.48261349028566,-3.33747010834808,0.00796505022836529,0.0181910178430428,-3.42509241630028,"NONE",FALSE,"High","Master Protein","Q5HYJ3","Protein FAM76B [OS=Homo sapiens]",0,8.078,4,1,1,2,1,339,38.7,9.25,7.66,1,NA,"nucleus",NA,"Pf16046","143684","B2R9C2; hsa:143684; Q5HYJ3; Q6PIU3; Q8TC53","ENSG00000077458",NA,NA,0,0,123.7,121.3,145.8,87.3,74.1,82.4,68.9,96.6,60.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000077458"
"715","NME2",0.249915919504859,6.66692204400838,3.33711470604101,0.00796971676334291,0.0181910178430428,-3.42569437324415,"NONE",FALSE,"High","Master Protein","P22392","Nucleoside diphosphate kinase B [OS=Homo sapiens]",0,25.186,22,3,3,3,3,152,17.3,8.41,8.49,3,"cell adhesion;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;cytoskeleton;mitochondrion;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00334","4831; 654364","A8MWA3; hsa:4831; hsa:654364; P22392; Q1WM23; Q6LCT6","ENSG00000243678","Neutrophil degranulation; Interconversion of nucleotide di- and triphosphates; Azathioprine ADME; Ribavirin ADME","Pyrimidine metabolism",5,0,85.3,89.4,92.3,113.7,111.1,106.2,102.8,112.5,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T94(100)]",0,"ENSG00000243678"
"716","SNRNP70",0.291117420157983,6.65354326640842,3.33268191516542,0.00802815880746714,0.0182576205863002,-3.43320277986362,"NONE",FALSE,"High","Master Protein","P08621","U1 small nuclear ribonucleoprotein 70 kDa [OS=Homo sapiens]",0,33.505,11,2,2,3,2,437,51.5,9.94,11.32,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf12220","6625","B3KUA3; hsa:6625; P08621; P78493; P78494; Q15364; Q15686; Q15687; Q15689; Q99377; Q9UE45; Q9UE46; Q9UE47; Q9UE48; Q9UFQ6","ENSG00000104852","mRNA Splicing - Major Pathway","mRNA processing",2,0,78.8,87.4,85.6,98.5,117.1,110.5,117.3,109.9,108.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S226(100); S320(100)]",0,"ENSG00000104852"
"717","H1-4",-0.348500161757061,6.6181490923281,-3.33237139155113,0.00803226933965014,0.0182576205863002,-3.43372878519235,"NONE",FALSE,"High","Master Protein","P10412","Histone H1.4 [OS=Homo sapiens]",0,135.492,41,12,13,21,4,219,21.9,11.03,58.08,12,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","3008","hsa:3008; P10412; Q4VB25","ENSG00000168298","Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Pathways affected in adenoid cystic carcinoma",3,9,105.5,102.9,103.7,82.4,68.1,95.2,96,107.9,124.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S104(100); S113(100)]",0,"ENSG00000168298"
"718","WASHC2A",0.225022934388725,6.66286508975847,3.33235713766808,0.00803245807657082,0.0182576205863002,-3.43375293036988,"NONE",FALSE,"High","Master Protein","Q641Q2","WASH complex subunit 2A [OS=Homo sapiens]",0,93.519,8,6,7,18,1,1341,147.1,4.81,56.96,6,"transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf15255","387680","A2A3S2; A2A3U6; hsa:387680; Q5SNT6; Q641Q2; Q6DHY0","ENSG00000099290",NA,NA,0,4,88.7,91.6,96.1,112.3,115.7,110.1,101.6,102,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S333(99.7); S498(100); S539(100); S728(100)]",0,"ENSG00000099290"
"719","ARFGAP3",0.26378549461579,6.65745768287493,3.33072022271248,0.00805416315381467,0.018281494112692,-3.43652581597924,"NONE",FALSE,"High","Master Protein","Q9NP61","ADP-ribosylation factor GTPase-activating protein 3 [OS=Homo sapiens]",0,22.285,3,1,2,3,1,516,56.9,7.36,6.75,1,"cell organization and biogenesis;transport","other membranes;cytosol;ER/Golgi","enzyme regulator activity;other molecular function","Pf01412","26286","E9PB03; hsa:26286; Q9BSC6; Q9H9J0; Q9NP61; Q9NT10; Q9NUP5; Q9Y4V3; Q9Y4V4","ENSG00000242247","CDC42 GTPase cycle; RHOG GTPase cycle; COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport","Ciliary landscape",5,0,84.6,79.8,78.4,104,99,98.7,117.3,131.1,121.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S454(98.9)]",0,"ENSG00000242247"
"720","ABR",0.261883768945294,6.66278457549087,3.32329525810929,0.00815338060627656,0.0184809960408935,-3.44910484340091,"NONE",FALSE,"High","Master Protein","Q12979","Active breakpoint cluster region-related protein [OS=Homo sapiens]",0,29.682,6,2,2,3,2,859,97.5,6.55,12.82,2,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00168, Pf00620, Pf00621","29","B3KW89; B7Z6H7; D3DTH3; D3DTH4; F5H3S2; F5H8B3; hsa:29; Q12979; Q13693; Q13694","ENSG00000159842; ENSG00000276016; ENSG00000278741","RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle",NA,9,0,92.3,92.7,86.6,111.6,109.9,117.8,96.3,110.2,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S53(100); S72(100)]",0,"ENSG00000159842"
"721","MTSS2",0.52098933427479,6.59589702675824,3.32069541303667,0.0081884195660783,0.0185346750788347,-3.45350989752394,"NONE",FALSE,"High","Master Protein","Q765P7","Protein MTSS 2 [OS=Homo sapiens]",0,22.086,4,2,2,6,2,747,79.9,7.47,22.25,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf08397","92154","A6NJI7; hsa:92154; Q765P7; Q9BUA8","ENSG00000132613",NA,NA,0,0,59.6,63.2,64.6,78.2,123.7,82.3,139.7,140.8,194.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S456(100); S612(100)]",0,"ENSG00000132613"
"722","HP1BP3",-0.313515171203435,6.56288964857118,-3.31460141160119,0.00827116193314257,0.0186960336217295,-3.46383631777834,"NONE",FALSE,"High","Master Protein","Q5SSJ5","Heterochromatin protein 1-binding protein 3 [OS=Homo sapiens]",0,47.587,10,7,7,12,7,553,61.2,9.67,28.53,7,"cell organization and biogenesis;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","50809","A6NI71; A8K5D7; B3KMZ8; B4E210; hsa:50809; Q05BI0; Q5SSJ5; Q5SSJ6; Q5SWC6; Q6PIM9; Q8NDF0; Q9UHY0","ENSG00000127483",NA,NA,0,0,117.2,116.3,109.2,93.2,104.3,85.8,88.2,81.3,81.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T51(100); S249(99.6)]",0,"ENSG00000127483"
"723","MVB12B",-0.431328164569322,6.62005370715815,-3.31085277157556,0.00832248868388499,0.0187304848103225,-3.47018917998126,"NONE",FALSE,"High","Master Protein","Q9H7P6","Multivesicular body subunit 12B [OS=Homo sapiens]",0,8.569,3,1,2,2,1,319,35.6,8.15,6.05,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf10240","89853","hsa:89853; Q8N6S7; Q9H7P6","ENSG00000196814","HCMV Late Events; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy",NA,5,0,105.9,106.2,136.7,91.3,63.6,103.8,94,96,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T226(100)]",0,"ENSG00000196814"
"724","AFAP1",-0.323244310871543,6.61976976629299,-3.31082320411422,0.00832289483058617,0.0187304848103225,-3.47023929040844,"NONE",FALSE,"High","Master Protein","Q8N556","Actin filament-associated protein 1 [OS=Homo sapiens]",0,38.528,5,2,3,5,2,730,80.7,8.68,13.17,2,NA,"cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169","60312","A8K442; B4DMU2; E9PDT7; hsa:60312; Q59EY5; Q8N556; Q9HBY1","ENSG00000196526",NA,NA,0,0,109.2,105.3,106.8,80.1,96.8,86.7,100.8,96,110.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S265(100); S668(100)]",0,"ENSG00000196526"
"725","NUMA1",-0.242038140958952,6.63549567369256,-3.31071709558324,0.00832435253495695,0.0187304848103225,-3.47041912160151,"NONE",FALSE,"High","Master Protein","Q14980","Nuclear mitotic apparatus protein 1 [OS=Homo sapiens]",0,67.958,2,2,2,8,2,2115,238.1,5.78,33.95,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf21670","4926","H0YH75; hsa:4926; Q14980; Q14981; Q9BTE9","ENSG00000137497","Recruitment of NuMA to mitotic centrosomes; Mitotic Prophase","Ectoderm differentiation; Ectoderm differentiation; 8p23.1 copy number variation syndrome",5,0,107.3,105.4,111.4,90.5,86.5,101.3,93.5,100.4,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100); S1757(99.6)]",0,"ENSG00000137497"
"726","SH3GL1",0.553680473006655,6.61424215314029,3.31013810646697,0.00833231125753316,0.0187304848103225,-3.47140039140645,"NONE",FALSE,"High","Master Protein","Q99961","Endophilin-A2 [OS=Homo sapiens]",0.003,2.39,2,1,2,3,1,368,41.5,5.43,6.76,1,"cell organization and biogenesis;transport;developmental processes;signal transduction","other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf00018, Pf03114","6455","B4DRA1; E7EVZ4; hsa:6455; M0QZV5; Q99668; Q99961","ENSG00000141985","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell","Fragile X syndrome",6,0,65.2,72.5,61.4,84.6,120.4,99.1,111.8,164.6,171.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S287(99.3)]",0,"ENSG00000141985"
"727","LIMA1",0.293346407803802,6.62894191592417,3.30443297767604,0.00841115517138616,0.0188817128469081,-3.48107010509653,"NONE",FALSE,"High","Master Protein","Q9UHB6","LIM domain and actin-binding protein 1 [OS=Homo sapiens]",0,123.889,17,11,13,38,11,759,85.2,6.84,109.95,11,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00412","51474","B2RB09; hsa:51474; Q2TAN7; Q59FE8; Q9BVF2; Q9H8J1; Q9HBN5; Q9NX96; Q9NXC3; Q9NXU6; Q9P0H8; Q9UHB5; Q9UHB6","ENSG00000050405",NA,NA,0,0,71.2,74.3,74.7,90.6,102.7,87.3,131.7,130.5,154.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S132(100); S225(99.2); S362(100); S369(99.7); S490(100); S609(100); S617(100); S698(100); S726(100)]",0,"ENSG00000050405"
"728","KIAA1143",0.389090133673353,6.62138423012032,3.29363352320688,0.00856251968129576,0.0191950990657619,-3.49937753389264,"NONE",FALSE,"High","Master Protein","Q96AT1","Uncharacterized protein KIAA1143 [OS=Homo sapiens]",0,8.777,9,1,1,3,1,154,17.5,6.11,7.99,1,NA,NA,NA,"Pf15377","57456","A8K0I4; hsa:57456; Q96AT1; Q96HJ8; Q9ULS7","ENSG00000163807; ENSG00000281665",NA,NA,0,0,72.7,81.3,76.9,89.8,124,108.2,104.5,126.8,123.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(100)]",0,"ENSG00000163807"
"729","TPI1",0.268254955374643,6.65253468161276,3.29108648514286,0.00859862718517287,0.0192496015997286,-3.50369592477468,"NONE",FALSE,"High","Master Protein","P60174","Triosephosphate isomerase [OS=Homo sapiens]",0,62.072,27,5,5,9,5,249,26.7,6.9,32.16,5,"other metabolic processes","cytosol","other molecular function","Pf00121","7167","B7Z5D8; D3DUS9; hsa:7167; P00938; P60174; Q6FHP9; Q6IS07; Q8WWD0; Q96AG5","ENSG00000111669","Glycolysis; Gluconeogenesis","Fatty acid beta-oxidation; Cori cycle; HIF1A and PPARG regulation of glycolysis; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; Disorders of fructose metabolism; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",10,0,77,75.5,82,98.9,102.7,92.8,126.1,122.4,143.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S212(100)]",0,"ENSG00000111669"
"730","SP3",-0.53938578092116,6.54433179492625,-3.28340732928379,0.00870844381975519,0.0194687401559459,-3.51671695567661,"NONE",FALSE,"High","Master Protein","Q02447","Transcription factor Sp3 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,781,81.9,5.26,5.52,1,"developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","6670","A0AVL9; B4E2B7; hsa:6670; Q02447; Q69B26; Q69B27; Q8TD56; Q8WWU4; Q9BQR1","ENSG00000172845","SUMOylation of transcription factors","Selenium metabolism and selenoproteins; MECP2 and associated Rett syndrome; Non-genomic actions of 1,25 dihydroxyvitamin D3; Sudden infant death syndrome (SIDS) susceptibility pathways",5,0,125.3,103.9,120.4,86.8,64.7,84.6,110.7,73.4,88.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S73(100)]",0,"ENSG00000172845"
"731","SUDS3",-0.57519552696953,6.48239186848969,-3.28094175884934,0.00874400934447462,0.0195215092341759,-3.52089808400472,"NONE",FALSE,"High","Master Protein","Q9H7L9","Sin3 histone deacetylase corepressor complex component SDS3 [OS=Homo sapiens]",0,8.632,7,1,1,1,1,328,38.1,5.66,3.53,1,"cell organization and biogenesis;other biological processes","cytosol;nucleus","other molecular function","Pf08598","64426","hsa:64426; Q4KMQ5; Q8N6H0; Q9H7L9; Q9H8D2","ENSG00000111707","Ub-specific processing proteases; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Potential therapeutics for SARS",NA,4,0,130.7,114.7,107.4,68.9,63.7,99.2,66.3,91.6,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S234(100); S236(99)]",0,"ENSG00000111707"
"732","STUB1",-0.311337524721228,6.63235117115125,-3.27349367301461,0.00885236055590518,0.019736410419723,-3.5335298141499,"NONE",FALSE,"High","Master Protein","Q9UNE7","E3 ubiquitin-protein ligase CHIP [OS=Homo sapiens]",0,46.596,6,2,3,9,2,303,34.8,5.87,37.78,2,"protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;other molecular function","Pf04564, Pf12895, Pf18391","10273","A2IDB9; O60526; Q969U2; Q9HBT1; Q9UNE7","ENSG00000103266","Antigen processing: Ubiquitination & Proteasome degradation; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Regulation of necroptotic cell death; Downregulation of ERBB2 signaling; Regulation of TNFR1 signaling; Downregulation of TGF-beta receptor signaling","Androgen receptor signaling pathway; Parkin-ubiquitin proteasomal system pathway; HDAC6 interactions in the central nervous system",11,0,105.5,105.3,115.1,95.1,85.5,84.5,110,96.6,96.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100)]",0,"ENSG00000103266"
"733","ADGRL3",0.380539367268459,6.69636856898496,3.26761506897663,0.0089388578347162,0.0199020681940748,-3.5435010181257,"NONE",FALSE,"High","Master Protein","Q9HAR2","Adhesion G protein-coupled receptor L3 [OS=Homo sapiens]",0,27.046,4,3,3,5,3,1447,161.7,6.44,12.87,3,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction","plasma membrane;other membranes;other cell component","other molecular function","Pf00002, Pf01825, Pf02140, Pf02191, Pf02354, Pf02793, Pf16489","23284","E9PE04; hsa:23284; O94867; Q9HAR2; Q9NWK5","ENSG00000150471",NA,"GPCRs, other; GPCRs, class B secretin-like",2,0,83.1,91.6,74.8,109.3,97.2,126.3,111.1,128.8,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1132(100); S1419(99.7)]",0,"ENSG00000150471"
"734","STK32C",-0.440208594187037,6.55968464870369,-3.2576316224169,0.00908775726454399,0.0202060216018199,-3.56043726773152,"NONE",FALSE,"High","Master Protein","Q86UX6","Serine/threonine-protein kinase 32C [OS=Homo sapiens]",0,11.955,3,1,1,4,1,486,55,6.61,3.59,1,"other metabolic processes;signal transduction",NA,"kinase activity;other molecular function","Pf00069","282974","hsa:282974; Q5T0Q5; Q86UE1; Q86UX6","ENSG00000165752",NA,NA,0,0,129.9,120.6,92.7,78,72,96.4,96.6,82.7,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100)]",0,"ENSG00000165752"
"735","ARHGAP1",-0.284227356939382,6.63662752226999,-3.25467944559004,0.00913227637512139,0.0202773810125144,-3.56544601602602,"NONE",FALSE,"High","Master Protein","Q07960","Rho GTPase-activating protein 1 [OS=Homo sapiens]",0,17.786,5,3,3,4,3,439,50.4,6.29,12.87,3,"transport;signal transduction;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf13716","392","D3DQQ6; hsa:392; Q07960","ENSG00000175220","RHOA GTPase cycle; RHOB GTPase cycle; RHOC GTPase cycle; RND2 GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle",NA,13,0,106.7,109.5,116.4,93.9,75.6,104.9,93.7,96.7,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S47(98.9); S51(99.8)]",0,"ENSG00000175220"
"736","TBC1D17",0.639462176799312,6.61741909817575,3.25381582059274,0.00914534241114176,0.0202788027377491,-3.56691131578911,"NONE",FALSE,"High","Master Protein","Q9HA65","TBC1 domain family member 17 [OS=Homo sapiens]",0,15.172,11,2,2,7,2,648,72.6,5.21,17.9,2,"other metabolic processes;transport","cytosol;other cytoplasmic organelle","enzyme regulator activity","Pf00566, Pf12068","79735","B4DT12; B9A6L8; F5H1W7; hsa:79735; Q9HA65","ENSG00000104946","TBC/RABGAPs",NA,1,0,65.3,63.1,84.9,99.8,100.7,138.5,94.1,147.7,122.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S602(99.2); T620(100)]",0,"ENSG00000104946"
"737","NCOR1",-0.277086835779487,6.5985713572978,-3.25107434592735,0.00918694689216678,0.020343415641813,-3.57156287972882,"NONE",FALSE,"High","Master Protein","O75376","Nuclear receptor corepressor 1 [OS=Homo sapiens]",0,44.076,4,6,8,10,6,2440,270,7.11,22.92,6,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00249, Pf15784","9611","B3DLF8; E9PGV6; hsa:9611; O75376; Q86YY0; Q9UPV5; Q9UQ18","ENSG00000141027","PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Heme signaling; Transcriptional activation of mitochondrial biogenesis; HDACs deacetylate histones; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Nuclear Receptor transcription pathway; Cytoprotection by HMOX1; Nuclear signaling by ERBB4; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NR1D1 (REV-ERBA) represses gene expression; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis","Androgen receptor signaling pathway; Adipogenesis; Ovarian infertility; MECP2 and associated Rett syndrome; Pathways affected in adenoid cystic carcinoma; Rett syndrome; 22q11.2 copy number variation syndrome; Notch signaling pathway",30,0,117.8,109.7,112.4,90.4,103.7,94.3,91.9,90.6,83.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1322(100); S1472(100); S1977(99.4); S1980(98.4); S1981(98.4); S2120(100); S2184(100)]",0,"ENSG00000141027"
"738","LRRC4C",0.584805904508809,6.54972720947547,3.24956297964152,0.00920996673927263,0.0203667557161151,-3.57412736525259,"NONE",FALSE,"High","Master Protein","Q9HCJ2","Leucine-rich repeat-containing protein 4C [OS=Homo sapiens]",0,3.857,2,1,1,1,1,640,71.9,7.15,2.53,1,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00560, Pf07679, Pf13855","57689","A8K0T1; hsa:57689; Q7L0N3; Q9HCJ2","ENSG00000148948",NA,NA,0,0,95.6,66.5,79.1,110.7,178.9,110.2,77.1,98.6,86.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S631(100)]",0,"ENSG00000148948"
"739","RFTN2",-0.337500835159492,6.59468185676157,-3.24552914797396,0.00927169835727338,0.0204755233005009,-3.58097228791342,"NONE",FALSE,"High","Master Protein","Q52LD8","Raftlin-2 [OS=Homo sapiens]",0,7.514,2,1,1,2,1,501,55.9,5.83,3.27,1,"transport;other biological processes","plasma membrane;other membranes",NA,"Pf15250","130132","hsa:130132; Q14DH4; Q2TA69; Q52LD8; Q53QE0; Q53SE1; Q96NM3","ENSG00000162944",NA,NA,0,0,113.4,117.5,107.2,92.5,67.4,107.8,93.1,91,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S453(99.5)]",0,"ENSG00000162944"
"740","SLC12A2",-0.427673658342605,6.53475269112416,-3.24258253455542,0.00931706132588981,0.0205451122998894,-3.58597262223061,"NONE",FALSE,"High","Master Protein","P55011","Solute carrier family 12 member 2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1212,131.4,6.4,4.39,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522, Pf08403","6558","hsa:6558; P55011; Q8N713; Q8WWH7","ENSG00000064651","Cation-coupled Chloride cotransporters","Polycystic kidney disease pathway",2,0,107.4,119.5,106.2,90.8,58.8,98.8,83.9,99.5,83.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S940(99.4)]",0,"ENSG00000064651"
"741","PABPC1",-1.33135593564099,6.1577818741191,-3.24108355133853,0.00934022585777562,0.0205451122998894,-3.58851645401978,"NONE",FALSE,"High","Master Protein","P11940","Polyadenylate-binding protein 1 [OS=Homo sapiens]",0,3.265,2,1,1,1,1,636,70.6,9.5,2.58,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf00658","26986","hsa:26986; P11940; Q15097; Q93004","ENSG00000070756","AUF1 (hnRNP D0) binds and destabilizes mRNA; Regulation of expression of SLITs and ROBOs; Deadenylation of mRNA; M-decay: degradation of maternal mRNAs by maternally stored factors; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Z-decay: degradation of maternal mRNAs by zygotically expressed factors","Translation factors; Endoderm differentiation; VEGFA-VEGFR2 signaling; Acute viral myocarditis",13,0,215.9,132.1,112.5,55.1,50,60.6,80.8,42.4,53.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T319(100)]",0,"ENSG00000070756"
"742","RELCH",0.423452633422781,6.63615998635048,3.24075402575327,0.00934532613710066,0.0205451122998894,-3.58907567979004,"NONE",FALSE,"High","Master Protein","Q9P260","RAB11-binding protein RELCH [OS=Homo sapiens]",0,13.825,2,2,3,5,2,1216,134.5,5.45,6.59,2,"transport","ER/Golgi;other cytoplasmic organelle",NA,NA,"57614","hsa:57614; Q9P260","ENSG00000134444",NA,NA,0,0,78.7,79.4,79,109.7,133.6,95.5,96.3,119.4,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(100); S180(100)]",0,"ENSG00000134444"
"743","ANTXR1",-0.259455841428293,6.62869139382072,-3.24012084229815,0.00935513438556813,0.0205451122998894,-3.59015024050065,"NONE",FALSE,"High","Master Protein","Q9H6X2","Anthrax toxin receptor 1 [OS=Homo sapiens]",0,34.392,6,2,2,13,2,564,62.7,7.61,42.28,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00092, Pf05586, Pf05587","84168","A8K7U8; hsa:84168; J7K7G4; J7KF88; Q4ZFV6; Q53QD8; Q96P02; Q9H6X2; Q9NVP3","ENSG00000169604",NA,"Primary ovarian insufficiency",1,0,107,108.9,101,92.8,76.3,96.3,107.2,102.2,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100); S563(100)]",0,"ENSG00000169604"
"744","ARHGEF17",0.233684627732256,6.66131708624216,3.23941026474668,0.00936615413671427,0.0205451122998894,-3.59135615789861,"NONE",FALSE,"High","Master Protein","Q96PE2","Rho guanine nucleotide exchange factor 17 [OS=Homo sapiens]",0,33.827,3,6,6,8,6,2063,221.5,6.29,21.14,6,"cell organization and biogenesis;other biological processes","cytosol","enzyme regulator activity","Pf00621, Pf19056, Pf19057","9828","B2RP20; hsa:9828; Q86XU2; Q8N2S0; Q96PE2; Q9Y4G3","ENSG00000110237","RHOC GTPase cycle; RHOA GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle",NA,5,0,84.2,90.5,87.2,102.8,103.5,115.4,104.3,114.5,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S79(100); S420(100); S764(100)]",0,"ENSG00000110237"
"745","HNRNPA3",0.435712053548746,6.61274609927978,3.2357101513232,0.00942375274504798,0.0206356504333687,-3.59763582071008,"NONE",FALSE,"High","Master Protein","P51991","Heterogeneous nuclear ribonucleoprotein A3 [OS=Homo sapiens]",0,23.18,6,1,1,3,1,378,39.6,9.01,8,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf00076","220988","D3DPF4; hsa:220988; P51991; Q53RW7; Q6URK5","ENSG00000170144","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA",NA,2,0,90.6,86.3,84.2,106,168.8,116.1,89.4,83,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S358(100)]",0,"ENSG00000170144"
"746","SLC16A2",0.340997669870985,6.66280785128311,3.2351363457911,0.00943271766133152,0.0206356504333687,-3.59860968987571,"NONE",FALSE,"High","Master Protein","P36021","Monocarboxylate transporter 8 [OS=Homo sapiens]",0,22.529,2,1,1,3,1,539,59.5,5.59,10.35,1,"cell-cell signaling;other metabolic processes;transport;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function",NA,"6567","hsa:6567; P36021; Q7Z797","ENSG00000147100","Transport of organic anions","Angiopoietin-like protein 8 regulatory pathway",2,0,77,72.6,81.6,116.9,89.5,92.9,124.6,130.3,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T80(100)]",0,"ENSG00000147100"
"747","ARHGEF40",0.287069986559754,6.65806327330327,3.23326254439945,0.00946205448640869,0.0206470400830857,-3.60178998703458,"NONE",FALSE,"High","Master Protein","Q8TER5","Rho guanine nucleotide exchange factor 40 [OS=Homo sapiens]",0,20.71,2,3,3,6,3,1519,164.6,6.15,15.61,3,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity","Pf00621","55701","A5PL07; hsa:55701; Q8TER5; Q9BWP5; Q9H7L6; Q9NTF9; Q9NW24","ENSG00000165801","RHOA GTPase cycle; RHOC GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events",NA,4,0,82.4,89.6,90.1,102.2,111.2,121,96.5,110.7,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S262(100); S1504(100); S1513(100)]",0,"ENSG00000165801"
"748","WDR44",0.255124137692759,6.65990345099784,3.23281605022734,0.00946905880417998,0.0206470400830857,-3.60254780993321,"NONE",FALSE,"High","Master Protein","Q5JSH3","WD repeat-containing protein 44 [OS=Homo sapiens]",0,85.395,13,7,8,18,7,913,101.3,5.45,41.63,7,"cell organization and biogenesis;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00400","54521","B4DSE9; F8W913; hsa:54521; Q0JS52; Q0JTF3; Q5JSH2; Q5JSH3; Q6ZSC1; Q7Z365; Q7Z3P6; Q8NAU8; Q8NHU5; Q9NUV4","ENSG00000131725",NA,"Ectoderm differentiation",1,0,88.8,90.8,92,118.1,109.1,109.1,103.9,104.9,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100); S96(99.4); S162(99.1); S344(100); S403(100); S561(100)]",0,"ENSG00000131725"
"749","CLASP2",0.265490689542974,6.67221965316323,3.23166740219559,0.00948710263611101,0.0206470400830857,-3.60449740410272,"NONE",FALSE,"High","Master Protein","O75122","CLIP-associating protein 2 [OS=Homo sapiens]",0,83.747,6,4,6,13,4,1294,141,8.4,49.02,4,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf12348, Pf21040","23122","B2RTR1; F5H604; hsa:23122; O75122; Q7L8F6; Q8N6R6; Q9BQT3; Q9BQT4; Q9H7A3; Q9NSZ2","ENSG00000163539","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Role of ABL in ROBO-SLIT signaling","7q11.23 copy number variation syndrome",8,0,81.5,85.1,83.2,100.7,115.8,100.4,116.7,114.3,129,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S370(99.8); S404(98.8); S525(100); S529(99.3); S596(100)]",0,"ENSG00000163539"
"750","RRBP1",-0.432885261566661,6.59939680021181,-3.23157666907518,0.00948852944994749,0.0206470400830857,-3.6046514064029,"NONE",FALSE,"High","Master Protein","Q9P2E9","Ribosome-binding protein 1 [OS=Homo sapiens]",0,37.85,7,8,8,10,8,1410,152.4,8.6,12.71,8,"protein metabolism;other metabolic processes;transport","other membranes;ER/Golgi;translational apparatus","other molecular function","Pf05104","6238","A0A0A0MRV0; A2A2S6; A6NCN6; hsa:6238; O75300; O75301; Q5W165; Q96SB2; Q9BWP1; Q9H476; Q9P2E9","ENSG00000125844","Signaling by ALK fusions and activated point mutants","Ectoderm differentiation",2,0,103.9,112.4,114.1,83.8,98.8,69.1,107.4,91.5,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S135(99.6); T225(100); T245(100); T255(100); S533(100); S573(100); S583(100)]",0,"ENSG00000125844"
"751","NSFL1C",0.309717755095523,6.68470178311489,3.22425283303888,0.00960443209867547,0.0208714156924612,-3.61708292468527,"NONE",FALSE,"High","Master Protein","Q9UNZ2-4","Isoform 2 of NSFL1 cofactor p47 [OS=Homo sapiens]",0,49.044,19,5,5,7,5,339,37.3,5.11,17.41,5,NA,NA,NA,NA,NA,"Q9UNZ2-4",NA,NA,NA,0,0,78.2,84.2,95.4,115,118.8,100.5,111.5,110.8,116.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(100); S140(100)]",0,"ENSG00000088833"
"752","SCAP",-0.315625582685689,6.60156276488774,-3.22318355956199,0.00962147542367188,0.0208806487917985,-3.61889802766887,"NONE",FALSE,"High","Master Protein","Q12770","Sterol regulatory element-binding protein cleavage-activating protein [OS=Homo sapiens]",0,27.266,4,2,2,2,2,1279,139.6,6.86,9.19,2,"cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;ER/Golgi","other molecular function","Pf00400, Pf12349","22937","hsa:22937; Q12770; Q8N2E0; Q8WUA1","ENSG00000114650","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Sterol regulatory element-binding proteins (SREBP) signaling",2,0,120.1,116.8,102.4,99.9,86.6,86.7,98,86.6,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S851(100)]",0,"ENSG00000114650"
"753","TERF2",-0.389868980902301,6.6577738217553,-3.21287896093042,0.00978732783958626,0.021212375875438,-3.63639160393239,"NONE",FALSE,"High","Master Protein","Q15554","Telomeric repeat-binding factor 2 [OS=Homo sapiens]",0,9.686,3,1,1,1,1,542,59.6,9.35,3.27,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00249, Pf08558, Pf16772","7014","hsa:7014; Q15554","ENSG00000132604","Meiotic synapsis; Telomere Extension By Telomerase; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand","Hematopoietic stem cell gene regulation by GABP alpha/beta complex; DNA repair pathways, full network; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",17,0,115.4,110.4,112.7,89.3,79.9,89.6,117.6,111,87.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100)]",0,"ENSG00000132604"
"754","TRIM9",-0.312788934597356,6.56707896169394,-3.20552145399109,0.00990754644241737,0.0214443439839381,-3.64888355817002,"NONE",FALSE,"High","Master Protein","Q9C026-5","Isoform 5 of E3 ubiquitin-protein ligase TRIM9 [OS=Homo sapiens]",0,28.266,6,3,5,9,3,550,61.3,7.37,31.63,3,NA,NA,NA,NA,NA,"Q9C026-5",NA,NA,NA,0,0,115.4,108.1,105.2,83.4,86.1,98.2,84.4,86.3,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T41(100); S46(100); S134(100); S543(100)]",0,"ENSG00000100505"
"755","OSBP",-0.268845910194147,6.65607862579329,-3.20472584936011,0.00992063707590272,0.0214443439839381,-3.65023444843319,"NONE",FALSE,"High","Master Protein","P22059","Oxysterol-binding protein 1 [OS=Homo sapiens]",0,81.657,8,6,9,13,6,807,89.4,7.3,42.32,6,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf00169, Pf01237","5007","hsa:5007; P22059; Q6P524","ENSG00000110048","Sphingolipid de novo biosynthesis; Synthesis of bile acids and bile salts",NA,2,0,100.6,102.3,103.9,91.9,69.6,94.6,104.3,115.7,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100); S240(100); S379(100)]",0,"ENSG00000110048"
"756","TRIM47",-0.234130831245983,6.63775679657113,-3.20351072560832,0.0099406647269992,0.0214592127439983,-3.6522976841093,"NONE",FALSE,"High","Master Protein","Q96LD4","E3 ubiquitin-protein ligase TRIM47 [OS=Homo sapiens]",0,23.27,2,2,2,3,2,638,69.5,6.44,10.56,2,"protein metabolism;other metabolic processes","cytosol;nucleus","other molecular function","Pf00643, Pf13445","91107","hsa:91107; Q96AD0; Q96GU5; Q96LD4; Q9BRN7","ENSG00000132481",NA,NA,0,0,107.9,104.5,99.3,86.6,83.1,98.2,106.7,104.9,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S588(100)]",0,"ENSG00000132481"
"757","PALS2",1.34186954950896,6.47670261975112,3.1998479460666,0.0100012868231714,0.0215615589107208,-3.6585171402027,"NONE",FALSE,"High","Master Protein","Q9NZW5","Protein PALS2 [OS=Homo sapiens]",0,10.297,5,1,1,2,1,540,61.1,6.18,6.68,1,"cell organization and biogenesis","plasma membrane;other membranes;other cell component",NA,"Pf00595, Pf00625, Pf02828, Pf07653","51678","A4D157; hsa:51678; Q9H0E1; Q9NZW5","ENSG00000105926",NA,NA,0,0,104.4,36.3,27.6,139.6,71.5,167.7,107.1,108.3,123.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100)]",0,"ENSG00000105926"
"758","SUZ12",-0.236556182217152,6.61799552373881,-3.19752580950641,0.0100399171484515,0.0216162859977215,-3.66246030930614,"NONE",FALSE,"High","Master Protein","Q15022","Polycomb protein SUZ12 [OS=Homo sapiens]",0,16.681,6,2,2,2,2,739,83,8.81,4.72,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf09733","23512","hsa:23512; Q15022; Q96BD9","ENSG00000178691","HCMV Early Events; SUMOylation of chromatin organization proteins; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6; Activation of anterior HOX genes in hindbrain development during early embryogenesis; PKMTs methylate histone lysines; PRC2 methylates histones and DNA; Defective pyroptosis","Interactome of polycomb repressive complex 2 (PRC2) ; Tumor suppressor activity of SMARCB1; Epithelial to mesenchymal transition in colorectal cancer; FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma; Pleural mesothelioma; NF1 copy number variation syndrome",15,0,111.9,104.5,102.3,91.2,88.6,94.5,93.2,98.6,105.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T348(77.1); S350(77.1); S546(100)]",0,"ENSG00000178691"
"759","SERINC1",-0.408263983634483,6.59016113248129,-3.19251933441577,0.0101237266555849,0.0217680130460008,-3.67096206786977,"NONE",FALSE,"High","Master Protein","Q9NRX5","Serine incorporator 1 [OS=Homo sapiens]",0,20.328,7,2,2,7,2,453,50.5,5.85,12.99,2,"other metabolic processes;other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf03348","57515","B3KY69; E1P565; hsa:57515; O75655; Q7Z2F5; Q8TAG1; Q9NRX5; Q9NTH8; Q9ULG7","ENSG00000111897","Serine biosynthesis","Sphingolipid pathway",2,0,113.2,119.8,113.6,73.8,105.8,89.7,86.2,87.1,101.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S364(100)]",0,"ENSG00000111897"
"760","LAMTOR1",-0.463510127644153,6.63515683902123,-3.18663492841096,0.010223154045281,0.0219528781603929,-3.68095531597742,"NONE",FALSE,"High","Master Protein","Q6IAA8","Ragulator complex protein LAMTOR1 [OS=Homo sapiens]",0,20.327,15,2,2,4,2,161,17.7,5.15,11.86,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf15454","55004","hsa:55004; Q6IAA8; Q8WZ09; Q9NWT0","ENSG00000149357","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; Amino acids regulate mTORC1; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; Neutrophil degranulation; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; RHOH GTPase cycle","Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins",17,0,107.5,97,105.7,81.5,69.1,70.3,144.6,105.7,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S56(100)]",0,"ENSG00000149357"
"761","PRKRA",0.344299139213595,6.68160401794707,3.18265419335852,0.0102909848350539,0.0220694970444257,-3.68771600644126,"NONE",FALSE,"High","Master Protein","O75569","Interferon-inducible double-stranded RNA-dependent protein kinase activator A [OS=Homo sapiens]",0,36.71,6,2,2,11,2,313,34.4,8.41,32.79,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00035","8575","A8K3I6; hsa:8575; O75569; Q53G24; Q6X7T5; Q8NDK4","ENSG00000180228","PKR-mediated signaling; MicroRNA (miRNA) biogenesis; Small interfering RNA (siRNA) biogenesis","VEGFA-VEGFR2 signaling; Ebola virus infection in host",5,0,76.5,76,80.5,113.2,80.9,106.2,120.1,152.8,131.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100)]",0,"ENSG00000180228"
"762","ABL2",0.342298004335761,6.66944309328815,3.18079070968486,0.0103228970935289,0.0221088819640935,-3.69088095719726,"NONE",FALSE,"High","Master Protein","P42684","Tyrosine-protein kinase ABL2 [OS=Homo sapiens]",0,15.66,2,2,2,3,2,1182,128.3,8.07,9.82,2,"cell adhesion;protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;cytoskeleton","cytoskeletal activity;kinase activity;other molecular function","Pf00017, Pf00018, Pf07714, Pf08919","27","A0M8X0; B7UEF2; B7UEF3; B7UEF4; B7UEF5; hsa:27; P42684; Q5T0X6; Q5W0C5; Q6NZY6; Q7Z301","ENSG00000143322","RAC3 GTPase cycle; RAC1 GTPase cycle; Negative regulation of FLT3; Role of ABL in ROBO-SLIT signaling","Ras signaling; Acute viral myocarditis; ErbB signaling pathway",7,0,78.8,85.5,78.1,118.4,83.4,111.8,114.2,126.4,119.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S631(100); S936(100)]",0,"ENSG00000143322"
"763","PSMD2",-0.239457623060773,6.63501999996044,-3.17510322738557,0.0104209264299024,0.0222742813569149,-3.7005409847866,"NONE",FALSE,"High","Master Protein","Q13200","26S proteasome non-ATPase regulatory subunit 2 [OS=Homo sapiens]",0,60.801,3,2,2,5,2,908,100.1,5.2,24.68,2,"protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cell component","enzyme regulator activity","Pf01851, Pf17781, Pf18051","5708","B4DX07; B4DXY1; E7EW34; E9PCS3; hsa:5708; Q12932; Q13200; Q15321; Q53XQ4; Q96I12","ENSG00000175166","Neutrophil degranulation; Regulation of expression of SLITs and ROBOs; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2","Proteasome degradation; Alzheimer's disease and miRNA effects; TNF-alpha signaling pathway; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",65,0,100.8,105.1,100.5,91.9,84.4,86.6,104.6,102.6,115.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000175166"
"764","GPATCH8",-0.324154188506635,6.57945508132202,-3.17472837411322,0.0104274209293401,0.0222742813569149,-3.70117768190038,"NONE",FALSE,"High","Master Protein","Q9UKJ3","G patch domain-containing protein 8 [OS=Homo sapiens]",0,33.203,4,4,4,6,4,1502,164.1,8.66,17.67,4,NA,"nucleus","other molecular function","Pf01585","23131","B9EGP9; hsa:23131; O60300; Q8TB99; Q9UKJ3","ENSG00000186566",NA,NA,0,0,108,114.6,118.3,87,104.5,90.3,82.4,84.2,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S653(100); S1035(100); S1081(100)]",0,"ENSG00000186566"
"765","CEP170",0.25672046340817,6.69400549947551,3.17385775174024,0.0104425209140637,0.0222773779500026,-3.70265646358409,"NONE",FALSE,"High","Master Protein","Q5SW79","Centrosomal protein of 170 kDa [OS=Homo sapiens]",0,101.734,9,10,12,21,10,1584,175.2,7.11,61.19,10,NA,"cytosol;cytoskeleton;other cell component",NA,"Pf00498, Pf15308","9859","hsa:9859; O75058; Q5SW77; Q5SW78; Q5SW79; Q7LGA9; Q86W31; Q9UQ08; Q9UQ09","ENSG00000143702; ENSG00000276725",NA,"Ciliary landscape",1,0,82.8,86.5,81.5,108.2,96.4,105.7,119.4,132.6,117.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S122(100); S359(100); S446(100); S667(100); S838(99); S881(100); S1112(100); S1165(100)]",0,"ENSG00000143702"
"766","DLG5",0.344485298594295,6.61852933122156,3.16992382926519,0.0105110313221491,0.0223942599448399,-3.70933852003591,"NONE",FALSE,"High","Master Protein","Q8TDM6","Disks large homolog 5 [OS=Homo sapiens]",0,48.202,3,5,5,9,5,1919,213.7,7.42,27.15,5,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00595, Pf00625, Pf04822, Pf16610","9231","A6H8Y3; hsa:9231; Q149N1; Q5T1H7; Q5T1H8; Q6DKG3; Q86WC0; Q8TDM6; Q8TDM7; Q9UE73; Q9Y4E3","ENSG00000151208; ENSG00000274429","RND2 GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle",NA,5,0,98.2,91.5,94.6,131.8,127.5,115.1,91.5,85.1,76.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T1011(100); S1209(99.5); S1263(100); S1666(100); S1795(100)]",0,"ENSG00000151208"
"767","ABI1",0.355570921625497,6.65534236536855,3.16067150474104,0.0106739908688471,0.0226843360798851,-3.72505522927826,"NONE",FALSE,"High","Master Protein","Q8IZP0","Abl interactor 1 [OS=Homo sapiens]",0,50.659,11,4,6,24,4,508,55,7.06,51.29,4,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00018, Pf07815","10006","A9Z1Y6; B3KX62; B4DQ58; H7BXI6; hsa:10006; O15147; O76049; O95060; Q5T2R3; Q5T2R4; Q5T2R6; Q5T2R7; Q5T2R9; Q5W070; Q5W072; Q8IZP0; Q8TB63; Q96S81; Q9NXZ9; Q9NYB8","ENSG00000136754","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RAC2 GTPase cycle; RAC3 GTPase cycle; VEGFA-VEGFR2 Pathway","EGF/EGFR signaling pathway",8,0,82.8,88.5,88.9,117.5,140.4,98.2,103,99.4,104.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(100); S216(99.4); S225(100); S231(100)]",0,"ENSG00000136754"
"768","UBAP2L",0.218961508334141,6.66627806216882,3.16009480499184,0.0106842337626356,0.0226843360798851,-3.7260348980294,"NONE",FALSE,"High","Master Protein","Q14157-1","Isoform 2 of Ubiquitin-associated protein 2-like [OS=Homo sapiens]",0,66.258,7,5,7,11,5,983,103.9,6.98,37.07,5,NA,NA,NA,NA,NA,"Q14157-1",NA,NA,NA,0,0,87.6,91.2,89.6,111.1,104.6,109.2,102.7,111.9,108.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S454(99.4); S467(100); S493(100); S609(100)]",0,"ENSG00000143569"
"769","MAPK4",-0.329622897012085,6.61216528335739,-3.15983331911192,0.010688881400387,0.0226843360798851,-3.72647909876369,"NONE",FALSE,"High","Master Protein","P31152","Mitogen-activated protein kinase 4 [OS=Homo sapiens]",0,4.09,2,1,1,1,1,587,65.9,5.45,2.71,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;signal transduction","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5596","A1A4C4; hsa:5596; P31152; Q0VG04","ENSG00000141639","MAPK6/MAPK4 signaling","MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; B cell receptor signaling pathway; S1P receptor signal transduction; TGF-beta signaling pathway; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; Splicing factor NOVA regulated synaptic proteins; EGF/EGFR signaling pathway; Osteoblast differentiation and related diseases; Insulin signaling; Regulation of actin cytoskeleton",13,0,117.2,116.4,130.7,92.4,103.7,101.6,90.1,85.3,74.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S434(100)]",0,"ENSG00000141639"
"770","UBA52",-0.295952992997401,6.61423128718426,-3.15540560634857,0.0107678956021357,0.0228223449645266,-3.73400084871347,"NONE",FALSE,"High","Master Protein","P62987","Ubiquitin-ribosomal protein eL40 fusion protein [OS=Homo sapiens]",0,58.125,43,6,7,12,6,128,14.7,9.83,32.28,6,"protein metabolism;other metabolic processes","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;translational apparatus;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00240, Pf01020","7311","hsa:7311; P02248; P02249; P02250; P14793; P62987; P62988; Q29120; Q6LBL4; Q6LDU5; Q8WYN8; Q91887; Q91888; Q9BWD6; Q9BX98; Q9UEF2; Q9UEG1; Q9UEK8; Q9UPK7","ENSG00000221983","Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Circadian Clock; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NOTCH1 Intracellular Domain Regulates Transcription; Peroxisomal protein import; Downregulation of ERBB2:ERBB3 signaling; Regulation of signaling by CBL; Signaling by CSF1 (M-CSF) in myeloid cells; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); FCERI mediated NF-kB activation; Downstream TCR signaling; E3 ubiquitin ligases ubiquitinate target proteins; Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation; Stimuli-sensing channels; Amyloid fiber formation; Fanconi Anemia Pathway; Budding and maturation of HIV virion; Membrane binding and targetting of GAG proteins; Endosomal Sorting Complex Required For Transport (ESCRT); Late endosomal microautophagy; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Separation of Sister Chromatids; Autodegradation of the E3 ubiquitin ligase COP1; ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; KEAP1-NFE2L2 pathway; Aggrephagy; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 HD Domain Mutants; NOTCH2 Activation and Transmission of Signal to the Nucleus; NOTCH3 Activation and Transmission of Signal to the Nucleus; Regulation of TP53 Degradation; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Activation of IRF3, IRF7 mediated by TBK1, IKBKE; IKK complex recruitment mediated by RIP1; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2; ER Quality Control Compartment (ERQC); SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Deactivation of the beta-catenin transactivating complex; Oxidative Stress Induced Senescence; Regulation of TP53 Activity through Phosphorylation; Signaling by ALK fusions and activated point mutants; Metalloprotease DUBs; Regulation of necroptotic cell death; Oncogene Induced Senescence; Cyclin D associated events in G1; APC/C:Cdc20 mediated degradation of Cyclin B; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Negative regulation of FLT3; Cargo recognition for clathrin-mediated endocytosis; Interferon alpha/beta signaling; Inactivation of CSF3 (G-CSF) signaling; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; Regulation of TP53 Activity through Methylation; Processing of DNA double-strand break ends; Regulation of BACH1 activity; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; p75NTR recruits signalling complexes; NF-kB is activated and signals survival; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; MAP3K8 (TPL2)-dependent MAPK1/3 activation; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; Termination of translesion DNA synthesis; Negative regulators of DDX58/IFIH1 signaling; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Prevention of phagosomal-lysosomal fusion; Downregulation of TGF-beta receptor signaling; HDR through Homologous Recombination (HRR); TICAM1-dependent activation of IRF3/IRF7; TICAM1,TRAF6-dependent induction of TAK1 complex; Glycogen synthesis; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER; Modulation by Mtb of host immune system; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; SARS-CoV-1 activates/modulates innate immune responses; Alpha-protein kinase 1 signaling pathway; Ovarian tumor domain proteases; Spry regulation of FGF signaling; RAS processing; PINK1-PRKN Mediated Mitophagy; Josephin domain DUBs; Regulation of FZD by ubiquitination; Chaperone Mediated Autophagy; Translesion synthesis by REV1; Translesion synthesis by POLK; Translesion synthesis by POLI; InlA-mediated entry of Listeria monocytogenes into host cells; Formation of Incision Complex in GG-NER; Iron uptake and transport; Recognition of DNA damage by PCNA-containing replication complex; VLDLR internalisation and degradation; Myoclonic epilepsy of Lafora; Evasion by RSV of host interferon responses; DNA Damage Recognition in GG-NER; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Negative regulation of MAPK pathway; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition); NRIF signals cell death from the nucleus; Assembly Of The HIV Virion; Dual Incision in GG-NER; Translesion Synthesis by POLH; Downregulation of ERBB4 signaling; Regulation of innate immune responses to cytosolic DNA; N-glycan trimming in the ER and Calnexin/Calreticulin cycle; Gap-filling DNA repair synthesis and ligation in GG-NER; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; Regulation of PTEN localization; Pexophagy; Maturation of protein E; Maturation of protein E; FLT3 signaling by CBL mutants; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","DNA replication; Cytoplasmic ribosomal proteins",199,0,114.2,113.7,112.9,98,73.3,106.6,93.6,94.5,85.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100); S65(99.5)]",0,"ENSG00000221983"
"771","FAS",0.363658263140909,6.67234492926665,3.1449344344581,0.0109571545758054,0.0231933544328332,-3.75179019054444,"NONE",FALSE,"High","Master Protein","P25445","Tumor necrosis factor receptor superfamily member 6 [OS=Homo sapiens]",0,6.057,8,1,1,1,1,335,37.7,7.94,3.09,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf00020, Pf00531","355","A9UJX4; B6VNV4; hsa:355; P25445; Q14292; Q14293; Q14294; Q14295; Q16652; Q5T9P1; Q5T9P2; Q5T9P3; Q6SSE9","ENSG00000026103","Regulation by c-FLIP; RIPK1-mediated regulated necrosis; CASP8 activity is inhibited; TP53 Regulates Transcription of Death Receptors and Ligands; Dimerization of procaspase-8; FasL/ CD95L signaling","miRNA regulation of DNA damage response; Alzheimer's disease and miRNA effects; Allograft rejection; Adipogenesis; Nanomaterial induced apoptosis; Apoptosis; Fas ligand pathway and stress induction of heat shock proteins; Photodynamic therapy-induced AP-1 survival signaling; MAPK signaling pathway; Apoptosis modulation by HSP70; VEGFA-VEGFR2 signaling; Nonalcoholic fatty liver disease; Control of immune tolerance by vasoactive intestinal peptide; Measles virus infection; Hepatitis B infection; Male infertility; IL-18 signaling pathway; 7q11.23 copy number variation syndrome; p53 transcriptional gene network; Complement system in neuronal development and plasticity; Familial hyperlipidemia type 4; Alzheimer's disease; Cell interactions of the pancreatic cancer microenvironment; T-cell receptor signaling pathway; DNA damage response",32,0,67.4,89,81.8,106.2,108.8,101.3,131.7,123.7,116.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S212(100)]",0,"ENSG00000026103"
"772","EHBP1",0.225365071429457,6.672223121363,3.14340949528747,0.0109850004800484,0.0232221771806205,-3.75438100273928,"NONE",FALSE,"High","Master Protein","Q8NDI1","EH domain-binding protein 1 [OS=Homo sapiens]",0,49.152,6,5,6,8,5,1231,139.9,5.35,23.57,5,"transport","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle",NA,"Pf00307, Pf10358, Pf12130","23301","hsa:23301; O94977; Q53TG7; Q53TV6; Q580X2; Q6NX72; Q6PIT3; Q6QNV2; Q8NDI1; Q9NWI9","ENSG00000115504",NA,"Ciliary landscape",1,0,87.9,89.2,88.6,112.6,105,104.3,105.3,113.9,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(100); T378(99.4); S436(100); T694(100); S751(100)]",0,"ENSG00000115504"
"773","CDC42EP4",0.448611231531673,6.6536183908522,3.12500774106878,0.0113268094911639,0.0239137814871662,-3.78564679940545,"NONE",FALSE,"High","Master Protein","Q9H3Q1","Cdc42 effector protein 4 [OS=Homo sapiens]",0,167.019,33,12,21,74,12,356,38,5.19,243.72,12,"cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00786, Pf14957","23580","B3KUS7; hsa:23580; O95828; Q96FT3; Q9H3Q1","ENSG00000179604","RAC1 GTPase cycle; RAC2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle",NA,4,0,80.3,89.4,85,117.7,157.6,101.4,113.1,93.6,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100); S74(99.5); S105(100); S118(100); S138(99.3); S140(98); S142(99.7); S292(100); S295(100); S322(100)]",0,"ENSG00000179604"
"774","SUN2",-0.407516501653537,6.61893103020986,-3.12419801401818,0.0113420984325054,0.0239151222762904,-3.78702265197846,"NONE",FALSE,"High","Master Protein","Q9UH99","SUN domain-containing protein 2 [OS=Homo sapiens]",0,11.745,4,1,1,1,1,717,80.3,6.73,3.89,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","other membranes;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf07738, Pf18580","25777","B0QY62; hsa:25777; O75156; Q2NKN8; Q2T9F7; Q504T5; Q6B4H1; Q7Z3E3; Q9UH99","ENSG00000100242","Meiotic synapsis",NA,1,0,100.6,125.9,93.4,88.7,60.2,89.6,103.1,121,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100)]",0,"ENSG00000100242"
"775","ARHGAP5",0.258048453609687,6.67018080224737,3.11916950721527,0.0114375200209127,0.0240852034504897,-3.79556698633325,"NONE",FALSE,"High","Master Protein","Q13017","Rho GTPase-activating protein 5 [OS=Homo sapiens]",0,51.302,3,3,5,6,3,1502,172.4,6.62,24.06,3,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf01846, Pf16512, Pf19518","394","A1L375; A1L376; A8KAA1; D3DS89; D3DS90; hsa:394; Q05BE8; Q05BU8; Q13017; Q59ER0; Q6DHZ3","ENSG00000100852","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOC GTPase cycle; RND2 GTPase cycle; RHOA GTPase cycle; RHOG GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle","Focal adhesion",15,0,90.4,97.5,91.4,118.9,108.4,117.9,93.7,106.3,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1176(100); S1202(100); S1218(99.5)]",0,"ENSG00000100852"
"776","CTPS2",-0.304889552405869,6.60649758152243,-3.11758381665264,0.0114677808254493,0.0240878399520305,-3.79826139830812,"NONE",FALSE,"High","Master Protein","Q9NRF8","CTP synthase 2 [OS=Homo sapiens]",0,6.603,3,1,1,2,1,586,65.6,6.9,3,1,"other metabolic processes","cytosol;other cell component","other molecular function","Pf00117, Pf06418, Pf07722","56474","B3KWM2; hsa:56474; Q9BRI0; Q9H809; Q9H8K9; Q9NRF8","ENSG00000047230","Interconversion of nucleotide di- and triphosphates","Pyrimidine metabolism",2,0,108.1,109.7,119.2,88.5,80.9,105.5,85.3,89.6,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S568(100)]",0,"ENSG00000047230"
"777","RBM10",-0.211960168168591,6.61862883777053,-3.11755709648098,0.0114682914477498,0.0240878399520305,-3.79830680148845,"NONE",FALSE,"High","Master Protein","P98175","RNA-binding protein 10 [OS=Homo sapiens]",0,39.989,4,3,3,7,3,930,103.5,5.97,24.63,3,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf00641, Pf01585, Pf17780","8241","A0A0A0MR66; C4AM81; hsa:8241; P98175; Q14136; Q5JRR2; Q9BTE4; Q9BTX0; Q9NTB1","ENSG00000182872","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA",NA,2,0,112.8,108,100.7,95.2,86.5,98.2,94.5,97.2,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(99.3); S723(100); S797(100)]",0,"ENSG00000182872"
"778","CAMSAP2",0.216845328646619,6.67772205611046,3.11633268073525,0.011491715068521,0.0241060141283113,-3.80038734619711,"NONE",FALSE,"High","Master Protein","Q08AD1","Calmodulin-regulated spectrin-associated protein 2 [OS=Homo sapiens]",0,65.509,8,8,11,16,8,1489,168,6.8,47.31,8,"cell organization and biogenesis;developmental processes;other biological processes","cytosol;cytoskeleton;ER/Golgi","cytoskeletal activity;other molecular function","Pf08683, Pf11971, Pf17095","23271","B1APG6; hsa:23271; Q08AD1; Q08AD2; Q6PGN8; Q96FB3; Q9UG20; Q9UPS4","ENSG00000118200",NA,NA,0,0,89.8,91,91.3,107.2,108.8,113.8,102.1,114.1,107.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S464(100); S611(100); S673(100); S844(100); S862(100); S1276(100); S1313(100)]",0,"ENSG00000118200"
"779","BRD3",-0.260183894345584,6.59363662953732,-3.11182978941629,0.0115782803937026,0.0242564231097852,-3.80803880906484,"NONE",FALSE,"High","Master Protein","Q15059","Bromodomain-containing protein 3 [OS=Homo sapiens]",0,17.193,2,1,1,6,1,726,79.5,9.36,18.3,1,"cell organization and biogenesis;other biological processes","nucleus","other molecular function","Pf00439, Pf17035","8019","B1APD9; hsa:8019; Q15059; Q4G5Y3; Q5T1R7; Q8N5M3; Q92645","ENSG00000169925",NA,NA,0,0,113.9,111.8,102.5,93.8,99.7,87.3,93.2,90.7,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S263(100)]",0,"ENSG00000169925"
"780","PLCD3",0.271188088680144,6.65803399398573,3.1024487219497,0.0117607804897319,0.0246071714862083,-3.82397980638051,"NONE",FALSE,"High","Master Protein","Q8N3E9","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 [OS=Homo sapiens]",0,79.647,11,4,4,9,4,789,89.2,6.98,52.08,4,"other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00168, Pf00387, Pf00388, Pf14788","113026","hsa:113026; Q8N3E9; Q8TEC1; Q8TF37; Q96FL6","ENSG00000161714","Synthesis of IP3 and IP4 in the cytosol","GPR40 pathway; Resistin as a regulator of inflammation",3,0,98,96.4,89.4,122.6,108.3,121.1,98.5,93,91.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T37(100); S489(100); S496(100); S557(99.3)]",0,"ENSG00000161714"
"781","GRIPAP1",-0.382418964035082,6.62800368265714,-3.0998939662877,0.0118109901622338,0.0246805837961146,-3.82832110750426,"NONE",FALSE,"High","Master Protein","Q4V328","GRIP1-associated protein 1 [OS=Homo sapiens]",0,20.182,5,2,2,2,2,841,95.9,5.11,7.76,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function",NA,"56850","A6NL78; hsa:56850; Q3MJ75; Q4V327; Q4V328; Q4V330; Q5HYG1; Q6N046; Q96DH8; Q9NQ43; Q9ULQ3","ENSG00000068400; ENSG00000292219",NA,NA,0,0,108.3,136.8,120.4,97.7,93.3,91.2,102.5,84.5,81.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S655(99.4); S692(99)]",0,"ENSG00000068400"
"782","DTD1",0.267274967471312,6.65967183471602,3.09522572676823,0.0119033054640249,0.0248416809683998,-3.83625392000854,"NONE",FALSE,"High","Master Protein","Q8TEA8","D-aminoacyl-tRNA deacylase 1 [OS=Homo sapiens]",0,26.912,8,1,4,11,1,209,23.4,8.24,29.7,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02580","92675","A8K5X5; D3DW37; hsa:92675; Q496D1; Q5W184; Q8TEA8; Q8WXU8; Q9BW67; Q9H464; Q9H474","ENSG00000125821",NA,NA,0,0,85,85.7,85.6,105.3,123.2,99.1,111.1,111.2,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(99.6); S197(100)]",0,"ENSG00000125821"
"783","CAP2",-0.195511784128203,6.66346294075982,-3.09402457760341,0.0119271778377071,0.0248597116617343,-3.83829506326502,"NONE",FALSE,"High","Master Protein","P40123","Adenylyl cyclase-associated protein 2 [OS=Homo sapiens]",0,37.313,4,2,4,10,2,477,52.8,6.37,25.58,2,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","cytoskeletal activity;other molecular function","Pf01213, Pf08603","10486","B2R5Y3; B7Z1C4; B7Z214; hsa:10486; P40123; Q6IAY2","ENSG00000112186","Role of ABL in ROBO-SLIT signaling","Ectoderm differentiation; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway",4,0,98.5,100.5,102.1,92.6,82.8,92.1,112.5,112.2,112.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(100); T307(100); S309(100)]",0,"ENSG00000112186"
"784","RAB12",-0.271523818990444,6.58029795313086,-3.08925088613408,0.0120225392029921,0.025026510177657,-3.84640715651164,"NONE",FALSE,"High","Master Protein","Q6IQ22","Ras-related protein Rab-12 [OS=Homo sapiens]",0,15.2,8,1,1,2,1,244,27.2,8.41,10.71,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle","other molecular function","Pf00071","201475","A6NEF5; hsa:201475; Q4KMQ3; Q6IQ22",NA,"RAB GEFs exchange GTP for GDP on RABs; RAB geranylgeranylation",NA,2,0,109.4,120.5,105.8,95.7,89.5,96,85.5,81,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100)]",0,"ENSG00000206418"
"785","FUBP1",-0.331735329751289,6.5738008816195,-3.08253358212621,0.0121580521017988,0.0252723217462063,-3.85782216949041,"NONE",FALSE,"High","Master Protein","Q96AE4","Far upstream element-binding protein 1 [OS=Homo sapiens]",0,15.2,4,1,2,2,1,644,67.5,7.61,8.11,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00013, Pf09005","8880","hsa:8880; Q12828; Q96AE4","ENSG00000162613",NA,NA,0,0,105.8,117.7,112.3,91.8,98.5,83.6,79.4,89.7,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T629(99.3)]",0,"ENSG00000162613"
"786","MSANTD2",0.279276629458223,6.63249039568095,3.08186643275253,0.0121715961351214,0.0252723217462063,-3.85895588897656,"NONE",FALSE,"High","Master Protein","Q6P1R3","Myb/SANT-like DNA-binding domain-containing protein 2 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,559,61.3,6.19,11.22,1,NA,NA,NA,"Pf13837","79684","B3KRY6; hsa:79684; Q6P1R3; Q9H042; Q9H5K8","ENSG00000120458",NA,NA,0,0,86,90.9,94.5,105,135.6,111.8,94.5,93,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S48(100)]",0,"ENSG00000120458"
"787","ZNF740",-0.396168136226697,6.5733904828115,-3.06898017672652,0.0124362586469733,0.0257890395322243,-3.8808541297359,"NONE",FALSE,"High","Master Protein","Q8NDX6","Zinc finger protein 740 [OS=Homo sapiens]",0,4.012,4,1,1,2,1,193,21.8,9.19,5.62,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","283337","A8K9M9; hsa:283337; Q8NDX6","ENSG00000139651","Generic Transcription Pathway",NA,1,0,122.5,109.2,117.5,82.8,110.7,81.7,83.6,82.2,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S44(100)]",0,"ENSG00000139651"
"788","UBA1",-0.278892925699632,6.60903927097941,-3.06276901252244,0.0125659234615939,0.0259957864775383,-3.89140898956036,"NONE",FALSE,"High","Master Protein","P22314","Ubiquitin-like modifier-activating enzyme 1 [OS=Homo sapiens]",0,54.924,6,4,4,4,4,1058,117.8,5.76,17.65,4,"protein metabolism;other metabolic processes;stress response","cytosol;mitochondrion;nucleus;other cell component","other molecular function","Pf00899, Pf09358, Pf10585, Pf16190, Pf16191","7317","hsa:7317; P22314; Q5JRR8; Q96E13","ENSG00000130985","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Antigen processing: Ubiquitination & Proteasome degradation","Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway",5,0,104.9,114,116.3,94.8,76.6,107.6,88.3,96.6,89.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S810(100)]",0,"ENSG00000130985"
"789","SEMA6A",0.41088293715171,6.64465302070978,3.06267884861838,0.012567815888957,0.0259957864775383,-3.89156220771621,"NONE",FALSE,"High","Master Protein","Q9H2E6","Semaphorin-6A [OS=Homo sapiens]",0,16.304,3,2,2,2,2,1030,114.3,8.41,4.62,2,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding","Pf01403, Pf01437","57556","hsa:57556; Q9H2E6; Q9P2H9","ENSG00000092421","Other semaphorin interactions","Spinal cord injury",2,0,74.2,66.9,91.2,110,94.1,111.4,103.8,137.3,124.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S760(99.1); T761(100); S994(99.3)]",0,"ENSG00000092421"
"790","POU3F3",-0.463703885356151,6.56805890456027,-3.05826812074622,0.0126607486358494,0.0261548630046914,-3.89905745602732,"NONE",FALSE,"High","Master Protein","P20264","POU domain, class 3, transcription factor 3 [OS=Homo sapiens]",0,25.764,3,1,2,4,1,500,50.3,7.87,11.47,1,"cell cycle OR cell proliferation;transport;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00046, Pf00157","5455","hsa:5455; P20264; P78379; Q4ZG25","ENSG00000198914","Nephron development",NA,1,0,116.2,116.2,117.3,79.5,59.7,117.2,89.4,84.6,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S393(100)]",0,"ENSG00000198914"
"791","BSG",-0.284122257179917,6.65312676552119,-3.04586344131473,0.0129258999555671,0.0266688605910057,-3.92013657640787,"NONE",FALSE,"High","Master Protein","P35613","Basigin [OS=Homo sapiens]",0,30.401,5,2,2,3,2,385,42.2,5.66,12.16,2,"developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf13927","682","A6NJW1; D3YLG5; hsa:682; P35613; Q7Z796; Q8IZL7","ENSG00000172270","Degradation of the extracellular matrix; Integrin cell surface interactions; Pyruvate metabolism; Aspirin ADME; Basigin interactions; Proton-coupled monocarboxylate transport; Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)","Matrix metalloproteinases; VEGFA-VEGFR2 signaling; IL-18 signaling pathway",10,0,101.5,106.1,102.9,84.3,90.3,86.4,119.1,102.6,110.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100)]",0,"ENSG00000172270"
"792","DNAJC5",0.879991267564589,6.50508046273747,3.03581706365057,0.013144801795889,0.0270862582460742,-3.937207612156,"NONE",FALSE,"High","Master Protein","Q9H3Z4","DnaJ homolog subfamily C member 5 [OS=Homo sapiens]",0,40.478,9,1,5,21,1,198,22.1,5.07,52.38,1,"cell-cell signaling;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00226","80331","A8K0M0; B3KY68; E1P5G8; hsa:80331; Q9H3Z4; Q9H3Z5; Q9H7H2","ENSG00000101152","Sensory processing of sound by inner hair cells of the cochlea; Neutrophil degranulation; GABA synthesis, release, reuptake and degradation",NA,3,0,52.8,67.1,109.1,115.7,115.8,218.9,65,84.4,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S10(99.5)]",0,"ENSG00000101152"
"793","STMN1",0.390010555664527,6.69092895780421,3.03431990501038,0.0131777466513578,0.0271199023140176,-3.93975155567537,"NONE",FALSE,"High","Master Protein","P16949","Stathmin [OS=Homo sapiens]",0,43.401,17,2,2,7,2,149,17.3,5.97,23.99,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity","Pf00836","3925","A2A2D1; B2R4E7; B7Z8N4; D3DPJ5; hsa:3925; P16949","ENSG00000117632","Nuclear signaling by ERBB4","Microtubule cytoskeleton regulation; Retinoblastoma gene in cancer; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; EGF/EGFR signaling pathway; IL-18 signaling pathway",7,0,84.3,83.4,75.1,117,113.2,100.9,104.5,143.1,121.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(100); S38(100)]",0,"ENSG00000117632"
"794","ATL1",0.298483007847352,6.67644480907249,3.02927542424702,0.0132893727449907,0.0273151842818952,-3.94832290433533,"NONE",FALSE,"High","Master Protein","Q8WXF7","Atlastin-1 [OS=Homo sapiens]",0,10.311,3,1,1,1,1,558,63.5,6.18,3.64,1,"cell organization and biogenesis;developmental processes","other membranes;ER/Golgi;other cell component","other molecular function","Pf02263","51062","A6NND5; A8K2C0; G5E9T1; hsa:51062; O95890; Q69YH7; Q8WXF7; Q96FK0","ENSG00000198513",NA,NA,0,0,74.7,86.4,77.6,106.4,82.9,110.1,133.2,124.8,128.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(99.6)]",0,"ENSG00000198513"
"795","NEXN",0.494455298680621,6.67247493901712,3.02559716497382,0.0133713755581818,0.0274491634100034,-3.95457268876659,"NONE",FALSE,"High","Master Protein","Q0ZGT2","Nexilin [OS=Homo sapiens]",0,9.736,2,1,1,4,1,675,80.6,5.33,10.76,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf07679","91624","A0PJ84; B4DPZ7; hsa:91624; Q0D2H2; Q0ZGT2; Q14CC2; Q14CC3; Q16081; Q7Z2X0; Q96DL0; Q9Y2V1","ENSG00000162614",NA,"VEGFA-VEGFR2 signaling",1,0,68.9,97.2,90.6,131,111.9,122.4,116.1,104.4,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100)]",0,"ENSG00000162614"
"796","PPP2R5A",0.37556198222681,6.63769078920876,3.01008789898712,0.0137228642951524,0.0281353197609154,-3.98092314751655,"NONE",FALSE,"High","Master Protein","Q15172","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform [OS=Homo sapiens]",0,3.696,2,1,2,4,1,486,56.2,6.71,2.26,1,"protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01603","5525","B2R6D2; B7Z7L2; D3DT99; hsa:5525; Q15172; Q2NL72; Q5VVB2; Q8TBI9","ENSG00000066027","PKR-mediated signaling; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling","Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome",27,0,94.5,90.5,80.7,114.5,138.3,112.4,89.5,88.9,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(99.6)]",0,"ENSG00000066027"
"797","TMCC2",-0.65215098310172,6.60873639849979,-3.00892535314463,0.0137495885290444,0.0281547408775413,-3.98289821464016,"NONE",FALSE,"High","Master Protein","O75069","Transmembrane and coiled-coil domains protein 2 [OS=Homo sapiens]",0,7.086,2,1,1,2,1,709,77.4,6.81,6.94,1,"protein metabolism;other metabolic processes","other membranes;ER/Golgi;other cell component",NA,"Pf10267","9911","A2RRH3; B2RAX5; B3KTM7; B7Z1P7; hsa:9911; O75069; Q6ZN09; Q7Z6C6","ENSG00000133069",NA,NA,0,0,117.6,119.2,106.2,80.7,40.9,92.9,117.7,134.4,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S438(100)]",0,"ENSG00000133069"
"798","ZNF462",-0.286884668375054,6.59879128809816,-3.00748444630171,0.013782785413218,0.0281873506195135,-3.98534616923822,"NONE",FALSE,"High","Master Protein","Q96JM2","Zinc finger protein 462 [OS=Homo sapiens]",0,37.844,2,3,3,3,3,2506,284.5,7.58,12.2,3,"cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function",NA,"58499","hsa:58499; Q5T0T4; Q8N408; Q96JM2","ENSG00000148143",NA,"Mesodermal commitment pathway",1,0,101.7,109,111,94.3,68.5,102.1,91.3,99.6,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1090(100); S2172(100)]",0,"ENSG00000148143"
"799","INTS12",0.523407721604394,6.61498755913557,2.99499503333274,0.014073978593286,0.0287468498926692,-4.00656320141955,"NONE",FALSE,"High","Master Protein","Q96CB8","Integrator complex subunit 12 [OS=Homo sapiens]",0,5.481,2,1,1,1,1,462,48.8,9.69,3.11,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00628","57117","B2RC48; hsa:57117; Q3B6Z3; Q96CB8; Q9HD71","ENSG00000138785","RNA polymerase II transcribes snRNA genes",NA,1,0,67.6,63,79.8,97.1,131.1,92.6,101.6,148.7,151.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S378(100)]",0,"ENSG00000138785"
"800","EYA1",-0.299127003176869,6.62631127643737,-2.99361938988665,0.0141064336251492,0.0287771245953043,-4.00890000385134,"NONE",FALSE,"High","Master Protein","Q99502","Eyes absent homolog 1 [OS=Homo sapiens]",0,4.64,2,1,1,1,1,592,64.6,6.21,2.28,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00702","2138","A6NHQ0; G5E9R4; hsa:2138; Q0P516; Q8WX80; Q99502","ENSG00000104313","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Formation of the ureteric bud","Genes controlling nephrogenesis; GDNF/RET signaling axis; Development of ureteric collection system; Markers of kidney cell lineage",6,0,107.7,108,115.9,92.6,98.9,85,90.5,94.1,108.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S314(100)]",0,"ENSG00000104313"
"801","C2orf49",-0.29169257227689,6.65718569912895,-2.98889920284865,0.0142183769918387,0.0289450541538161,-4.01691794240134,"NONE",FALSE,"High","Master Protein","Q9BVC5","Ashwin [OS=Homo sapiens]",0,9.989,9,2,2,2,2,232,25.8,9.74,5.59,2,"RNA metabolism OR transcription;other metabolic processes;developmental processes","nucleus;other cell component",NA,"Pf15323","79074","B3KXN3; B4E2G9; hsa:79074; Q9BVC5","ENSG00000135974","tRNA processing in the nucleus",NA,1,0,113.7,112.2,103.4,101.6,75.8,91.8,111.3,99,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S182(100)]",0,"ENSG00000135974"
"802","MYEF2",-0.245203430482558,6.63143720676701,-2.98865370540506,0.0142242239162748,0.0289450541538161,-4.01733494615413,"NONE",FALSE,"High","Master Protein","Q9P2K5","Myelin expression factor 2 [OS=Homo sapiens]",0,42.614,4,1,2,10,1,600,64.1,8.75,39.87,1,"developmental processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076","50804","A7MCZ9; C9J921; C9K0J4; hsa:50804; Q6NUM5; Q7L388; Q7Z4B7; Q9H922; Q9NUQ1; Q9P2K5","ENSG00000104177",NA,"Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Mitochondrial gene expression",4,0,107.3,111.8,106.1,93.3,76.7,106.2,97.5,96.9,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S17(100)]",0,"ENSG00000104177"
"803","PCDH1",0.214912555268165,6.63889922332884,2.9843045988469,0.0143282126581708,0.0291203525007905,-4.02472219855203,"NONE",FALSE,"High","Master Protein","Q08174-2","Isoform 2 of Protocadherin-1 [OS=Homo sapiens]",0,80.393,4,4,5,16,4,1237,133.6,5.06,65.17,4,NA,NA,NA,NA,NA,"Q08174-2",NA,NA,NA,0,0,90,94.3,91,106.7,120.3,108.8,95.9,101,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S962(100); S984(100); S1173(100)]",0,"ENSG00000156453"
"804","HSP90AB1",-0.308825424808363,6.65876254873765,-2.97920098244299,0.0144512315629184,0.0293338431724912,-4.0333906068492,"NONE",FALSE,"High","Master Protein","P08238","Heat shock protein HSP 90-beta [OS=Homo sapiens]",0,257.293,19,15,15,59,7,724,83.2,5.03,237.08,15,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00183, Pf13589","3326","B2R5P0; hsa:3326; P08238; Q5T9W7; Q9NQW0; Q9NTK6","ENSG00000096384","Potential therapeutics for SARS; Regulation of actin dynamics for phagocytic cup formation; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Aryl hydrocarbon receptor signalling; Neutrophil degranulation; Estrogen-dependent gene expression; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; Uptake and function of diphtheria toxin; Assembly and release of respiratory syncytial virus (RSV) virions; Respiratory syncytial virus genome replication","Nuclear receptors meta-pathway; NRF2 pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway",25,1,101.3,104.7,106.2,99.8,69.4,83.6,107.5,124.4,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S226(100); S255(100)]",0,"ENSG00000096384"
"805","CLASP1",0.50585279195729,6.63111311222953,2.97778750680568,0.0144854924631684,0.0293668617389948,-4.03579128644256,"NONE",FALSE,"High","Master Protein","Q7Z460","CLIP-associating protein 1 [OS=Homo sapiens]",0,74.03,7,6,8,17,2,1538,169.3,9.03,35.04,6,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","cytosol;cytoskeleton;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf02985, Pf12348, Pf21040","23332","A2RU21; B7ZLX3; F5GWS0; hsa:23332; O75118; Q2KHQ9; Q5H9P0; Q7Z460; Q8N5B8; Q9BQT5","ENSG00000074054","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Role of ABL in ROBO-SLIT signaling","Microtubule cytoskeleton regulation; Splicing factor NOVA regulated synaptic proteins; 7q11.23 copy number variation syndrome",17,4,68.3,83.6,78.3,107.6,162.6,91.4,110.5,101.8,126.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S600(99.7); S646(97.6); S688(100); S797(98.9); S1091(99.6)]",0,"ENSG00000074054"
"806","PRKAA1",0.301614524788731,6.65179426423067,2.97572016877537,0.0145357514133725,0.0294321914474241,-4.03930243217431,"NONE",FALSE,"High","Master Protein","Q13131","5'-AMP-activated protein kinase catalytic subunit alpha-1 [OS=Homo sapiens]",0,29.016,6,3,3,5,3,559,64,8.12,14.37,3,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf16579, Pf21147","5562","A8MTQ6; B2R7E1; hsa:5562; O00286; Q13131; Q5D0E1; Q86VS1; Q9UNQ4","ENSG00000132356","Activation of AMPK downstream of NMDARs; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK","AMP-activated protein kinase signaling; Target of rapamycin signaling; Energy metabolism; Thyroxine (thyroid hormone) production; Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Leptin signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; mir-124 predicted interactions with cell cycle and differentiation ; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin and adiponectin; Lipid metabolism pathway; PI3K-Akt signaling pathway; Hereditary leiomyomatosis and renal cell carcinoma pathway; Thermogenesis; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; IL-18 signaling pathway; Insulin signaling; 1q21.1 copy number variation syndrome; Autophagy; p53 transcriptional gene network; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Pleural mesothelioma; Affected pathways in Duchenne muscular dystrophy; ADHD and autism (ASD) linked metabolic pathways and SNP",36,0,81.9,78.2,84.4,99.9,104.8,110.4,102.1,118.6,137.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S486(99.3); S496(100); S508(100)]",0,"ENSG00000132356"
"807","CCAR2",0.272120911544037,6.66144277599083,2.9728662890032,0.014605424248037,0.0295366200406399,-4.04414929506816,"NONE",FALSE,"High","Master Protein","Q8N163","Cell cycle and apoptosis regulator protein 2 [OS=Homo sapiens]",0,31.863,2,1,4,7,1,923,102.8,5.22,25.71,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","cytoskeleton;mitochondrion;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf14443, Pf14444, Pf19256, Pf19257","57805","A6NL03; B2RB79; D3DSR6; hsa:57805; Q6P0Q9; Q8N163; Q8N3G7; Q8N8M1; Q8TF34; Q9H9Q9; Q9HD12; Q9NT55","ENSG00000158941","Regulation of HSF1-mediated heat shock response","TAR syndrome",2,0,84.3,84.1,94.9,109,96.5,122.9,105.5,111.8,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S678(100)]",0,"ENSG00000158941"
"808","KLC4",0.230374044034924,6.65246755442572,2.96893912889957,0.0147018565073063,0.0296948388860444,-4.05081868649851,"NONE",FALSE,"High","Master Protein","Q9NSK0","Kinesin light chain 4 [OS=Homo sapiens]",0,50.824,9,4,5,11,4,619,68.6,6.18,39.62,4,"other biological processes","cytoskeleton;other cell component","cytoskeletal activity","Pf13374, Pf13424","89953","B3KNY4; B3KPI3; B3KSQ3; B4DME9; hsa:89953; Q66K28; Q96EG6; Q9NSK0","ENSG00000137171","MHC class II antigen presentation; COPI-dependent Golgi-to-ER retrograde traffic; Kinesins; RHO GTPases activate KTN1","Alzheimer's disease and miRNA effects; Alzheimer's disease",6,0,91.1,88.1,84.5,104.1,109.9,109.3,101.1,106.7,116.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S460(99.5); S519(99.6); S590(100); S611(99.6)]",0,"ENSG00000137171"
"809","SEC31A",-0.199443435462896,6.61186754797272,-2.96785513756872,0.0147285882761073,0.0297120594148419,-4.05265954398215,"NONE",FALSE,"High","Master Protein","O94979","Protein transport protein Sec31A [OS=Homo sapiens]",0,58.769,5,4,4,6,4,1220,132.9,6.89,24.58,4,"cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf12931","22872","B4DIW6; B7ZKZ7; B7ZL00; H7C2W3; hsa:22872; O94979; Q17RR5; Q5H9P6; Q5XG74; Q659G7; Q6ZU90; Q7LCX9; Q86TJ0; Q8IZH4; Q9P048; Q9P0A6; Q9UM05; Q9UM06","ENSG00000138674","MHC class II antigen presentation; Signaling by ALK fusions and activated point mutants; COPII-mediated vesicle transport; XBP1(S) activates chaperone genes; Antigen Presentation: Folding, assembly and peptide loading of class I MHC","Sterol regulatory element-binding proteins (SREBP) signaling",6,0,107.7,106.9,104.4,94.6,86.3,101.2,92,98.5,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S527(100); S799(100); S1163(99.6)]",0,"ENSG00000138674"
"810","PDE3A",0.48463000272473,6.65141783112012,2.96515463885064,0.0147953995888506,0.0298099902827212,-4.05724548096822,"NONE",FALSE,"High","Master Protein","Q14432","cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A [OS=Homo sapiens]",0,28.926,5,3,3,4,3,1141,124.9,6,15.25,3,"other metabolic processes;signal transduction;other biological processes","other membranes;cytosol","other molecular function","Pf00233","5139","hsa:5139; O60865; Q13348; Q14432; Q17RD1","ENSG00000172572","G alpha (s) signalling events","NO/cGMP/PKG mediated neuroprotection; Phosphodiesterases in neuronal function",3,0,75.8,67.8,79.2,96.7,82,140.2,110.9,131.2,132.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S312(99.7); S408(100); S520(100)]",0,"ENSG00000172572"
"811","SIPA1L3",-0.251342534299208,6.6305468886338,-2.95938620272967,0.0149391492437425,0.0300625050133017,-4.06704079938771,"NONE",FALSE,"High","Master Protein","O60292","Signal-induced proliferation-associated 1-like protein 3 [OS=Homo sapiens]",0,39.253,3,4,6,6,3,1781,194.5,8.32,15.28,4,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","enzyme regulator activity","Pf00595, Pf02145, Pf11881, Pf21022","23094","hsa:23094; O60292; Q2TV87","ENSG00000105738",NA,NA,0,0,111.5,100.3,101,86.4,93.1,89,108.2,106.1,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S172(99.6); S1364(100); S1495(100); T1703(99.3)]",0,"ENSG00000105738"
"812","TERF2IP",0.204297459204639,6.67046246902537,2.95095637142146,0.0151517846662085,0.0304528479990792,-4.08135402939476,"NONE",FALSE,"High","Master Protein","Q9NYB0","Telomeric repeat-binding factor 2-interacting protein 1 [OS=Homo sapiens]",0,37.681,4,1,1,5,1,399,44.2,4.73,19.32,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf08914, Pf11626, Pf16589","54386","B4DQN4; hsa:54386; Q4W4Y2; Q8WYZ3; Q9NWR2; Q9NYB0","ENSG00000166848","Meiotic synapsis; Inhibition of DNA recombination at telomere; Recognition and association of DNA glycosylase with site containing an affected purine; Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; Cleavage of the damaged purine; Packaging Of Telomere Ends; DNA Damage/Telomere Stress Induced Senescence; Telomere Extension By Telomerase; Polymerase switching on the C-strand of the telomere; Telomere C-strand synthesis initiation; Removal of the Flap Intermediate from the C-strand","Splicing factor NOVA regulated synaptic proteins; SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction",16,0,89.3,90.2,88.7,111.2,102.3,105.9,110.5,108.6,109.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000166848"
"813","DIP2B",-0.440616628061212,6.57310588640655,-2.94983620873891,0.0151802709549275,0.0304725734298175,-4.08325585435732,"NONE",FALSE,"High","Master Protein","Q9P265","Disco-interacting protein 2 homolog B [OS=Homo sapiens]",0,19.455,2,3,3,3,3,1576,171.4,8.09,9.26,3,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","cytoskeletal activity","Pf00501, Pf06464","57609","hsa:57609; Q6B011; Q8N1L5; Q8NB38; Q9P265","ENSG00000066084",NA,NA,0,0,132.6,113.7,113.9,71.4,74.2,119.2,86.2,83.5,87.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(100); S203(100); T283(100)]",0,"ENSG00000066084"
"814","GPALPP1",0.457543511779329,6.63156233467976,2.94639556188436,0.0152681098247184,0.030611247216143,-4.08909722846317,"NONE",FALSE,"High","Master Protein","Q8IXQ4","GPALPP motifs-containing protein 1 [OS=Homo sapiens]",0,24.478,6,1,1,4,1,340,38.1,5.41,12.12,1,NA,NA,NA,"Pf12572","55425","A8K8X8; hsa:55425; Q05BX8; Q05D87; Q5T3Z3; Q5T3Z5; Q8IXQ4; Q9C0F9; Q9H2R0; Q9P0W6","ENSG00000133114",NA,NA,0,0,71.4,83,80.2,102.7,157.2,94.6,116.6,99.9,117.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100)]",0,"ENSG00000133114"
"815","DOK1",0.472408989277977,6.66161304656327,2.94414049492442,0.0153259617502053,0.0306895332224969,-4.09292561595702,"NONE",FALSE,"High","Master Protein","Q99704","Docking protein 1 [OS=Homo sapiens]",0,10.95,2,1,1,1,1,481,52.4,6.47,4.04,1,"signal transduction;other biological processes","cytosol;nucleus;other cell component",NA,"Pf00169, Pf02174","1796","hsa:1796; O43204; Q53TY2; Q99704; Q9UHG6","ENSG00000115325","RET signaling; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1","Kit receptor signaling pathway; VEGFA-VEGFR2 signaling; GDNF signaling",5,0,76.3,72.8,78.5,119,81.9,119.4,115.9,156.6,105.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S269(100)]",0,"ENSG00000115325"
"816","PPFIBP2",0.202797478831988,6.67774768179747,2.94051856578592,0.0154193469280506,0.0308386938561011,-4.09907422461101,"NONE",FALSE,"High","Master Protein","Q8ND30","Liprin-beta-2 [OS=Homo sapiens]",0,11.482,3,2,2,3,2,876,98.5,6.27,9.42,2,"cell organization and biogenesis","cytosol;other cell component","other molecular function","Pf00536, Pf07647","8495","B7Z433; E9PK77; hsa:8495; O75337; Q8ND30; Q8WW26","ENSG00000166387","Receptor-type tyrosine-protein phosphatases","Ectoderm differentiation",2,0,80.7,82,85,104.1,89.3,98.8,125,125.3,134.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000166387"
"817","PGM1",-0.295578368241337,6.61187954478252,-2.933722161902,0.0155961467308561,0.0311541143999476,-4.1106108893195,"NONE",FALSE,"High","Master Protein","P36871","Phosphoglucomutase-1 [OS=Homo sapiens]",0,23.694,8,3,3,3,3,562,61.4,6.76,9.73,3,"other metabolic processes","non-structural extracellular;cytosol;other cell component","other molecular function","Pf02878, Pf02879, Pf02880","5236","B2R5N9; B4DPV0; hsa:5236; P36871; Q16105; Q16106; Q5BKZ9; Q6NW22; Q86U74; Q96J40; Q9NTY4","ENSG00000079739","Neutrophil degranulation; Glycogen synthesis; Glycogen breakdown (glycogenolysis); Galactose catabolism; Defective PGM1 causes PGM1-CDG","Ectoderm differentiation; Clear cell renal cell carcinoma pathways; Glycogen synthesis and degradation; Opioid receptor pathways; Disorders of galactose metabolism ; Disorders of fructose metabolism; UDP-derived sugars synthesis in fibroblasts; Glucuronidation",13,0,114.1,123.8,104.7,90.1,85.6,104,82.2,94,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(99.3); S505(100)]",0,"ENSG00000079739"
"818","TRIM28",-0.317296831815995,6.56559251246713,-2.93070893189442,0.0156751908913754,0.0312720596322628,-4.1157253340432,"NONE",FALSE,"High","Master Protein","Q13263","Transcription intermediary factor 1-beta [OS=Homo sapiens]",0,180.887,22,8,16,63,8,835,88.5,5.77,172.88,8,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00628, Pf00643, Pf14634","10155","hsa:10155; O00677; Q13263; Q7Z632; Q93040; Q96IM1","ENSG00000130726","Generic Transcription Pathway; HCMV Early Events; SUMOylation of transcription cofactors","Corticotropin-releasing hormone signaling pathway; Mesodermal commitment pathway; ATM signaling in development and disease",6,0,118.5,107,110.9,83.8,105.5,90.3,85.5,80.8,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(97.5); S258; S473(100); T541(100); S594(100); S598(99.4); S752(100)]",0,"ENSG00000130726"
"819","GPM6A",0.333359797881294,6.6231712454214,2.93001260077711,0.0156935152198672,0.0312720596322628,-4.11690720067171,"NONE",FALSE,"High","Master Protein","P51674","Neuronal membrane glycoprotein M6-a [OS=Homo sapiens]",0,35.437,9,3,3,4,3,278,31.2,5.27,14.01,3,"cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf01275","2823","B7Z642; E9PHI5; hsa:2823; P51674; Q92602","ENSG00000150625",NA,NA,0,0,82.7,97.3,95.4,106.1,121.9,133.9,83.6,86.4,100.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S267(99.7)]",0,"ENSG00000150625"
"820","GTPBP1",0.277492260583262,6.64818544473798,2.91155508626461,0.0161872607007051,0.0322165969067692,-4.14822939529015,"NONE",FALSE,"High","Master Protein","O00178","GTP-binding protein 1 [OS=Homo sapiens]",0,30.401,3,1,5,13,1,669,72.4,8.34,34.29,1,"protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;other cytoplasmic organelle","nucleic acid binding activity;other molecular function","Pf00009, Pf03144","9567","hsa:9567; O00178; Q6IC67","ENSG00000100226",NA,NA,0,0,84.1,88.1,88.3,105.7,119,108.2,96.9,101.4,121.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(100)]",0,"ENSG00000100226"
"821","AKAP1",0.246653222862276,6.68452222410523,2.89809267030582,0.0165573219210874,0.0329129712243785,-4.17106800936625,"NONE",FALSE,"High","Master Protein","Q92667","A-kinase anchor protein 1, mitochondrial [OS=Homo sapiens]",0,61.298,10,5,6,9,5,903,97.3,4.94,28.7,5,"stress response;other biological processes","other membranes;cytosol;mitochondrion","other molecular function","Pf00013, Pf00567","8165","A8K8Q1; D3DTZ0; hsa:8165; Q13320; Q92667; Q9BW14","ENSG00000121057","Factors involved in megakaryocyte development and platelet production; Mitochondrial calcium ion transport","G protein signaling pathways",3,0,77.6,80.2,80.6,104.4,81.1,101.9,138,129.6,137.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T70(99.5); S151(99.5); S429(100); S445(99.7); T533(100)]",0,"ENSG00000121057"
"822","FBXL20",-0.251782668476522,6.60916611623739,-2.89644858539844,0.0166031005010224,0.0329638199728328,-4.17385672217492,"NONE",FALSE,"High","Master Protein","Q96IG2","F-box/LRR-repeat protein 20 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,436,48.4,7.49,9.29,1,"protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;other cell component",NA,"Pf12937, Pf13516","84961","A8K729; hsa:84961; Q38J52; Q96IG2","ENSG00000108306","Neddylation; Antigen processing: Ubiquitination & Proteasome degradation","17q12 copy number variation syndrome",3,0,115.6,114.5,105.5,91.3,90,103.8,82.7,95.1,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T417(100)]",0,"ENSG00000108306"
"823","PDLIM3",0.258493195864531,6.62056319863357,2.89244933008386,0.016714994924238,0.0330907090434536,-4.18063989041862,"NONE",FALSE,"High","Master Protein","Q53GG5-2","Isoform 2 of PDZ and LIM domain protein 3 [OS=Homo sapiens]",0,15.2,7,1,2,6,1,316,34.3,7.71,15.71,1,NA,NA,NA,NA,NA,"Q53GG5-2",NA,NA,NA,0,0,86.8,89.8,90.5,115.3,120.6,99.1,95,100.4,98.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S170(99.4)]",0,"ENSG00000154553"
"824","PYGO2",0.237192807019696,6.62905516633744,2.89123880059863,0.0167490148800736,0.0330907090434536,-4.18269296352854,"NONE",FALSE,"High","Master Protein","Q9BRQ0","Pygopus homolog 2 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,406,41.2,7.28,9.25,1,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","nucleus","enzyme regulator activity;other molecular function","Pf00628","90780","hsa:90780; Q8WYZ4; Q96CY2; Q9BRQ0","ENSG00000163348","Deactivation of the beta-catenin transactivating complex; Formation of the beta-catenin:TCF transactivating complex","1q21.1 copy number variation syndrome",3,0,99,84.9,92.8,106,121.4,114.7,97.7,93.7,95.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T302(100)]",0,"ENSG00000163348"
"825","SMARCC2",0.226110033722466,6.63611937828302,2.89119863477489,0.0167501448795502,0.0330907090434536,-4.18276108433782,"NONE",FALSE,"High","Master Protein","Q8TAQ2","SWI/SNF complex subunit SMARCC2 [OS=Homo sapiens]",0,74.832,4,5,7,30,5,1214,132.8,5.69,92.28,5,"cell organization and biogenesis;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00249, Pf04433, Pf16495, Pf16496, Pf16498","6601","F8VTJ5; hsa:6601; Q59GV3; Q8TAQ2; Q92923; Q96E12; Q96GY4","ENSG00000139613","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines","Androgen receptor network in prostate cancer; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome; 10q11.21q11.23 copy number variation syndrome",7,0,89.6,91.4,92.8,114.4,105.3,112.9,96.7,105.9,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(99.7); S304(100); S347(100)]",0,"ENSG00000139613"
"826","KIAA1191",0.60613167103979,6.58905170082456,2.89056938650184,0.0167678578570183,0.0330907090434536,-4.18382827488961,"NONE",FALSE,"High","Master Protein","Q96A73","Putative monooxygenase p33MONOX [OS=Homo sapiens]",0,7.451,6,1,1,2,1,305,33.2,9.39,2.7,1,NA,"other cell component","other molecular function","Pf15302","57179","B2RD69; B8K1S6; hsa:57179; Q6IA24; Q8NDU3; Q96A73; Q9BRE5; Q9H7D5; Q9ULM9","ENSG00000122203",NA,"5q35 copy number variation",1,0,70.6,82.7,64.2,102.1,137.3,108.8,118.7,82.6,145,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(99.2)]",0,"ENSG00000122203"
"827","TMX2",-0.434123471346746,6.53410464263473,-2.89055040790423,0.016768392389054,0.0330907090434536,-4.18386046192462,"NONE",FALSE,"High","Master Protein","Q9Y320","Thioredoxin-related transmembrane protein 2 [OS=Homo sapiens]",0,2.755,9,1,1,1,1,296,34,8.69,3.24,1,"developmental processes","other membranes;mitochondrion;ER/Golgi;other cell component","other molecular function","Pf00085","51075","B7Z4R4; hsa:51075; Q53G73; Q561W0; Q5J7Q7; Q8NBP9; Q9H3L1; Q9Y320","ENSG00000213593",NA,NA,0,0,126.7,123,98.6,73.3,104.9,83.1,85.8,76.8,94.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S288(97.8)]",0,"ENSG00000213593"
"828","ILDR2",-0.515416870652921,6.58834981406133,-2.88395957790063,0.0169550734044495,0.0334186954058715,-4.19503745717522,"NONE",FALSE,"High","Master Protein","Q71H61","Immunoglobulin-like domain-containing receptor 2 [OS=Homo sapiens]",0,6.725,5,3,3,4,3,639,71.2,8.12,5.31,3,"cell-cell signaling;transport;other biological processes","other membranes;ER/Golgi;nucleus;other cell component",NA,"Pf05624","387597","hsa:387597; Q71H61","ENSG00000143195",NA,NA,0,0,103.4,102.9,95,64.2,84.3,61.3,114.5,100.3,159.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S410(100); S547(100)]",0,"ENSG00000143195"
"829","OSTM1",-0.313935171974919,6.63368466019546,-2.87625586685846,0.0171759525180184,0.0337894530868154,-4.20809958866296,"NONE",FALSE,"High","Master Protein","Q86WC4","Osteopetrosis-associated transmembrane protein 1 [OS=Homo sapiens]",0,3.903,4,1,1,3,1,334,37.2,6.01,7.49,1,"transport;other biological processes","other membranes;cytosol;other cytoplasmic organelle",NA,"Pf09777","28962","E1P5E3; hsa:28962; Q5R391; Q6PCA7; Q7RTW6; Q86WC4; Q8NC29; Q8TC82; Q9Y2S9","ENSG00000081087","Stimuli-sensing channels","Autosomal recessive osteopetrosis pathways",2,0,100.8,102.7,100.2,81.7,91.3,75.2,122.1,105.6,112.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(99.5)]",0,"ENSG00000081087"
"830","ZBTB7A",0.50884606501115,6.61976490481294,2.87595676178994,0.0171845870478289,0.0337894530868154,-4.20860669269024,"NONE",FALSE,"High","Master Protein","O95365","Zinc finger and BTB domain-containing protein 7A [OS=Homo sapiens]",0,9.071,4,1,1,1,1,584,61.4,5.19,3.38,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf00651","51341","D6W619; hsa:51341; O00456; O95365; Q14D41; Q5XG86","ENSG00000178951",NA,"IL-18 signaling pathway",1,0,112.1,66.5,68.5,126.9,106.6,114.1,103.8,103.5,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S526(99)]",0,"ENSG00000178951"
"831","PJA1",0.413916969707398,6.63021522542198,2.87112770189931,0.0173246029753117,0.0340237690201068,-4.2167933974822,"NONE",FALSE,"High","Master Protein","Q8NG27","E3 ubiquitin-protein ligase Praja-1 [OS=Homo sapiens]",0,11.771,3,2,2,4,2,643,71,5.17,7.34,2,"protein metabolism;other metabolic processes","other cell component","other molecular function","Pf13639","64219","A2A322; Q5JUT8; Q5JUT9; Q8NG27; Q8NG28; Q9HAC1","ENSG00000181191","Antigen processing: Ubiquitination & Proteasome degradation","TGF-beta signaling pathway",2,0,77.7,79.3,83.8,109.8,143,92.6,110.7,96.4,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(100); S265(100)]",0,"ENSG00000181191"
"832","SCRIB",0.216468972950379,6.66124498110678,2.86612258726427,0.0174709452358059,0.0342699310394655,-4.22527754736998,"NONE",FALSE,"High","Master Protein","Q14160","Protein scribble homolog [OS=Homo sapiens]",0,380.315,16,20,30,67,20,1630,174.8,5.07,234.91,20,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00560, Pf00595, Pf13855","23513","hsa:23513; Q14160; Q6P496; Q7Z5D1; Q8WWV8; Q96C69; Q96GG1","ENSG00000180900; ENSG00000274287","RND2 GTPase cycle; CDC42 GTPase cycle; RHOQ GTPase cycle; Asymmetric localization of PCP proteins; RHOJ GTPase cycle; RND3 GTPase cycle","Thyroid stimulating hormone (TSH) signaling pathway; Complement system in neuronal development and plasticity",8,0,87.5,91.2,85.3,106.4,103.2,110,112.4,112,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S504(99.6); S708(100); S835(100); S853(100); S1220(100); S1226(99.6); S1309(100); T1342(100); S1348(100); S1378(100); S1448(100); S1475(100); S1486(100); S1508(100); S1541(100); S1566(100)]",0,"ENSG00000180900"
"833","SRF",-0.225689913168016,6.61668507889965,-2.86267321686558,0.0175725290477735,0.0344278120119644,-4.23112394253667,"NONE",FALSE,"High","Master Protein","P11831","Serum response factor [OS=Homo sapiens]",0,29.94,5,2,2,3,2,508,51.6,8.1,11.12,2,"cell adhesion;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00319","6722","hsa:6722; P11831; Q5T648","ENSG00000112658","RHO GTPases Activate Formins; NGF-stimulated transcription; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Cardiogenesis; Regulation of NPAS4 gene transcription","Heart development; SRF and miRs in smooth muscle differentiation and proliferation; Genes targeted by miRNAs in adipocytes; Cell differentiation - expanded index; Cell differentiation - index; Mesodermal commitment pathway; Mesodermal commitment pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; PDGFR-beta pathway; Envelope proteins and their potential roles in EDMD physiopathology; 22q11.2 copy number variation syndrome; Insulin signaling; Orexin receptor pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling; Serotonin receptor 4/6/7 and NR3C signaling",22,0,109.5,104.5,114.2,100.8,87.9,95.5,87.1,93.4,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S224(100)]",0,"ENSG00000112658"
"834","CHAMP1",-0.199861051079605,6.61820378650517,-2.85246795290634,0.0178765947974809,0.0349815380209697,-4.24841796069725,"NONE",FALSE,"High","Master Protein","Q96JM3","Chromosome alignment-maintaining phosphoprotein 1 [OS=Homo sapiens]",0,86.022,15,9,11,13,9,812,89,8.44,48.54,9,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function",NA,"283489","B3KU06; hsa:283489; Q6P181; Q8NC88; Q96JM3; Q9BST0","ENSG00000198824",NA,NA,0,0,106.5,105,108.3,93.7,99.5,93.8,95.3,94.1,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S204(100); S214(100); S416(100); S427(100); S445(100); S459(99.5); S476(100); S542(100); S603(100); S653(99.5)]",0,"ENSG00000198824"
"835","BMP2K",0.255143736560709,6.64763644499644,2.8456067246708,0.018084018039073,0.0353450508260684,-4.26004246275137,"NONE",FALSE,"High","Master Protein","Q9NSY1","BMP-2-inducible protein kinase [OS=Homo sapiens]",0,40.701,7,4,5,10,4,1161,129.1,6.51,18.72,4,"other metabolic processes;other biological processes","nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf15282","55589","hsa:55589; O94791; Q4W5H2; Q8IYF2; Q8N2G7; Q8NHG9; Q9NSY1; Q9NTG8","ENSG00000138756",NA,NA,0,0,94,95.7,88.9,120.8,111.6,112.1,102.1,95.3,90.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S949(100); T1014(100); S1029(100)]",0,"ENSG00000138756"
"836","ULK1",-0.195900459275112,6.650796076559,-2.84428133056257,0.0181243665070828,0.0353815384444487,-4.26228773239767,"NONE",FALSE,"High","Master Protein","O75385","Serine/threonine-protein kinase ULK1 [OS=Homo sapiens]",0,43.129,5,3,3,6,3,1050,112.6,8.79,13.4,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00069, Pf12063, Pf21127","8408","hsa:8408; O75385; Q9UQ28","ENSG00000177169","RAB GEFs exchange GTP for GDP on RABs; Regulation of TNFR1 signaling; Macroautophagy; TBC/RABGAPs; Receptor Mediated Mitophagy","Target of rapamycin signaling; Alzheimer's disease and miRNA effects; Nanoparticle triggered autophagic cell death; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; 7q11.23 copy number variation syndrome; p53 transcriptional gene network; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; Alzheimer's disease; Clock-controlled autophagy in bone metabolism; 8q11.23 (RB1CC1) copy number variation; ADHD and autism (ASD) linked metabolic pathways and SNP",20,0,100.8,111.9,105.1,94.7,87.6,100.4,101.9,99.6,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S623(100); S638(99.2); S758(100)]",0,"ENSG00000177169"
"837","AKAP17A",-0.373208158028472,6.57171184238078,-2.83436163790493,0.0184292577525762,0.0359010657962965,-4.27908939959879,"NONE",FALSE,"High","Master Protein","Q02040","A-kinase anchor protein 17A [OS=Homo sapiens]",0,9.244,3,2,2,3,2,695,80.7,9.73,7.92,2,"RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus","other molecular function",NA,"8227","hsa:8227; Q02040; Q02832; Q2TB98; Q5JQ74; Q5JQ76; Q8N6U9","ENSG00000197976; ENSG00000292343",NA,NA,0,0,111.3,113.8,110.3,89.9,102.6,73.7,91,81.5,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S537(100); S633(100)]",0,"ENSG00000197976"
"838","MYPOP",-0.266775140837471,6.57721724206118,-2.83419275225341,0.0184344933439316,0.0359010657962965,-4.27937541117535,"NONE",FALSE,"High","Master Protein","Q86VE0","Myb-related transcription factor, partner of profilin [OS=Homo sapiens]",0,13.922,4,1,1,1,1,399,42.5,10.07,3.97,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf13873","339344","hsa:339344; Q86VE0","ENSG00000176182",NA,NA,0,0,113.3,96.3,113.8,85.5,98.4,92,93.3,94.8,87.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100)]",0,"ENSG00000176182"
"839","ZYX",0.320432092735699,6.61879389575667,2.82776252293419,0.0186349599255575,0.0362482176382716,-4.29026408147836,"NONE",FALSE,"High","Master Protein","Q15942","Zyxin [OS=Homo sapiens]",0,59.321,12,5,6,17,5,572,61.2,6.67,48.77,5,"cell adhesion;cell-cell signaling;cell organization and biogenesis;stress response;signal transduction","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00412","7791","A4D2G6; B4DQX7; hsa:7791; Q15942; Q6I9S4","ENSG00000159840; ENSG00000285443",NA,"Integrin-mediated cell adhesion; Focal adhesion",2,0,66.6,72.9,68.8,83.2,105.5,82,145.1,137,163.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S259(99.5); S267(100); S281(100); S344(100)]",0,"ENSG00000159840"
"840","PDHA1",-0.434181699913114,6.5514557208144,-2.82354559052156,0.0187676223162878,0.036462809071645,-4.29740370595659,"NONE",FALSE,"High","Master Protein","P08559","Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial [OS=Homo sapiens]",0,5.512,5,2,2,2,2,390,43.3,8.06,2.28,2,"other metabolic processes","mitochondrion;nucleus;other cell component","other molecular function","Pf00676","5160","A5YVE9; B2R5P7; B7Z3T7; B7Z3X5; hsa:5160; P08559; Q53H41; Q5JPT8; Q9NP12; Q9UBJ8; Q9UBU0; Q9UNG4; Q9UNG5","ENSG00000131828","Glyoxylate metabolism and glycine degradation; Regulation of pyruvate dehydrogenase (PDH) complex; Signaling by Retinoic Acid; Mitochondrial protein degradation","TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc); Amino acid metabolism; Lipid metabolism pathway; PI3K/AKT/mTOR - vitamin D3 signaling; Hereditary leiomyomatosis and renal cell carcinoma pathway; Metabolic reprogramming in colon cancer; Thiamine metabolic pathways; TCA cycle in senescence; Neuroinflammation and glutamatergic signaling; Acetylcholine synthesis; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",17,0,118.9,120.6,117.9,74.5,125.3,80.7,82.6,79.5,84.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T231(99.5)]",0,"ENSG00000131828"
"841","CCNK",-0.26232428968228,6.62041744203388,-2.81928501039816,0.0189026286291502,0.0366814386715495,-4.30461628786361,"NONE",FALSE,"High","Master Protein","O75909-1","Isoform 3 of Cyclin-K [OS=Homo sapiens]",0,21.272,6,2,3,7,2,357,41.3,8.15,20.28,2,NA,NA,NA,NA,NA,"O75909-1",NA,NA,NA,0,0,104.7,109.2,102.2,91.3,99.6,80.8,100,99.8,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S324(100); S340(100)]",0,"ENSG00000090061"
"842","PALM",0.399016013428787,6.63735230823151,2.81718147334725,0.0189696459914689,0.0367677699027045,-4.30817693509931,"NONE",FALSE,"High","Master Protein","O75781","Paralemmin-1 [OS=Homo sapiens]",0,182.159,19,9,16,34,9,387,42.1,5,99.3,9,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding","Pf03285","5064","hsa:5064; O43359; O75781; O95673; Q92559; Q9UPJ4; Q9UQS2; Q9UQS3","ENSG00000099864",NA,NA,0,0,83.4,84.5,87.7,115.3,149.8,99.2,112,92.3,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S116(100); S124(100); T141(100); T145(100); S152(100); T154(100); S162(100); S249(99.6)]",0,"ENSG00000099864"
"843","SLC16A1",0.307594330165819,6.67179877707221,2.81333290883916,0.0190928816728812,0.036962731779528,-4.31469076646499,"NONE",FALSE,"High","Master Protein","P53985","Monocarboxylate transporter 1 [OS=Homo sapiens]",0,92.802,9,5,7,12,5,500,53.9,8.66,41.51,5,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","transporter activity;other molecular function",NA,"6566","hsa:6566; P53985; Q49A45; Q5T8R6; Q9NSJ9","ENSG00000155380; ENSG00000281917","Basigin interactions; Pyruvate metabolism; Aspirin ADME; Proton-coupled monocarboxylate transport; Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)","Photodynamic therapy-induced HIF-1 survival signaling; Fragile X syndrome; Glucose metabolism in triple-negative breast cancer cells",8,0,83.7,83.3,79.9,111.8,88.7,113.7,126.1,123.3,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S461(100); S467(100); S498(100)]",0,"ENSG00000155380"
"844","MAP3K7",0.330795138274159,6.64954972873248,2.80858121040969,0.0192461545772558,0.0371936339386707,-4.32273206878519,"NONE",FALSE,"High","Master Protein","O43318","Mitogen-activated protein kinase kinase kinase 7 [OS=Homo sapiens]",0,33.497,5,2,2,4,2,606,67.2,7.11,17.32,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf07714","6885","B2RE27; E1P523; hsa:6885; O43317; O43318; O43319; Q5TDN2; Q5TDN3; Q5TDT7; Q9NTR3; Q9NZ70","ENSG00000135341","FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; CLEC7A (Dectin-1) signaling; Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; TRAF6-mediated induction of TAK1 complex within TLR4 complex; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation; Ca2+ pathway; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TAK1-dependent IKK and NF-kappa-B activation  ; TNFR1-induced NF-kappa-B signaling pathway; TICAM1,TRAF6-dependent induction of TAK1 complex; activated TAK1 mediates p38 MAPK activation; IRAK2 mediated activation of TAK1 complex; Alpha-protein kinase 1 signaling pathway","IL-1 signaling pathway; RANKL/RANK signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; IL-17 signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; Ebstein-Barr virus LMP1 signaling; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Nod-like receptor (NLR) signaling pathway; Fas ligand pathway and stress induction of heat shock proteins; Wnt signaling pathway; IL6 signaling pathway; TGF-beta signaling pathway; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; Angiopoietin-like protein 8 regulatory pathway; Wnt signaling pathway and pluripotency; p38 MAPK signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; miRNA role in immune response in sepsis; Signal transduction through IL1R; Measles virus infection; Hepatitis B infection; IL-18 signaling pathway; Insulin signaling; Host-pathogen interaction of human coronaviruses - interferon induction; T-cell receptor signaling pathway; DNA damage response (only ATM dependent); Toll-like receptor signaling pathway",50,0,84.1,92.7,85.5,107.1,146.3,102.8,94.8,107.3,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S374(99.5); S439(100)]",0,"ENSG00000135341"
"845","R3HDM2",0.283224391102411,6.66335375070708,2.80822380939472,0.0192577332586867,0.0371936339386707,-4.32333684829524,"NONE",FALSE,"High","Master Protein","Q9Y2K5","R3H domain-containing protein 2 [OS=Homo sapiens]",0,36.025,3,2,3,5,2,976,106.9,8.85,14.52,2,NA,"nucleus",NA,"Pf01424","22864","B7ZL65; hsa:22864; Q2M1T9; Q3ZCT5; Q9Y2K5","ENSG00000179912",NA,NA,0,0,83.7,90.8,73.3,95.2,111.5,110.2,113.6,117.6,124.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100); S855(100)]",0,"ENSG00000179912"
"846","HEPACAM",-0.287023142750185,6.56582074858455,-2.80317233311466,0.0194221407105317,0.0374662702301918,-4.33188398590604,"NONE",FALSE,"High","Master Protein","Q14CZ8","Hepatic and glial cell adhesion molecule [OS=Homo sapiens]",0,139.98,24,8,14,48,7,416,46,9.11,127.55,8,"cell adhesion;cell cycle OR cell proliferation;other biological processes","other membranes;other cell component",NA,"Pf07686, Pf13927","220296","hsa:220296; Q14CZ8; Q67IP8; Q6ZWL4; Q8N7I3; Q8ND35","ENSG00000165478",NA,NA,0,2,118,124.3,109,95.8,111,89.8,82.1,75,84.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S278(100); T295(100); S299(100); S318(100); S350(100); S364(99.3); S376(99.4); S383(99.4)]",0,"ENSG00000165478"
"847","PAGR1",0.408234837932433,6.61377878954949,2.80247918676971,0.0194448105912822,0.0374662702301918,-4.33305668242991,"NONE",FALSE,"High","Master Protein","Q9BTK6","PAXIP1-associated glutamate-rich protein 1 [OS=Homo sapiens]",0,20.387,7,1,1,3,1,254,27.7,4.46,10.33,1,"DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","other molecular function","Pf15364","79447","A2ICR6; hsa:79447; Q9BTK6","ENSG00000280789","Formation of WDR5-containing histone-modifying complexes; Activation of anterior HOX genes in hindbrain development during early embryogenesis","16p11.2 proximal deletion syndrome; Kleefstra syndrome",4,0,81.8,78.7,80.9,118.9,109.9,102.5,126.3,92.7,98.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S237(100)]",0,"ENSG00000280789"
"848","SYN1",-0.231030527662319,6.59263420181218,-2.79272397391131,0.0197667140070261,0.0380416005418238,-4.34955805288545,"NONE",FALSE,"High","Master Protein","P17600","Synapsin-1 [OS=Homo sapiens]",0,10.897,3,1,1,1,1,705,74.1,9.83,3.79,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;other biological processes","other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf02078, Pf02750, Pf10581","6853","B1AJQ1; hsa:6853; O75825; P17600; Q5H9A9","ENSG00000008056","Sensory processing of sound by inner hair cells of the cochlea; Serotonin Neurotransmitter Release Cycle; Dopamine Neurotransmitter Release Cycle","Synaptic vesicle pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; GDNF signaling; Monoamine transport",7,0,105,105.9,105.5,84.7,91.1,100.6,88.7,95.6,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S510(99.2)]",0,"ENSG00000008056"
"849","MTMR10",0.541992344165591,6.61430606636306,2.7794328651892,0.020213979147105,0.0388206634281328,-4.37203141793755,"NONE",FALSE,"High","Master Protein","Q9NXD2","Myotubularin-related protein 10 [OS=Homo sapiens]",0,4.489,2,1,1,3,1,777,88.2,8.53,6.59,1,NA,"cytosol;other cell component",NA,"Pf06602, Pf12578","54893","hsa:54893; Q6P4Q6; Q9NXD2","ENSG00000166912; ENSG00000277086","Synthesis of PIPs at the early endosome membrane","15q13.3 copy number variation syndrome; 15q11q13 copy number variation",3,0,60.3,68.2,103.8,100.9,108,132.3,95.5,118.5,115.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S769(99.5)]",0,"ENSG00000166912"
"850","NOP56",-0.218627154518064,6.64526187209735,-2.77928254871677,0.0202190955354858,0.0388206634281328,-4.37228551954549,"NONE",FALSE,"High","Master Protein","O00567","Nucleolar protein 56 [OS=Homo sapiens]",0,130.673,11,5,10,29,5,594,66,9.19,85.34,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01798, Pf08156","10528","hsa:10528; O00567; Q2M3T6; Q9NQ05","ENSG00000101361","Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; Association of TriC/CCT with target proteins during biosynthesis",NA,3,0,102.1,105.1,102.3,85.9,94,94,100.3,105.8,113.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T468(98.4); S519(99.6)]",0,"ENSG00000101361"
"851","LMNA",0.251994117571572,6.64646900503591,2.77393568370247,0.0204019420189866,0.0391256984429918,-4.38132317170325,"NONE",FALSE,"High","Master Protein","P02545","Prelamin-A/C [OS=Homo sapiens]",0,60.533,11,6,9,13,6,664,74.1,7.02,38.78,6,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00038, Pf00932","4000","B4DI32; D3DVB0; D6RAQ3; E7EUI9; hsa:4000; P02545; P02546; Q5I6Y4; Q5I6Y6; Q5TCJ2; Q5TCJ3; Q6UYC3; Q969I8; Q96JA2","ENSG00000160789","Signaling by BRAF and RAF1 fusions; XBP1(S) activates chaperone genes","Arrhythmogenic right ventricular cardiomyopathy; Adipogenesis; Fas ligand pathway and stress induction of heat shock proteins; Lamin A processing pathway; Nephrotic syndrome; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome; Primary ovarian insufficiency; 7q11.23 distal copy number variation",14,0,85.4,83.6,91.4,101.6,100.8,120.3,97.8,110.3,114.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(99.5); S392(100); S404(99.3); S406(99.3); S636(100)]",0,"ENSG00000160789"
"852","FAM53C",0.210587093685886,6.67226540936578,2.77264857368722,0.0204462059509532,0.0391283777876861,-4.3834984657904,"NONE",FALSE,"High","Master Protein","Q9NYF3","Protein FAM53C [OS=Homo sapiens]",0,32.294,11,5,5,7,5,392,43.1,8.65,20.76,5,"transport","nucleus",NA,"Pf15242","51307","B2RDJ5; D3DQB9; hsa:51307; Q9NYF3","ENSG00000120709",NA,NA,0,0,86.9,90.5,96.5,104.7,116.9,111.5,104.8,100.3,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S122(100); S234(100); S273(100); S299(100)]",0,"ENSG00000120709"
"853","EIF3CL",0.19630757346704,6.68219860305934,2.77250090209948,0.0204512905961374,0.0391283777876861,-4.38374803296042,"NONE",FALSE,"High","Master Protein","B5ME19","Eukaryotic translation initiation factor 3 subunit C-like protein [OS=Homo sapiens]",0,49.811,2,2,2,10,2,914,105.4,5.64,36.51,2,"cell organization and biogenesis;protein metabolism;other metabolic processes","translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf01399, Pf05470","728689","B5ME19; hsa:728689","ENSG00000205609",NA,NA,0,0,84.9,90.4,89.3,108.2,95.2,110.3,109.2,116.4,118.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000205609"
"854","CCDC86",0.238205225704665,6.67467944277693,2.76619032009742,0.020669773886756,0.0394587150060144,-4.39441169303687,"NONE",FALSE,"High","Master Protein","Q9H6F5","Coiled-coil domain-containing protein 86 [OS=Homo sapiens]",0,58.666,23,4,4,11,4,360,40.2,10.33,44.74,4,NA,"nucleus;other cell component",NA,"Pf03879","79080","B4DY99; hsa:79080; Q9H6F5","ENSG00000110104",NA,NA,0,0,80.4,89,78,95.5,104.4,103.9,119.2,119.1,140.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100); S47(99.3); S91(100); S102(100); S113(99.3)]",0,"ENSG00000110104"
"855","TBC1D10B",0.202511333240323,6.65138053599282,2.7659593118994,0.0206778163241428,0.0394587150060144,-4.39480200286652,"NONE",FALSE,"High","Master Protein","Q4KMP7","TBC1 domain family member 10B [OS=Homo sapiens]",0,125.229,9,8,11,22,8,808,87.1,9.19,62.42,8,"transport;other biological processes","plasma membrane;other membranes;cytosol","enzyme regulator activity","Pf00566","26000","B9A6L0; hsa:26000; Q4KMP7; Q6IN54; Q6P530; Q71RG7; Q86VC5; Q9H8Z2; Q9NUN6; Q9UFP2","ENSG00000169221","TBC/RABGAPs",NA,1,0,92.9,94.6,91.1,116.1,108.9,107.6,96.9,101,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); S132(100); T148(99.3); T152(99.2); S661(100); S678(100)]",0,"ENSG00000169221"
"856","KDM5C",-0.3961948938058,6.51181595932627,-2.76542348961437,0.0206964828708017,0.0394587150060144,-4.39570731093338,"NONE",FALSE,"High","Master Protein","P41229","Lysine-specific demethylase 5C [OS=Homo sapiens]",0,19.099,2,2,3,5,2,1560,175.6,5.58,3.96,2,"cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00628, Pf01388, Pf02373, Pf02375, Pf02928, Pf08429, Pf21323","8242","B0QZ44; B4E3I2; F5H3T1; hsa:8242; P41229; Q5JUX3; Q5JUX4; Q5JUX5; Q7Z5S5","ENSG00000126012","HDMs demethylate histones","Clear cell renal cell carcinoma pathways",2,0,129,105.3,116.2,81.8,102,88.3,67.4,90.7,80.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S301(100)]",0,"ENSG00000126012"
"857","TTYH3",-0.373511907316959,6.57035796683074,-2.76469395339179,0.0207219252012441,0.0394611224369082,-4.39693988143164,"NONE",FALSE,"High","Master Protein","Q9C0H2","Protein tweety homolog 3 [OS=Homo sapiens]",0,29.907,6,2,3,6,2,523,57.5,5.39,17.93,2,"transport","plasma membrane;other membranes","transporter activity","Pf04906","80727","A4D201; B7WP98; hsa:80727; Q6L749; Q6ZVG3; Q8TEG6; Q9C0H2","ENSG00000136295","Stimuli-sensing channels",NA,1,0,106.8,107.9,114.4,84.6,100.9,75.7,98.4,80.6,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S437(100); S496(100)]",0,"ENSG00000136295"
"858","PTDSS2",0.470160822696324,6.61906405382523,2.76174239337611,0.0208251823199622,0.0396115356016063,-4.40192625955836,"NONE",FALSE,"High","Master Protein","Q9BVG9","Phosphatidylserine synthase 2 [OS=Homo sapiens]",0,14.996,3,2,2,4,2,487,56.2,6.25,5.2,2,"other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf03034","81490","hsa:81490; Q9BVG9","ENSG00000174915","Synthesis of PS","Kennedy pathway from sphingolipids; Glycerolipids and glycerophospholipids",3,0,70.6,76.5,78.9,103.5,128.3,100,89.9,144,124,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000174915"
"859","CCDC6",0.23637901686675,6.66173653703712,2.75650482787839,0.0210096920881992,0.0399159691361363,-4.41077319014436,"NONE",FALSE,"High","Master Protein","Q16204","Coiled-coil domain-containing protein 6 [OS=Homo sapiens]",0,58.945,6,2,4,12,2,474,53.3,7.34,40.23,2,"cell organization and biogenesis","cytosol;cytoskeleton","cytoskeletal activity;other molecular function","Pf09755","8030","hsa:8030; Q15250; Q16204; Q6GSG7","ENSG00000108091",NA,"Retinoblastoma gene in cancer; Mesodermal commitment pathway; 16p11.2 proximal deletion syndrome",3,0,90.1,94.2,85.4,105.7,110.5,115.5,95.1,110.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(100); S244(100); S323(100)]",0,"ENSG00000108091"
"860","PPP1R7",0.274012393192693,6.65738035986228,2.75165825551522,0.0211818960831554,0.0401963423345461,-4.41895802144331,"NONE",FALSE,"High","Master Protein","Q15435","Protein phosphatase 1 regulatory subunit 7 [OS=Homo sapiens]",0,13.179,4,1,2,3,1,360,41.5,4.91,4.29,1,"other biological processes","other cell component","enzyme regulator activity","Pf12799, Pf14580","5510","B4DFD4; B5MCY6; hsa:5510; Q15435; Q9UQE5; Q9UQE6; Q9Y6K4","ENSG00000115685",NA,"2q37 copy number variation syndrome",1,0,82.3,77.8,81.7,114.6,91.7,94,115.8,120.1,136.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100)]",0,"ENSG00000115685"
"861","TCEA1",0.256018089268827,6.68221930713658,2.74854430384097,0.0212932882898192,0.0403371939933944,-4.42421596869011,"NONE",FALSE,"High","Master Protein","P23193","Transcription elongation factor A protein 1 [OS=Homo sapiens]",0,57.018,5,2,4,17,2,301,33.9,8.38,45.02,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf01096, Pf07500, Pf08711","6917","A6NF25; A8K339; hsa:6917; P23193; Q15563; Q6FG87","ENSG00000187735","Formation of RNA Pol II elongation complex ; Formation of HIV elongation complex in the absence of HIV Tat; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER",NA,15,0,80.9,92.7,88.6,114.7,100.2,110,101.9,114.8,123.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(100)]",0,"ENSG00000187735"
"862","DNPH1",0.245698304597613,6.66127829611651,2.74820247147784,0.0213055522195502,0.0403371939933944,-4.42479311583039,"NONE",FALSE,"High","Master Protein","O43598","5-hydroxymethyl-dUMP N-hydrolase [OS=Homo sapiens]",0,16.154,10,1,1,6,1,174,19.1,5.05,14.94,1,"other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf05014","10591","B2LUJ9; hsa:10591; O43598","ENSG00000112667","Purine catabolism",NA,1,0,83.6,80.3,91.7,105.3,104.2,105.1,105.4,110.2,131,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100)]",0,"ENSG00000112667"
"863","RPS17",-0.682031032902467,6.50056925837285,-2.74628125308264,0.0213746123904202,0.0404210514729614,-4.42803673371949,"NONE",FALSE,"High","Master Protein","P08708","Small ribosomal subunit protein eS17 [OS=Homo sapiens]",0,16.006,33,2,2,2,2,135,15.5,9.85,3.81,2,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","other molecular function","Pf00833","6218","B2R4U4; hsa:6218; P08708; P0CW22","ENSG00000182774; ENSG00000278229","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",19,0,137.8,155.9,81.2,60.8,72.4,84.1,93.6,101.2,68.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(99.1)]",0,"ENSG00000182774"
"864","KBTBD11",0.192324215642695,6.64756659704195,2.73984669330778,0.0216075564276333,0.0408142732521962,-4.43889837912233,"NONE",FALSE,"High","Master Protein","O94819","Kelch repeat and BTB domain-containing protein 11 [OS=Homo sapiens]",0,35.769,5,2,3,7,2,623,65.7,6.07,18.66,2,NA,NA,NA,"Pf00651, Pf01344","9920","hsa:9920; O94819; Q3L1I0","ENSG00000176595; ENSG00000273645",NA,NA,0,0,97.2,99.1,96.9,113.8,113.5,120.9,91.2,87.9,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S107(100); S310(100); S314(100)]",0,"ENSG00000176595"
"865","TJP2",-0.195801733786851,6.61755950288094,-2.73534554799355,0.0217720256923758,0.0410768193598673,-4.44649461812567,"NONE",FALSE,"High","Master Protein","Q9UDY2","Tight junction protein ZO-2 [OS=Homo sapiens]",0,45.118,6,7,7,14,7,1190,133.9,7.4,35.61,7,"cell adhesion;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00595, Pf00625, Pf07653","9414","A2A3H9; B7Z2R8; B7Z7T6; F5H301; F5H886; hsa:9414; Q15883; Q5VXL0; Q5VXL1; Q8N756; Q8NI14; Q99839; Q9UDY0; Q9UDY1; Q9UDY2","ENSG00000119139","RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; Signaling by Hippo; Apoptotic cleavage of cell adhesion  proteins","1q21.1 copy number variation syndrome; 15q11q13 copy number variation",7,0,118.8,107.5,113.2,101,90,109.9,86.2,89.5,86,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S174(100); S244(100); S266(100); S415(100); S702(100)]",0,"ENSG00000119139"
"866","CRACD",-0.259432317222387,6.62591732559354,-2.73432156378768,0.021809617200612,0.0410768193598673,-4.44822251177558,"NONE",FALSE,"High","Master Protein","Q6ZU35","Capping protein-inhibiting regulator of actin dynamics [OS=Homo sapiens]",0,51.809,7,7,7,14,7,1233,136.7,5.6,37.98,7,"cell organization and biogenesis;other biological processes","cytosol",NA,"Pf15262","57482","hsa:57482; Q6ZU35; Q9NTE2; Q9NTP8; Q9ULK9","ENSG00000109265",NA,NA,0,0,103.9,95.5,99.6,78.7,87.1,88.1,114.7,101.4,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S132(99.2); S420(100); S556(100); S874(99.1); S1017(100); S1072(100); S1143(100)]",0,"ENSG00000109265"
"867","CAMKK2",0.724868420048089,6.70032240628078,2.73398300849621,0.0218220602849295,0.0410768193598673,-4.44879378055176,"NONE",FALSE,"High","Master Protein","Q96RR4-3","Isoform 3 of Calcium/calmodulin-dependent protein kinase kinase 2 [OS=Homo sapiens]",0,10.383,4,1,1,3,1,541,59.6,5.76,7.51,1,NA,NA,NA,NA,NA,"Q96RR4-3",NA,NA,NA,0,0,98.5,41.4,81.9,123.4,95.4,135.6,117.9,122.7,155.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S522(100)]",0,"ENSG00000110931"
"868","RNF180",-0.325729026908554,6.64824900778607,-2.73250553987809,0.0218764461262526,0.0411317512419864,-4.45128672119948,"NONE",FALSE,"High","Master Protein","Q86T96","E3 ubiquitin-protein ligase RNF180 [OS=Homo sapiens]",0,10.169,2,1,1,1,1,592,68.2,8.56,3.97,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf00097, Pf19332","285671","hsa:285671; Q0JSU3; Q495A8; Q86T96; Q8NBD1","ENSG00000164197",NA,NA,0,0,93.7,102.3,109.4,75.7,70.1,99.6,126.8,109,111,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S230(100)]",0,"ENSG00000164197"
"869","SMPD4",-0.63046583413559,6.44331705609787,-2.73179999457474,0.0219024654866051,0.0411332838597693,-4.45247713467475,"NONE",FALSE,"High","Master Protein","Q9NXE4","Sphingomyelin phosphodiesterase 4 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,866,97.7,8.27,4.73,1,"cell organization and biogenesis;other metabolic processes;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus","other molecular function","Pf14724","55627","B1PBA3; B4DM23; B4DQ31; B4DRB8; B4DWK7; B4E0L6; E7ESA2; E9PCE6; hsa:55627; Q6FI76; Q6P1P7; Q6ZT43; Q9H0M2; Q9NW20; Q9NWL2; Q9NXE4; Q9P2C9","ENSG00000136699; ENSG00000292130","Glycosphingolipid catabolism",NA,1,0,152.3,107.8,112.3,60.1,90.8,84.4,58.1,83.8,90.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100)]",0,"ENSG00000136699"
"870","CMIP",-0.485341586318609,6.60018323909214,-2.71966688775144,0.0223548211485857,0.0419345610511401,-4.47294256888599,"NONE",FALSE,"High","Master Protein","Q8IY22","C-Maf-inducing protein [OS=Homo sapiens]",0,14.896,2,1,1,1,1,773,86.3,6.7,3.99,1,"developmental processes","cytosol;nucleus",NA,NA,"80790","hsa:80790; Q8IY22; Q9C0G9","ENSG00000153815",NA,NA,0,0,92.8,164.6,124.4,86.9,76.5,105.8,79.6,92.3,81.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S377(100)]",0,"ENSG00000153815"
"871","HACD3",-0.488076448500604,6.54713772902184,-2.7127034399403,0.0226186720369155,0.0423807953665282,-4.48468301820723,"NONE",FALSE,"High","Master Protein","Q9P035","Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 [OS=Homo sapiens]",0,42.508,8,3,4,36,3,362,43.1,8.94,69.2,3,"other metabolic processes;signal transduction;other biological processes","other membranes;ER/Golgi;nucleus","enzyme regulator activity;other molecular function","Pf04387","51495","A0PJA1; B4DRF4; hsa:51495; Q280Z3; Q6PD63; Q8IUI5; Q8NC86; Q8NCB1; Q96T12; Q9NQA7; Q9P035","ENSG00000074696","Synthesis of very long-chain fatty acyl-CoAs",NA,1,0,124.5,119.9,114.3,91.3,50.4,117.1,86.6,88.4,78.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S114(100); S135(100)]",0,"ENSG00000074696"
"872","SHARPIN",0.214192346103051,6.66152814977622,2.70544749497762,0.0228969391123381,0.0428529869625411,-4.4969125512784,"NONE",FALSE,"High","Master Protein","Q9H0F6","Sharpin [OS=Homo sapiens]",0,37.315,11,2,2,3,2,387,39.9,5.8,12.05,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;other cell component","other molecular function","Pf16764","81858","A6NEG3; C0L3L2; D3DWL3; hsa:81858; Q8IXF5; Q8IXF6; Q8N2E7; Q8TB25; Q9BUE4; Q9H0F6","ENSG00000179526","Neurexins and neuroligins; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; TNFR1-induced proapoptotic signaling",NA,4,0,85.4,80.9,87.6,105.4,100,99.8,112.7,127.6,113.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S131(99.4); S165(100)]",0,"ENSG00000179526"
"873","SAMD4B",0.204875117929674,6.64642955217933,2.70206639603586,0.0230277781621077,0.0430181081837889,-4.5026097794655,"NONE",FALSE,"High","Master Protein","Q5PRF9","Protein Smaug homolog 2 [OS=Homo sapiens]",0,31.646,8,2,2,5,2,694,75.4,6.83,24.79,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00536","55095","A5Z0M6; hsa:55095; Q5PRF9; Q6P194","ENSG00000179134",NA,NA,0,0,96,95,90.1,103.6,122.6,115.4,97.1,96.5,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(100)]",0,"ENSG00000179134"
"874","SNTB1",0.3685160388548,6.65796327433828,2.70180605042656,0.0230378839170536,0.0430181081837889,-4.50304842916914,"NONE",FALSE,"High","Master Protein","Q13884","Beta-1-syntrophin [OS=Homo sapiens]",0,106.402,12,5,6,16,5,538,58,8.63,77.01,5,"other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00595, Pf18012","6641","A8K9E0; hsa:6641; O14912; Q13884; Q4KMG8","ENSG00000172164",NA,"IL-18 signaling pathway; 13q12.12 copy number variation",2,0,82.2,91,92.4,113.6,95.9,142,95.7,108.9,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S87(100); S219(100); S389(100)]",0,"ENSG00000172164"
"875","TOB2",-0.275562984040197,6.61568997120167,-2.69951708176899,0.0231269262138433,0.0431350212354198,-4.50690481564738,"NONE",FALSE,"High","Master Protein","Q14106","Protein Tob2 [OS=Homo sapiens]",0,3.262,2,1,1,1,1,344,36.6,6.93,2.73,1,"other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf07145, Pf07742","10766","hsa:10766; Q14106; Q6FHR7; Q6PIT9; Q9BY97; Q9UBI0","ENSG00000183864",NA,"Bone morphogenic protein signaling and regulation",1,0,104.3,120.1,116,89.5,94.3,103.8,96.7,93.1,80.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S222(100)]",0,"ENSG00000183864"
"876","ASAP1",0.225378897972848,6.6530061002824,2.69361388585115,0.0233581636790988,0.043516578909006,-4.5168483496193,"NONE",FALSE,"High","Master Protein","Q9ULH1","Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 [OS=Homo sapiens]",0,42.269,4,3,5,7,3,1129,125.4,7.31,23.06,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf01412, Pf12796, Pf14604, Pf16746","50807","B2RNV3; hsa:50807; Q9ULH1","ENSG00000153317","VxPx cargo-targeting to cilium","EGF/EGFR signaling pathway; CCL18 signaling pathway",3,0,88.3,95.5,88.3,110.3,121,102.6,101.6,99.2,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S843(100); S1008(100); S1041(100)]",0,"ENSG00000153317"
"877","RIDA",0.405625556611121,6.67735426673279,2.68638121766178,0.0236446476697753,0.0440000741129685,-4.52902730697952,"NONE",FALSE,"High","Master Protein","P52758","2-iminobutanoate/2-iminopropanoate deaminase [OS=Homo sapiens]",0,14.315,18,3,5,10,3,137,14.5,8.68,10.13,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","nucleic acid binding activity;other molecular function","Pf01042","10247","hsa:10247; P52758; Q6FHU9; Q6IBG0","ENSG00000132541","Threonine catabolism",NA,1,0,85.3,82.5,87.4,112.6,98,137.3,104.8,128.6,91.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S3(99.2); S136(100)]; Met-loss [N-Term]",0,"ENSG00000132541"
"878","FMNL2",-0.48148716955326,6.58404861565138,-2.68485016783946,0.0237057432862561,0.0440312734197889,-4.53160484280232,"NONE",FALSE,"High","Master Protein","Q96PY5","Formin-like protein 2 [OS=Homo sapiens]",0,10.222,2,2,2,5,2,1086,123.2,7.4,12.65,2,"cell organization and biogenesis;other biological processes","cytosol","cytoskeletal activity;other molecular function","Pf02181, Pf06367, Pf06371","114793","B2RZH5; hsa:114793; Q14CC9; Q4ZG52; Q8N3E0; Q96PY5","ENSG00000157827","CDC42 GTPase cycle; RHOC GTPase cycle; RHO GTPases Activate Formins","Epithelial to mesenchymal transition in colorectal cancer",4,0,108.3,127.8,101.9,78.5,89.7,72.8,102.2,78,122.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(100); S190(100)]",0,"ENSG00000157827"
"879","CERT1",0.698325488887206,6.57878410275548,2.68459394789183,0.0237159830617945,0.0440312734197889,-4.53203617167238,"NONE",FALSE,"High","Master Protein","Q9Y5P4","Ceramide transfer protein [OS=Homo sapiens]",0,8.702,2,1,1,1,1,624,70.8,5.48,2.84,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;nucleus","transporter activity;kinase activity;other molecular function","Pf00169, Pf01852","10087","A8K7S2; B3KUB7; hsa:10087; Q53YV1; Q53YV2; Q96Q85; Q96Q88; Q9H2S7; Q9H2S8; Q9Y5P4","ENSG00000113163",NA,"Sphingolipid pathway",1,0,92.5,98.7,68.9,156.7,115.4,140.9,72.4,105.1,60.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S123(100)]",0,"ENSG00000113163"
"880","SLC35C2",-0.343773564993741,6.62574470058461,-2.68393462175509,0.0237423533145921,0.0440312734197889,-4.53314607643623,"NONE",FALSE,"High","Master Protein","Q9NQQ7","Solute carrier family 35 member C2 [OS=Homo sapiens]",0,14.897,4,1,1,2,1,365,40.4,8.18,7.68,1,"protein metabolism;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;nucleus","transporter activity","Pf03151","51006","B7Z6V6; E1P5T0; hsa:51006; Q53GK3; Q5JW05; Q96CJ8; Q9NQQ7; Q9Y304","ENSG00000080189",NA,NA,0,0,93.4,79.4,91.6,57.1,67.8,76.2,145.4,128.9,171.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100)]",0,"ENSG00000080189"
"881","SP9",-0.42340150714577,6.4796376567413,-2.67389723062563,0.0241474610702669,0.0447317326522991,-4.55003827464606,"NONE",FALSE,"High","Master Protein","P0CG40","Transcription factor Sp9 [OS=Homo sapiens]",0.003,2.353,4,1,1,2,1,484,48.9,8.76,2.14,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","100131390","hsa:100131390; P0CG40","ENSG00000217236",NA,NA,0,0,140.6,101,108.4,80.6,78.2,96.3,94.5,66.4,70.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T30(99.3)]",0,"ENSG00000217236"
"882","CC2D1A",0.339544188386526,6.63333129379472,2.66789702493427,0.0243929340782408,0.0451352249610986,-4.56013192670191,"NONE",FALSE,"High","Master Protein","Q6P1N0","Coiled-coil and C2 domain-containing protein 1A [OS=Homo sapiens]",0,17.221,3,2,2,2,2,951,104,8.09,7.38,2,"other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus","nucleic acid binding activity;other molecular function","Pf00168, Pf21528","54862","hsa:54862; Q6P1N0; Q7Z435; Q86XV0; Q8NF89; Q9H603; Q9NXI1","ENSG00000132024; ENSG00000288293",NA,"Sudden infant death syndrome (SIDS) susceptibility pathways",1,0,85.4,93.3,72.1,104.3,95.8,125.2,97.6,113.7,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T204(97.4); S455(100)]",0,"ENSG00000132024"
"883","APC",0.240148613848829,6.6541014489685,2.66636395750684,0.02445605357211,0.0452007694560403,-4.56271036006744,"NONE",FALSE,"High","Master Protein","P25054","Adenomatous polyposis coli protein [OS=Homo sapiens]",0,67.844,4,9,9,17,9,2843,311.5,7.8,37.77,9,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00514, Pf05923, Pf05924, Pf05937, Pf05956, Pf05972, Pf11414, Pf16629, Pf16630, Pf16633, Pf16634, Pf16635, Pf16636, Pf16689, Pf18797","324","B7Z2B6; D3DT03; hsa:324; P25054; Q15162; Q15163; Q93042","ENSG00000134982","Deactivation of the beta-catenin transactivating complex; Disassembly of the destruction complex and recruitment of AXIN to the membrane; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Ovarian tumor domain proteases; Apoptotic cleavage of cellular proteins; APC truncation mutants are not K63 polyubiquitinated","Microtubule cytoskeleton regulation; Alzheimer's disease and miRNA effects; Gastric cancer network 1; Brain-derived neurotrophic factor (BDNF) signaling pathway; Endoderm differentiation; Extracellular vesicle-mediated signaling in recipient cells; Copper homeostasis; Wnt signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; Regulation of Wnt / B-catenin signaling by small molecule compounds; Physico-chemical features and toxicity-associated pathways; Embryonic stem cell pluripotency pathways; Wnt signaling pathway and pluripotency; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Regulation of sister chromatid separation at the metaphase-anaphase transition; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Ciliary landscape; Influence of laminopathies on Wnt signaling; Overlap between signal transduction pathways contributing to LMNA laminopathies; Pleural mesothelioma; Regulation of actin cytoskeleton; Cohesin complex - Cornelia de Lange syndrome; Alzheimer's disease; 2q21.1 copy number variation syndrome; HDAC6 interactions in the central nervous system; DNA damage response (only ATM dependent)",45,0,85.8,97.7,91.4,107,129.6,108.2,94.2,103.3,102.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S780(100); S1042(100); S1360(100); S1392(98.7); S2129(99.8); S2449(100); S2724(100)]",0,"ENSG00000134982"
"884","GPR37L1",0.9802772066006,6.55719899073722,2.65998313004747,0.0247205298033955,0.0456379011754994,-4.57343983417255,"NONE",FALSE,"High","Master Protein","O60883","G-protein coupled receptor 37-like 1 [OS=Homo sapiens]",0,9.835,2,1,2,4,1,481,52.7,7.36,10.97,1,"stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00001","9283","B2R7M9; hsa:9283; O60883; Q5SXP7; Q86VP7","ENSG00000170075","G alpha (i) signalling events; Peptide ligand-binding receptors","GPCRs, class A rhodopsin-like",3,0,69,55.9,16.6,103,50.3,141.1,189.3,185.4,149.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S471(100)]",0,"ENSG00000170075"
"885","SOX2",-0.181759124824061,6.63978852613202,-2.65523141390684,0.0249193430380733,0.0459529580091928,-4.58142748652113,"NONE",FALSE,"High","Master Protein","P48431","Transcription factor SOX-2 [OS=Homo sapiens]",0,14.079,8,2,3,3,2,317,34.3,9.74,7.1,2,"cell organization and biogenesis;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505, Pf12336","6657","hsa:6657; P48431; Q14537","ENSG00000181449","Transcriptional Regulation by MECP2; Deactivation of the beta-catenin transactivating complex; Formation of the anterior neural plate; Formation of the posterior neural plate; Interleukin-4 and Interleukin-13 signaling; Germ layer formation at gastrulation; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation; Specification of the neural plate border; POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation","Cell differentiation - expanded index; Cardiac progenitor differentiation; Endoderm differentiation; Dopaminergic neurogenesis; Mesodermal commitment pathway; Ectoderm differentiation; let-7 inhibition of ES cell reprogramming; Pre-implantation embryo; Wnt signaling pathway and pluripotency; Neurogenesis regulation in the olfactory epithelium; Cell lineage map for neuronal differentiation; Sudden infant death syndrome (SIDS) susceptibility pathways",22,0,99,105.8,101.5,91.4,86.9,97.2,106.7,104.1,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S250(98.6)]",0,"ENSG00000181449"
"886","USP6NL",-0.256305703347881,6.62295959408852,-2.65309098412424,0.0250094221130011,0.0460670168040834,-4.58502486715438,"NONE",FALSE,"High","Master Protein","Q92738","USP6 N-terminal-like protein [OS=Homo sapiens]",0,22.405,4,2,2,4,2,828,94,9.07,16.42,2,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf00566","9712","A8KA79; hsa:9712; Q15400; Q5VV10; Q7L0K9; Q92738","ENSG00000148429","Retrograde transport at the Trans-Golgi-Network","EGF/EGFR signaling pathway",2,0,108.3,107.6,99.8,97.8,86.2,82.8,105.6,106.6,93.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S585(100); S716(100)]",0,"ENSG00000148429"
"887","SMAP1",0.455981117054201,6.68129047112016,2.64698596558705,0.025268145985314,0.0464911096370152,-4.59528307610224,"NONE",FALSE,"High","Master Protein","Q8IYB5","Stromal membrane-associated protein 1 [OS=Homo sapiens]",0,28.522,6,1,2,5,1,467,50.4,8.75,11.36,1,"other biological processes","plasma membrane;other membranes;other cell component","enzyme regulator activity;other molecular function","Pf01412","60682","hsa:60682; Q53H70; Q5SYQ2; Q6PK24; Q8IYB5; Q8NDH4; Q96L38; Q96L39; Q9H8X4","ENSG00000112305",NA,NA,0,0,101.2,82.1,96.8,140,92.5,148.6,86.8,99.5,86.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(99.5)]",0,"ENSG00000112305"
"888","MFGE8",0.251844744482483,6.66252744831435,2.6423575510907,0.0254660787011534,0.0468025230183359,-4.60305778064062,"NONE",FALSE,"High","Master Protein","Q08431","Lactadherin [OS=Homo sapiens]",0,16.197,6,2,2,2,2,387,43.1,8.15,4.97,2,"cell adhesion;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi","signal transduction activity or receptor binding;other molecular function","Pf00008, Pf00754","4240","B2R6M7; F5GZN3; hsa:4240; Q08431; Q53FU9; Q7Z3D2; Q9BTL9","ENSG00000140545","Amyloid fiber formation; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation","Extracellular vesicle-mediated signaling in recipient cells; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; Ebola virus infection in host; Complement system in neuronal development and plasticity; Extrafollicular and follicular B cell activation by SARS-CoV-2",9,0,79.2,94.2,90.2,101.7,107.9,118.4,98.6,115.1,112.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100)]",0,"ENSG00000140545"
"889","SEPTIN9",0.661954447888364,6.5498577851834,2.63982555727547,0.0255750150216758,0.0469168457624742,-4.60731008664361,"NONE",FALSE,"High","Master Protein","Q9UHD8","Septin-9 [OS=Homo sapiens]",0,60.623,10,5,6,14,5,586,65.4,8.97,41.46,5,"cell cycle OR cell proliferation;other biological processes","cytoskeleton;other cell component","other molecular function","Pf00735","10801","A8K2V3; B3KPM0; B4DTL9; B4E0N2; B4E274; B7Z654; hsa:10801; Q96QF3; Q96QF4; Q96QF5; Q9HA04; Q9UG40; Q9UHD8; Q9Y5W4","ENSG00000184640",NA,NA,0,0,64.7,68.5,74.2,101.9,205.2,81.1,100.1,92.9,134.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); T49(100); S111(100)]",0,"ENSG00000184640"
"890","WAC",0.355255366415115,6.5932622727212,2.63957593811129,0.025585779858212,0.0469168457624742,-4.60772927062082,"NONE",FALSE,"High","Master Protein","Q9BTA9","WW domain-containing adapter protein with coiled-coil [OS=Homo sapiens]",0,27.683,7,4,4,7,4,647,70.7,9.45,13.31,4,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;signal transduction;other biological processes","nucleus","other molecular function","Pf00397","51322","A8K2A9; C9JBT9; D3DRW5; D3DRW6; D3DRW7; hsa:51322; Q53EN9; Q5JU75; Q5JU77; Q5VXK0; Q5VXK2; Q8TCK1; Q96DP3; Q96FW6; Q96JI3; Q9BTA9","ENSG00000095787","E3 ubiquitin ligases ubiquitinate target proteins",NA,1,0,84.3,91.4,81.3,104.2,151.7,101.9,90.1,89.4,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S53(100); S64(99.6); S511(100)]",0,"ENSG00000095787"
"891","ZNF652",-0.333673682187811,6.5998077179229,-2.63288367455717,0.0258760814185411,0.0473959201740281,-4.61896526116283,"NONE",FALSE,"High","Master Protein","Q9Y2D9","Zinc finger protein 652 [OS=Homo sapiens]",0,7.306,2,1,1,1,1,606,69.7,8.65,2.72,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096","22834","A4QPD9; hsa:22834; Q5H9Q0; Q9Y2D9","ENSG00000198740",NA,NA,0,0,109.2,111.4,102.6,92.3,95.9,73.6,106.5,101.4,87.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S57(100)]",0,"ENSG00000198740"
"892","PLEKHA2",0.293934546929414,6.65272278671485,2.63018887641874,0.0259939073143134,0.0475583595705824,-4.62348844170758,"NONE",FALSE,"High","Master Protein","Q9HB19","Pleckstrin homology domain-containing family A member 2 [OS=Homo sapiens]",0,3.239,3,1,1,1,1,425,47.2,8.66,2.13,1,"other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00169","59339","A8K727; hsa:59339; Q9HB19","ENSG00000169499","Synthesis of PIPs at the plasma membrane",NA,1,0,81.6,79.2,84,99.6,104.1,110.1,101.3,137.4,119.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S184(100)]",0,"ENSG00000169499"
"893","EPB41L4B",0.338300738516259,6.6844135464195,2.62855093386799,0.0260657860484591,0.0476364645364897,-4.62623734902181,"NONE",FALSE,"High","Master Protein","Q9H329","Band 4.1-like protein 4B [OS=Homo sapiens]",0,12.021,2,1,1,1,1,900,99.7,9.04,3.46,1,"cell organization and biogenesis;stress response;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity","Pf00373, Pf08736, Pf09379, Pf09380","54566","hsa:54566; Q5T4G5; Q5T4G6; Q9H328; Q9H329; Q9P2V3","ENSG00000095203",NA,"Glucocorticoid receptor pathway; Nuclear receptors meta-pathway",2,0,85.6,92.4,78,128.4,88.4,113,116,111.4,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S602(100)]",0,"ENSG00000095203"
"894","EXOC1",0.436125363569795,6.68623369657204,2.62757371213436,0.0261087647066614,0.0476616375853148,-4.62787726059191,"NONE",FALSE,"High","Master Protein","Q9NV70-2","Isoform 2 of Exocyst complex component 1 [OS=Homo sapiens]",0,31.987,6,4,7,12,4,879,100.2,6.6,36.6,4,NA,NA,NA,NA,NA,"Q9NV70-2",NA,NA,NA,0,0,87.5,89.9,90.4,129.4,86.8,148.3,94,111.1,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S448(100); S455(100); S458(99.7); S467(99.5); S486(100)]",0,"ENSG00000090989"
"895","UBQLN4",0.380541311935007,6.6797503598446,2.62447760597061,0.0262454016436778,0.0478575368519353,-4.63307231064751,"NONE",FALSE,"High","Master Protein","Q9NRR5","Ubiquilin-4 [OS=Homo sapiens]",0,24.981,11,2,2,2,2,601,63.8,5.22,8.46,2,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00240, Pf00627","56893","A6ND44; B2RAY7; hsa:56893; Q5VYA0; Q5VYA1; Q9BR98; Q9NRR5; Q9UHX4","ENSG00000160803",NA,NA,0,0,80.4,78.9,80.6,99.1,97.4,125.7,104.8,156.3,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100)]",0,"ENSG00000160803"
"896","PTK2",0.261471985160991,6.63317574363874,2.62266959790302,0.0263255230403899,0.0479500598235673,-4.6361055703406,"NONE",FALSE,"High","Master Protein","Q05397","Focal adhesion kinase 1 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1052,119.2,6.62,8.15,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;kinase activity;other molecular function","Pf00373, Pf03623, Pf07714, Pf18038, Pf21477","5747","B4E2N6; F5H4S4; hsa:5747; J3QT16; Q05397; Q14291; Q8IYN9; Q9UD85","ENSG00000169398","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs; Signal regulatory protein family interactions; EPHB-mediated forward signaling; DCC mediated attractive signaling; RAF/MAP kinase cascade; VEGFA-VEGFR2 Pathway; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; MET activates PTK2 signaling; GRB2:SOS provides linkage to MAPK signaling for Integrins ; p130Cas linkage to MAPK signaling for integrins; Apoptotic cleavage of cellular proteins","Androgen receptor signaling pathway; Integrin-mediated cell adhesion; RANKL/RANK signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; Corticotropin-releasing hormone signaling pathway; Alpha 6 beta 4 signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); Apoptosis-related network due to altered Notch3 in ovarian cancer; Focal adhesion; Hepatocyte growth factor receptor signaling; Overview of nanoparticle effects; MFAP5-mediated ovarian cancer cell motility and invasiveness; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; Physico-chemical features and toxicity-associated pathways; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; EGF/EGFR signaling pathway; Hippo-Merlin signaling dysregulation; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Small cell lung cancer; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; Pleural mesothelioma; Regulation of actin cytoskeleton; 2q13 copy number variation syndrome; TROP2 regulatory signaling; Macrophage-stimulating protein (MSP) signaling network map; 8q11.23 (RB1CC1) copy number variation; ErbB signaling pathway",51,0,76.4,88.1,79.2,104.9,98.7,98.7,106.8,112.1,137.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S910(100)]",0,"ENSG00000169398"
"897","KCTD12",-0.254679790344465,6.60944109317769,-2.61365689266193,0.0267285827649733,0.0486299298466404,-4.65122097989208,"NONE",FALSE,"High","Master Protein","Q96CX2","BTB/POZ domain-containing protein KCTD12 [OS=Homo sapiens]",0,60.801,18,2,5,12,2,325,35.7,5.64,56.64,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf02214","115207","hsa:115207; Q96CX2","ENSG00000178695",NA,NA,0,0,107.7,106.8,108.4,92.1,72.5,108.4,89.4,100.2,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S151(100); S176(99.3); S185(100)]",0,"ENSG00000178695"
"898","C1orf226",-0.219537170029503,6.5833566870217,-2.61111915586595,0.0268431828771698,0.0487840472778854,-4.65547554556701,"NONE",FALSE,"High","Master Protein","A1L170","Uncharacterized protein C1orf226 [OS=Homo sapiens]",0,53.061,24,5,7,11,5,272,29,5.27,31.57,5,NA,NA,NA,"Pf15429","400793","A1L170; B4DF31; hsa:400793","ENSG00000239887",NA,NA,0,0,108.4,117.5,113.7,90,101.9,109.9,80.5,84.1,84.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(99.6); S223(99.7); S249(100); S258(99.4)]",0,"ENSG00000239887"
"899","BCKDHA",1.09833358844221,6.31079209359052,2.6098139655198,0.026902314310295,0.0488371267568425,-4.65766345820303,"NONE",FALSE,"High","Master Protein","P12694","2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial [OS=Homo sapiens]",0,15.2,3,1,1,4,1,445,50.4,8.27,13.12,1,"other metabolic processes","mitochondrion","other molecular function","Pf00676","593","B4DP47; E7EW46; hsa:593; P12694; Q16034; Q16472","ENSG00000248098","Glyoxylate metabolism and glycine degradation; Branched-chain amino acid catabolism","Lipid metabolism pathway",3,0,44.2,60.8,102.3,99.3,169.7,244.8,45.5,62.6,89.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S337(99.6)]",0,"ENSG00000248098"
"900","RABL6",-0.20628415853683,6.67752076702025,-2.60522539170519,0.0271112341643232,0.0491617046179727,-4.66535392457727,"NONE",FALSE,"High","Master Protein","Q3YEC7","Rab-like protein 6 [OS=Homo sapiens]",0,6.118,2,1,1,1,1,729,79.5,5.22,3,1,NA,"cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf08477","55684","A8QVZ7; A8QVZ8; C6K8I4; C6K8I5; hsa:55684; Q3YEC7; Q4F968; Q5T5R7; Q8IWK1; Q8TCL4; Q8WU94; Q96SR8; Q9BU21; Q9H935","ENSG00000196642",NA,NA,0,0,109,105.6,110.4,101.6,92.8,93,104.4,97.2,109.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S492(100)]",0,"ENSG00000196642"
"901","PCBP2",-0.500196504624078,6.52579939271976,-2.59893783635671,0.0274001445303595,0.0496304504700852,-4.67588821705626,"NONE",FALSE,"High","Master Protein","Q15366","Poly(rC)-binding protein 2 [OS=Homo sapiens]",0,45.655,10,3,3,6,1,365,38.6,6.79,18.46,3,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013","5094","A8K7X6; B4DXP5; F8VYL7; G3V0E8; hsa:5094; I6L8F9; Q15366; Q32Q82; Q59HD4; Q68Y55; Q6IPF4; Q6PKG5","ENSG00000197111","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA; Negative regulators of DDX58/IFIH1 signaling; SARS-CoV-1 activates/modulates innate immune responses","mRNA processing; Ferroptosis; Modulators of TCR signaling and T cell activation",7,0,123,125.5,116.4,91.3,53.2,114.9,83.4,92,65.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100)]",0,"ENSG00000197111"
"902","MAST2",0.205733031991459,6.67045369166746,2.59711019519713,0.0274846992767861,0.0497284137690852,-4.67894947725009,"NONE",FALSE,"High","Master Protein","Q6P0Q8","Microtubule-associated serine/threonine-protein kinase 2 [OS=Homo sapiens]",0,57.708,4,5,5,8,4,1798,196.3,8.16,24.94,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf08926, Pf17820","23139","hsa:23139; O94899; Q5VT07; Q5VT08; Q6P0Q8; Q7LGC4; Q8NDG1; Q96B94; Q9BYE8","ENSG00000086015",NA,NA,0,1,91.1,92.6,96.2,117.1,99.3,116.7,97.6,102.5,105.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S74(100); S148(100); S1381(100); S1399(100)]",0,"ENSG00000086015"
"903","CHMP2B",0.212206164175026,6.62873131123347,2.59580215670331,0.0275453748569298,0.0497830030636871,-4.68114018949702,"NONE",FALSE,"High","Master Protein","Q9UQN3-2","Isoform 2 of Charged multivesicular body protein 2b [OS=Homo sapiens]",0,11.604,9,2,2,3,2,172,19.1,6.24,9.88,2,NA,NA,NA,NA,NA,"Q9UQN3-2",NA,NA,NA,0,0,100,92.6,103.4,109.3,136.8,117.9,87.2,86.2,85.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S158(100)]; Met-loss [N-Term]",0,"ENSG00000083937"
"904","OTUD5",-0.339746679617827,6.59806784138585,-2.5897662018884,0.027827100030379,0.0502365345681178,-4.69124680476809,"NONE",FALSE,"High","Master Protein","Q96G74","OTU domain-containing protein 5 [OS=Homo sapiens]",0,23.423,6,2,2,2,2,571,60.6,6.54,9.27,2,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf02338","55593","B4DGG7; G5E9D7; hsa:55593; Q4KMN9; Q8N6T5; Q96G74; Q9H650; Q9H9U0; Q9NT65","ENSG00000068308; ENSG00000292211","Ovarian tumor domain proteases; Negative regulators of DDX58/IFIH1 signaling","Gastric cancer network 2; Novel intracellular components of RIG-I-like receptor pathway",4,0,104.9,110.2,122.3,93.8,107.1,75.4,87.3,88,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100); S508(99.4)]",0,"ENSG00000068308"
"905","CADM4",-0.347211418057386,6.57063614277976,-2.58871305240298,0.027876549165943,0.0502701969489713,-4.69300978572153,"NONE",FALSE,"High","Master Protein","Q8NFZ8","Cell adhesion molecule 4 [OS=Homo sapiens]",0,45.601,9,2,2,5,2,388,42.8,6.3,24.31,2,"cell adhesion;other biological processes","other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf07686, Pf08205, Pf13927","199731","B2R7L5; hsa:199731; Q8NFZ8; Q9Y4A4","ENSG00000105767",NA,NA,0,0,111,119.1,104.9,77.6,76.9,110.5,83.4,85,103.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S361(100)]",0,"ENSG00000105767"
"906","ZBTB44",-0.242622187439451,6.65065730399082,-2.58805707593392,0.0279073939281198,0.0502702725062821,-4.69410783307479,"NONE",FALSE,"High","Master Protein","Q8NCP5","Zinc finger and BTB domain-containing protein 44 [OS=Homo sapiens]",0,6.841,3,1,1,1,1,570,63.8,6.61,2.34,1,NA,"nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf00651","29068","hsa:29068; Q6IPT8; Q86VJ7; Q86XX5; Q8NCP5","ENSG00000196323",NA,NA,0,0,116.5,109.3,99,91.5,92.6,93.8,94.3,101.4,113.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S161(100)]",0,"ENSG00000196323"
"907","NCAM1",0.20759330931277,6.66758254554557,2.58579374936995,0.0280140798820861,0.0504068118716257,-4.69789607354571,"NONE",FALSE,"High","Master Protein","P13591-1","Isoform 2 of Neural cell adhesion molecule 1 [OS=Homo sapiens]",0,89.613,8,6,7,29,6,848,93.3,4.87,81.94,6,NA,NA,NA,NA,NA,"P13591-1",NA,NA,NA,0,0,89.6,92.5,89.2,115.6,100.2,107.5,109.8,105.3,104.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S349(100); S774(100); T788(100); T802(99.5)]",0,"ENSG00000149294"
"908","CTNND1",0.367218881930373,6.67461233731279,2.56543191582201,0.0289923524700412,0.0521096026774308,-4.73195032537089,"NONE",FALSE,"High","Master Protein","O60716-3","Isoform 1AC of Catenin delta-1 [OS=Homo sapiens]",0,109.963,11,8,13,37,8,939,104.9,6.87,122.86,8,NA,NA,NA,NA,NA,"O60716-3",NA,NA,NA,0,0,89.7,85.2,87.7,114.3,91.2,139.8,104.3,114.9,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T177(100); S252(100); S268(99.8); S349(100); S352(100); S864(100); S920(100)]",0,"ENSG00000198561"
"909","TRAFD1",0.170050319832602,6.65696122727149,2.55829010598638,0.0293434834323357,0.0526826897267017,-4.74388317250567,"NONE",FALSE,"High","Master Protein","O14545","TRAF-type zinc finger domain-containing protein 1 [OS=Homo sapiens]",0,48.399,8,3,5,12,3,582,64.8,5.29,33.65,3,"other biological processes","mitochondrion","other molecular function","Pf21366","10906","A8K5L6; B4DI89; hsa:10906; O14545","ENSG00000135148",NA,NA,0,0,91.9,98.5,99.7,109.7,114.6,116.4,93.1,98.2,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100); S327(99.5); S415(99.5)]",0,"ENSG00000135148"
"910","LRRFIP2",0.32375781741802,6.68775178508951,2.5567874874571,0.0294178982390322,0.052715051924646,-4.74639303408258,"NONE",FALSE,"High","Master Protein","Q9Y608","Leucine-rich repeat flightless-interacting protein 2 [OS=Homo sapiens]",0,23.239,5,2,3,6,2,721,82.1,6.95,13.16,2,"cell-cell signaling;signal transduction;other biological processes",NA,"other molecular function","Pf09738","9209","A8K649; A8MXR0; B4DY63; Q68CV3; Q9NXH5; Q9Y608","ENSG00000093167",NA,"VEGFA-VEGFR2 signaling",1,0,81.2,77.2,101.8,115.8,106.7,113.5,124.6,102.2,108.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(99.5); S328(100)]",0,"ENSG00000093167"
"911","PALM2AKAP2",0.211290280169319,6.65217626567299,2.55662189407206,0.0294261104799954,0.052715051924646,-4.74666961220227,"NONE",FALSE,"High","Master Protein","Q9Y2D5","PALM2-AKAP2 fusion protein [OS=Homo sapiens]",0,53.463,5,3,3,7,3,1103,122,5.06,30.34,3,NA,"plasma membrane;other membranes",NA,"Pf03285, Pf15304","445815","A9Z1X9; B1ALX9; B2RTU4; B3KQ00; B4DTZ2; B7ZW07; B9EJB5; hsa:445815; Q8IXS6; Q8N9D5; Q96DU1; Q9UG26; Q9Y2D5","ENSG00000157654",NA,NA,0,0,79.7,81.9,86.9,93.3,109.2,99.3,118.1,115.3,129.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(100); S696(100); S951(100)]",0,"ENSG00000157654"
"912","EIF5B",0.264409881186748,6.68159889475729,2.55215713731118,0.0296483930415306,0.0530550191269495,-4.75412550356637,"NONE",FALSE,"High","Master Protein","O60841","Eukaryotic translation initiation factor 5B [OS=Homo sapiens]",0,54.351,3,3,3,12,3,1220,138.7,5.49,49.19,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","nucleic acid binding activity;other molecular function","Pf00009, Pf11987, Pf14578","9669","hsa:9669; O60841; O95805; Q53RV7; Q53SI8; Q9UF81; Q9UMN7","ENSG00000158417","GTP hydrolysis and joining of the 60S ribosomal subunit","Translation factors; Ciliary landscape",3,0,82.5,85.4,91.1,114.4,119.5,94,118,111.9,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100); S214(100)]",0,"ENSG00000158417"
"913","DPF2",0.257707235735154,6.63536107283545,2.54365614128569,0.0300762561572922,0.0537617196590371,-4.76831492824347,"NONE",FALSE,"High","Master Protein","Q92785","Zinc finger protein ubi-d4 [OS=Homo sapiens]",0,14.314,4,1,1,1,1,391,44.1,6.33,4.12,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00628, Pf14051","5977","A8K7C9; B4DT58; hsa:5977; Q92785","ENSG00000133884",NA,"Tumor suppressor activity of SMARCB1",1,0,86.1,87.5,78,92.5,104.4,118.2,104.7,110.1,120.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S142(100)]",0,"ENSG00000133884"
"914","ZMYM4",-0.411873453196345,6.60467889338525,-2.53955753247574,0.0302847331155832,0.0540751470947831,-4.77515290623214,"NONE",FALSE,"High","Master Protein","Q5VZL5","Zinc finger MYM-type protein 4 [OS=Homo sapiens]",0,37.97,4,4,4,8,4,1548,172.7,6.84,13.11,4,"cell organization and biogenesis;other biological processes",NA,"nucleic acid binding activity;other molecular function","Pf06467, Pf12012","9202","A0JP19; A0JP20; hsa:9202; O43308; Q5T5E1; Q5T5E2; Q5VZL5; Q7L3Q4","ENSG00000146463",NA,NA,0,0,108.5,107.2,115.3,87.8,74.3,85.4,79.2,128.4,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(100); S1071(99.5); S1256(100)]",0,"ENSG00000146463"
"915","DNTTIP2",0.314471302400229,6.61548050226136,2.53199629724601,0.0306731170727752,0.0547087727461957,-4.78776224701129,"NONE",FALSE,"High","Master Protein","Q5QJE6","Deoxynucleotidyltransferase terminal-interacting protein 2 [OS=Homo sapiens]",0,13.772,3,1,1,1,1,756,84.4,6.16,3.1,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf08698","30836","hsa:30836; Q12987; Q53H59; Q5QJE6; Q5TFJ4; Q6TLI0; Q76MJ8; Q86WX9","ENSG00000067334",NA,NA,0,0,91.5,101.3,89.9,107.3,137,125.6,74.6,90.4,96.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S141(100)]",0,"ENSG00000067334"
"916","THRAP3",-0.291881844189613,6.58946679549546,-2.52790826787609,0.0308851580458342,0.0550268318021849,-4.79457652440643,"NONE",FALSE,"High","Master Protein","Q9Y2W1","Thyroid hormone receptor-associated protein 3 [OS=Homo sapiens]",0,242.262,19,21,27,73,21,955,108.6,10.15,178.65,21,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf15440","9967","D3DPS5; hsa:9967; Q5VTK6; Q9Y2W1","ENSG00000054118","PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation","Interactome of polycomb repressive complex 2 (PRC2)",3,0,108.5,107.5,107.2,88.3,106.3,79.1,97.2,86.8,100.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100); S211(99.6); S243(100); S248(100); S253(100); S320(100); S379(100); S535(99.6); S560(100); S575(100); S672(100); S682(100); S939(99.5)]",0,"ENSG00000054118"
"917","EIF3B",0.346641733641651,6.64018436725786,2.51664746777128,0.0314768053204302,0.056019788749119,-4.81333575615018,"NONE",FALSE,"High","Master Protein","P55884","Eukaryotic translation initiation factor 3 subunit B [OS=Homo sapiens]",0,44.395,8,2,2,7,2,814,92.4,5,38.62,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08662","8662","A4D208; hsa:8662; P55884; Q2NL77; Q9UMF9","ENSG00000106263","L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit","Translation factors; nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell",8,0,76.9,74,94.7,98.9,133.2,101.1,102.2,108.5,131.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S119(100)]",0,"ENSG00000106263"
"918","DOCK7",0.205039808338561,6.63841159241089,2.51446943137997,0.0315925331673966,0.0561645034087051,-4.81696219314981,"NONE",FALSE,"High","Master Protein","Q96N67","Dedicator of cytokinesis protein 7 [OS=Homo sapiens]",0,71.84,3,4,5,11,4,2140,242.4,6.8,36.47,4,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","other cell component","enzyme regulator activity;other molecular function","Pf06920, Pf11878, Pf14429, Pf20421, Pf20422","85440","hsa:85440; Q00M63; Q2PPY7; Q45RE8; Q45RE9; Q5T1B9; Q5T1C0; Q6ZV32; Q8TB82; Q96N67; Q96NG6; Q96NI0; Q9C092","ENSG00000116641","CDC42 GTPase cycle; RAC1 GTPase cycle; Factors involved in megakaryocyte development and platelet production; MET activates RAP1 and RAC1",NA,4,0,94.7,86.7,95.3,109.8,104.8,116.7,90.9,104.3,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S30(100); S900(100); S929(99.7); S1432(100)]",0,"ENSG00000116641"
"919","CAST",0.457573718376713,6.58221790589546,2.51195213263274,0.0317268139009006,0.0563418501482805,-4.82115271525494,"NONE",FALSE,"High","Master Protein","P20810","Calpastatin [OS=Homo sapiens]",0,17.045,7,2,2,2,2,708,76.5,5.07,4.61,2,"cell organization and biogenesis;other biological processes","other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity","Pf00748","831","B7Z468; G5E946; G5E9D3; hsa:831; O95360; P20810; Q05DE8; Q7Z4K0; Q96D08; Q9H1Z5","ENSG00000153113","Degradation of the extracellular matrix; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models",NA,2,0,59.5,67.4,63.7,80.9,129.1,67.4,142,175,152.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(99.3); S243(100)]",0,"ENSG00000153113"
"920","RAD23B",0.443450277181973,6.60355756980031,2.50705447843335,0.0319896963480513,0.056746939608717,-4.8293033538032,"NONE",FALSE,"High","Master Protein","P54727","UV excision repair protein RAD23 homolog B [OS=Homo sapiens]",0,15.2,7,1,2,3,1,409,43.1,4.84,20.4,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00240, Pf00627, Pf09280","5887","B3KWK8; G5E9P0; hsa:5887; P54727; Q7Z5K8; Q8WUB0","ENSG00000119318","Josephin domain DUBs; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; N-glycan trimming in the ER and Calnexin/Calreticulin cycle","Nucleotide excision repair; DNA repair pathways, full network; Nucleotide excision repair in xeroderma pigmentosum ; HDAC6 interactions in the central nervous system",8,0,55.6,70.6,69,80.4,127.1,75.7,147.7,134.9,172.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T159(99.2); S160(99.2)]",0,"ENSG00000119318"
"921","BCL9",-0.581216979396332,6.52477914051327,-2.50294046381346,0.0322121869007679,0.05707789849127,-4.83614735573227,"NONE",FALSE,"High","Master Protein","O00512","B-cell CLL/lymphoma 9 protein [OS=Homo sapiens]",0,9.741,2,1,1,1,1,1426,149.2,8.91,3.65,1,"cell-cell signaling;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;ER/Golgi;nucleus","other molecular function","Pf11502","607","hsa:607; O00512; Q5T489","ENSG00000116128","Formation of the beta-catenin:TCF transactivating complex; Deactivation of the beta-catenin transactivating complex","Wnt signaling pathway; Wnt/beta-catenin signaling pathway in leukemia; 1q21.1 copy number variation syndrome",5,0,118.1,85.8,154.5,92.1,57.8,83.8,96,99.4,68.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S291(100)]",0,"ENSG00000116128"
"922","ZNF148",-0.216455100970336,6.65777441717374,-2.50186188129314,0.0322707715068247,0.05707789849127,-4.83794128459426,"NONE",FALSE,"High","Master Protein","Q9UQR1","Zinc finger protein 148 [OS=Homo sapiens]",0,30.401,5,2,3,4,2,794,88.9,6.48,18.39,2,"stress response;other biological processes","ER/Golgi;nucleus","nucleic acid binding activity;other molecular function","Pf00096","7707","D3DN27; O00389; O43591; Q58EY5; Q6PJ98; Q9UQR1","ENSG00000163848",NA,NA,0,0,103.1,100.5,103.1,98,70.5,98.8,107.7,113.1,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S306(100); S412(100)]",0,"ENSG00000163848"
"923","CASKIN1",-0.199790598681425,6.62752990758214,-2.5016702932134,0.0322811889138739,0.05707789849127,-4.83825992263044,"NONE",FALSE,"High","Master Protein","Q8WXD9","Caskin-1 [OS=Homo sapiens]",0,74.271,5,5,5,8,5,1431,149.7,9.14,31.69,5,"signal transduction","other cell component","other molecular function","Pf00536, Pf07653, Pf12796, Pf16600, Pf16632, Pf16907","57524","hsa:57524; Q8WXD9; Q9P2P0","ENSG00000167971",NA,NA,0,0,112.9,109.5,102.7,99.9,96.3,92.7,100.3,93.8,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T737(100); S787(100); T1065(100); S1242(100); S1257(100)]",0,"ENSG00000167971"
"924","WDR77",0.212899648096953,6.6584147828521,2.49688929202306,0.03254223422208,0.0574771929117256,-4.84620976803889,"NONE",FALSE,"High","Master Protein","Q9BQA1","Methylosome protein WDR77 [OS=Homo sapiens]",0,14.167,4,1,1,4,1,342,36.7,5.17,15.79,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400","79084","B3KMW6; B4DP38; hsa:79084; Q3LID2; Q53FU2; Q6JZZ5; Q96GK4; Q9BQA1; Q9BWY3","ENSG00000116455","RMTs methylate histone arginines; snRNP Assembly",NA,2,0,92,87.9,96.5,117.7,112,102.4,98.2,105,101.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T5(100)]",0,"ENSG00000116455"
"925","SMAD2",0.420557772884671,6.59243146067803,2.48461390049372,0.0332221047507464,0.0586145675169925,-4.86660670159832,"NONE",FALSE,"High","Master Protein","Q15796","Mothers against decapentaplegic homolog 2 [OS=Homo sapiens]",0,2.797,3,1,1,1,1,467,52.3,6.58,1.78,1,"cell-cell signaling;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf03165, Pf03166","4087","hsa:4087; Q15796","ENSG00000175387","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Ub-specific processing proteases; Downregulation of TGF-beta receptor signaling; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Formation of axial mesoderm; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Signaling by NODAL; FOXO-mediated transcription of cell cycle genes; Germ layer formation at gastrulation; Formation of definitive endoderm; Transcriptional regulation of pluripotent stem cells; Signaling by Activin; SMAD2/3 Phosphorylation Motif Mutants in Cancer; TGFBR1 KD Mutants in Cancer; SMAD4 MH2 Domain Mutants in Cancer; SMAD2/3 MH2 Domain Mutants in Cancer","Cell cycle; AGE/RAGE pathway; Endoderm differentiation; Mesodermal commitment pathway; Extracellular vesicle-mediated signaling in recipient cells; Mesodermal commitment pathway; TGF-beta signaling pathway; Hypothesized pathways in pathogenesis of cardiovascular disease; Tgif disruption of Shh signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Canonical and non-canonical TGF-B signaling; Chromosomal and microsatellite instability in colorectal cancer ; Epithelial to mesenchymal transition in colorectal cancer; Pancreatic adenocarcinoma pathway; Neovascularization processes; Envelope proteins and their potential roles in EDMD physiopathology; Hippo signaling regulation pathways; Hepatitis B infection; TGF-beta receptor signaling in skeletal dysplasias; Regucalcin in proximal tubule epithelial kidney cells; Overlap between signal transduction pathways contributing to LMNA laminopathies; LDLRAD4 and what we know about it; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Progeria-associated lipodystrophy; Th17 cell differentiation pathway; GDNF signaling; Inflammatory bowel disease signaling; Macrophage-stimulating protein (MSP) signaling network map; HDAC6 interactions in the central nervous system; TGF-beta receptor signaling",49,0,60.6,101.4,69.8,100.2,95.9,116.4,102.2,119.3,120.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T172(100)]",0,"ENSG00000175387"
"926","WNK1",0.678348291298922,6.54167469130895,2.47886777597803,0.0335451721660409,0.0591206490010569,-4.87614719958442,"NONE",FALSE,"High","Master Protein","Q9H4A3","Serine/threonine-protein kinase WNK1 [OS=Homo sapiens]",0,22.362,2,3,5,7,2,2382,250.6,6.34,13.86,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf12202","65125","A1L4B0; C5HTZ5; C5HTZ6; C5HTZ7; H6WZW3; hsa:65125; O15052; P54963; Q4VBX9; Q6IFS5; Q86WL5; Q8N673; Q96CZ6; Q9H4A3; Q9P1S9","ENSG00000060237","Stimuli-sensing channels","Ciliary landscape",2,0,71.4,71.3,74.5,103.1,206.9,96.3,89.8,71.8,139.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S185(100); S378(100); S2032(100)]",0,"ENSG00000060237"
"927","MARCKSL1",0.470983021938029,6.62977291910197,2.47807474117066,0.0335900031258411,0.0591357983833577,-4.87746353192501,"NONE",FALSE,"High","Master Protein","P49006","MARCKS-related protein [OS=Homo sapiens]",0,136.133,61,7,12,51,7,195,19.5,4.67,152.14,7,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf02063","65108","D3DPQ0; hsa:65108; P49006; Q5TEE6; Q6NXS5","ENSG00000175130",NA,NA,0,0,71.1,94,85.2,114,184.4,93.6,108.2,96.9,92,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); T85(100); S104(100); T148(100); S165(100); S184(94.8)]",0,"ENSG00000175130"
"928","CDC5L",0.844944960681461,6.42874439131385,2.47577420892735,0.0337203903168788,0.0593013760745111,-4.88128159588234,"NONE",FALSE,"High","Master Protein","Q99459","Cell division cycle 5-like protein [OS=Homo sapiens]",0,9.832,2,1,1,1,1,802,92.2,8.18,3.15,1,"cell cycle OR cell proliferation;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf11831, Pf13921","988","hsa:988; Q76N46; Q99459; Q99974","ENSG00000096401","mRNA Splicing - Major Pathway",NA,1,0,35.1,58.9,47.6,93.8,39.1,126.7,107,246.8,167.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S303(100)]",0,"ENSG00000096401"
"929","RPS27",-0.616772066685382,6.57075037248573,-2.47491042236823,0.0337694764583514,0.0593237734984171,-4.88271497600598,"NONE",FALSE,"High","Master Protein","P42677","Small ribosomal subunit protein eS27 [OS=Homo sapiens]",0,11.816,24,3,3,5,3,84,9.5,9.45,11.04,3,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01667","6232","hsa:6232; P42677; Q5T4L6","ENSG00000177954","Separation of Sister Chromatids; Regulation of expression of SLITs and ROBOs; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); SARS-CoV-1 modulates host translation machinery","Cytoplasmic ribosomal proteins",25,0,110.6,104.8,106.1,70.8,59.7,71.5,73.3,145.3,146.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S11(100); S78(100)]",0,"ENSG00000177954"
"930","CBX3",-0.461253935441351,6.55985529589235,-2.47311921102166,0.033871490716153,0.0593895937143159,-4.88568699304329,"NONE",FALSE,"High","Master Protein","Q13185","Chromobox protein homolog 3 [OS=Homo sapiens]",0,33.847,15,5,7,13,5,183,20.8,5.33,35.02,5,"cell organization and biogenesis;stress response;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00385, Pf01393","11335","hsa:11335; Q13185; Q96CD7; Q99409; Q9BVS3; Q9P0Z6","ENSG00000122565","Transcriptional Regulation by E2F6; RNA Polymerase I Promoter Escape; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression","Exercise-induced circadian regulation; Effect of progerin on genes involved in progeria; NIPBL role in DNA damage - Cornelia de Lange syndrome",6,0,118.5,115.8,115.4,74.3,128.3,67.2,92.7,80.6,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100); S99(99.5); S176(100)]",0,"ENSG00000122565"
"931","DECR2",-0.243007778935226,6.65333942451308,-2.4729748570339,0.0338797253358016,0.0593895937143159,-4.88592648800231,"NONE",FALSE,"High","Master Protein","Q9NUI1","Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] [OS=Homo sapiens]",0,6.345,4,1,1,1,1,292,30.8,9.22,2.92,1,"other metabolic processes","other membranes;cytosol;other cytoplasmic organelle","other molecular function","Pf13561","26063","hsa:26063; Q6ZRS7; Q96ET0; Q9NUI1","ENSG00000242612; ENSG00000274296","Peroxisomal protein import; Beta-oxidation of very long chain fatty acids",NA,2,0,112.2,105.4,101,101.2,68.7,99.3,101.9,104.5,110.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S287(100)]",0,"ENSG00000242612"
"932","HOMER3",0.271319544614617,6.68973014941722,2.4657638728957,0.0342936054714832,0.0600506052891209,-4.89788621000604,"NONE",FALSE,"High","Master Protein","Q9NSC5","Homer protein homolog 3 [OS=Homo sapiens]",0,64.286,14,4,5,9,4,361,39.8,5.45,26.42,4,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00568","9454","B2RA10; E9PCW9; hsa:9454; O14580; O95350; Q9NSB9; Q9NSC0; Q9NSC1; Q9NSC5","ENSG00000051128","Neurexins and neuroligins","PKC-gamma calcium signaling pathway in ataxia; Cell lineage map for neuronal differentiation",3,0,85.5,89.5,83.4,115.3,86,118.1,108,128.8,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100); T243(100); S256(100)]",0,"ENSG00000051128"
"933","SRRT",-0.299543305860219,6.59755310215283,-2.46197866935162,0.0345128590690563,0.0603697599150052,-4.90416105771488,"NONE",FALSE,"High","Master Protein","Q9BXP5","Serrate RNA effector molecule homolog [OS=Homo sapiens]",0,57.325,5,4,5,19,4,876,100.6,5.96,48.72,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04959, Pf12066","51593","A4D2E5; A4D2E6; A6NK22; B4DJL4; B4DZA6; hsa:51593; O95808; Q32MI4; Q6NT74; Q8TDQ5; Q9BWP6; Q9BXP4; Q9BXP5; Q9Y4S4","ENSG00000087087","mRNA Splicing - Major Pathway; RNA polymerase II transcribes snRNA genes",NA,2,0,114.4,111.8,113.4,95.9,69.8,111.7,92.3,96.9,79.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100); S74(100); T544(100)]",0,"ENSG00000087087"
"934","BAG6",-0.179751164913708,6.57834743622208,-2.46035216622309,0.0346074979216179,0.0604704888737478,-4.90685670627535,"NONE",FALSE,"High","Master Protein","P46379","Large proline-rich protein BAG6 [OS=Homo sapiens]",0,47.48,5,3,5,7,3,1132,119.3,5.6,19.73,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;translation activity;other molecular function","Pf00240, Pf12057, Pf20960","7917","A2ADJ7; A3KQ42; A3KQ44; A6NGY6; A6PWF7; B0UX84; B4DZ12; B4E3V4; E7EMZ4; F8VXY4; hsa:7917; O95874; P46379; Q5HYL9; Q5SQ35; Q5SQ36; Q5SQ37; Q5SQ41; Q5SRP8; Q5SRP9; Q5STC1; Q5STX1; Q5STX3; Q96SA6; Q9BCN4","ENSG00000096155; ENSG00000204463; ENSG00000227761; ENSG00000228760; ENSG00000229524; ENSG00000233348; ENSG00000234651","Insertion of tail-anchored proteins into the endoplasmic reticulum membrane",NA,1,0,101.8,110.2,113.3,94.1,94.1,105.9,85.2,88,83.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(98.3); S964(100); S973(100)]",0,"ENSG00000204463"
"935","CSPG5",-0.260256529474834,6.60059448713202,-2.45935592689934,0.0346655913142449,0.0605072139303184,-4.90850760579981,"NONE",FALSE,"High","Master Protein","O95196","Chondroitin sulfate proteoglycan 5 [OS=Homo sapiens]",0,23.215,5,3,3,4,3,566,60,4.5,10.71,3,"cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding","Pf06566, Pf06567","10675","hsa:10675; O95196; Q71M39; Q71M40","ENSG00000114646","A tetrasaccharide linker sequence is required for GAG synthesis; Defective B4GALT7 causes EDS, progeroid type; Defective B3GAT3 causes JDSSDHD; Defective B3GALT6 causes EDSP2 and SEMDJL1; Chondroitin sulfate biosynthesis; Dermatan sulfate biosynthesis; CS/DS degradation; Defective CHST3 causes SEDCJD; Defective CHST14 causes EDS, musculocontractural type; Defective CHSY1 causes TPBS",NA,10,0,123.8,111.3,109.9,104.6,101.3,87.1,94.1,82.5,83,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T493(100); S543(100)]",0,"ENSG00000114646"
"936","KRT78",0.817547483271511,6.50279156731857,2.45704478148306,0.0348007321392392,0.0606781996273913,-4.91233690392904,"NONE",FALSE,"High","Master Protein","Q8N1N4","Keratin, type II cytoskeletal 78 [OS=Homo sapiens]",0,4.474,3,2,2,6,1,520,56.8,6.02,9.35,2,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton","bone, tooth or skin structural activity","Pf00038, Pf16208","196374","A8K4D6; hsa:196374; Q5HYM7; Q7RTT2; Q8N1N4","ENSG00000170423","Formation of the cornified envelope",NA,2,0,71.5,66.2,64.2,107.5,62.2,274.8,83.4,109.7,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S4(98.7)]",0,"ENSG00000170423"
"937","NFIX",0.25010226808511,6.65983638089999,2.45398107279541,0.0349806814707213,0.0609268646320354,-4.91741187032301,"NONE",FALSE,"High","Master Protein","Q14938","Nuclear factor 1 X-type [OS=Homo sapiens]",0,38.595,10,3,3,7,3,502,55.1,8.68,14.26,3,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4784","B4DM25; hsa:4784; O60413; Q0VG09; Q12859; Q13050; Q13052; Q14938; Q5U094; Q9UPH1; Q9Y6R8","ENSG00000008441","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination","Oxidative stress response",3,0,93.8,93.9,96.5,114.2,103.7,130.6,96.9,101.8,86.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(99.6); S301(100)]",0,"ENSG00000008441"
"938","DENND2A",0.219884717111468,6.6267725794128,2.44903660316457,0.035273041273804,0.0613705792738252,-4.92559927031592,"NONE",FALSE,"High","Master Protein","Q9ULE3","DENN domain-containing protein 2A [OS=Homo sapiens]",0,40.521,7,4,5,7,3,1009,113.8,8.95,20.86,4,"transport","cytosol;cytoskeleton","enzyme regulator activity","Pf02141, Pf03455, Pf03456","27147","C9JUI3; hsa:27147; Q1RMD5; Q86XY0; Q9ULE3","ENSG00000146966","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,78.6,77.1,81.8,103.5,81.9,95.5,110.7,129.9,136.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(100); S404(98.8); S776(100)]",0,"ENSG00000146966"
"939","PRR12",-0.261443163132371,6.58789968625762,-2.44628050762417,0.035437052538449,0.0615902766163459,-4.93016138390713,"NONE",FALSE,"High","Master Protein","Q9ULL5","Proline-rich protein 12 [OS=Homo sapiens]",0,55.766,4,4,4,8,4,2036,210.9,7.87,29.99,4,NA,"nucleus;other cell component",NA,"Pf13926","57479","E9PB06; hsa:57479; Q8N4J6; Q9ULL5","ENSG00000126464",NA,NA,0,0,113.4,100.1,108,102.1,72.1,93.5,84.4,101.2,96.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S651(100); S709(99.4); S917(100); S1925(100)]",0,"ENSG00000126464"
"940","CCND2",0.304465445075007,6.60622985921183,2.43498469881576,0.0361171588770793,0.0627055354121206,-4.94884683104144,"NONE",FALSE,"High","Master Protein","P30279","G1/S-specific cyclin-D2 [OS=Homo sapiens]",0,4.551,7,1,1,1,1,289,33,5.19,2.69,1,"cell cycle OR cell proliferation;other biological processes","other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00134, Pf02984","894","A8K531; hsa:894; P30279; Q13955; Q5U035","ENSG00000118971","Cyclin D associated events in G1; Defective binding of RB1 mutants to E2F1,(E2F2, E2F3); Drug-mediated inhibition of CDK4/CDK6 activity; Regulation of RUNX1 Expression and Activity","miRNA regulation of DNA damage response; Cell cycle; SRF and miRs in smooth muscle differentiation and proliferation; Glioblastoma signaling pathways; Focal adhesion; Ovarian infertility; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Hedgehog signaling pathway; lncRNA in canonical Wnt signaling and colorectal cancer; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; G1 to S cell cycle control; Measles virus infection; IL-2 signaling pathway; Pleural mesothelioma; Hippocampal synaptogenesis and neurogenesis; JAK-STAT signaling in the regulation of beta cells; DNA damage response; DNA damage response (only ATM dependent)",24,0,70.3,75.6,63,85.6,97.7,77,152.9,140.1,156,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(99.4)]",0,"ENSG00000118971"
"941","SNW1",-0.242235772613445,6.58246860504864,-2.42585972417406,0.0366759600563654,0.0636080412454711,-4.96392664005349,"NONE",FALSE,"High","Master Protein","Q13573","SNW domain-containing protein 1 [OS=Homo sapiens]",0,24.852,3,2,3,5,2,536,61.5,9.52,15.87,2,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","nucleus","signal transduction activity or receptor binding;other molecular function","Pf02731","22938","A8K8A9; hsa:22938; Q13483; Q13573; Q32N03; Q5D0D6","ENSG00000100603","mRNA Splicing - Major Pathway; Formation of paraxial mesoderm; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Pre-NOTCH Transcription and Translation; Downregulation of SMAD2/3:SMAD4 transcriptional activity; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; NOTCH3 Intracellular Domain Regulates Transcription; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells; NOTCH4 Intracellular Domain Regulates Transcription; RUNX3 regulates NOTCH signaling","TGF-beta signaling pathway; Novel intracellular components of RIG-I-like receptor pathway; Splicing factor NOVA regulated synaptic proteins; Notch signaling pathway",16,0,109.8,104,117.8,91.9,105.8,92.8,82.6,83.7,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S224(100); S232(100)]",0,"ENSG00000100603"
"942","ZNF609",-0.186959813585267,6.65031122372044,-2.41973832050109,0.0370555991688603,0.0641982355027388,-4.97403531574952,"NONE",FALSE,"High","Master Protein","O15014","Zinc finger protein 609 [OS=Homo sapiens]",0,26.051,4,5,5,6,5,1411,151.1,8.03,15.46,5,"other biological processes","nucleus","other molecular function",NA,"23060","hsa:23060; O15014; Q0D2I2","ENSG00000180357",NA,NA,0,0,101.7,107.2,104.8,92.4,94.3,96.3,108.8,100,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S491(100); T746(100); S758(100); S1055(100); S1313(100)]",0,"ENSG00000180357"
"943","APBA2",0.171445835168262,6.65345092557715,2.41285999232784,0.0374868068614345,0.064876425024243,-4.98538668627064,"NONE",FALSE,"High","Master Protein","Q99767","Amyloid-beta A4 precursor protein-binding family A member 2 [OS=Homo sapiens]",0,30.401,2,2,2,3,2,749,82.5,4.86,15.79,2,"cell-cell signaling;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00595, Pf00640","321","E9PGI4; hsa:321; O60571; Q5XKC0; Q99767","ENSG00000034053; ENSG00000276495","Neurexins and neuroligins","IL-18 signaling pathway; 15q11q13 copy number variation",3,0,86.8,81.5,84.1,99,89.8,103.1,117,116.2,130.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S480(100)]",0,"ENSG00000034053"
"944","HTT",-0.19204165532451,6.64979077870834,-2.40151974024675,0.0382085593258852,0.0659777075484,-5.00408455959485,"NONE",FALSE,"High","Master Protein","P42858","Huntingtin [OS=Homo sapiens]",0,83.958,2,4,7,14,4,3142,347.4,6.2,54.65,4,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf20925, Pf20926, Pf20927","3064","hsa:3064; P42858; Q9UQB7","ENSG00000197386","Regulation of MECP2 expression and activity","Mesodermal commitment pathway; Mesodermal commitment pathway; ERK pathway in Huntington's disease; Rett syndrome; 15q25 copy number variation; HDAC6 interactions in the central nervous system",7,0,108.2,101.1,108.7,96.8,81.4,103.4,94.8,102.7,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S419(100); S432(100); S1199(100); S1864(100); S1874(100)]",0,"ENSG00000197386"
"945","GNL1",0.19338813995789,6.6417672660398,2.40131325750234,0.0382218270575046,0.0659777075484,-5.00442481039918,"NONE",FALSE,"High","Master Protein","P36915","Guanine nucleotide-binding protein-like 1 [OS=Homo sapiens]",0,35.676,5,2,2,6,2,607,68.6,5.8,13,2,"stress response;signal transduction;other biological processes","non-structural extracellular","other molecular function","Pf01926","2794","B0S838; hsa:2794; P36915; Q96CT5","ENSG00000204590; ENSG00000206492; ENSG00000226882; ENSG00000228581; ENSG00000229470; ENSG00000232143; ENSG00000235986",NA,NA,0,0,92.9,85,95.4,108,105.2,111.5,103.5,95,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S68(100)]",0,"ENSG00000204590"
"946","RASAL2",0.194633338660983,6.65268041861704,2.40096164040192,0.0382444309686191,0.0659777075484,-5.00500420308045,"NONE",FALSE,"High","Master Protein","Q9UJF2-2","Isoform 2 of Ras GTPase-activating protein nGAP [OS=Homo sapiens]",0,15.397,4,3,3,3,3,1280,143.8,7.55,5.72,3,NA,NA,NA,NA,NA,"Q9UJF2-2",NA,NA,NA,0,0,96,96.9,88.2,111.2,100.2,120.6,97.2,97.8,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S134(100); S877(99.5); S1069(99.1)]",0,"ENSG00000075391"
"947","HOMEZ",-0.344639115614522,6.58814133450292,-2.39990313312258,0.0383125572262748,0.0660254418091663,-5.00674827966833,"NONE",FALSE,"High","Master Protein","Q8IX15","Homeobox and leucine zipper protein Homez [OS=Homo sapiens]",0,15.2,4,1,1,4,1,550,61.2,4.93,18.01,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf11569","57594","A1L445; B4DZ80; F8WCA3; hsa:57594; Q6P049; Q86XB6; Q8IX15; Q9P2A5","ENSG00000290292",NA,NA,0,0,92.7,136.8,124.3,96.8,74.1,104.3,78.5,96.9,83.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T451(100)]",0,"ENSG00000215271"
"948","SIPA1",0.348449394391136,6.64573512101577,2.39371199143746,0.0387134233023117,0.066645893279929,-5.01694547267753,"NONE",FALSE,"High","Master Protein","Q96FS4","Signal-induced proliferation-associated protein 1 [OS=Homo sapiens]",0,8.915,2,1,2,2,1,1042,112.1,6.6,2.87,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","enzyme regulator activity","Pf00595, Pf02145, Pf21022","6494","hsa:6494; O14518; O60484; O60618; Q2YD83; Q96FS4","ENSG00000213445","Rap1 signalling","MAPK cascade",2,0,92.6,71.9,87.9,119.1,111.4,100.2,92,121.3,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S55(99.4)]",0,"ENSG00000213445"
"949","MAP1S",0.189695943292034,6.64093910565521,2.38735320452049,0.0391294412972432,0.0672910939906226,-5.02741197283819,"NONE",FALSE,"High","Master Protein","Q66K74","Microtubule-associated protein 1S [OS=Homo sapiens]",0,132.747,12,8,16,36,8,1059,112.1,7.3,129.04,8,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function",NA,"55201","B4DH53; hsa:55201; Q27QB1; Q66K74; Q6NXF1; Q8N3L8; Q8N3W5; Q8NI88; Q96H94; Q96IT4; Q96SP8; Q9BRC6; Q9H928; Q9NVK7","ENSG00000130479",NA,NA,0,0,94.1,95.7,89.6,112.5,118.2,102.8,97.2,99.9,97,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S475(99.6); S547(100); S592(100); S595(97.8); S600(96.2); S640(99.2); S646(100); S657(100); S731(100); S741(100); S759(100)]",0,"ENSG00000130479"
"950","SCAF11",-0.271546528533545,6.64201111806384,-2.38174649177652,0.039499901998761,0.0678566737494505,-5.03663477121588,"NONE",FALSE,"High","Master Protein","Q99590","Protein SCAF11 [OS=Homo sapiens]",0,20.389,2,2,2,2,2,1463,164.6,8.41,7.99,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf13639","9169","A6NEU9; A6NLW5; hsa:9169; Q8IW59; Q99590","ENSG00000139218",NA,"Apoptosis",1,0,97.4,94.8,113.1,88.6,93.7,76,118.8,104.8,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S608(100); S902(100)]",0,"ENSG00000139218"
"951","GNB2",-0.239449338888732,6.61233768490345,-2.37932900134435,0.0396606986885516,0.068061262102751,-5.04060974684951,"NONE",FALSE,"High","Master Protein","P62879","Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [OS=Homo sapiens]",0,45.508,14,4,4,7,2,340,37.3,6,21.23,4,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00400","2783","B3KPU1; hsa:2783; P11016; P54312; P62879","ENSG00000172354","G alpha (12/13) signalling events; G alpha (q) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; G alpha (s) signalling events; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation","Corticotropin-releasing hormone signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells",36,2,113.7,109,109.2,100.7,72.6,109.7,95.3,87.1,92.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T31(99.4)]",0,"ENSG00000172354"
"952","TAOK1",0.189816752176091,6.64140113080691,2.37740445366851,0.0397891677774168,0.0682100019041431,-5.04377346495153,"NONE",FALSE,"High","Master Protein","Q7L7X3","Serine/threonine-protein kinase TAO1 [OS=Homo sapiens]",0,22.393,2,2,2,7,2,1001,116,7.65,18.74,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00069","57551","A2RUT8; B7ZLV6; hsa:57551; Q7L7X3; Q96L75; Q9H2K7; Q9H7S5; Q9P2I6","ENSG00000160551","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Microtubule cytoskeleton regulation; MAPK signaling pathway",8,0,90.2,90.7,88.6,102.8,116.9,102.8,101.4,100.4,111.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S421(100); S445(100)]",0,"ENSG00000160551"
"953","CHMP5",0.380034341717746,6.63758175993803,2.37273885923621,0.0401023097858915,0.0686746795074238,-5.05144041259022,"NONE",FALSE,"High","Master Protein","Q9NZZ3","Charged multivesicular body protein 5 [OS=Homo sapiens]",0,15.2,10,1,1,1,1,219,24.6,4.83,4.46,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component",NA,"Pf03357","51510","B2RD95; B4DIR6; hsa:51510; Q5VXW2; Q96AV2; Q9HB68; Q9NYS4; Q9NZZ3; Q9Y323","ENSG00000086065","Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT)","Ferroptosis",3,0,57.3,85.5,85,109.3,94.2,95,121.9,115.5,154.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S86(100)]",0,"ENSG00000086065"
"954","CCZ1",-0.220614000617215,6.6105384355821,-2.36396300844204,0.0406978954491534,0.0696215569947781,-5.06585121963685,"NONE",FALSE,"High","Master Protein","P86791","Vacuolar fusion protein CCZ1 homolog [OS=Homo sapiens]",0,9.727,3,1,1,1,1,482,55.8,6.48,3.84,1,"transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity","Pf19031, Pf19032, Pf19033","221960; 51622","A2RU45; hsa:221960; hsa:51622; O95766; P86791; Q9UG65; Q9Y359","ENSG00000122674","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,111.4,105.6,111.9,95.3,82.2,107.9,82.8,98,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100)]",0,"ENSG00000122674"
"955","FRYL",0.245165138327531,6.63536112876654,2.36294777533634,0.0407673538321919,0.0696673523079971,-5.0675174388229,"NONE",FALSE,"High","Master Protein","O94915","Protein furry homolog-like [OS=Homo sapiens]",0,29.92,2,4,4,4,4,3013,339.4,5.58,12.2,4,"cell organization and biogenesis;developmental processes;other biological processes","other cell component",NA,"Pf14222, Pf14225, Pf14228, Pf19421","285527","hsa:285527; O94915; O95640; Q8WTZ5; Q9NT40","ENSG00000075539",NA,NA,0,0,68,78.8,80.1,86.5,76.8,109.5,136.2,138.4,135,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S844(100); T1959(100); S1978(100); S2272(100)]",0,"ENSG00000075539"
"956","OGFR",-0.25387233099777,6.56790971678099,-2.36010994829671,0.0409621250907611,0.0699269750503369,-5.07217394257502,"NONE",FALSE,"High","Master Protein","Q9NZT2","Opioid growth factor receptor [OS=Homo sapiens]",0,30.401,3,1,1,5,1,677,73.3,4.84,19.64,1,"other biological processes","other membranes;nucleus;other cell component","other molecular function","Pf04664, Pf04680","11054","hsa:11054; O96029; Q4VXW5; Q96CM2; Q9BQW1; Q9H4H0; Q9H7J5; Q9NZT2; Q9NZT3; Q9NZT4","ENSG00000060491",NA,NA,0,0,102.2,110.9,111.9,91.6,91.2,95.3,77.1,88.1,101.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S315(100)]",0,"ENSG00000060491"
"957","PPP6R2",0.467764577423701,6.61877871253096,2.35841275635611,0.0410790462785447,0.0700532952210918,-5.07495811376643,"NONE",FALSE,"High","Master Protein","O75170","Serine/threonine-protein phosphatase 6 regulatory subunit 2 [OS=Homo sapiens]",0,10.553,2,1,1,1,1,966,104.9,4.87,3.08,1,NA,"cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf04499","9701","A6PVG3; B7Z7T3; hsa:9701; O75170; Q5U5P3; Q7Z2L2; Q7Z5G5; Q7Z731; Q9UGB9","ENSG00000100239",NA,NA,0,0,93,90,65.9,86.8,145,132,91.6,105.9,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S771(98.8)]",0,"ENSG00000100239"
"958","CREB1",-0.207800564900703,6.63035633958698,-2.35101350781629,0.041592625614547,0.0708550782911698,-5.08709010687557,"NONE",FALSE,"High","Master Protein","P16220","Cyclic AMP-responsive element-binding protein 1 [OS=Homo sapiens]",0,32.298,11,2,3,7,2,327,35.1,5.27,15.6,2,"cell-cell signaling;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00170, Pf02173","1385","hsa:1385; P16220; P21934; Q6V963; Q9UMA7","ENSG00000118260","ADORA2B mediated anti-inflammatory cytokines production; FCGR3A-mediated IL10 synthesis; HCMV Early Events; AKT phosphorylates targets in the nucleus; Constitutive Signaling by AKT1 E17K in Cancer; NGF-stimulated transcription; Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; MECP2 regulates transcription of neuronal ligands; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; NCAM signaling for neurite out-growth; Regulation of MECP2 expression and activity; Transcriptional regulation of granulopoiesis; CREB phosphorylation; Gastrin-CREB signalling pathway via PKC and MAPK; NOTCH2 intracellular domain regulates transcription; MECP2 regulates neuronal receptors and channels; CaMK IV-mediated phosphorylation of CREB; CREB1 phosphorylation through the activation of Adenylate Cyclase; CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde; PKA-mediated phosphorylation of CREB; CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling; MECP2 regulates transcription factors","Androgen receptor signaling pathway; miRNA regulation of DNA damage response; Energy metabolism; miRNAs involved in DNA damage response; Folate-alcohol and cancer pathway hypotheses; Sterol regulatory element-binding proteins (SREBP) signaling; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; ATM signaling pathway; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; MFAP5-mediated ovarian cancer cell motility and invasiveness; Ovarian infertility; MECP2 and associated Rett syndrome; Transcription factor regulation in adipogenesis; BDNF-TrkB signaling; ERK pathway in Huntington's disease; VEGFA-VEGFR2 signaling; Mitochondrial gene expression; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; p38 MAPK signaling pathway; NO/cGMP/PKG mediated neuroprotection; White fat cell differentiation; PI3K-Akt signaling pathway; Phosphodiesterases in neuronal function; Acute viral myocarditis; Thermogenesis; EGF/EGFR signaling pathway; G1 to S cell cycle control; Fragile X syndrome; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Gastrin signaling pathway; Hepatitis B infection; Melanoma; mBDNF and proBDNF regulation of GABA neurotransmission; CAMKK2 pathway; GPR143 in melanocytes and retinal pigment epithelium cells; Galanin receptor pathway; Neuroinflammation and glutamatergic signaling; Vasopressin-regulated water reabsorption; Pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Rubinstein-Taybi syndrome 1; Smith-Magenis and Potocki-Lupski syndrome copy number variation; Interferon type I signaling pathways; T-cell receptor signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling",85,0,102.9,99.6,102.3,88.6,85.4,94.7,112.8,95.5,107.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S326(100)]",0,"ENSG00000118260"
"959","STX4",-0.207036851180253,6.62694488490566,-2.34139309228964,0.0422698018175979,0.0719335939169133,-5.10284882619219,"NONE",FALSE,"High","Master Protein","Q12846","Syntaxin-4 [OS=Homo sapiens]",0,16.072,11,2,2,3,2,297,34.2,6.28,3.78,2,"cell organization and biogenesis;stress response;transport;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00804, Pf05739","6810","A8MXY0; hsa:6810; Q12846; Q15525; Q6FHE8","ENSG00000103496","Translocation of SLC2A4 (GLUT4) to the plasma membrane; ER-Phagosome pathway; trans-Golgi Network Vesicle Budding; Disinhibition of SNARE formation; Other interleukin signaling","Insulin signaling; Vasopressin-regulated water reabsorption",7,0,91,103.8,100,90.3,80.1,88.3,102.8,107.4,125.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(100)]",0,"ENSG00000103496"
"960","PNPLA6",0.229190269653857,6.64358831838635,2.33723152624125,0.0425660701750778,0.0723623192976323,-5.10966030191126,"NONE",FALSE,"High","Master Protein","Q8IY17","Patatin-like phospholipase domain-containing protein 6 [OS=Homo sapiens]",0,45.029,4,3,3,5,3,1375,150.9,7.74,20.33,3,"other metabolic processes","other membranes;cytosol;ER/Golgi","other molecular function","Pf00027, Pf01734","10908","A6NGQ0; B4DFB9; B7Z7T2; F5H5K9; hsa:10908; J3KQS3; O60859; Q86W58; Q8IY17; Q9UG58","ENSG00000032444","Glycerophospholipid catabolism",NA,1,0,92.8,82.8,82.7,102.8,96.8,113.5,101.2,123.2,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S354(100); S420(100); T464(100)]",0,"ENSG00000032444"
"961","PRAG1",-0.207005015447515,6.66078231990434,-2.32994408420064,0.0430897824167098,0.0731764046868579,-5.12158015937839,"NONE",FALSE,"High","Master Protein","Q86YV5","Inactive tyrosine-protein kinase PRAG1 [OS=Homo sapiens]",0,50.01,4,4,4,7,4,1406,149.5,7.2,20.84,4,"other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf07714","157285","Q86YV5; Q8N3N5","ENSG00000275342","RND2 GTPase cycle",NA,1,0,97.7,95.8,92.5,78.5,74.6,96.3,117.3,133.6,122.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S696(100); S740(100)]",0,"ENSG00000275342"
"962","TMPO",0.184782109202115,6.652012095688,2.32129499249413,0.0437195410441519,0.0741687016466278,-5.13571398649663,"NONE",FALSE,"High","Master Protein","P42167","Lamina-associated polypeptide 2, isoforms beta/gamma [OS=Homo sapiens]",0,55.967,11,3,5,11,3,454,50.6,9.38,47.81,3,NA,"other membranes;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03020, Pf08198","7112","A2T926; hsa:7112; P42167; Q14861","ENSG00000120802","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOG GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle","Envelope proteins and their potential roles in EDMD physiopathology; Overlap between signal transduction pathways contributing to LMNA laminopathies",12,0,87.5,86.9,92.7,95,109.4,115,106.7,108.1,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T74(100); T160(100); T208(100)]",0,"ENSG00000120802"
"963","TGFB1I1",0.251338303889773,6.66965051297602,2.32044656479991,0.0437817998207149,0.0741971934656352,-5.13709965440545,"NONE",FALSE,"High","Master Protein","O43294","Transforming growth factor beta-1-induced transcript 1 protein [OS=Homo sapiens]",0,13.198,6,1,1,1,1,461,49.8,7.03,4.19,1,"cell adhesion;cell-cell signaling;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00412, Pf03535","7041","B2R8D5; hsa:7041; O43294; Q9BPW3; Q9Y2V5","ENSG00000140682",NA,"Androgen receptor signaling pathway; Serotonin transporter activity; TGF-beta signaling pathway; Monoamine transport",4,0,94.7,80,83.1,102.9,94.1,118.6,123.6,110.9,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S68(100)]",0,"ENSG00000140682"
"964","MGRN1",0.511307284530451,6.57784463031325,2.31583493678908,0.0441217273566356,0.0746957044045947,-5.14462898802648,"NONE",FALSE,"High","Master Protein","O60291","E3 ubiquitin-protein ligase MGRN1 [OS=Homo sapiens]",0,5.948,4,1,1,1,1,552,60.7,5.15,2.79,1,"protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13920","23295","A4URL3; A4URL4; O60291; Q86W76","ENSG00000102858","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,108.7,49.4,85.2,116.9,124.6,106.8,105.9,92.1,99.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S506(99.4)]",0,"ENSG00000102858"
"965","DDX21",0.199068292542745,6.65690424743676,2.31517518004018,0.044170569256601,0.0747009005458786,-5.14570582122841,"NONE",FALSE,"High","Master Protein","Q9NR30","Nucleolar RNA helicase 2 [OS=Homo sapiens]",0,29.553,2,1,1,2,1,783,87.3,9.28,9.38,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","cytosol;mitochondrion;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00270, Pf00271, Pf08152","9188","B2RDL0; hsa:9188; Q13436; Q5VX41; Q68D35; Q9NR30","ENSG00000165732","B-WICH complex positively regulates rRNA expression; Major pathway of rRNA processing in the nucleolus and cytosol","10q11.21q11.23 copy number variation syndrome; Rubinstein-Taybi syndrome 1",4,0,85.8,83.2,77.5,100,102.9,91.6,121.3,128.5,125.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S121(100)]",0,"ENSG00000165732"
"966","DTNB",-0.299301743855812,6.63325155406038,-2.31392653958728,0.0442631510836032,0.0747799819549073,-5.14774357616538,"NONE",FALSE,"High","Master Protein","O60941-6","Isoform 6 of Dystrobrevin beta [OS=Homo sapiens]",0,13.621,5,2,2,4,1,545,61.5,8.09,5.43,2,NA,NA,NA,NA,NA,"O60941-6",NA,NA,NA,0,0,117.7,117,110.1,99.3,70.8,111.5,81.3,103.1,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss [N-Term]; Phospho [S530(98.8)]",0,"ENSG00000138101"
"967","AJUBA",-0.192174604335395,6.62973114340561,-2.31286046141033,0.0443423467747418,0.0748363081038041,-5.14948314971577,"NONE",FALSE,"High","Master Protein","Q96IF1","LIM domain-containing protein ajuba [OS=Homo sapiens]",0,21.562,9,3,3,3,3,538,56.9,7.14,6.37,3,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00412","84962","A8MX18; D3DS37; hsa:84962; Q96IF1","ENSG00000129474","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; Regulation of PLK1 Activity at G2/M Transition; Activation of anterior HOX genes in hindbrain development during early embryogenesis","Interleukin-1 induced activation of NF-kB; Hippo-Merlin signaling dysregulation; Head and neck squamous cell carcinoma; Pleural mesothelioma",7,0,96.6,102.7,111.1,90.8,100.8,90.7,99.7,102.3,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S79(100); S137(99.4); S230(100)]",0,"ENSG00000129474"
"968","OTUB1",0.198369826615797,6.6419029214297,2.31196059227978,0.0444093031196277,0.074871882945488,-5.15095133661772,"NONE",FALSE,"High","Master Protein","Q96FW1","Ubiquitin thioesterase OTUB1 [OS=Homo sapiens]",0,29.117,10,1,2,3,1,271,31.3,4.94,14.05,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus","enzyme regulator activity;other molecular function","Pf10275","55611","hsa:55611; Q32Q78; Q96FW1; Q96II3; Q9NXQ4; Q9P0B8","ENSG00000167770","Ub-specific processing proteases; Ovarian tumor domain proteases",NA,2,0,97.8,84.7,86.5,105.8,109.4,104.6,102,100,113.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000167770"
"969","ARHGAP17",-0.248058014451983,6.56542688194634,-2.30890008352007,0.0446377662252911,0.0751793957478587,-5.15594352589976,"NONE",FALSE,"High","Master Protein","Q68EM7","Rho GTPase-activating protein 17 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,881,95.4,7.62,9.95,1,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf03114","55114","A8K6M6; hsa:55114; Q68EM7; Q6ZUS4; Q7Z2F2; Q8NDG2; Q96KS2; Q96KS3; Q96SS8; Q9BVF6; Q9H8U5; Q9NW54","ENSG00000140750; ENSG00000288353","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle",NA,6,0,103.4,117.5,115.9,89.5,98.9,103.9,78.4,93.8,76.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S676(99.3)]",0,"ENSG00000140750"
"970","RPTOR",0.247765101797981,6.67235657573299,2.30402606405173,0.0450039790773838,0.0756558052614907,-5.16388999161403,"NONE",FALSE,"High","Master Protein","Q8N122","Regulatory-associated protein of mTOR [OS=Homo sapiens]",0,44.756,3,2,3,6,2,1335,148.9,6.89,26.99,2,"cell organization and biogenesis;stress response;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00400, Pf02985, Pf14538","57521","B2RN36; C6KEF2; F5H7J5; hsa:57521; Q8N122; Q8N4V9; Q8TB32; Q9P2P3","ENSG00000141564","Amino acids regulate mTORC1; Regulation of PTEN gene transcription; mTORC1-mediated signalling; TP53 Regulates Metabolic Genes; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; HSF1-dependent transactivation","AMP-activated protein kinase signaling; Target of rapamycin signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K-Akt signaling pathway; Thermogenesis; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; CAMKK2 pathway; Autophagy; p53 transcriptional gene network; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; JAK-STAT signaling in the regulation of beta cells; ADHD and autism (ASD) linked metabolic pathways and SNP; Interferon type I signaling pathways",34,0,89.1,86.8,91.7,113.5,85.2,125.3,102.2,109.3,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S859(100); S863(100); S877(100)]",0,"ENSG00000141564"
"971","PRR36",0.26639661278591,6.65912845840659,2.3037547267447,0.0450244522347373,0.0756558052614907,-5.16433223256252,"NONE",FALSE,"High","Master Protein","Q9H6K5","Proline-rich protein 36 [OS=Homo sapiens]",0,15.116,2,2,2,2,2,1346,132.7,10.48,5.14,2,NA,NA,NA,"Pf15363","80164","A0A087WZ52; hsa:80164; Q9H3X1; Q9H6K5","ENSG00000183248",NA,NA,0,0,81.9,80.3,99.1,97.3,100.3,127.4,107.9,110.8,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S110(100); S1310(100)]",0,"ENSG00000183248"
"972","PDS5B",-0.176565184355463,6.57580290322952,-2.30328775921793,0.0450597075454466,0.0756558052614907,-5.16509328810451,"NONE",FALSE,"High","Master Protein","Q9NTI5","Sister chromatid cohesion protein PDS5 homolog B [OS=Homo sapiens]",0,49.897,4,3,3,6,3,1447,164.6,8.47,24.79,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf20168","23047","hsa:23047; Q5R3S3; Q5W0K8; Q6NSC3; Q8IXT6; Q9H5N8; Q9NTI5; Q9Y2I5; Q9Y451","ENSG00000083642","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin","Cohesin complex - Cornelia de Lange syndrome; 10q22q23 copy number variation",6,0,111.1,115.5,108.4,100.7,88,111.9,80.9,85.2,80.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1166(99.2); S1182(100); S1358(100)]",0,"ENSG00000083642"
"973","ARHGAP32",0.203212582459966,6.63160126277323,2.30187382299523,0.0451666220363365,0.0757573763240506,-5.16739742914967,"NONE",FALSE,"High","Master Protein","A7KAX9","Rho GTPase-activating protein 32 [OS=Homo sapiens]",0,18.946,2,4,4,5,4,2087,230.4,6.74,10.72,4,"signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00620, Pf14604","9743","A7KAX9; hsa:9743; I7H0B0; O94820; Q86YL6; Q8IUG4; Q9BWG3","ENSG00000134909","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle","Fragile X syndrome",13,0,94.8,86.4,95.4,102.2,126.1,110,91.9,98.7,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S871(100); S892(100); S904(100); S952(100)]",0,"ENSG00000134909"
"974","KIAA1958",0.358618750951782,6.66823513591075,2.29899813432927,0.0453848316574014,0.0760452210111694,-5.17208238769116,"NONE",FALSE,"High","Master Protein","Q8N8K9","Uncharacterized protein KIAA1958 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,716,79.2,6.83,4.16,1,NA,NA,NA,"Pf12012","158405","B7ZKW6; hsa:158405; Q2M336; Q5T252; Q8N8K9; Q8TF43; Q96N02","ENSG00000165185",NA,NA,0,0,92.5,83.3,91,142.8,103.5,101.3,102.4,97,104.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S84(99.3)]",0,"ENSG00000165185"
"975","LARP4",-0.254070664887433,6.64076179374095,-2.29533619403364,0.0456641933857229,0.0764348344671793,-5.17804585000712,"NONE",FALSE,"High","Master Protein","Q71RC2","La-related protein 4 [OS=Homo sapiens]",0,19.975,5,2,2,5,2,724,80.5,6.61,13.97,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","nucleic acid binding activity","Pf05383","113251","A8K6T1; E9PDG5; G3XAA8; G5E976; hsa:113251; Q5CZ97; Q6ZV14; Q71RC2; Q96NF9","ENSG00000161813",NA,NA,0,0,96.8,103.1,105.6,89.6,101.3,74.7,105.6,108,115.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S597(100); S722(100)]",0,"ENSG00000161813"
"976","ZC3HC1",-0.291792050894739,6.62192809065647,-2.2932657955084,0.0458228819398941,0.0766218681617901,-5.18141628102083,"NONE",FALSE,"High","Master Protein","Q86WB0","Zinc finger C3HC-type protein 1 [OS=Homo sapiens]",0,44.709,17,5,5,10,5,502,55.2,5.62,17.8,5,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","other membranes;nucleus","other molecular function","Pf07967, Pf08600","51530","A6NH66; hsa:51530; Q75MF3; Q75MF4; Q86WB0; Q8N330; Q96F75; Q9HA34; Q9NVX4; Q9P0R0","ENSG00000091732","Nuclear events stimulated by ALK signaling in cancer",NA,1,0,108.3,99.3,106.4,84.2,95.5,83.9,97.3,94.1,128.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S321(100); S344(100); S370(100); S395(99.5)]",0,"ENSG00000091732"
"977","RGS6",0.232158181561013,6.56687740745537,2.29247102791998,0.0458839408728382,0.0766454365450071,-5.18270986162007,"NONE",FALSE,"High","Master Protein","P49758","Regulator of G-protein signaling 6 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,472,54.4,7.42,5.9,1,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00610, Pf00615, Pf00631, Pf18148","9628","C9JE95; F8W7W5; hsa:9628; O75576; O75577; P49758; Q7Z4K3; Q7Z4K4; Q7Z4K5; Q7Z4K6; Q8TE13; Q8TE14; Q8TE15; Q8TE16; Q8TE17; Q8TE18; Q8TE19; Q8TE20; Q8TE21; Q8TE22; Q9UDS8; Q9UDT0; Q9Y245; Q9Y647","ENSG00000182732","G alpha (i) signalling events; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","Myometrial relaxation and contraction pathways; Calcium regulation in cardiac cells",4,0,89.7,79.9,89.4,103.4,104.3,107.3,84,102.9,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S244(100)]",0,"ENSG00000182732"
"978","MARCKS",0.394562413800059,6.65023062707458,2.28945542700629,0.046116340957751,0.0769548757086397,-5.18761693909878,"NONE",FALSE,"High","Master Protein","P29966","Myristoylated alanine-rich C-kinase substrate [OS=Homo sapiens]",0,358.753,38,11,30,112,11,332,31.5,4.45,400.08,11,"cell organization and biogenesis;stress response;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf02063","4082","E1P560; hsa:4082; P29966; Q2LA83; Q5TDB7","ENSG00000277443","Acetylcholine regulates insulin secretion","Brain-derived neurotrophic factor (BDNF) signaling pathway",2,0,75,86.8,83.7,106.2,163.2,90.2,120.8,104.5,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S46(100); S101(100); S118(99.3); S131(99.4); S145(100); T150(100); S159(100); S170(100)]",0,"ENSG00000277443"
"979","NCKIPSD",0.210169649969846,6.66709221353813,2.27623400357777,0.0471488876355659,0.0785975328102591,-5.20910900849836,"NONE",FALSE,"High","Master Protein","Q9NZQ3","NCK-interacting protein with SH3 domain [OS=Homo sapiens]",0,13.271,2,1,2,4,1,722,78.9,6.38,10.69,1,"cell organization and biogenesis;transport;other biological processes","cytosol;cytoskeleton;nucleus","cytoskeletal activity;other molecular function","Pf00018, Pf09431","51517","B4DFL5; hsa:51517; Q6GU34; Q6SPF3; Q8TC10; Q9NZQ3; Q9UGM8","ENSG00000213672","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHO GTPases Activate WASPs and WAVEs",NA,3,0,87.7,86.2,91.3,112.1,89.3,113.9,107.8,118.9,104.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T180(99.7)]",0,"ENSG00000213672"
"980","SRSF10",0.249008836133349,6.55986209277031,2.27228762313716,0.0474614298945251,0.0790378097835356,-5.21551694602545,"NONE",FALSE,"High","Master Protein","O75494","Serine/arginine-rich splicing factor 10 [OS=Homo sapiens]",0,13.606,12,3,3,7,3,262,31.3,11.27,6.86,3,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","10772","A6NFM6; A6NI42; A6NIU7; B4DJP9; hsa:10772; O60572; O75494; Q5JRH9; Q5JRI0; Q5JRI2; Q5JRI3; Q5JRI4; Q96G09; Q96P17","ENSG00000188529","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",3,0,99.7,93.8,103.1,124.6,108.5,126.9,68.3,84.8,72.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S23(99.4); S133(100); S160(100)]",0,"ENSG00000188529"
"981","CBL",0.179608545015671,6.64578480997628,2.26950074081742,0.0476833583145236,0.0793264431899108,-5.22004016026562,"NONE",FALSE,"High","Master Protein","P22681","E3 ubiquitin-protein ligase CBL [OS=Homo sapiens]",0,23.182,2,1,2,8,1,906,99.6,6.54,25.74,1,"protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00097, Pf00627, Pf02262, Pf02761, Pf02762","867","A3KMP8; P22681","ENSG00000110395","Spry regulation of FGF signaling; Regulation of signaling by CBL; Regulation of KIT signaling; Negative regulation of FLT3; Cargo recognition for clathrin-mediated endocytosis; Interleukin-6 signaling; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell; Signaling by CSF1 (M-CSF) in myeloid cells; TGF-beta receptor signaling activates SMADs; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1; FLT3 signaling by CBL mutants","RANKL/RANK signaling pathway; Prolactin signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Physico-chemical features and toxicity-associated pathways; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; IL-4 signaling pathway; MET in type 1 papillary renal cell carcinoma; EGF/EGFR signaling pathway; Insulin signaling; IL-2 signaling pathway; 4p16.3 copy number variation; Interferon type I signaling pathways; ErbB signaling pathway; T-cell receptor signaling pathway",39,0,87.7,93.8,98.6,106.7,104,119,95.3,105.6,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S483(100)]",0,"ENSG00000110395"
"982","AATF",-0.284114656368775,6.58040731145155,-2.2669771432269,0.0478851923908343,0.0795810936678631,-5.22413462675417,"NONE",FALSE,"High","Master Protein","Q9NY61","Protein AATF [OS=Homo sapiens]",0,15.2,3,1,1,1,1,560,63.1,4.94,4.55,1,"cell adhesion;stress response;developmental processes;other biological processes","nucleus;other cell component","cytoskeletal activity;other molecular function","Pf08164, Pf13339","26574","A6NCJ6; B3KQ26; hsa:26574; Q9NY61; Q9P0A4; Q9UNX5","ENSG00000275700; ENSG00000276072","NRAGE signals death through JNK","17q12 copy number variation syndrome",2,0,112.3,118.6,106.7,98.7,108,79.6,95.2,80.7,85,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000275700"
"983","CCDC120",0.279945027214624,6.61050601811791,2.26327825767695,0.0481825286060296,0.0799937809613838,-5.23013350239465,"NONE",FALSE,"High","Master Protein","Q96HB5","Coiled-coil domain-containing protein 120 [OS=Homo sapiens]",0,7.951,2,1,1,1,1,630,67.5,9.38,3.13,1,"cell organization and biogenesis;other biological processes","cytoskeleton;other cytoplasmic organelle;other cell component",NA,"Pf11819","90060","A8K5Q5; B4DF24; B4DFC1; B4DTU2; F5GZU4; hsa:90060; Q96HB5","ENSG00000147144; ENSG00000292279",NA,NA,0,0,100,95.9,74.2,108,121.6,111.2,87.6,96.9,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S360(100)]",0,"ENSG00000147144"
"984","MEX3C",0.293726400820952,6.69792272967213,2.26196176341122,0.0482887885767822,0.0800887225175899,-5.23226789157759,"NONE",FALSE,"High","Master Protein","Q5U5Q3","RNA-binding E3 ubiquitin-protein ligase MEX3C [OS=Homo sapiens]",0,13.666,2,1,1,1,1,659,69.3,5,4.18,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf13920","51320","A1L022; Q5U5Q3; Q9NZE3","ENSG00000176624","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,73.6,98.4,91,108.7,93.3,126.1,109.1,125.2,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S545(100)]",0,"ENSG00000176624"
"985","CTIF",0.355016403006336,6.61611883818398,2.25327679890191,0.0489955267011526,0.0811783752043463,-5.24633913753172,"NONE",FALSE,"High","Master Protein","O43310","CBP80/20-dependent translation initiation factor [OS=Homo sapiens]",0,15.2,5,1,1,1,1,598,67.5,6.54,4.36,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;other cell component","nucleic acid binding activity","Pf02854","9811","B3KTR8; hsa:9811; O43310; Q8IVD5","ENSG00000134030; ENSG00000282825",NA,NA,0,0,86.9,100.4,69.5,95.6,131.4,119.9,89.8,102.8,109.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S292(99)]",0,"ENSG00000134030"
"986","TPD52L2",0.553729780104734,6.59527038065719,2.25127301083012,0.0491600078038699,0.0813682887788192,-5.24958331017446,"NONE",FALSE,"High","Master Protein","O43399","Tumor protein D54 [OS=Homo sapiens]",0,13.056,5,1,1,4,1,206,22.2,5.36,10.8,1,"other metabolic processes;other biological processes","other cell component","other molecular function","Pf04201","7165","B4DPJ6; E1P5G7; hsa:7165; O43398; O43399; Q5JWU5; Q5JWU6; Q5JWU8; Q5U0E0; Q9H3Z6","ENSG00000101150",NA,NA,0,0,57.3,68.1,64.7,77,175.3,72.1,159.7,133.3,149.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S166(100)]",0,"ENSG00000101150"
"987","PCBP1",-0.16048291540187,6.61762125700943,-2.24914995091618,0.0493348651915159,0.0815749746631753,-5.25301962482429,"NONE",FALSE,"High","Master Protein","Q15365","Poly(rC)-binding protein 1 [OS=Homo sapiens]",0,114.013,17,4,10,41,2,356,37.5,7.09,120.82,4,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013","5093","hsa:5093; Q13157; Q14975; Q15365","ENSG00000169564","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","Ferroptosis",3,2,107.2,101.5,110.2,95.8,100.5,98.3,94.5,91.1,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S173(100); S190(99.6)]",0,"ENSG00000169564"
"988","PPFIA1",0.224573676482702,6.62555091049904,2.24516064677287,0.0496650654026364,0.0820378408270269,-5.25947389304014,"NONE",FALSE,"High","Master Protein","Q13136","Liprin-alpha-1 [OS=Homo sapiens]",0,36.286,3,2,4,7,2,1202,135.7,6.29,24.52,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","cytosol;other cell component",NA,"Pf00536, Pf07647","8500","A6NLE3; hsa:8500; Q13135; Q13136; Q14567; Q8N4I2","ENSG00000131626; ENSG00000288198","Glutamate Neurotransmitter Release Cycle; Serotonin Neurotransmitter Release Cycle; Norepinephrine Neurotransmitter Release Cycle; Dopamine Neurotransmitter Release Cycle; Acetylcholine Neurotransmitter Release Cycle; Receptor-type tyrosine-protein phosphatases","Cell lineage map for neuronal differentiation",7,0,86.5,91.8,101.8,101.3,110.5,129,90.7,95.4,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S693(97.5)]",0,"ENSG00000131626"
"989","GOLM2",0.189411717327705,6.64887108531267,2.24274742189802,0.0498658530452616,0.0822862205964277,-5.26337652232271,"NONE",FALSE,"High","Master Protein","Q6P4E1","Protein GOLM2 [OS=Homo sapiens]",0.004,2.116,3,1,1,1,1,436,49.5,5.29,1.7,1,NA,"other membranes;ER/Golgi",NA,NA,"113201","B4DPZ6; G5E934; Q6P4E1; Q6UY45; Q96EM1","ENSG00000166734",NA,NA,0,0,99.8,97.9,97,119.2,117.9,111.6,97.7,87.8,88.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(99.4)]",0,"ENSG00000166734"
"990","PEAK1",0.167252165141612,6.63039171398927,2.24131551760183,0.0499853644815968,0.0824001159939051,-5.26569156313065,"NONE",FALSE,"High","Master Protein","Q9H792","Inactive tyrosine-protein kinase PEAK1 [OS=Homo sapiens]",0,49.689,4,5,5,7,5,1746,193,6.89,25.33,5,"cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;other cell component","kinase activity;other molecular function","Pf00069","79834","hsa:79834; Q6ZS78; Q8NAZ4; Q8NCM3; Q8TEG7; Q9H792","ENSG00000173517","RHOV GTPase cycle; RHOU GTPase cycle",NA,2,0,99.3,97.6,93,113.4,113.1,113.3,87.1,91.6,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S281(100); S792(100); T1151(100); T1165(100)]",0,"ENSG00000173517"
"991","EZR",0.24588080566041,6.6446251673755,2.23248228864714,0.0507287904592826,0.0835412573456602,-5.27996259215899,"NONE",FALSE,"High","Master Protein","P15311","Ezrin [OS=Homo sapiens]",0,48.587,11,6,7,11,4,586,69.4,6.27,29.64,6,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00373, Pf00769, Pf09379, Pf09380, Pf20492","7430","E1P5A8; hsa:7430; P15311; P23714; Q4VX75; Q96CU8; Q9NSJ4","ENSG00000092820","Recycling pathway of L1; Sensory processing of sound by inner hair cells of the cochlea; Sensory processing of sound by outer hair cells of the cochlea; Netrin-1 signaling","Pathogenic Escherichia coli infection; AGE/RAGE pathway; VEGFA-VEGFR2 signaling; 16p11.2 proximal deletion syndrome; CCL18 signaling pathway; Regulation of actin cytoskeleton; GDNF signaling",11,0,95.8,85.1,96.8,107.9,99.2,131.2,94.9,103.5,91.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S535(99.6)]",0,"ENSG00000092820"
"992","SUPV3L1",-0.248256375838524,6.60998838434383,-2.23081849555573,0.0508700158589538,0.0836229534276008,-5.28264866028909,"NONE",FALSE,"High","Master Protein","Q8IYB8","ATP-dependent RNA helicase SUPV3L1, mitochondrial [OS=Homo sapiens]",0,27.036,2,1,1,3,1,786,87.9,7.99,10.7,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","mitochondrion;nucleus;other cytoplasmic organelle","nucleic acid binding activity;other molecular function","Pf00271, Pf12513, Pf18114, Pf18147","6832","A8K301; hsa:6832; O43630; Q8IYB8","ENSG00000156502","Mitochondrial RNA degradation",NA,1,0,102.8,108.5,112,85.9,75.8,115.5,93.5,91.8,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S725(100)]",0,"ENSG00000156502"
"993","DACT3",0.172938455604567,6.64384361305198,2.23069071416733,0.0508808779127498,0.0836229534276008,-5.28285492773272,"NONE",FALSE,"High","Master Protein","Q96B18","Dapper homolog 3 [OS=Homo sapiens]",0,19.15,5,3,3,4,3,629,64.9,10.36,11.59,3,"cell-cell signaling;signal transduction;other biological processes","other cell component","other molecular function","Pf15268","147906","hsa:147906; Q96B18","ENSG00000197380",NA,NA,0,0,84,87.6,90.7,98,111.3,101.5,110.6,105.7,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S6(100); S426(100); S505(100)]",0,"ENSG00000197380"
"994","AGAP1",-0.359000478642685,6.6489660043352,-2.22654121724527,0.0512348317459405,0.0841199652005783,-5.28955111632615,"NONE",FALSE,"High","Master Protein","Q9UPQ3","Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 [OS=Homo sapiens]",0,13.656,3,2,2,2,2,857,94.4,7.94,5.68,2,"transport","other cell component","enzyme regulator activity;other molecular function","Pf00071, Pf01412, Pf12796","116987","B2RTX7; hsa:116987; Q541S5; Q6P9D7; Q9NV93; Q9UPQ3","ENSG00000157985",NA,"2q37 copy number variation syndrome",1,0,114.3,102.6,87.5,84.1,52.3,99.6,134.7,112.5,119.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S521(100); T836(100)]",0,"ENSG00000157985"
"995","MAP2K2",0.32747720861441,6.66468967398243,2.22211102748681,0.0516153655375865,0.0846595744294885,-5.29669592727137,"NONE",FALSE,"High","Master Protein","P36507","Dual specificity mitogen-activated protein kinase kinase 2 [OS=Homo sapiens]",0,29.522,11,2,2,6,2,400,44.4,6.55,12.98,2,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069","5605","hsa:5605; P36507","ENSG00000126934","Signaling by BRAF and RAF1 fusions; Uptake and function of anthrax toxins; Signal transduction by L1; RAF activation; MAPK1 (ERK2) activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; Negative feedback regulation of MAPK pathway; Signaling by MAP2K mutants","IL-5 signaling pathway; MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; Thyroxine (thyroid hormone) production; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Alzheimer's disease and miRNA effects; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Glioblastoma signaling pathways; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Amyotrophic lateral sclerosis (ALS); Common pathways underlying drug addiction; Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Bladder cancer; Kit receptor signaling pathway; Hepatocyte growth factor receptor signaling; IL6 signaling pathway; Pathways affected in adenoid cystic carcinoma; TGF-beta signaling pathway; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Endometrial cancer; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Ethanol metabolism production of ROS by CYP2E1; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Melanoma; Netrin-UNC5B signaling pathway; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Kisspeptin/kisspeptin receptor system in the ovary; Host-pathogen interaction of human coronaviruses - MAPK signaling; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; Kallmann syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; Acute myeloid leukemia; Macrophage-stimulating protein (MSP) signaling network map; GNAQ pathways in port-wine stain; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 2 and ELK-SRF/GATA4 signaling; Serotonin receptor 4/6/7 and NR3C signaling; Toll-like receptor signaling pathway",88,0,102.4,86.1,87.5,116.9,104.1,132,81.8,113.4,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T394(100)]",0,"ENSG00000126934"
"996","ALDOA",0.216831711231292,6.67748673279178,2.21607791827656,0.0521379937541545,0.0854309295248797,-5.30641858813152,"NONE",FALSE,"High","Master Protein","P04075","Fructose-bisphosphate aldolase A [OS=Homo sapiens]",0,91.973,21,6,7,12,5,364,39.4,8.09,40.64,6,"cell organization and biogenesis;other metabolic processes;other biological processes","non-structural extracellular;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00274","226","B4DXI7; hsa:226; P04075; Q6FH76; Q6FI10; Q96B15; Q9BWD9; Q9UCN2","ENSG00000149925","Glycolysis; Gluconeogenesis; Neutrophil degranulation; Platelet degranulation","VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; Aerobic glycolysis; 16p11.2 proximal deletion syndrome; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders; Sudden infant death syndrome (SIDS) susceptibility pathways",11,1,88.1,85.1,91.3,109.1,84.8,120.3,107.1,118.4,112.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000149925"
"997","SCD",0.443109445151778,6.67299777641895,2.21482111683987,0.0522475101436472,0.0855245100846863,-5.30844292605814,"NONE",FALSE,"High","Master Protein","O00767","Stearoyl-CoA desaturase [OS=Homo sapiens]",0,36.216,4,2,2,5,2,359,41.5,9,19.21,2,"other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function",NA,"6319","B2R5U0; D3DR68; hsa:6319; O00767; Q16150; Q53GR9; Q5W037; Q5W038; Q6GSS4; Q96KF6; Q9BS07; Q9Y695","ENSG00000099194","Activation of gene expression by SREBF (SREBP); Fatty acyl-CoA biosynthesis; NR1H2 & NR1H3 regulate gene expression linked to lipogenesis","Sterol regulatory element-binding proteins (SREBP) signaling; SREBF and miR33 in cholesterol and lipid homeostasis; Adipogenesis; Liver X receptor pathway; Nuclear receptors meta-pathway; Fatty acid biosynthesis; Angiopoietin-like protein 8 regulatory pathway; PPAR signaling pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis pathway in hepatocytes",13,0,92.7,83.5,86.3,138.8,73.4,144.5,99.7,105.8,93.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T199(100)]",0,"ENSG00000099194"
"998","TANK",0.284249653761037,6.65173790676109,2.21259494141173,0.0524420442301501,0.0857569300436924,-5.31202773812573,"NONE",FALSE,"High","Master Protein","Q92844","TRAF family member-associated NF-kappa-B activator [OS=Homo sapiens]",0,8.28,2,1,1,2,1,425,47.8,5.68,6.18,1,"stress response;signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity;other molecular function","Pf12845","10010","D3DPB5; hsa:10010; Q7Z4J6; Q92844; Q92885","ENSG00000136560","Activation of IRF3, IRF7 mediated by TBK1, IKBKE; TICAM1-dependent activation of IRF3/IRF7; TRAF6 mediated IRF7 activation","TNF-alpha signaling pathway; Interleukin-1 (IL-1) structural pathway; Novel intracellular components of RIG-I-like receptor pathway; SARS-CoV-2 innate immunity evasion and cell-specific immune response",7,0,79.8,80.6,90.1,99.5,134.6,94.1,122,109.7,108.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S129(100)]",0,"ENSG00000136560"
"999","NEK1",0.142083221042107,6.6750952717807,2.20807555269674,0.0528391313758048,0.0863197821875009,-5.31930174958598,"NONE",FALSE,"High","Master Protein","Q96PY6","Serine/threonine-protein kinase Nek1 [OS=Homo sapiens]",0,57.076,5,5,6,10,5,1258,142.7,5.94,33.39,5,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","kinase activity;other molecular function","Pf00069","4750","G5E9Z3; hsa:4750; Q05DG5; Q14CB7; Q5H9T1; Q6PIB8; Q96PY6; Q96SS2; Q9H6P7; Q9Y594","ENSG00000137601",NA,"Ciliopathies; Bardet-Biedl syndrome",2,0,90,91,93.5,103.1,101.4,110.4,107.6,113.3,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S414(100); S436(99.5); S675(100); S1052(100); S1126(100)]",0,"ENSG00000137601"
"1000","RBM15",-0.170298800042704,6.64615270829024,-2.20714980138819,0.0529208293300168,0.0863667934665875,-5.32079116599965,"NONE",FALSE,"High","Master Protein","Q96T37","RNA-binding protein 15 [OS=Homo sapiens]",0,75.389,7,8,10,22,8,977,107.1,10.08,54.93,8,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","other membranes;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf07744","64783","A1A693; hsa:64783; Q3ZB86; Q4V760; Q5D058; Q5T613; Q86VW9; Q96PE4; Q96SC5; Q96SC6; Q96SC9; Q96SD0; Q96T37; Q96T38; Q9BRA5; Q9H6R8; Q9H9Y0","ENSG00000162775",NA,NA,0,0,101.5,104,98.2,91.8,77.5,103.5,106,106.3,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100); S128(100); S294(100); T568(100); S670(100); S674(100); S700(100); S708(100)]",0,"ENSG00000162775"
"1001","PRKAB2",0.199756085582766,6.65266776247319,2.19823793730381,0.0537135868779467,0.0875730007840249,-5.33511885711743,"NONE",FALSE,"High","Master Protein","O43741","5'-AMP-activated protein kinase subunit beta-2 [OS=Homo sapiens]",0,29.673,13,2,3,6,2,272,30.3,6.46,12.24,2,"other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf04739, Pf16561","5565","A8K9V5; B4DH06; hsa:5565; O43741; Q5VXY0","ENSG00000131791","Translocation of SLC2A4 (GLUT4) to the plasma membrane; Activation of AMPK downstream of NMDARs; Regulation of TP53 Activity through Phosphorylation; TP53 Regulates Metabolic Genes; Carnitine metabolism; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; AMPK inhibits chREBP transcriptional activation activity; Activation of PPARGC1A (PGC-1alpha) by phosphorylation; Lipophagy","AMP-activated protein kinase signaling; Target of rapamycin signaling; Energy metabolism; Sterol regulatory element-binding proteins (SREBP) signaling; Angiopoietin-like protein 8 regulatory pathway; Lipid metabolism pathway; Caloric restriction and aging; Thermogenesis; Nonalcoholic fatty liver disease; Synaptic signaling pathways associated with autism spectrum disorder; Hippo signaling regulation pathways; 1q21.1 copy number variation syndrome; Autophagy; p53 transcriptional gene network; Pleural mesothelioma",25,0,86.3,82.6,85.8,101.9,106.9,97.5,123.8,114.2,107.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(99.6)]",0,"ENSG00000131791"
"1002","LRCH4",0.302600112138254,6.64833722693943,2.19257255384351,0.0542235150618716,0.0883161442923898,-5.34421730424862,"NONE",FALSE,"High","Master Protein","O75427","Leucine-rich repeat and calponin homology domain-containing protein 4 [OS=Homo sapiens]",0,13.179,3,1,1,1,1,683,73.4,8.22,4.2,1,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;nucleus",NA,"Pf00307, Pf13855","4034","A4D2D5; hsa:4034; O75427; Q8WV85; Q96ID0","ENSG00000077454",NA,NA,0,0,91.9,81.8,92.3,113.4,148,92.8,102.8,102.5,98.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S513(98.6)]",0,"ENSG00000077454"
"1003","MTX3",0.163478583701233,6.63293681086183,2.19083464324032,0.0543808767124422,0.088484138379567,-5.34700679315735,"NONE",FALSE,"High","Master Protein","Q5HYI7","Metaxin-3 [OS=Homo sapiens]",0,46.981,16,3,3,7,3,312,35.1,7.8,23.89,3,"cell organization and biogenesis;transport","other cell component",NA,"Pf10568, Pf17171","345778","B4DL65; E9PB57; hsa:345778; Q5HYI7; Q7Z380; Q8NB92","ENSG00000177034",NA,NA,0,0,87.9,95.7,93.6,100.9,109.1,115.7,95,101.1,101.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S249(100); S284(100); S311(100)]",0,"ENSG00000177034"
"1004","NUFIP2",0.181636200018121,6.64531356237706,2.18315339674591,0.0550816902912294,0.0895351778439108,-5.35932705691936,"NONE",FALSE,"High","Master Protein","Q7Z417","FMR1-interacting protein NUFIP2 [OS=Homo sapiens]",0,61.475,7,3,4,7,3,695,76.1,8.7,27.98,3,NA,"cytosol;nucleus;other cell component","nucleic acid binding activity","Pf15293","57532","A1L3A6; A1L3A7; hsa:57532; Q7Z417; Q9P2M5","ENSG00000108256",NA,NA,0,0,77.8,82.5,87.4,96.9,105.2,92.1,114.9,122,130.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S212(100); S629(100)]",0,"ENSG00000108256"
"1005","NFIA",0.343351006459168,6.6408566382227,2.17366372105095,0.0559595551059539,0.090871635754146,-5.3745279984781,"NONE",FALSE,"High","Master Protein","Q12857","Nuclear factor 1 A-type [OS=Homo sapiens]",0,39.921,9,2,2,3,2,509,55.9,8.44,11.71,2,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4774","B4DRJ3; B4DS53; F5H0R0; F8W8W3; hsa:4774; Q12857; Q8TA97; Q9H3X9; Q9P2A9","ENSG00000162599","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination",NA,2,0,84.4,76.8,101.5,91,118.2,139.7,97.9,98.2,104.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S287(100); S300(100)]",0,"ENSG00000162599"
"1006","USP10",-0.167003300782858,6.6461925893896,-2.17077549514159,0.0562294080773746,0.0912190795052439,-5.37915005537896,"NONE",FALSE,"High","Master Protein","Q14694","Ubiquitin carboxyl-terminal hydrolase 10 [OS=Homo sapiens]",0,33.398,9,3,4,6,3,798,87.1,5.31,21.59,3,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;translational apparatus;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00443, Pf07145","9100","B2RDJ8; B4DS84; hsa:9100; Q14694; Q9BWG7; Q9NSL7","ENSG00000103194","Ub-specific processing proteases; Termination of translesion DNA synthesis","VEGFA-VEGFR2 signaling",3,0,93.2,91.5,94.8,84.2,72.3,95.3,115.7,129.5,122.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(99.3); S211(99.3); S365(100)]",0,"ENSG00000103194"
"1007","EMSY",-0.199546189843943,6.62983248069024,-2.16761192858357,0.0565264277939408,0.0916098611317889,-5.38421035761785,"NONE",FALSE,"High","Master Protein","Q7Z589","BRCA2-interacting transcriptional repressor EMSY [OS=Homo sapiens]",0,15.275,2,2,2,2,2,1322,141.4,9.33,6.2,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","other molecular function","Pf03735","56946","B7ZKT8; B7ZKU0; B7ZKU2; hsa:56946; Q17RM7; Q4G109; Q7Z589; Q8NBU6; Q8TE50; Q9H8I9; Q9NRH0","ENSG00000158636",NA,"Mesodermal commitment pathway",1,0,101.6,111.2,95.8,97.9,90.5,84.6,102.1,99.3,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(99.5)]",0,"ENSG00000158636"
"1008","UBXN7",0.352380119492699,6.60568594903925,2.16358847399907,0.0569063675705976,0.0921341189238248,-5.39064247826973,"NONE",FALSE,"High","Master Protein","O94888","UBX domain-containing protein 7 [OS=Homo sapiens]",0,8.433,4,1,2,2,1,489,54.8,5.16,5.11,1,"protein metabolism;other metabolic processes","other membranes;cytosol;ER/Golgi;nucleus","other molecular function","Pf00789, Pf13899, Pf14555","26043","D3DXB3; hsa:26043; O94888; Q6ZP77; Q86X20; Q8N327","ENSG00000163960","Neddylation; KEAP1-NFE2L2 pathway","3q29 copy number variation syndrome",3,0,55.9,82.5,82.5,98,94.1,93.5,116.7,118.5,166.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S280(100)]",0,"ENSG00000163960"
"1009","IRX5",-0.180153261490844,6.61737623568254,-2.16052309185771,0.0571974871699302,0.0925136759775284,-5.39554023550203,"NONE",FALSE,"High","Master Protein","P78411","Iroquois-class homeodomain protein IRX-5 [OS=Homo sapiens]",0,4.015,2,1,1,1,1,483,50.3,6.47,2.19,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05920","10265","H0YMS7; hsa:10265; P78411; P78416; Q7Z2E1","ENSG00000176842",NA,"FTO obesity variant mechanism; Pre-implantation embryo",2,0,100.5,104.6,104.9,96.8,99,87.4,102.5,95.8,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T237(100)]",0,"ENSG00000176842"
"1010","AAK1",0.209003330834168,6.66305917894373,2.15741960656092,0.0574936878825289,0.0929006917072151,-5.40049645061466,"NONE",FALSE,"High","Master Protein","Q2M2I8","AP2-associated protein kinase 1 [OS=Homo sapiens]",0,75.564,10,6,7,16,6,961,103.8,6.6,48.25,6,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00069","22848","hsa:22848; Q2M2I8; Q4ZFZ3; Q53RX6; Q9UPV4","ENSG00000115977","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,90,96.9,90.1,115.4,112.9,104,110.1,101.8,94.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T620(100); S623(99.4); S624(100); S637(100); S652(99.7); S731(100)]",0,"ENSG00000115977"
"1011","USP39",0.200175827157178,6.62449727390057,2.15593820096451,0.0576355959280722,0.0930378759194994,-5.40286136851095,"NONE",FALSE,"High","Master Protein","Q53GS9","Ubiquitin carboxyl-terminal hydrolase 39 [OS=Homo sapiens]",0,58.419,5,5,5,15,5,565,65.3,8.91,40.24,5,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00443, Pf02148","10713","A8K086; B3KM40; B4DHT4; D6W5L4; G5E9H0; hsa:10713; Q53GS9; Q6NX47; Q96RK9; Q9BV89; Q9H381; Q9P050; Q9Y310","ENSG00000168883","mRNA Splicing - Major Pathway",NA,1,0,90.5,90.2,95.4,104.4,129.8,102.6,95.2,93.3,102.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(99.1); S82(100)]",0,"ENSG00000168883"
"1012","PIP5K1C",0.321396392733662,6.66552485590812,2.149774387005,0.0582296768664897,0.0939039848281732,-5.412695272887,"NONE",FALSE,"High","Master Protein","O60331","Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma [OS=Homo sapiens]",0,25.948,6,1,2,5,1,668,73.2,5.29,13.19,1,"cell adhesion;cell-cell signaling;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf01504","23396","B7Z9E7; C6GIJ7; C6GIJ8; hsa:23396; O60331; Q7LE07","ENSG00000186111","Clathrin-mediated endocytosis; Synthesis of PIPs at the plasma membrane; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion","B cell receptor signaling pathway; Focal adhesion; Regulation of actin cytoskeleton",7,0,81.4,100.8,80.5,111.9,87.6,133.7,104.2,117.2,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S555(98.8)]",0,"ENSG00000186111"
"1013","PCDH9",-0.305036537028388,6.61132192768812,-2.1475939689852,0.0584412387879982,0.094152124088858,-5.41617163251741,"NONE",FALSE,"High","Master Protein","Q9HC56","Protocadherin-9 [OS=Homo sapiens]",0,7.909,2,1,1,1,1,1237,136,5.47,4.09,1,"cell adhesion;developmental processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00028, Pf08266, Pf08374","5101","A2A6U1; hsa:5101; Q5VT83; Q7Z3U0; Q8N3K7; Q9HC56","ENSG00000184226",NA,NA,0,0,136.1,120.4,93.4,103.3,85.8,89.2,97,96.4,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S943(100); T954(100)]",0,"ENSG00000184226"
"1014","RAB11FIP5",-0.233727809686759,6.64838163882919,-2.14519910405955,0.0586744609142174,0.0943647739092701,-5.41998848322943,"NONE",FALSE,"High","Master Protein","Q9BXF6","Rab11 family-interacting protein 5 [OS=Homo sapiens]",0,9.24,5,3,3,3,3,653,70.4,9.23,6.98,3,"cell-cell signaling;transport;other biological processes","other membranes;cytoskeleton;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00168, Pf09457","26056","hsa:26056; O94939; Q9BXF6; Q9P0M1","ENSG00000135631",NA,NA,0,0,102.9,103.6,92.9,80.3,101.4,81.9,116.4,109.2,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S176(99.4); S307(100); S482(100)]",0,"ENSG00000135631"
"1015","CTPS1",-0.314705388040317,6.59369486492895,-2.14505138287918,0.0586888759300914,0.0943647739092701,-5.42022386744286,"NONE",FALSE,"High","Master Protein","P17812","CTP synthase 1 [OS=Homo sapiens]",0,13.518,2,1,1,2,1,591,66.6,6.46,5.02,1,"cell cycle OR cell proliferation;other metabolic processes;other biological processes","cytosol;other cell component","other molecular function","Pf00117, Pf06418, Pf07722","1503","B4DR64; D3DPW1; hsa:1503; P17812; Q5VW67; Q96GK6","ENSG00000171793","Interconversion of nucleotide di- and triphosphates","Pyrimidine metabolism",2,0,118,115.1,105.1,99.5,66.9,104.6,89.3,106.7,78.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S575(99.6)]",0,"ENSG00000171793"
"1016","PIP4P2",0.327252852471892,6.63851006704678,2.138553652002,0.0593263244024041,0.0952958281739404,-5.43057197648579,"NONE",FALSE,"High","Master Protein","Q8N4L2","Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase [OS=Homo sapiens]",0,7.514,10,1,1,1,1,257,28.1,8.68,2.88,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle","other molecular function","Pf09788","55529","B2R9H4; hsa:55529; Q68CU2; Q8N4L2","ENSG00000155099",NA,NA,0,0,91.3,79.4,77.5,114,77.7,122.9,126.1,102.9,104.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(100); T22(100)]",0,"ENSG00000155099"
"1017","KIF13B",0.196653420647455,6.64245017156547,2.13584390018968,0.0595941233632647,0.0955915051005572,-5.43488419813302,"NONE",FALSE,"High","Master Protein","Q9NQT8","Kinesin-like protein KIF13B [OS=Homo sapiens]",0,55.16,3,4,4,5,4,1826,202.7,5.88,17.72,4,"transport;signal transduction;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00225, Pf00498, Pf01302, Pf12423, Pf12473, Pf16183","23303","B4DGY5; B5MC45; F8VPJ2; hsa:23303; O75134; Q9BYJ6; Q9NQT8","ENSG00000197892","COPI-dependent Golgi-to-ER retrograde traffic; Kinesins",NA,2,0,90.1,90.4,88.8,106,95.3,117.6,93.9,110.5,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S435(100); S1381(100); S1644(100); S1797(100)]",0,"ENSG00000197892"
"1018","PPP1R9B",0.401638264583749,6.54347317272988,2.13550654990089,0.0596275442355192,0.0955915051005572,-5.4354209130028,"NONE",FALSE,"High","Master Protein","Q96SB3","Neurabin-2 [OS=Homo sapiens]",0,24.504,2,1,1,3,1,817,89.3,4.97,12.26,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00595, Pf17817","84687","D3DTX6; hsa:84687; Q8TCR9; Q96SB3","ENSG00000108819",NA,NA,0,0,51.8,57.7,69.8,69.9,108.9,66.2,169.4,138.1,191,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S100(99.7)]",0,"ENSG00000108819"
"1019","PSMD11",0.215463459614762,6.65211278421429,2.13122757304953,0.0600530242430829,0.0961791320556539,-5.44222604681508,"NONE",FALSE,"High","Master Protein","O00231","26S proteasome non-ATPase regulatory subunit 11 [OS=Homo sapiens]",0,2.799,2,1,1,1,1,422,47.4,6.48,2.37,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;cytosol;nucleus;other cell component","other molecular function","Pf01399, Pf18055, Pf18503","5717","A8K3I7; E1P663; hsa:5717; O00231; O00495; Q53FT5","ENSG00000108671","Separation of Sister Chromatids; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2","Proteasome degradation; Parkin-ubiquitin proteasomal system pathway; VEGFA-VEGFR2 signaling",63,0,85.2,68.5,85.4,91.3,89.4,104,119,132,141,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000108671"
"1020","CRACDL",-0.187831500952376,6.50865189797275,-2.12881103624723,0.0602946004914582,0.0964713607863332,-5.44606708579113,"NONE",FALSE,"High","Master Protein","Q6NV74","CRACD-like protein [OS=Homo sapiens]",0,16.847,3,2,2,3,2,962,102.1,7.96,10.01,2,NA,NA,NA,"Pf15262","343990","Q6NV74","ENSG00000196872",NA,NA,0,0,65.4,73.7,67.6,57.7,51.9,59.9,148.3,172.4,219.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); S690(100)]",0,"ENSG00000196872"
"1021","SPIRE2",0.347158091233367,6.64042615379071,2.12574400779329,0.0606025500524148,0.0968691103678168,-5.45093983802942,"NONE",FALSE,"High","Master Protein","Q8WWL2","Protein spire homolog 2 [OS=Homo sapiens]",0,9.72,2,1,1,1,1,714,79.6,7.62,3.34,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity","Pf16474","84501","A4QPB1; hsa:84501; Q2TA98; Q6P433; Q8ND47; Q8WWL2; Q96JJ5","ENSG00000204991",NA,NA,0,0,94.3,105.9,69.1,119.2,136.9,99.8,97.9,95.1,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(100)]",0,"ENSG00000204991"
"1022","NELFE",0.284917805832298,6.64089568328065,2.12007547791036,0.061175688348828,0.0976307810834955,-5.45993913103585,"NONE",FALSE,"High","Master Protein","P18615","Negative elongation factor E [OS=Homo sapiens]",0,27.593,12,5,5,8,5,380,43.2,9.33,24,5,"other biological processes","plasma membrane;other membranes;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","7936","A2BE08; B4DUN1; B4DYX9; hsa:7936; P18615; Q5JP74; Q5JP75; Q96F56; Q9NPK2","ENSG00000204356; ENSG00000206268; ENSG00000206357; ENSG00000229363; ENSG00000231044; ENSG00000233801","Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes","Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation",16,0,82.3,76,71.1,91.7,117,86.4,113.7,134.9,153.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100); T91(100); S115(100); S251(100)]",0,"ENSG00000204356"
"1023","AKT1S1",0.325271566996215,6.66446910838536,2.11984888712228,0.0611987065247647,0.0976307810834955,-5.46029868505278,"NONE",FALSE,"High","Master Protein","Q96B36","Proline-rich AKT1 substrate 1 [OS=Homo sapiens]",0,45.224,14,3,5,13,3,256,27.4,4.75,29.08,3,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity","Pf15798","84335","A8MTQ1; B2RE93; hsa:84335; J3KPM3; Q96B36; Q96BI4; Q96IK7; Q96NG2; Q9BWR5","ENSG00000204673","HSF1-dependent transactivation; Constitutive Signaling by AKT1 E17K in Cancer; mTORC1-mediated signalling; AKT phosphorylates targets in the cytosol","Target of rapamycin signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Thermogenesis; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Thyroid hormones production and peripheral downstream signaling effects; Autophagy; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; p53 transcriptional gene network; Pleural mesothelioma; Network map of SARS-CoV-2 signaling pathway; DYRK1A involvement regarding cell proliferation in brain development; JAK-STAT signaling in the regulation of beta cells; ADHD and autism (ASD) linked metabolic pathways and SNP",22,0,79.5,87.8,92,110.3,154.1,91.2,113.5,101.2,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S183(100); S212(100)]",0,"ENSG00000204673"
"1024","SZRD1",0.311271614219068,6.65687110237803,2.11610304752318,0.0615804337596923,0.0981438163045096,-5.46624057685827,"NONE",FALSE,"High","Master Protein","Q7Z422","SUZ domain-containing protein 1 [OS=Homo sapiens]",0,30.722,16,2,2,3,1,152,17,8.95,7.48,2,NA,NA,NA,"Pf12752, Pf12901","26099","A8MXJ2; C9K0U0; hsa:26099; Q7Z422; Q7Z424; Q8IVM2; Q8TBV3; Q9Y403","ENSG00000055070; ENSG00000291379",NA,NA,0,0,73.8,85.4,108.9,124.2,100.3,114.6,107.7,107.1,91.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S39(100)]",0,"ENSG00000055070"
"1025","SPECC1L",0.191210434806329,6.65130803287834,2.1085854834109,0.0623534315146599,0.099278829494561,-5.47815396290347,"NONE",FALSE,"High","Master Protein","Q69YQ0","Cytospin-A [OS=Homo sapiens]",0,10.581,2,1,1,2,1,1117,124.5,5.76,4.45,1,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component",NA,"Pf00307","23384","B7Z758; F5H1H6; hsa:23384; O15081; Q69YQ0","ENSG00000100014",NA,NA,0,0,84.3,90.3,87.4,106.2,115.2,93.4,109.2,112.4,109.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S384(99.4)]",0,"ENSG00000100014"
"1026","SLC23A2",-0.175736228044206,6.60192316940014,-2.10102748056389,0.0631399628473188,0.100433157277607,-5.49011587530921,"NONE",FALSE,"High","Master Protein","Q9UGH3","Solute carrier family 23 member 2 [OS=Homo sapiens]",0,14.406,3,1,2,3,1,650,70.3,7.68,7.65,1,"cell adhesion;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf00860","9962","B4DJZ1; hsa:9962; Q8WWR4; Q92512; Q96D54; Q9UGH3; Q9UNU1; Q9UP85","ENSG00000089057","Vitamin C (ascorbate) metabolism",NA,1,0,107.1,114.8,102.5,99.9,98.7,95.8,82.9,93.4,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S81(100)]",0,"ENSG00000089057"
"1027","ARHGEF12",0.137281601672134,6.63600592297703,2.09808095893879,0.0634491641999616,0.100826714678031,-5.4947750180031,"NONE",FALSE,"High","Master Protein","Q9NZN5-2","Isoform 2 of Rho guanine nucleotide exchange factor 12 [OS=Homo sapiens]",0,44.009,4,4,4,7,4,1525,171,5.74,15.79,4,NA,NA,NA,NA,NA,"Q9NZN5-2",NA,NA,NA,0,0,87,93.9,90.8,101.6,101.4,108,104.7,105.7,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(100); S290(100); T717(100); S1370(100)]",0,"ENSG00000196914"
"1028","NDE1",0.221148538505188,6.64676594723572,2.0946615662543,0.0638098058470558,0.10130117037198,-5.50017886290167,"NONE",FALSE,"High","Master Protein","Q9NXR1-1","Isoform 2 of Nuclear distribution protein nudE homolog 1 [OS=Homo sapiens]",0.006,1.785,3,1,1,1,1,346,38.8,5.27,2.4,1,NA,NA,NA,NA,NA,"Q9NXR1-1",NA,NA,NA,0,0,95.5,84.9,77.6,110.9,97.3,99.8,103.1,116.7,118.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S309(98)]",0,"ENSG00000072864"
"1029","RTKN",-0.247661747943591,6.6388890900942,-2.09377829991773,0.0639032820434114,0.10135097793474,-5.50157420611016,"NONE",FALSE,"High","Master Protein","Q9BST9","Rhotekin [OS=Homo sapiens]",0,27.349,9,3,3,6,3,563,62.6,7.44,11.97,3,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton","enzyme regulator activity;other molecular function","Pf00169, Pf08174","6242","H7BXD4; hsa:6242; Q8WVN1; Q96PT6; Q9BST9; Q9HB05","ENSG00000114993","RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; RHO GTPases Activate Rhotekin and Rhophilins","G13 signaling pathway",5,0,101.3,105.3,106.6,84.4,91,95.1,88.5,118.2,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100); S239(99.4); S520(100)]",0,"ENSG00000114993"
"1030","GFPT1",0.282698702327039,6.69909159286246,2.09282182686382,0.0640046535695706,0.101413198665572,-5.50308495247396,"NONE",FALSE,"High","Master Protein","Q06210","Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 [OS=Homo sapiens]",0,21.463,2,1,1,5,1,699,78.8,7.11,18.57,1,"protein metabolism;other metabolic processes;other biological processes","cytosol","other molecular function","Pf01380, Pf13522","2673","hsa:2673; Q06210; Q53QE6; Q9BXF8","ENSG00000198380","XBP1(S) activates chaperone genes; Synthesis of UDP-N-acetyl-glucosamine; Defective GFPT1 causes CMSTA1","UDP-derived sugars synthesis in fibroblasts",4,0,82.6,80.1,78.3,114,70.4,115.4,118.8,144.4,142.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S261(100)]",0,"ENSG00000198380"
"1031","FMN2",0.197233644728932,6.61292226036092,2.08986872347134,0.0643186096671144,0.101811805021077,-5.50774775665058,"NONE",FALSE,"High","Master Protein","Q9NZ56","Formin-2 [OS=Homo sapiens]",0,267.533,18,13,17,43,13,1722,180,5.47,163.48,13,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity","Pf02181","56776","B0QZA7; B4DP05; hsa:56776; Q59GF6; Q5VU37; Q9NZ55; Q9NZ56","ENSG00000155816",NA,NA,0,0,94.7,92.6,102.3,111.9,132.6,108.3,94.1,84.7,83.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S73(100); S93(100); S295(100); S317(100); T345(100); S361(100); S396(100); S400(100); S482(100); S499(100); S511(99.4); S516(100); S747(98)]",0,"ENSG00000155816"
"1032","VCP",-0.2256343728074,6.67100840090145,-2.0884131151866,0.0644739029248815,0.101958730206789,-5.51004519077878,"NONE",FALSE,"High","Master Protein","P55072","Transitional endoplasmic reticulum ATPase [OS=Homo sapiens]",0,48.672,6,4,4,7,4,806,89.3,5.26,20.49,4,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","non-structural extracellular;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00004, Pf02359, Pf02933, Pf17862","7415","B2R5T8; P55072; Q0V924; Q2TAI5; Q969G7; Q9UCD5; V9HW80","ENSG00000165280","Aggrephagy; Neutrophil degranulation; HSF1 activation; E3 ubiquitin ligases ubiquitinate target proteins; ABC-family proteins mediated transport; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Defective CFTR causes cystic fibrosis; Neddylation; KEAP1-NFE2L2 pathway; Attachment and Entry; Attachment and Entry; Ovarian tumor domain proteases; Josephin domain DUBs; Protein methylation; RHOH GTPase cycle; Translesion Synthesis by POLH; N-glycan trimming in the ER and Calnexin/Calreticulin cycle","Alstrom syndrome; Clock-controlled autophagy in bone metabolism; HDAC6 interactions in the central nervous system",21,0,98,99.3,96.9,85.5,67.5,101.1,120.1,109.3,139.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S770(100)]",0,"ENSG00000165280"
"1033","ANO8",0.258495361049198,6.672967345161,2.08722053730076,0.0646014018090592,0.102061459586045,-5.51192703166467,"NONE",FALSE,"High","Master Protein","Q9HCE9","Anoctamin-8 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1232,135.9,5.82,4.79,1,"transport","plasma membrane;other membranes;ER/Golgi","transporter activity","Pf04547","57719","A6NIJ0; hsa:57719; Q9HCE9","ENSG00000074855","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Stimuli-sensing channels; Induction of Cell-Cell Fusion",NA,4,0,85.7,84.4,74.7,103.8,104.2,96.2,138.6,123.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S641(100)]",0,"ENSG00000074855"
"1034","CCNL2",-0.137189272216204,6.64010846180177,-2.08399256360833,0.0649477167055158,0.102507812622403,-5.51701863627151,"NONE",FALSE,"High","Master Protein","Q96S94","Cyclin-L2 [OS=Homo sapiens]",0,18.5,6,2,2,3,2,520,58.1,10.26,11.84,2,"other biological processes","nucleus;other cell component","enzyme regulator activity","Pf00134, Pf02984","81669","A0A024R072; A0A024R077; A0A0C4DGC4; A8K8A3; B1B152; F2Z3J5; hsa:81669; Q5T2N5; Q5T2N6; Q6IQ12; Q7Z4Z8; Q8N3C9; Q8N3D5; Q8NHE3; Q8TEL0; Q96B00; Q96S94","ENSG00000221978",NA,"1p36 copy number variation syndrome",1,0,103.5,98.3,101.2,97.8,89.5,94.7,101.5,102.1,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S330(100); S348(100)]",0,"ENSG00000221978"
"1035","MEIS1",-0.201092367736382,6.65919940656264,-2.08341795047262,0.0650095502844282,0.102507812622403,-5.51792468663333,"NONE",FALSE,"High","Master Protein","O00470","Homeobox protein Meis1 [OS=Homo sapiens]",0,8.551,3,1,3,6,1,390,43,6.33,5.4,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05920, Pf16493","4211","A8MV50; hsa:4211; O00470","ENSG00000143995","Activation of anterior HOX genes in hindbrain development during early embryogenesis","Mesodermal commitment pathway; Nephrogenesis",3,0,92.9,103.8,103.7,89.5,97,83.6,113,118.8,105.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(100)]",0,"ENSG00000143995"
"1036","LEO1",0.231458523717448,6.67595858191519,2.0823500439075,0.0651246162790333,0.102590129119095,-5.51960831408954,"NONE",FALSE,"High","Master Protein","Q8WVC0","RNA polymerase-associated protein LEO1 [OS=Homo sapiens]",0,14.066,5,3,4,4,2,666,75.4,4.51,10.74,3,"cell-cell signaling;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","cytoskeleton;nucleus","other molecular function","Pf04004","123169","hsa:123169; Q8WVC0; Q96N99","ENSG00000166477","E3 ubiquitin ligases ubiquitinate target proteins; Formation of the beta-catenin:TCF transactivating complex; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events","Endoderm differentiation",6,0,89,85.6,90.4,115.6,89.8,113.4,101.5,128,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S546(100); S630(100); S658(100)]",0,"ENSG00000166477"
"1037","CPSF7",-0.168906175481324,6.62984384984499,-2.08062179036107,0.0653112468107825,0.10278491301369,-5.52233233838909,"NONE",FALSE,"High","Master Protein","Q8N684","Cleavage and polyadenylation specificity factor subunit 7 [OS=Homo sapiens]",0,17.564,7,2,2,3,2,471,52,8,10.3,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf00076","79869","B3KU04; C9K0Q4; hsa:79869; Q7Z3H9; Q8N684; Q9H025; Q9H9V1","ENSG00000149532","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; RHOBTB1 GTPase cycle; Processing of Intronless Pre-mRNAs",NA,5,0,113,97.8,105.4,102.1,92.1,91.7,98,95.2,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(100); T203(99.3)]",0,"ENSG00000149532"
"1038","ZNF219",0.229660457514638,6.64253091481429,2.07784157880484,0.0656125494489562,0.10315961531859,-5.52671264728731,"NONE",FALSE,"High","Master Protein","Q9P2Y4","Zinc finger protein 219 [OS=Homo sapiens]",0,43.614,7,2,2,3,2,722,76.8,9.39,15.55,2,"developmental processes;signal transduction;other biological processes","other membranes;nucleus","nucleic acid binding activity;other molecular function","Pf00096","51222","D3DS16; hsa:51222; Q53Y57; Q8IYC1; Q9BW28; Q9P2Y4","ENSG00000165804",NA,"Ectoderm differentiation; IL-18 signaling pathway",2,0,89.6,89.8,87.9,101.7,103.4,121.1,112.9,91.3,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S698(100)]",0,"ENSG00000165804"
"1039","DCTN2",0.268095857043652,6.66108770154422,2.07593105377436,0.0658203703854655,0.10338275737408,-5.52972146050641,"NONE",FALSE,"High","Master Protein","Q13561","Dynactin subunit 2 [OS=Homo sapiens]",0,15.2,6,1,1,1,1,401,44.2,5.21,4.57,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf04912","10540","B2RBK5; hsa:10540; Q13561; Q86YN2; Q9BW17","ENSG00000175203","MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2","Vasopressin-regulated water reabsorption",12,0,72,82.6,102.9,111.9,107.6,100.9,118.5,115.3,103.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T198(100)]",0,"ENSG00000175203"
"1040","ADCY2",0.177873566516838,6.65069481877981,2.07537321481584,0.0658811689148547,0.10338275737408,-5.53059978305959,"NONE",FALSE,"High","Master Protein","Q08462","Adenylate cyclase type 2 [OS=Homo sapiens]",0,17.025,2,2,2,5,2,1091,123.5,8.09,12.97,2,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00211, Pf06327, Pf16214","108","B7Z2C1; hsa:108; Q08462; Q2NKL8; Q9UDB2; Q9UPU2","ENSG00000078295","FCGR3A-mediated IL10 synthesis; G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; G alpha (s) signalling events; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Adenylate cyclase activating pathway; Hedgehog 'off' state","Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Phosphodiesterases in neuronal function; Thermogenesis; Envelope proteins and their potential roles in EDMD physiopathology; GPR143 in melanocytes and retinal pigment epithelium cells; Calcium regulation in cardiac cells",23,0,82.5,95.9,86.4,109.8,92.8,105.3,103.6,114.1,111.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S1085(100)]",0,"ENSG00000078295"
"1041","CSTF2T",0.266001682384145,6.64703980738777,2.06997060266479,0.06647277904956,0.104210927386054,-5.53910162579487,"NONE",FALSE,"High","Master Protein","Q9H0L4","Cleavage stimulation factor subunit 2 tau variant [OS=Homo sapiens]",0,12.541,4,1,1,1,1,616,64.4,7.25,4.08,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf14304, Pf14327","23283","B2RAR9; hsa:23283; O75174; Q53HK6; Q7LGE8; Q8N6T1; Q9H0L4","ENSG00000177613","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs","mRNA processing",5,0,71.5,99.1,90.9,106.2,120.2,101.5,115.1,107,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S563(98.2)]",0,"ENSG00000177613"
"1042","SEPTIN10",0.238726491510745,6.62221905721216,2.06850004976775,0.0666346876005705,0.104364501117208,-5.54141431238534,"NONE",FALSE,"High","Master Protein","Q9P0V9","Septin-10 [OS=Homo sapiens]",0,9.719,4,1,2,2,1,454,52.6,6.8,2.81,1,"cell cycle OR cell proliferation","cytoskeleton;other cell component","other molecular function","Pf00735","151011","B3KRQ9; hsa:151011; Q86VP5; Q9HAH6; Q9P0V9","ENSG00000186522",NA,NA,0,0,83.4,104.5,112.4,123.4,136,112.2,82.6,78.2,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S24(96); S28(100)]",0,"ENSG00000186522"
"1043","EMD",-0.181344425938659,6.64765648839946,-2.06675308956608,0.0668275180875043,0.104566164447562,-5.54416088258541,"NONE",FALSE,"High","Master Protein","P50402","Emerin [OS=Homo sapiens]",0,37.404,13,3,3,5,3,254,29,5.5,23.35,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity","Pf03020","2010","hsa:2010; P50402; Q6FI02","ENSG00000102119","RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOD GTPase cycle; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane; Initiation of Nuclear Envelope (NE) Reformation; Depolymerization of the Nuclear Lamina","Arrhythmogenic right ventricular cardiomyopathy; Envelope proteins and their potential roles in EDMD physiopathology; Influence of laminopathies on Wnt signaling",12,0,98.7,98.1,104.9,90.7,73.2,106,106.9,109.6,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(100); S87(100)]",0,"ENSG00000102119"
"1044","YEATS2",-0.1772809654731,6.61179604540046,-2.06415332039235,0.067115468633847,0.104916134875899,-5.54824660105468,"NONE",FALSE,"High","Master Protein","Q9ULM3","YEATS domain-containing protein 2 [OS=Homo sapiens]",0,20.325,2,2,2,3,2,1422,150.7,8.98,8.16,2,"cell organization and biogenesis;other biological processes","cytoskeleton;nucleus;other cell component","other molecular function","Pf03366","55689","A7E2B9; D3DNS9; hsa:55689; Q641P6; Q9NW96; Q9ULM3","ENSG00000163872","Formation of WDR5-containing histone-modifying complexes; HATs acetylate histones",NA,2,0,107.2,102,102.3,95.2,81,102.1,88.3,102.7,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S447(100); S465(100)]",0,"ENSG00000163872"
"1045","RALGPS1",0.22762140281514,6.63905044464662,2.0537557977603,0.0682789770989057,0.106632813995612,-5.56456731393339,"NONE",FALSE,"High","Master Protein","Q5JS13","Ras-specific guanine nucleotide-releasing factor RalGPS1 [OS=Homo sapiens]",0,10.459,3,1,1,1,1,557,62.1,9.11,3.5,1,"signal transduction;other biological processes","plasma membrane;other membranes;other cell component","enzyme regulator activity","Pf00169, Pf00617","9649","B4DR86; E9PBQ5; hsa:9649; O15059; Q5JS13; Q5JT60; Q5JT65; Q5JUG5; Q8N4S6; Q8N5H4; Q8WUV7; Q9NZ16","ENSG00000136828",NA,NA,0,0,101.5,98.6,85.1,115.1,130,105,92.4,87.1,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100)]",0,"ENSG00000136828"
"1046","IRX1",0.237188778318144,6.61207807880438,2.0525212138794,0.0684184007044607,0.106748403393575,-5.56650309798607,"NONE",FALSE,"High","Master Protein","P78414","Iroquois-class homeodomain protein IRX-1 [OS=Homo sapiens]",0,25.479,8,2,2,2,2,480,49.6,6.2,8.42,2,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05920","79192","hsa:79192; P78414; Q7Z2F8; Q8N312","ENSG00000170549","Nephron development",NA,1,0,96.5,93.2,97,122.4,123.3,107.3,92.7,94.4,75.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S267(100); S447(100)]",0,"ENSG00000170549"
"1047","SGPP1",-0.185013118895187,6.65358660252178,-2.04796264916485,0.068935561086376,0.107436775380894,-5.57364685937147,"NONE",FALSE,"High","Master Protein","Q9BX95","Sphingosine-1-phosphate phosphatase 1 [OS=Homo sapiens]",0,23.038,3,1,1,3,1,441,49.1,8.82,12.28,1,"other metabolic processes;transport;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf01569","81537","B2RAH0; hsa:81537; Q9BX95; Q9H189","ENSG00000126821; ENSG00000285281","Sphingolipid catabolism","Sphingolipid metabolism: integrated pathway; Sphingolipid metabolism in senescence; Biosynthesis and turnover of 1-deoxy-sphingoid bases",4,0,91.6,108.1,100.3,88.4,84.5,94.8,116.5,102.2,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S112(100)]",0,"ENSG00000126821"
"1048","DAXX",0.196919116594273,6.66209032192722,2.0474736073586,0.0689912626220445,0.107436775380894,-5.57441287419542,"NONE",FALSE,"High","Master Protein","Q9UER7","Death domain-associated protein 6 [OS=Homo sapiens]",0,33.812,8,3,3,5,3,740,81.3,4.87,17.34,3,"cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf03344, Pf20920","1616","B4E1I3; F5ANJ6; F5ANJ7; F5H082; hsa:1616; O14747; O15141; O15208; Q5STK9; Q9BWI3; Q9UER7","ENSG00000204209; ENSG00000206206; ENSG00000206279; ENSG00000227046; ENSG00000231617","SUMOylation of transcription cofactors; HCMV Early Events; Inhibition of DNA recombination at telomere; Regulation of TP53 Degradation; Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations; Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations","Androgen receptor signaling pathway; Amyotrophic lateral sclerosis (ALS); Fas ligand pathway and stress induction of heat shock proteins; MAPK signaling pathway; p38 MAPK signaling pathway",11,0,83.6,98.7,85.3,109.5,90.1,115.6,105.1,114.3,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S495(100); S671(100); S688(99)]",0,"ENSG00000204209"
"1049","CAMK2G",0.13325890830456,6.64921325069364,2.04039235849512,0.0698026315232821,0.108596658385125,-5.58549665002765,"NONE",FALSE,"High","Master Protein","Q13555-6","Isoform 6 of Calcium/calmodulin-dependent protein kinase type II subunit gamma [OS=Homo sapiens]",0,134.031,15,8,17,71,1,588,65.2,7.94,216.58,8,NA,NA,NA,NA,NA,"Q13555-6",NA,NA,NA,0,0,86.3,91.9,92.4,102,103.7,103.4,108.6,107.1,107.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T287(100); S311(100); S315(100); S321(99.4); S402(99.7); S449(100)]",0,"ENSG00000148660"
"1050","HDAC2",-0.349831996864349,6.42365568033188,-2.03872437436696,0.0699950665811374,0.108792332057539,-5.58810524034398,"NONE",FALSE,"High","Master Protein","Q92769","Histone deacetylase 2 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,488,55.3,5.91,4.15,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00850","3066","B3KRS5; B4DL58; E1P561; hsa:3066; Q5SRI8; Q5SZ86; Q8NEH4; Q92769","ENSG00000196591","Regulation of TP53 Activity through Acetylation; Potential therapeutics for SARS; SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Regulation of PTEN gene transcription; HDACs deacetylate histones; NoRC negatively regulates rRNA expression; Factors involved in megakaryocyte development and platelet production; RNA Polymerase I Transcription Initiation; p75NTR negatively regulates cell cycle via SC1; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; Regulation of MECP2 expression and activity; STAT3 nuclear events downstream of ALK signaling; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; EGR2 and SOX10-mediated initiation of Schwann cell myelination; MECP2 regulates neuronal receptors and channels","Cell cycle; Neural crest differentiation; Notch signaling; Initiation of transcription and translation elongation at the HIV-1 LTR; Ethanol effects on histone modifications; Effect of progerin on genes involved in progeria; Ciliary landscape; 7q11.23 copy number variation syndrome; SARS-CoV-2 innate immunity evasion and cell-specific immune response; TAR syndrome; Notch signaling pathway",30,0,124.5,118.5,125.4,95.1,131.8,79.1,56.5,60.4,69.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S424(100)]",0,"ENSG00000196591"
"1051","REPS1",0.301490275317095,6.69626979391406,2.03315370367408,0.0706414186179194,0.109692478767312,-5.59681123056035,"NONE",FALSE,"High","Master Protein","Q96D71","RalBP1-associated Eps domain-containing protein 1 [OS=Homo sapiens]",0,47.936,9,3,7,10,3,796,86.6,5.69,21.8,3,"transport","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf12763","85021","B7ZBZ8; B7ZBZ9; B7ZC00; hsa:85021; J3KP76; Q5JWJ5; Q5JWJ6; Q5JWJ7; Q8NDR7; Q8WU62; Q96D71; Q9BXY9","ENSG00000135597","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,75,101.7,78.4,116.8,81.3,119.1,126.5,120.6,111.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S392(99.3); S540(98.6); S558(98.6); S736(100)]",0,"ENSG00000135597"
"1052","ERBB2",0.222530337231906,6.64271630765634,2.03249619346863,0.070718081518158,0.109707137868473,-5.59783818492105,"NONE",FALSE,"High","Master Protein","P04626","Receptor tyrosine-protein kinase erbB-2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1255,137.8,5.91,5.9,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00757, Pf01030, Pf07714, Pf14843, Pf21314","2064","B2RZG3; B4DHN3; hsa:2064; P04626; Q14256; Q6LDV1; Q9UMK4; X5D2V5","ENSG00000141736","PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; SHC1 events in ERBB2 signaling; GRB7 events in ERBB2 signaling; Downregulation of ERBB2:ERBB3 signaling; GRB2 events in ERBB2 signaling; PI3K events in ERBB2 signaling; ERBB2 Regulates Cell Motility; ERBB2 Activates PTK6 Signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Sema4D induced cell migration and growth-cone collapse; PLCG1 events in ERBB2 signaling; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors; Signaling by ERBB2 ECD mutants; Constitutive Signaling by Overexpressed ERBB2; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants","Leptin signaling pathway; Prolactin signaling pathway; Glioblastoma signaling pathways; Mammary gland development pathway - Puberty (Stage 2 of 4); Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Bladder cancer; Extracellular vesicle-mediated signaling in recipient cells; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Pathways affected in adenoid cystic carcinoma; Physico-chemical features and toxicity-associated pathways; Endometrial cancer; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; EGF/EGFR signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; 2q11.2 copy number variation syndrome; 17q12 copy number variation syndrome; ErbB signaling pathway; DNA damage response (only ATM dependent)",52,0,93.1,85,89.8,103.3,119.6,105.1,116.8,98.8,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1054(100)]",0,"ENSG00000141736"
"1053","SNTA1",0.328710585103059,6.60916450887673,2.02834399880412,0.0712040400055893,0.110333963136609,-5.60432039244242,"NONE",FALSE,"High","Master Protein","Q13424","Alpha-1-syntrophin [OS=Homo sapiens]",0,15.148,4,1,1,2,1,505,53.9,6.8,8.49,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00595, Pf18012","6640","A8K7H9; B4DX40; E1P5N1; hsa:6640; Q13424; Q16438","ENSG00000101400",NA,"13q12.12 copy number variation; Sudden infant death syndrome (SIDS) susceptibility pathways",2,0,91.3,86.9,98.5,96,114.6,156.6,84.2,83,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S189(100)]",0,"ENSG00000101400"
"1054","GOLM1",0.236485835414317,6.66344553710097,2.02789013080384,0.0712573511923935,0.110333963136609,-5.605028630775,"NONE",FALSE,"High","Master Protein","Q8NBJ4","Golgi membrane protein 1 [OS=Homo sapiens]",0,65.961,12,2,3,9,2,401,45.3,4.97,32.59,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;ER/Golgi",NA,NA,"51280","hsa:51280; Q6IAF4; Q8NBJ4; Q9NRB9","ENSG00000135052","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,91.6,88.1,97.8,113.4,96.8,125.5,106.5,106.6,88.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S187(100); S309(100)]",0,"ENSG00000135052"
"1055","RPRD1A",0.253468331360813,6.61812888244863,2.02716251425358,0.0713428959601465,0.110361712044511,-5.6061639086864,"NONE",FALSE,"High","Master Protein","Q96P16","Regulation of nuclear pre-mRNA domain-containing protein 1A [OS=Homo sapiens]",0,15.2,8,1,1,1,1,312,35.7,7.55,4.42,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","other molecular function","Pf04818, Pf16566","55197","A8KA42; B2RBA3; hsa:55197; Q7Z5G8; Q96FY9; Q96P16; Q9NVL4","ENSG00000141425","RNA polymerase II transcribes snRNA genes",NA,1,0,99.1,81.6,92.9,95.1,116.5,128.5,93.4,102.2,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S156(99.7)]",0,"ENSG00000141425"
"1056","SEMA6D",-0.143846775611137,6.63735462179626,-2.02228082748963,0.0719193570740176,0.111148097296209,-5.61377646028997,"NONE",FALSE,"High","Master Protein","Q8NFY4","Semaphorin-6D [OS=Homo sapiens]",0,33.642,4,3,3,4,3,1073,119.8,8.51,10.54,3,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding","Pf01403, Pf01437","80031","A6NF10; A6NM95; A6NNK1; A7E2A0; hsa:80031; Q8NFY3; Q8NFY4; Q8NFY5; Q8NFY6; Q8NFY7; Q9P249","ENSG00000137872","Other semaphorin interactions","VEGFA-VEGFR2 signaling; IL-18 signaling pathway",3,0,103.3,97.5,102.5,90.2,92.8,100,99.8,107.7,102.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S713(99.6); S931(99.1)]",0,"ENSG00000137872"
"1057","TTYH1",-0.182591426541578,6.62639920037011,-2.02166910835857,0.0719919040184809,0.111154954927305,-5.61472986498466,"NONE",FALSE,"High","Master Protein","Q9H313-3","Isoform 3 of Protein tweety homolog 1 [OS=Homo sapiens]",0,61.779,10,3,4,14,2,460,49.7,6.23,45.69,3,NA,NA,NA,NA,NA,"Q9H313-3",NA,NA,NA,0,1,99,92.8,111.1,92.5,83.3,95.1,108.8,96.3,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T156(99.9); T157(99.9); T166(100); S435(100)]",0,"ENSG00000167614"
"1058","EDC3",0.24633248164585,6.62123616552676,2.01648511908597,0.0726094961129349,0.112002549769669,-5.6228048167323,"NONE",FALSE,"High","Master Protein","Q96F86","Enhancer of mRNA-decapping protein 3 [OS=Homo sapiens]",0,14.937,3,1,1,2,1,508,56,7.11,9.49,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;other cell component","nucleic acid binding activity;other molecular function","Pf03853, Pf09532, Pf12701, Pf16598","80153","B3KPH0; D3DW61; hsa:80153; Q96F86; Q9H797","ENSG00000179151","mRNA decay by 5' to 3' exoribonuclease",NA,1,0,88.8,91.8,100.8,107.1,141.4,109.9,98.3,80,94.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S131(100)]",0,"ENSG00000179151"
"1059","MEPCE",0.203883893503797,6.65808363231301,2.01363351972588,0.0729513608087253,0.112423626855373,-5.62724312042317,"NONE",FALSE,"High","Master Protein","Q7L2J0","7SK snRNA methylphosphate capping enzyme [OS=Homo sapiens]",0,56.956,12,5,6,6,5,689,74.3,9.57,20.89,5,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf06859","56257","B3KP86; D6W5V7; hsa:56257; Q7L2J0; Q9NPD4","ENSG00000146834",NA,"IL-18 signaling pathway; 1p36 copy number variation syndrome",2,0,94.2,90,85.4,102.6,128.2,100,103.8,101.4,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(98.8); S69(100); S216(100); S217(100); S330(100)]",0,"ENSG00000146834"
"1060","PRKAR1A",-0.156657269105031,6.63163412495967,-2.00848415572992,0.0735725657932821,0.11327398808928,-5.63525130268929,"NONE",FALSE,"High","Master Protein","P10644","cAMP-dependent protein kinase type I-alpha regulatory subunit [OS=Homo sapiens]",0,24.327,5,2,2,3,2,381,43,5.35,12.33,2,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00027, Pf02197","5573","hsa:5573; K7ER48; P10644; Q567S7","ENSG00000108946","FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; Factors involved in megakaryocyte development and platelet production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase","Mesodermal commitment pathway; Myometrial relaxation and contraction pathways; Mesodermal commitment pathway; G protein signaling pathways; Cannabinoid receptor signaling; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Fragile X syndrome; Cardiomyocyte signaling pathways converging on titin; Calcium regulation in cardiac cells; ADHD and autism (ASD) linked metabolic pathways and SNP; EPAC1 and PKA reduction of retinal inflammation; Sudden infant death syndrome (SIDS) susceptibility pathways",27,0,102.5,113.1,117.1,106.6,98,101.4,91.2,91.2,85.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(100)]",0,"ENSG00000108946"
"1061","KDM1B",-0.293805689415017,6.61825873451104,-2.00119720041966,0.0744602203587343,0.114532591541427,-5.6465695994543,"NONE",FALSE,"High","Master Protein","Q8NB78","Lysine-specific histone demethylase 2 [OS=Homo sapiens]",0,9.33,2,1,1,1,1,822,92,7.87,3.09,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf01593, Pf04433, Pf07496","221656","A2A2C5; A2A2C6; hsa:221656; Q5TGV3; Q6AI15; Q6ZUU4; Q8N258; Q8NB78; Q96EL7","ENSG00000165097","UCH proteinases; HDMs demethylate histones; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","Vitamin D-sensitive calcium signaling in depression",4,0,121.1,93,100.3,92.7,76.2,84.8,108.4,87.7,128,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S247(100)]",0,"ENSG00000165097"
"1062","HNRNPDL",-0.424045802953587,6.58548128848182,-1.9940447755693,0.0753413481525416,0.115715460522075,-5.65766259093992,"NONE",FALSE,"High","Master Protein","O14979","Heterogeneous nuclear ribonucleoprotein D-like [OS=Homo sapiens]",0,27.746,4,1,1,2,1,420,46.4,9.57,8.13,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf00076","9987","hsa:9987; O14979; Q6SPF2; Q7KZ74; Q7KZ75; Q96IM0; Q96S43","ENSG00000152795","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation",NA,1,0,101.3,118.9,119.5,102.5,48.4,106.5,91.6,111.1,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S241(100)]",0,"ENSG00000152795"
"1063","CDC23",0.274714123612324,6.64487772489992,1.9938051519976,0.075371038317994,0.115715460522075,-5.65803395083237,"NONE",FALSE,"High","Master Protein","Q9UJX2","Cell division cycle protein 23 homolog [OS=Homo sapiens]",0,9.11,2,2,2,2,2,597,68.8,7.02,5.22,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf04049","8697","A8K6E5; B4E3A2; B7WP05; D3DQB7; hsa:8697; O75433; Q53FN2; Q9BS73; Q9UJX2","ENSG00000094880","Separation of Sister Chromatids; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects","Cell cycle",19,0,87.7,70.3,104.7,104,96.7,124,109.9,104.8,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S588(100); T596(100)]",0,"ENSG00000094880"
"1064","SPIN1",0.198395162811893,6.6397067710058,1.99303790890225,0.0754661768371505,0.115752632141193,-5.6592228727437,"NONE",FALSE,"High","Master Protein","Q9Y657","Spindlin-1 [OS=Homo sapiens]",0,3.967,10,1,1,1,1,262,29.6,6.96,2.95,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;nucleus","other molecular function","Pf02513","10927","A8K0X6; B3KRQ4; hsa:10927; Q7KZJ8; Q9GZT2; Q9H0N7; Q9Y657","ENSG00000106723",NA,NA,0,0,107.2,81.7,91,110,115.9,104.2,99,98.4,100.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(100)]",0,"ENSG00000106723"
"1065","DENND5A",-0.141102171393709,6.66018578209468,-1.98929518922224,0.0759319077176866,0.116357627601187,-5.6650198964051,"NONE",FALSE,"High","Master Protein","Q6IQ26","DENN domain-containing protein 5A [OS=Homo sapiens]",0,17.672,2,2,2,5,2,1287,147,6.65,13.73,2,"transport;other biological processes","other membranes;cytosol;ER/Golgi","enzyme regulator activity;other molecular function","Pf01477, Pf02141, Pf02759, Pf03455, Pf03456","23258","B4DJ15; E9PS91; Q6IQ26; Q96GN3; Q9H6U7; Q9UFV0; Q9UPR1","ENSG00000184014","RAB GEFs exchange GTP for GDP on RABs",NA,1,0,95.4,95.9,93.3,85.7,80.3,96.5,115.3,116.5,127.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100); S1085(99.7)]",0,"ENSG00000184014"
"1066","LARP7",-0.153872415051271,6.61301569348947,-1.98760517582932,0.0761430971190201,0.116571795964579,-5.66763604925406,"NONE",FALSE,"High","Master Protein","Q4G0J3","La-related protein 7 [OS=Homo sapiens]",0,36.28,5,2,4,7,2,582,66.9,9.55,24.37,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf05383, Pf08777","51574","B2ZHN6; hsa:51574; Q3B7A9; Q4G0J3; Q9P1S7; Q9Y3Z8","ENSG00000174720",NA,"VEGFA-VEGFR2 signaling",1,0,101.2,105.7,101,91.1,96.9,97.7,98.8,92.4,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T257(99.5); S261(100); S300(100)]",0,"ENSG00000174720"
"1067","PREX1",0.160481893188506,6.59939737162676,1.98579459281115,0.0763699697191991,0.116809550685785,-5.6704378232373,"NONE",FALSE,"High","Master Protein","Q8TCU6","Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein [OS=Homo sapiens]",0,28.622,3,2,2,4,2,1659,186.1,6.44,10.63,2,"cell organization and biogenesis;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00610, Pf00621","57580","E1P5X9; hsa:57580; Q5JS95; Q5JS96; Q69YL2; Q7Z2L9; Q8TCU6; Q9BQH0; Q9BX55; Q9H4Q6; Q9P2D2; Q9UGQ4","ENSG00000124126","RAC1 GTPase cycle; RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; CDC42 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle","Chemokine signaling pathway",13,0,88,97.4,99.3,107.7,114.4,110.8,83.5,91.9,95.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1200(100)]",0,"ENSG00000124126"
"1068","SLC7A11",-0.265676471994576,6.61729521838667,-1.97673293762063,0.0775150639653842,0.118449985385306,-5.68444425255142,"NONE",FALSE,"High","Master Protein","Q9UPY5","Cystine/glutamate transporter [OS=Homo sapiens]",0,3.566,3,1,1,1,1,501,55.4,9.19,2.25,1,"cell adhesion;other metabolic processes;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity","Pf13520","23657","A8K2U4; hsa:23657; Q9UPY5","ENSG00000151012","NFE2L2 regulating anti-oxidant/detoxification enzymes; Basigin interactions; Amino acid transport across the plasma membrane","Nuclear receptors meta-pathway; NRF2 pathway; Transcriptional activation by NRF2 in response to phytochemicals; mRNA, protein, and metabolite inducation pathway by cyclosporin A; Ferroptosis; NRF2-ARE regulation; p53 transcriptional gene network; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Amino acid metabolism in triple-negative breast cancer cells",12,0,116.1,100.5,112.3,107.5,63,104.1,93.1,94.9,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(100)]",0,"ENSG00000151012"
"1069","ZDHHC8",0.211723260035654,6.62832165304534,1.96183890084909,0.0794324805358434,0.121222223455485,-5.70740721623978,"NONE",FALSE,"High","Master Protein","Q9ULC8","Palmitoyltransferase ZDHHC8 [OS=Homo sapiens]",0,22.983,7,4,4,5,4,765,81.4,9.17,7.78,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi","other molecular function","Pf01529","29801","hsa:29801; Q2TGE9; Q6ICL1; Q6ZNF5; Q7Z6L9; Q9ULC8","ENSG00000099904","HDL assembly; Maturation of spike protein","22q11.2 copy number variation syndrome",3,0,92,86.4,100.3,99,107.1,129.8,95.5,91.8,99.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S526(100); S725(100); S743(99.1)]",0,"ENSG00000099904"
"1070","RHPN1",-0.204158036429074,6.58819818573054,-1.96149094508795,0.0794778058194661,0.121222223455485,-5.70794280076095,"NONE",FALSE,"High","Master Protein","Q8TCX5","Rhophilin-1 [OS=Homo sapiens]",0,3.106,5,2,2,2,1,670,73.5,7.53,5.24,2,"protein metabolism;signal transduction;other biological processes","cytosol",NA,"Pf00595, Pf02185, Pf03097","114822","hsa:114822; Q8TAV1; Q8TCX5; Q96PV9","ENSG00000158106","RHOA GTPase cycle; RHO GTPases Activate Rhotekin and Rhophilins","Ectoderm differentiation",3,0,105.9,139.9,120.8,112.2,108.8,103.2,76.1,76.5,69.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S102(97); T106(100)]",0,"ENSG00000158106"
"1071","UPF1",-0.226848939018087,6.61083594402733,-1.95955553497154,0.0797303608562592,0.12145561169544,-5.71092110810999,"NONE",FALSE,"High","Master Protein","Q92900","Regulator of nonsense transcripts 1 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1129,124.3,6.61,4.75,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09416, Pf13086, Pf13087, Pf18141","5976","hsa:5976; O00239; O43343; Q86Z25; Q92842; Q92900","ENSG00000005007","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Pathophysiological roles of DUX4 in FSHD1",3,0,130.1,104,102.3,90.6,96.9,103.5,81.5,101,90.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1107(100)]",0,"ENSG00000005007"
"1072","BCL2L13",0.337935904668883,6.64298884282701,1.9591783644122,0.0797796665058283,0.12145561169544,-5.71150137165529,"NONE",FALSE,"High","Master Protein","Q9BXK5","Bcl-2-like protein 13 [OS=Homo sapiens]",0,57.097,6,2,3,14,2,485,52.7,4.44,44.99,2,"other biological processes","other membranes;mitochondrion;nucleus","enzyme regulator activity","Pf00452","23786","B3KPE7; hsa:23786; Q96B37; Q96IB7; Q9BXK5; Q9BY01; Q9HC05; Q9UFE0; Q9UKN3","ENSG00000099968",NA,"Regulation of apoptosis by parathyroid hormone-related protein; TAR syndrome",2,0,70.3,75,88.1,109.6,116.7,82.3,144.1,117.8,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(99.5); S426(100)]",0,"ENSG00000099968"
"1073","RTN3",-0.197241779225908,6.63170251758236,-1.95628655935848,0.0801586539417111,0.121918847374532,-5.71594872913497,"NONE",FALSE,"High","Master Protein","O95197","Reticulon-3 [OS=Homo sapiens]",0,36.798,6,4,6,11,4,1032,112.5,4.96,41.5,4,"cell organization and biogenesis;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component",NA,"Pf02453","10313","B3KQS2; B7Z308; B7Z4M0; F5H774; hsa:10313; O95197; Q147U9; Q496K2; Q53GN3; Q59EP0; Q5UEP2; Q6T930; Q7RTM7; Q7RTM8; Q7RTN3","ENSG00000133318","Synaptic adhesion-like molecules","Alzheimer's disease and miRNA effects; Alzheimer's disease",3,0,83.2,89.1,100.2,87.7,72,77.7,112.9,126.4,151.1,"High","High","High","High","High","High","High","High","High","High",1,"Met-loss+Acetyl [N-Term]; Phospho [S30(99)]",0,"ENSG00000133318"
"1074","VCL",0.273632282081954,6.63283578739283,1.94605374874574,0.0815133848993822,0.123863914483977,-5.73166334016255,"NONE",FALSE,"High","Master Protein","P18206","Vinculin [OS=Homo sapiens]",0,22.574,3,2,2,3,2,1134,123.7,5.66,6.24,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf01044","7414","hsa:7414; P18206; Q16450; Q5SWX2; Q7Z3B8; Q8IXU7","ENSG00000035403","Platelet degranulation ; Neutrophil degranulation; Signaling by BRAF and RAF1 fusions; Signaling by ALK fusions and activated point mutants; Smooth Muscle Contraction; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants","Integrin-mediated cell adhesion; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; VEGFA-VEGFR2 signaling; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Melanoma; Regulation of actin cytoskeleton",18,0,98.5,85.8,79.2,108,83,131.5,98.3,110,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S290(100)]",0,"ENSG00000035403"
"1075","NELFB",-0.321014774982639,6.60039927968278,-1.94240087421421,0.0820021907531749,0.124490767729471,-5.73726449046008,"NONE",FALSE,"High","Master Protein","Q8WX92","Negative elongation factor B [OS=Homo sapiens]",0,30.401,4,1,1,6,1,580,65.7,6.13,15.33,1,"cell cycle OR cell proliferation;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf06209","25920","A0A0X1KG71; A2BFA3; hsa:25920; Q8WX92; Q96EW5; Q9H9R4; Q9ULN8; Q9Y3W0","ENSG00000188986","Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; NTRK3 as a dependence receptor","Initiation of transcription and translation elongation at the HIV-1 LTR; 4p16.3 copy number variation; 5q35 copy number variation",18,0,97.4,111.5,114.3,93.8,65.9,100.5,97.1,119.4,79.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S557(100)]",0,"ENSG00000188986"
"1076","HSF1",0.209750506632837,6.6352108764335,1.93775122524799,0.0826283677973634,0.125324810636893,-5.74438745314331,"NONE",FALSE,"High","Master Protein","Q00613","Heat shock factor protein 1 [OS=Homo sapiens]",0,12.943,4,1,1,1,1,529,57.2,5.19,3.47,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00447, Pf06546","3297","A8K4L0; A8MW26; hsa:3297; Q00613; Q53XT4","ENSG00000185122; ENSG00000284774","Regulation of HSF1-mediated heat shock response; Attenuation phase; Aggrephagy; HSF1 activation","10q11.21q11.23 copy number variation syndrome; HDAC6 interactions in the central nervous system",7,0,105.9,84.9,79.9,104.3,112.9,105.4,99.9,100.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(100)]",0,"ENSG00000185122"
"1077","FLYWCH1",-0.162809197580629,6.58309180712476,-1.93651589090292,0.0827954869342308,0.12546168493655,-5.74627865866003,"NONE",FALSE,"High","Master Protein","Q4VC44","FLYWCH-type zinc finger-containing protein 1 [OS=Homo sapiens]",0.01,1.539,2,1,1,1,1,716,80.1,8.34,2.21,1,"stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04500, Pf15423, Pf16662","84256","D3DUA1; hsa:84256; Q4VC44; Q6ZSQ1; Q8WV62; Q9BQG6; Q9BUS5; Q9HCM0","ENSG00000059122",NA,NA,0,0,117.1,100.9,99.7,98.8,82.2,104.1,86,91.8,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S696(99.4)]",0,"ENSG00000059122"
"1078","YY1AP1",-0.342046241449693,6.61287461282692,-1.932546268562,0.0833346605173798,0.126161563974363,-5.75235229779267,"NONE",FALSE,"High","Master Protein","Q9H869","YY1-associated protein 1 [OS=Homo sapiens]",0,9.997,2,1,1,2,1,796,87.9,7.84,5.55,1,"cell cycle OR cell proliferation;other biological processes","nucleus;other cell component","other molecular function",NA,"55249","B0QZ54; B4DMP2; B4E0I0; D3DV96; D3DV98; H7BY62; hsa:55249; Q5VYZ1; Q5VYZ4; Q5VYZ7; Q7L4C3; Q7L5E2; Q8IXA6; Q8TEW5; Q8TF04; Q96HB6; Q9BQ64; Q9H869; Q9NV84","ENSG00000163374",NA,"Envelope proteins and their potential roles in EDMD physiopathology",1,0,113.8,102.4,111.1,76.3,81.4,102.1,122.9,80.3,99.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S711(100)]",0,"ENSG00000163374"
"1079","BRD7",-0.394240779060663,6.51071377998088,-1.93124930939073,0.0835115336875796,0.126312162166941,-5.75433550373938,"NONE",FALSE,"High","Master Protein","Q9NPI1","Bromodomain-containing protein 7 [OS=Homo sapiens]",0,10.168,2,1,1,1,1,651,74.1,6.39,3.7,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00439, Pf12024","29117","hsa:29117; Q4VC09; Q8N2L9; Q96KA4; Q9BV48; Q9NPI1; Q9UH59","ENSG00000166164","Regulation of TP53 Activity through Acetylation",NA,1,0,124.8,113.8,116.8,81.1,59.4,133.3,69.5,82.8,77.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S279(100)]",0,"ENSG00000166164"
"1080","BRAF",-0.15763374355681,6.61361900996814,-1.93049621545483,0.083614398848423,0.126350647148728,-5.75548680725112,"NONE",FALSE,"High","Master Protein","P15056","Serine/threonine-protein kinase B-raf [OS=Homo sapiens]",0,32.905,7,3,4,4,3,766,84.4,7.53,16.66,3,"cell adhesion;cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component","kinase activity;other molecular function","Pf00130, Pf02196, Pf07714","673","A4D1T4; B6HY61; B6HY62; B6HY63; B6HY64; B6HY65; B6HY66; hsa:673; P15056; Q13878; Q3MIN6; Q9UDP8; Q9Y6T3","ENSG00000157764","Signaling by BRAF and RAF1 fusions; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; Spry regulation of FGF signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Signaling by high-kinase activity BRAF mutants; Frs2-mediated activation; ARMS-mediated activation; Signalling to p38 via RIT and RIN; Negative feedback regulation of MAPK pathway","Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Alzheimer's disease and miRNA effects; Pilocytic astrocytoma; Glioblastoma signaling pathways; B cell receptor signaling pathway; Corticotropin-releasing hormone signaling pathway; Polycystic kidney disease pathway; Bladder cancer; Focal adhesion; BDNF-TrkB signaling; MAPK signaling pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Endometrial cancer; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Rett syndrome; EGF/EGFR signaling pathway; Relationship between inflammation, COX-2 and EGFR; Fragile X syndrome; Hepatitis B infection; Melanoma; EGFR tyrosine kinase inhibitor resistance; Regucalcin in proximal tubule epithelial kidney cells; MAPK pathway in congenital thyroid cancer; TCA cycle in senescence; Regulation of actin cytoskeleton; Alzheimer's disease; GDNF signaling; Acute myeloid leukemia; ErbB signaling pathway; Estrogen signaling pathway; Serotonin HTR1 group and FOS pathway; Serotonin receptor 4/6/7 and NR3C signaling",56,0,107.6,105.5,104.3,95.9,84.2,109.7,93,89.6,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S365(99.5); T401(99.2); S729(100)]",0,"ENSG00000157764"
"1081","CYBRD1",0.539760989176658,6.55175367710822,1.91781482677725,0.0853645164313465,0.128875939700238,-5.77484398589173,"NONE",FALSE,"High","Master Protein","Q53TN4","Plasma membrane ascorbate-dependent reductase CYBRD1 [OS=Homo sapiens]",0,30.989,13,2,4,4,2,286,31.6,8.76,11.36,2,"transport;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle","transporter activity;other molecular function","Pf03188","79901","B2RE79; B4DWD7; hsa:79901; Q53TN4; Q6KC16; Q6KC17; Q6P147; Q6ZR51; Q9H0Q8; Q9H5G5","ENSG00000071967","Iron uptake and transport","Iron metabolism disorders",2,0,74.9,81.4,70.6,101.8,209.8,79.9,103.9,76.4,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S260(99.3); S284(99.7)]",0,"ENSG00000071967"
"1082","FRMD4A",-0.154518469665564,6.64765757162212,-1.91592747834468,0.085627902209187,0.129154100189827,-5.77772005916515,"NONE",FALSE,"High","Master Protein","Q9P2Q2","FERM domain-containing protein 4A [OS=Homo sapiens]",0,87.861,9,6,11,16,6,1039,115.4,8.87,50.56,6,"other biological processes","cytoskeleton;other cell component","other molecular function","Pf00373, Pf09379, Pf09380, Pf11819","55691","A7E2Y3; hsa:55691; Q5T377; Q9P2Q2","ENSG00000151474",NA,NA,0,0,101.8,94.3,102.5,88.2,97.1,92.6,110.1,103.2,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100); S365(98.6); S694(100); S711(100); S727(99.6); S800(100)]",0,"ENSG00000151474"
"1083","TBC1D9B",0.162889391041542,6.64059702521738,1.91398626017641,0.0858996003071242,0.12944427303899,-5.78067691088208,"NONE",FALSE,"High","Master Protein","Q66K14","TBC1 domain family member 9B [OS=Homo sapiens]",0,103.574,6,5,9,16,5,1250,140.4,5.25,54.97,5,NA,"other membranes","enzyme regulator activity;other molecular function","Pf00566, Pf02893","23061","D3DWQ5; D3DWQ6; hsa:23061; O75163; Q53EY0; Q66K14; Q6MZI2; Q96H49","ENSG00000197226; ENSG00000284400",NA,NA,0,0,88.4,87.3,96.9,102,109.4,107.6,95.1,103.2,113.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S411(100); S435(100); S442(100); S995(99.7); S1238(100)]",0,"ENSG00000197226"
"1084","ELF2",-0.379040135644705,6.44569584436535,-1.90522715073842,0.0871356242524136,0.131185736881863,-5.79400210138737,"NONE",FALSE,"High","Master Protein","Q15723-1","Isoform 1 of ETS-related transcription factor Elf-2 [OS=Homo sapiens]",0,7.915,5,1,2,5,1,581,62.7,6.7,2.7,1,NA,NA,NA,NA,NA,"Q15723-1",NA,NA,NA,0,0,121.2,137.9,112.3,86.6,129.2,83.7,55.4,66,76.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S400(95.8)]",0,"ENSG00000109381"
"1085","HDAC4",0.150107927268783,6.65478573006001,1.89440496146391,0.088685768387585,0.133396473740589,-5.81042790745408,"NONE",FALSE,"High","Master Protein","P56524","Histone deacetylase 4 [OS=Homo sapiens]",0,34.96,8,4,4,6,4,1084,119,6.96,18.47,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00850, Pf12203","9759","E9PGB9; F5GX36; hsa:9759; P56524; Q86YH7; Q9UND6","ENSG00000068024","SUMOylation of chromatin organization proteins; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; SUMOylation of intracellular receptors; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; RUNX3 regulates p14-ARF; RUNX2 regulates chondrocyte maturation","MicroRNAs in cardiomyocyte hypertrophy; Genes targeted by miRNAs in adipocytes; Neural crest differentiation; Cardiac hypertrophic response; Initiation of transcription and translation elongation at the HIV-1 LTR; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling; Ethanol effects on histone modifications; Endochondral ossification; Endochondral ossification with skeletal dysplasias; CAMKK2 pathway; 2q37 copy number variation syndrome",20,0,87.3,103.5,95.4,108,111.3,111.3,97.4,96.2,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100); T355; S565(100); S632(99.5)]",0,"ENSG00000068024"
"1086","GRIA1",0.266521594642152,6.59939481045088,1.8912756920549,0.0891387806375711,0.133954410681875,-5.81516959137024,"NONE",FALSE,"High","Master Protein","P42261","Glutamate receptor 1 [OS=Homo sapiens]",0,20.128,2,1,1,4,1,906,101.4,7.71,12.01,1,"cell-cell signaling;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;cytoskeletal activity;other molecular function","Pf00060, Pf00497, Pf01094, Pf10613","2890","B7Z2S0; B7Z2W8; B7Z3F6; B7Z9G9; D3DQI4; E7ESV8; hsa:2890; P42261; Q2NKM6","ENSG00000155511","COPII-mediated vesicle transport; Cargo concentration in the ER; Unblocking of NMDA receptors, glutamate binding and activation; Synaptic adhesion-like molecules; Long-term potentiation; Trafficking of GluR2-containing AMPA receptors; Activation of AMPA receptors","Brain-derived neurotrophic factor (BDNF) signaling pathway; Amyotrophic lateral sclerosis (ALS); Common pathways underlying drug addiction; MECP2 and associated Rett syndrome; Phosphodiesterases in neuronal function; Fragile X syndrome; PKC-gamma calcium signaling pathway in ataxia; 3q29 copy number variation syndrome; Neuroinflammation and glutamatergic signaling; Orexin receptor pathway; NRXN1 deletion syndrome; HDAC6 interactions in the central nervous system",20,0,80.8,62.2,76.4,80.7,75.5,111.9,118.6,148,144.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S849(100)]",0,"ENSG00000155511"
"1087","VPS52",0.347732883458323,6.60740202216617,1.88600897751867,0.0899061072848753,0.134983226392747,-5.82314202640297,"NONE",FALSE,"High","Master Protein","Q8N1B4","Vacuolar protein sorting-associated protein 52 homolog [OS=Homo sapiens]",0,14.37,3,1,1,1,1,723,82.2,5.99,4.28,1,"transport;developmental processes;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf04129, Pf20655","6293","A2BF38; B0UZZ4; B4DNI9; hsa:6293; Q53GR4; Q5JPA0; Q5SQW1; Q8IUN6; Q8N1B4; Q9NPT5","ENSG00000206286; ENSG00000223501; ENSG00000224455; ENSG00000225590; ENSG00000228425; ENSG00000236014","Retrograde transport at the Trans-Golgi-Network",NA,1,0,86.3,87.7,73.1,88.5,120.9,123.4,83,125,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S355(100)]",0,"ENSG00000223501"
"1088","MYO9B",0.18881127518944,6.64234577956751,1.88289922350655,0.0903620702045374,0.135543105306806,-5.82784461888602,"NONE",FALSE,"High","Master Protein","Q13459","Unconventional myosin-IXb [OS=Homo sapiens]",0,101.376,4,7,8,12,7,2157,243.2,8.75,48.33,7,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00063, Pf00612, Pf00620, Pf00788","4650","hsa:4650; O75314; Q13459; Q9NUJ2; Q9UHN0","ENSG00000099331","RHOA GTPase cycle; RAC1 GTPase cycle; Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RHOB GTPase cycle; RHOC GTPase cycle; CDC42 GTPase cycle; RHOF GTPase cycle; SLIT2:ROBO1 increases RHOA activity","Vitamin D receptor pathway",10,0,84.3,79.9,86.5,101.5,106.9,91.4,106,118.5,134.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1281(100); S1290(100); S1331(100); T1346(100); S1992(100)]",0,"ENSG00000099331"
"1089","FAM117B",0.182106093625655,6.6877506034879,1.87984922917514,0.0908113666437478,0.136091965438564,-5.83245338929979,"NONE",FALSE,"High","Master Protein","Q6P1L5","Protein FAM117B [OS=Homo sapiens]",0,23.675,5,2,2,5,2,589,61.9,9.82,12.71,2,NA,NA,NA,"Pf15388","150864","hsa:150864; Q53QZ5; Q585T9; Q6P1L5; Q8N8W1; Q96Q34","ENSG00000138439",NA,NA,0,0,83.9,92,100.4,99.1,105.3,123.4,102.1,111.7,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(99.2); S273(100)]",0,"ENSG00000138439"
"1090","SBF2",-0.256719647646441,6.63426594145317,-1.86986004573056,0.0922975082360826,0.138192232514942,-5.84752369976036,"NONE",FALSE,"High","Master Protein","Q86WG5","Myotubularin-related protein 13 [OS=Homo sapiens]",0,26.344,2,2,2,2,2,1849,208.3,7.06,8.25,2,"other metabolic processes;developmental processes","other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf02141, Pf02893, Pf03456, Pf06602, Pf12335","81846","hsa:81846; Q3MJF0; Q68DQ3; Q6P459; Q6PJD1; Q7Z325; Q7Z621; Q86VE2; Q86WG5; Q96FE2; Q9C097","ENSG00000133812","RAB GEFs exchange GTP for GDP on RABs; Synthesis of PIPs at the plasma membrane","Intracellular trafficking proteins involved in CMT neuropathy",3,0,95.4,99.8,110.3,92.2,62.3,105.7,113,96.6,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1214(100); S1687(100)]",0,"ENSG00000133812"
"1091","TMCC1",-0.33893782763626,6.64811652663052,-1.86919302836015,0.0923975467619369,0.138215212021522,-5.84852868197116,"NONE",FALSE,"High","Master Protein","O94876","Transmembrane and coiled-coil domains protein 1 [OS=Homo sapiens]",0,26.248,6,3,3,6,3,653,72,6.55,19.74,3,"cell organization and biogenesis;transport","other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf10267","23023","A8K5Y3; B4DE04; hsa:23023; O94876; Q68E06; Q8IXM8","ENSG00000172765",NA,NA,0,0,101.8,112.6,101.2,95.8,54.8,101.2,125.5,118.9,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S382(100); S414(99.4)]",0,"ENSG00000172765"
"1092","SP4",-0.286895367271541,6.59701492409552,-1.86781947245674,0.0926038693943266,0.13839699162229,-5.85059766829661,"NONE",FALSE,"High","Master Protein","Q02446","Transcription factor Sp4 [OS=Homo sapiens]",0,51.795,9,3,5,16,3,784,81.9,7.05,14.57,3,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","6671","hsa:6671; O60402; Q02446; Q32M52","ENSG00000105866",NA,NA,0,0,122.7,149.4,96,98.2,112,94.6,88.5,78.9,75.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S46(100); S757(100)]",0,"ENSG00000105866"
"1093","EI24",-0.1481996881376,6.65106830651419,-1.85464431939403,0.0946048205342047,0.141258066890963,-5.87040734831221,"NONE",FALSE,"High","Master Protein","O14681","Etoposide-induced protein 2.4 homolog [OS=Homo sapiens]",0,23.861,8,2,3,4,2,340,38.9,9.72,12.73,2,"other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus","other molecular function","Pf07264","9538","A8K7D6; B4DKL6; hsa:9538; O14681; Q9BUQ1","ENSG00000149547",NA,"miRNA regulation of p53 pathway in prostate cancer",1,0,90.2,97.1,94.8,87.1,79.3,92,125.4,119.4,112.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S326(100); S330(100)]",0,"ENSG00000149547"
"1094","NLGN2",0.248930806342265,6.64329392792656,1.85095465551255,0.0951723463441915,0.141975566027167,-5.87594320663531,"NONE",FALSE,"High","Master Protein","Q8NFZ4","Neuroligin-2 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,835,90.8,6.18,9.55,1,"cell adhesion;cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00135","57555","hsa:57555; Q8NFZ4; Q9P2I1","ENSG00000169992; ENSG00000283859","Neurexins and neuroligins","Disruption of postsynaptic signaling by CNV; NRXN1 deletion syndrome",3,0,89.6,89.4,79.5,126.4,86.3,99.3,107.1,101.6,118.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S718(100)]",0,"ENSG00000169992"
"1095","HMG20A",-0.194230963787533,6.63944058797689,-1.84690288386159,0.0957992132512113,0.142780197283997,-5.8820163701746,"NONE",FALSE,"High","Master Protein","Q9NP66","High mobility group protein 20A [OS=Homo sapiens]",0,5.827,4,1,1,2,1,347,40.1,6.49,5.36,1,"cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00505","10363","A6NHY3; D3DW78; hsa:10363; Q53G31; Q9NP66; Q9NSF6","ENSG00000140382",NA,NA,0,0,96.6,112.3,106.2,94.8,106.6,85.4,104.4,94.6,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100)]",0,"ENSG00000140382"
"1096","MICALL1",0.182720021022065,6.62040673213133,1.83839865007624,0.0971274269939275,0.144627701509206,-5.89474276617441,"NONE",FALSE,"High","Master Protein","Q8N3F8","MICAL-like protein 1 [OS=Homo sapiens]",0,9.351,2,1,1,1,1,863,93.4,7.25,3.4,1,"cell organization and biogenesis;transport;developmental processes;other biological processes","other membranes;other cytoplasmic organelle","other molecular function","Pf00307, Pf00412, Pf12130","85377","hsa:85377; Q5TI16; Q7RTP5; Q8N3F8; Q8N3N8; Q9BVL9; Q9BY92; Q9UH43; Q9UH44; Q9UH45","ENSG00000100139",NA,NA,0,0,101,103.6,93.8,115.2,112.2,121.8,77.2,96.6,84.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S578(100)]",0,"ENSG00000100139"
"1097","FCHO2",0.148515611613159,6.65863773835172,1.8364245102303,0.0974381871164815,0.144958178098539,-5.89769302403529,"NONE",FALSE,"High","Master Protein","Q0JRZ9","F-BAR domain only protein 2 [OS=Homo sapiens]",0,82.478,6,3,5,9,3,810,88.9,6.86,33.61,3,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf00611, Pf10291","115548","A8K6W7; B2RNQ9; B4DHK0; E9PG79; hsa:115548; Q0JRZ9; Q0JTJ3; Q96CF5","ENSG00000157107","Cargo recognition for clathrin-mediated endocytosis",NA,2,0,96.4,100.2,101.4,116.7,106.2,118.8,95,97.6,86.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100); S403(100); S488(100); S496(100)]",0,"ENSG00000157107"
"1098","TSC22D4",-0.16155913363405,6.62981241498385,-1.83561586894502,0.0975657457413024,0.145015753232974,-5.89890106300372,"NONE",FALSE,"High","Master Protein","Q9Y3Q8","TSC22 domain family protein 4 [OS=Homo sapiens]",0,38.16,11,3,3,6,3,395,41,7.21,23.6,3,"cell organization and biogenesis;stress response;developmental processes;other biological processes","nucleus;other cell component",NA,"Pf01166","81628","A4D2C3; A8MWR6; D6W5V9; hsa:81628; Q9Y3Q8","ENSG00000166925",NA,NA,0,0,105.7,107.8,105.9,98.9,105,92.3,97.5,89,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S190(99.2); T229(100)]",0,"ENSG00000166925"
"1099","USP5",0.356528684109437,6.67513302235544,1.8315000201518,0.098217400416505,0.145851499071644,-5.90504583362752,"NONE",FALSE,"High","Master Protein","P45974","Ubiquitin carboxyl-terminal hydrolase 5 [OS=Homo sapiens]",0,29.464,3,1,1,5,1,858,95.7,5.03,21.01,1,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cytoplasmic organelle","other molecular function","Pf00443, Pf00627, Pf02148, Pf17807","8078","D3DUS7; D3DUS8; hsa:8078; P45974; Q96J22","ENSG00000111667","Synthesis of active ubiquitin: roles of E1 and E2 enzymes; Ub-specific processing proteases","IL-18 signaling pathway",3,0,71.6,89.8,90.8,115.4,72.5,138.3,97.3,132.1,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T623(100)]",0,"ENSG00000111667"
"1100","ARHGAP39",-0.146192167348214,6.59478708050836,-1.82981091070118,0.0984859994549214,0.146117410100392,-5.90756568177224,"NONE",FALSE,"High","Master Protein","Q9C0H5","Rho GTPase-activating protein 39 [OS=Homo sapiens]",0,27.459,3,2,2,2,2,1083,121.2,7.5,8.04,2,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity","Pf00620, Pf00784","80728","B4E1I1; hsa:80728; Q9C0H5","ENSG00000147799","RHOA GTPase cycle; CDC42 GTPase cycle; RHOC GTPase cycle; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOF GTPase cycle; Inactivation of CDC42 and RAC1",NA,11,0,119.8,103.3,108.8,101.2,91.6,111.7,81.3,87.4,86.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S286(99.7); S604(100)]",0,"ENSG00000147799"
"1101","NRCAM",0.2990176543831,6.60354183243623,1.8060634050024,0.102334961666298,0.151689970426338,-5.94287345228279,"NONE",FALSE,"High","Master Protein","Q92823","Neuronal cell adhesion molecule [OS=Homo sapiens]",0,6.558,2,1,1,2,1,1304,143.8,5.66,2.41,1,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","cytoskeletal activity;other molecular function","Pf00041, Pf07679, Pf13882, Pf13927","4897","A4D0S3; E9PDA4; hsa:4897; O15051; O15179; Q14BM2; Q92823; Q9UHI3; Q9UHI4","ENSG00000091129","Neurofascin interactions; Interaction between L1 and Ankyrins; NrCAM interactions",NA,3,0,82.1,73.3,116.7,101,128.7,120,95.4,100.8,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1295(99.1)]",0,"ENSG00000091129"
"1102","POP5",0.161352722841605,6.6318184579606,1.7920375829016,0.104673025766922,0.155014862115804,-5.9636208491646,"NONE",FALSE,"High","Master Protein","Q969H6","Ribonuclease P/MRP protein subunit POP5 [OS=Homo sapiens]",0,30.986,12,1,2,6,1,163,18.8,7.27,15.28,1,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01900","51367","A6NL80; hsa:51367; Q53FS5; Q969H6; Q9Y2Q6","ENSG00000167272","tRNA processing in the nucleus",NA,1,0,82.5,96,89.9,105.1,89.6,114.1,109,103.5,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(100)]",0,"ENSG00000167272"
"1103","GPBP1",-0.205691843085958,6.64469400289312,-1.78894124082367,0.105195767190816,0.155647771582422,-5.96819025523486,"NONE",FALSE,"High","Master Protein","Q86WP2","Vasculin [OS=Homo sapiens]",0,13.193,4,1,1,2,1,473,53.3,7.05,8.24,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15337","65056","A6NKW3; hsa:65056; Q6NSH6; Q86WP2; Q9H0D4; Q9H785; Q9NSN4","ENSG00000062194",NA,NA,0,0,105.2,97.2,103.8,83.2,96.5,95,110,93.7,120.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S381(99.3)]",0,"ENSG00000062194"
"1104","YBX1",0.141229572113364,6.64330111823681,1.78419072266014,0.106002450179156,0.156699274177883,-5.97519314995975,"NONE",FALSE,"High","Master Protein","P67809","Y-box-binding protein 1 [OS=Homo sapiens]",0,44.283,16,3,5,9,3,324,35.9,9.88,20.67,3,"RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00313","4904","hsa:4904; P16990; P16991; P67809; Q14972; Q15325; Q5FVF0","ENSG00000065978","mRNA Splicing - Major Pathway; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; Interferon gamma signaling; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Noncanonical activation of NOTCH3","Brain-derived neurotrophic factor (BDNF) signaling pathway; MECP2 and associated Rett syndrome; mRNA processing; Sudden infant death syndrome (SIDS) susceptibility pathways",10,0,88.3,91.8,99.9,100.3,116.7,108.2,102.1,98.3,102,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S174(100); S314(99.2)]",0,"ENSG00000065978"
"1105","MARK3",-0.171658335222399,6.604263074833,-1.78286460094563,0.106228652445006,0.156891548226471,-5.97714636990063,"NONE",FALSE,"High","Master Protein","P27448","MAP/microtubule affinity-regulating kinase 3 [OS=Homo sapiens]",0,61.142,8,4,5,9,3,753,84.4,9.57,22.88,4,"protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00627, Pf02149","4140","A0A0A0MQR8; A0A0A0MST9; A0A0A0MT23; hsa:4140; O60219; P27448; Q86TT8; Q8TB41; Q8WX83; Q96RG1; Q9UMY9; Q9UN34","ENSG00000075413","Signaling by BRAF and RAF1 fusions; RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants","Complement system in neuronal development and plasticity",10,1,106.6,104.4,103.4,91.2,80.1,113.4,88,99.5,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T211(100); S469(100); T507(100)]",0,"ENSG00000075413"
"1106","ZCCHC8",0.220818370857829,6.65392608272012,1.77919004726262,0.106857758571696,0.157677994565107,-5.98255475329863,"NONE",FALSE,"High","Master Protein","Q6NZY4","Zinc finger CCHC domain-containing protein 8 [OS=Homo sapiens]",0,10.754,2,1,1,1,1,707,78.5,4.87,3.28,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf00098, Pf04046","55596","hsa:55596; Q6NZY4; Q7L2P6; Q8N2K5; Q96SK7; Q9NSS2; Q9NSS3","ENSG00000033030",NA,NA,0,0,94,92.2,88.2,110.2,90.9,125.7,104.2,111.5,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T479(100)]",0,"ENSG00000033030"
"1107","LRRC4B",0.250966443145812,6.65124145607878,1.77240239366498,0.108028861482792,0.159262061373005,-5.99253040214067,"NONE",FALSE,"High","Master Protein","Q9NT99","Leucine-rich repeat-containing protein 4B [OS=Homo sapiens]",0,18.766,4,2,2,7,2,713,76.4,7.23,16.01,2,"cell adhesion;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding","Pf07679, Pf13855","94030","Q3ZCQ4; Q58F20; Q9NT99","ENSG00000131409","Receptor-type tyrosine-protein phosphatases",NA,1,0,98.3,100.2,82.8,119.1,134.5,98.8,103.6,100.6,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S693(100); S704(100)]",0,"ENSG00000131409"
"1108","TOM1L1",0.139372320418841,6.66298619599128,1.76222638304811,0.109806666248006,0.161736894690204,-6.0074497210355,"NONE",FALSE,"High","Master Protein","O75674","TOM1-like protein 1 [OS=Homo sapiens]",0,23.297,5,1,2,4,1,476,53,5.24,20.48,1,"protein metabolism;other metabolic processes;transport;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00790, Pf03127","10040","B7Z9E2; hsa:10040; O75674; Q53G06; Q8N749","ENSG00000141198",NA,NA,0,0,91.2,91.7,95.6,110.7,102.8,104,107.6,109.4,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S323(100)]",0,"ENSG00000141198"
"1109","RBM25",0.261877961658346,6.6345901740122,1.76068829120053,0.110077702287338,0.161989909948544,-6.0097009627794,"NONE",FALSE,"High","Master Protein","P49756","RNA-binding protein 25 [OS=Homo sapiens]",0,48.323,4,3,3,7,3,843,100.1,6.32,24.65,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf01480","58517","A0PJL9; B2RNA8; B3KT03; hsa:58517; P49756; Q2TA72; Q5XJ17; Q6P665; Q9H6A1; Q9UEQ5; Q9UIE9","ENSG00000119707","mRNA Splicing - Major Pathway",NA,1,0,88.5,89.7,95.4,121.6,133.9,92.9,109.9,89.1,90.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S583(100); S677(100)]",0,"ENSG00000119707"
"1110","CCDC177",0.157942579017868,6.56685281141405,1.73369471367594,0.114935214972843,0.168985829581693,-6.049045778747,"NONE",FALSE,"High","Master Protein","Q9NQR7","Coiled-coil domain-containing protein 177 [OS=Homo sapiens]",0,2.764,2,2,3,3,2,707,79.7,10.74,4.2,2,NA,NA,NA,"Pf15558","56936","B2R5G1; hsa:56936; Q2M359; Q9NQR7","ENSG00000267909",NA,NA,0,0,99.3,105,98.4,109.3,136.3,112.6,82.6,73.4,76.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S209(100)]",0,"ENSG00000267909"
"1111","HMGN1",0.48106132423643,6.56316143625539,1.73302967789334,0.115057323978062,0.169013098768854,-6.05001113708143,"NONE",FALSE,"High","Master Protein","P05114","Non-histone chromosomal protein HMG-14 [OS=Homo sapiens]",0,36.638,18,3,4,5,3,100,10.7,9.6,16.19,3,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01101","3150","hsa:3150; P05114; Q3KQR8","ENSG00000205581","Formation of TC-NER Pre-Incision Complex; Dual incision in TC-NER; Gap-filling DNA repair synthesis and ligation in TC-NER","ATM signaling in development and disease ; p38 MAPK signaling pathway; Pleural mesothelioma; Nucleotide excision repair in xeroderma pigmentosum",8,0,66.8,91.3,78,105.3,207.2,74.8,115.1,87.3,92.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(100); S99(100)]",0,"ENSG00000205581"
"1112","STK11IP",-0.271518016601798,6.53895646542381,-1.73034277749312,0.115551879462844,0.169586931010217,-6.05390944431423,"NONE",FALSE,"High","Master Protein","Q8N1F8","Serine/threonine-protein kinase 11-interacting protein [OS=Homo sapiens]",0,27.312,3,4,4,9,4,1088,120.2,5.36,18.55,4,"other biological processes","non-structural extracellular;other cytoplasmic organelle;other cell component","other molecular function","Pf15904","114790","C9JQV3; hsa:114790; Q8N1F8; Q8NAW9; Q8WXE4; Q96CN3; Q96PY9","ENSG00000144589","Neutrophil degranulation",NA,1,0,112.6,114.3,114.5,88.4,122.8,86.4,68.7,77.6,93.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100); S482(100); S761(100)]",0,"ENSG00000144589"
"1113","GGT7",0.224976268306945,6.65092552082942,1.7228647510463,0.116938523111278,0.17146780747314,-6.06474232484363,"NONE",FALSE,"High","Master Protein","Q9UJ14","Glutathione hydrolase 7 [OS=Homo sapiens]",0,12.065,3,1,1,2,1,662,70.4,5.1,5.24,1,"other metabolic processes;other biological processes","plasma membrane;other membranes","other molecular function","Pf01019","2686","hsa:2686; Q8N899; Q8NF66; Q9BYP5; Q9BYP6; Q9UJ14","ENSG00000131067","Glutathione synthesis and recycling; Aflatoxin activation and detoxification; Paracetamol ADME",NA,3,0,101.4,71,83.5,101.7,86.8,114.5,107.5,114.7,129.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S72(99.5)]",0,"ENSG00000131067"
"1114","NAA10",-0.13913859227586,6.61611889894465,-1.71026483305996,0.119309243240644,0.174786970348951,-6.08293900800392,"NONE",FALSE,"High","Master Protein","P41227","N-alpha-acetyltransferase 10 [OS=Homo sapiens]",0,12.517,5,1,1,1,1,235,26.4,5.64,4.05,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00583","8260","A6NM98; hsa:8260; P41227","ENSG00000102030",NA,NA,0,0,105.5,104.1,100.3,95.9,94.9,98.3,88.8,104.9,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S205(100)]",0,"ENSG00000102030"
"1115","SPARCL1",0.28251932787327,6.64215132734093,1.70891184475851,0.119566395576737,0.175006598727565,-6.08488877640357,"NONE",FALSE,"High","Master Protein","Q14515","SPARC-like protein 1 [OS=Homo sapiens]",0,9.335,3,2,2,2,2,664,75.2,4.81,5.76,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","extracellular matrix;ER/Golgi;other cell component","other molecular function","Pf07648, Pf09289, Pf10591","8404","B4E2Z0; E7ESU2; hsa:8404; Q14515; Q14800","ENSG00000152583","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,73.4,88,80.2,106.1,92.9,102.4,134,134.5,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S84(100); S92(100)]",0,"ENSG00000152583"
"1116","UNK",0.146039240400956,6.61634795154081,1.70428999931589,0.12044863967967,0.176139946198227,-6.0915430479071,"NONE",FALSE,"High","Master Protein","Q9C0B0","RING finger protein unkempt homolog [OS=Homo sapiens]",0,28.937,2,1,1,2,1,810,88,6.86,9.84,1,"developmental processes;other biological processes","other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00642, Pf18384","85451","hsa:85451; Q9C0B0","ENSG00000132478",NA,NA,0,0,86.1,90.4,98.1,104.3,112.6,101.2,102,102.3,92.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S385(100)]",0,"ENSG00000132478"
"1117","GORASP2",0.125444359676456,6.6637727229062,1.70291375448687,0.120712485576002,0.176316746677238,-6.09352263174646,"NONE",FALSE,"High","Master Protein","Q9H8Y8","Golgi reassembly-stacking protein 2 [OS=Homo sapiens]",0,59.312,13,3,5,6,3,452,47.1,4.82,27.47,3,"cell organization and biogenesis;stress response;other biological processes","other membranes;ER/Golgi",NA,"Pf04495","26003","B4DKT0; hsa:26003; Q53TE3; Q96I74; Q96K84; Q9H8Y8; Q9H946; Q9UFW4","ENSG00000115806","Golgi Cisternae Pericentriolar Stack Reorganization",NA,1,0,79.9,89.4,90.8,101.5,95,96.4,118.5,122.4,117.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T222(100); T415(100); T433(99)]",0,"ENSG00000115806"
"1118","STAT3",0.213154027609867,6.64608512315725,1.702532791026,0.120785614451686,0.176316746677238,-6.0940704569075,"NONE",FALSE,"High","Master Protein","P40763","Signal transducer and activator of transcription 3 [OS=Homo sapiens]",0,29.718,3,1,2,10,1,770,88,6.3,27.69,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00017, Pf01017, Pf02864, Pf02865, Pf21354","6774","A8K7B8; hsa:6774; K7ENL3; O14916; P40763; Q9BW54","ENSG00000168610","Signaling by ALK fusions and activated point mutants; Senescence-Associated Secretory Phenotype (SASP); Interleukin-4 and Interleukin-13 signaling; Transcriptional regulation of granulopoiesis; PKR-mediated signaling; Interleukin-7 signaling; Signaling by SCF-KIT; Downstream signal transduction; Signaling by ALK; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; Cytoprotection by HMOX1; Association of TriC/CCT with target proteins during biosynthesis; Interleukin-10 signaling; Growth hormone receptor signaling; Interleukin-6 signaling; Signaling by Leptin; PTK6 Activates STAT3; Signaling by CSF3 (G-CSF); Inactivation of CSF3 (G-CSF) signaling; Signaling by cytosolic FGFR1 fusion mutants; Signaling by CSF1 (M-CSF) in myeloid cells; STAT3 nuclear events downstream of ALK signaling; BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members; POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation; Interleukin-20 family signaling; Interleukin-35 Signalling; Interleukin-23 signaling; Interleukin-27 signaling; Interleukin-37 signaling; Signalling to STAT3; Nuclear events stimulated by ALK signaling in cancer; MET activates STAT3; Interleukin-15 signaling; Interleukin-9 signaling; Interleukin-21 signaling","IL-5 signaling pathway; Androgen receptor signaling pathway; Physiological and pathological hypertrophy of the heart; MicroRNAs in cardiomyocyte hypertrophy; Transcription factors regulate miRNAs related to cardiac hypertrophy; Cell differentiation - expanded index; Cell differentiation - index; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; Microtubule cytoskeleton regulation; IL-7 signaling pathway; IL-17 signaling pathway; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Androgen receptor network in prostate cancer; AGE/RAGE pathway; Interleukin-11 signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Mammary gland development pathway - Involution (Stage 4 of 4); Dopaminergic neurogenesis; IL-3 signaling pathway; TCA cycle nutrient use and invasiveness of ovarian cancer; Estrogen receptor pathway; Nuclear receptors meta-pathway; Kit receptor signaling pathway; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; VEGFA-VEGFR2 signaling; Development of pulmonary dendritic cells and macrophage subsets; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Leptin-insulin signaling overlap; IL-4 signaling pathway; PDGFR-beta pathway; Prion disease pathway; Clear cell renal cell carcinoma pathways; MET in type 1 papillary renal cell carcinoma; Non-small cell lung cancer; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Extracellular vesicles in the crosstalk of cardiac cells; ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; EGF/EGFR signaling pathway; IL-10 anti-inflammatory signaling pathway ; Regulatory circuits of the STAT3 signaling pathway; Interactions between immune cells and microRNAs in tumor microenvironment; Neural crest cell migration during development; Neural crest cell migration in cancer; Cancer immunotherapy by PD-1 blockade; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; EGFR tyrosine kinase inhibitor resistance; TGF-beta receptor signaling in skeletal dysplasias; mBDNF and proBDNF regulation of GABA neurotransmission; IL-2 signaling pathway; Neuroinflammation and glutamatergic signaling; CCL18 signaling pathway; Th17 cell differentiation pathway; Urotensin-II-mediated signaling pathway; Inflammatory bowel disease signaling; 2q11.2 copy number variation syndrome; 2q21.1 copy number variation syndrome; Neurogenesis regulation in the olfactory epithelium; Acute myeloid leukemia; Autophagy in pancreatic ductal adenocarcinoma; IL-26 signaling pathways; JAK-STAT signaling in the regulation of beta cells; TAR syndrome; Osteoarthritic chondrocyte hypertrophy; IL-19 signaling pathway; TGF-beta receptor signaling; EPO receptor signaling; Interferon type I signaling pathways; Notch signaling pathway; Serotonin HTR1 group and FOS pathway",119,0,93,71.2,100.3,99.6,101,115.5,101.3,116.1,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(100)]",0,"ENSG00000168610"
"1119","AP3B1",-0.315815869402286,6.60835131292259,-1.69941375454232,0.121385852190836,0.177034594079933,-6.09855316523171,"NONE",FALSE,"High","Master Protein","O00203","AP-3 complex subunit beta-1 [OS=Homo sapiens]",0,9.333,2,2,2,2,2,1094,121.2,6.04,3.4,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf01602, Pf14796, Pf14797","8546","E5RJ68; hsa:8546; O00203; O00580; Q7Z393; Q9HD66","ENSG00000132842","Golgi Associated Vesicle Biogenesis; Signaling by BRAF and RAF1 fusions",NA,2,0,109.7,109.1,108.8,107.9,56,101.3,95.1,115.9,82.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S276(100); S750(100)]",0,"ENSG00000132842"
"1120","PEX14",-0.187103183689298,6.64448968387657,-1.69578210315953,0.122088149848182,0.177899875493065,-6.10376706157656,"NONE",FALSE,"High","Master Protein","O75381","Peroxisomal membrane protein PEX14 [OS=Homo sapiens]",0,5.096,3,1,1,2,1,377,41.2,4.94,4.66,1,"cell organization and biogenesis;stress response;transport;other biological processes","other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;transporter activity;cytoskeletal activity;other molecular function","Pf04695","5195","B2R7N1; B3KML6; B7Z1N2; hsa:5195; O75381; Q8WX51","ENSG00000142655","E3 ubiquitin ligases ubiquitinate target proteins; Peroxisomal protein import; Class I peroxisomal membrane protein import",NA,3,0,90.7,93.6,103.1,87.6,80.5,88.6,131.4,104.8,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S232(100)]",0,"ENSG00000142655"
"1121","SH2B1",-0.147400288533452,6.59910162316844,-1.6849432573516,0.124206156227777,0.180824662768718,-6.11929248953224,"NONE",FALSE,"High","Master Protein","Q9NRF2","SH2B adapter protein 1 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,756,79.3,5.38,5.63,1,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus","signal transduction activity or receptor binding","Pf00017, Pf00169, Pf08916","25970","A8K2R7; hsa:25970; Q96FK3; Q96SX3; Q9NRF1; Q9NRF2; Q9NRF3; Q9P2P7; Q9Y3Y3","ENSG00000178188","Factors involved in megakaryocyte development and platelet production","Leptin signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; 16p11.2 distal deletion syndrome",4,0,101.5,107.8,96.4,87.9,86.7,107,92.5,100.5,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S125(99.6)]",0,"ENSG00000178188"
"1122","SLC26A6",-0.223790019005936,6.57421990596466,-1.68218441824584,0.124750544943058,0.181294261270636,-6.12323562406254,"NONE",FALSE,"High","Master Protein","Q9BXS9","Solute carrier family 26 member 6 [OS=Homo sapiens]",0,9.816,2,1,1,1,1,759,82.9,8.37,3,1,"stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","transporter activity;other molecular function","Pf00916, Pf01740","65010","B4DMZ1; hsa:65010; Q548A7; Q96Q90; Q9BXS9; Q9NQU1","ENSG00000225697","Multifunctional anion exchangers","Thyroxine (thyroid hormone) production; Proximal tubule transport",3,0,109.5,121.9,109,101,84.3,109.1,97.2,78.8,70.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S616(99.1)]",0,"ENSG00000225697"
"1123","ERBB4",-0.226386168469119,6.61406370914072,-1.6821826639628,0.124750891793458,0.181294261270636,-6.12323813029759,"NONE",FALSE,"High","Master Protein","Q15303","Receptor tyrosine-protein kinase erbB-4 [OS=Homo sapiens]",0,30.055,2,1,1,3,1,1308,146.7,6.39,13.54,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;mitochondrion;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;kinase activity;other molecular function","Pf00757, Pf01030, Pf07714, Pf14843, Pf21314","2066","B7ZLD7; B7ZLE2; B7ZLE3; hsa:2066; Q15303; Q2M1W1; Q59EW4","ENSG00000178568",NA,"Mammary gland development pathway - Embryonic development (Stage 1 of 4); Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); EV release from cardiac cells and their functional effects; Physico-chemical features and toxicity-associated pathways; Melanoma; Neurogenesis regulation in the olfactory epithelium; 10q22q23 copy number variation; ErbB signaling pathway",8,0,105.3,92.2,105.5,90.5,82.2,89.6,121.9,88.9,106.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T699(100)]",0,"ENSG00000178568"
"1124","MIA2",0.173863090728132,6.63105359861008,1.67731371205464,0.125716931889722,0.182535616409276,-6.13018862673921,"NONE",FALSE,"High","Master Protein","Q96PC5","Melanoma inhibitory activity protein 2 [OS=Homo sapiens]",0,36.19,3,3,4,9,3,1412,159.7,4.69,19.88,3,"transport;other biological processes","other membranes;ER/Golgi","enzyme regulator activity;other molecular function","Pf07653","4253","A0A193H6U5; A1L4H0; B3KRA6; B4DQS6; D3DSA6; G3XAC5; hsa:4253; O00169; O15320; Q6MZN2; Q6P2R8; Q86TF6; Q8IX92; Q8IX93; Q96PC5; Q9H6C1","ENSG00000150527","Cargo concentration in the ER",NA,1,0,82.3,84.9,94.3,99.2,101.5,106.5,98.5,102.8,129.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S747(99.7); S1144(100)]",0,"ENSG00000150527"
"1125","SNX2",0.376621379873034,6.63595486655665,1.6756180538106,0.126054949500516,0.182863713408748,-6.13260662799502,"NONE",FALSE,"High","Master Protein","O60749","Sorting nexin-2 [OS=Homo sapiens]",0,13.322,5,1,1,2,1,519,58.4,5.12,7.3,1,"cell organization and biogenesis;transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00787, Pf03700, Pf09325","6643","B3KN44; B4DEK4; B7Z408; hsa:6643; O43650; O60749; P82862; Q53XK8; Q597H6; Q9BTS8","ENSG00000205302","Golgi Associated Vesicle Biogenesis",NA,1,0,97.8,105,64.7,119.6,77.4,141.1,89.9,106.7,102.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T104(100)]",0,"ENSG00000205302"
"1126","FBXL2",0.158653828379696,6.66788243240089,1.67411907655035,0.126354444058792,0.183135393165141,-6.13474305240101,"NONE",FALSE,"High","Master Protein","Q9UKC9","F-box/LRR-repeat protein 2 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,423,47,7.4,3.52,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;other cell component","other molecular function","Pf00646, Pf13516","25827","B4DQV0; E9PD06; hsa:25827; Q6IAN3; Q9NVQ8; Q9UK27; Q9UKA5; Q9UKC9; Q9Y3Y9","ENSG00000153558",NA,NA,0,0,96,86.5,91.2,113.5,86.9,112.3,102,109,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T404(100)]",0,"ENSG00000153558"
"1127","SGTA",0.141808356754377,6.63650953992002,1.67236411251924,0.126705901661054,0.18348183807528,-6.13724299645005,"NONE",FALSE,"High","Master Protein","O43765","Small glutamine-rich tetratricopeptide repeat-containing protein alpha [OS=Homo sapiens]",0,58.119,8,3,5,12,3,313,34,4.87,35.45,3,"cell organization and biogenesis;other biological processes","other membranes;cytosol;nucleus;other cell component","other molecular function","Pf00515, Pf13181, Pf16546","6449","D6W610; hsa:6449; O43765; Q6FIA9; Q9BTZ9","ENSG00000104969","Insertion of tail-anchored proteins into the endoplasmic reticulum membrane",NA,1,0,91,90,100.3,102,118.9,105.1,94.8,97.4,106.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T81(100)]",0,"ENSG00000104969"
"1128","EFHD2",-0.184553974082339,6.60810464848804,-1.67009158883042,0.127162320494503,0.183979527523961,-6.14047807312169,"NONE",FALSE,"High","Master Protein","Q96C19","EF-hand domain-containing protein D2 [OS=Homo sapiens]",0,19.814,7,2,2,2,2,240,26.7,5.2,7.13,2,NA,"other membranes","other molecular function","Pf21008","79180","hsa:79180; Q5JYW9; Q96C19","ENSG00000142634","RHOD GTPase cycle",NA,1,0,107.8,97.6,92.9,87.3,96.6,85.7,105.4,93.9,115.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S74(99.4)]",0,"ENSG00000142634"
"1129","ANAPC4",-0.185743227222782,6.6383700887043,-1.66855168060361,0.127472442602024,0.184264859456602,-6.1426688576149,"NONE",FALSE,"High","Master Protein","Q9UJX5","Anaphase-promoting complex subunit 4 [OS=Homo sapiens]",0,19.597,3,1,1,2,1,808,92.1,5.53,6.75,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus","other molecular function","Pf12894, Pf12896","29945","A8K8H1; E9PCR4; hsa:29945; Q6PCC6; Q9NSH6; Q9UJX5","ENSG00000053900","Separation of Sister Chromatids; Antigen processing: Ubiquitination & Proteasome degradation; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; CDK-mediated phosphorylation and removal of Cdc6; Autodegradation of Cdh1 by Cdh1:APC/C; Assembly of the pre-replicative complex; Inactivation of APC/C via direct inhibition of the APC/C complex; APC/C:Cdc20 mediated degradation of Cyclin B; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase; Regulation of APC/C activators between G1/S and early anaphase; Phosphorylation of the APC/C; APC-Cdc20 mediated degradation of Nek2A; Senescence-Associated Secretory Phenotype (SASP); Transcriptional Regulation by VENTX; Aberrant regulation of mitotic exit in cancer due to RB1 defects","Cell cycle",19,0,95.6,100.8,108.7,105.7,73.6,91.8,96.1,115.2,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S777(100)]",0,"ENSG00000053900"
"1130","PNN",-0.16595146019778,6.63553299557075,-1.65418121642154,0.130399577160021,0.18832930081872,-6.16305965666673,"NONE",FALSE,"High","Master Protein","Q9H307","Pinin [OS=Homo sapiens]",0,44.862,8,6,6,7,6,717,81.6,7.14,20.95,6,"cell adhesion;RNA metabolism OR transcription;other metabolic processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04696, Pf04697","5411","B4DZX8; hsa:5411; O60899; Q53EM7; Q6P5X4; Q7KYL1; Q99738; Q9H307; Q9UHZ9; Q9UQR9","ENSG00000100941","mRNA Splicing - Major Pathway",NA,1,0,98,102.1,95.8,94.9,94,82.2,100,108.1,122.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(100); S100(100); S381(100)]",0,"ENSG00000100941"
"1131","TRAPPC10",-0.163531739212626,6.5915318006386,-1.65133827772242,0.130985784150041,0.189008664662128,-6.16708205137251,"NONE",FALSE,"High","Master Protein","P48553","Trafficking protein particle complex subunit 10 [OS=Homo sapiens]",0,3.997,2,1,1,1,1,1259,142.1,6.04,2.38,1,"cell organization and biogenesis;transport","cytosol;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf12584","7109","hsa:7109; P48553; Q3MIR2; Q86SI7; Q9UMD4; Q9Y4L3","ENSG00000160218","RAB GEFs exchange GTP for GDP on RABs; COPII-mediated vesicle transport",NA,2,0,90.9,112.8,104.2,93.9,90.8,95.9,85.1,99.9,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S708(100)]",0,"ENSG00000160218"
"1132","LNPK",-0.268470049039391,6.63750036266468,-1.64804524554003,0.131667763503074,0.18982018160293,-6.17173646433982,"NONE",FALSE,"High","Master Protein","Q9C0E8","Endoplasmic reticulum junction formation protein lunapark [OS=Homo sapiens]",0,17.549,8,2,2,2,2,428,47.7,5.11,6.74,2,"cell organization and biogenesis;stress response;developmental processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf10058","80856","B7ZLA8; hsa:80856; Q2M2V8; Q2YD99; Q658W8; Q8N5V9; Q96MS5; Q9C0E8","ENSG00000144320",NA,NA,0,0,78.5,98.3,123.9,71.6,87.4,92.2,116.8,102.7,129.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S177(100); S384(100)]",0,"ENSG00000144320"
"1133","EIF4G2",-0.17995733967371,6.66423514695705,-1.6475009158006,0.131780800095662,0.18982018160293,-6.17250532881526,"NONE",FALSE,"High","Master Protein","P78344","Eukaryotic translation initiation factor 4 gamma 2 [OS=Homo sapiens]",0,35.629,2,2,4,6,2,907,102.3,7.14,21.61,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;translational apparatus;other cell component","nucleic acid binding activity","Pf02020, Pf02847, Pf02854","1982","hsa:1982; O60877; P78344; P78404; Q0VH00; Q0VH01; Q2NKW9; Q49A79; Q53EU1; Q58EZ2; Q8NI71; Q96C16","ENSG00000110321","ISG15 antiviral mechanism","VEGFA-VEGFR2 signaling; Exercise-induced circadian regulation; Acute viral myocarditis",4,0,105.1,110.1,98.8,99,75.2,104.5,108.1,114.5,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S395(99.5); T508(100)]",0,"ENSG00000110321"
"1134","VASP",-0.206814928828339,6.67372506052539,-1.63489544312752,0.134422997289829,0.19345531885097,-6.19027078764992,"NONE",FALSE,"High","Master Protein","P50552","Vasodilator-stimulated phosphoprotein [OS=Homo sapiens]",0,11.674,7,1,1,1,1,380,39.8,8.94,3.62,1,"cell organization and biogenesis;developmental processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00568, Pf08776","7408","B2RBT9; hsa:7408; P50552; Q6PIZ1; Q93035","ENSG00000125753","Generation of second messenger molecules; Signaling by ROBO receptors; Cell-extracellular matrix interactions","Integrin-mediated cell adhesion; Focal adhesion",5,0,87.2,97.9,116.8,96.5,65.1,102.8,115.3,115.3,115.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(99.4)]",0,"ENSG00000125753"
"1135","STIM2",-0.165039558923015,6.57322500402053,-1.63328868197771,0.134763181720421,0.193774019883459,-6.19252976587773,"NONE",FALSE,"High","Master Protein","Q9P246","Stromal interaction molecule 2 [OS=Homo sapiens]",0,17.584,5,2,2,5,2,746,83.9,6.76,9.28,2,"transport;other biological processes","plasma membrane;other membranes;ER/Golgi","transporter activity;other molecular function","Pf07647, Pf16533","57620","A6H8L7; B7ZVY0; hsa:57620; Q96BF1; Q9BQH2; Q9H8R1; Q9P246","ENSG00000109689",NA,"Calcium regulation in cardiac cells",1,0,111.1,103.1,99.4,101.1,86.2,94.9,98.2,92.8,80,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S640(100)]",0,"ENSG00000109689"
"1136","RGL1",0.171034422579647,6.65310110065412,1.63138288898108,0.135167678548143,0.194184552280431,-6.19520753724291,"NONE",FALSE,"High","Master Protein","Q9NZL6","Ral guanine nucleotide dissociation stimulator-like 1 [OS=Homo sapiens]",0,30.925,8,3,4,8,3,768,86.6,6.09,6.65,3,"signal transduction","plasma membrane;other membranes;cytosol","enzyme regulator activity","Pf00617, Pf00618, Pf00788","23179","hsa:23179; Q5SXQ2; Q5SXQ6; Q9HBY3; Q9HBY4; Q9NZL5; Q9NZL6; Q9UG43; Q9Y2G6","ENSG00000143344","PPARA activates gene expression; RAF/MAP kinase cascade","Ras signaling",3,0,95.3,93.6,85.1,115.2,103.7,100.3,113.4,101.1,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S508(99.3); T749(100)]",0,"ENSG00000143344"
"1137","UBE2V1",0.182348754383809,6.65145581311731,1.61763361178595,0.138118296796375,0.198248953713003,-6.2144737731432,"NONE",FALSE,"High","Master Protein","Q13404","Ubiquitin-conjugating enzyme E2 variant 1 [OS=Homo sapiens]",0.004,2.083,8,1,1,2,1,147,16.5,7.93,5.24,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component",NA,"Pf00179","387522; 7335","E1P629; hsa:387522; hsa:7335; Q13403; Q13404; Q13532; Q5TGE0; Q5TGE3; Q96H34; Q9GZT0; Q9GZW1; Q9H4J3; Q9H4J4; Q9UKL1; Q9UM48; Q9UM49; Q9UM50","ENSG00000244687","SARS-CoV-2 activates/modulates innate and adaptive immune responses; FCERI mediated NF-kB activation; Downstream TCR signaling; Antigen processing: Ubiquitination & Proteasome degradation; CLEC7A (Dectin-1) signaling; Aggrephagy; IKK complex recruitment mediated by RIP1; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; NOD1/2 Signaling Pathway; TICAM1, RIP1-mediated IKK complex recruitment; TAK1-dependent IKK and NF-kappa-B activation  ; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; activated TAK1 mediates p38 MAPK activation; TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling","IL-1 signaling pathway; Interleukin-1 induced activation of NF-kB; MYD88 distinct input-output pathway",19,0,81.8,88.4,100.2,97.6,123.8,104.1,101,99.8,119.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(100)]",0,"ENSG00000244687"
"1138","PRKAR2A",-0.185049389547862,6.60241749616607,-1.61527679116661,0.138629822921751,0.198808322502898,-6.21776697239884,"NONE",FALSE,"High","Master Protein","P13861","cAMP-dependent protein kinase type II-alpha regulatory subunit [OS=Homo sapiens]",0,23.216,11,2,2,5,2,404,45.5,5.07,17.31,2,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00027, Pf02197","5576","hsa:5576; P13861; Q16823; Q9BUB1","ENSG00000114302","Factors involved in megakaryocyte development and platelet production; FCGR3A-mediated IL10 synthesis; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Hedgehog 'off' state; DARPP-32 events; CREB1 phosphorylation through the activation of Adenylate Cyclase; ROBO receptors bind AKAP5","Myometrial relaxation and contraction pathways; G protein signaling pathways; TGF-beta signaling pathway; Lipid metabolism pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; GDNF signaling; Calcium regulation in cardiac cells; EPAC1 and PKA reduction of retinal inflammation; Sudden infant death syndrome (SIDS) susceptibility pathways",22,0,123.2,103.7,102.2,96.4,112,91.1,91.1,81.9,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S99(100)]",0,"ENSG00000114302"
"1139","EEF2",-0.163187173692283,6.65480286386554,-1.61229050436765,0.13928040140609,0.199320554469833,-6.22193579162189,"NONE",FALSE,"High","Master Protein","P13639","Elongation factor 2 [OS=Homo sapiens]",0,42.458,8,8,8,15,8,858,95.3,6.83,32.78,8,"protein metabolism;other metabolic processes;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf00009, Pf00679, Pf03144, Pf03764, Pf14492","1938","A0A384N6H1; B2RMP5; D6W618; hsa:1938; P13639; Q58J86","ENSG00000167658","Neutrophil degranulation; Protein methylation; Uptake and function of diphtheria toxin; Peptide chain elongation; Synthesis of diphthamide-EEF2","Translation factors; AMP-activated protein kinase signaling; Brain-derived neurotrophic factor (BDNF) signaling pathway; IL-18 signaling pathway",9,0,94.9,87.1,99.8,84.9,83.8,87.1,112.4,114.1,149.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T57(100); S502(99.5)]",0,"ENSG00000167658"
"1140","SIRT2",0.126852928961881,6.66290475003142,1.61202702213221,0.139337933208711,0.199320554469833,-6.22230339788755,"NONE",FALSE,"High","Master Protein","Q8IXJ6","NAD-dependent protein deacetylase sirtuin-2 [OS=Homo sapiens]",0,43.703,9,2,2,5,2,389,43.2,5.36,26.43,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","other molecular function","Pf02146","22933","A8K3V1; B2RB45; hsa:22933; O95889; Q8IXJ6; Q924Y7; Q9P0G8; Q9UNT0; Q9Y6E9; U5TP13","ENSG00000068903; ENSG00000283100","Initiation of Nuclear Envelope (NE) Reformation","NAD+ metabolism; NAD+ biosynthetic pathways; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; HDAC6 interactions in the central nervous system",5,0,88.2,96.7,90.3,102.2,97.6,111.4,110.7,101.8,112.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S368(100); S372(100)]",0,"ENSG00000068903"
"1141","CLCC1",0.13537153537718,6.65420073126524,1.61195619361587,0.139353402359117,0.199320554469833,-6.22240221085857,"NONE",FALSE,"High","Master Protein","Q96S66","Chloride channel CLIC-like protein 1 [OS=Homo sapiens]",0.006,1.794,2,1,1,1,1,551,62,5.55,2.6,1,"transport","other membranes;ER/Golgi;nucleus;other cell component","transporter activity","Pf05934","23155","hsa:23155; O94861; Q8WYP8; Q8WYP9; Q96S66; Q9BU25","ENSG00000121940",NA,NA,0,0,78.2,93.2,89.3,93.9,99.2,103.9,114.4,111.9,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S438(99.3)]",0,"ENSG00000121940"
"1142","LRIG1",0.183882101669438,6.65833787323874,1.60852479970652,0.140104668821893,0.200219631801514,-6.22718637612513,"NONE",FALSE,"High","Master Protein","Q96JA1","Leucine-rich repeats and immunoglobulin-like domains protein 1 [OS=Homo sapiens]",0,45.224,4,2,2,6,2,1093,119,7.09,21.46,2,"developmental processes;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes",NA,"Pf01463, Pf07679, Pf12799, Pf13855, Pf13927","26018","hsa:26018; Q6IQ51; Q96CF9; Q96JA1; Q9BYB8; Q9UFI4","ENSG00000144749","Signaling by EGFR; Negative regulation of MET activity","GDNF signaling",3,0,103.5,94,90.4,112.6,96.6,125.2,103.5,101,86.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1069(100)]",0,"ENSG00000144749"
"1143","GPS1",-0.123016365153023,6.63691436032664,-1.60678354993092,0.140487278292171,0.200590759556275,-6.22961184982776,"NONE",FALSE,"High","Master Protein","Q13098","COP9 signalosome complex subunit 1 [OS=Homo sapiens]",0,28.986,4,2,2,4,2,491,55.5,6.74,9.94,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity","Pf01399, Pf10602, Pf21151","2873","hsa:2873; Q13098; Q8NA10; Q9BWL1","ENSG00000169727","Neddylation; Cargo recognition for clathrin-mediated endocytosis; Formation of TC-NER Pre-Incision Complex; RHOBTB1 GTPase cycle; DNA Damage Recognition in GG-NER",NA,5,0,108.6,99.5,99.2,99,91.3,97.7,94.6,101.2,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S474(100)]",0,"ENSG00000169727"
"1144","ACAP2",-0.18405429618221,6.64565004353702,-1.59800995489155,0.142429344717118,0.203185918337707,-6.24181002464984,"NONE",FALSE,"High","Master Protein","Q15057","Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 [OS=Homo sapiens]",0,38.793,4,4,5,8,4,778,88,6.8,23.58,4,"transport;other biological processes","other membranes;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf01412, Pf12796, Pf16746","23527","A8K2V4; hsa:23527; Q15057; Q8N5Z8; Q9UQR3","ENSG00000114331",NA,NA,0,0,98.7,98.8,101.3,99.8,63.5,104.1,105.7,113,110.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S379(99.6); S521(100); S540(100)]",0,"ENSG00000114331"
"1145","CLTC",0.305285758676227,6.66958718492031,1.59502011139317,0.143096604148682,0.203959526611921,-6.24595807865675,"NONE",FALSE,"High","Master Protein","Q00610","Clathrin heavy chain 1 [OS=Homo sapiens]",0,41.93,3,4,4,7,4,1675,191.5,5.69,16.52,4,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00637, Pf01394, Pf09268, Pf13838","1213","D3DU00; hsa:1213; Q00610; Q6N0A0; Q86TF2","ENSG00000141367","ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants; Recycling pathway of L1; MHC class II antigen presentation; RHOV GTPase cycle; Lysosome Vesicle Biogenesis; RHOU GTPase cycle; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Retrograde neurotrophin signalling; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation; Entry of Influenza Virion into Host Cell via Endocytosis; Formation of annular gap junctions","Synaptic vesicle pathway; VEGFA-VEGFR2 signaling; Dengue-2 interactions with complement and coagulation cascades; Ebola virus infection in host; Fragile X syndrome; 7q11.23 copy number variation syndrome; Complement and coagulation cascades",25,0,88.1,89.6,93.3,111.6,79.3,152.9,85.3,110.2,111.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T394(100)]",0,"ENSG00000141367"
"1146","PARVA",0.237674288930473,6.6337531985578,1.59268553829692,0.14361955779781,0.204526281261803,-6.24919389470201,"NONE",FALSE,"High","Master Protein","Q9NVD7","Alpha-parvin [OS=Homo sapiens]",0,5.836,5,2,3,8,2,372,42.2,5.95,10.87,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity","Pf00307","55742","hsa:55742; Q96C85; Q9HA48; Q9NVD7","ENSG00000197702","Localization of the PINCH-ILK-PARVIN complex to focal adhesions; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion",5,0,83.7,93.1,90.8,112.5,142.1,87.2,91.6,108.2,104,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100); T36(100)]",0,"ENSG00000197702"
"1147","IFI16",0.1762809786847,6.60078470119821,1.59188274044776,0.143799780492805,0.20460439560964,-6.25030597107745,"NONE",FALSE,"High","Master Protein","Q16666","Gamma-interferon-inducible protein 16 [OS=Homo sapiens]",0,60.801,3,1,6,34,1,785,88.2,9.28,136.18,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02758, Pf02760","3428","A0A346JEQ3; B4DJT8; H3BLV7; hsa:3428; Q16666; Q59GX0; Q5T3W7; Q5T3W8; Q5T3X0; Q5T3X1; Q5T3X2; Q8N9E5; Q8NEQ7; Q96AJ5; Q9UH78","ENSG00000163565","IRF3-mediated induction of type I IFN",NA,2,0,96.9,92.5,97.8,107.3,141.8,99.4,90.5,85.5,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S153(100)]",0,"ENSG00000163565"
"1148","GYS1",0.232686860452453,6.65007451401959,1.57918276384333,0.146677727426663,0.208517466167521,-6.26785516149435,"NONE",FALSE,"High","Master Protein","P13807","Glycogen [starch] synthase, muscle [OS=Homo sapiens]",0,27.12,7,3,3,5,3,737,83.7,6.18,13.82,3,"other metabolic processes;developmental processes","cytosol;other cell component","other molecular function","Pf05693","2997","hsa:2997; P13807; Q9BTT9","ENSG00000104812","Glycogen synthesis; Myoclonic epilepsy of Lafora; Glycogen storage disease type XV (GYG1); Glycogen storage disease type 0 (muscle GYS1)","AMP-activated protein kinase signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Insulin signaling; Glycogen synthesis and degradation; Disorders of galactose metabolism ; 2q37 copy number variation syndrome",12,0,84.2,87,101.9,104.9,91.7,132.1,85.5,107.7,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S641(100); S698(100); S727(100)]",0,"ENSG00000104812"
"1149","GRB10",0.128255426116497,6.63858811259001,1.57775662691492,0.147004079707107,0.208695621944361,-6.26982070740279,"NONE",FALSE,"High","Master Protein","Q13322","Growth factor receptor-bound protein 10 [OS=Homo sapiens]",0,10.467,3,1,1,1,1,594,67.2,7.87,3.78,1,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00017, Pf00169, Pf00788, Pf08947","2887","A4D258; A7VJ95; A8K0E6; D3DVM9; hsa:2887; O00427; O00701; O75222; Q13322; Q92606; Q92907; Q92948","ENSG00000106070","RET signaling; Signaling by SCF-KIT; FLT3 Signaling; Response of EIF2AK1 (HRI) to heme deficiency; IRS activation; Signal attenuation","Kit receptor signaling pathway; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; VEGFA-VEGFR2 signaling; Clear cell renal cell carcinoma pathways; EGF/EGFR signaling pathway; Insulin signaling",13,0,106.2,88.3,94.2,107.5,109.5,109.3,99.6,96.9,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100)]",0,"ENSG00000106070"
"1150","FAM171A2",0.223902887001321,6.62702331182156,1.5775177684906,0.147058802227951,0.208695621944361,-6.27014980768967,"NONE",FALSE,"High","Master Protein","A8MVW0","Protein FAM171A2 [OS=Homo sapiens]",0,37.936,8,3,3,5,3,826,87.4,8.05,15.39,3,NA,"other membranes",NA,"Pf10577, Pf20771","284069","A8MQB4; A8MVW0; hsa:284069","ENSG00000161682",NA,NA,0,0,95.8,93.5,92,103.1,92,141,85.5,100.4,92.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S446(100); S789(100)]",0,"ENSG00000161682"
"1151","WBP4",0.382045194817579,6.58156501877094,1.56562222179518,0.149807037489042,0.212411021009658,-6.28650245183616,"NONE",FALSE,"High","Master Protein","O75554","WW domain-binding protein 4 [OS=Homo sapiens]",0,9.48,4,1,1,1,1,376,42.5,5.57,2.7,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity;other molecular function","Pf00397, Pf06220","11193","B7Z4M2; hsa:11193; O75554; Q32P29","ENSG00000120688","mRNA Splicing - Major Pathway",NA,1,0,70.2,79.6,77.5,85.1,182.4,77.8,121.7,94.7,128.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S262(100)]",0,"ENSG00000120688"
"1152","PRICKLE2",0.141351384523134,6.65893770308822,1.56002007820405,0.151116990786723,0.214082403614525,-6.29417830404992,"NONE",FALSE,"High","Master Protein","Q7Z3G6","Prickle-like protein 2 [OS=Homo sapiens]",0,15.131,3,2,3,5,2,844,95.6,7.36,6.38,2,"cell-cell signaling;signal transduction","other membranes;nucleus;other cell component","other molecular function","Pf00412, Pf06297","166336","hsa:166336; Q0VF44; Q7Z3G6","ENSG00000163637",NA,"Wnt signaling",1,0,81.8,95.2,84.1,104.1,92.5,99.8,107.7,114,131,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S753(100); S806(99.7)]",0,"ENSG00000163637"
"1153","SCAMP3",-0.138327236560051,6.67046081631151,-1.55936790532181,0.151270145534177,0.214113510417847,-6.2950708269947,"NONE",FALSE,"High","Master Protein","O14828","Secretory carrier-associated membrane protein 3 [OS=Homo sapiens]",0,7.615,2,1,1,3,1,347,38.3,7.64,8.36,1,"transport","other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf04144","10067","A9Z1W6; B1AVS6; hsa:10067; O14828; O15128; Q96FR8; Q9BPY0","ENSG00000116521; ENSG00000263290",NA,NA,0,0,107,106.4,99,106.5,82.4,97,106.9,108.4,99.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(100)]",0,"ENSG00000116521"
"1154","ARHGEF7",-0.179021712043739,6.64836110426358,-1.55819243464882,0.151546537033275,0.214318846133713,-6.29667894262526,"NONE",FALSE,"High","Master Protein","Q14155-1","Isoform 1 of Rho guanine nucleotide exchange factor 7 [OS=Homo sapiens]",0,35.104,6,4,6,33,3,646,73.1,7.21,77.24,4,NA,NA,NA,NA,NA,"Q14155-1",NA,NA,NA,0,0,91.2,84.4,89.8,80,86.6,69.9,125.8,127.9,163.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(100); S340(100); S498(99.5); S516(100)]",0,"ENSG00000102606"
"1155","ADGRB2",-0.143709619332669,6.62108143535743,-1.55707530716497,0.151809623896083,0.214505027011609,-6.29820657312269,"NONE",FALSE,"High","Master Protein","O60241","Adhesion G protein-coupled receptor B2 [OS=Homo sapiens]",0,11.9,2,1,1,1,1,1585,172.5,7.42,3.22,1,"developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes","other molecular function","Pf00002, Pf00090, Pf01825, Pf16489, Pf19188","576","B9EGK9; hsa:576; O60241; Q5T6K0; Q8NGW8; Q96GZ9","ENSG00000121753",NA,NA,0,0,101.5,86.9,89.3,79.1,77.7,95.9,112.3,113.9,128.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1275(100)]",0,"ENSG00000121753"
"1156","CD276",-0.134386855654672,6.64384790432523,-1.55638367655299,0.151972707270732,0.21454970438221,-6.29915202574961,"NONE",FALSE,"High","Master Protein","Q5ZPR3","CD276 antigen [OS=Homo sapiens]",0,8.236,2,1,1,6,1,534,57.2,4.91,14.91,1,"signal transduction;other biological processes","plasma membrane;other membranes","signal transduction activity or receptor binding","Pf07686, Pf13927","80381","hsa:80381; Q5ZPR3; Q6P5Y4; Q6UXI2; Q8NBI8; Q8NC34; Q8NCB6; Q9BXR1","ENSG00000103855",NA,NA,0,0,80.7,93,88.7,82.9,77.7,80.2,134.5,122.8,145.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S525(100)]",0,"ENSG00000103855"
"1157","STAG2",-0.214668189554111,6.60338757531502,-1.54775818386956,0.154019599966319,0.217251501421809,-6.31092194033255,"NONE",FALSE,"High","Master Protein","Q8N3U4","Cohesin subunit SA-2 [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1231,141.2,5.43,3.91,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf08514, Pf21581","10735","B1AMT5; D3DTF5; hsa:10735; O00540; Q5JTI6; Q68DE9; Q8N3U4; Q9H1N8","ENSG00000101972","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; Meiotic synapsis; SUMOylation of DNA damage response and repair proteins; Estrogen-dependent gene expression; Establishment of Sister Chromatid Cohesion; Cohesin Loading onto Chromatin","Cell cycle; Cohesin complex - Cornelia de Lange syndrome",9,0,83.8,105.2,120.9,103.1,74,90.6,91.6,110.3,96.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1061(100)]",0,"ENSG00000101972"
"1158","MEF2D",0.290299659830921,6.62555901527962,1.54415535791252,0.154881756224142,0.218278951777029,-6.31582658642446,"NONE",FALSE,"High","Master Protein","Q14814","Myocyte-specific enhancer factor 2D [OS=Homo sapiens]",0,2.834,3,1,1,1,1,521,55.9,7.88,2.95,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00319, Pf12347","4209","D3DVC0; hsa:4209; Q14814; Q14815; Q5T9U5; Q5T9U6","ENSG00000116604; ENSG00000291761","NGF-stimulated transcription; Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; Myogenesis","Energy metabolism; SRF and miRs in smooth muscle differentiation and proliferation; Cell differentiation - expanded index; Cell differentiation - index; B cell receptor signaling pathway; Adipogenesis; p38 MAPK signaling pathway; Epithelial to mesenchymal transition in colorectal cancer; EGF/EGFR signaling pathway; Gastrin signaling pathway; Modulators of TCR signaling and T cell activation; Pleural mesothelioma; Calcium mediated T-cell apoptosis involved in inclusion body myositis",18,0,108.2,77.2,92.9,101.6,88.6,159.2,94,93.9,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(100)]",0,"ENSG00000116604"
"1159","PDPK1",-0.121487117594796,6.64187972260444,-1.53739136618173,0.156511877011736,0.220386008009623,-6.32501607452668,"NONE",FALSE,"High","Master Protein","O15530","3-phosphoinositide-dependent protein kinase 1 [OS=Homo sapiens]",0,41.965,8,2,3,8,2,556,63.1,7.36,30.71,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf14593","5170","H0Y4Z0; hsa:5170; O15530; Q59EH6; Q6FI20; Q8IV52; Q9BRD5","ENSG00000140992","Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated NF-kB activation; Downstream TCR signaling; CLEC7A (Dectin-1) signaling; Constitutive Signaling by AKT1 E17K in Cancer; PIP3 activates AKT signaling; Regulation of TP53 Degradation; GPVI-mediated activation cascade; CD28 dependent PI3K/Akt signaling; G beta:gamma signalling through PI3Kgamma; RHO GTPases activate PKNs; Activation of AKT2; Integrin signaling; RSK activation; VEGFR2 mediated vascular permeability; VEGFR2 mediated cell proliferation; Estrogen-stimulated signaling through PRKCZ; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways","MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Cardiac hypertrophic response; Focal adhesion; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin-insulin signaling overlap; PPAR signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; EGF/EGFR signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; Modulators of TCR signaling and T cell activation; GDNF signaling; Primary ovarian insufficiency; Macrophage-stimulating protein (MSP) signaling network map; ErbB signaling pathway; T-cell receptor signaling pathway; Serotonin HTR1 group and FOS pathway",46,0,100.2,103.5,97.8,89.9,98.4,98.5,100.1,101.5,112,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S25(97.9); S241(100)]",0,"ENSG00000140992"
"1160","DNM1L",0.165222159806157,6.69998647549437,1.5362301826102,0.156793236616084,0.220591863928836,-6.32659120198025,"NONE",FALSE,"High","Master Protein","O00429","Dynamin-1-like protein [OS=Homo sapiens]",0,25.263,2,1,1,3,1,736,81.8,6.81,13.92,1,"cell organization and biogenesis;transport;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00350, Pf01031, Pf02212","10059","A8K4X9; B4DGC9; B4DSU8; G8JLD5; hsa:10059; J3KPI2; O00429; O14541; O60709; Q59GN9; Q7L6B3; Q8TBT7; Q9BWM1; Q9Y5J2","ENSG00000087470","Apoptotic execution phase","Synaptic vesicle pathway; CAMKK2 pathway",3,0,83,93.1,84.1,110.4,80.3,107.3,124.6,131.6,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S616(100)]",0,"ENSG00000087470"
"1161","RANBP3",0.123940674340822,6.64418839899501,1.53479176660772,0.157142388074574,0.220892659205603,-6.3285413947602,"NONE",FALSE,"High","Master Protein","Q9H6Z4","Ran-binding protein 3 [OS=Homo sapiens]",0,28.721,5,3,4,16,3,567,60.2,4.78,42.82,3,"transport","nucleus;other cell component","other molecular function","Pf00638","8498","B2RAT8; hsa:8498; O60405; O75759; O75760; Q9BT47; Q9H6Z4; Q9UG74","ENSG00000031823",NA,NA,0,0,91.5,96.9,92.2,110.6,101.8,103.6,97.1,109.7,99.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S126(98.8); S333(100)]",0,"ENSG00000031823"
"1162","GNG2",0.200056676015594,6.63714018432648,1.53309200809943,0.157555857840917,0.221283270220634,-6.33084449065127,"NONE",FALSE,"High","Master Protein","P59768","Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [OS=Homo sapiens]",0,19.739,23,1,1,3,1,71,7.8,7.99,8.82,1,"cell cycle OR cell proliferation;signal transduction;other biological processes","plasma membrane;other membranes","other molecular function","Pf00631","54331","hsa:54331; P59768; Q5JPE2; Q6P9A9","ENSG00000186469","G alpha (q) signalling events; G alpha (12/13) signalling events; G alpha (i) signalling events; G alpha (z) signalling events; ADP signalling through P2Y purinoceptor 12; G alpha (s) signalling events; Extra-nuclear estrogen signaling; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Thrombin signalling through proteinase activated receptors (PARs); Activation of G protein gated Potassium channels; G-protein activation; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; G beta:gamma signalling through PI3Kgamma; Prostacyclin signalling through prostacyclin receptor; Adrenaline,noradrenaline inhibits insulin secretion; Ca2+ pathway; G beta:gamma signalling through PLC beta; ADP signalling through P2Y purinoceptor 1; Glucagon-type ligand receptors; Thromboxane signalling through TP receptor; Vasopressin regulates renal water homeostasis via Aquaporins; Presynaptic function of Kainate receptors; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding; G beta:gamma signalling through BTK; G beta:gamma signalling through CDC42; Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits; Glucagon signaling in metabolic regulation","Nicotine effect on dopaminergic neurons; Thyroid stimulating hormone (TSH) signaling pathway; Myometrial relaxation and contraction pathways; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Calcium regulation in cardiac cells",36,0,77.6,92.6,78,92.1,92,110.4,132.2,118.6,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T52(100)]",0,"ENSG00000186469"
"1163","SRGAP3",0.140342149122406,6.6650561138703,1.52914891279023,0.158518710471277,0.222444140575343,-6.33618125766772,"NONE",FALSE,"High","Master Protein","O43295","SLIT-ROBO Rho GTPase-activating protein 3 [OS=Homo sapiens]",0,71.264,9,9,9,16,9,1099,124.4,6.68,36.64,9,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity","Pf00018, Pf00611, Pf00620","9901","hsa:9901; O43295; Q8IX13; Q8IZV8","ENSG00000196220","CDC42 GTPase cycle; RAC1 GTPase cycle; Inactivation of CDC42 and RAC1",NA,3,0,92,93.7,87.7,105.5,114.7,95.5,102.3,109,116.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S858(100); S874(99.3); S895(99.4); S908(100); S919(100); S1069(99.4)]",0,"ENSG00000196220"
"1164","PCYT1A",-0.118212025086296,6.61825310529822,-1.5281458523639,0.158764468560607,0.222597605404562,-6.33753751669797,"NONE",FALSE,"High","Master Protein","P49585","Choline-phosphate cytidylyltransferase A [OS=Homo sapiens]",0,42.729,11,5,8,17,5,367,41.7,7.25,41.75,5,"other metabolic processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01467","5130","A9LYK9; D3DXB1; hsa:5130; P49585; Q86Y88","ENSG00000161217","Synthesis of PC","Trans-sulfuration, one-carbon metabolism and related pathways; Kennedy pathway from sphingolipids; One-carbon metabolism and related pathways; Glycerolipids and glycerophospholipids; 3q29 copy number variation syndrome; Acetylcholine synthesis",7,0,111.8,102.2,106.9,104.5,87.6,107.1,86.5,95.1,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S315(100); S329(100); S331(100); S343(99.6); S347(100); S362(100)]",0,"ENSG00000161217"
"1165","RSF1",-0.155760824225566,6.65067253409991,-1.52707264202878,0.159027784651306,0.222775403048009,-6.33898802877496,"NONE",FALSE,"High","Master Protein","Q96T23","Remodeling and spacing factor 1 [OS=Homo sapiens]",0,128.331,8,8,9,21,8,1441,163.7,5.01,69.53,8,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00628, Pf15612","51773","hsa:51773; Q86X86; Q96T23; Q9H3L8; Q9NVZ8; Q9NYU0","ENSG00000048649","Deposition of new CENPA-containing nucleosomes at the centromere",NA,1,0,98.8,104.7,98.6,97.7,72.5,103.8,111.1,112.2,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S473(100); S604(100); S622(100); S865(99.6); S1282(100); T1305(100); S1345(100)]",0,"ENSG00000048649"
"1166","SCARF2",0.119060583757795,6.65778763952902,1.50072912347885,0.165612507206613,0.231800696193133,-6.37439737441807,"NONE",FALSE,"High","Master Protein","Q96GP6","Scavenger receptor class F member 2 [OS=Homo sapiens]",0,109.837,7,7,7,13,7,871,92.3,8.32,50.24,7,"cell adhesion;transport","other membranes","other molecular function",NA,"91179","E5RFB8; hsa:91179; Q58A83; Q8IXF3; Q96GP6; Q9BW74","ENSG00000244486",NA,"22q11.2 copy number variation syndrome",1,0,86.5,86.4,87.7,92.8,92,108.4,108.3,122.1,124.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S483(100); S653(100); S687(100); S698(99.4); S742(100)]",0,"ENSG00000244486"
"1167","DOCK1",-0.134242564487564,6.66758074846417,-1.49434741622298,0.167243086119073,0.233882362079115,-6.38291812162119,"NONE",FALSE,"High","Master Protein","Q14185","Dedicator of cytokinesis protein 1 [OS=Homo sapiens]",0,16.814,2,2,2,3,2,1865,215.2,7.56,8.55,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf06920, Pf14429, Pf16172, Pf20421, Pf20422","1793","A9Z1Z5; hsa:1793; Q14185","ENSG00000150760","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; RAC1 GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; DCC mediated attractive signaling; VEGFA-VEGFR2 Pathway; Factors involved in megakaryocyte development and platelet production; PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases","Integrin-mediated cell adhesion; Androgen receptor network in prostate cancer; Focal adhesion; Hepatocyte growth factor receptor signaling; Regulation of actin cytoskeleton",14,0,90.4,92.1,109.1,90.8,83.7,95.9,120.6,109.7,115.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1681(100); T1767(100)]",0,"ENSG00000150760"
"1168","SOX13",0.113093783561807,6.63986241673761,1.49312023717497,0.167558241476489,0.234122474391806,-6.38455404810815,"NONE",FALSE,"High","Master Protein","Q9UN79","Transcription factor SOX-13 [OS=Homo sapiens]",0,22.441,6,2,3,5,2,622,69.2,6.71,11.97,2,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00505","9580","B4E2B0; hsa:9580; O95275; O95826; Q3KQV7; Q5SXX1; Q9UHW7; Q9UN79","ENSG00000143842","Deactivation of the beta-catenin transactivating complex",NA,1,0,94.3,90.5,88.7,100.6,96,110.3,109.7,101.4,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S310(100); S335(99.3)]",0,"ENSG00000143842"
"1169","IKBKG",-0.158598056684569,6.6718627985677,-1.49154976480368,0.167962314422079,0.234377696741413,-6.38664639326388,"NONE",FALSE,"High","Master Protein","Q9Y6K9","NF-kappa-B essential modulator [OS=Homo sapiens]",0,12.663,3,1,1,1,1,419,48.2,5.71,4.06,1,"cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf11577, Pf16516, Pf18414","8517","hsa:8517; Q7LBY6; Q7Z7F1; Q9Y6K9","ENSG00000269335","PKR-mediated signaling; NOD1/2 Signaling Pathway; activated TAK1 mediates p38 MAPK activation; FCERI mediated NF-kB activation; Downstream TCR signaling; Activation of NF-kappaB in B cells; ER-Phagosome pathway; CLEC7A (Dectin-1) signaling; Ub-specific processing proteases; SARS-CoV-2 activates/modulates innate and adaptive immune responses; IKK complex recruitment mediated by RIP1; JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1; TICAM1, RIP1-mediated IKK complex recruitment; TAK1-dependent IKK and NF-kappa-B activation  ; Regulation of TNFR1 signaling; TNFR1-induced NF-kappa-B signaling pathway; MAP3K8 (TPL2)-dependent MAPK1/3 activation; IRAK1 recruits IKK complex; IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation; Regulation of NF-kappa B signaling; Ovarian tumor domain proteases; RIP-mediated NFkB activation via ZBP1; IKBKB deficiency causes SCID; IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR); IkBA variant leads to EDA-ID; TRAF6 mediated NF-kB activation; NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10; SUMOylation of immune response proteins","Nucleotide-binding oligomerization domain (NOD) pathway; MicroRNAs in cardiomyocyte hypertrophy; IL-1 signaling pathway; RANKL/RANK signaling pathway; Leptin signaling pathway; IL-17 signaling pathway; B cell receptor signaling pathway; TNF-alpha signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis; Ebstein-Barr virus LMP1 signaling; Cardiac hypertrophic response; Nod-like receptor (NLR) signaling pathway; RAC1/PAK1/p38/MMP2 pathway; MAPK signaling pathway; MAPK and NFkB signaling pathways inhibited by Yersinia YopJ; Toll-like receptor signaling related to MyD88; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Novel intracellular components of RIG-I-like receptor pathway; ATM signaling in development and disease ; Chemokine signaling pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; Fibrin complement receptor 3 signaling pathway; PI3K-Akt signaling pathway; Ras signaling; Pancreatic adenocarcinoma pathway; miRNA role in immune response in sepsis; Suppression of HMGB1-mediated inflammation by THBD; Altered glycosylation of MUC1 in tumor microenvironment; Resistin as a regulator of inflammation; Vitamin D in inflammatory diseases; Canonical NF-kB pathway; Measles virus infection; Cytosolic DNA-sensing pathway; Small cell lung cancer; Hepatitis B infection; Host-pathogen interaction of human coronaviruses - interferon induction; STING pathway in Kawasaki-like disease and COVID-19; Modulators of TCR signaling and T cell activation; CCL18 signaling pathway; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; Network map of SARS-CoV-2 signaling pathway; Acute myeloid leukemia; T-cell receptor signaling pathway; Estrogen signaling pathway; Toll-like receptor signaling pathway",76,0,96.3,110.9,101.1,96.6,107.4,83.7,105.2,104.5,116.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100)]",0,"ENSG00000269335"
"1170","RBMXL1",0.229071155811146,6.63104093927568,1.49129428469302,0.168028128178587,0.234377696741413,-6.3869866407127,"NONE",FALSE,"High","Master Protein","Q96E39","RNA binding motif protein, X-linked-like-1 [OS=Homo sapiens]",0,51.529,15,7,7,21,2,390,42.1,9.89,50.39,7,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf00076, Pf08081","494115","hsa:494115; Q96E39","ENSG00000213516",NA,NA,0,5,90.9,89.2,92.2,101.8,150.4,95.7,97.8,87.3,112.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S88(100); S189(99.1); S208(100); S326(100); S351(100)]",0,"ENSG00000213516"
"1171","FAM169A",-0.144965158778068,6.61867684950646,-1.48893407240357,0.168637201934979,0.234970666270935,-6.39012824673952,"NONE",FALSE,"High","Master Protein","Q9Y6X4","Soluble lamin-associated protein of 75 kDa [OS=Homo sapiens]",0,124.057,21,7,11,27,7,670,74.9,4.6,80.52,7,NA,"other membranes;nucleus",NA,NA,"26049","A8K1T9; hsa:26049; Q6MZT0; Q9H989; Q9Y6X4","ENSG00000198780","RHOF GTPase cycle",NA,1,0,95.7,106,102.6,103.6,80.6,94.8,106.4,99.8,91.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); S447(99.6); S526(100); S635(99.6)]",0,"ENSG00000198780"
"1172","TRIM16",0.311347319381822,6.631993439971,1.48853185537576,0.168741189258294,0.234970666270935,-6.3906633163733,"NONE",FALSE,"High","Master Protein","O95361","Tripartite motif-containing protein 16 [OS=Homo sapiens]",0,11.501,4,1,1,2,1,564,63.9,5.49,2.74,1,"other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00622, Pf00643, Pf13765","10626","O95361; Q6IAL8; Q7Z6I2; Q96BE8; Q96J43","ENSG00000221926",NA,NA,0,0,101,76.3,103.5,137.1,114.9,101.3,84.7,115.9,77.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(99.4)]",0,"ENSG00000221926"
"1173","CDC42EP1",-0.131340228216373,6.6430423648381,-1.47923923550934,0.171159256300396,0.237982587107761,-6.40300014226667,"NONE",FALSE,"High","Master Protein","Q00587","Cdc42 effector protein 1 [OS=Homo sapiens]",0,81.123,24,7,9,25,7,391,40.3,7.15,70.85,7,"cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00786, Pf14957","11135","A8K825; hsa:11135; Q00587; Q96GN1","ENSG00000128283","RHOJ GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle",NA,7,0,98.1,101,100.4,88,90.9,101.9,111.4,108.1,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S101(100); S121(100); S192(100); S195(100); T367(100)]",0,"ENSG00000128283"
"1174","PLEKHO1",-0.166398993948087,6.63816696674985,-1.4790996493252,0.171195807147372,0.237982587107761,-6.40318508733738,"NONE",FALSE,"High","Master Protein","Q53GL0","Pleckstrin homology domain-containing family O member 1 [OS=Homo sapiens]",0,18.369,5,2,2,6,2,409,46.2,8.82,13.55,2,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;nucleus;other cell component",NA,"Pf00169","51177","hsa:51177; Q336K5; Q53GL0; Q8IZ51; Q9NRV3; Q9UL48","ENSG00000023902",NA,NA,0,0,91.3,112.5,98.4,83.1,107.6,91.3,107.6,107.1,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S271(100)]",0,"ENSG00000023902"
"1175","TBC1D5",0.112992749140607,6.66644843028352,1.47607956248449,0.171988284470402,0.238880749153784,-6.4071838767284,"NONE",FALSE,"High","Master Protein","Q92609","TBC1 domain family member 5 [OS=Homo sapiens]",0,33.613,5,3,4,9,3,795,88.9,6.54,28.51,3,"other metabolic processes;stress response;transport;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00566","9779","A6NP25; C9JP52; hsa:9779; Q92609","ENSG00000131374",NA,NA,0,0,92.6,90.6,100.5,109.8,95.6,111.2,104.5,107.3,101.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S522(100); S541(100); S554(99.7)]",0,"ENSG00000131374"
"1176","ZC3H13",-0.0948747895030442,6.63560934849363,-1.47366965081318,0.172622935055617,0.239558358852694,-6.410371070328,"NONE",FALSE,"High","Master Protein","Q5T200","Zinc finger CCCH domain-containing protein 13 [OS=Homo sapiens]",0,113.728,9,18,20,37,18,1668,196.5,9.42,79.31,18,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf00642","23091","A2A323; hsa:23091; O94936; Q5T1Z9; Q5T200; Q7Z7J3; Q8NDT6; Q9H0L6","ENSG00000123200",NA,NA,0,0,101.9,103.6,102.6,98.6,100.5,100.2,95.1,97.7,100.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100); S77(100); S198(100); S207(100); S209(100); S242(100); S265(99.6); S325(100); T364(100); S643(99.4); S877(99.6); S986(100); T1033(100)]",0,"ENSG00000123200"
"1177","PI4K2A",-0.18344952848978,6.60807511448288,-1.47233007784034,0.172976590448604,0.239845195932134,-6.41214128592277,"NONE",FALSE,"High","Master Protein","Q9BTU6","Phosphatidylinositol 4-kinase type 2-alpha [OS=Homo sapiens]",0,25.184,7,2,2,4,2,479,54,8.29,12.44,2,"cell organization and biogenesis;other metabolic processes","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00454","55361","D3DR59; hsa:55361; Q9BTU6; Q9NSG8","ENSG00000155252","Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane","Thymic stromal lymphopoietin (TSLP) signaling pathway; Wnt signaling pathway",5,0,105.3,108.9,106.4,94.6,117.6,84.2,99.2,84.9,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100); S51(100); S462(100)]",0,"ENSG00000155252"
"1178","AIDA",0.332574017777346,6.61583749363889,1.47025057759754,0.173526837099372,0.240403903349894,-6.41488728920795,"NONE",FALSE,"High","Master Protein","Q96BJ3","Axin interactor, dorsalization-associated protein [OS=Homo sapiens]",0,8.352,4,1,1,3,1,306,35,6.55,2.71,1,"developmental processes;other biological processes","other membranes;other cell component","other molecular function","Pf08910, Pf14186","64853","A8K1F0; hsa:64853; Q49A81; Q5JRA4; Q658P1; Q96BJ3; Q9H9E8","ENSG00000186063",NA,NA,0,0,81.2,117.2,70.6,92.7,128.8,128.6,76.3,114.2,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(100)]",0,"ENSG00000186063"
"1179","IL1RAP",-0.0979215480518887,6.64679476417265,-1.46902035548484,0.173853074836886,0.240651584507038,-6.41651065879771,"NONE",FALSE,"High","Master Protein","Q9NPH3","Interleukin-1 receptor accessory protein [OS=Homo sapiens]",0,58.263,3,3,5,12,3,570,65.4,8.12,41.88,3,"cell adhesion;cell-cell signaling;cell organization and biogenesis;stress response;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;other molecular function","Pf01582, Pf18452","3556","B1NLD0; D3DNW0; hsa:3556; O14915; Q86WJ7; Q9NPH3","ENSG00000196083",NA,"IL-1 signaling pathway; Interleukin-1 (IL-1) structural pathway; Signal transduction through IL1R; 2q13 copy number variation syndrome",4,0,96.5,94.4,96,95.3,83.6,94.1,113.4,108.5,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S557(99.8)]",0,"ENSG00000196083"
"1180","SARM1",-0.102253911649283,6.635087280108,-1.46207026823253,0.175706148586256,0.24294697163764,-6.4256656744693,"NONE",FALSE,"High","Master Protein","Q6SZW1","NAD(+) hydrolase SARM1 [OS=Homo sapiens]",0,35.351,4,2,2,5,2,724,79.3,6.55,21.27,2,"other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;mitochondrion;other cell component","other molecular function","Pf07647, Pf13676","23098","hsa:23098; O60277; Q6SZW1; Q7LGG3; Q9NXY5","ENSG00000004139",NA,NA,0,0,97.5,94.7,104,93.6,88.6,101,102.4,101.4,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S572(100)]",0,"ENSG00000004139"
"1181","AMOTL1",0.21203803520826,6.66264525359651,1.46168618449395,0.175809052392189,0.24294697163764,-6.42617080769124,"NONE",FALSE,"High","Master Protein","Q8IY63","Angiomotin-like protein 1 [OS=Homo sapiens]",0,14.978,2,2,2,3,2,956,106.5,7.11,9.92,2,"cell-cell signaling;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","other molecular function","Pf12240","154810","hsa:154810; Q63HK7; Q8IY63; Q8NDN0; Q8TEN8; Q8WXD1; Q96CM5","ENSG00000166025","Signaling by Hippo",NA,1,0,73.1,72.2,90.3,78.6,81.1,119.3,138.2,127.7,148,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S793(100); S828(100)]",0,"ENSG00000166025"
"1182","NOVA1",-0.144743194517959,6.64401697644672,-1.45010399432592,0.178936750369089,0.247040680922347,-6.44136361732017,"NONE",FALSE,"High","Master Protein","P51513","RNA-binding protein Nova-1 [OS=Homo sapiens]",0,14.266,2,1,2,3,1,507,51.7,8.72,8.58,1,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00013","4857","A8K0S4; A8K4Q7; D3DS81; D3DS82; hsa:4857; P51513; Q6B004","ENSG00000139910",NA,NA,0,0,102.1,95.2,96.9,92.3,103.1,81.5,112.1,106,112.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S154(99.3)]",0,"ENSG00000139910"
"1183","HSP90AA1",0.184720874153458,6.67802400424377,1.44959895963118,0.179074219075452,0.247040680922347,-6.44202433706899,"NONE",FALSE,"High","Master Protein","P07900","Heat shock protein HSP 90-alpha [OS=Homo sapiens]",0,223.28,23,16,16,28,9,732,84.6,5.02,101.91,16,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;transport;developmental processes;other biological processes","non-structural extracellular;extracellular matrix;plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00183, Pf13589","3320","A8K500; B3KPJ9; hsa:3320; P07900; Q2PP14; Q5CAQ6; Q5CAQ7; Q9BVQ5","ENSG00000080824","Regulation of actin dynamics for phagocytic cup formation; Potential therapeutics for SARS; The role of GTSE1 in G2/M progression after G2 checkpoint; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Recruitment of NuMA to mitotic centrosomes; Aggrephagy; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Extra-nuclear estrogen signaling; Neutrophil degranulation; vRNP Assembly; Estrogen-dependent gene expression; Regulation of necroptotic cell death; Interleukin-4 and Interleukin-13 signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Sema3A PAK dependent Axon repulsion; DDX58/IFIH1-mediated induction of interferon-alpha/beta; PIWI-interacting RNA (piRNA) biogenesis; VEGFR2 mediated vascular permeability; RHOBTB2 GTPase cycle; Chaperone Mediated Autophagy; HSF1 activation; Attenuation phase; eNOS activation; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; Uptake and function of diphtheria toxin; Constitutive Signaling by Overexpressed ERBB2; Assembly and release of respiratory syncytial virus (RSV) virions; Respiratory syncytial virus genome replication; Scavenging by Class F Receptors; Drug-mediated inhibition of ERBB2 signaling; Resistance of ERBB2 KD mutants to trastuzumab; Resistance of ERBB2 KD mutants to sapitinib; Resistance of ERBB2 KD mutants to tesevatinib; Resistance of ERBB2 KD mutants to neratinib; Resistance of ERBB2 KD mutants to osimertinib; Resistance of ERBB2 KD mutants to afatinib; Resistance of ERBB2 KD mutants to AEE788; Resistance of ERBB2 KD mutants to lapatinib; Drug resistance in ERBB2 TMD/JMD mutants","Nucleotide-binding oligomerization domain (NOD) pathway; TNF-alpha signaling pathway; Corticotropin-releasing hormone signaling pathway; Aryl hydrocarbon receptor pathway; Ebstein-Barr virus LMP1 signaling; Aryl hydrocarbon receptor pathway; Constitutive androstane receptor pathway; Pregnane X receptor pathway; Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; NRF2 pathway; Photodynamic therapy-induced AP-1 survival signaling; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Th17 cell differentiation pathway; HDAC6 interactions in the central nervous system",71,7,82.8,85.3,100.2,114.1,80.9,116.9,115,120.5,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S231(100); S263(100)]",0,"ENSG00000080824"
"1184","SERINC3",-0.238456505869744,6.60873230657444,-1.44514084537279,0.180291662302712,0.248510129119955,-6.44785034812563,"NONE",FALSE,"High","Master Protein","Q13530","Serine incorporator 3 [OS=Homo sapiens]",0,9.934,6,1,1,1,1,473,52.5,7.46,3.23,1,"other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","transporter activity","Pf03348","10955","B4DUE9; hsa:10955; O43717; Q13530; Q9BR33","ENSG00000132824","Serine biosynthesis",NA,1,0,78.2,116.1,110.2,99.6,60.3,97.7,99.7,101.4,118.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(99.3)]",0,"ENSG00000132824"
"1185","SLC15A2",-0.278944658056745,6.55365779605148,-1.44017355997999,0.181656555493009,0.250180167565056,-6.45432820320937,"NONE",FALSE,"High","Master Protein","Q16348","Solute carrier family 15 member 2 [OS=Homo sapiens]",0,52.18,3,2,3,19,2,729,81.7,8.16,82.11,2,"stress response;transport;other biological processes","plasma membrane;other membranes","transporter activity","Pf00854","6565","A8K1A5; B4E2A7; hsa:6565; Q16348","ENSG00000163406","Proton/oligopeptide cotransporters","Carnosine metabolism of glial cells",2,0,118.1,116.7,112.9,112.1,61,116.6,86.3,88.3,64.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S9(100); S28(100)]",0,"ENSG00000163406"
"1186","CHERP",0.16829159076324,6.66777295521596,1.43841349010016,0.182142313319661,0.250637652055385,-6.45662007668927,"NONE",FALSE,"High","Master Protein","Q8IWX8","Calcium homeostasis endoplasmic reticulum protein [OS=Homo sapiens]",0,16.014,3,2,2,4,2,916,103.6,9.04,6.44,2,"RNA metabolism OR transcription;other metabolic processes;transport;developmental processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf01585, Pf01805, Pf04818","10523","hsa:10523; O00302; Q4G0Y5; Q8IWX8; Q8WU30; Q99492","ENSG00000085872","mRNA Splicing - Major Pathway",NA,1,0,86,94.2,81,92.6,101.4,112.4,100.9,129.8,124.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S817(100); T819(100); S904(100)]",0,"ENSG00000085872"
"1187","ICE1",-0.182019034738848,6.58481346329392,-1.42441363541067,0.186046066295793,0.255793749110981,-6.47478548169817,"NONE",FALSE,"High","Master Protein","Q9Y2F5","Little elongation complex subunit 1 [OS=Homo sapiens]",0,24.716,2,2,2,3,2,2266,247.7,5.48,7.03,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function",NA,"23379","hsa:23379; Q68DE1; Q6ZT40; Q7L587; Q7Z3A9; Q9NTH9; Q9Y2F5","ENSG00000164151","RNA polymerase II transcribes snRNA genes",NA,1,0,122.8,101.4,113.8,99.9,108.6,97.5,76.2,98.6,76.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S960(100); S1692(100)]",0,"ENSG00000164151"
"1188","PRKD3",-0.131117753476655,6.59457955117971,-1.41902545382358,0.187567555220197,0.257668560706534,-6.48174615026864,"NONE",FALSE,"High","Master Protein","O94806","Serine/threonine-protein kinase D3 [OS=Homo sapiens]",0,51.577,7,4,4,7,2,890,100.4,6.87,26.17,4,"protein metabolism;other metabolic processes;signal transduction","plasma membrane;other membranes;cytosol;nucleus","kinase activity;other molecular function","Pf00069, Pf00130, Pf00169","23683","D6W587; hsa:23683; O94806; Q53TR7; Q8NEL8","ENSG00000115825","Sphingolipid de novo biosynthesis","G protein signaling pathways; Hippo signaling regulation pathways; Chronic hyperglycemia impairment of neuron function",4,0,105.7,106,96.1,103.8,84.7,95.3,86.3,94.5,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S364(100); S391(100); S735(100)]",0,"ENSG00000115825"
"1189","GIT2",0.17286348285918,6.64946480521649,1.4168643641365,0.188180784193994,0.258293557447096,-6.4845331038175,"NONE",FALSE,"High","Master Protein","Q14161","ARF GTPase-activating protein GIT2 [OS=Homo sapiens]",0,16.518,3,1,1,2,1,759,84.5,7.23,7,1,"transport;developmental processes;other biological processes","nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00023, Pf01412, Pf08518, Pf12205, Pf16559","9815","hsa:9815; Q14161; Q86U59; Q96CI2; Q9BV91; Q9Y5V2","ENSG00000139436","CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle","Integrin-mediated cell adhesion",9,0,80.5,90.8,85.5,87.4,109.9,108.3,106.7,107.1,140.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S415(100)]",0,"ENSG00000139436"
"1190","RPS6KB1",0.113100689846815,6.68199995785902,1.41112477009751,0.189817790263489,0.26011391665862,-6.49192144414311,"NONE",FALSE,"High","Master Protein","P23443","Ribosomal protein S6 kinase beta-1 [OS=Homo sapiens]",0,2.966,2,2,2,3,2,525,59.1,6.65,6.12,2,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00433","6198","B2R779; B4DLT4; B4DTG1; E7ESB8; F6UYM1; hsa:6198; P23443; Q7Z721","ENSG00000108443","mTORC1-mediated signalling","IL-5 signaling pathway; AMP-activated protein kinase signaling; Target of rapamycin signaling; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Kit receptor signaling pathway; IL6 signaling pathway; BDNF-TrkB signaling; Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; PI3K-Akt signaling pathway; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Thermogenesis; EGF/EGFR signaling pathway; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; IL-18 signaling pathway; Cytoplasmic ribosomal proteins; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; IL-2 signaling pathway; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Pleural mesothelioma; GDNF signaling; G13 signaling pathway; Acute myeloid leukemia; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways; ErbB signaling pathway",42,0,91.9,91.1,98.3,105,97.8,112.1,99.4,113.1,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S441(100); S447(100)]",0,"ENSG00000108443"
"1191","KIAA0930",0.212672075085623,6.65354054472493,1.41109685711837,0.189825781090941,0.26011391665862,-6.4919573274183,"NONE",FALSE,"High","Master Protein","Q6ICG6","Uncharacterized protein KIAA0930 [OS=Homo sapiens]",0,4.816,2,1,1,2,1,404,45.8,7.94,5.07,1,NA,NA,NA,"Pf09741","23313","B0QY17; B0QY19; B3KT48; hsa:23313; Q6ICG6; Q6ZVE5; Q7Z6K9; Q8IZ76; Q9Y2E2","ENSG00000100364",NA,NA,0,0,77.1,77.3,72.3,98.4,58.2,114,133.5,155.1,150.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S362(100)]",0,"ENSG00000100364"
"1192","PKD2",0.1503930546441,6.63914392924686,1.40683016105507,0.19105062381975,0.261572666169322,-6.49743686717208,"NONE",FALSE,"High","Master Protein","Q13563","Polycystin-2 [OS=Homo sapiens]",0,10.95,2,1,1,1,1,968,109.6,5.69,3.24,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;transporter activity;cytoskeletal activity;other molecular function","Pf08016, Pf18109, Pf20519","5311","hsa:5311; O60441; Q13563; Q15764; Q2M1Q3; Q2M1Q5","ENSG00000118762","VxPx cargo-targeting to cilium","Polycystic kidney disease pathway; Ciliopathies; Bardet-Biedl syndrome",4,0,91.5,104.3,86.3,106.4,114.4,105,87.9,102.3,108.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S166(100)]",0,"ENSG00000118762"
"1193","PRRC2A",0.121375764624015,6.66079838616145,1.40423681688183,0.191798392415133,0.262278265875181,-6.50076206729083,"NONE",FALSE,"High","Master Protein","P48634","Protein PRRC2A [OS=Homo sapiens]",0,71.096,5,6,7,12,6,2157,228.7,9.45,38.17,6,"other biological processes","plasma membrane;other membranes;cytosol;nucleus",NA,"Pf07001","7916","B0UX77; B0UZE9; B0UZL3; hsa:7916; O95875; P48634; Q05BK4; Q4LE37; Q5SQ29; Q5SQ30; Q5ST84; Q5STX6; Q5STX7; Q68DW9; Q6P9P7; Q6PIN1; Q8MGQ9; Q96QC6","ENSG00000204469; ENSG00000206427; ENSG00000225164; ENSG00000225748; ENSG00000226618; ENSG00000231370; ENSG00000231825",NA,NA,0,0,85,90.1,96.3,102.1,110.2,96.7,106.3,106.4,120.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S363(99.4); T610(100); T782(100); S1147(100); S1219(100); S1690(99.4)]",0,"ENSG00000204469"
"1194","REEP2",0.349568031323231,6.67896838532256,1.40385618005626,0.19190835591878,0.262278265875181,-6.50124978246975,"NONE",FALSE,"High","Master Protein","Q9BRK0","Receptor expression-enhancing protein 2 [OS=Homo sapiens]",0,4.15,4,1,1,1,1,252,28.2,9.54,2.11,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi","signal transduction activity or receptor binding;cytoskeletal activity","Pf03134","51308","hsa:51308; Q53EM8; Q9BRK0; Q9NYF2","ENSG00000132563",NA,NA,0,0,94.5,81.7,72.7,98.4,93.3,132.4,138,143.6,81.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S150(100)]",0,"ENSG00000132563"
"1195","RNPC3",-0.186188453180211,6.58479753223425,-1.40337266649639,0.192048117476005,0.262278265875181,-6.50186918960253,"NONE",FALSE,"High","Master Protein","Q96LT9","RNA-binding region-containing protein 3 [OS=Homo sapiens]",0,6.435,6,2,2,3,2,517,58.5,7.72,2.51,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf00076","55599","A8K1C9; D3DT74; hsa:55599; Q5TZ87; Q96FK7; Q96JI8; Q96LT9; Q9NSU7; Q9NXX2","ENSG00000185946","mRNA Splicing - Minor Pathway",NA,1,0,101.1,105.8,110.3,88.6,113.9,91.1,84.4,82.6,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(99.3); S108(100)]",0,"ENSG00000185946"
"1196","GCFC2",0.182101750467718,6.63717201030186,1.39511117073245,0.194449593381056,0.26533589999823,-6.51243087215983,"NONE",FALSE,"High","Master Protein","P16383","Intron Large complex component GCFC2 [OS=Homo sapiens]",0,8.128,2,1,1,1,1,781,89.3,5.99,2.88,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf07842","6936","A4UHQ8; A4UHQ9; hsa:6936; O95032; P16383; Q53TY0; Q6P2F2","ENSG00000005436","mRNA Splicing - Major Pathway",NA,1,0,96.7,79.8,114.9,109.7,110.8,118.6,87,89.8,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S180(100)]",0,"ENSG00000005436"
"1197","COIL",-0.116250744195894,6.65535745242814,-1.38700204051518,0.196831618733105,0.268361906242629,-6.52275762394368,"NONE",FALSE,"High","Master Protein","P38432","Coilin [OS=Homo sapiens]",0,20.086,5,2,2,5,2,576,62.6,9.07,16.74,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf15862","8161","B2R931; hsa:8161; P38432","ENSG00000121058",NA,NA,0,0,101,98.7,105.4,96.1,82.6,109.3,108,103,99.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T122(100); S566(100)]",0,"ENSG00000121058"
"1198","LSM14A",-0.125421020494108,6.62419979916866,-1.37955026618689,0.199042383705652,0.271149557769302,-6.53221194904754,"NONE",FALSE,"High","Master Protein","Q8ND56","Protein LSM14 homolog A [OS=Homo sapiens]",0,65.774,13,9,10,20,8,463,50.5,9.52,62.45,9,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","nucleic acid binding activity","Pf09532, Pf12701","26065","B4DTG6; hsa:26065; Q76LX7; Q8ND56; Q96AR3; Q96K73; Q96SN5; Q9UFR3","ENSG00000257103; ENSG00000262860",NA,NA,0,1,98.8,104.2,103.9,92,83.7,112.6,101.9,98.8,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S13(100); S178(99.6); S183(99); S192(100); S216(100)]",0,"ENSG00000257103"
"1199","RAPGEF1",0.0892744747781711,6.65393940161221,1.37867509052885,0.19930340586467,0.271278697557249,-6.53332008585723,"NONE",FALSE,"High","Master Protein","Q13905","Rap guanine nucleotide exchange factor 1 [OS=Homo sapiens]",0,33.577,5,3,3,6,3,1077,120.5,5.92,20.71,3,"developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00617, Pf00618","2889","hsa:2889; Q13905; Q5JUE4; Q68DL3; Q8IV73","ENSG00000107263","RAC3 GTPase cycle; Regulation of signaling by CBL; Downstream signal transduction; Erythropoietin activates RAS; Frs2-mediated activation; MET activates RAP1 and RAC1","Integrin-mediated cell adhesion; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; IL-3 signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; MET in type 1 papillary renal cell carcinoma; Insulin signaling; Interferon type I signaling pathways",17,0,92.3,89.4,97.4,103.1,99,104.5,104.7,108.1,107.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S253(100); S281(100); S311(100)]",0,"ENSG00000107263"
"1200","SPPL2B",0.211209807242769,6.62809523105256,1.37466067696589,0.200504433748062,0.272686029897364,-6.53839706309986,"NONE",FALSE,"High","Master Protein","Q8TCT7","Signal peptide peptidase-like 2B [OS=Homo sapiens]",0,12.226,5,1,1,1,1,592,64.6,8.32,4.16,1,"protein metabolism;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle","other molecular function","Pf02225, Pf04258","56928","D6W609; hsa:56928; O60365; Q567S3; Q8IUH9; Q8TCT7; Q9BUY6; Q9H3M4; Q9NPN2; Q9P1Z6","ENSG00000005206","Regulation of TNFR1 signaling",NA,1,0,86.2,77.7,96.5,99.8,81.4,125.6,119.3,108.7,93.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S550(100)]",0,"ENSG00000005206"
"1201","PAK2",-0.144399536407653,6.6906031280133,-1.37330909715076,0.200910176267624,0.273010331114707,-6.54010415883686,"NONE",FALSE,"High","Master Protein","Q13177","Serine/threonine-protein kinase PAK 2 [OS=Homo sapiens]",0,20.098,4,3,3,8,3,524,58,5.96,24.52,3,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf00786","5062","hsa:5062; Q13154; Q13177; Q6ISC3","ENSG00000180370","Regulation of activated PAK-2p34 by proteasome mediated degradation; MAPK6/MAPK4 signaling; FCERI mediated MAPK activation; Generation of second messenger molecules; Regulation of PAK-2p34 activity by PS-GAP/RHG10; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation; RHOU GTPase cycle; Ephrin signaling; Sema3A PAK dependent Axon repulsion; Smooth Muscle Contraction; RHO GTPases activate PAKs; VEGFR2 mediated vascular permeability; Activation of RAC1; RHOH GTPase cycle; CD209 (DC-SIGN) signaling; CD28 dependent Vav1 pathway; Nef and signal transduction; Stimulation of the cell death response by PAK-2p34","Integrin-mediated cell adhesion; Apoptosis-related network due to altered Notch3 in ovarian cancer; Focal adhesion; Fas ligand pathway and stress induction of heat shock proteins; TGF-beta signaling pathway; MAPK signaling pathway; VEGFA-VEGFR2 signaling; MET in type 1 papillary renal cell carcinoma; Ras signaling; Pancreatic adenocarcinoma pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; 3q29 copy number variation syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; ErbB signaling pathway",45,0,89.1,98.3,92.7,91.8,65.1,100,128.5,136.9,124.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S141(100)]",0,"ENSG00000180370"
"1202","TMEM230",-0.208308860482003,6.55761211349922,-1.36767559281999,0.202608846907035,0.275089549211548,-6.5472073489166,"NONE",FALSE,"High","Master Protein","Q96A57","Transmembrane protein 230 [OS=Homo sapiens]",0,35.98,22,3,4,9,3,120,13.2,9.31,31.81,3,"transport","other membranes;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf05915","29058","B2RDM8; D3DVZ9; hsa:29058; Q0VGC8; Q5TDS5; Q96A57; Q96ES2; Q9P0A7","ENSG00000089063",NA,NA,0,0,73.2,77.7,73.7,53.5,75.1,61.8,173.9,136,178.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(99.7); S24(99.7)]",0,"ENSG00000089063"
"1203","TUBB2B",-0.107643680630376,6.63709843833442,-1.35790765939666,0.205582968706592,0.278895598444853,-6.55947695582747,"NONE",FALSE,"High","Master Protein","Q9BVA1","Tubulin beta-2B chain [OS=Homo sapiens]",0,281.564,42,14,22,61,5,445,49.9,4.89,162.78,14,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00091, Pf03953","347733","A8K068; hsa:347733; Q9BVA1","ENSG00000137285","MHC class II antigen presentation; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Assembly and cell surface presentation of NMDA receptors; Intraflagellar transport; Recycling pathway of L1; COPI-dependent Golgi-to-ER retrograde traffic; Separation of Sister Chromatids; The role of GTSE1 in G2/M progression after G2 checkpoint; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; RHO GTPases Activate Formins; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Activation of AMPK downstream of NMDARs; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; PKR-mediated signaling; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",35,13,105.8,98.9,103.7,99,82.6,111.1,97.8,99.6,98.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T55(100); S75(100); S172(100); T312(100)]",0,"ENSG00000137285"
"1204","SIPA1L2",-0.097402723211057,6.66945721717169,-1.35338170933698,0.2069734678581,0.280548753774434,-6.56514189382771,"NONE",FALSE,"High","Master Protein","Q9P2F8","Signal-induced proliferation-associated 1-like protein 2 [OS=Homo sapiens]",0,51.808,4,5,5,8,5,1722,190.3,6.77,25.61,5,"other biological processes","other cell component","enzyme regulator activity","Pf00595, Pf02145, Pf11881, Pf21022","57568","hsa:57568; Q2TV88; Q5VXR7; Q5VXR8; Q641Q4; Q8NA38; Q96DZ3; Q9H9F6; Q9P2F8","ENSG00000116991",NA,NA,0,0,101.2,103.9,99.4,96,94.9,101.9,110.1,102.1,105.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(99.2); S194(99.4); S1461(100); S1488(100); S1652(100)]",0,"ENSG00000116991"
"1205","STX12",0.134032006782047,6.6334792377535,1.35094936739277,0.207724021722533,0.281332450996825,-6.56818105430791,"NONE",FALSE,"High","Master Protein","Q86Y82","Syntaxin-12 [OS=Homo sapiens]",0,7.847,4,1,2,5,1,276,31.6,5.59,5.51,1,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf05739, Pf14523","23673","B1AJQ7; hsa:23673; O95564; Q86Y82","ENSG00000117758",NA,NA,0,0,92,93.1,96.4,99.2,123.7,104.8,90.3,98.6,108.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S142(100)]",0,"ENSG00000117758"
"1206","CARMIL1",0.107351414789124,6.65796034646622,1.34741457027183,0.208818848910362,0.282562663162067,-6.57259108799349,"NONE",FALSE,"High","Master Protein","Q5VZK9","F-actin-uncapping protein LRRC16A [OS=Homo sapiens]",0,85.663,8,8,8,14,8,1371,151.5,7.85,41.64,8,"cell organization and biogenesis;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13516, Pf16000, Pf17888","55604","B8X1J0; hsa:55604; Q5VZK9; Q6ZUH5; Q6ZW07; Q9NXU7","ENSG00000079691","Factors involved in megakaryocyte development and platelet production",NA,1,0,79.8,88.3,80.3,96.8,79.9,95.7,127,136.1,126.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S122(100); S880(100); T916(100); S960(100); S1094(100); S1360(100)]",0,"ENSG00000079691"
"1207","SNIP1",-0.175228786438732,6.56362035504184,-1.34689998053346,0.208978636296945,0.282562663162067,-6.57323243786146,"NONE",FALSE,"High","Master Protein","Q8TAD8","Smad nuclear-interacting protein 1 [OS=Homo sapiens]",0,41.173,10,4,5,11,4,396,45.8,9.99,15.6,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus","nucleic acid binding activity","Pf00498","79753","hsa:79753; Q8TAD8; Q96SP9; Q9H9T7","ENSG00000163877","mRNA Splicing - Major Pathway","TGF-beta signaling pathway",2,0,99.5,110.4,107.9,88.4,122.6,87.7,91.9,88.8,79.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(100); S54(99.5); S76(100)]",0,"ENSG00000163877"
"1208","RRAS2",0.142601473579386,6.64903867981627,1.34600562699335,0.209256590505769,0.282704267968059,-6.5743467028431,"NONE",FALSE,"High","Master Protein","P62070","Ras-related protein R-Ras2 [OS=Homo sapiens]",0,40.111,8,3,3,5,3,204,23.4,6.01,20.92,3,"developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi","other molecular function","Pf00071","22800","B2R9Z3; B7Z5Z2; B7Z6C4; B7Z7H6; hsa:22800; P17082; P62070","ENSG00000133818","RND1 GTPase cycle","MAPK signaling pathway; Ras signaling; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; EGFR tyrosine kinase inhibitor resistance; Regulation of actin cytoskeleton",6,0,95.1,94.6,95.4,108.3,87.8,125.3,99,103.9,92.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S186(100)]",0,"ENSG00000133818"
"1209","GPR161",0.235395150344506,6.56226204998735,1.34477411645039,0.209639837941316,0.282869073711488,-6.5758802028818,"NONE",FALSE,"High","Master Protein","Q8N6U8","G-protein coupled receptor 161 [OS=Homo sapiens]",0,16.351,5,2,2,2,2,529,58.5,8.24,5.74,2,"signal transduction;other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf00001","23432","B3KV34; B7Z5D7; B7Z5E8; B7Z5Z6; F5GXD6; F5H6J7; hsa:23432; O75963; Q5TGK0; Q5TGK1; Q5TGK2; Q8N6U8","ENSG00000143147","Hedgehog 'off' state; Hedgehog 'on' state","Hedgehog signaling pathway; GPCRs, class A rhodopsin-like; Ciliopathies; Alstrom syndrome; Bardet-Biedl syndrome",7,0,95.1,89.3,67.6,77.9,115.3,117.8,97.1,107.8,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S360(100); S517(100)]",0,"ENSG00000143147"
"1210","LRATD2",0.121647947353436,6.67765026904851,1.3444999717934,0.209725232347366,0.282869073711488,-6.57622144278765,"NONE",FALSE,"High","Master Protein","Q96KN1","Protein LRATD2 [OS=Homo sapiens]",0,8.476,10,2,3,7,2,310,34.5,5.54,10.03,2,NA,"plasma membrane;other membranes;other cell component",NA,"Pf04970","157638","hsa:157638; Q96KN1","ENSG00000168672",NA,NA,0,0,87.3,85.5,84.5,102,85.9,98.6,118.6,139.8,117,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100); T289(99.1)]",0,"ENSG00000168672"
"1211","AKAP13",0.100567752258509,6.66620113750594,1.33341849417533,0.213201598263216,0.287320403274623,-6.58997522564127,"NONE",FALSE,"High","Master Protein","Q12802","A-kinase anchor protein 13 [OS=Homo sapiens]",0,74.173,4,7,9,13,7,2813,307.4,5.24,36.91,7,"developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf00621, Pf10522","11214","hsa:11214; Q12802; Q14572; Q59FP6; Q86W90; Q8WXQ6; Q96JP6; Q96P79; Q9Y5T0; Q9Y5T6","ENSG00000170776","RHOC GTPase cycle; RHOA GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle","Glucocorticoid receptor pathway; Nuclear receptors meta-pathway; G protein signaling pathways",8,0,93.9,89.3,94.2,106.5,89.5,109.4,109.1,105.8,112.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S790(100); S983(100); S1559(100); S1876(100); S1929(100); S2498(99.5); S2728(100)]",0,"ENSG00000170776"
"1212","GRAMD2B",-0.187550863235677,6.67913237925309,-1.3311353207104,0.21392382524599,0.288055843895591,-6.59279929613566,"NONE",FALSE,"High","Master Protein","Q96HH9","GRAM domain-containing protein 2B [OS=Homo sapiens]",0,54.599,15,4,4,5,4,432,47.8,7.9,18.22,4,NA,"cytoskeleton","other molecular function","Pf02893","65983","B7Z1F2; B7Z3R1; B7Z6D8; B7Z8T2; D3DSZ3; hsa:65983; Q96HH9; Q9H753","ENSG00000155324",NA,NA,0,0,96.2,94.6,94.2,75.8,66.4,113.9,134.8,120.1,124.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S72(99.4); T220(99.7)]",0,"ENSG00000155324"
"1213","STAT5B",-0.244712209715394,6.5758223301074,-1.32062673797034,0.217274430277381,0.292326356317136,-6.60575445053639,"NONE",FALSE,"High","Master Protein","P51692","Signal transducer and activator of transcription 5B [OS=Homo sapiens]",0,6.041,2,1,1,1,1,787,89.8,6.05,2.38,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00017, Pf01017, Pf02864, Pf02865, Pf21354","6777","hsa:6777; P51692; Q8WWS8","ENSG00000173757","Interleukin-3, Interleukin-5 and GM-CSF signaling; Interleukin-7 signaling; Signaling by SCF-KIT; Downstream signal transduction; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Growth hormone receptor signaling; Signaling by Leptin; Signaling by CSF3 (G-CSF); Inactivation of CSF3 (G-CSF) signaling; Signaling by cytosolic FGFR1 fusion mutants; Prolactin receptor signaling; Interleukin-20 family signaling; Erythropoietin activates STAT5; Signaling by FLT3 fusion proteins; Interleukin-2 signaling; STAT5 activation downstream of FLT3 ITD mutants; Interleukin-15 signaling; Interleukin-9 signaling; Interleukin-21 signaling; STAT5 Activation","IL-5 signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; AGE/RAGE pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; RAC1/PAK1/p38/MMP2 pathway; Chemokine signaling pathway; IL-4 signaling pathway; PDGFR-beta pathway; White fat cell differentiation; Non-small cell lung cancer; EGF/EGFR signaling pathway; Measles virus infection; Hepatitis B infection; Endochondral ossification; Endochondral ossification with skeletal dysplasias; IL-2 signaling pathway; 3q29 copy number variation syndrome; FOXP3 in COVID-19; Familial partial lipodystrophy; Acute myeloid leukemia; JAK-STAT signaling in the regulation of beta cells; EPO receptor signaling; ErbB signaling pathway",51,0,115.1,107.7,99.3,93.8,78.9,99.3,92.5,117.4,69.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000173757"
"1214","SLC39A10",-0.193801832056621,6.64104641090933,-1.31585426379687,0.218810527818735,0.294150561285152,-6.61161461089843,"NONE",FALSE,"High","Master Protein","Q9ULF5","Zinc transporter ZIP10 [OS=Homo sapiens]",0,17.391,5,3,3,5,3,831,94.1,6.76,10.44,3,"transport;other biological processes","plasma membrane;other membranes","transporter activity","Pf02535","57181","A8K5C6; B4DGU0; hsa:57181; Q3MJA4; Q68CR5; Q6DKH6; Q9ULF5; Q9Y3Z1","ENSG00000196950","Zinc influx into cells by the SLC39 gene family","Nuclear receptors meta-pathway; NRF2 pathway; Zinc homeostasis",4,0,93.7,96.4,93.8,99.5,60.2,92.2,129.1,128,101.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T536(100); S546(100); S591(100)]",0,"ENSG00000196950"
"1215","USP24",-0.146467862051484,6.64665618288831,-1.31240691993999,0.219925738572044,0.29540642415603,-6.61583848519676,"NONE",FALSE,"High","Master Protein","Q9UPU5","Ubiquitin carboxyl-terminal hydrolase 24 [OS=Homo sapiens]",0,69.002,2,4,5,17,3,2620,294.2,6.14,53.33,4,"protein metabolism","cytosol;nucleus","other molecular function","Pf00443","23358","hsa:23358; Q6ZSY2; Q8N2Y4; Q9NXD1; Q9UPU5","ENSG00000162402","Ub-specific processing proteases",NA,1,0,108.9,102.5,103.6,105.8,71.4,110.3,97.4,106.5,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2047(100); S2561(100)]",0,"ENSG00000162402"
"1216","UBE4B",0.160705748897975,6.6591129584287,1.30722349157838,0.221611482897932,0.297425937573541,-6.62217501127323,"NONE",FALSE,"High","Master Protein","O95155","Ubiquitin conjugation factor E4 B [OS=Homo sapiens]",0,13.048,3,2,2,2,2,1302,146.1,6.55,5.1,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf04564, Pf10408","10277","A8K8S9; G0ZJH6; O75169; O95155; O95338; Q5SZ12; Q5SZ16; Q96QD4; Q9BYI7","ENSG00000130939",NA,NA,0,0,87.4,90.1,88.1,97.3,128.6,92.8,113.3,100.8,123.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S105(100); S238(100)]",0,"ENSG00000130939"
"1217","TOMM20",-0.122980925053474,6.62733165685277,-1.30155880753448,0.22346602345458,0.299668488313784,-6.62907986739981,"NONE",FALSE,"High","Master Protein","Q15388","Mitochondrial import receptor subunit TOM20 homolog [OS=Homo sapiens]",0,8.352,9,1,2,6,1,145,16.3,8.6,14.49,1,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;mitochondrion;other cell component","transporter activity;other molecular function","Pf02064","9804","A8K195; hsa:9804; Q15388; Q498B3; Q6IBT4","ENSG00000173726","Ub-specific processing proteases; Mitochondrial protein import; PINK1-PRKN Mediated Mitophagy",NA,3,0,96.4,96.7,96.9,93.4,93.2,87.6,118.2,104.8,101,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S138(100)]",0,"ENSG00000173726"
"1218","CRK",-0.118703241876288,6.62636132524742,-1.29465873177251,0.225742414727886,0.302472595103374,-6.63746225120709,"NONE",FALSE,"High","Master Protein","P46108-2","Isoform Crk-I of Adapter molecule crk [OS=Homo sapiens]",0,28.309,16,2,2,4,2,204,22.9,5.48,13.03,2,NA,NA,NA,NA,NA,"P46108-2",NA,NA,NA,0,0,91.9,111.3,109.1,99.8,104.6,93.6,93.1,95.5,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(100); S194(100)]",0,"ENSG00000167193"
"1219","TXLNB",0.253778156791268,6.66182198413891,1.28533556345211,0.228848710844582,0.306383179736143,-6.64873855911769,"NONE",FALSE,"High","Master Protein","Q8N3L3","Beta-taxilin [OS=Homo sapiens]",0,11.28,4,1,1,1,1,684,76.5,4.93,3.69,1,NA,"other cell component","other molecular function","Pf09728","167838","hsa:167838; Q5HYH7; Q5VTF3; Q76L25; Q86T52; Q8N3L3; Q8N3S2","ENSG00000164440",NA,NA,0,0,91.6,92.5,83.8,132.8,84.6,104.3,125.1,107.9,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S554(100)]",0,"ENSG00000164440"
"1220","BRAP",0.141725225677819,6.65739964087474,1.28354556394766,0.229449131836548,0.306480985162149,-6.65089698246598,"NONE",FALSE,"High","Master Protein","Q7Z569","BRCA1-associated protein [OS=Homo sapiens]",0,21.034,4,2,2,2,2,592,67.3,5.92,6.49,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02148, Pf07576, Pf13639","8315","B4DRM1; B9EGS8; hsa:8315; O43238; O75341; Q7Z569","ENSG00000089234","RAF activation; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Negative regulation of MAPK pathway","Ras signaling",6,0,93.7,94.2,93.5,117.1,116.6,91.8,101.5,107.2,98.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T99(99.5); S117(100)]",0,"ENSG00000089234"
"1221","IRF2BP2",0.112471609796929,6.64402461848659,1.28351648618704,0.229458896151487,0.306480985162149,-6.65093202759372,"NONE",FALSE,"High","Master Protein","Q7Z5L9","Interferon regulatory factor 2-binding protein 2 [OS=Homo sapiens]",0,44.289,12,4,4,6,4,587,61,8.69,22.36,4,"other biological processes","nucleus;other cell component","other molecular function","Pf11261","359948","B1AM35; B1AM36; hsa:359948; Q6P083; Q7Z5L8; Q7Z5L9; Q8N351; Q8WUH8","ENSG00000168264",NA,NA,0,0,83.1,85.5,88.4,95.5,107.1,90.1,120.5,114.3,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S175(100); S240(100); S360(100)]",0,"ENSG00000168264"
"1222","CGN",0.149986703703703,6.62106876387272,1.28343830999048,0.229485149429011,0.306480985162149,-6.65102624440932,"NONE",FALSE,"High","Master Protein","Q9P2M7","Cingulin [OS=Homo sapiens]",0,13.899,2,1,1,2,1,1203,137,5.52,7.46,1,"cell organization and biogenesis","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity","Pf01576","57530","A6H8L3; A7MD22; hsa:57530; Q5T386; Q9NR25; Q9P2M7","ENSG00000143375","TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","15q11q13 copy number variation",2,0,82.7,86.3,83.9,105.1,69.2,112.7,116.8,109.4,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S165(100)]",0,"ENSG00000143375"
"1223","PKN2",-0.253563582569638,6.61236955801339,-1.2781247903793,0.231275370858893,0.308501012380969,-6.65742051504177,"NONE",FALSE,"High","Master Protein","Q16513","Serine/threonine-protein kinase N2 [OS=Homo sapiens]",0,12.484,4,2,2,4,2,984,112,6.3,3.26,2,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00433, Pf02185","5586","B4DQ21; B4DTP5; B4DVG1; D3DT24; hsa:5586; Q08AF4; Q16513; Q9H1W4","ENSG00000065243","RAC1 GTPase cycle; RHOC GTPase cycle; RHOA GTPase cycle; RHOB GTPase cycle; RHO GTPases activate PKNs","PI3K-Akt signaling pathway",6,0,98.7,103.6,92,62.2,111.5,85.8,104.2,96.6,147.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S583(100)]",0,"ENSG00000065243"
"1224","EFNB1",-0.131208855887746,6.6185303839273,-1.27782783627085,0.231375759285727,0.308501012380969,-6.65777731492917,"NONE",FALSE,"High","Master Protein","P98172","Ephrin-B1 [OS=Homo sapiens]",0,27.006,4,1,2,7,1,346,38,8.94,21.08,1,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","signal transduction activity or receptor binding","Pf00812","1947","D3DVU0; hsa:1947; P98172","ENSG00000090776","EPHB-mediated forward signaling; Ephrin signaling; EPH-ephrin mediated repulsion of cells",NA,4,0,102.5,90.6,98,89.4,99,86.5,96.6,116.3,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S281(100)]",0,"ENSG00000090776"
"1225","BORCS6",-0.093518200269302,6.62682823276099,-1.27369307792769,0.232777295799175,0.310116364689187,-6.66273925513881,"NONE",FALSE,"High","Master Protein","Q96GS4","BLOC-1-related complex subunit 6 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,357,37.2,5.76,5.13,1,"cell organization and biogenesis;transport;other biological processes","other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf10157","54785","hsa:54785; Q53HS4; Q96GS4; Q9NXW8","ENSG00000196544",NA,NA,0,0,104.2,98,97.4,98.1,85.3,102.6,98.8,105.9,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T196(100)]",0,"ENSG00000196544"
"1226","PARD3",0.173488445877771,6.65144914122474,1.27268558372102,0.233119858835075,0.310319420570018,-6.66394657588033,"NONE",FALSE,"High","Master Protein","Q8TEW0","Partitioning defective 3 homolog [OS=Homo sapiens]",0,45.03,5,5,5,7,5,1356,151.3,7.68,25.59,5,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","other molecular function","Pf00595, Pf12053","56288","F5H5T0; hsa:56288; Q5T2U1; Q5VUA2; Q5VUA3; Q5VWV0; Q5VWV1; Q5VWV3; Q5VWV4; Q5VWV5; Q6IQ47; Q8TCZ9; Q8TEW0; Q8TEW1; Q8TEW2; Q8TEW3; Q96K28; Q96RM6; Q96RM7; Q9BY57; Q9BY58; Q9HC48; Q9NWL4; Q9NYE6","ENSG00000148498","Tight junction interactions; TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)","Chemokine signaling pathway; Complement system in neuronal development and plasticity",4,0,92.1,91.8,90.5,101.2,131.1,99,106.2,89.1,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(100); S695(99.2); S873(100)]",0,"ENSG00000148498"
"1227","RBM8A",0.139773233555237,6.65972129381986,1.27038409934737,0.233903955823653,0.311109418014835,-6.6667019913833,"NONE",FALSE,"High","Master Protein","Q9Y5S9","RNA-binding protein 8A [OS=Homo sapiens]",0,4.48,5,1,1,1,1,174,19.9,5.72,2.4,1,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076","9939","B3KQI9; hsa:9939; Q6FHD1; Q6IQ40; Q9GZX8; Q9NZI4; Q9Y5S9","ENSG00000265241","Regulation of expression of SLITs and ROBOs; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway",NA,6,0,83.2,85.3,81.8,91.8,108.1,91.5,132.4,111,132.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S42(100)]",0,"ENSG00000265241"
"1228","ENO1",-0.143698031046146,6.64843510406973,-1.26981115440872,0.234099490707207,0.311115935532706,-6.66738738953893,"NONE",FALSE,"High","Master Protein","P06733","Alpha-enolase [OS=Homo sapiens]",0,218.577,39,16,20,40,16,434,47.1,7.39,108,16,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00113, Pf03952","2023","B2RD59; hsa:2023; P06733; P22712; Q16704; Q4TUS4; Q53FT9; Q53HR3; Q658M5; Q6GMP2; Q71V37; Q7Z3V6; Q8WU71; Q96GV1; Q9BT62; Q9UCH6; Q9UM55","ENSG00000074800","Glycolysis; Gluconeogenesis; Manipulation of host energy metabolism","Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Aerobic glycolysis; IL-18 signaling pathway; Glycolysis and gluconeogenesis; Metabolic Epileptic Disorders",9,0,109.1,100.2,105.9,105.5,71.9,110.9,93.3,106.7,100.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(100); S40(99.5); S272(100); S419(100)]",0,"ENSG00000074800"
"1229","RRP12",-0.116028979176469,6.62441082944316,-1.26905724579559,0.234356989927511,0.311204725436694,-6.66828893450354,"NONE",FALSE,"High","Master Protein","Q5JTH9","RRP12-like protein [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1297,143.6,8.75,7.49,1,"RNA metabolism OR transcription;other metabolic processes","plasma membrane;other membranes;cytosol;nucleus;other cell component",NA,"Pf08161","23223","B4DK00; E9PCK7; hsa:23223; Q5JTH8; Q5JTH9; Q69YK4; Q96E87; Q9BUH3; Q9Y4C7","ENSG00000052749",NA,NA,0,0,104.9,92.2,92.1,84.8,83.1,103,111.3,107.3,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1080(100)]",0,"ENSG00000052749"
"1230","RNF25",-0.140705064542432,6.61730366841883,-1.26746804440892,0.234900548817763,0.311618633173995,-6.67018809784199,"NONE",FALSE,"High","Master Protein","Q96BH1","E3 ubiquitin-protein ligase RNF25 [OS=Homo sapiens]",0,2.944,2,1,1,1,1,459,51.2,6.54,2.78,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;translational apparatus;nucleus","other molecular function","Pf05773, Pf13639","64320","A8K0D6; hsa:64320; Q53HQ5; Q96BH1; Q9H874","ENSG00000163481","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,102.3,86.6,104.2,86.5,91.4,94.3,93.7,117.1,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S450(100)]",0,"ENSG00000163481"
"1231","ATP2B2",0.0998687939751894,6.62550017207071,1.26702994780527,0.235050574410042,0.311618633173995,-6.67071134405048,"NONE",FALSE,"High","Master Protein","Q01814","Plasma membrane calcium-transporting ATPase 2 [OS=Homo sapiens]",0,36.112,4,3,5,7,1,1243,136.8,5.91,19.65,3,"transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","signal transduction activity or receptor binding;transporter activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf12424, Pf13246","491","hsa:491; O00766; Q01814; Q12994; Q16818","ENSG00000157087","Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels","Vitamin D-sensitive calcium signaling in depression; PKC-gamma calcium signaling pathway in ataxia; Calcium regulation in cardiac cells",6,0,86.4,87.8,88.9,94.6,98.7,100.3,112.3,102.3,118.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S18(99.6); S1150(99.7); S1234(98.9)]",0,"ENSG00000157087"
"1232","APOOL",-0.325651061844185,6.4566298586804,-1.26615560153873,0.235350228685826,0.311713830453617,-6.67175524537512,"NONE",FALSE,"High","Master Protein","Q6UXV4","MICOS complex subunit MIC27 [OS=Homo sapiens]",0,6.062,4,1,1,1,1,268,29.1,9.52,3.16,1,"cell organization and biogenesis","non-structural extracellular;other membranes;mitochondrion;other cell component",NA,"Pf09769","139322","hsa:139322; Q3KNU7; Q5H9D1; Q6UXV4","ENSG00000155008","Platelet degranulation ; Cristae formation",NA,2,0,111.7,101.9,105.7,72.7,152.5,61.8,74.2,92.9,70.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(99.6)]",0,"ENSG00000155008"
"1233","PSIP1",-0.129897307012153,6.64551901673481,-1.26570615906156,0.235504382934626,0.311713830453617,-6.67229164488313,"NONE",FALSE,"High","Master Protein","O75475","PC4 and SFRS1-interacting protein [OS=Homo sapiens]",0,107.799,16,8,8,16,8,530,60.1,9.13,66.04,8,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00855, Pf11467","11168","D3DRI9; hsa:11168; O00256; O75475; O95368; Q6P391; Q86YB9; Q9NZI3; Q9UER6","ENSG00000164985","Vpr-mediated nuclear import of PICs; Formation of WDR5-containing histone-modifying complexes; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection","MECP2 and associated Rett syndrome",8,0,96.4,106.4,106,98.8,85.2,103.7,106.2,108.6,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S106(100); T122(100); S129(100); S177(100); S273(98.9)]",0,"ENSG00000164985"
"1234","PRKCG",-0.132688127155098,6.5963503161095,-1.26399652194364,0.236091529804117,0.312237744441101,-6.67433081788673,"NONE",FALSE,"High","Master Protein","P05129","Protein kinase C gamma type [OS=Homo sapiens]",0,10.516,4,2,2,2,1,697,78.4,7.46,5.32,2,"cell-cell signaling;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf00130, Pf00168, Pf00433","5582","B7Z8Q0; hsa:5582; P05129","ENSG00000126583","G alpha (z) signalling events; Disinhibition of SNARE formation; WNT5A-dependent internalization of FZD4; Trafficking of GluR2-containing AMPA receptors; Calmodulin induced events","Glioblastoma signaling pathways; Common pathways underlying drug addiction; Myometrial relaxation and contraction pathways; Focal adhesion; G protein signaling pathways; Wnt signaling pathway; MAPK signaling pathway; Wnt signaling pathway and pluripotency; Ras signaling; Non-small cell lung cancer; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Hippo signaling regulation pathways; Hepatitis B infection; PKC-gamma calcium signaling pathway in ataxia; Osteoblast differentiation and related diseases; EGFR tyrosine kinase inhibitor resistance; Kisspeptin/kisspeptin receptor system in the ovary; Neuroinflammation and glutamatergic signaling; Opioid receptor pathways; Chronic hyperglycemia impairment of neuron function; Calcium regulation in cardiac cells; ErbB signaling pathway",29,0,102.9,101.6,111.6,96.4,113.6,92.7,87.2,84.2,98.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T514(100); T655(100)]",0,"ENSG00000126583"
"1235","ARID1A",-0.115610945425521,6.64523663187456,-1.26306149501621,0.236413157977685,0.312409938315452,-6.67544524136578,"NONE",FALSE,"High","Master Protein","O14497","AT-rich interactive domain-containing protein 1A [OS=Homo sapiens]",0,56.016,3,4,4,6,4,2285,241.9,6.7,22.01,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01388, Pf12031","8289","D3DPL1; hsa:8289; O14497; Q53FK9; Q5T0W1; Q5T0W2; Q5T0W3; Q8NFD6; Q96T89; Q9BY33; Q9HBJ5; Q9UPZ1","ENSG00000117713","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; RMTs methylate histone arginines","Androgen receptor network in prostate cancer; Pathways affected in adenoid cystic carcinoma; Tumor suppressor activity of SMARCB1; Thermogenesis; Kleefstra syndrome",7,0,99.3,90.6,107.3,94,79.5,104.8,109.9,108.2,102.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S696(100); S1184(100); S1751(100); S1755(99.4)]",0,"ENSG00000117713"
"1236","UVRAG",0.252267756186224,6.62496445291978,1.26147402204326,0.236960037032455,0.312879272198193,-6.67733594247886,"NONE",FALSE,"High","Master Protein","Q9P2Y5","UV radiation resistance-associated gene protein [OS=Homo sapiens]",0,14.416,3,1,1,1,1,699,78.1,8.29,3.2,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;transport;other biological processes","other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00168, Pf10186","7405","B3KTC1; hsa:7405; O00392; Q9P2Y5","ENSG00000198382","Macroautophagy; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex; SARS-CoV-2 modulates autophagy","Nanoparticle triggered autophagic cell death; Autophagy",6,0,93.6,76.5,86.5,124.7,74.7,109.2,124,114.7,84.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S498(100)]",0,"ENSG00000198382"
"1237","DNMBP",0.227131545581401,6.62384965454436,1.25889598602796,0.237850374248323,0.313782183329952,-6.68040279658748,"NONE",FALSE,"High","Master Protein","Q6XZF7","Dynamin-binding protein [OS=Homo sapiens]",0,17.211,3,3,3,3,3,1577,177.2,5.39,8.08,3,"cell organization and biogenesis;signal transduction;other biological processes","cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity","Pf00018, Pf00621, Pf03114, Pf07653, Pf14604","23268","hsa:23268; Q6XZF7; Q8IVY3; Q9Y2L3","ENSG00000107554","CDC42 GTPase cycle","15q11q13 copy number variation",2,0,77.2,57.3,102.8,104.6,71.2,100.5,117.6,130.1,138.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S659(100); S684(100); S1379(100)]",0,"ENSG00000107554"
"1238","HSPA4",0.135834532325579,6.6547590006765,1.25812982911648,0.238115498682273,0.313782183329952,-6.68131335860074,"NONE",FALSE,"High","Master Protein","P34932","Heat shock 70 kDa protein 4 [OS=Homo sapiens]",0,7.914,2,1,1,1,1,840,94.3,5.19,2.96,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport","non-structural extracellular;cytosol;mitochondrion;nucleus","other molecular function","Pf00012","3308","hsa:3308; O95756; P34932; Q2TAL4; Q9BUK9","ENSG00000170606","Regulation of HSF1-mediated heat shock response","Parkin-ubiquitin proteasomal system pathway; HDAC6 interactions in the central nervous system",3,0,90.1,84.2,96.5,103.6,90.2,111.6,118.2,113.5,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S647(100)]",0,"ENSG00000170606"
"1239","DISP2",-0.155957132706313,6.61713494257211,-1.25782611341322,0.238220664917776,0.313782183329952,-6.6816742087861,"NONE",FALSE,"High","Master Protein","A7MBM2","Protein dispatched homolog 2 [OS=Homo sapiens]",0,18.351,3,2,2,3,2,1401,151.9,7.85,9.52,2,"transport;signal transduction","plasma membrane;other membranes","transporter activity",NA,"85455","A7MBM2; Q6AHW3; Q9C0C1","ENSG00000140323","Release of Hh-Np from the secreting cell",NA,1,0,98.2,107.7,96.1,84.8,113.8,86.6,106.8,104.1,94.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1373(100)]",0,"ENSG00000140323"
"1240","KCNQ2",0.104905994030337,6.63720650447102,1.25652752440404,0.238670751021845,0.314121504570686,-6.68321638266704,"NONE",FALSE,"High","Master Protein","O43526","Potassium voltage-gated channel subfamily KQT member 2 [OS=Homo sapiens]",0,28.019,4,3,3,3,3,872,95.8,9.23,11.76,3,"cell-cell signaling;transport;developmental processes","plasma membrane;other membranes;other cell component","transporter activity;cytoskeletal activity;other molecular function","Pf00520, Pf03520, Pf11956, Pf16642","3785","hsa:3785; O43526; O43796; O75580; O95845; Q4VXP4; Q4VXR6; Q5VYT8; Q96J59; Q99454","ENSG00000075043","Interaction between L1 and Ankyrins; Voltage gated Potassium channels","Splicing factor NOVA regulated synaptic proteins; Vitamin D-sensitive calcium signaling in depression; KCNQ2-related epilepsies; Acetaminophen in analgesia and antipyresis",6,0,87.2,87.8,86.9,88.4,100.7,104.7,116.4,108.6,116.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S468(99.6); S507(100)]",0,"ENSG00000075043"
"1241","SRSF9",-0.14923830124665,6.66165305722593,-1.25472056450776,0.239298196209624,0.314693518303068,-6.68536038699063,"NONE",FALSE,"High","Master Protein","Q13242","Serine/arginine-rich splicing factor 9 [OS=Homo sapiens]",0.003,2.188,4,1,1,3,1,221,25.5,8.65,6.82,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf00076","8683","hsa:8683; Q13242; Q52LD1","ENSG00000111786","mRNA Splicing - Major Pathway; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination","mRNA processing",6,0,81.7,100,99.1,83.6,83.6,90.7,137.7,110.9,122.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S189(100)]",0,"ENSG00000111786"
"1242","KCNH7",0.229325622365976,6.60970990465837,1.2522678255727,0.240152041966558,0.315562103453641,-6.68826708422417,"NONE",FALSE,"High","Master Protein","Q9NS40","Potassium voltage-gated channel subfamily H member 7 [OS=Homo sapiens]",0,7.363,3,2,3,4,2,1196,134.9,7.65,2.12,2,"transport;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function","Pf00027, Pf00520, Pf13426","90134","hsa:90134; Q53QU4; Q53TB7; Q53TP9; Q8IV15; Q9NS40","ENSG00000184611","Voltage gated Potassium channels",NA,1,0,95.4,87.3,111.4,119.7,94.4,135.4,67.7,91.6,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1104(98.5)]",0,"ENSG00000184611"
"1243","HNRNPK",-0.0849610606369158,6.63864763169947,-1.24708663053848,0.241963914742341,0.317687135043846,-6.69439379052299,"NONE",FALSE,"High","Master Protein","P61978-2","Isoform 2 of Heterogeneous nuclear ribonucleoprotein K [OS=Homo sapiens]",0,62.639,16,6,7,29,6,464,51,5.33,62.37,6,NA,NA,NA,NA,NA,"P61978-2",NA,NA,NA,0,0,98.8,102,102,94.9,102.4,99.6,99.5,99,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S284(100); S379(100)]",0,"ENSG00000165119"
"1244","U2SURP",0.0846520016515324,6.66136276316354,1.24192770569548,0.243779085872053,0.319813077285523,-6.70047598318845,"NONE",FALSE,"High","Master Protein","O15042","U2 snRNP-associated SURP motif-containing protein [OS=Homo sapiens]",0,10.384,2,3,3,7,3,1029,118.2,8.47,7.27,3,"RNA metabolism OR transcription;other metabolic processes","nucleus",NA,"Pf00076, Pf01805, Pf04818, Pf08312","23350","A0PJ60; hsa:23350; O15042; Q0D2M1; Q2NKQ7; Q9BR70","ENSG00000163714","mRNA Splicing - Major Pathway",NA,1,0,92.7,91.5,90.7,103.4,99.6,98.6,106.4,112.5,114.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S485(99.5); T919(100)]",0,"ENSG00000163714"
"1245","TRIM3",0.122536072738548,6.62844153082701,1.24131358206551,0.24399590412839,0.319840414086371,-6.70119880194723,"NONE",FALSE,"High","Master Protein","O75382","Tripartite motif-containing protein 3 [OS=Homo sapiens]",0,33.2,4,2,3,4,2,744,80.8,7.83,14.72,2,"protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf00097, Pf00630, Pf00643, Pf01436","10612","B7Z5E6; F5H2Q8; hsa:10612; O75382; Q4V9L4; Q9C038; Q9C039","ENSG00000110171","Interferon gamma signaling",NA,1,0,94.4,97.5,91.8,108.9,118.4,97.2,96.6,91,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100); S427(100)]",0,"ENSG00000110171"
"1246","RAPGEF2",0.100708923516775,6.65170473526398,1.23720842782909,0.245449284758993,0.321487345687542,-6.70602389942387,"NONE",FALSE,"High","Master Protein","Q9Y4G8","Rap guanine nucleotide exchange factor 2 [OS=Homo sapiens]",0,62.078,6,5,5,7,5,1499,167.3,6.67,27.86,5,"cell organization and biogenesis;protein metabolism;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00595, Pf00617, Pf00618, Pf00788","9693","D3DP27; hsa:9693; Q9Y4G8","ENSG00000109756","RAF/MAP kinase cascade","MAPK signaling pathway",2,0,92.9,98.6,97,108.8,92.1,117.7,97.5,103.2,97.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S930(100); S959(99.4); S1080(100); S1159(98.7); T1217(98.6)]",0,"ENSG00000109756"
"1247","KLHL13",0.140439547310821,6.66158196728552,1.23442824532295,0.246437575966336,0.322522954271901,-6.70928508706047,"NONE",FALSE,"High","Master Protein","Q9P2N7","Kelch-like protein 13 [OS=Homo sapiens]",0,9.627,3,1,1,1,1,655,73.8,6.62,3.7,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;other cell component","other molecular function","Pf00651, Pf01344, Pf07707","90293","B3KV78; B3KWM7; B7Z3S9; B7Z5P2; B7Z802; D3DWH6; hsa:90293; Q6P2E3; Q96QI7; Q9P2N7; Q9UDN9","ENSG00000003096","Antigen processing: Ubiquitination & Proteasome degradation; Neddylation",NA,2,0,87.9,83.1,104.9,106.6,99.6,107.5,103.7,122,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S645(98.3)]",0,"ENSG00000003096"
"1248","STK11",0.195566772820929,6.67691811944719,1.23217193286293,0.247242022796064,0.323316491348699,-6.71192785919527,"NONE",FALSE,"High","Master Protein","Q15831","Serine/threonine-protein kinase STK11 [OS=Homo sapiens]",0,7.934,3,1,1,2,1,433,48.6,7.43,7.19,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;mitochondrion;nucleus;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069","6794","B2RBX7; E7EW76; hsa:6794; Q15831","ENSG00000118046","Regulation of TP53 Activity through Phosphorylation; Energy dependent regulation of mTOR by LKB1-AMPK; FOXO-mediated transcription of cell death genes; AMPK inhibits chREBP transcriptional activation activity","AMP-activated protein kinase signaling; Polycystic kidney disease pathway; mir-124 predicted interactions with cell cycle and differentiation ; ATM signaling in development and disease ; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Female steroid hormones in cardiomyocyte energy metabolism; ADHD and autism (ASD) linked metabolic pathways and SNP",14,0,94.7,91.2,83.7,121.6,70.5,121.7,117.9,109.6,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S31(100)]",0,"ENSG00000118046"
"1249","CDS2",-0.176476986589129,6.6209440275458,-1.22837193036552,0.248601671105315,0.324785157652662,-6.71637078827459,"NONE",FALSE,"High","Master Protein","O95674","Phosphatidate cytidylyltransferase 2 [OS=Homo sapiens]",0,58.372,11,3,4,11,3,445,51.4,7.09,41.36,3,"cell organization and biogenesis;other metabolic processes","other membranes;mitochondrion;ER/Golgi","other molecular function","Pf01148","8760","B2RDC6; D3DW04; hsa:8760; O95674; Q5TDY2; Q5TDY3; Q5TDY4; Q5TDY5; Q9BYK5; Q9NTT2","ENSG00000101290","Synthesis of PG",NA,1,0,111.3,111.4,106.4,109.3,69.5,114.3,93.3,101.3,79.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S33(100)]",0,"ENSG00000101290"
"1250","EPB41L5",-0.104633047121022,6.63250003887354,-1.22792176884045,0.248763141584453,0.324785157652662,-6.71689645234814,"NONE",FALSE,"High","Master Protein","Q9HCM4","Band 4.1-like protein 5 [OS=Homo sapiens]",0,91.572,8,3,6,12,3,733,81.8,6.58,45.11,3,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00373, Pf08736, Pf09379, Pf09380","57669","hsa:57669; Q7Z5S1; Q8IZ12; Q9H975; Q9HCM4","ENSG00000115109","Neurexins and neuroligins","Endoderm differentiation; Mesodermal commitment pathway; Mesodermal commitment pathway",4,0,100.5,109.7,102.5,100.3,87.7,109.4,101.3,90.1,96.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S436(98.4); S517(100); S550(100)]",0,"ENSG00000115109"
"1251","FOXO1",0.375384781365008,6.60048368018753,1.22630678298419,0.249343129407844,0.325282164023662,-6.71878115531477,"NONE",FALSE,"High","Master Protein","Q12778","Forkhead box protein O1 [OS=Homo sapiens]",0.003,2.309,4,1,1,1,1,655,69.6,6.77,2.54,1,"cell-cell signaling;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250, Pf16675, Pf16676","2308","hsa:2308; O43523; Q12778; Q5VYC7; Q6NSK6","ENSG00000150907","Constitutive Signaling by AKT1 E17K in Cancer; MAPK6/MAPK4 signaling; AKT phosphorylates targets in the nucleus; Regulation of localization of FOXO transcription factors; FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes; Interleukin-4 and Interleukin-13 signaling; FOXO-mediated transcription of cell cycle genes; FOXO-mediated transcription of cell death genes; Regulation of FOXO transcriptional activity by acetylation; AKT-mediated inactivation of FOXO1A","Androgen receptor signaling pathway; Energy metabolism; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; AGE/RAGE pathway; Adipogenesis; Constitutive androstane receptor pathway; Pregnane X receptor pathway; Vitamin D receptor pathway; Nuclear receptors meta-pathway; Copper homeostasis; Melatonin metabolism and effects; RAC1/PAK1/p38/MMP2 pathway; Transcription factor regulation in adipogenesis; NAD metabolism, sirtuins and aging; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; miRNA regulation of prostate cancer signaling pathways; White fat cell differentiation; Somatroph axis (GH) and its relationship to dietary restriction and aging; EGF/EGFR signaling pathway; Leukocyte-intrinsic Hippo pathway functions; Gastrin signaling pathway; Thyroid hormones production and peripheral downstream signaling effects; Insulin signaling; Kynurenine pathway and links to cell senescence; FOXA2 pathway; Pleural mesothelioma; Interactions of natural killer cells in pancreatic cancer; GDNF signaling; DYRK1A involvement regarding cell proliferation in brain development; Warburg effect modulated by deubiquitinating enzymes and their substrates; Extrafollicular and follicular B cell activation by SARS-CoV-2; Primary ovarian insufficiency; Rubinstein-Taybi syndrome 1; ErbB signaling pathway",52,0,103.5,87.4,82,130.4,176.8,85.4,59.4,109.7,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000150907"
"1252","PPP1R9A",-0.17676335108068,6.6520830031073,-1.21960877709433,0.251760302270663,0.328039336299685,-6.72657848772326,"NONE",FALSE,"High","Master Protein","Q9ULJ8-3","Isoform 3 of Neurabin-1 [OS=Homo sapiens]",0,52.726,6,4,5,8,4,1374,154,5.59,23.84,4,NA,NA,NA,NA,NA,"Q9ULJ8-3",NA,NA,NA,0,0,97.9,97.9,103,85.6,64.8,121.4,107.3,114.9,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S199(99.4); S338(100); S1250(100)]",0,"ENSG00000158528"
"1253","NR2C2",0.174795903418448,6.66347080489762,1.2193374084975,0.251858632587932,0.328039336299685,-6.72689373837864,"NONE",FALSE,"High","Master Protein","P49116","Nuclear receptor subfamily 2 group C member 2 [OS=Homo sapiens]",0,34.624,9,3,3,3,3,596,65.4,6.28,10.91,3,"developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00104, Pf00105","7182","A8K3H5; B6ZGT8; hsa:7182; P49116; P55092","ENSG00000177463","Nuclear Receptor transcription pathway","Androgen receptor signaling pathway; Nuclear receptors; Hypothesized pathways in pathogenesis of cardiovascular disease; Epithelial to mesenchymal transition in colorectal cancer",5,0,99.5,84.3,99.7,97.5,96.1,136.4,98,111.8,94.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S19(100); S46(100); T352(99.4)]",0,"ENSG00000177463"
"1254","DCAF10",-0.136975919258249,6.63319736712655,-1.21453623020254,0.253603486794982,0.330048556977201,-6.73246281355528,"NONE",FALSE,"High","Master Protein","Q5QP82","DDB1- and CUL4-associated factor 10 [OS=Homo sapiens]",0,15.2,5,1,1,2,1,559,60.5,7.5,7.97,1,"protein metabolism;other metabolic processes","nucleus;other cell component",NA,"Pf00400","79269","A4VCJ5; hsa:79269; Q32NE2; Q5QP82; Q8N2Q5; Q96ET5; Q9BTQ5; Q9H5P6","ENSG00000122741","Neddylation",NA,1,0,126.3,86.6,97.6,97.8,85.5,96.7,103.6,98.7,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S92(100)]",0,"ENSG00000122741"
"1255","RCN1",-0.229166189788195,6.58041691532078,-1.21325536702739,0.254070629716448,0.330393041989836,-6.73394581871871,"NONE",FALSE,"High","Master Protein","Q15293","Reticulocalbin-1 [OS=Homo sapiens]",0,20.009,11,3,3,3,3,331,38.9,5,5.98,3,"developmental processes","ER/Golgi","other molecular function","Pf13202","5954","B7Z1M1; D3DR00; hsa:5954; Q15293","ENSG00000049449","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation","VEGFA-VEGFR2 signaling",3,0,89.8,117,108.6,96.7,108,74.8,116,81.9,85,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100)]",0,"ENSG00000049449"
"1256","PRRC2C",0.0920602133897406,6.65731351161888,1.20886555391214,0.255676915503556,0.332217138616085,-6.73901971029742,"NONE",FALSE,"High","Master Protein","Q9Y520","Protein PRRC2C [OS=Homo sapiens]",0,38.485,2,5,6,10,5,2896,316.7,9.13,24.56,5,"cell organization and biogenesis;other biological processes","cytosol;other cell component",NA,"Pf07001","23215","hsa:23215; Q05DM8; Q49A39; Q6PD54; Q9H2N2; Q9HA05; Q9NSM8; Q9NXL3; Q9UF29; Q9UPQ6; Q9Y520","ENSG00000117523",NA,"VEGFA-VEGFR2 signaling",1,0,93,95.2,92.8,104.3,109.1,99.3,108.7,101.9,105.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2105(100); T2673(100); T2682(98.1); S2694(99.6)]",0,"ENSG00000117523"
"1257","TUBB4B",-0.155626016102391,6.58096424706591,-1.20591348537705,0.256761717052207,0.333361274645348,-6.74242421048935,"NONE",FALSE,"High","Master Protein","P68371","Tubulin beta-4B chain [OS=Homo sapiens]",0,180.606,40,13,17,48,2,445,49.8,4.89,113.24,13,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response","non-structural extracellular;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00091, Pf03953","10383","A2BFA2; hsa:10383; P05217; P68371","ENSG00000188229","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Recruitment of NuMA to mitotic centrosomes; Regulation of PLK1 Activity at G2/M Transition; Loss of Nlp from mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Anchoring of the basal body to the plasma membrane; AURKA Activation by TPX2; Neutrophil degranulation; COPI-dependent Golgi-to-ER retrograde traffic; COPI-mediated anterograde transport; Intraflagellar transport; Recycling pathway of L1; The role of GTSE1 in G2/M progression after G2 checkpoint; Translocation of SLC2A4 (GLUT4) to the plasma membrane; Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane; Gap junction assembly; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Formation of tubulin folding intermediates by CCT/TriC; Post-chaperonin tubulin folding pathway; RHO GTPases activate IQGAPs; COPI-independent Golgi-to-ER retrograde traffic; Carboxyterminal post-translational modifications of tubulin; HCMV Early Events; Assembly and cell surface presentation of NMDA receptors; Activation of AMPK downstream of NMDARs; Aggrephagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Kinesins; PKR-mediated signaling; Prefoldin mediated transfer of substrate  to CCT/TriC; Hedgehog 'off' state","Alzheimer's disease and miRNA effects; Pathogenic Escherichia coli infection; Parkin-ubiquitin proteasomal system pathway; Alzheimer's disease",42,0,125.2,109.3,96.7,107.7,80,107.9,75.4,86.9,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S172(100); T312(100)]",0,"ENSG00000188229"
"1258","AMOT",0.108102699523375,6.64694973249453,1.20238499391197,0.258063204655076,0.33464361895932,-6.74648543754539,"NONE",FALSE,"High","Master Protein","Q4VCS5","Angiomotin [OS=Homo sapiens]",0,15.2,2,1,1,2,1,1084,118,7.64,10.71,1,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf12240","154796","hsa:154796; Q4VCS5; Q504X5; Q9HD27; Q9UPT1","ENSG00000126016",NA,"VEGFA-VEGFR2 signaling; Hippo-Merlin signaling dysregulation; Pleural mesothelioma; GNAQ pathways in port-wine stain",4,0,88.4,94.7,95.1,102.2,99.9,109.7,93.2,112.8,109.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S714(100)]",0,"ENSG00000126016"
"1259","RBM17",0.250288473636168,6.64672052799157,1.20183395303777,0.258266935707286,0.33464361895932,-6.74711888359889,"NONE",FALSE,"High","Master Protein","Q96I25","Splicing factor 45 [OS=Homo sapiens]",0,27.901,8,2,2,3,2,401,44.9,5.97,16.12,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf00076, Pf01585","84991","hsa:84991; Q96GY6; Q96I25","ENSG00000134453","mRNA Splicing - Major Pathway","mRNA processing",2,0,77.5,81.9,99.2,96.4,69.5,150.8,115,104.7,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T71(100); S222(100)]",0,"ENSG00000134453"
"1260","U2AF2",-0.154682218452637,6.66273735650753,-1.20157003150496,0.258364558755357,0.33464361895932,-6.74742219734869,"NONE",FALSE,"High","Master Protein","P26368","Splicing factor U2AF 65 kDa subunit [OS=Homo sapiens]",0,36.064,8,3,3,8,3,475,53.5,9.09,25.38,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00076","11338","hsa:11338; P26368; Q96HC5","ENSG00000063244","mRNA Splicing - Major Pathway; Protein hydroxylation; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination","mRNA processing; Warburg effect modulated by deubiquitinating enzymes and their substrates",7,0,101.9,97.6,101.3,97.3,63.9,115.4,107.3,114,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100); S79(100)]",0,"ENSG00000063244"
"1261","CALD1",0.292623761961615,6.59092404047014,1.19978318720971,0.259026284029409,0.335234651495635,-6.74947444866174,"NONE",FALSE,"High","Master Protein","Q05682-4","Isoform 4 of Caldesmon [OS=Homo sapiens]",0,22.235,10,4,4,4,4,538,62.6,6.37,11.18,4,NA,NA,NA,NA,NA,"Q05682-4",NA,NA,NA,0,0,74.8,83.5,85.9,94.5,180.7,74.1,118.3,88.7,113.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100); T533(99.7)]",0,"ENSG00000122786"
"1262","SLC30A1",-0.188624990226907,6.62344637171146,-1.19844774507162,0.259521730980475,0.335609718668887,-6.75100677730015,"NONE",FALSE,"High","Master Protein","Q9Y6M5","Proton-coupled zinc antiporter SLC30A1 [OS=Homo sapiens]",0,13.931,3,1,1,1,1,507,55.3,6.48,4.75,1,"stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf01545","7779","hsa:7779; Q0VAK9; Q9BZF6; Q9Y6M5","ENSG00000170385","Zinc efflux and compartmentalization by the SLC30 family","Zinc homeostasis",2,0,131.6,113.5,86.4,104.6,97.6,87.4,94.1,107.5,83.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S468(99.5)]",0,"ENSG00000170385"
"1263","MAST1",-0.188328352773881,6.67608086126311,-1.19614657717781,0.260377249146577,0.336449462080138,-6.75364425210708,"NONE",FALSE,"High","Master Protein","Q9Y2H9","Microtubule-associated serine/threonine-protein kinase 1 [OS=Homo sapiens]",0,21.107,2,2,2,3,1,1570,170.6,8.44,9.89,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf08926, Pf17820","22983","hsa:22983; O00114; Q8N6X0; Q9Y2H9","ENSG00000105613",NA,NA,0,0,96.9,105.9,98.3,94.3,75,97.3,141.4,108.6,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S789(100); S1258(100)]",0,"ENSG00000105613"
"1264","ZRANB2",-0.159251695256271,6.63928884242077,-1.17704602889191,0.267566079997946,0.345465065313804,-6.77539096962073,"NONE",FALSE,"High","Master Protein","O95218-2","Isoform 2 of Zinc finger Ran-binding domain-containing protein 2 [OS=Homo sapiens]",0,101.461,19,6,8,21,6,320,36.3,9.76,68.58,6,NA,NA,NA,NA,NA,"O95218-2",NA,NA,NA,0,0,99.4,112.1,104.1,110.6,93.1,85.2,107,103.4,84.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S153(100); S188(100); S280(100); S307(99.7)]",0,"ENSG00000132485"
"1265","ARFGAP1",0.124392290775176,6.641051342801,1.17372434143894,0.268832305101534,0.34682555092941,-6.77914620749695,"NONE",FALSE,"High","Master Protein","Q8N6T3","ADP-ribosylation factor GTPase-activating protein 1 [OS=Homo sapiens]",0,11.333,3,1,1,2,1,406,44.6,5.66,7.72,1,"transport;other biological processes","other membranes;cytosol;ER/Golgi;other cell component","enzyme regulator activity;other molecular function","Pf01412","55738","B7Z3U0; B7Z8H8; B7ZBI3; E1P5I9; E7EV62; hsa:55738; Q6PK71; Q8N6T3; Q96KC4; Q96T02; Q9NSU3; Q9NVF6; Q9UIL0","ENSG00000101199","COPI-mediated anterograde transport; COPI-dependent Golgi-to-ER retrograde traffic; Clathrin-mediated endocytosis; XBP1(S) activates chaperone genes","IL-18 signaling pathway",5,0,95.6,103.7,98.9,112.3,91.3,127.4,93.4,95.9,86.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T189(100)]",0,"ENSG00000101199"
"1266","SEPTIN7",0.111086562602685,6.65398875692802,1.17236905442582,0.269350310966065,0.347219358212178,-6.78067610855495,"NONE",FALSE,"High","Master Protein","Q16181","Septin-7 [OS=Homo sapiens]",0,71.021,15,8,8,19,8,437,50.6,8.63,53.8,8,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00735","989","hsa:989; Q16181; Q52M76; Q6NX50","ENSG00000122545","MAPK6/MAPK4 signaling",NA,1,0,97.9,101,95.5,118.4,98.2,110.3,91.4,105.4,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T228(100); S334(100); T426(100)]",0,"ENSG00000122545"
"1267","EFCC1",0.10872670936562,6.64210833852291,1.16864120190457,0.270779243164203,0.348784959795793,-6.78487742610423,"NONE",FALSE,"High","Master Protein","Q9HA90","EF-hand and coiled-coil domain-containing protein 1 [OS=Homo sapiens]",0,15.2,3,1,1,1,1,598,65.7,5.6,4.36,1,NA,NA,"other molecular function","Pf15799","79825","A8MYE2; hsa:79825; Q9HA90","ENSG00000114654",NA,NA,0,0,93.7,85.8,84.2,99.6,109,90,110.8,115,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S394(100)]",0,"ENSG00000114654"
"1268","DDB2",0.120944497777668,6.60196538776446,1.16808688115425,0.270992235919771,0.348784959795793,-6.78550129320097,"NONE",FALSE,"High","Master Protein","Q92466","DNA damage-binding protein 2 [OS=Homo sapiens]",0,19.569,3,1,2,4,1,427,47.8,9.47,14.67,1,"protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400","1643","B2R875; hsa:1643; Q76E54; Q76E55; Q76E56; Q76E57; Q92466","ENSG00000134574","TP53 Regulates Transcription of DNA Repair Genes; Ub-specific processing proteases; Neddylation; Formation of Incision Complex in GG-NER; DNA Damage Recognition in GG-NER; Dual Incision in GG-NER","miRNA regulation of DNA damage response; miRNA regulation of p53 pathway in prostate cancer; Endometrial cancer; Chromosomal and microsatellite instability in colorectal cancer ; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Small cell lung cancer; Hepatitis B infection; Melanoma; Nucleotide excision repair; DNA repair pathways, full network; p53 transcriptional gene network; Nucleotide excision repair in xeroderma pigmentosum ; DNA damage response",21,0,75.7,74.9,67.9,85.8,70.7,79.1,160.5,133.4,156,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S26(99.7)]",0,"ENSG00000134574"
"1269","USP14",-0.324197740642139,6.58378750562176,-1.16734533212459,0.271277378002623,0.3488768171003,-6.78633553150314,"NONE",FALSE,"High","Master Protein","P54578","Ubiquitin carboxyl-terminal hydrolase 14 [OS=Homo sapiens]",0,28.436,3,1,1,4,1,494,56,5.3,17.8,1,"cell-cell signaling;protein metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00443","9097","B7Z4N8; hsa:9097; J3QRZ5; P54578; Q53XY5","ENSG00000101557","Ub-specific processing proteases; Regulation of NF-kappa B signaling",NA,2,0,107.8,110.3,108.6,94.4,44.6,129.6,89.6,123,75.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S143(100)]",0,"ENSG00000101557"
"1270","GLIS2",-0.158127185126065,6.48907699078713,-1.16621648604884,0.271711902804505,0.349160492422797,-6.7876047134893,"NONE",FALSE,"High","Master Protein","Q9BZE0","Zinc finger protein GLIS2 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,524,55.7,8.84,4.32,1,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","84662","B3KX84; hsa:84662; Q9BZE0","ENSG00000126603; ENSG00000274636",NA,"Ciliopathies; Orexin receptor pathway",2,0,86.6,94.2,121.8,99,70.9,103.4,80.1,89.2,77,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(98.9)]",0,"ENSG00000126603"
"1271","SUGT1",-0.136197629331606,6.61733209490828,-1.16357522954021,0.272730760667089,0.350194021564665,-6.79057072240348,"NONE",FALSE,"High","Master Protein","Q9Y2Z0","Protein SGT1 homolog [OS=Homo sapiens]",0,8.827,3,1,1,1,1,365,41,5.16,3.14,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04969, Pf05002","10910","A2A303; hsa:10910; Q5JAK5; Q5TAM6; Q6VXY6; Q9Y2Z0","ENSG00000165416","The NLRP3 inflammasome; Purinergic signaling in leishmaniasis infection","Nucleotide-binding oligomerization domain (NOD) pathway",3,0,94.3,83.7,71.7,83.1,59.6,82.6,128.1,143,158.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T265(100)]",0,"ENSG00000165416"
"1272","PI4KB",0.0826644529195359,6.66000036802088,1.15776746341631,0.274981768931498,0.352653149942372,-6.79707477812872,"NONE",FALSE,"High","Master Protein","Q9UBF8","Phosphatidylinositol 4-kinase beta [OS=Homo sapiens]",0,57.255,6,4,4,5,4,816,91.3,6.25,24.3,4,"cell organization and biogenesis;other metabolic processes;transport;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00454, Pf21245","5298","B4DGI2; hsa:5298; O15096; P78405; Q5VWB9; Q5VWC0; Q5VWC1; Q9BWR6; Q9UBF8","ENSG00000143393","Synthesis of PIPs at the Golgi membrane",NA,1,0,88.5,89.7,93,104.3,96.8,95.7,113.6,110.6,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(99.5); S277(100); S428(100)]",0,"ENSG00000143393"
"1273","SNAPIN",-0.136619576378594,6.65349449849354,-1.15751976438829,0.275078100414607,0.352653149942372,-6.79735162851772,"NONE",FALSE,"High","Master Protein","O95295","SNARE-associated protein Snapin [OS=Homo sapiens]",0,25.467,11,1,1,3,1,136,14.9,9.31,12.03,1,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf14712","23557","D3DV56; hsa:23557; O95295; Q5SXU8","ENSG00000143553","Golgi Associated Vesicle Biogenesis","Alstrom syndrome",2,0,92.9,101,103.9,92.5,102.4,87.4,121.8,98,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S133(100)]",0,"ENSG00000143553"
"1274","NUCB1",0.157729302848792,6.61528378039636,1.15653448748698,0.275461544896722,0.352714983240332,-6.79845241907189,"NONE",FALSE,"High","Master Protein","Q02818","Nucleobindin-1 [OS=Homo sapiens]",0,5.691,3,1,1,1,1,461,53.8,5.25,2.86,1,"signal transduction","ER/Golgi","enzyme regulator activity;nucleic acid binding activity;other molecular function",NA,"4924","B2RD64; hsa:4924; Q02818; Q15838; Q7Z4J7; Q9BUR1","ENSG00000104805","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation",NA,2,0,97.4,96.8,93,113,133.8,94.6,103.4,82,89.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S369(100)]",0,"ENSG00000104805"
"1275","RPL24",0.234721027132244,6.57318281791762,1.15628532242002,0.275558580656509,0.352714983240332,-6.7987306841878,"NONE",FALSE,"High","Master Protein","P83731","Large ribosomal subunit protein eL24 [OS=Homo sapiens]",0,9.909,8,1,2,3,1,157,17.8,11.25,9.33,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes","cytosol;ER/Golgi;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf01246","6152","B2R4Y3; hsa:6152; P38663; P83731; Q6IBS3","ENSG00000114391","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,72.7,68.7,68.2,91.1,66.8,90.5,98.4,202.1,165.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T83(100)]",0,"ENSG00000114391"
"1276","SVIL",0.111049108193725,6.63997333928443,1.15142005281226,0.277458763524874,0.354868888771626,-6.80415509521254,"NONE",FALSE,"High","Master Protein","O95425-3","Isoform SV3 of Supervillin [OS=Homo sapiens]",0,146.348,7,12,18,39,12,2187,244.5,7.01,103.1,12,NA,NA,NA,NA,NA,"O95425-3",NA,NA,NA,0,0,82.7,82.6,78,92.5,95.3,83.8,135.4,120.5,134,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100); S221(100); S245(100); S263(99.3); S270(100); S646(99.4); S680(100); S742(100); S878(100); S887(100); S941(100)]",0,"ENSG00000197321"
"1277","ANKZF1",-0.204846199156573,6.60097552870167,-1.14639487082103,0.279432273424017,0.357113132519965,-6.80973962778145,"NONE",FALSE,"High","Master Protein","Q9H8Y5","tRNA endonuclease ANKZF1 [OS=Homo sapiens]",0,15.969,5,2,2,2,2,726,80.9,8.41,5.54,2,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response","other cell component","other molecular function","Pf00023, Pf18716, Pf18826","55139","hsa:55139; Q9H8Y5; Q9NVZ4","ENSG00000163516",NA,NA,0,0,123.6,108.3,102.2,108.5,76.8,102.7,110.2,85.8,71.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S56(100)]",0,"ENSG00000163516"
"1278","PLCB1",0.138690535264329,6.7023162575519,1.14203577513504,0.281153162477829,0.359031268516288,-6.81456892840431,"NONE",FALSE,"High","Master Protein","Q9NQ66","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [OS=Homo sapiens]",0,8.396,2,1,1,2,1,1216,138.5,6.23,6.69,1,"cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00387, Pf00388, Pf06631, Pf08703, Pf09279, Pf17787","23236","D3DW12; D3DW13; hsa:23236; O60325; Q17RQ6; Q5TFF7; Q5TGC9; Q8IV93; Q9BQW2; Q9H4H2; Q9H8H5; Q9NQ65; Q9NQ66; Q9NQH9; Q9NTH4; Q9UJP6; Q9UM26","ENSG00000182621","Ca2+ pathway; G alpha (q) signalling events; G beta:gamma signalling through PLC beta; Presynaptic function of Kainate receptors; Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion; Synthesis of IP3 and IP4 in the cytosol; PLC beta mediated events; Acetylcholine regulates insulin secretion","AMP-activated protein kinase signaling; Thyroid stimulating hormone (TSH) signaling pathway; Alzheimer's disease and miRNA effects; Endothelin pathways; S1P receptor signal transduction; Cell-type dependent selectivity of CCK2R signaling; Chemokine signaling pathway; GPR40 pathway; Wnt signaling; Non-genomic actions of 1,25 dihydroxyvitamin D3; Resistin as a regulator of inflammation; Hippo signaling regulation pathways; Fragile X syndrome; PKC-gamma calcium signaling pathway in ataxia; Kisspeptin/kisspeptin receptor system in the ovary; GPR143 in melanocytes and retinal pigment epithelium cells; Airway smooth muscle cell contraction; Neuroinflammation and glutamatergic signaling; Alzheimer's disease",27,0,83.8,91.8,100,115.7,77.4,116.1,108.5,121.9,114.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1199(98.9)]",0,"ENSG00000182621"
"1279","ARMC10",-0.205670331827249,6.63514880082309,-1.12525709559428,0.287855117251082,0.36710578163883,-6.83302660433801,"NONE",FALSE,"High","Master Protein","Q8N2F6","Armadillo repeat-containing protein 10 [OS=Homo sapiens]",0,37.333,6,2,2,3,2,343,37.5,6.61,12.29,2,"other biological processes","other membranes;mitochondrion;ER/Golgi","other molecular function","Pf04826","83787","A8K703; B4DWJ8; F5GX65; hsa:83787; Q75K91; Q75MG6; Q75ML8; Q8IZC1; Q8IZC2; Q8IZC3; Q8N2F6; Q9BTM6","ENSG00000170632",NA,NA,0,0,107.3,95.3,94.9,86.2,110.6,72.2,126.1,90.2,122.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S45(100)]",0,"ENSG00000170632"
"1280","WIPF2",0.0976367291096212,6.6532052399882,1.12508102828273,0.287926103246141,0.36710578163883,-6.83321918318644,"NONE",FALSE,"High","Master Protein","Q8TF74","WAS/WASL-interacting protein family member 2 [OS=Homo sapiens]",0,23.088,10,2,2,4,2,440,46.3,10.93,11.28,2,NA,"cytosol;cytoskeleton","cytoskeletal activity","Pf02205","147179","A8K0L3; hsa:147179; Q658J8; Q71RE1; Q8TE44; Q8TF74","ENSG00000171475","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; RHOJ GTPase cycle",NA,6,0,90.3,103.4,93.2,99.8,106.9,113.9,95,101.1,109.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S235(100)]",0,"ENSG00000171475"
"1281","TCOF1",-0.0757571722425601,6.64276101387624,-1.12317703463675,0.288694623030882,0.367798301940983,-6.83530025767369,"NONE",FALSE,"High","Master Protein","Q13428","Treacle protein [OS=Homo sapiens]",0,102.622,8,9,10,13,9,1488,152,9.04,38.92,9,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus","other molecular function","Pf03546","6949","A0JLU0; B4E111; hsa:6949; Q13428; Q6SC72; Q7Z5W9; Q96A52; Q99408; Q99860","ENSG00000070814",NA,NA,0,0,93.3,98.2,94.7,93.5,93,93.6,109.3,107.8,113.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S233(100); S381(100); S446(100); S906(100); S1111(99.5); S1228(99.6); S1350(100); S1378(100); S1471(100)]",0,"ENSG00000070814"
"1282","TCF20",-0.134513556078236,6.59470974496766,-1.11465922252214,0.292152391597891,0.371913184935849,-6.84457712497716,"NONE",FALSE,"High","Master Protein","Q9UGU0","Transcription factor 20 [OS=Homo sapiens]",0,15.059,2,2,2,3,2,1960,211.6,9.04,9.39,2,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf13771","6942","A9JX12; hsa:6942; O14528; Q13078; Q4V353; Q9H4M0; Q9UGU0","ENSG00000100207; ENSG00000262024; ENSG00000276461",NA,"Matrix metalloproteinases",1,0,107.1,97.6,112.7,101.3,114.7,86.1,93.6,81.6,94.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1369(98.6); T1671(100)]",0,"ENSG00000100207"
"1283","PHF3",-0.153149615606232,6.65523407755777,-1.11246313781919,0.293049106472295,0.372763945255483,-6.84696010131676,"NONE",FALSE,"High","Master Protein","Q92576","PHD finger protein 3 [OS=Homo sapiens]",0,18.361,2,2,2,2,2,2039,229.3,6.96,6.55,2,"RNA metabolism OR transcription;other metabolic processes","nucleus","other molecular function","Pf00628, Pf07500, Pf07744","23469","A3KFI8; hsa:23469; Q14CR5; Q5CZI1; Q5T1T6; Q92576; Q9NQ16; Q9UI45","ENSG00000118482",NA,NA,0,0,99.9,114.7,97.1,92.6,108.8,90.2,120.1,96.9,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(100); S1614(99.4)]",0,"ENSG00000118482"
"1284","GNAO1",-0.119618599093093,6.66205875066071,-1.10885564484592,0.294526790927969,0.374351809029942,-6.85086673499102,"NONE",FALSE,"High","Master Protein","P09471-2","Isoform Alpha-2 of Guanine nucleotide-binding protein G(o) subunit alpha [OS=Homo sapiens]",0,13.764,8,3,3,3,1,354,40.1,5.9,5.15,3,NA,NA,NA,NA,NA,"P09471-2",NA,NA,NA,0,0,97.3,100.1,110.7,105.2,74,108,102.8,97.8,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100)]",0,"ENSG00000087258"
"1285","STX17",0.12374843053603,6.66400618100133,1.10160884767149,0.297512717204471,0.377852727219998,-6.85868481532994,"NONE",FALSE,"High","Master Protein","P56962","Syntaxin-17 [OS=Homo sapiens]",0,17.27,5,1,2,2,1,302,33.4,6.57,6.7,1,"cell organization and biogenesis;other metabolic processes;transport","plasma membrane;other membranes;cytosol;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function",NA,"55014","hsa:55014; P56962; Q4VXC2","ENSG00000136874","COPII-mediated vesicle transport",NA,1,0,96.4,86.7,80.1,99.1,102.7,95.5,129.7,112.7,110.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S289(99.6)]",0,"ENSG00000136874"
"1286","KLHL22",-0.328425566426709,6.57985874541396,-1.10048017316733,0.297979879002898,0.37815175935671,-6.85989889478455,"NONE",FALSE,"High","Master Protein","Q53GT1","Kelch-like protein 22 [OS=Homo sapiens]",0,5.917,2,1,1,2,1,634,71.6,5.49,5.83,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00651, Pf01344, Pf07707, Pf13415, Pf13964","84861","A8K3Q4; A8MTV3; B7Z2G1; D3DX30; hsa:84861; Q53GT1; Q96B68; Q96KC6","ENSG00000099910","Antigen processing: Ubiquitination & Proteasome degradation; Neddylation","22q11.2 copy number variation syndrome",3,0,105.7,109.1,111.7,72.7,154.4,65.2,106.4,65.4,114,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T605(100)]",0,"ENSG00000099910"
"1287","CDK13",-0.098930083974019,6.59693025010501,-1.08863830891432,0.30291562581861,0.384116784254834,-6.8725785234118,"NONE",FALSE,"High","Master Protein","Q14004","Cyclin-dependent kinase 13 [OS=Homo sapiens]",0,52.607,6,7,7,9,6,1512,164.8,9.69,22.9,7,"RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;cytosol;ER/Golgi;nucleus;other cell component","kinase activity;other molecular function","Pf00069","8621","hsa:8621; Q14004; Q53G78; Q6DKQ9; Q75MH4; Q75MH5; Q96JN4; Q9H4A0; Q9H4A1; Q9UDR4","ENSG00000065883","Neutrophil degranulation; TP53 Regulates Transcription of DNA Repair Genes",NA,2,1,110,103.8,104.3,101.3,86.5,114.7,89.2,93.6,81.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100); S360(100); S400(100); S525(100); T871(100); T1246(100)]",0,"ENSG00000065883"
"1288","ADD3",0.164535797726225,6.64890081585479,1.08803328407801,0.303169490710484,0.384140224254278,-6.87322348472838,"NONE",FALSE,"High","Master Protein","Q9UEY8","Gamma-adducin [OS=Homo sapiens]",0,252.277,9,7,18,58,7,706,79.1,6.32,208.77,7,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00596","120","D3DRA8; hsa:120; O43243; Q5VU09; Q92773; Q9UEY7; Q9UEY8","ENSG00000148700","RHOD GTPase cycle; RHOF GTPase cycle; Miscellaneous transport and binding events",NA,3,0,97,100.7,99.6,128.9,89,120,103.3,94.3,78,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S423(100); S650(100); S677(100); S681(99.6); S683(99.5)]",0,"ENSG00000148700"
"1289","RNF13",-0.181761000152151,6.57933625782072,-1.086490393117,0.30381762264647,0.38466280850197,-6.8748669534129,"NONE",FALSE,"High","Master Protein","O43567","E3 ubiquitin-protein ligase RNF13 [OS=Homo sapiens]",0,3.625,2,1,1,1,1,381,42.8,4.98,2.42,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf02225, Pf13639","11342","A6NC87; B3KR12; hsa:11342; O43567; Q05D66; Q6IBJ9","ENSG00000082996",NA,NA,0,0,115.3,97.7,97.1,105.7,64.6,103.7,108.8,94.5,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T380(100)]",0,"ENSG00000082996"
"1290","TFG",0.194300567040102,6.66747086535203,1.08081516165459,0.306210856537098,0.38739233943298,-6.88089647181211,"NONE",FALSE,"High","Master Protein","Q92734","Protein TFG [OS=Homo sapiens]",0,15.2,6,1,1,1,1,400,43.4,5.1,4.74,1,"cell organization and biogenesis;transport","cytosol;ER/Golgi;other cell component","other molecular function","Pf00564","10342","D3DN49; G5E9V1; hsa:10342; K0J5S8; K0J6K2; Q15656; Q92734; Q969I2","ENSG00000114354","Signaling by ALK fusions and activated point mutants; COPII-mediated vesicle transport",NA,2,0,109.7,85.5,74.6,105,88.9,116.1,134.4,94.8,110.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S197(100)]",0,"ENSG00000114354"
"1291","ZC3H14",-0.124478087080954,6.65357183639706,-1.07796415218958,0.307418589343932,0.388619006823623,-6.88391614208292,"NONE",FALSE,"High","Master Protein","Q6PJT7","Zinc finger CCCH domain-containing protein 14 [OS=Homo sapiens]",0,9.227,2,1,1,3,1,736,82.8,7.31,5.88,1,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf14608","79882","A8MY46; B4DXU8; B4DZW7; B4E2H4; G3V5R4; hsa:79882; Q6MZU4; Q6PJ32; Q6PJT7; Q6PUI6; Q6PUI8; Q86TQ5; Q86TW0; Q86TW1; Q8NCT6; Q8NCZ3; Q8TDE2; Q9HAC9; Q9Y5A0","ENSG00000100722",NA,NA,0,0,94.4,96.7,91.1,93.3,92.1,80.3,131.6,108.8,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S515(100)]",0,"ENSG00000100722"
"1292","PSAT1",-0.212792446039773,6.63650977358213,-1.07571644377331,0.308373335223478,0.389524212913867,-6.88629241717707,"NONE",FALSE,"High","Master Protein","Q9Y617","Phosphoserine aminotransferase [OS=Homo sapiens]",0,25.097,5,2,3,4,1,370,40.4,7.66,12.54,2,"other metabolic processes","cytosol;other cell component","other molecular function","Pf00266","29968","hsa:29968; Q5T7G5; Q5T7G6; Q96AW2; Q9BQ12; Q9Y617","ENSG00000135069","Serine biosynthesis","Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Metabolic reprogramming in colon cancer; Male infertility; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells",7,0,104.7,111.4,108.2,108.1,67.5,105.3,93.8,128.6,77.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S344(100)]",0,"ENSG00000135069"
"1293","SSR1",-0.297521971529326,6.62892327014756,-1.07273255766126,0.309644301701209,0.390827146462779,-6.88944096932537,"NONE",FALSE,"High","Master Protein","P43307","Translocon-associated protein subunit alpha [OS=Homo sapiens]",0,10.694,10,1,1,1,1,286,32.2,4.49,3.63,1,"other biological processes","other membranes;ER/Golgi",NA,"Pf03896","6745","A8K685; hsa:6745; P43307; Q53GX2; Q53H19; Q5TAM3; Q6IB43; Q8NBH9; Q96IA2; Q9TNQ8; Q9UN49","ENSG00000124783","SRP-dependent cotranslational protein targeting to membrane; XBP1(S) activates chaperone genes",NA,2,0,91.5,81.4,168.4,93.7,67.4,114.7,87.8,86.3,117,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S268(100)]",0,"ENSG00000124783"
"1294","NEIL2",-0.238870141213543,6.54039675846453,-1.07156142628516,0.310144234956096,0.391155634813253,-6.89067485386667,"NONE",FALSE,"High","Master Protein","Q969S2","Endonuclease 8-like 2 [OS=Homo sapiens]",0,13.625,6,1,1,3,1,332,36.8,6.79,3.39,1,"DNA metabolism;other metabolic processes;stress response","cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf06831","252969","B4DFR7; hsa:252969; Q7Z3Q7; Q8N842; Q8NG52; Q969S2","ENSG00000154328; ENSG00000292286","Recognition and association of DNA glycosylase with site containing an affected pyrimidine; Cleavage of the damaged pyrimidine ; APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway","Base excision repair; DNA repair pathways, full network; 8p23.1 copy number variation syndrome",6,0,138.2,95.7,87.5,89.3,67.4,109.2,68.3,96.9,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(98.5)]",0,"ENSG00000154328"
"1295","LENG1",-0.161934583606919,6.60625355524917,-1.06472858192314,0.313073394376147,0.394545003569012,-6.89785269183842,"NONE",FALSE,"High","Master Protein","Q96BZ8","Leukocyte receptor cluster member 1 [OS=Homo sapiens]",0,14.706,9,1,1,1,1,264,30.5,9.8,4.14,1,NA,"nucleus",NA,"Pf10197","79165","hsa:79165; Q96BZ8; Q9HCU7","ENSG00000105617; ENSG00000275935; ENSG00000276628; ENSG00000276774; ENSG00000276959; ENSG00000277457; ENSG00000277808; ENSG00000278257; ENSG00000278426; ENSG00000278516","mRNA Splicing - Major Pathway",NA,1,0,132.8,104.2,80.8,94.9,81.4,101.2,90.6,96.5,108.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100)]",0,"ENSG00000105617"
"1296","EFR3B",-0.154414413210561,6.64890381196667,-1.06338537957854,0.313651691871215,0.39496879717116,-6.89925946077908,"NONE",FALSE,"High","Master Protein","Q9Y2G0","Protein EFR3 homolog B [OS=Homo sapiens]",0,3.87,2,1,1,1,1,817,92.4,6.7,2.77,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton",NA,"Pf21052","22979","B7WPL8; hsa:22979; Q86XU6; Q9Y2G0","ENSG00000084710",NA,NA,0,0,67.9,98.6,104.1,84.2,66.3,90.6,134.4,130.7,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S689(100)]",0,"ENSG00000084710"
"1297","SZT2",-0.0878649689544311,6.60443251136381,-1.06150553714352,0.314462403519402,0.395684381298122,-6.9012259149727,"NONE",FALSE,"High","Master Protein","Q5T011","KICSTOR complex protein SZT2 [OS=Homo sapiens]",0,22.434,2,2,2,3,2,3432,377.8,6.27,6.77,2,"cell organization and biogenesis;stress response;developmental processes;other biological processes","other membranes;other cytoplasmic organelle;other cell component",NA,NA,"23334","A0PJK5; A7E2X4; hsa:23334; O75055; Q5JUY7; Q5T011; Q5T012; Q5XKC7; Q6ZNI8; Q6ZT24; Q7Z636; Q8NAY9; Q9H5H7; Q9UFQ8","ENSG00000198198","Amino acids regulate mTORC1",NA,1,0,101.5,97.7,109.6,104.3,90.3,102.1,87.7,99,88.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1388(98.5); S1819(92.8)]",0,"ENSG00000198198"
"1298","SLC4A2",-0.160388399471128,6.57625600738656,-1.05797518908163,0.315989246831454,0.397078176558268,-6.90491149746755,"NONE",FALSE,"High","Master Protein","P04920","Anion exchange protein 2 [OS=Homo sapiens]",0,21.796,3,2,2,3,2,1241,136.9,6.29,6.74,2,"transport;developmental processes;other biological processes","plasma membrane;other membranes","transporter activity;other molecular function","Pf00955, Pf07565","6522","B2R6T0; B4DIT0; D3DX05; F8W682; hsa:6522; P04920; Q45EY5; Q969L3","ENSG00000164889","Bicarbonate transporters","Proximal tubule transport",2,0,89.5,116.5,97.8,90.8,97.4,91,94.1,80.2,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S144(99.5)]",0,"ENSG00000164889"
"1299","NOP2",0.0954823021992199,6.67403599540256,1.05781950133519,0.316056710385534,0.397078176558268,-6.90507380773825,"NONE",FALSE,"High","Master Protein","P46087","Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase [OS=Homo sapiens]",0,9.954,2,1,1,1,1,812,89.2,9.23,3.54,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","other molecular function","Pf01189, Pf08062, Pf17125","4839","A1A4Z3; B3KPD6; hsa:4839; P46087; Q05BA7; Q0P5S5; Q3KQS4; Q58F30","ENSG00000111641","rRNA modification in the nucleus and cytosol; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation","Imatinib and chronic myeloid leukemia",3,0,92.6,93.6,89,105,109.7,92.4,110.5,117.3,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S732(100)]",0,"ENSG00000111641"
"1300","PHGDH",0.0832438648420473,6.63335589805086,1.05502937739027,0.317267607199432,0.398292873038056,-6.90797941332337,"NONE",FALSE,"High","Master Protein","O43175","D-3-phosphoglycerate dehydrogenase [OS=Homo sapiens]",0,103.423,18,7,7,8,7,533,56.6,6.71,27.44,7,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes","cytosol","other molecular function","Pf00389, Pf02826, Pf19304","26227","B2RD08; hsa:26227; O43175; Q5SZU3; Q9BQ01","ENSG00000092621","Serine biosynthesis","Trans-sulfuration, one-carbon metabolism and related pathways; Clear cell renal cell carcinoma pathways; Neuroinflammation and glutamatergic signaling; Amino acid metabolism in triple-negative breast cancer cells",5,0,103.6,93.9,99.1,102.9,106.2,117.5,88.4,94.3,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(100)]",0,"ENSG00000092621"
"1301","KIAA1671",0.0772384220125923,6.65618432633242,1.05302278666069,0.318140638631495,0.399081877207225,-6.91006530143843,"NONE",FALSE,"High","Master Protein","Q9BY89","Uncharacterized protein KIAA1671 [OS=Homo sapiens]",0,72.202,5,5,5,6,5,1806,196.6,8.47,28.02,5,NA,NA,NA,"Pf15327","85379","B0QYF2; B7ZW08; hsa:85379; Q5THZ5; Q9BY89","ENSG00000197077",NA,NA,0,0,94.1,87.1,95.7,103.2,102.2,97.9,109.6,106.7,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S448(99.3); S749(100); S774(100); S1224(100); S1701(100)]",0,"ENSG00000197077"
"1302","SPICE1",0.382703432716314,6.6149080723371,1.04955179858934,0.319655119057574,0.400673697620554,-6.91366602853402,"NONE",FALSE,"High","Master Protein","Q8N0Z3","Spindle and centriole-associated protein 1 [OS=Homo sapiens]",0,9.003,2,1,1,1,1,855,96.2,7.44,3.48,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component",NA,"Pf15678","152185","D3DN72; hsa:152185; Q8N0Z3; Q8WUX6","ENSG00000163611",NA,NA,0,0,108.6,40.3,129.8,128.7,78.7,120.7,112.7,97.1,96,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S640(100)]",0,"ENSG00000163611"
"1303","PTPN12",0.104415206660733,6.66722746835715,1.04711625445226,0.320721077144898,0.401701303070202,-6.91618697807071,"NONE",FALSE,"High","Master Protein","Q05209","Tyrosine-protein phosphatase non-receptor type 12 [OS=Homo sapiens]",0,8.693,3,2,2,5,2,780,88.1,5.62,10.35,2,"protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00102","5782","A4D1C5; B4DKY2; E9PBR5; E9PEH9; hsa:5782; Q05209; Q16130; Q59FD6; Q75MN8; Q86XU4","ENSG00000127947","Signaling by PDGF; SHC1 events in ERBB2 signaling; Downregulation of ERBB2 signaling; EGFR downregulation; Interleukin-37 signaling; Constitutive Signaling by Overexpressed ERBB2","EGF/EGFR signaling pathway",7,0,82.4,91,91,88.4,114.3,98.2,120.2,113.6,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S435(100); T509(100)]",0,"ENSG00000127947"
"1304","PAK4",-0.126742104265539,6.61636432415252,-1.04603566138953,0.321194881180363,0.401986231661314,-6.91730397408679,"NONE",FALSE,"High","Master Protein","O96013","Serine/threonine-protein kinase PAK 4 [OS=Homo sapiens]",0,10.771,4,1,1,1,1,591,64,9.73,3.98,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;ER/Golgi;other cell component","kinase activity;other molecular function","Pf00069, Pf00786","10298","B4DGG6; hsa:10298; O96013; Q8N4E1; Q8NCH5; Q8NDE3; Q9BU33; Q9ULS8","ENSG00000130669","RHOG GTPase cycle; RAC2 GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RAC3 GTPase cycle; RHOJ GTPase cycle; RHOV GTPase cycle; RHOU GTPase cycle; Activation of RAC1; RHOH GTPase cycle","Integrin-mediated cell adhesion; Focal adhesion; MET in type 1 papillary renal cell carcinoma; Ras signaling; Pancreatic adenocarcinoma pathway; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-Merlin signaling dysregulation; Neural crest cell migration during development; Neural crest cell migration in cancer; 22q11.2 copy number variation syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; TROP2 regulatory signaling; ErbB signaling pathway",25,0,95.4,104.1,108,93.7,115.1,87.9,103.3,87.4,99.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100)]",0,"ENSG00000130669"
"1305","N4BP1",0.0991527809192103,6.64943475769975,1.04412762268363,0.322032789555898,0.402726063260709,-6.91927405276574,"NONE",FALSE,"High","Master Protein","O75113","NEDD4-binding protein 1 [OS=Homo sapiens]",0,8.323,2,2,2,2,2,896,100.3,5.36,2.93,2,"stress response;other biological processes","cytosol;nucleus","nucleic acid binding activity;other molecular function","Pf11977","9683","A7MD49; hsa:9683; O75113; Q2YDX1","ENSG00000102921","Regulation of NF-kappa B signaling",NA,1,0,88.4,102.2,89,112.5,99.7,96.4,108.3,102.4,104.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T242(100)]",0,"ENSG00000102921"
"1306","TRIM2",0.123556323607527,6.66933385893588,1.03987723865323,0.323905288055326,0.404757603450453,-6.92365234972614,"NONE",FALSE,"High","Master Protein","Q9C040","Tripartite motif-containing protein 2 [OS=Homo sapiens]",0,47.445,8,5,5,6,5,744,81.5,6.96,18.85,5,"protein metabolism;other metabolic processes;other biological processes","other cell component","other molecular function","Pf00630, Pf00643, Pf01436, Pf13445","23321","D3DP09; hsa:23321; O60272; Q9BSI9; Q9C040; Q9UFZ1","ENSG00000109654","Interferon gamma signaling",NA,1,0,98.7,88.6,95.4,108.2,83.1,122.4,97.3,116.8,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100); S440(99.6); S459(99.2)]",0,"ENSG00000109654"
"1307","ARHGAP31",-0.134369668714114,6.63972846937981,-1.03384103840102,0.326578671852253,0.407566934693592,-6.92984573707027,"NONE",FALSE,"High","Master Protein","Q2M1Z3","Rho GTPase-activating protein 31 [OS=Homo sapiens]",0,20.201,2,2,2,2,2,1444,156.9,5.76,7.32,2,"signal transduction;other biological processes","cytosol;other cell component","enzyme regulator activity;other molecular function","Pf00620","57514","hsa:57514; Q2M1Z3; Q9ULL6","ENSG00000031081","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOU GTPase cycle","Genetic causes of porto-sinusoidal vascular disease",5,0,100.5,93.5,108.2,86.5,108.5,93.4,90.2,105.4,122.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S954(100); S1080(100)]",0,"ENSG00000031081"
"1308","TPR",-0.0989169682327731,6.64794481863228,-1.03355814695525,0.326704369840359,0.407566934693592,-6.9301352891793,"NONE",FALSE,"High","Master Protein","P12270","Nucleoprotein TPR [OS=Homo sapiens]",0,30.401,2,2,2,2,2,2363,267.1,5.02,10.34,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf07926","7175","hsa:7175; P12270; Q15624; Q15655; Q5SWY0; Q99968","ENSG00000047410","Transport of Mature mRNA derived from an Intron-Containing Transcript; HCMV Late Events; HCMV Early Events; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Signaling by ALK fusions and activated point mutants",NA,29,0,111.4,98.5,87.8,94.9,90.8,96.2,105.9,115,102.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S379(100); S2155(100)]",0,"ENSG00000047410"
"1309","ANKIB1",-0.13198962517983,6.5798836285061,-1.03311208167696,0.326902645535485,0.407566934693592,-6.93059172842963,"NONE",FALSE,"High","Master Protein","Q9P2G1","Ankyrin repeat and IBR domain-containing protein 1 [OS=Homo sapiens]",0,67.568,4,4,5,11,4,1089,121.9,5.11,29.19,4,"protein metabolism;other metabolic processes;other biological processes","other cell component","other molecular function","Pf00023, Pf01485, Pf12796, Pf19422","54467","hsa:54467; Q6GMS4; Q6P3S9; Q9NTD7; Q9NW49; Q9P2G1","ENSG00000001629",NA,NA,0,0,98.7,97,108.7,86.4,106.3,98,94.2,79.6,106.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S737(100); S891(99.4); S911(99.6)]",0,"ENSG00000001629"
"1310","FOXK1",0.0892414315017129,6.64253998509182,1.0320733332709,0.327364720451868,0.407831468532404,-6.93165402435047,"NONE",FALSE,"High","Master Protein","P85037","Forkhead box protein K1 [OS=Homo sapiens]",0,69.833,11,5,6,10,5,733,75.4,9.32,31.62,5,"other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250, Pf00498","221937","hsa:221937; P85037","ENSG00000164916","UCH proteinases",NA,1,0,94.4,94.5,95.7,110,94.4,107.4,95,110.8,97.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100); S223(100); S257(99.1); S420(100); S441(100); S445(100)]",0,"ENSG00000164916"
"1311","ACTN1",0.135734313363087,6.67036549948578,1.02983874587614,0.328360420028985,0.408759882141345,-6.93393637143854,"NONE",FALSE,"High","Master Protein","P12814","Alpha-actinin-1 [OS=Homo sapiens]",0,50.357,3,2,3,4,1,892,103,5.41,13.67,2,"cell adhesion;cell organization and biogenesis;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;cytoskeleton;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00307, Pf00435, Pf08726","87","B3V8S3; B4DHH3; B7TY16; hsa:87; P12814; Q1HE25; Q9BTN1","ENSG00000072110","Platelet degranulation ; RHOD GTPase cycle; RHOF GTPase cycle; Nephrin family interactions; Syndecan interactions; RHOBTB2 GTPase cycle; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components","Arrhythmogenic right ventricular cardiomyopathy; Focal adhesion; Ebola virus infection in host; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Regulation of actin cytoskeleton",12,2,96.6,96.6,83,113.7,76.3,118.6,116,107.7,103.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S140(100)]",0,"ENSG00000072110"
"1312","CDH6",-0.159597598141146,6.56691473109288,-1.02891650029244,0.328772024097865,0.40896032265832,-6.9348771742431,"NONE",FALSE,"High","Master Protein","P55285","Cadherin-6 [OS=Homo sapiens]",0,16.453,3,2,2,3,2,790,88.3,4.93,7.19,2,"cell adhesion;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00028, Pf01049","1004","A8K5H5; hsa:1004; P55285; Q9BWS0","ENSG00000113361","Adherens junctions interactions","Neural crest differentiation; Ectoderm differentiation; Ectoderm differentiation; TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Pleural mesothelioma",8,0,128.8,121.9,97.5,108.8,75.6,123.9,77,86.1,68.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S648(100); S786(100)]",0,"ENSG00000113361"
"1313","VPS26B",-0.079610659697142,6.6697353328706,-1.02166385249499,0.332022478461794,0.412689021210699,-6.9422522083246,"NONE",FALSE,"High","Master Protein","Q4G0F5","Vacuolar protein sorting-associated protein 26B [OS=Homo sapiens]",0,7.681,7,2,3,5,2,336,39.1,7.36,4.57,2,"stress response;transport;other biological processes","other membranes;cytosol;other cytoplasmic organelle;other cell component",NA,"Pf03643","112936","hsa:112936; Q4G0F5; Q96A55","ENSG00000151502",NA,NA,0,0,94.6,95,106,97.1,83.3,105.4,105,112.8,110.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S319(100)]",0,"ENSG00000151502"
"1314","HNRNPM",-0.152934679784876,6.63691018323932,-1.02073370290498,0.332441089033066,0.412894868570748,-6.94319502495878,"NONE",FALSE,"High","Master Protein","P52272","Heterogeneous nuclear ribonucleoprotein M [OS=Homo sapiens]",0,30.974,4,2,3,4,2,730,77.5,8.7,8.92,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf11532","4670","hsa:4670; P52272; Q15584; Q8WZ44; Q96H56; Q9BWL9; Q9Y492","ENSG00000099783","mRNA Splicing - Major Pathway; FGFR2 alternative splicing; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",4,0,89.8,94.6,92,78.4,100.8,78.4,99.1,140.6,133.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S618(100)]",0,"ENSG00000099783"
"1315","EEF1D",0.0876041505545597,6.63982284833341,1.01949669955546,0.332998411687981,0.413272553516946,-6.94444780523596,"NONE",FALSE,"High","Master Protein","P29692","Elongation factor 1-delta [OS=Homo sapiens]",0,38.292,5,1,3,42,1,281,31.1,5.01,100.3,1,"protein metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00736, Pf10587","1936","B4DDU4; D3DWK3; E9PBQ9; hsa:1936; P29692; Q4VBZ6; Q969J1; Q96I38","ENSG00000104529; ENSG00000273594","Eukaryotic Translation Elongation","Translation factors",2,0,98.3,94,92.8,100.7,107.5,108.2,104.3,92.3,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S133(100)]",0,"ENSG00000104529"
"1316","ARGLU1",0.433336043005646,6.46996382231978,1.01833839446332,0.333520912663672,0.413606481357988,-6.94561977644913,"NONE",FALSE,"High","Master Protein","Q9NWB6","Arginine and glutamate-rich protein 1 [OS=Homo sapiens]",0,6.491,5,1,1,1,1,273,33.2,10.35,2.56,1,NA,"cytosol;mitochondrion;nucleus",NA,"Pf15346","55082","B4E0Y3; hsa:55082; Q5T257; Q6IQ34; Q9NWB6","ENSG00000134884",NA,NA,0,0,73.7,77.3,67.7,91.1,243.8,54.9,108.4,64.9,126.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S77(99.4)]",0,"ENSG00000134884"
"1317","DNAJB1",-0.104551239823598,6.61638969871417,-1.01688393665323,0.334177875774004,0.414106524877126,-6.94708987695332,"NONE",FALSE,"High","Master Protein","P25685","DnaJ homolog subfamily B member 1 [OS=Homo sapiens]",0,6.382,5,2,2,2,2,340,38,8.63,1.9,2,"protein metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00226, Pf01556","3337","B4DX52; hsa:3337; P25685","ENSG00000132002","MAPK6/MAPK4 signaling; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; Regulation of HSF1-mediated heat shock response; Attenuation phase","Nuclear receptors meta-pathway; NRF2 pathway",7,0,105.5,85.3,108.6,95,93.8,95.6,95.6,97.1,111,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100)]",0,"ENSG00000132002"
"1318","ITPRID2",0.0862708145228437,6.64022533864309,1.01425887225946,0.335366042959766,0.415263567610272,-6.9497388927352,"NONE",FALSE,"High","Master Protein","P28290","Protein ITPRID2 [OS=Homo sapiens]",0,146.527,13,13,16,35,13,1259,138.3,5.19,99.03,13,NA,"plasma membrane;other membranes;cytosol;nucleus","signal transduction activity or receptor binding;cytoskeletal activity","Pf14722, Pf14723","6744","A8K6T0; hsa:6744; P28290; Q68DA6; Q7Z7L2; Q8N1L3; Q8N263; Q8N7H2; Q8NEN5; Q96E36; Q96PW1","ENSG00000138434",NA,NA,0,0,80.6,89.1,78,89.5,93.3,88.4,127.9,129.2,127.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S92(100); S270(100); S300(100); S330(100); S593(100); S641(100); S668(100); S737(100); S739(100); S746(100); S1134(99.5); S1165(99.5)]",0,"ENSG00000138434"
"1319","MEX3A",0.156244161345327,6.65317304593172,1.01182975386064,0.336468334450407,0.416312601837046,-6.95218525995193,"NONE",FALSE,"High","Master Protein","A1L020","RNA-binding protein MEX3A [OS=Homo sapiens]",0,15.2,4,1,1,1,1,520,54.1,7.27,5.76,1,NA,"cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf13920","92312","A1L020; hsa:92312","ENSG00000254726",NA,NA,0,0,79.4,78.4,108,108.8,114.6,84,106.9,107.9,129,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S338(100)]",0,"ENSG00000254726"
"1320","NFRKB",0.102299033264762,6.63718374475256,1.00365137921927,0.340199441755618,0.420610218897855,-6.96038688485463,"NONE",FALSE,"High","Master Protein","Q6P4R8","Nuclear factor related to kappa-B-binding protein [OS=Homo sapiens]",0,26.52,4,2,2,3,2,1299,138.9,9.25,5.46,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf14465","4798","hsa:4798; Q12869; Q15312; Q6P4R8; Q9H048","ENSG00000170322","UCH proteinases; DNA Damage Recognition in GG-NER","Overview of nanoparticle effects",3,0,84,96.4,97.7,114.7,91.8,100.2,97.6,111.7,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(98); S1291(99.6)]",0,"ENSG00000170322"
"1321","PTPN13",-0.109987123854224,6.62339926158491,-1.00200757541028,0.340953079199818,0.421222880585997,-6.96202886438315,"NONE",FALSE,"High","Master Protein","Q12923","Tyrosine-protein phosphatase non-receptor type 13 [OS=Homo sapiens]",0,29.742,2,5,5,7,5,2485,276.7,6.42,13.33,5,"protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00102, Pf00373, Pf00595, Pf09379, Pf09380, Pf16599","5783","B2RTR0; hsa:5783; Q12923; Q15159; Q15263; Q15264; Q15265; Q15674; Q16826; Q8IWH7; Q9NYN9; Q9UDA8","ENSG00000163629","Synthesis of PIPs at the plasma membrane; RND2 GTPase cycle; RND3 GTPase cycle; RND1 GTPase cycle; Interleukin-37 signaling","Apoptosis modulation and signaling; Ectoderm differentiation; Ectoderm differentiation",8,0,98.8,99.7,112.4,92.4,87.8,116,87.4,93.3,106.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(100); S938(100); S1033(100)]",0,"ENSG00000163629"
"1322","RHBDF1",0.0911050778003499,6.61765127276924,0.999141181614245,0.342270210552507,0.422275503482184,-6.96488686097021,"NONE",FALSE,"High","Master Protein","Q96CC6","Inactive rhomboid protein 1 [OS=Homo sapiens]",0,6.07,2,3,3,5,3,855,97.3,8.44,12.46,3,"cell cycle OR cell proliferation;transport;other biological processes","other membranes;ER/Golgi","other molecular function","Pf01694, Pf12595","64285","hsa:64285; Q04842; Q1W6H2; Q4TT59; Q96CC6; Q96S34; Q9H6E1","ENSG00000007384",NA,NA,0,0,73.1,77.8,70.1,81.8,63.1,91.5,150.1,147.4,163.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S76(100); S390(100)]",0,"ENSG00000007384"
"1323","HSD17B4",-0.147863039251846,6.64287893799253,-0.998623912243839,0.3425083024188,0.422275503482184,-6.96540190806803,"NONE",FALSE,"High","Master Protein","P51659","Peroxisomal multifunctional enzyme type 2 [OS=Homo sapiens]",0,27.507,2,1,2,4,1,736,79.6,8.84,16.88,1,"other metabolic processes;developmental processes","cytosol;other cytoplasmic organelle","other molecular function","Pf00106, Pf01575, Pf02036","3295","B4DNV1; B4DVS5; E9PB82; F5HE57; hsa:3295; P51659","ENSG00000133835","TYSND1 cleaves peroxisomal proteins; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol; alpha-linolenic acid (ALA) metabolism; Beta-oxidation of pristanoyl-CoA; Beta-oxidation of very long chain fatty acids","Androgen receptor network in prostate cancer; Steroid biosynthesis; Disorders of bile acid synthesis and biliary transport; Primary ovarian insufficiency",10,0,104.9,97.2,101.5,98,62.4,120.5,105.5,101.3,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S318(99.3)]",0,"ENSG00000133835"
"1324","DOCK6",0.0901434908471401,6.6454382431347,0.998465260866397,0.342581352089713,0.422275503482184,-6.96555983451092,"NONE",FALSE,"High","Master Protein","Q96HP0","Dedicator of cytokinesis protein 6 [OS=Homo sapiens]",0,18.55,2,3,3,3,3,2047,229.4,6.74,10.65,3,"signal transduction","cytosol;other cell component","enzyme regulator activity","Pf06920, Pf11878, Pf14429, Pf20421, Pf20422","57572","A6H8X5; hsa:57572; Q7Z7P4; Q96HP0; Q9P2F2","ENSG00000130158","CDC42 GTPase cycle; RAC1 GTPase cycle; Factors involved in megakaryocyte development and platelet production","Genetic causes of porto-sinusoidal vascular disease",4,0,87.6,82.6,75.5,91.7,80.8,92.6,125.3,144.6,127.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S880(100); S1308(100); S1343(100)]",0,"ENSG00000130158"
"1325","MRTFB",0.173734754084712,6.60619333918876,0.995392522113522,0.343998452043422,0.423558867101728,-6.96861451655614,"NONE",FALSE,"High","Master Protein","Q9ULH7","Myocardin-related transcription factor B [OS=Homo sapiens]",0,8.254,3,1,1,1,1,1088,118.1,6.28,3.41,1,"other biological processes","nucleus","other molecular function","Pf02037, Pf02755","57496","A6ND53; B4DGT8; hsa:57496; Q68CT1; Q6UB16; Q86WW2; Q8N226; Q9ULH7","ENSG00000186260",NA,NA,0,0,75.6,73.1,68.1,83,107,65.2,130,131.6,208,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S211(99.3)]",0,"ENSG00000186260"
"1326","SF3B1",-0.0877956659058894,6.63244620441005,-0.995082697425033,0.344141579520154,0.423558867101728,-6.96892209637177,"NONE",FALSE,"High","Master Protein","O75533","Splicing factor 3B subunit 1 [OS=Homo sapiens]",0,55.588,7,6,7,12,6,1304,145.7,7.09,34.41,6,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf08920","23451","E9PCH3; hsa:23451; O75533","ENSG00000115524","B-WICH complex positively regulates rRNA expression; mRNA Splicing - Major Pathway; mRNA Splicing - Minor Pathway","mRNA processing; 10q11.21q11.23 copy number variation syndrome",5,0,105.8,104,104.6,102.3,92.4,108.1,101.7,95,85.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S129(100); T211(100); T235(100); T248(100); T426(100)]",0,"ENSG00000115524"
"1327","ARFIP1",0.175434911406406,6.68356852664943,0.993089864194425,0.345063250279367,0.424373190999192,-6.97089863078148,"NONE",FALSE,"High","Master Protein","P53367","Arfaptin-1 [OS=Homo sapiens]",0,15.2,7,1,1,1,1,373,41.7,6.7,4.28,1,"transport;other biological processes","other membranes;cytosol;ER/Golgi","other molecular function","Pf06456","27236","B4DS69; hsa:27236; P53367; Q2M2X4; Q3SYL4; Q9Y2X6","ENSG00000164144",NA,NA,0,0,115.5,92.2,88.1,121.1,91.1,122.5,120,83.6,97.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S79(98.7)]",0,"ENSG00000164144"
"1328","RFFL",0.145640387099488,6.66007601047248,0.989356220874034,0.34679495472986,0.426181751595732,-6.97459306309329,"NONE",FALSE,"High","Master Protein","Q8WZ73","E3 ubiquitin-protein ligase rififylin [OS=Homo sapiens]",0,16.876,5,1,1,3,1,363,40.5,5.48,9.27,1,"protein metabolism;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf13920, Pf21272","117584","E1P633; Q8NHW0; Q8TBY7; Q8WZ73; Q96BE6","ENSG00000092871","Regulation of TP53 Degradation","TNF-alpha signaling pathway; 17q12 copy number variation syndrome",3,0,77.5,96.8,95,88.3,129.7,101.3,100.5,107.9,130.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(100)]",0,"ENSG00000092871"
"1329","ZCRB1",0.114885153547268,6.54068157645302,0.987448543794231,0.34768223458004,0.426950644721313,-6.97647633253386,"NONE",FALSE,"High","Master Protein","Q8TBF4","Zinc finger CCHC-type and RNA-binding motif-containing protein 1 [OS=Homo sapiens]",0,5.06,6,1,1,1,1,217,24.6,8.53,2.13,1,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus","other molecular function","Pf00076, Pf00098","85437","hsa:85437; Q6PJX0; Q8TBF4; Q96TA6","ENSG00000139168","mRNA Splicing - Minor Pathway; Replication of the SARS-CoV-1 genome; Replication of the SARS-CoV-2 genome",NA,3,0,95.2,92.3,91,94,97,122.3,77.4,87.4,96.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S210(100)]",0,"ENSG00000139168"
"1330","SHROOM3",0.0849676929477692,6.66395340417426,0.982672662318917,0.349910900563847,0.429364353173081,-6.98117811135018,"NONE",FALSE,"High","Master Protein","Q8TF72","Protein Shroom3 [OS=Homo sapiens]",0,15.123,3,3,3,4,3,1996,216.7,7.8,9.92,3,"cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","cytoskeletal activity","Pf00595, Pf08687, Pf08688","57619","hsa:57619; Q5QTQ3; Q6ZRW3; Q8TF72; Q96IR9; Q9P247","ENSG00000138771",NA,NA,0,0,83.8,105.2,96.4,107.3,96.6,108,103.8,107.8,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S910(100); S1441(100); S1462(100)]",0,"ENSG00000138771"
"1331","KLF3",0.186129887871163,6.61350313676632,0.97753560759159,0.352319849725721,0.431995488168578,-6.98621467375995,"NONE",FALSE,"High","Master Protein","P57682","Krueppel-like factor 3 [OS=Homo sapiens]",0,15.212,8,2,2,3,2,345,38.8,9.38,6.11,2,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","51274","hsa:51274; P57682; Q6PIR1; Q86TN0; Q9P2X6","ENSG00000109787",NA,NA,0,0,95.6,100.2,94.1,97.3,84.1,166.5,84.5,89.5,91,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(99.4); S250(100)]",0,"ENSG00000109787"
"1332","USF1",-0.124944112247598,6.64881223442454,-0.976607885211236,0.352756190035383,0.432161117250444,-6.98712194623412,"NONE",FALSE,"High","Master Protein","P22415","Upstream stimulatory factor 1 [OS=Homo sapiens]",0.004,2.132,2,1,1,1,1,310,33.5,5.54,2.44,1,"stress response;other biological processes","ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00010","7391","B2RBZ4; hsa:7391; P22415; Q5SY46; Q7Z5Y1","ENSG00000158773","Estrogen-dependent gene expression","7q11.23 copy number variation syndrome; Familial hyperlipidemia type 2",3,0,100.5,109.1,98.3,96.8,107.7,89.7,114,106.2,88.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S186(100)]",0,"ENSG00000158773"
"1333","ASPSCR1",0.131576326952703,6.63813801249039,0.975587756182701,0.353236450999197,0.432161117250444,-6.98811877443578,"NONE",FALSE,"High","Master Protein","Q9BZE9","Tether containing UBX domain for GLUT4 [OS=Homo sapiens]",0,12.088,3,1,1,1,1,553,60.1,6.64,3.67,1,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component",NA,"Pf00789, Pf11470","79058","A8K3K9; hsa:79058; Q7Z6N7; Q8WV59; Q96LS5; Q96M40; Q9BZE9","ENSG00000169696","Translocation of SLC2A4 (GLUT4) to the plasma membrane",NA,1,0,90.9,85.8,96.1,101.1,125.4,92.4,118.1,93.1,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S500(100)]",0,"ENSG00000169696"
"1334","SF3A1",-0.132611560896493,6.63644682988698,-0.975082438313165,0.353474524747907,0.432161117250444,-6.98861223438674,"NONE",FALSE,"High","Master Protein","Q15459","Splicing factor 3A subunit 1 [OS=Homo sapiens]",0,30.401,3,1,1,4,1,793,88.8,5.22,19.16,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf00240, Pf01805, Pf12230","10291","E9PAW1; hsa:10291; Q15459","ENSG00000099995","mRNA Splicing - Major Pathway","mRNA processing",2,0,97.8,106.3,103.9,105.4,97.2,86.9,111.5,105.1,84,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S329(100)]",0,"ENSG00000099995"
"1335","CMTM4",0.213680266385802,6.68987717117599,0.974998358592413,0.353514149221411,0.432161117250444,-6.98869432075425,"NONE",FALSE,"High","Master Protein","Q8IZR5","CKLF-like MARVEL transmembrane domain-containing protein 4 [OS=Homo sapiens]",0,9.827,6,1,2,2,1,234,25.8,7.75,5.66,1,NA,"other membranes",NA,"Pf01284","146223","hsa:146223; Q52M40; Q8IZR4; Q8IZR5; Q8IZV1","ENSG00000183723",NA,NA,0,0,100.5,95.6,71.6,116,100.9,98.8,130.3,138.8,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S194(99.4)]",0,"ENSG00000183723"
"1336","OSBPL11",-0.0975952194526393,6.61448613759884,-0.962134276299527,0.359615109795447,0.439290313762103,-7.00118495138773,"NONE",FALSE,"High","Master Protein","Q9BXB4","Oxysterol-binding protein-related protein 11 [OS=Homo sapiens]",0,35.618,4,2,3,5,2,747,83.6,7.06,20.27,2,"transport;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","transporter activity;other molecular function","Pf00169, Pf01237","114885","A8K9I7; hsa:114885; Q9BXB4","ENSG00000144909","RHOH GTPase cycle",NA,1,0,106.9,102,105,96.9,90.6,113.5,85.1,88.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100); S286(99.5)]",0,"ENSG00000144909"
"1337","C9orf78",-0.100139581821242,6.61995029966193,-0.960474408069557,0.360407895544106,0.439929458136111,-7.00278669383032,"NONE",FALSE,"High","Master Protein","Q9NZ63","Splicing factor C9orf78 [OS=Homo sapiens]",0,12.319,6,1,1,3,1,289,33.7,6.74,8.78,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf07052","51759","B3KPX8; Q8WVU6; Q9NT39; Q9NZ63","ENSG00000136819","mRNA Splicing - Major Pathway",NA,1,0,98.6,97.2,110.9,99.9,110.5,89.4,97.3,90.2,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S261(100)]",0,"ENSG00000136819"
"1338","FAM171B",-0.0990567235504587,6.638682379063,-0.95900942542053,0.361108658709897,0.440209137488109,-7.00419848200192,"NONE",FALSE,"High","Master Protein","Q6P995","Protein FAM171B [OS=Homo sapiens]",0,24.974,3,3,3,4,3,826,92.1,8.65,10.81,3,NA,"other membranes",NA,"Pf10577, Pf20771","165215","hsa:165215; Q53SK3; Q6P995; Q8N1Y4; Q8N3K1; Q8N970; Q8NB81; Q8TF55; Q8WYR8","ENSG00000144369",NA,NA,0,0,95.9,112,112.2,102.5,111.6,96.4,101.4,88.5,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S436(100); S794(100)]",0,"ENSG00000144369"
"1339","BRD4",-0.0940625964111206,6.63763201964952,-0.958867726199855,0.361176492093491,0.440209137488109,-7.00433494181559,"NONE",FALSE,"High","Master Protein","O60885","Bromodomain-containing protein 4 [OS=Homo sapiens]",0,13.09,2,2,2,3,2,1362,152.1,9.19,8.65,2,"cell organization and biogenesis;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;kinase activity;other molecular function","Pf00439, Pf17035, Pf17105","23476","hsa:23476; O60433; O60885; Q4G0X8; Q86YS8; Q96PD3","ENSG00000141867","Potential therapeutics for SARS","VEGFA-VEGFR2 signaling; 7q11.23 copy number variation syndrome",3,0,109.9,101.2,103,109,81.5,106.7,101.8,96,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S601(100); S1117(100)]",0,"ENSG00000141867"
"1340","PPP1CB",-0.106596980362793,6.60578660102946,-0.956634491104702,0.362246799516209,0.441184161798846,-7.00648340526894,"NONE",FALSE,"High","Master Protein","P62140","Serine/threonine-protein phosphatase PP1-beta catalytic subunit [OS=Homo sapiens]",0,7.871,5,1,1,2,1,327,37.2,6.19,5.84,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00149, Pf16891","5500","B2R5V4; D6W565; hsa:5500; P37140; P62140; Q5U087; Q6FG45","ENSG00000213639","Circadian Clock; RHO GTPases activate CIT; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; Triglyceride catabolism; Regulation of PLK1 Activity at G2/M Transition; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; RHO GTPases activate PAKs; Downregulation of TGF-beta receptor signaling; Maturation of hRSV A proteins","Common pathways underlying drug addiction; Focal adhesion; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Airway smooth muscle cell contraction; Neuroinflammation and glutamatergic signaling; G13 signaling pathway",19,0,106.4,105.4,107.5,94.9,82.9,124.6,91.1,86.1,89.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T316(100)]",0,"ENSG00000213639"
"1341","MYL9",0.191346699502307,6.63464129727928,0.952700102322032,0.364138021301217,0.443156786550027,-7.01025838610079,"NONE",FALSE,"High","Master Protein","P24844","Myosin regulatory light polypeptide 9 [OS=Homo sapiens]",0,13.066,10,1,2,2,1,172,19.8,4.92,5.89,1,"cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf13499","10398","E1P5T6; hsa:10398; P24844; Q9BQL9; Q9BUF9; Q9H136","ENSG00000101335","RHO GTPases activate CIT; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; EPHA-mediated growth cone collapse; Sema4D induced cell migration and growth-cone collapse; Smooth Muscle Contraction; RHO GTPases activate PKNs; RHO GTPases Activate ROCKs; RHO GTPases activate PAKs","Focal adhesion; Striated muscle contraction pathway",10,0,75.3,91.8,96.1,104.1,87.2,116,91.2,156,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S20(99.5)]",0,"ENSG00000101335"
"1342","EBAG9",-0.0817681558180725,6.65265758815851,-0.939957020606806,0.370312690848673,0.450335552507478,-7.02239671236347,"NONE",FALSE,"High","Master Protein","O00559","Receptor-binding cancer antigen expressed on SiSo cells [OS=Homo sapiens]",0,40.885,9,1,1,5,1,213,24.4,6.29,24.22,1,"other biological processes","other membranes;ER/Golgi;other cell component","enzyme regulator activity",NA,"9166","A8K3N6; hsa:9166; O00559; Q5Y8C7; Q6IB20; Q9BS76","ENSG00000147654","Estrogen-dependent gene expression",NA,1,0,90.9,88.6,99.3,90.6,92,88.7,119.5,108.9,127.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100)]",0,"ENSG00000147654"
"1343","LRRC47",0.161738921954602,6.6780444703462,0.93630160540239,0.372097808549107,0.4521694888698,-7.02585360432119,"NONE",FALSE,"High","Master Protein","Q8N1G4","Leucine-rich repeat-containing protein 47 [OS=Homo sapiens]",0,99.962,6,3,4,12,3,583,63.4,8.28,54.07,3,"protein metabolism;RNA metabolism OR transcription;other metabolic processes",NA,"other molecular function","Pf00560, Pf13855","57470","hsa:57470; Q8N1G4; Q9ULN5","ENSG00000130764",NA,NA,0,0,92.3,86.6,97.3,122.9,68.7,122.2,111.5,118.3,95.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S520(100)]",0,"ENSG00000130764"
"1344","SOS1",-0.0635381143262075,6.62969427463201,-0.931332189671693,0.374534548520427,0.454791951774804,-7.03053515211296,"NONE",FALSE,"High","Master Protein","Q07889","Son of sevenless homolog 1 [OS=Homo sapiens]",0,22.043,3,2,2,2,2,1333,152.4,6.84,6.88,2,"cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00169, Pf00617, Pf00618, Pf00621","6654","A8K2G3; B4DXG2; hsa:6654; Q07889","ENSG00000115904","Role of LAT2/NTAL/LAB on calcium mobilization; FCERI mediated MAPK activation; FCERI mediated Ca+2 mobilization; Potential therapeutics for SARS; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; RAC1 GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RET signaling; Interleukin receptor SHC signaling; RAF/MAP kinase cascade; Downstream signal transduction; Tie2 Signaling; DAP12 signaling; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; Regulation of KIT signaling; SHC1 events in ERBB2 signaling; SHC1 events in ERBB4 signaling; GRB2 events in ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; GRB2 events in EGFR signaling; SHC1 events in EGFR signaling; NCAM signaling for neurite out-growth; Signaling by FGFR1 in disease; Signaling by CSF1 (M-CSF) in myeloid cells; SHC-mediated cascade:FGFR1; FRS-mediated FGFR1 signaling; SHC-mediated cascade:FGFR2; FRS-mediated FGFR2 signaling; Signaling by FGFR2 in disease; SHC-mediated cascade:FGFR3; FRS-mediated FGFR3 signaling; FRS-mediated FGFR4 signaling; SHC-mediated cascade:FGFR4; Signaling by FGFR3 in disease; Activated NTRK2 signals through FRS2 and FRS3; Activation of RAC1; Erythropoietin activates RAS; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; EGFR Transactivation by Gastrin; Constitutive Signaling by EGFRvIII; Signaling by ERBB2 ECD mutants; SOS-mediated signalling; Signalling to RAS; SHC-related events triggered by IGF1R; Signaling by FGFR4 in disease; MET activates RAS signaling; Activated NTRK2 signals through RAS; Activated NTRK3 signals through RAS; Constitutive Signaling by Overexpressed ERBB2; Signaling by FLT3 fusion proteins; Signaling by FLT3 ITD and TKD mutants; Signal attenuation; GRB2:SOS provides linkage to MAPK signaling for Integrins ; Interleukin-15 signaling","IL-5 signaling pathway; Integrin-mediated cell adhesion; Leptin signaling pathway; Prolactin signaling pathway; Pilocytic astrocytoma; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; TNF-alpha signaling pathway; Oncostatin M signaling pathway; Alpha 6 beta 4 signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Hepatocyte growth factor receptor signaling; RAC1/PAK1/p38/MMP2 pathway; IL6 signaling pathway; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; BDNF-TrkB signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; Angiopoietin-like protein 8 regulatory pathway; Chemokine signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; PDGFR-beta pathway; miRNA regulation of prostate cancer signaling pathways; Endometrial cancer; PI3K-Akt signaling pathway; MET in type 1 papillary renal cell carcinoma; MAPK cascade; Ras signaling; Epithelial to mesenchymal transition in colorectal cancer; Non-small cell lung cancer; Breast cancer pathway; Acute viral myocarditis; Thermogenesis; EGF/EGFR signaling pathway; Envelope proteins and their potential roles in EDMD physiopathology; Fragile X syndrome; Gastrin signaling pathway; Hepatitis B infection; Melanoma; Thyroid hormones production and peripheral downstream signaling effects; EGFR tyrosine kinase inhibitor resistance; Insulin signaling; IL-2 signaling pathway; MAPK pathway in congenital thyroid cancer; Pleural mesothelioma; Regulation of actin cytoskeleton; Acute myeloid leukemia; 4p16.3 copy number variation; 5q35 copy number variation; EPO receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; DNA damage response (only ATM dependent)",120,0,102.8,106.5,98.4,98.2,101.8,104.5,96,95.1,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1082(100); S1210(100)]",0,"ENSG00000115904"
"1345","SLC35F6",0.0783937022738401,6.64085598591883,0.920124222213382,0.38007237423161,0.461173319513746,-7.04101750535456,"NONE",FALSE,"High","Master Protein","Q8N357","Solute carrier family 35 member F6 [OS=Homo sapiens]",0.006,2.017,4,1,1,2,1,371,40.2,6.93,1.64,1,"cell organization and biogenesis;transport;other biological processes","other membranes;cytosol;mitochondrion;nucleus;other cytoplasmic organelle;other cell component","transporter activity","Pf06027","54978","D6W543; hsa:54978; Q53GK2; Q8N357; Q8NBX6; Q9NWX0","ENSG00000213699",NA,NA,0,0,91.3,96.4,108,114.2,97.4,110.4,94.6,93.3,99.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T365(100)]",0,"ENSG00000213699"
"1346","PSMA5",-0.0754340378406448,6.65464725144736,-0.918057113296517,0.381100089184066,0.462076779753637,-7.0429391910362,"NONE",FALSE,"High","Master Protein","P28066","Proteasome subunit alpha type-5 [OS=Homo sapiens]",0,37.796,5,1,3,9,1,241,26.4,4.79,29.19,1,"protein metabolism;other metabolic processes","non-structural extracellular;cytosol;nucleus;other cell component",NA,"Pf00227, Pf10584","5686","B2R8F6; B4E2V4; hsa:5686; P28066; Q3T1C1; Q6IBF7","ENSG00000143106","Downstream TCR signaling; Separation of Sister Chromatids; FCERI mediated NF-kB activation; Antigen processing: Ubiquitination & Proteasome degradation; Activation of NF-kappaB in B cells; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha; ER-Phagosome pathway; Cross-presentation of soluble exogenous antigens (endosomes); SCF-beta-TrCP mediated degradation of Emi1; APC/C:Cdc20 mediated degradation of Securin; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1; Cdc20:Phospho-APC/C mediated degradation of Cyclin A; Vpu mediated degradation of CD4; Vif-mediated degradation of APOBEC3G; Degradation of beta-catenin by the destruction complex; Regulation of activated PAK-2p34 by proteasome mediated degradation; Autodegradation of the E3 ubiquitin ligase COP1; Regulation of ornithine decarboxylase (ODC); ABC-family proteins mediated transport; AUF1 (hnRNP D0) binds and destabilizes mRNA; Asymmetric localization of PCP proteins; Degradation of AXIN; Degradation of DVL; Hedgehog ligand biogenesis; Hh mutants are degraded by ERAD; Dectin-1 mediated noncanonical NF-kB signaling; Degradation of GLI1 by the proteasome; Degradation of GLI2 by the proteasome; GLI3 is processed to GLI3R by the proteasome; Hedgehog 'on' state; Regulation of RAS by GAPs; NIK-->noncanonical NF-kB signaling; Defective CFTR causes cystic fibrosis; MAPK6/MAPK4 signaling; UCH proteinases; Ub-specific processing proteases; Orc1 removal from chromatin; CDK-mediated phosphorylation and removal of Cdc6; G2/M Checkpoints; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A; Ubiquitin-dependent degradation of Cyclin D; The role of GTSE1 in G2/M progression after G2 checkpoint; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; RUNX1 regulates transcription of genes involved in differentiation of HSCs; Regulation of RUNX2 expression and activity; Regulation of PTEN stability and activity; Neddylation; Regulation of expression of SLITs and ROBOs; Interleukin-1 signaling; KEAP1-NFE2L2 pathway; Somitogenesis; Neutrophil degranulation; Autodegradation of Cdh1 by Cdh1:APC/C; SCF(Skp2)-mediated degradation of p27/p21; Assembly of the pre-replicative complex; Regulation of RUNX3 expression and activity; Negative regulation of NOTCH4 signaling; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2","Proteasome degradation; Alzheimer's disease and miRNA effects; Alzheimer's disease",63,0,90.7,83.7,86.9,90.4,73,86.4,136.5,132.3,127.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S56(100)]",0,"ENSG00000143106"
"1347","MAPRE3",0.083578067268828,6.67296774284633,0.908959658117644,0.385646669299974,0.466957814322578,-7.0513535261397,"NONE",FALSE,"High","Master Protein","Q9UPY8","Microtubule-associated protein RP/EB family member 3 [OS=Homo sapiens]",0.01,1.516,2,1,1,2,1,281,32,5.54,4.14,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00307, Pf03271","22924","B7WPK5; hsa:22924; O00265; Q6FHB0; Q6FI15; Q9BZP7; Q9BZP8; Q9UPY8","ENSG00000084764",NA,NA,0,0,91.2,90.5,91.7,108,102.7,90.7,118.5,111.9,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(99.7)]",0,"ENSG00000084764"
"1348","STAT1",-0.0868877534842634,6.60999775345738,-0.908359998916924,0.385947705810393,0.466957814322578,-7.05190568420292,"NONE",FALSE,"High","Master Protein","P42224","Signal transducer and activator of transcription 1-alpha/beta [OS=Homo sapiens]",0,32.229,3,1,2,4,1,750,87.3,6.05,14.08,1,"cell cycle OR cell proliferation;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00017, Pf01017, Pf02864, Pf02865, Pf12162, Pf21354","6772","A8K989; B2RCA0; D2KFR8; D3DPI7; hsa:6772; P42224; Q53S88; Q53XW4; Q68D00; Q9UDL5","ENSG00000115415","Regulation of RUNX2 expression and activity; PKR-mediated signaling; ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Signaling by ALK fusions and activated point mutants; Signaling by SCF-KIT; Downstream signal transduction; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants; Signaling by PDGFRA extracellular domain mutants; Interleukin-4 and Interleukin-13 signaling; Growth hormone receptor signaling; Interleukin-6 signaling; Interferon alpha/beta signaling; Signaling by CSF3 (G-CSF); Inactivation of CSF3 (G-CSF) signaling; Signaling by cytosolic FGFR1 fusion mutants; Signaling by CSF1 (M-CSF) in myeloid cells; NOTCH3 Intracellular Domain Regulates Transcription; Interleukin-20 family signaling; Interleukin-35 Signalling; Interleukin-27 signaling; Interleukin-9 signaling; Interleukin-21 signaling","IL-5 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Type III interferon signaling; IL-9 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; AGE/RAGE pathway; Allograft rejection; Interleukin-11 signaling pathway; Adipogenesis; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Endoderm differentiation; Kit receptor signaling pathway; IL6 signaling pathway; VEGFA-VEGFR2 signaling; Chemokine signaling pathway; IL-4 signaling pathway; PDGFR-beta pathway; p38 MAPK signaling pathway; Immune response to tuberculosis; Ebola virus infection in host; Pancreatic adenocarcinoma pathway; Acute viral myocarditis; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; IL-10 anti-inflammatory signaling pathway ; Overview of interferons-mediated signaling pathway; Measles virus infection; Tryptophan metabolism; Hepatitis B infection; Endochondral ossification; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; Endochondral ossification with skeletal dysplasias; TGF-beta receptor signaling in skeletal dysplasias; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; IL-2 signaling pathway; SARS coronavirus and innate immunity; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Neuroinflammation and glutamatergic signaling; Pleural mesothelioma; CCL18 signaling pathway; Th17 cell differentiation pathway; Inflammatory bowel disease signaling; 2q13 copy number variation syndrome; TROP2 regulatory signaling; IL-26 signaling pathways; JAK-STAT signaling in the regulation of beta cells; IL-19 signaling pathway; TGF-beta receptor signaling; EPO receptor signaling; Interferon type I signaling pathways; Type II interferon signaling; Toll-like receptor signaling pathway",83,0,90.1,98.1,98.1,85.4,84.2,106.6,96.8,106.2,112.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(100)]",0,"ENSG00000115415"
"1349","PTPN14",-0.0730364663884266,6.6098469089864,-0.908287475663264,0.385984124706591,0.466957814322578,-7.05197244185989,"NONE",FALSE,"High","Master Protein","Q15678","Tyrosine-protein phosphatase non-receptor type 14 [OS=Homo sapiens]",0,25.245,2,2,3,4,2,1187,135.2,8.31,12.27,2,"protein metabolism;other metabolic processes;developmental processes;other biological processes","cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00102, Pf00373, Pf09379, Pf09380","5784","hsa:5784; Q15678; Q5VSI0","ENSG00000152104","Interleukin-37 signaling","VEGFA-VEGFR2 signaling",2,0,99.3,106.3,109.3,105.6,90.1,110.9,86,94.5,86.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S314(100); S594(100)]",0,"ENSG00000152104"
"1350","SF1",-0.0799278173047586,6.64415121867015,-0.9071277596891,0.386566828972187,0.467316344357488,-7.05303935132098,"NONE",FALSE,"High","Master Protein","Q15637","Splicing factor 1 [OS=Homo sapiens]",0,27.083,4,1,1,21,1,639,68.3,8.98,76.51,1,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","translational apparatus;nucleus","nucleic acid binding activity;other molecular function","Pf00013, Pf00098, Pf16275","7536","B7Z1Q1; C9JJE2; hsa:7536; Q14818; Q14819; Q15637; Q15913; Q8IY00; Q92744; Q92745; Q969H7; Q9BW01; Q9UEI0","ENSG00000168066","mRNA Splicing - Major Pathway",NA,1,0,92.8,99.6,96,95.6,93.5,92.2,118.3,102.5,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S82(100)]",0,"ENSG00000168066"
"1351","GTF2F2",-0.126845426057149,6.62456964078857,-0.899437791111805,0.390446467716122,0.471460652616666,-7.06008487284774,"NONE",FALSE,"High","Master Protein","P13984","General transcription factor IIF subunit 2 [OS=Homo sapiens]",0,7.68,4,1,1,6,1,249,28.4,9.23,7.6,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytoskeleton;nucleus","nucleic acid binding activity;other molecular function","Pf02270, Pf17683","2963","A6NNS5; hsa:2963; P13984; Q5W0H3","ENSG00000188342","TP53 Regulates Transcription of DNA Repair Genes; Estrogen-dependent gene expression; Viral Messenger RNA Synthesis; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM","Eukaryotic transcription initiation",33,0,97.4,99.1,102.5,89.6,124.8,79.1,104.8,95,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S248(100)]",0,"ENSG00000188342"
"1352","CHMP2A",-0.125203480121212,6.63599770501456,-0.898997173438599,0.390669592882618,0.471460652616666,-7.06048703299334,"NONE",FALSE,"High","Master Protein","O43633","Charged multivesicular body protein 2a [OS=Homo sapiens]",0,14.039,8,1,1,1,1,222,25.1,5.97,4.22,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf03357","27243","B2R4W6; hsa:27243; O43633; Q3ZTT0","ENSG00000130724","Budding and maturation of HIV virion; Endosomal Sorting Complex Required For Transport (ESCRT); HCMV Late Events; Late endosomal microautophagy; Sealing of the nuclear envelope (NE) by ESCRT-III; Lysosome Vesicle Biogenesis; Macroautophagy; Pyroptosis; Translation of Replicase and Assembly of the Replication Transcription Complex; Translation of Replicase and Assembly of the Replication Transcription Complex",NA,10,0,79.8,103.7,115.7,90.3,74.2,112.6,99,109.5,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100)]",0,"ENSG00000130724"
"1353","PBDC1",-0.142944369060513,6.67624243436747,-0.89861798917381,0.390861680753891,0.471460652616666,-7.06083298853845,"NONE",FALSE,"High","Master Protein","Q9BVG4","Protein PBDC1 [OS=Homo sapiens]",0,16.612,12,3,3,4,3,233,26,4.79,8.12,3,NA,NA,NA,"Pf04669","51260","hsa:51260; Q9BVG4","ENSG00000102390",NA,NA,0,0,99.5,111.9,107.8,118.4,79,94,100.8,121.7,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(99.7); S197(100)]",0,"ENSG00000102390"
"1354","INO80B",0.0777590835631115,6.63262642046707,0.895030890054963,0.392682138875954,0.472868194617983,-7.06409964315931,"NONE",FALSE,"High","Master Protein","Q9C086","INO80 complex subunit B [OS=Homo sapiens]",0,8.414,4,1,2,3,1,356,38.6,9.61,6.46,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus","other molecular function","Pf04438, Pf04795","83444","hsa:83444; Q9C086","ENSG00000115274","UCH proteinases; DNA Damage Recognition in GG-NER",NA,2,0,91.9,92.2,91.2,97.7,84.8,116.1,103.6,102.8,110.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(100)]",0,"ENSG00000115274"
"1355","PPP1R10",0.10079511083457,6.63707100457372,0.89494144058068,0.392727610864352,0.472868194617983,-7.06418096079721,"NONE",FALSE,"High","Master Protein","Q96QC0","Serine/threonine-protein phosphatase 1 regulatory subunit 10 [OS=Homo sapiens]",0,16.117,5,2,2,2,2,940,99,9.17,6.12,2,"transport;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00642, Pf08711","5514","hsa:5514; O00405; Q96QC0","ENSG00000204569; ENSG00000206489; ENSG00000227804; ENSG00000230995; ENSG00000231737; ENSG00000235291; ENSG00000238104",NA,NA,0,0,78.4,84.1,82.9,78.8,102.8,93.6,120.8,118.3,152.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(99.5)]",0,"ENSG00000204569"
"1356","PKN1",-0.0913978776143933,6.62788468907999,-0.894606645501837,0.392897838175236,0.472868194617983,-7.06448525873105,"NONE",FALSE,"High","Master Protein","Q16512","Serine/threonine-protein kinase N1 [OS=Homo sapiens]",0,64.003,10,4,4,9,4,942,103.9,6.37,34.37,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00069, Pf00433, Pf02185","5585","A8K7W5; B2R9R4; B3KVN3; hsa:5585; Q15143; Q16512; Q504U4; Q8IUV5; Q9UD44","ENSG00000123143","RHOC GTPase cycle; RHOA GTPase cycle; RAC1 GTPase cycle; RHOB GTPase cycle; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3","Apoptosis-related network due to altered Notch3 in ovarian cancer; PI3K-Akt signaling pathway; IL-18 signaling pathway; G13 signaling pathway",10,0,102.9,91.7,99.7,101.2,75,103.2,95.2,113.1,105,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S562(99.5); S573(97.2); T774(99.5); S916(100)]",0,"ENSG00000123143"
"1357","CBR1",0.117484670278991,6.60412437592046,0.8896940967037,0.39540161062896,0.475530897970864,-7.06893923539772,"NONE",FALSE,"High","Master Protein","P16152","Carbonyl reductase [NADPH] 1 [OS=Homo sapiens]",0.006,1.778,3,1,1,1,1,277,30.4,8.32,1.79,1,"other metabolic processes;other biological processes","cytosol","other molecular function","Pf00106","873","B2RBZ7; B4DFK7; hsa:873; P16152; Q3LHW8","ENSG00000159228","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Nuclear receptors meta-pathway; NRF2 pathway; Omega-6-fatty acids in senescence; Prostaglandin synthesis and regulation",5,0,98.8,100.5,78.8,99.7,105.1,107.4,83.9,103.7,109,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S151(100)]",0,"ENSG00000159228"
"1358","KLF13",-0.0857299746659015,6.58662359869226,-0.888818776655477,0.395848908266386,0.475718275619103,-7.06973066714661,"NONE",FALSE,"High","Master Protein","Q9Y2Y9","Krueppel-like factor 13 [OS=Homo sapiens]",0.006,1.918,3,1,1,1,1,288,31.2,9.54,2.12,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","51621","hsa:51621; Q9Y2Y9; Q9Y356","ENSG00000169926; ENSG00000275746",NA,"15q13.3 copy number variation syndrome; 15q11q13 copy number variation",2,0,105.1,113,103.3,105.1,88.6,114.9,86.8,89.3,76.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(100)]",0,"ENSG00000169926"
"1359","DKC1",-0.0628051802847942,6.64722314663793,-0.88656472277802,0.397002388133086,0.476753419744809,-7.07176565930986,"NONE",FALSE,"High","Master Protein","O60832","H/ACA ribonucleoprotein complex subunit DKC1 [OS=Homo sapiens]",0,66.096,9,5,6,15,5,514,57.6,9.42,44.66,5,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01472, Pf01509, Pf08068, Pf16198","1736","F5BSB3; hsa:1736; O43845; O60832; Q96G67; Q9Y505","ENSG00000130826","rRNA modification in the nucleus and cytosol; Telomere Extension By Telomerase",NA,2,0,102.1,100.2,101.5,98.3,96.4,105.9,98.1,96.1,106.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S455(100); S494(100); S513(100)]",0,"ENSG00000130826"
"1360","PBXIP1",0.084255097398704,6.62930826290699,0.885039187843151,0.397784395151724,0.477341274182068,-7.07314044763325,"NONE",FALSE,"High","Master Protein","Q96AQ6","Pre-B-cell leukemia transcription factor-interacting protein 1 [OS=Homo sapiens]",0,28.122,3,3,4,4,3,731,80.6,5.33,12.79,3,"cell adhesion;cell organization and biogenesis;other metabolic processes;stress response;developmental processes;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function",NA,"57326","hsa:57326; Q5T174; Q5T176; Q96AQ6; Q9H8X6; Q9HA02; Q9HD85","ENSG00000163346",NA,"VEGFA-VEGFR2 signaling",1,0,75.7,90.7,93.4,95.1,88.9,98,109.9,110.4,131.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S43(100); S551(99.4)]",0,"ENSG00000163346"
"1361","TDRD3",0.16842266168131,6.66030265284578,0.883768765772686,0.398436451490702,0.477772438525221,-7.07428379902207,"NONE",FALSE,"High","Master Protein","Q9H7E2","Tudor domain-containing protein 3 [OS=Homo sapiens]",0,4.769,3,1,1,1,1,651,73.1,9.23,2.4,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00567, Pf00627, Pf08585","81550","B2MWP9; hsa:81550; Q53XA6; Q6P992; Q9H7E2","ENSG00000083544",NA,NA,0,0,117.3,85.1,73.4,108.2,80.8,117.7,123.3,117.1,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S489(100)]",0,"ENSG00000083544"
"1362","PLCD1",0.114309394508589,6.6252998355256,0.880408569254946,0.400164710055432,0.479492516013557,-7.07730117689375,"NONE",FALSE,"High","Master Protein","P51178","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 [OS=Homo sapiens]",0,37.72,6,2,2,9,2,756,85.6,6.7,19.65,2,"other metabolic processes;transport;signal transduction","plasma membrane;other membranes;other cell component","other molecular function","Pf00168, Pf00387, Pf00388, Pf09279, Pf16457","5333","B3KR14; hsa:5333; P51178; Q86VN8","ENSG00000187091","Synthesis of IP3 and IP4 in the cytosol","Myometrial relaxation and contraction pathways; GPR40 pathway; Non-genomic actions of 1,25 dihydroxyvitamin D3; Resistin as a regulator of inflammation; Orexin receptor pathway",6,0,110.4,94.9,88.1,115.7,91.5,114.4,81.9,97.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S179(100)]",0,"ENSG00000187091"
"1363","LSM12",0.201040350744286,6.64488947218556,0.875381278418469,0.402760178001562,0.482248430299743,-7.08179731375852,"NONE",FALSE,"High","Master Protein","Q3MHD2","Protein LSM12 [OS=Homo sapiens]",0,22.576,7,1,1,3,1,195,21.7,7.74,11.27,1,NA,"other cell component","nucleic acid binding activity","Pf09793, Pf21166","124801","hsa:124801; Q3MHD2; Q86YB1; Q96NL5","ENSG00000161654",NA,NA,0,0,88.2,97.1,97.5,129.7,80.6,118.7,111.9,112.8,68.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T75(100)]",0,"ENSG00000161654"
"1364","YWHAQ",0.0844948057718398,6.62579467060514,0.87361588611166,0.40367438449162,0.482897034607047,-7.08337098468329,"NONE",FALSE,"High","Master Protein","P27348","14-3-3 protein theta [OS=Homo sapiens]",0,98.507,40,7,8,11,4,245,27.7,4.78,34.19,7,"signal transduction;other biological processes","cytosol;other cell component","other molecular function","Pf00244","10971","D6W4Z5; hsa:10971; P27348; Q567U5; Q5TZU8; Q9UP48","ENSG00000134308","Translocation of SLC2A4 (GLUT4) to the plasma membrane; Regulation of localization of FOXO transcription factors; TP53 Regulates Metabolic Genes; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex; RHO GTPases activate PKNs; SARS-CoV-1 targets host intracellular signalling and regulatory pathways; SARS-CoV-2 targets host intracellular signalling and regulatory pathways; Activation of BAD and translocation to mitochondria","Cell cycle; Pathogenic Escherichia coli infection; Primary focal segmental glomerulosclerosis (FSGS); IL-3 signaling pathway; Myometrial relaxation and contraction pathways; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Leukocyte-intrinsic Hippo pathway functions; Hepatitis B infection; Opioid receptor pathways; Calcium regulation in cardiac cells; Sudden infant death syndrome (SIDS) susceptibility pathways",19,0,96.8,95.3,98.1,108.1,106.9,104.4,106.7,90.6,89.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S45(100)]",0,"ENSG00000134308"
"1365","SPEG",-0.0839216898068926,6.62858419827925,-0.873192865821405,0.403893659459938,0.482897034607047,-7.08374766303935,"NONE",FALSE,"High","Master Protein","Q15772","Striated muscle preferentially expressed protein kinase [OS=Homo sapiens]",0,31.091,2,6,7,7,6,3267,354.1,8.51,13.59,6,"other metabolic processes;other biological processes","nucleus","kinase activity;other molecular function","Pf00069, Pf07679, Pf16650","10290","A8K0G6; A8MRU0; hsa:10290; Q15772; Q27J74; Q695L1; Q6FGA6; Q6ZQW1; Q6ZTL8; Q9P2P9","ENSG00000072195",NA,NA,0,0,104.9,100.8,98.1,96.4,109.2,93.5,105.7,93.1,97.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(100); S390(100); S2015(99.6); S2109(99.4); S2130(100); T2495(99.1)]",0,"ENSG00000072195"
"1366","PNPO",-0.0990068296821027,6.66880978576586,-0.871159985245835,0.404948570612091,0.483803855958223,-7.08555567170381,"NONE",FALSE,"High","Master Protein","Q9NVS9","Pyridoxine-5'-phosphate oxidase [OS=Homo sapiens]",0,15.2,6,1,1,2,1,261,30,7.06,8.88,1,"other metabolic processes","cytosol","other molecular function","Pf01243, Pf10590","55163","B4E0V0; B4E152; B4E1D7; D3DTT9; hsa:55163; Q9NVS9","ENSG00000108439","Vitamin B6 activation to pyridoxal phosphate","Selenium micronutrient network; Vitamin B6-dependent and responsive disorders",3,0,103.9,88.8,87.5,83.8,89.2,94.1,106.5,128,144.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S241(100)]",0,"ENSG00000108439"
"1367","PGBD5",-0.102858115105235,6.62858014374796,-0.866305283262785,0.407475533817704,0.486466767513162,-7.08985880995126,"NONE",FALSE,"High","Master Protein","Q8N414","PiggyBac transposable element-derived protein 5 [OS=Homo sapiens]",0,10.214,2,1,1,2,1,524,58.4,8.85,6.47,1,"DNA metabolism;other metabolic processes","nucleus","other molecular function","Pf13843","79605","A0A0A0MS21; A0PJF3; B4DM72; B7Z9K3; B9EK58; hsa:79605; Q5SR37; Q6PJN2; Q8N414; U3REJ1","ENSG00000177614",NA,"Clear cell renal cell carcinoma pathways",1,0,98.9,115.4,100.9,99.3,84.4,115.3,82.4,99.6,103.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S521(100)]",0,"ENSG00000177614"
"1368","TBC1D15",-0.0735369010620426,6.64803048726675,-0.863765335330357,0.408801970775225,0.487602033763495,-7.09210199711585,"NONE",FALSE,"High","Master Protein","Q8TC07-3","Isoform 3 of TBC1 domain family member 15 [OS=Homo sapiens]",0,29.223,5,2,2,6,2,682,78.5,5.35,19.95,2,NA,NA,NA,NA,NA,"Q8TC07-3",NA,NA,NA,0,0,103,83.7,95.6,90,85.2,97.4,115.1,114.2,114.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100); S666(100)]",0,"ENSG00000121749"
"1369","MLF1",0.0898438812656694,6.66677316212632,0.863340717946918,0.409024009940088,0.487602033763495,-7.09247645391052,"NONE",FALSE,"High","Master Protein","P58340","Myeloid leukemia factor 1 [OS=Homo sapiens]",0.006,1.842,3,1,1,2,1,268,30.6,9.45,2.02,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytoskeleton;other cell component","nucleic acid binding activity;other molecular function","Pf10248","4291","E9PEU9; hsa:4291; P58340; Q2TLE3; Q2TLE5; Q8N8F8; Q96MH1","ENSG00000178053",NA,NA,0,0,102.1,93.3,98.1,96.5,101.2,125.7,95.2,100.6,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S34(100)]",0,"ENSG00000178053"
"1370","FAM110B",0.0793050430595006,6.69098514718458,0.861395733441848,0.410042139304337,0.488360207927098,-7.09418966159768,"NONE",FALSE,"High","Master Protein","Q8TC76","Protein FAM110B [OS=Homo sapiens]",0,11.947,5,2,2,2,2,370,40.7,9.39,6.24,2,NA,"cytosol;cytoskeleton;mitochondrion",NA,"Pf14160, Pf14161","90362","hsa:90362; Q5BM08; Q8TC76; Q9Y4K2","ENSG00000169122",NA,NA,0,0,81.7,94.9,101.5,103.5,107.8,95.2,114,113.4,116.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(99.7); S301(100)]",0,"ENSG00000169122"
"1371","BANP",-0.159085965033258,6.5450999559735,-0.86098287021855,0.41025848349758,0.488360207927098,-7.09455289993146,"NONE",FALSE,"High","Master Protein","Q8N9N5","Protein BANP [OS=Homo sapiens]",0,7.48,3,1,1,1,1,519,56.5,5.49,3.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf10523","54971","A8MU25; A8MX25; B2RCF7; B4DNJ9; F5GZM0; hsa:54971; Q8N9N5; Q96GJ7; Q9NWY1","ENSG00000172530","Regulation of TP53 Activity through Association with Co-factors",NA,1,0,115.9,95.9,90.5,107.6,64.6,98,112,85.6,79.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S145(100)]",0,"ENSG00000172530"
"1372","S1PR1",-0.0820939106524108,6.6574974339489,-0.854431535358571,0.413701993551478,0.492100330521875,-7.10029681243696,"NONE",FALSE,"High","Master Protein","P21453","Sphingosine 1-phosphate receptor 1 [OS=Homo sapiens]",0,11.678,3,1,1,2,1,382,42.8,9.5,6.91,1,"cell adhesion;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00001","1901","D3DT66; hsa:1901; P21453; Q9BYY4; Q9NYN8","ENSG00000170989","Potential therapeutics for SARS; Interleukin-4 and Interleukin-13 signaling; Lysosphingolipid and LPA receptors","GPCRs, other; Small ligand GPCRs; S1P receptor signal transduction; VEGFA-VEGFR2 signaling; Sphingolipid metabolism in senescence; GDNF signaling; Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; Primary ovarian insufficiency",11,0,97.1,94.5,98.1,84.5,86.4,111.3,112.6,113.8,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S351(100)]",0,"ENSG00000170989"
"1373","AP2M1",0.083729525084772,6.64378267840966,0.849903968832401,0.4160933638425,0.49458439169043,-7.10424437494957,"NONE",FALSE,"High","Master Protein","Q96CW1","AP-2 complex subunit mu [OS=Homo sapiens]",0,15.2,4,1,1,3,1,435,49.6,9.54,14.55,1,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00928, Pf01217","1173","A6NE12; D3DNT1; hsa:1173; P20172; P53679; Q96CW1","ENSG00000161203","Potential therapeutics for SARS; Recycling pathway of L1; MHC class II antigen presentation; Cargo recognition for clathrin-mediated endocytosis; WNT5A-dependent internalization of FZD4; EPH-ephrin mediated repulsion of cells; LDL clearance; Nef Mediated CD4 Down-regulation; Retrograde neurotrophin signalling; Nef Mediated CD8 Down-regulation; WNT5A-dependent internalization of FZD2, FZD5 and ROR2; VLDLR internalisation and degradation; Nef mediated downregulation of CD28 cell surface expression; Formation of annular gap junctions","Synaptic vesicle pathway; GABA receptor signaling; EGF/EGFR signaling pathway; Fragile X syndrome; GDNF signaling",21,0,93.4,88.4,103.3,110.9,84.4,113.5,97.4,106.7,100.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T156(100)]",0,"ENSG00000161203"
"1374","NFATC2IP",0.178863258956986,6.63666117022979,0.847851059903056,0.417180789670008,0.495516047118962,-7.1060283567729,"NONE",FALSE,"High","Master Protein","Q8NCF5","NFATC2-interacting protein [OS=Homo sapiens]",0,15.2,4,1,1,1,1,419,45.8,6.6,3.83,1,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component",NA,"Pf11976","84901","B7Z4G5; hsa:84901; Q66K34; Q6NVK1; Q8NCF5; Q8NFR2; Q96ST9","ENSG00000176953",NA,"16p11.2 distal deletion syndrome",1,0,114.4,75.1,74.6,114.2,108.7,78.8,104.6,101.4,150.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S204(100)]",0,"ENSG00000176953"
"1375","MPP2",0.131271747509424,6.62378108199851,0.847097290577753,0.417580549755937,0.495630150692137,-7.10668245248233,"NONE",FALSE,"High","Master Protein","Q14168","MAGUK p55 subfamily member 2 [OS=Homo sapiens]",0,8.801,5,1,1,1,1,576,64.5,6.77,2.85,1,"cell-cell signaling;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component",NA,"Pf00595, Pf00625, Pf02828, Pf07653","4355","B4DGE9; B4DRJ0; B7Z3G8; E7EV80; E7EV91; E7EX01; hsa:4355; Q14168; Q53ES9; Q5CZB9; Q9BQJ2","ENSG00000108852",NA,NA,0,0,112.2,85.5,84.6,97.1,113.9,109,111.1,106.6,82.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T141(100)]",0,"ENSG00000108852"
"1376","STK39",-0.0674201615539953,6.63959257717352,-0.84533409796788,0.418516679980761,0.496380248349275,-7.1082105366935,"NONE",FALSE,"High","Master Protein","Q9UEW8","STE20/SPS1-related proline-alanine-rich protein kinase [OS=Homo sapiens]",0,6.753,2,1,1,2,1,545,59.4,6.29,5.53,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069, Pf12202","27347","O14774; Q53S90; Q53SL7; Q53SS1; Q9UER4; Q9UEW8; X5D9C8","ENSG00000198648",NA,NA,0,0,97.5,96.6,108,102.1,97.1,98,95,98.1,108,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T354(100)]",0,"ENSG00000198648"
"1377","CDK17",-0.0758355076104555,6.6382221717937,-0.844594891213271,0.41890957329188,0.496485420197784,-7.1088503604249,"NONE",FALSE,"High","Master Protein","Q00537","Cyclin-dependent kinase 17 [OS=Homo sapiens]",0,8.861,3,2,2,2,1,523,59.5,9.03,5.45,2,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","kinase activity;other molecular function","Pf00069","5128","A8K1U6; B2RCQ2; hsa:5128; Q00537; Q8NEB8","ENSG00000059758",NA,NA,0,1,87.4,80.1,85.7,74.7,80,88.1,124.6,132.6,157.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S137(100); S146(100)]",0,"ENSG00000059758"
"1378","DYNC1I2",0.060620027494358,6.65249886126778,0.843740073704823,0.419364228937814,0.496663586086003,-7.10958965057606,"NONE",FALSE,"High","Master Protein","Q13409-2","Isoform 2B of Cytoplasmic dynein 1 intermediate chain 2 [OS=Homo sapiens]",0,138.364,8,2,9,86,2,632,70.6,5.24,266.86,2,NA,NA,NA,NA,NA,"Q13409-2",NA,NA,NA,0,0,78.4,76.1,86.3,84.4,79.9,91.2,134.4,138.2,153.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S81(99.4); S95(99.3)]",0,"ENSG00000077380"
"1379","ARHGEF2",-0.0733740005852495,6.64138396409806,-0.841962038263203,0.420311000798713,0.497423896521755,-7.11112532114064,"NONE",FALSE,"High","Master Protein","Q92974","Rho guanine nucleotide exchange factor 2 [OS=Homo sapiens]",0,11.504,2,3,3,4,3,986,111.5,7.27,10.47,3,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity;cytoskeletal activity;other molecular function","Pf00621, Pf17838","9181","D3DVA6; hsa:9181; O75142; Q15079; Q5VY92; Q8TDA3; Q8WUG4; Q92974; Q9H023","ENSG00000116584","RHOA GTPase cycle; RHOB GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events","Pathogenic Escherichia coli infection",5,0,100.8,87.7,87.7,87,90.3,91.3,109.4,117.5,128.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S174(100); S932(100)]",0,"ENSG00000116584"
"1380","YAP1",0.207149555721214,6.57289756928632,0.84128098856642,0.420674033854305,0.497492770471178,-7.11171279709658,"NONE",FALSE,"High","Master Protein","P46937","Transcriptional coactivator YAP1 [OS=Homo sapiens]",0,19.879,13,3,3,4,3,504,54.4,5.17,6.44,3,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00397","10413","B4DTY1; B7ZA01; E3WEB5; E3WEB6; E9PRV2; F5H202; hsa:10413; K0KQ18; K0KYZ8; K0L195; K0L1G3; P46937; Q7Z574; Q8IUY9","ENSG00000137693","Nuclear signaling by ERBB4; RUNX2 regulates osteoblast differentiation; Zygotic genome activation (ZGA); RUNX1 regulates transcription of genes involved in differentiation of HSCs; Formation of axial mesoderm; Signaling by Hippo; YAP1- and WWTR1 (TAZ)-stimulated gene expression; EGR2 and SOX10-mediated initiation of Schwann cell myelination; RUNX3 regulates YAP1-mediated transcription","Mesodermal commitment pathway; Mesodermal commitment pathway; RAC1/PAK1/p38/MMP2 pathway; TGF-beta signaling pathway; miR-509-3p alteration of YAP1/ECM axis; Ciliary landscape; Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; Hippo-YAP signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Leukocyte-intrinsic Hippo pathway functions; Netrin-UNC5B signaling pathway; Galanin receptor pathway; Pleural mesothelioma; GNAQ pathways in port-wine stain",24,0,91.7,102.8,94.8,94.9,119.4,136.2,64,73.7,121.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S109(99.4); S367(99.3)]",0,"ENSG00000137693"
"1381","GIGYF1",0.107251641613293,6.61324591508111,0.838343088649007,0.422242531350064,0.49898610511463,-7.11424234108499,"NONE",FALSE,"High","Master Protein","O75420","GRB10-interacting GYF protein 1 [OS=Homo sapiens]",0,19.458,4,2,2,4,2,1035,114.5,5.39,13.07,2,"signal transduction","cytosol;other cell component",NA,"Pf02213",NA,"O75420; Q6Y7W7; Q8WZ38","ENSG00000146830",NA,NA,0,0,81.7,115.4,90.1,106.9,88.2,118.1,88.5,100.5,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S406(100); S538(100)]",0,"ENSG00000146830"
"1382","ATRX",0.126119738031894,6.60568920520345,0.833743770220042,0.424706024705011,0.501534176786236,-7.11818702977296,"NONE",FALSE,"High","Master Protein","P46100","Transcriptional regulator ATRX [OS=Homo sapiens]",0,89.36,5,8,10,12,8,2492,282.4,6.55,35.18,8,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf17981","546","D3DTE2; P46100; P51068; Q15886; Q59FB5; Q59H31; Q5H9A2; Q5JWI4; Q7Z2J1; Q9H0Z1; Q9NTS3","ENSG00000085224","Inhibition of DNA recombination at telomere; Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations; Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations","Pathways affected in adenoid cystic carcinoma",4,0,102.4,95.6,102.4,123.5,79.5,127.6,83.1,95.8,77.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S598(100); S677(100); S1076(99.7); S1352(100)]",0,"ENSG00000085224"
"1383","TP53BP1",-0.0670833247888352,6.63751167602167,-0.832378561260604,0.425439135964847,0.501836654123781,-7.11935431634044,"NONE",FALSE,"High","Master Protein","Q12888","TP53-binding protein 1 [OS=Homo sapiens]",0,597.567,24,27,43,175,27,1972,213.4,4.7,490.27,27,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09038, Pf18428","7158","F8VY86; hsa:7158; Q12888; Q2M1Z7; Q4LE46; Q5FWZ3; Q7Z3U4","ENSG00000067369","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Processing of DNA double-strand break ends; G2/M DNA damage checkpoint; Nonhomologous End-Joining (NHEJ); SUMOylation of transcription factors","ATM signaling pathway; ATM signaling in development and disease",7,0,101.8,100.4,103.3,102.5,103.7,96.4,103.7,95.4,93.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(100); S265(100); S294(100); S366(100); S380(100); S500(100); S525(100); S552(100); S598(100); S630(100); S639(99.5); S727(100); S831(99.4); T1056(99.6); S1094(100); S1101(100); S1114(99.5); S1362(100); S1462(100); S1656(100)]",0,"ENSG00000067369"
"1384","LMNB2",-0.100892166023642,6.6482333073603,-0.83212170509396,0.425577162565755,0.501836654123781,-7.11957374966761,"NONE",FALSE,"High","Master Protein","Q03252","Lamin-B2 [OS=Homo sapiens]",0,35.01,9,5,6,6,3,620,69.9,5.59,15.79,5,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;nucleus","cytoskeletal activity;other molecular function","Pf00038, Pf00932","84823","hsa:84823; O75292; Q03252; Q14734; Q96DF6","ENSG00000176619",NA,"Gastric cancer network 2; Fas ligand pathway and stress induction of heat shock proteins; IL-18 signaling pathway; Familial partial lipodystrophy; Progeria-associated lipodystrophy; Acquired partial lipodystrophy / Barraquer-Simons syndrome",6,0,99,106.8,95,96.8,73.7,115.1,106.3,113.1,94.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S316(100); S407(100); S420(99.5)]",0,"ENSG00000176619"
"1385","PPP2R5E",0.0664884522575626,6.6372570004142,0.828294411958665,0.427637431090057,0.503902012663518,-7.12283647968135,"NONE",FALSE,"High","Master Protein","Q16537","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform [OS=Homo sapiens]",0,2.942,2,1,2,2,1,467,54.7,6.95,4.18,1,"signal transduction","cytosol;nucleus;other cell component","enzyme regulator activity","Pf01603","5529","A4FU37; B7ZAW5; B7ZKK8; B7ZKK9; hsa:5529; J3KQN6; Q16537; Q52LW4","ENSG00000154001","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling","Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Wnt signaling pathway and pluripotency; PI3K-Akt signaling pathway; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome; DNA damage response (only ATM dependent)",28,0,98.5,99.2,98.9,107,96.2,117.4,88.4,98,99,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S32(100)]",0,"ENSG00000154001"
"1386","UFL1",0.156837581339123,6.57859380513772,0.821979698997486,0.431051437257512,0.507558402311875,-7.12819121388195,"NONE",FALSE,"High","Master Protein","O94874","E3 UFM1-protein ligase 1 [OS=Homo sapiens]",0,30.289,2,1,2,16,1,794,89.5,6.79,27.72,1,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","other molecular function","Pf09743","23376","A0PJ53; B4DJ57; C0H5X5; hsa:23376; O94874; Q8N765; Q9NTQ0","ENSG00000014123","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,81.7,95.4,120.6,103.1,86.6,147.1,75.3,81.1,91.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S458(100)]",0,"ENSG00000014123"
"1387","POLDIP3",-0.11870104169753,6.63474366216819,-0.819460446291013,0.432418570222304,0.50880108623129,-7.13031755951864,"NONE",FALSE,"High","Master Protein","Q9BY77","Polymerase delta-interacting protein 3 [OS=Homo sapiens]",0,30.401,5,2,2,4,2,421,46.1,9.99,13.29,2,"other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","84271","A8K6F8; A8K6V9; hsa:84271; Q009A7; Q5H972; Q6PGN6; Q7Z6Z0; Q9BY77; Q9NSP5; Q9NSP6","ENSG00000100227","Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination",NA,3,0,82.5,113,103.5,97,82.3,99.7,122.5,96.3,96.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S127(99.7)]",0,"ENSG00000100227"
"1388","USP47",0.0955970695188473,6.65018071728076,0.815195824742204,0.434739514386745,0.511163463601706,-7.13390413403512,"NONE",FALSE,"High","Master Protein","Q96K76","Ubiquitin carboxyl-terminal hydrolase 47 [OS=Homo sapiens]",0,23.665,2,2,2,3,2,1375,157.2,5.08,10.02,2,"protein metabolism;DNA metabolism;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00443, Pf19718","55031","B3KXF5; E9PM46; hsa:55031; Q658U0; Q86Y73; Q8TEP6; Q96K76; Q9BWI0; Q9NWN1","ENSG00000170242","Ub-specific processing proteases",NA,1,0,89.2,87.6,102.2,102.7,80.7,121,107.8,110.8,97.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S832(100); S933(99.6)]",0,"ENSG00000170242"
"1389","SMG6",-0.0960141911206822,6.64758105636071,-0.813830302076644,0.435484440500012,0.51167070330887,-7.13504910696416,"NONE",FALSE,"High","Master Protein","Q86US8","Telomerase-binding protein EST1A [OS=Homo sapiens]",0,4.612,2,2,2,2,2,1419,160.4,7.05,2.04,2,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf10373, Pf10374, Pf13638","23293","B7Z874; hsa:23293; O94837; Q86US8; Q86VH6; Q9UF60","ENSG00000070366","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",NA,1,0,92.4,105,100.3,90.6,115.1,87.7,101.1,100.7,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S332(100)]",0,"ENSG00000070366"
"1390","MCM2",-0.123755835488963,6.6397824389944,-0.812597935535303,0.436157461206606,0.512092788985022,-7.13608099583217,"NONE",FALSE,"High","Master Protein","P49736","DNA replication licensing factor MCM2 [OS=Homo sapiens]",0,12.237,2,2,2,2,2,904,101.8,5.52,4.58,2,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00493, Pf12619, Pf14551, Pf17207, Pf17855","4171","hsa:4171; P49736; Q14577; Q15023; Q8N2V1; Q969W7; Q96AE1; Q9BRM7","ENSG00000073111","Orc1 removal from chromatin; Assembly of the pre-replicative complex; Activation of ATR in response to replication stress; Activation of the pre-replicative complex; Unwinding of DNA","Cell cycle; Ciliary landscape; G1 to S cell cycle control; DNA replication; 1p36 copy number variation syndrome",11,0,84.6,104.6,94.4,86.8,93.2,87.7,92.3,136.5,125.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S41(99.2)]",0,"ENSG00000073111"
"1391","DUS3L",0.119423755183929,6.62135556240133,0.811750231638989,0.436620814173392,0.512268273710263,-7.13679000735646,"NONE",FALSE,"High","Master Protein","Q96G46","tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like [OS=Homo sapiens]",0,29.984,4,1,3,4,1,650,72.5,8.05,15.51,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes",NA,"other molecular function","Pf01207","56931","hsa:56931; Q96G46; Q96HM5; Q9BSU4; Q9H877; Q9NPR1","ENSG00000141994",NA,NA,0,0,97.4,100.1,100,93.8,102.6,139.2,79.2,93.4,97,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T273(99.1); S276(99.1)]",0,"ENSG00000141994"
"1392","RGS12",-0.0658265644655982,6.63813727048662,-0.809366674878138,0.437925426669564,0.51342981057811,-7.13878013646115,"NONE",FALSE,"High","Master Protein","O14924","Regulator of G-protein signaling 12 [OS=Homo sapiens]",0,46.059,3,3,3,6,3,1447,156.3,7.44,22.73,3,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00595, Pf00615, Pf02188, Pf02196, Pf16611, Pf16612, Pf16613","6002","B1AQ30; B1AQ31; B1AQ32; B7Z764; E7EMN9; hsa:6002; O14922; O14923; O14924; O43510; O75338; Q147X0; Q8WX95","ENSG00000159788","G alpha (i) signalling events",NA,1,0,100.9,103.7,106.8,104.9,88.2,111.1,94.9,100,89.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S16(100); S850(100)]",0,"ENSG00000159788"
"1393","KPNA3",-0.0669593246422018,6.66128263866496,-0.802537618813244,0.441677645868215,0.51745722760727,-7.14445372330397,"NONE",FALSE,"High","Master Protein","O00505","Importin subunit alpha-4 [OS=Homo sapiens]",0,15.2,3,1,1,2,1,521,57.8,4.94,8.39,1,"cell organization and biogenesis;transport;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00514, Pf01749, Pf16186","3839","hsa:3839; O00191; O00505; O43195; Q5JVM9; Q8IYQ9; Q96AA7","ENSG00000102753","ISG15 antiviral mechanism; NS1 Mediated Effects on Host Pathways",NA,2,0,105.3,102.2,93.5,101.7,92.3,99.4,108.9,108.2,98.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S60(100)]",0,"ENSG00000102753"
"1394","EPS15",0.0937853694133226,6.6953974066903,0.79842497029201,0.443947635136614,0.519743572842865,-7.14785024977597,"NONE",FALSE,"High","Master Protein","P42566","Epidermal growth factor receptor substrate 15 [OS=Homo sapiens]",0,77.124,9,5,5,14,5,896,98.6,4.64,39.64,5,"cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function",NA,"2060","B2R8J7; D3DPJ2; hsa:2060; P42566; Q5SRH4","ENSG00000085832","Cargo recognition for clathrin-mediated endocytosis; EGFR downregulation; Negative regulation of MET activity; InlB-mediated entry of Listeria monocytogenes into host cell","VEGFA-VEGFR2 signaling; Ebola virus infection in host; EGF/EGFR signaling pathway",8,0,94,94.9,96.1,118.9,89.1,102.1,120.5,107.7,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S324(99.6); S563(99.5); T777(100); S796(100); S814(100)]",0,"ENSG00000085832"
"1395","TPMT",-0.0995161824904693,6.66327729071368,-0.787789449541248,0.449853771006243,0.526280540704078,-7.15656294914626,"NONE",FALSE,"High","Master Protein","P51580","Thiopurine S-methyltransferase [OS=Homo sapiens]",0,11.055,6,1,2,4,1,245,28.2,6.23,8.85,1,"other metabolic processes","cytosol","other molecular function","Pf05724","7172","hsa:7172; O14806; O15423; O15424; O15425; O15426; O15515; O15548; O43213; P51580; Q5VUK6; Q9UBE6; Q9UBT8; Q9UE62","ENSG00000137364","Azathioprine ADME; Methylation; Defective TPMT causes TPMT deficiency","Metapathway biotransformation Phase I and II; Methylation pathways",5,0,97.8,100.8,103.5,110,71.9,103.5,113.5,109.3,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000137364"
"1396","IRF3",0.207816864668915,6.58441363891334,0.78542367704011,0.451174549978509,0.527447611436194,-7.15848706744943,"NONE",FALSE,"High","Master Protein","Q14653","Interferon regulatory factor 3 [OS=Homo sapiens]",0,4.247,5,1,1,1,1,427,47.2,5.34,2.52,1,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00605, Pf10401","3661","A8K7L2; B2RAZ3; hsa:3661; Q14653; Q5FBY1; Q5FBY2; Q5FBY4; Q7Z5G6","ENSG00000126456","ISG15 antiviral mechanism; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Activation of IRF3, IRF7 mediated by TBK1, IKBKE; Interferon gamma signaling; Interferon alpha/beta signaling; Negative regulators of DDX58/IFIH1 signaling; TICAM1-dependent activation of IRF3/IRF7; SARS-CoV-1 activates/modulates innate immune responses; TRAF3-dependent IRF activation pathway; TRAF6 mediated IRF7 activation; Evasion by RSV of host interferon responses; Regulation of innate immune responses to cytosolic DNA; IRF3-mediated induction of type I IFN; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production; IRF3 mediated activation of type 1 IFN","Apoptosis; TLR4 signaling and tolerance; Toll-like receptor signaling related to MyD88; Novel intracellular components of RIG-I-like receptor pathway; Fibrin complement receptor 3 signaling pathway; White fat cell differentiation; Ebola virus infection in host; Measles virus infection; Cytosolic DNA-sensing pathway; Hepatitis B infection; Type I interferon induction and signaling during SARS-CoV-2 infection; Host-pathogen interaction of human coronaviruses - interferon induction; SARS coronavirus and innate immunity; STING pathway in Kawasaki-like disease and COVID-19; Mitochondrial immune response to SARS-CoV-2; SARS-CoV-2 innate immunity evasion and cell-specific immune response; Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation; Lung pathology of COVID-19; Urotensin-II-mediated signaling pathway; Induction of autophagy and toll-like receptor signaling pathways by graphene oxide ; Toll-like receptor signaling pathway",38,0,92.8,51.9,66.3,76.6,45.2,124.6,137.4,170.3,155,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S175(99)]",0,"ENSG00000126456"
"1397","FOXC1",-0.119028647791011,6.61919485675557,-0.779023880165227,0.454760238399576,0.531258918445317,-7.16366661308933,"NONE",FALSE,"High","Master Protein","Q12948","Forkhead box protein C1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,553,56.8,8.51,4.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00250","2296","Q12948; Q86UP7; Q9BYM1; Q9NUE5; Q9UDD0; Q9UP06","ENSG00000054598","Formation of the ureteric bud; Formation of intermediate mesoderm","Heart development; Mesodermal commitment pathway; Mesodermal commitment pathway; BMP signaling in eyelid development; 22q11.2 copy number variation syndrome; Genes controlling nephrogenesis; GDNF/RET signaling axis; Development of ureteric collection system",10,0,90.6,103.9,93.3,76.9,109.5,92.4,124.7,97.7,101.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S320(100)]",0,"ENSG00000054598"
"1398","KDM5A",-0.0640691275449345,6.61574964572885,-0.776039567016065,0.456438660293558,0.532838264377029,-7.16606914952436,"NONE",FALSE,"High","Master Protein","P29375","Lysine-specific demethylase 5A [OS=Homo sapiens]",0,7.947,2,2,2,3,2,1690,192,6.49,4.41,2,"cell organization and biogenesis;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00628, Pf01388, Pf02373, Pf02375, Pf02928, Pf08429, Pf21323","5927","A8MV76; hsa:5927; P29375; Q4LE72; Q86XZ1","ENSG00000073614","HDMs demethylate histones; Chromatin modifications during the maternal to zygotic transition (MZT)",NA,2,0,97.4,101.4,95.9,88.9,97.7,105.2,103.3,99.7,96.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S198(96.6); S1331(99.5)]",0,"ENSG00000073614"
"1399","ACTN4",-0.101656043754021,6.60890703519434,-0.767396118597046,0.461322665395982,0.538154817674227,-7.17298168809965,"NONE",FALSE,"High","Master Protein","O43707","Alpha-actinin-4 [OS=Homo sapiens]",0,50.357,3,2,3,4,1,911,104.8,5.44,13.79,2,"cell organization and biogenesis;transport;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf00307, Pf00435, Pf08726","81","A4K467; D6PXK4; hsa:81; O43707; O76048","ENSG00000130402; ENSG00000282844","Platelet degranulation ; Nephrin family interactions","Arrhythmogenic right ventricular cardiomyopathy; Primary focal segmental glomerulosclerosis (FSGS); Focal adhesion; Striated muscle contraction pathway; Ebola virus infection in host; Nephrotic syndrome; Alstrom syndrome",9,0,108.8,93.8,107.9,114.7,80.1,96.5,104.3,93.4,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S159(100)]",0,"ENSG00000130402"
"1400","NF1",-0.0564990521939146,6.66043838175043,-0.753319582410128,0.46934899382712,0.547126827089899,-7.18409260217449,"NONE",FALSE,"High","Master Protein","P21359","Neurofibromin [OS=Homo sapiens]",0,105.304,3,7,9,20,7,2839,319.2,7.39,62.72,7,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00616, Pf13716","4763","hsa:4763; O00662; P21359; Q14284; Q14930; Q14931; Q9UMK3","ENSG00000196712","Regulation of RAS by GAPs; RAS signaling downstream of NF1 loss-of-function variants","Pilocytic astrocytoma; Glioblastoma signaling pathways; Aryl hydrocarbon receptor pathway; MECP2 and associated Rett syndrome; MAPK signaling pathway; Ras signaling; Transcription co-factors SKI and SKIL protein partners; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Melanoma; EGFR tyrosine kinase inhibitor resistance; NF1 copy number variation syndrome",14,0,94.5,91.9,92,89.6,86,98.7,114.7,111.7,129.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S864(99.7); S2515(100); S2543(100); T2565(99.5); S2597(100); S2817(100)]",0,"ENSG00000196712"
"1401","MAP7D1",-0.0594935309701601,6.66152162910971,-0.752106845937449,0.470044668247755,0.547172537627307,-7.18504130422477,"NONE",FALSE,"High","Master Protein","Q3KQU3","MAP7 domain-containing protein 1 [OS=Homo sapiens]",0,106.307,14,8,9,12,8,841,92.8,10.11,47.35,8,"cell organization and biogenesis","cytoskeleton;other cell component",NA,"Pf05672","55700","D3DPS4; hsa:55700; Q3KQU3; Q7L8J5; Q8N905; Q8TAK0; Q9HBQ2; Q9NW29; Q9ULN3","ENSG00000116871",NA,NA,0,0,93.4,93.3,103.2,93.1,84.6,107.7,109.3,107.8,113.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S70(99); S116(99.5); S254(100); S273(100); S460(100); S544(100); S834(100)]",0,"ENSG00000116871"
"1402","MAST3",0.0792103198316996,6.63638470980183,0.752082290839231,0.47005876087836,0.547172537627307,-7.18506049921712,"NONE",FALSE,"High","Master Protein","O60307","Microtubule-associated serine/threonine-protein kinase 3 [OS=Homo sapiens]",0,42.939,7,5,6,8,5,1309,143,8.06,17.74,5,"cell organization and biogenesis;protein metabolism;other metabolic processes;signal transduction","other cell component","kinase activity;other molecular function","Pf00069, Pf08926, Pf17820","23031","hsa:23031; O60307; Q7LDZ8; Q9UPI0","ENSG00000099308",NA,NA,0,0,102.4,93.8,91.5,113.3,97.4,101.5,88.5,109.5,101.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S146(100); S348(100)]",0,"ENSG00000099308"
"1403","RGL2",0.0709081616041329,6.63577119240239,0.750077690388004,0.471210153794404,0.548121861006748,-7.18662563936345,"NONE",FALSE,"High","Master Protein","O15211","Ral guanine nucleotide dissociation stimulator-like 2 [OS=Homo sapiens]",0,33.692,8,3,3,7,3,777,83.5,6.18,17.38,3,"signal transduction;other biological processes","cytosol","enzyme regulator activity","Pf00617, Pf00618, Pf00788","5863","B4DG72; hsa:5863; O15211; Q5STK0; Q9Y3F3","ENSG00000206282; ENSG00000224841; ENSG00000228736; ENSG00000237441; ENSG00000237825","RAF/MAP kinase cascade","Ras signaling",2,0,79.6,83.8,92.8,93.2,90,93,107.8,119.5,142.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S409(100); S619(100)]",0,"ENSG00000237441"
"1404","TJAP1",0.0573607614332579,6.66330543352976,0.742116883455629,0.475800469461859,0.552898832475516,-7.1928045429497,"NONE",FALSE,"High","Master Protein","Q5JTD0","Tight junction-associated protein 1 [OS=Homo sapiens]",0,46.731,8,3,3,7,3,557,61.8,5.97,27.8,3,"cell organization and biogenesis","plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component",NA,"Pf15453","93643","hsa:93643; Q05BH9; Q5JTD0; Q5JTD1; Q5JWW1; Q68DB2; Q6P2P3; Q9H7V7","ENSG00000137221",NA,NA,0,0,89.4,92.2,93.4,95.6,108.4,96,111.6,110.2,116.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S300(100); T422(100); S545(100)]",0,"ENSG00000137221"
"1405","IQSEC2",0.069062718095533,6.6440217853227,0.741781640670357,0.475994399281924,0.552898832475516,-7.19306345859346,"NONE",FALSE,"High","Master Protein","Q5JU85","IQ motif and SEC7 domain-containing protein 2 [OS=Homo sapiens]",0,25.179,3,3,3,5,1,1488,162.7,8.56,16.5,3,"cell organization and biogenesis;other biological processes","other cell component","enzyme regulator activity","Pf01369, Pf16453","23096","A0A1W2PQN3; B3KT97; C7SDG1; hsa:23096; O60275; Q5JU85; Q5JUX1","ENSG00000124313",NA,NA,0,2,85.9,93,94.8,94.3,102.2,102.9,100.8,122.1,106.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S246(100); S326(99.1)]",0,"ENSG00000124313"
"1406","PCDH7",0.0600950550378281,6.64558054949202,0.738840065707294,0.477698188320281,0.554483245617851,-7.19533083154797,"NONE",FALSE,"High","Master Protein","O60245","Protocadherin-7 [OS=Homo sapiens]",0,41.302,4,3,4,7,3,1069,116,5.19,24.77,3,"cell adhesion","plasma membrane;other membranes","other molecular function","Pf00028, Pf08266, Pf08374","5099","hsa:5099; O60245; O60246; O60247; Q4W5C4","ENSG00000169851","RHOA GTPase cycle; RHOB GTPase cycle; Platelet degranulation",NA,3,0,94.9,102.8,100.5,108.5,106.6,108,103.1,91.6,92.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S974(100); S989(100); S999(98.4); S1011(99.5)]",0,"ENSG00000169851"
"1407","UBE2J1",-0.0764705955588525,6.61068408056777,-0.738177155023769,0.478082687649646,0.554535143030719,-7.19584069531853,"NONE",FALSE,"High","Master Protein","Q9Y385","Ubiquitin-conjugating enzyme E2 J1 [OS=Homo sapiens]",0,25.48,5,1,1,3,1,318,35.2,6.74,15.06,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf00179","51465","A8K3F9; hsa:51465; Q53F25; Q5W0N4; Q9BZ32; Q9NQL3; Q9NY66; Q9P011; Q9P0S0; Q9UF10; Q9Y385","ENSG00000198833","Antigen processing: Ubiquitination & Proteasome degradation","Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway",3,0,102.1,104.8,93.8,91,108.7,98.4,94,90.7,107.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S266(100)]",0,"ENSG00000198833"
"1408","IGF2BP2",-0.0702481287661314,6.65073467643852,-0.73145318140109,0.481993808741653,0.558674641950553,-7.20098920155972,"NONE",FALSE,"High","Master Protein","Q9Y6M1","Insulin-like growth factor 2 mRNA-binding protein 2 [OS=Homo sapiens]",0,35.423,6,2,3,10,2,599,66.1,8.46,26.8,2,"other metabolic processes;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf00076","10644","A0A4Z0; B3FTN2; B3FTN3; B3FTN4; hsa:10644; Q9Y6M1","ENSG00000073792","Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA",NA,1,0,97.7,97.7,106.6,97.9,80.8,115.8,104.2,97.5,104.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S162(99.3); S164(100)]",0,"ENSG00000073792"
"1409","DNAJB2",-0.0633581947244082,6.65152439934096,-0.729931199820293,0.482881898747536,0.559306784070957,-7.20214872998869,"NONE",FALSE,"High","Master Protein","P25686","DnaJ homolog subfamily B member 2 [OS=Homo sapiens]",0,6.937,2,1,1,4,1,324,35.6,5.95,4.99,1,"protein metabolism;other metabolic processes;stress response;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","other molecular function","Pf00226","3300","A8K9P6; hsa:3300; P25686; Q53QD7; Q8IUK1; Q8IUK2; Q96F52","ENSG00000135924",NA,NA,0,0,100,89.7,102.1,99.5,95.6,92.9,110.6,100.3,112.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S313(100)]",0,"ENSG00000135924"
"1410","KANK1",0.0510205479398405,6.66861321222378,0.725719749180289,0.48534469864146,0.561760672470116,-7.20534597813801,"NONE",FALSE,"High","Master Protein","Q14678","KN motif and ankyrin repeat domain-containing protein 1 [OS=Homo sapiens]",0,29.108,2,2,2,4,2,1352,147.2,5.3,16.47,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;nucleus;other cell component","other molecular function","Pf00023, Pf12075","23189","A2A2W8; D3DRH3; hsa:23189; Q14678; Q5W0W0; Q8IY65; Q8WX74","ENSG00000107104","Estrogen-dependent gene expression; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB","VEGFA-VEGFR2 signaling",3,0,93.2,87.7,93.6,94.3,99.1,101.9,109.5,114.5,121.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100); S881(99.4)]",0,"ENSG00000107104"
"1411","PHYHIPL",0.0786425094940437,6.67392062486741,0.716435450475765,0.490801885774111,0.567674470292947,-7.21233584617033,"NONE",FALSE,"High","Master Protein","Q96FC7","Phytanoyl-CoA hydroxylase-interacting protein-like [OS=Homo sapiens]",0,68.406,8,2,6,14,2,376,42.5,6.42,58.07,2,NA,"other cell component",NA,"Pf00041, Pf19281","84457","B7WP61; hsa:84457; Q68DF3; Q6UXY3; Q8N3W3; Q96FC7; Q96JM9; Q96NP7","ENSG00000165443",NA,NA,0,0,88.1,90.9,96.6,99.8,83,116.2,99.6,123.1,120.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S12(100); S15(100); S25(100)]",0,"ENSG00000165443"
"1412","VEPH1",0.105019188740103,6.65743836340649,0.710799850878903,0.49413304928227,0.571122617867326,-7.2165392938669,"NONE",FALSE,"High","Master Protein","Q14D04","Ventricular zone-expressed PH domain-containing protein homolog 1 [OS=Homo sapiens]",0,19.105,5,3,3,4,3,833,94.7,6.71,8.82,3,"other biological processes","plasma membrane;other membranes","other molecular function","Pf00169","79674","D3DNL0; F5GZ91; hsa:79674; Q14D04; Q2TAA9; Q3MIX2; Q6PEL3; Q86TL5; Q8TCR3; Q96SP7; Q9C0H1; Q9H9Q7","ENSG00000197415",NA,NA,0,0,105.4,96.1,98.9,116,77,132,92.7,103.1,88.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S430(100); S478(98.1)]",0,"ENSG00000197415"
"1413","AHDC1",0.104975827584555,6.66147806704415,0.708826584756393,0.495302750863459,0.572069419256309,-7.21800404439427,"NONE",FALSE,"High","Master Protein","Q5TGY3","Transcription factor Gibbin [OS=Homo sapiens]",0,34.041,4,3,3,3,3,1603,168.2,9.04,11.69,3,"developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf15735","27245","hsa:27245; Q5TGY3; Q5TGY4; Q6PJK1; Q6ZUQ6; Q99769; Q9NUF5","ENSG00000126705",NA,"Mesodermal commitment pathway",1,0,94.7,88.4,110.3,114,79.7,126.2,106.3,101.1,88.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S896(100)]",0,"ENSG00000126705"
"1414","SPIRE1",-0.0893588977941713,6.66173784785784,-0.705191174214948,0.49746222587713,0.573819550900021,-7.22069300046202,"NONE",FALSE,"High","Master Protein","Q08AE8-2","Isoform 2 of Protein spire homolog 1 [OS=Homo sapiens]",0,42.265,8,5,6,9,5,742,83.9,8.62,25.06,5,NA,NA,NA,NA,NA,"Q08AE8-2",NA,NA,NA,0,0,101.7,105.5,102.5,101.8,78.3,116.6,108.4,108.3,86.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S387(100); S468(98.4); T495(99.5); S509(100)]",0,"ENSG00000134278"
"1415","JUN",-0.0945909445658746,6.61318726109952,-0.705091962288976,0.497521240516869,0.573819550900021,-7.22076620863974,"NONE",FALSE,"High","Master Protein","P05412","Transcription factor Jun [OS=Homo sapiens]",0,7.778,4,1,2,2,1,331,35.7,8.76,5.31,1,"stress response;signal transduction;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00170, Pf03957","3725","hsa:3725; P05412; Q6FHM7; Q96G93","ENSG00000177606","FCERI mediated MAPK activation; MAPK6/MAPK4 signaling; Oxidative Stress Induced Senescence; Regulation of PTEN gene transcription; TP53 Regulates Transcription of DNA Repair Genes; Signaling by ALK fusions and activated point mutants; Activation of anterior HOX genes in hindbrain development during early embryogenesis; Estrogen-dependent gene expression; Pre-NOTCH Transcription and Translation; Senescence-Associated Secretory Phenotype (SASP); WNT5:FZD7-mediated leishmania damping; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models; Activation of the AP-1 family of transcription factors","IL-5 signaling pathway; Androgen receptor signaling pathway; Physiological and pathological hypertrophy of the heart; IL-1 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; Prolactin signaling pathway; Androgen receptor network in prostate cancer; B cell receptor signaling pathway; TNF-alpha signaling pathway; AGE/RAGE pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Quercetin and Nf-kB / AP-1 induced apoptosis; ATM signaling pathway; Apoptosis; Polycystic kidney disease pathway; Selenium metabolism and selenoproteins; IL-3 signaling pathway; Aryl hydrocarbon receptor pathway; Glucocorticoid receptor pathway; Estrogen receptor pathway; Nuclear receptors meta-pathway; Myometrial relaxation and contraction pathways; Focal adhesion; Hepatocyte growth factor receptor signaling; Fas ligand pathway and stress induction of heat shock proteins; Copper homeostasis; MFAP5-mediated ovarian cancer cell motility and invasiveness; Photodynamic therapy-induced AP-1 survival signaling; Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; Hepatitis C and hepatocellular carcinoma; TGF-beta signaling pathway; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; PDGFR-beta pathway; Wnt signaling pathway and pluripotency; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; lncRNA in canonical Wnt signaling and colorectal cancer; Breast cancer pathway; Wnt signaling; ncRNAs involved in Wnt signaling in hepatocellular carcinoma; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Nonalcoholic fatty liver disease; Signal transduction through IL1R; MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; Neural crest cell migration during development; Neural crest cell migration in cancer; Cancer immunotherapy by PD-1 blockade; Measles virus infection; Gastrin signaling pathway; Hepatitis B infection; Netrin-UNC5B signaling pathway; IL-18 signaling pathway; Insulin signaling; TGF-beta receptor signaling in skeletal dysplasias; Host-pathogen interaction of human coronaviruses - MAPK signaling; Host-pathogen interaction of human coronaviruses - interferon induction; IL-2 signaling pathway; 3q29 copy number variation syndrome; Neuroinflammation; MAPK pathway in congenital thyroid cancer; Pleural mesothelioma; Th17 cell differentiation pathway; Inflammatory bowel disease signaling; 2q37 copy number variation syndrome; TROP2 regulatory signaling; IL-26 signaling pathways; Macrophage-stimulating protein (MSP) signaling network map; Osteoarthritic chondrocyte hypertrophy; 5q35 copy number variation; TGF-beta receptor signaling; ErbB signaling pathway; T-cell receptor signaling pathway; Sudden infant death syndrome (SIDS) susceptibility pathways; DNA damage response (only ATM dependent); Estrogen signaling pathway; Toll-like receptor signaling pathway",98,0,81.3,82.5,77.1,70.2,85.2,69.8,138.1,124.3,180.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S63(99.4)]",0,"ENSG00000177606"
"1416","FHIP1B",0.128493310848904,6.6486049197063,0.700680275103453,0.500149840731312,0.576443884232699,-7.22401219043663,"NONE",FALSE,"High","Master Protein","Q8N612","FHF complex subunit HOOK-interacting protein 1B [OS=Homo sapiens]",0,11.395,3,1,1,1,1,972,105.5,6.77,3.57,1,"cell organization and biogenesis;transport;other biological processes","cytosol;other cell component",NA,"Pf10257, Pf19311, Pf19314","84067","hsa:84067; Q8N612; Q9C0A4; Q9H0N3; Q9H624","ENSG00000051009",NA,NA,0,0,69,108.2,102,104,97,107.6,92.7,100.2,138.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S510(100)]",0,"ENSG00000051009"
"1417","KDM1A",0.118663340848387,6.61844007084258,0.698656867150537,0.501358301988916,0.577428898268109,-7.22549480210874,"NONE",FALSE,"High","Master Protein","O60341","Lysine-specific histone demethylase 1A [OS=Homo sapiens]",0,30.401,4,2,2,4,2,852,92.8,6.52,18.35,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01593, Pf04433","23028","A8MWP9; hsa:23028; O60341; Q5TH94; Q5TH95; Q86VT7; Q8IXK4; Q8NDP6; Q8TAZ3; Q96AW4","ENSG00000004487","Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; Estrogen-dependent gene expression; Factors involved in megakaryocyte development and platelet production; HDMs demethylate histones; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3","Androgen receptor signaling pathway; Effect of progerin on genes involved in progeria; Thermogenesis; Vitamin D-sensitive calcium signaling in depression; Thyroid hormones production and peripheral downstream signaling effects; Neurogenesis regulation in the olfactory epithelium",14,0,103.6,91.8,98.7,101.2,83.2,140.7,81.1,89.5,105.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S166(100)]",0,"ENSG00000004487"
"1418","PWP1",-0.131775902737729,6.63086319535489,-0.69082153302119,0.506054810021933,0.582356889620138,-7.23119943336969,"NONE",FALSE,"High","Master Protein","Q13610","Periodic tryptophan protein 1 homolog [OS=Homo sapiens]",0,23.976,5,1,2,3,1,501,55.8,4.77,9.1,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","ER/Golgi;nucleus;other cell component","other molecular function","Pf00400","11137","A8K3R6; hsa:11137; Q13610; Q7Z3X9","ENSG00000136045",NA,NA,0,0,112.8,99.6,108.9,101.1,125.6,83.4,97.4,73.6,115.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100)]",0,"ENSG00000136045"
"1419","SYNRG",-0.071805990406026,6.650932776911,-0.690329300266936,0.506350751452804,0.582356889620138,-7.23155586815807,"NONE",FALSE,"High","Master Protein","Q9UMZ2","Synergin gamma [OS=Homo sapiens]",0,26.683,3,3,3,3,3,1314,140.6,5.03,11.11,3,"transport","other membranes;ER/Golgi;other cell component",NA,NA,"11276","A8MWU4; B7ZKZ2; B7ZKZ3; hsa:11276; Q17RI2; Q5BKU5; Q6ZT17; Q9UMZ2","ENSG00000274047; ENSG00000275066",NA,"17q12 copy number variation syndrome",1,0,94.6,110.6,91.3,89.9,110.6,94,106.5,104.3,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S752(100); S935(99.6); S1075(100)]",0,"ENSG00000275066"
"1420","TOP2B",-0.0676833770099838,6.61717932601099,-0.689584107048294,0.506798979755117,0.582461926028416,-7.23209503870847,"NONE",FALSE,"High","Master Protein","Q02880","DNA topoisomerase 2-beta [OS=Homo sapiens]",0,48.733,4,4,5,6,4,1626,183.2,8,19.22,4,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00204, Pf00521, Pf01751, Pf02518, Pf08070, Pf16898","7155","hsa:7155; Q02880; Q13600; Q9UMG8; Q9UQP8","ENSG00000077097","SUMOylation of DNA replication proteins",NA,1,0,99.7,97.3,109.9,100.3,108.4,96.8,84.9,94,103.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1466(100); S1524(99.6); S1550(99.7)]",0,"ENSG00000077097"
"1421","UBAC1",0.0737563111221435,6.65560712827949,0.687922542169334,0.50779927159246,0.583200852384867,-7.23329533438783,"NONE",FALSE,"High","Master Protein","Q9BSL1","Ubiquitin-associated domain-containing protein 1 [OS=Homo sapiens]",0,6.715,2,2,2,3,2,405,45.3,4.92,7.78,2,"protein metabolism;other metabolic processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cell component","other molecular function","Pf00627","10422","hsa:10422; O75500; Q9BSL1; Q9UMW7","ENSG00000130560","Antigen processing: Ubiquitination & Proteasome degradation",NA,1,0,88.5,93.2,101.1,100.7,120.4,94.1,102.7,99,115,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S98(100)]",0,"ENSG00000130560"
"1422","SHROOM2",0.0630036526868762,6.63708142538846,0.667690331409037,0.520075645456358,0.596880065671432,-7.24769990297233,"NONE",FALSE,"High","Master Protein","Q13796","Protein Shroom2 [OS=Homo sapiens]",0,33.178,3,4,4,5,4,1616,176.3,7.09,15.08,4,"cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","transporter activity;cytoskeletal activity;other molecular function","Pf00595, Pf08687, Pf08688","357","B9EIQ7; hsa:357; Q13796","ENSG00000146950",NA,"VEGFA-VEGFR2 signaling",1,0,100.2,98,97.1,97.7,119.4,108.5,88.8,94.8,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S974(100); S1036(100); S1297(99.6)]",0,"ENSG00000146950"
"1423","EML4",-0.0584354611142741,6.65284421659319,-0.653818783368196,0.528594521532002,0.606230681054271,-7.25734950240487,"NONE",FALSE,"High","Master Protein","Q9HC35","Echinoderm microtubule-associated protein-like 4 [OS=Homo sapiens]",0,26.14,5,2,3,5,2,981,108.8,6.4,22.35,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf00400, Pf03451","27436","A6H8Y6; A6P4T4; A6P4V4; B2RBK3; B2RTW7; B5MCW9; hsa:27436; Q3SWW0; Q53R29; Q53TW8; Q6PJ45; Q9HC35; Q9NV40","ENSG00000143924","EML4 and NUDC in mitotic spindle formation; ALK mutants bind TKIs; Signaling by ALK fusions and activated point mutants","Non-small cell lung cancer",4,0,107.6,97.8,94.8,101.5,88.8,102.8,96,102.2,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S144(100); S146(99.5)]",0,"ENSG00000143924"
"1424","MAP4K4",0.0600224319911895,6.60775398096687,0.64967241384048,0.531156882875391,0.608068099951106,-7.26019793686991,"NONE",FALSE,"High","Master Protein","O95819-3","Isoform 3 of Mitogen-activated protein kinase kinase kinase kinase 4 [OS=Homo sapiens]",0,73.456,8,8,9,18,2,1320,150.9,7.42,42.27,8,NA,NA,NA,NA,NA,"O95819-3",NA,NA,NA,0,4,102.6,102.3,102.1,108.4,127.9,101.8,86,91.3,80.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T181(100); S643(100); S708(100); S716(100); S788(99.5); S923(100); S981(100)]",0,"ENSG00000071054"
"1425","ACTR10",0.141143043325072,6.63447989954682,0.649225630159817,0.531433421691085,0.608068099951106,-7.26050387435766,"NONE",FALSE,"High","Master Protein","Q9NZ32","Actin-related protein 10 [OS=Homo sapiens]",0,20.012,6,2,2,3,2,417,46.3,7.37,9.98,2,"transport","non-structural extracellular;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component",NA,"Pf00022","55860","hsa:55860; Q9H9Y5; Q9NWY2; Q9NZ32","ENSG00000131966","MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Neutrophil degranulation",NA,5,0,80.5,81.5,85.1,84.5,146.4,71.9,124.4,103.3,151.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S414(100)]",0,"ENSG00000131966"
"1426","ETV6",0.0955882531968815,6.57176548712251,0.648328029729394,0.531989252086388,0.608068099951106,-7.26111792852716,"NONE",FALSE,"High","Master Protein","P41212","Transcription factor ETV6 [OS=Homo sapiens]",0,5.083,2,1,1,3,1,452,53,7.43,2.65,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00178, Pf02198","2120","A3QVP6; A8K076; hsa:2120; P41212; Q9UMF6; Q9UMF7; Q9UMG0","ENSG00000139083","Signaling by FLT3 fusion proteins; Signaling by membrane-tethered fusions of PDGFRA or PDGFRB","Hematopoietic stem cell gene regulation by GABP alpha/beta complex; Exercise-induced circadian regulation",4,0,106.2,88.4,92.4,99.1,104.2,114.6,74.5,90.2,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100)]",0,"ENSG00000139083"
"1427","HMGA1",-0.0538655205920611,6.64680854739539,-0.648240403513246,0.532043532116886,0.608068099951106,-7.26117783250011,"NONE",FALSE,"High","Master Protein","P17096","High mobility group protein HMG-I/HMG-Y [OS=Homo sapiens]",0,12.326,26,2,2,3,2,107,11.7,10.32,4.89,2,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function",NA,"3159","hsa:3159; P10910; P17096; Q5T6U9; Q9UKB0","ENSG00000137309","Vpr-mediated nuclear import of PICs; 2-LTR circle formation; Integration of viral DNA into host genomic DNA; Autointegration results in viral DNA circles; APOBEC3G mediated resistance to HIV-1 infection; Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Adipogenesis; Pre-implantation embryo; Male infertility; 7q11.23 copy number variation syndrome; NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; Orexin receptor pathway",13,0,102.4,90.6,88.9,97.1,91.3,89.7,114,113.6,111.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T53(100)]",0,"ENSG00000137309"
"1428","PRKD1",0.0439304536256424,6.67112293941079,0.648214485805858,0.532059587457217,0.608068099951106,-7.26119554922007,"NONE",FALSE,"High","Master Protein","Q15139","Serine/threonine-protein kinase D1 [OS=Homo sapiens]",0,60.266,7,4,4,8,2,912,101.6,6.62,33.09,4,"cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;kinase activity;other molecular function","Pf00069, Pf00130, Pf00169","5587","A6NL64; B2RAF6; Q15139","ENSG00000184304","Sphingolipid de novo biosynthesis","Apoptosis modulation and signaling; Cardiac hypertrophic response; Myometrial relaxation and contraction pathways; G protein signaling pathways; VEGFA-VEGFR2 signaling; Wnt signaling pathway and pluripotency; Gastrin signaling pathway; Osteoblast differentiation and related diseases; Calcium regulation in cardiac cells",10,2,90.3,94.2,89.9,93.7,94.5,103.9,113.1,116.3,118.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S205(100); S219(99.5); S397(100); S742(100)]",0,"ENSG00000184304"
"1429","RBSN",-0.201974836216905,6.60303761287623,-0.644174807116488,0.534565547629045,0.610504530252345,-7.26394904162665,"NONE",FALSE,"High","Master Protein","Q9H1K0","Rabenosyn-5 [OS=Homo sapiens]",0,7.609,3,2,2,2,2,784,88.8,5.5,4.33,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf01363, Pf11464, Pf16601","64145","B4DWY8; C9J4P5; hsa:64145; Q3KP30; Q59EY8; Q8NAQ1; Q9H1K0","ENSG00000131381","Factors involved in megakaryocyte development and platelet production; Toll Like Receptor 9 (TLR9) Cascade",NA,2,0,95.2,104.6,68,50.2,148.8,64.3,131,116.7,144.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(99.2); S548(100)]",0,"ENSG00000131381"
"1430","ZDHHC14",0.106791668105465,6.56073861247681,0.643413435249213,0.535038629152029,0.610617512430847,-7.26446623451298,"NONE",FALSE,"High","Master Protein","Q8IZN3","Palmitoyltransferase ZDHHC14 [OS=Homo sapiens]",0,13.312,2,1,1,1,1,488,53.4,8.24,3.84,1,"protein metabolism;other metabolic processes;other biological processes","other membranes;ER/Golgi","other molecular function","Pf01529","79683","A6NDB7; hsa:79683; Q5JS07; Q5JS08; Q6PHS4; Q8IZN2; Q8IZN3; Q9H7F1","ENSG00000175048",NA,NA,0,0,113.5,125.3,81,106.7,131.9,114.1,68.1,87.6,75.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S455(100)]",0,"ENSG00000175048"
"1431","TRPT1",0.0849429837193698,6.66697925297804,0.642507472087902,0.535601872775421,0.610833163081403,-7.26508091613743,"NONE",FALSE,"High","Master Protein","Q86TN4","tRNA 2'-phosphotransferase 1 [OS=Homo sapiens]",0,15.2,7,1,1,1,1,253,27.7,9.98,3.23,1,"RNA metabolism OR transcription;other metabolic processes",NA,"other molecular function","Pf01885","83707","A8MU17; A8MYC9; F5H2B2; hsa:83707; Q86TN4; Q9BSB9","ENSG00000149743",NA,NA,0,0,82.8,88,89,100.6,65.2,118,121,119,129.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S240(99.4)]",0,"ENSG00000149743"
"1432","FAM193A",0.060775655247796,6.6312710967631,0.639077623056958,0.5377373773727,0.612840363039278,-7.26740081478443,"NONE",FALSE,"High","Master Protein","P78312","Protein FAM193A [OS=Homo sapiens]",0,25.309,4,3,3,10,3,1265,139.9,6.48,19.11,3,NA,NA,NA,"Pf15914","8603","B7ZM85; B9EGR0; E9PFA1; hsa:8603; O43607; P78311; P78312; P78313; Q9UEG8","ENSG00000125386",NA,NA,0,0,101.4,100.6,92.8,109.9,114.8,95.4,95,100,91.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S383(99.5); S1144(100)]",0,"ENSG00000125386"
"1433","PCDHGC3",0.0918011831690313,6.63504052937765,0.6313173820919,0.54258738557645,0.617936226978902,-7.27260761844668,"NONE",FALSE,"High","Master Protein","Q9UN70","Protocadherin gamma-C3 [OS=Homo sapiens]",0,4.429,2,2,4,4,2,934,101,5.21,9.37,2,"cell adhesion;cell organization and biogenesis;developmental processes;other biological processes","plasma membrane;other membranes","other molecular function","Pf00028, Pf08266, Pf15974, Pf16492","5098","hsa:5098; O60622; Q08192; Q9UN70; Q9Y5C4","ENSG00000240184",NA,NA,0,0,77.1,77.9,77.9,85,63.9,101.8,165.3,119.3,150.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S733(99.6); S769(100)]",0,"ENSG00000240184"
"1434","HS1BP3",-0.0832071668188128,6.63910986203479,-0.630689863514166,0.542980679008988,0.61795290665458,-7.27302610148435,"NONE",FALSE,"High","Master Protein","Q53T59","HCLS1-binding protein 3 [OS=Homo sapiens]",0,11.707,5,1,2,5,1,392,42.8,5.01,8.36,1,"other biological processes","mitochondrion;ER/Golgi","other molecular function","Pf00787","64342","B2RAW2; D6W529; hsa:64342; Q53T59; Q86VC2; Q8N367","ENSG00000118960",NA,NA,0,0,88.2,102.5,120.8,104.7,76.7,115.8,91.6,95.5,104.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S194(100)]",0,"ENSG00000118960"
"1435","GAB2",0.0697048500102087,6.65212614862563,0.628687835824332,0.544236540660281,0.618950546590647,-7.27435866456494,"NONE",FALSE,"High","Master Protein","Q9UQC2","GRB2-associated-binding protein 2 [OS=Homo sapiens]",0,42.923,11,6,6,7,6,676,74.4,8.31,18.57,6,"signal transduction;other biological processes","plasma membrane;other membranes;cytosol;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00169","9846","A2RRM2; A6NEW9; A7MD36; hsa:9846; O60317; Q9UQC2","ENSG00000033327","PIP3 activates AKT signaling; Role of LAT2/NTAL/LAB on calcium mobilization; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RET signaling; Interleukin receptor SHC signaling; PI3K Cascade; Signaling by SCF-KIT; Signaling by CSF3 (G-CSF); Signaling by cytosolic FGFR1 fusion mutants; Signaling by CSF1 (M-CSF) in myeloid cells; Signaling by FLT3 fusion proteins; Signaling by FLT3 ITD and TKD mutants; STAT5 activation downstream of FLT3 ITD mutants; Interleukin-15 signaling; STAT5 Activation","RANKL/RANK signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; B cell receptor signaling pathway; IL-3 signaling pathway; Kit receptor signaling pathway; Imatinib and chronic myeloid leukemia; BDNF-TrkB signaling; IL-4 signaling pathway; Ras signaling; EGF/EGFR signaling pathway; IL-2 signaling pathway; GDNF signaling; Interferon type I signaling pathways; T-cell receptor signaling pathway",32,0,87.9,89.4,93.6,93.1,114.5,92.8,114.7,101,124.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(99); S210(100); S223(100); S285(100); T391(100); S405(100)]",0,"ENSG00000033327"
"1436","STX1B",-0.0744572179767014,6.62704641611491,-0.626267493970829,0.545757048323271,0.62024756466823,-7.27596445164133,"NONE",FALSE,"High","Master Protein","P61266","Syntaxin-1B [OS=Homo sapiens]",0,11.716,6,1,1,1,1,288,33.2,5.38,4.13,1,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00804, Pf05739","112755","hsa:112755; P61266; Q15531; Q2VPS2","ENSG00000099365","LGI-ADAM interactions; Toxicity of botulinum toxin type C (botC)","Synaptic vesicle pathway; 15q11q13 copy number variation",4,0,105.8,100.1,88.6,96.3,78.1,108.6,108.7,110.6,91.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000099365"
"1437","PRKCE",-0.126506410842754,6.64688612545186,-0.622582621633975,0.54807665676346,0.62245031582322,-7.27839823814488,"NONE",FALSE,"High","Master Protein","Q02156","Protein kinase C epsilon type [OS=Homo sapiens]",0,35.993,5,2,2,6,2,737,83.6,7.12,18.99,2,"cell adhesion;cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00130, Pf00168, Pf00433","5581","B0LPH7; hsa:5581; Q02156; Q32MQ3; Q53SL4; Q53SM5; Q9UE81","ENSG00000171132","Role of phospholipids in phagocytosis; G alpha (z) signalling events; SHC1 events in ERBB2 signaling; DAG and IP3 signaling; Effects of PIP2 hydrolysis","Physiological and pathological hypertrophy of the heart; Oncostatin M signaling pathway; Myometrial relaxation and contraction pathways; G protein signaling pathways; VEGFA-VEGFR2 signaling; Wnt signaling pathway and pluripotency; Non-genomic actions of 1,25 dihydroxyvitamin D3; Hippo signaling regulation pathways; Gastrin signaling pathway; Osteoblast differentiation and related diseases; Kisspeptin/kisspeptin receptor system in the ovary; Opioid receptor pathways; Orexin receptor pathway; Chronic hyperglycemia impairment of neuron function; Calcium regulation in cardiac cells; HDAC6 interactions in the central nervous system",21,0,90.3,108.2,114.5,111.7,61.5,119.1,117.3,99.5,83.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T710(100)]",0,"ENSG00000171132"
"1438","DCTN1",0.056367955458561,6.67850282974585,0.620331504207612,0.549496507448709,0.623628859635809,-7.27987854089544,"NONE",FALSE,"High","Master Protein","Q14203","Dynactin subunit 1 [OS=Homo sapiens]",0,15.2,2,1,2,2,1,1278,141.6,5.81,10.34,1,"cell cycle OR cell proliferation;cell organization and biogenesis;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf01302, Pf12455","1639","A8MY36; B4DM45; E9PFS5; E9PGE1; G5E9H4; hsa:1639; O95296; Q14203; Q6IQ37; Q9BRM9; Q9UIU1; Q9UIU2","ENSG00000204843","Signaling by ALK fusions and activated point mutants; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; XBP1(S) activates chaperone genes","Vasopressin-regulated water reabsorption; HDAC6 interactions in the central nervous system",8,0,85.3,89.9,108.1,103.7,90.2,107.6,110.8,110.2,111,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T108(100)]",0,"ENSG00000204843"
"1439","RPS6KC1",-0.0541058722554224,6.66046481115387,-0.618777479134742,0.550477909345922,0.624308511502811,-7.28089755914228,"NONE",FALSE,"High","Master Protein","Q96S38","Ribosomal protein S6 kinase delta-1 [OS=Homo sapiens]",0,34.507,5,3,4,4,3,1066,118.6,4.87,14.18,3,"other metabolic processes;signal transduction","other membranes;other cytoplasmic organelle","kinase activity;other molecular function","Pf00069, Pf00787, Pf04212","26750","B1APS8; B3KVM4; D3DTA4; hsa:26750; Q8TDD3; Q96S38; Q9NSF4; Q9UL66","ENSG00000136643",NA,NA,0,0,94.1,103,105.2,96.4,88.5,115.4,97.6,103,107.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S282(99.5); S528(100); S664(99.5)]",0,"ENSG00000136643"
"1440","NAV1",0.0451295691446116,6.66461408539942,0.617540589940446,0.551259749430756,0.624761049354857,-7.2817069362443,"NONE",FALSE,"High","Master Protein","Q8NEY1","Neuron navigator 1 [OS=Homo sapiens]",0,207.258,13,16,18,31,16,1877,202.3,8.07,102.18,16,"cell organization and biogenesis;developmental processes","cytoskeleton;other cell component","other molecular function",NA,"89796","A8MS88; hsa:89796; Q5SVH1; Q5SVH2; Q5SVH3; Q5SVH7; Q5VUY9; Q8IVL2; Q8NEY1; Q96II1; Q9H7V9; Q9H9S9; Q9H9T5; Q9UGI1; Q9ULK7; Q9ULR9","ENSG00000134369",NA,NA,0,0,100.2,100.5,105.4,103.1,115.4,111.7,90.7,98.9,98.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100); S199(100); S377(100); S391(100); S507(100); S541(99.4); S672(100); S760(100); S808(100); S954(100); S1000(100); S1181(98.6); S1253(100)]",0,"ENSG00000134369"
"1441","G3BP2",0.0560971936433265,6.64764768510264,0.61575913642301,0.552386924548132,0.62560406721898,-7.2828700292542,"NONE",FALSE,"High","Master Protein","Q9UN86-2","Isoform B of Ras GTPase-activating protein-binding protein 2 [OS=Homo sapiens]",0,45.601,4,1,3,8,1,449,50.8,5.38,40.38,1,NA,NA,NA,NA,NA,"Q9UN86-2",NA,NA,NA,0,0,93.9,95.3,101.6,111.4,92.5,107.2,97.3,109.5,93.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T227(99.2)]",0,"ENSG00000138757"
"1442","NOTCH2",0.0507854466781463,6.63212750981062,0.612054577906065,0.554735107388803,0.627827805311045,-7.28527875680287,"NONE",FALSE,"High","Master Protein","Q04721","Neurogenic locus notch homolog protein 2 [OS=Homo sapiens]",0,77.483,3,4,7,20,4,2471,265.2,5.14,38.16,4,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00008, Pf00066, Pf06816, Pf07645, Pf07684, Pf12661, Pf12796","4853","hsa:4853; Q04721; Q5T3X7; Q99734; Q9H240","ENSG00000134250","NOTCH2 Activation and Transmission of Signal to the Nucleus; Pre-NOTCH Processing in Golgi; Pre-NOTCH Transcription and Translation; Notch-HLH transcription pathway; NOTCH2 intracellular domain regulates transcription; NOTCH4 Intracellular Domain Regulates Transcription; Pre-NOTCH Processing in the Endoplasmic Reticulum; Defective LFNG causes SCDO3","Neural crest differentiation; Notch signaling; Canonical and non-canonical Notch signaling; OSX and miRNAs in tooth development; Epithelial to mesenchymal transition in colorectal cancer; Breast cancer pathway; Head and neck squamous cell carcinoma; Osteoblast differentiation and related diseases; Genes controlling nephrogenesis; Nephrogenesis; Primary ovarian insufficiency; Notch signaling pathway",20,0,93.9,97.7,95.1,97,93.2,117.9,100.6,101.2,98.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1778(100); T1802(100); S1804(99.5); S2081(100)]",0,"ENSG00000134250"
"1443","PUS1",0.0873615290451486,6.6739313275751,0.609443873003549,0.556393340909626,0.629106366361497,-7.28696818056955,"NONE",FALSE,"High","Master Protein","Q9Y606","Pseudouridylate synthase 1 homolog [OS=Homo sapiens]",0,3.699,4,1,1,1,1,427,47.4,8.41,2.15,1,"RNA metabolism OR transcription;other metabolic processes","mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01416","80324","A8K877; B3KQC1; hsa:80324; Q8WYT2; Q9BU44; Q9Y606","ENSG00000177192",NA,NA,0,0,94.8,91.4,101,105.5,113.5,100.5,126.8,97.4,91.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T426(100)]",0,"ENSG00000177192"
"1444","SRCAP",-0.0631968592117795,6.61180622231649,-0.609062549618695,0.556635780040442,0.629106366361497,-7.28721438113795,"NONE",FALSE,"High","Master Protein","Q6ZRS2","Helicase SRCAP [OS=Homo sapiens]",0,30.792,2,3,3,4,3,3230,343.3,5.96,11.95,3,"cell organization and biogenesis;other biological processes","ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00176, Pf00271, Pf07529","10847","B0JZA6; hsa:10847; O15026; Q6ZRS2; Q7Z744; Q9Y5L9","ENSG00000080603",NA,"Pathways affected in adenoid cystic carcinoma",1,0,106.2,103.5,97.7,99.2,114.3,93.8,84.7,94.6,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1859(100); S2790(99.5); S3016(100)]",0,"ENSG00000080603"
"1445","PAXX",-0.071981326517518,6.65503892868304,-0.607508129578581,0.557624673953678,0.629787867053566,-7.28821651340399,"NONE",FALSE,"High","Master Protein","Q9BUH6","Protein PAXX [OS=Homo sapiens]",0,22.659,15,2,2,2,2,204,21.6,5.48,7.39,2,"DNA metabolism;other metabolic processes;stress response","nucleus;other cell component","other molecular function","Pf15384","286257","hsa:286257; Q8IY19; Q9BUH6","ENSG00000148362",NA,NA,0,0,92.8,108,98.8,89.3,116.9,94.1,102.5,97.4,116.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100); S152(100)]",0,"ENSG00000148362"
"1446","IWS1",0.0806395150888912,6.60898208360084,0.604965489811598,0.559244396455879,0.631180397659747,-7.28985063834018,"NONE",FALSE,"High","Master Protein","Q96ST2","Protein IWS1 homolog [OS=Homo sapiens]",0,6.842,3,2,2,3,2,819,91.9,4.69,2.39,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","nucleus",NA,"Pf08711","55677","hsa:55677; Q2TB65; Q6P157; Q8N3E8; Q96MI7; Q96ST2; Q9NV97; Q9NWH8","ENSG00000163166","Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events",NA,3,0,91.4,93.1,107.8,111.7,84,119.6,98.4,79.2,99.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S440(100)]",0,"ENSG00000163166"
"1447","NFIC",0.0766607242326591,6.64275781075983,0.601467399741751,0.561477097044807,0.633262351331807,-7.29208844257838,"NONE",FALSE,"High","Master Protein","P08651","Nuclear factor 1 C-type [OS=Homo sapiens]",0,15.618,3,1,1,3,1,508,55.6,8.38,8.57,1,"DNA metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4782","A8K1H0; B7Z4U5; B7Z9C3; hsa:4782; K7EMU1; P08651; P08652; Q14932; Q9UPJ3; Q9UPJ9; Q9UPK0; Q9UPK1","ENSG00000141905","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination",NA,2,0,89.8,87.5,100.6,101.3,75,122.9,98.3,106.5,114.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S339(99.7)]",0,"ENSG00000141905"
"1448","CLIP1",0.0415402596355561,6.65418761351108,0.600658029511604,0.561994401398192,0.633408054614537,-7.29260450069716,"NONE",FALSE,"High","Master Protein","P30622","CAP-Gly domain-containing linker protein 1 [OS=Homo sapiens]",0,35.282,4,3,4,5,3,1438,162.1,5.36,16.18,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","other membranes;cytosol;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf01302, Pf16641","6249","A0AVD3; hsa:6249; P30622; Q17RS4; Q29RG0","ENSG00000130779","RHO GTPases Activate Formins; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases activate IQGAPs; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Microtubule cytoskeleton regulation; PAFAH1B1 copy number variation",9,0,98.3,98.2,101.2,104.6,108.2,105.9,101.5,99.2,94.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T146(99.6); T182(100); S204(100)]",0,"ENSG00000130779"
"1449","EPRS1",-0.0617531243806928,6.64983899146584,-0.598705472719139,0.563243468480403,0.634377736756396,-7.29384680698425,"NONE",FALSE,"High","Master Protein","P07814","Bifunctional glutamate/proline--tRNA ligase [OS=Homo sapiens]",0,35.568,2,2,3,10,2,1512,170.5,7.33,31.45,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes;cytosol;other cell component","nucleic acid binding activity;other molecular function","Pf00458, Pf00587, Pf00749, Pf03129, Pf03950, Pf09180, Pf20974","2058","A0AVA9; B9EGH3; hsa:2058; P07814; Q05BP6; Q05DF8; Q5DSM1; Q5H9S5; Q6PD57; Q86X73","ENSG00000136628","tRNA modification in the nucleus and cytosol; Selenoamino acid metabolism; Cytosolic tRNA aminoacylation","Parkinson's disease pathway; VEGFA-VEGFR2 signaling; Amino acid metabolism",6,0,98.5,94.2,95.3,93.2,75.6,112.7,113,102.1,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S886(99)]",0,"ENSG00000136628"
"1450","CTR9",-0.0552578900855512,6.59938569514906,-0.597763483587117,0.56384662322597,0.634619095934334,-7.29444480186417,"NONE",FALSE,"High","Master Protein","Q6PD62","RNA polymerase-associated protein CTR9 homolog [OS=Homo sapiens]",0,15.666,3,3,5,7,3,1173,133.4,6.77,6.15,3,"cell-cell signaling;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf13181, Pf13374","9646","D3DQV8; hsa:9646; Q15015; Q6PD62","ENSG00000198730","E3 ubiquitin ligases ubiquitinate target proteins; Formation of RNA Pol II elongation complex ; RNA Polymerase II Pre-transcription Events","Endoderm differentiation",5,0,101.8,113,106,109.3,106.1,102.9,81.7,94.1,79.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S970(100)]",0,"ENSG00000198730"
"1451","NMNAT1",-0.0787107597134291,6.56569038828334,-0.593869314050613,0.566343890931791,0.636990509993579,-7.29690762810384,"NONE",FALSE,"High","Master Protein","Q9HAN9","Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 [OS=Homo sapiens]",0,14.398,7,1,1,1,1,279,31.9,8.87,3.75,1,"other metabolic processes;stress response;other biological processes","nucleus;other cell component","other molecular function","Pf01467","64802","B1AN63; hsa:64802; Q8TAE9; Q9H247; Q9H6B6; Q9HAN9","ENSG00000173614","Nicotinate metabolism","NAD biosynthesis II (from tryptophan); NAD+ metabolism; NAD+ biosynthetic pathways",4,0,84.3,98.7,125.2,94,100.3,106.1,78.3,90.1,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S117(98.9)]",0,"ENSG00000173614"
"1452","PRRC2B",-0.0601374307541791,6.64933758257748,-0.592377106836774,0.567302452582585,0.63762920290274,-7.29784739677625,"NONE",FALSE,"High","Master Protein","Q5JSZ5","Protein PRRC2B [OS=Homo sapiens]",0,57.522,4,6,6,10,6,2229,242.8,8.34,34.43,6,"other biological processes",NA,NA,"Pf07001","84726","hsa:84726; O60270; Q5JSZ5; Q5JSZ7; Q66VZ2; Q68CR0; Q96EI9; Q9H683","ENSG00000288701",NA,NA,0,0,105.1,96,93.9,100.8,107.3,86.9,106.5,110.4,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S219(100); S388(100); S480(100); S556(100); S613(100); S853(100)]",0,"ENSG00000288701"
"1453","MLC1",-0.0776018502056557,6.62971699222887,-0.584423036727797,0.572427180757822,0.642946427389377,-7.30281964773859,"NONE",FALSE,"High","Master Protein","Q15049","Membrane protein MLC1 [OS=Homo sapiens]",0,78.138,8,3,8,26,3,377,41.1,7.49,68.28,3,"transport;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function",NA,"23209","B3KW61; B7Z659; hsa:23209; Q15049; Q5JZ83; Q8TAG4; Q96RP5; Q9UGY8","ENSG00000100427",NA,NA,0,0,100.8,106.9,101.8,104.5,70.6,122.7,95.2,100.2,90,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100); S357(100)]",0,"ENSG00000100427"
"1454","NCL",0.0842080109989896,6.64080375459266,0.582993726387086,0.573350775978315,0.643540898484601,-7.30370650805169,"NONE",FALSE,"High","Master Protein","P19338","Nucleolin [OS=Homo sapiens]",0,26.891,6,4,4,8,4,710,76.6,4.7,22.99,4,"developmental processes;other biological processes","plasma membrane;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076","4691","hsa:4691; P19338; Q53SK1; Q8NB06; Q9UCF0; Q9UDG1","ENSG00000115053","Respiratory syncytial virus (RSV) attachment and entry; Major pathway of rRNA processing in the nucleolus and cytosol","Pathogenic Escherichia coli infection; VEGFA-VEGFR2 signaling",4,0,85.6,89.4,90.8,89.3,127.7,87.1,100,129,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S67(100); S563(100)]",0,"ENSG00000115053"
"1455","ALKBH5",0.0840236467888795,6.57972458851926,0.575257725252124,0.578363864009226,0.648721529940246,-7.30847142566527,"NONE",FALSE,"High","Master Protein","Q6P6C2","RNA demethylase ALKBH5 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,394,44.2,9.09,5.81,1,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;stress response;transport;other biological processes","cytosol;ER/Golgi;nucleus","other molecular function","Pf13532","54890","B4DVJ4; D3DXC6; hsa:54890; Q6P6C2; Q9NXD6","ENSG00000091542","Reversal of alkylation damage by DNA dioxygenases","Smith-Magenis and Potocki-Lupski syndrome copy number variation",2,0,62.2,67.3,75.5,61,87.7,67.1,154.6,153.2,217.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S371(100)]",0,"ENSG00000091542"
"1456","VAC14",0.084857505187272,6.6989382554035,0.573970378584275,0.579200412825667,0.649213649540857,-7.30925859277706,"NONE",FALSE,"High","Master Protein","Q08AM6","Protein VAC14 homolog [OS=Homo sapiens]",0,4.016,2,1,1,2,1,782,87.9,6.13,2.73,1,"other metabolic processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","other molecular function","Pf11916, Pf12755","55697","B3KPJ5; B3KSM8; hsa:55697; Q08AM6; Q13174; Q6IA12; Q7L4Y1; Q9BW96; Q9H6V6","ENSG00000103043","Synthesis of PIPs at the Golgi membrane; Synthesis of PIPs at the early endosome membrane; Synthesis of PIPs at the late endosome membrane",NA,3,0,82.8,105.9,105.8,107.6,85.4,124.8,107,119.9,92.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S517(98.6)]",0,"ENSG00000103043"
"1457","TMF1",-0.0443365340381154,6.64411341248077,-0.57150822486087,0.580802217543477,0.650218387894179,-7.31075952739136,"NONE",FALSE,"High","Master Protein","P82094","TATA element modulatory factor [OS=Homo sapiens]",0,39.703,4,2,3,5,2,1093,122.8,4.92,14.95,2,"cell-cell signaling;cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus","nucleic acid binding activity;other molecular function","Pf12325, Pf12329","7110","B7ZLJ2; hsa:7110; P82094; Q17R87; Q59GK0","ENSG00000144747","Retrograde transport at the Trans-Golgi-Network",NA,1,0,98,98.7,109.8,109.2,94.2,101.5,97.1,95.8,98.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S344(100); T401(100)]",0,"ENSG00000144747"
"1458","CARD19",-0.117490512693743,6.70258363544186,-0.571367820254621,0.580893633302521,0.650218387894179,-7.31084493677534,"NONE",FALSE,"High","Master Protein","Q96LW7-2","Isoform 2 of Caspase recruitment domain-containing protein 19 [OS=Homo sapiens]",0,15.2,13,1,1,1,1,183,20.6,8.1,4.18,1,NA,NA,NA,NA,NA,"Q96LW7-2",NA,NA,NA,0,0,136.2,89.6,115.6,110.8,101,101.9,75.5,102.9,130.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S113(100)]",0,"ENSG00000165233"
"1459","KAZN",0.0789779685227172,6.62513345682813,0.570293454801142,0.581593398968075,0.650555467522891,-7.31149783408843,"NONE",FALSE,"High","Master Protein","Q674X7","Kazrin [OS=Homo sapiens]",0,7.571,4,2,2,2,2,775,86.3,7.03,4.2,2,"other biological processes","plasma membrane;cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf00536, Pf07647","23254","B0QYQ0; B1AJZ1; B1AK78; hsa:23254; Q5TGF1; Q674X4; Q674X6; Q674X7; Q6ZUD1; Q8IYN7; Q8N409; Q9UIL2; Q9UPX4","ENSG00000189337","Formation of the cornified envelope",NA,1,0,109.6,92.9,99.6,102.5,100.2,124.6,76.1,95.6,104.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S769(100)]",0,"ENSG00000189337"
"1460","SLC9A1",-0.158195991398351,6.56487518525374,-0.565477638809938,0.584735702276501,0.653210948237034,-7.31441031725281,"NONE",FALSE,"High","Master Protein","P19634","Sodium/hydrogen exchanger 1 [OS=Homo sapiens]",0,22.935,3,2,2,2,2,815,90.7,7.21,7.33,2,"cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;mitochondrion;nucleus;other cell component","transporter activity;other molecular function","Pf00999, Pf16644","6548","B1ALD6; D3DPL4; hsa:6548; P19634; Q96EM2","ENSG00000090020","Hyaluronan uptake and degradation; Sodium/Proton exchangers","Osteoclast signaling; G protein signaling pathways; Gastrin signaling pathway; Opioid receptor pathways; Regulation of actin cytoskeleton",7,0,119.7,89.4,89.8,97.2,103.9,72.1,128.3,64,109.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S785(99.4)]",0,"ENSG00000090020"
"1461","HABP4",0.0530453242408617,6.67876393968666,0.565428382374636,0.584767889322492,0.653210948237034,-7.31443998698745,"NONE",FALSE,"High","Master Protein","Q5JVS0","Intracellular hyaluronan-binding protein 4 [OS=Homo sapiens]",0,43.041,12,2,2,3,2,413,45.8,7.46,14.08,2,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;other membranes;cytosol;cytoskeleton;nucleus;other cell component","translation activity;nucleic acid binding activity;other molecular function","Pf04774, Pf16174","22927","hsa:22927; O75804; Q5JVS0; Q8WV33; Q9NYJ2","ENSG00000130956","Platelet degranulation",NA,1,0,88.8,94.9,97,106.7,87.2,103.6,121.1,106.9,108.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100); S108(100)]",0,"ENSG00000130956"
"1462","AFDN",-0.042761110421818,6.6588050623044,-0.561748362726114,0.587175336176813,0.655451538057837,-7.31664981642169,"NONE",FALSE,"High","Master Protein","P55196","Afadin [OS=Homo sapiens]",0,62.133,5,8,8,13,8,1824,206.7,6.47,35.8,8,"cell adhesion;cell-cell signaling;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00498, Pf00595, Pf00788, Pf01843","4301","O75087; O75088; O75089; P55196; Q59FP0; Q5TIG6; Q5TIG7; Q9NSN7; Q9NU92","ENSG00000130396",NA,"VEGFA-VEGFR2 signaling; Ras signaling; 1q21.1 copy number variation syndrome",3,0,93.6,99.9,93.1,98.6,99.1,91.6,107.7,110.4,114.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S216(100); S1083(100); S1182(100); S1275(100); T1330(100); S1774(100); S1799(100)]",0,"ENSG00000130396"
"1463","RIOK2",0.0612819797117297,6.66536797672559,0.559731352135662,0.588497113600461,0.656477983182469,-7.31785528851637,"NONE",FALSE,"High","Master Protein","Q9BVS4","Serine/threonine-protein kinase RIO2 [OS=Homo sapiens]",0,22.192,5,2,2,2,2,552,63.2,5.94,6.51,2,"cell cycle OR cell proliferation;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf01163, Pf09202","55781","D6RDI3; hsa:55781; Q9BVS4; Q9NUT0","ENSG00000058729","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,90.7,95.3,106.5,106.5,89.6,117.3,94.8,114.9,98,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S337(99.6); S350(100)]",0,"ENSG00000058729"
"1464","PUM2",0.041971636596573,6.64349907763565,0.553796678032724,0.592395442406984,0.660375247273359,-7.32137859769633,"NONE",FALSE,"High","Master Protein","Q8TB72","Pumilio homolog 2 [OS=Homo sapiens]",0,37.164,5,4,4,7,4,1066,114.1,7.08,23.72,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00806","23369","B3KSL0; B4E2B6; D6W527; hsa:23369; O00234; Q53TV7; Q8TB72; Q8WY43; Q9HAN2","ENSG00000055917","Neddylation","Male infertility",2,0,93.7,96.3,96.7,97.1,109.2,102.8,100.6,99,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S82(100); S136(100); S182(100); S587(100)]",0,"ENSG00000055917"
"1465","STIM1",-0.0747016210056062,6.62406548896733,-0.553120004711311,0.592840804960584,0.660420610031176,-7.32177809019527,"NONE",FALSE,"High","Master Protein","Q13586","Stromal interaction molecule 1 [OS=Homo sapiens]",0,26.397,3,2,2,6,2,685,77.4,6.67,18.12,2,"transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi","cytoskeletal activity;other molecular function","Pf07647, Pf16533","6786","E9PQJ4; hsa:6786; Q13586; Q8N382","ENSG00000167323","Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; Ion homeostasis; Elevation of cytosolic Ca2+ levels","CAMKK2 pathway; Affected pathways in Duchenne muscular dystrophy",5,0,103.8,101.9,97.7,111,77.7,101.6,112.9,93.7,86.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S257(100); S575(100)]",0,"ENSG00000167323"
"1466","ILF3",0.0524464629355252,6.6523243514149,0.547526156614178,0.596529300250772,0.664076274221869,-7.32506301244729,"NONE",FALSE,"High","Master Protein","Q12906-7","Isoform 7 of Interleukin enhancer-binding factor 3 [OS=Homo sapiens]",0,46.975,9,3,3,5,3,898,95.7,8.81,20.91,3,NA,NA,NA,NA,NA,"Q12906-7",NA,NA,NA,0,0,89.9,92.8,99.3,102.5,88.8,108.7,114.8,108.4,96.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100); S190(99.4); S482(100)]",0,"ENSG00000129351"
"1467","CAAP1",0.0594617046648382,6.64494447635129,0.544788228069981,0.598339068615496,0.665636918868772,-7.32665939854911,"NONE",FALSE,"High","Master Protein","Q9H8G2","Caspase activity and apoptosis inhibitor 1 [OS=Homo sapiens]",0,23.177,5,1,2,2,1,361,38.3,4.72,6.78,1,"other biological processes",NA,NA,"Pf15335","79886","B4DWT4; D3DRK4; hsa:79886; Q5VY32; Q6IPE6; Q96C59; Q9H8G2","ENSG00000120159",NA,"Acute viral myocarditis",1,0,84.8,81.7,81.6,95.5,97.9,74.8,130.2,124.9,136.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S312(99.6)]",0,"ENSG00000120159"
"1468","DDX17",0.0749772736982948,6.65867234708045,0.540378061739753,0.6012602654148,0.668431030760868,-7.32921498632046,"NONE",FALSE,"High","Master Protein","Q92841","Probable ATP-dependent RNA helicase DDX17 [OS=Homo sapiens]",0,11.974,5,1,1,1,1,729,80.2,8.27,3.67,1,"RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00270, Pf00271","10521","B1AHM0; H3BLZ8; hsa:10521; Q69YT1; Q6ICD6; Q92841","ENSG00000100201","SUMOylation of transcription cofactors","Novel intracellular components of RIG-I-like receptor pathway",2,0,110.4,87.2,77.2,94.2,88.1,108.6,125.5,114.7,105.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S64(100)]",0,"ENSG00000100201"
"1469","RETREG2",0.0730119505252702,6.63669609437269,0.539260780590771,0.602001515243242,0.668799505021763,-7.32985932259924,"NONE",FALSE,"High","Master Protein","Q8NC44","Reticulophagy regulator 2 [OS=Homo sapiens]",0,86.922,13,4,4,9,4,543,57.8,4.45,39.19,4,"cell organization and biogenesis;other metabolic processes","other membranes;ER/Golgi","other molecular function",NA,"79137","hsa:79137; Q6P1P5; Q8NC44; Q9H0K7","ENSG00000144567",NA,NA,0,0,91.9,99.2,89.6,103.4,119.9,88.7,103.9,91.5,118.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T330(99.4); S379(100); S385(100)]",0,"ENSG00000144567"
"1470","FAM171A1",0.0579439211581958,6.62386484381187,0.536593717428854,0.603772888134458,0.670311124786011,-7.33139234435419,"NONE",FALSE,"High","Master Protein","Q5VUB5","Protein FAM171A1 [OS=Homo sapiens]",0,34.461,5,3,3,3,3,890,97.8,6.58,11.02,3,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes",NA,"Pf10577, Pf20771","221061","D3DRT9; hsa:221061; Q32M49; Q5VUB5; Q8N4I0","ENSG00000148468",NA,NA,0,0,99.1,102.6,106.4,113.7,95.8,120.1,97.7,86.6,79.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T448(100); S494(99.4); S849(100)]",0,"ENSG00000148468"
"1471","CCNYL1",-0.0809979036765966,6.61166257549083,-0.535474537292749,0.60451702026416,0.670681017723392,-7.33203351501778,"NONE",FALSE,"High","Master Protein","Q8N7R7","Cyclin-Y-like protein 1 [OS=Homo sapiens]",0,44.126,13,4,4,8,2,359,40.7,6.07,27.08,4,"other biological processes","plasma membrane;other membranes","enzyme regulator activity;other molecular function","Pf00134","151195","hsa:151195; Q6NX60; Q8N7R7","ENSG00000163249",NA,NA,0,2,94.1,97.7,92.5,83.7,94.4,100.8,127.1,89.5,102.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S88(100); S122(99.5); S344(100)]",0,"ENSG00000163249"
"1472","GATAD2B",0.0420006131507318,6.64184209839202,0.530987308660791,0.607505332468084,0.673538520779833,-7.33459155171575,"NONE",FALSE,"High","Master Protein","Q8WXI9","Transcriptional repressor p66-beta [OS=Homo sapiens]",0,71.193,11,4,7,10,4,593,65.2,9.7,35.47,4,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00320, Pf16563","57459","D3DUZ2; hsa:57459; Q5VUR2; Q7LG68; Q8WXI9; Q9ULS0","ENSG00000143614; ENSG00000261992","Potential therapeutics for SARS; Regulation of PTEN gene transcription; HDACs deacetylate histones; RNA Polymerase I Transcription Initiation; ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression; Regulation of TP53 Activity through Acetylation",NA,6,0,99.9,101.8,94.4,109.3,91.1,111.5,99.5,97.4,96.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T120(100); S135(99.4); S334(99.3); S486(100)]",0,"ENSG00000143614"
"1473","PLPP3",0.150528897043696,6.65485688458536,0.52953743415983,0.608472526824031,0.674152860676727,-7.33541374510854,"NONE",FALSE,"High","Master Protein","O14495","Phospholipid phosphatase 3 [OS=Homo sapiens]",0,9.318,4,1,1,1,1,311,35.1,9.14,3.65,1,"cell adhesion;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf01569","8613","B2R651; D3DQ52; hsa:8613; O14495; Q5U0F7; Q96GW0; Q99782","ENSG00000162407","Sphingolipid catabolism","Triacylglyceride synthesis; Sphingolipid metabolism: integrated pathway",3,0,115.1,94,101.2,131.9,59.2,164.6,91.5,103.9,71.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S297(100)]",0,"ENSG00000162407"
"1474","MAD1L1",-0.0796759952961024,6.52494343732522,-0.525458423362214,0.611197858227904,0.6767129610773,-7.33771549061844,"NONE",FALSE,"High","Master Protein","Q9Y6D9","Mitotic spindle assembly checkpoint protein MAD1 [OS=Homo sapiens]",0,7.955,3,1,1,2,1,718,83,5.92,2.6,1,"cell cycle OR cell proliferation;cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf05557","8379","B3KR41; hsa:8379; Q13312; Q75MI0; Q86UM4; Q9UNH0; Q9Y6D9","ENSG00000002822","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Cell cycle; Regulation of sister chromatid separation at the metaphase-anaphase transition; Pleural mesothelioma; CCL18 signaling pathway",10,0,88.4,78.7,115.9,90,106.5,80.1,95.3,87.8,99.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S428(100)]",0,"ENSG00000002822"
"1475","AKAP8L",-0.0525987554580185,6.64927184088494,-0.521427328358402,0.613897342506056,0.678469898077245,-7.33997368965977,"NONE",FALSE,"High","Master Protein","Q9ULX6","A-kinase anchor protein 8-like [OS=Homo sapiens]",0,9.1,2,2,2,3,2,646,71.6,5.05,5.4,2,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04988","26993","B4DJ74; B5BU90; hsa:26993; O94792; Q96J58; Q9NRQ0; Q9UGM0; Q9ULX6","ENSG00000011243","Formation of WDR5-containing histone-modifying complexes",NA,1,0,95,88.9,108.6,91.6,110.3,93.6,106.9,103,108.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(100)]",0,"ENSG00000011243"
"1476","PPP2R5D",-0.0687663711786888,6.56590506959343,-0.521341036388738,0.613955196036988,0.678469898077245,-7.34002185041824,"NONE",FALSE,"High","Master Protein","Q14738","Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform [OS=Homo sapiens]",0,6.71,2,1,2,2,1,602,69.9,8.13,2.07,1,"protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01603","5528","A8K3I9; B5BUA6; hsa:5528; O00494; O00696; Q14738; Q15171; Q5TC39","ENSG00000112640","Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; EML4 and NUDC in mitotic spindle formation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Disassembly of the destruction complex and recruitment of AXIN to the membrane; RAF activation; Beta-catenin phosphorylation cascade; Signaling by GSK3beta mutants; CTNNB1 S33 mutants aren't phosphorylated; CTNNB1 S37 mutants aren't phosphorylated; CTNNB1 S45 mutants aren't phosphorylated; CTNNB1 T41 mutants aren't phosphorylated; APC truncation mutants have impaired AXIN binding; AXIN missense mutants destabilize the destruction complex; Truncations of AMER1 destabilize the destruction complex; Regulation of glycolysis by fructose 2,6-bisphosphate metabolism; Negative regulation of MAPK pathway; Platelet sensitization by LDL; CTLA4 inhibitory signaling; DARPP-32 events; PP2A-mediated dephosphorylation of key metabolic factors; ERKs are inactivated","Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; 16p11.2 proximal deletion syndrome; Glycogen synthesis and degradation; Cohesin complex - Cornelia de Lange syndrome",33,0,123.9,111.6,83.9,109.3,98.4,96.8,81.5,82.8,89.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S598(99.4)]",0,"ENSG00000112640"
"1477","MAF1",-0.0722825467946482,6.60622749388305,-0.521226653811375,0.614031886924075,0.678469898077245,-7.34008567733276,"NONE",FALSE,"High","Master Protein","Q9H063","Repressor of RNA polymerase III transcription MAF1 homolog [OS=Homo sapiens]",0,21.848,10,1,2,3,1,256,28.8,4.55,9.05,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09174","84232","D3DWL4; hsa:84232; Q9H063","ENSG00000179632","Regulation of PTEN gene transcription",NA,1,0,110.2,99.2,95.8,97.3,98.4,102.2,80.5,91.2,117.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S68(97.7)]",0,"ENSG00000179632"
"1478","STRIP1",-0.0406265116620208,6.6279926526133,-0.520063508116149,0.614812028070027,0.678872279979894,-7.34073397578446,"NONE",FALSE,"High","Master Protein","Q5VSL9","Striatin-interacting protein 1 [OS=Homo sapiens]",0,37.587,2,1,1,6,1,837,95.5,6.29,27.88,1,"cell organization and biogenesis;other biological processes","cytosol;nucleus","other molecular function","Pf07923, Pf11882","85369","hsa:85369; Q0V925; Q5VSL8; Q5VSL9; Q658K2; Q6ZV31; Q8N598; Q96SN2; Q9C0A2","ENSG00000143093",NA,NA,0,0,101.9,102.9,100.2,101.7,89.8,112.5,92.2,93.6,101.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S335(100)]",0,"ENSG00000143093"
"1479","KDM3B",-0.0713392246067457,6.60410904388542,-0.505522944650722,0.62460716804076,0.689221702665666,-7.34872272968904,"NONE",FALSE,"High","Master Protein","Q7LBC6","Lysine-specific demethylase 3B [OS=Homo sapiens]",0,19.377,2,1,3,4,1,1761,191.5,7.18,10.13,1,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf02373","51780","A6H8X7; hsa:51780; Q7LBC6; Q9BVH6; Q9BW93; Q9BZ52; Q9NYF4; Q9UPS0","ENSG00000120733","HDMs demethylate histones","Thermogenesis",2,0,97.2,101.1,89.4,106.5,93.1,81.1,110.9,88,109.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S727(99.2); T729(99.2)]",0,"ENSG00000120733"
"1480","CNP",-0.049145828721092,6.65364263033197,-0.501032211959987,0.627648100354507,0.692109256607132,-7.35114660403814,"NONE",FALSE,"High","Master Protein","P09543","2',3'-cyclic-nucleotide 3'-phosphodiesterase [OS=Homo sapiens]",0,20.683,7,3,4,5,3,421,47.5,9.07,9.58,3,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;transport;developmental processes;other biological processes","non-structural extracellular;other membranes;cytoskeleton;mitochondrion;other cell component","nucleic acid binding activity;other molecular function","Pf05881, Pf13671","1267","hsa:1267; P09543","ENSG00000173786",NA,"Glial cell differentiation; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Cell lineage map for neuronal differentiation",5,0,90.1,96.3,88.5,97.6,69.9,101.5,122.5,115.7,115.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S22(100); S170(100)]",0,"ENSG00000173786"
"1481","FYN",0.0344970165682872,6.63928303311963,0.498610493907655,0.629291046803086,0.693125422205391,-7.35244520983521,"NONE",FALSE,"High","Master Protein","P06241","Tyrosine-protein kinase Fyn [OS=Homo sapiens]",0,25.705,4,3,4,5,3,537,60.7,6.67,14.15,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;kinase activity;other molecular function","Pf00017, Pf00018, Pf07714","2534","B5BU57; E1P557; H0UI48; hsa:2534; P06241; Q16248; Q5R3A6; Q5R3A7; Q8N5D7","ENSG00000010810","FCGR activation; Role of LAT2/NTAL/LAB on calcium mobilization; FCGR3A-mediated IL10 synthesis; FCGR3A-mediated phagocytosis; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Regulation of signaling by CBL; Nephrin family interactions; EPHB-mediated forward signaling; RAF/MAP kinase cascade; GPVI-mediated activation cascade; DAP12 signaling; CD28 dependent PI3K/Akt signaling; VEGFA-VEGFR2 Pathway; Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants; Ephrin signaling; Regulation of KIT signaling; Signaling by ERBB2; CRMPs in Sema3A signaling; EPH-ephrin mediated repulsion of cells; Sema3A PAK dependent Axon repulsion; SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion; EPHA-mediated growth cone collapse; NCAM signaling for neurite out-growth; Signaling by CSF1 (M-CSF) in myeloid cells; Reelin signalling pathway; Platelet Adhesion to exposed collagen; CD209 (DC-SIGN) signaling; CD28 dependent Vav1 pathway; Dectin-2 family; Nef and signal transduction; PECAM1 interactions; CTLA4 inhibitory signaling; FLT3 signaling through SRC family kinases","Integrin-mediated cell adhesion; Leptin signaling pathway; Prolactin signaling pathway; IL-7 signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Pathogenic Escherichia coli infection; B cell receptor signaling pathway; Interleukin-11 signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Primary focal segmental glomerulosclerosis (FSGS); T cell receptor and co-stimulatory signaling; Ectoderm differentiation; IL-3 signaling pathway; Kit receptor signaling pathway; Focal adhesion; Ectoderm differentiation; T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; VEGFA-VEGFR2 signaling; Prion disease pathway; Acute viral myocarditis; NRF2-ARE regulation; Fragile X syndrome; Gastrin signaling pathway; Netrin-UNC5B signaling pathway; Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; IL-2 signaling pathway; 15q13.3 copy number variation syndrome; Congenital generalized lipodystrophy; Network map of SARS-CoV-2 signaling pathway; GDNF signaling; Interferon type I signaling pathways; T-cell receptor signaling pathway",72,0,96.5,96.9,97.2,104.9,99,103.4,102.2,102.4,95.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S186(100)]",0,"ENSG00000010810"
"1482","FBXL7",0.0441940277347062,6.63583056491015,0.498421960853016,0.629419041487983,0.693125422205391,-7.35254605695874,"NONE",FALSE,"High","Master Protein","Q9UJT9","F-box/LRR-repeat protein 7 [OS=Homo sapiens]",0,9.382,5,1,1,1,1,491,54.5,8.27,3.66,1,"cell cycle OR cell proliferation;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;other cell component",NA,"Pf00646, Pf13516","23194","B9EGF1; D6RDY7; hsa:23194; O94926; Q9UJT9","ENSG00000183580","Antigen processing: Ubiquitination & Proteasome degradation; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis; Neddylation",NA,3,0,85.4,92.2,91.6,99.4,98.2,91.6,107.6,105.7,126,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100)]",0,"ENSG00000183580"
"1483","AGPS",0.0429323773493158,6.6670952964869,0.494457148685676,0.632113737823954,0.695389469603176,-7.35465846128547,"NONE",FALSE,"High","Master Protein","O00116","Alkyldihydroxyacetonephosphate synthase, peroxisomal [OS=Homo sapiens]",0,14.77,3,1,1,1,1,658,72.9,7.34,4.37,1,"other metabolic processes","cytosol;other cytoplasmic organelle","other molecular function","Pf01565, Pf02913","8540","A5D8U9; hsa:8540; O00116; Q2TU35","ENSG00000018510","Plasmalogen biosynthesis; TYSND1 cleaves peroxisomal proteins","Triacylglyceride synthesis",4,0,97.8,106.3,102.7,105.3,105.8,117.2,90,106,92.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S65(100)]",0,"ENSG00000018510"
"1484","RECQL5",0.0539119336584317,6.66613591338508,0.494143447516998,0.632327189271515,0.695389469603176,-7.35482491332379,"NONE",FALSE,"High","Master Protein","O94762","ATP-dependent DNA helicase Q5 [OS=Homo sapiens]",0,15.2,2,1,1,2,1,991,108.8,8.56,8.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00270, Pf00271, Pf06959, Pf16124","9400","hsa:9400; O94762; Q6P4G0; Q9H0B1; Q9P1W7; Q9UNC8","ENSG00000108469",NA,NA,0,0,89.3,80.1,101.9,101.5,94.6,93.2,125.4,108.4,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S815(100)]",0,"ENSG00000108469"
"1485","ZNF777",-0.0610192249360137,6.64248742709991,-0.493022045853054,0.633090515014493,0.695760081147241,-7.35541911608918,"NONE",FALSE,"High","Master Protein","Q9ULD5","Zinc finger protein 777 [OS=Homo sapiens]",0,7.27,2,1,1,3,1,831,93.7,6.61,4.19,1,"cell organization and biogenesis;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf01352","27153","hsa:27153; Q8N2R2; Q8N659; Q9ULD5","ENSG00000196453","Generic Transcription Pathway",NA,1,0,104,108.7,87.1,100.1,74.5,115.6,102.1,108.6,98.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(99.3)]",0,"ENSG00000196453"
"1486","DYNC1LI1",0.0395408069488994,6.6667040605435,0.491934472411392,0.633831248549271,0.696105381986817,-7.35599416848323,"NONE",FALSE,"High","Master Protein","Q9Y6G9","Cytoplasmic dynein 1 light intermediate chain 1 [OS=Homo sapiens]",0,30.401,7,2,4,4,2,523,56.5,6.42,15.67,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","other molecular function","Pf05783","51143","A2RRG7; hsa:51143; Q53HC8; Q53HK7; Q9Y6G9","ENSG00000144635","MHC class II antigen presentation; RHO GTPases Activate Formins; HCMV Early Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic; Aggrephagy; EML4 and NUDC in mitotic spindle formation; Neutrophil degranulation; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","Ciliary landscape; Intraflagellar transport proteins binding to dynein; Vasopressin-regulated water reabsorption",16,0,95,101.3,98.6,107.3,104.6,102.2,94.4,103.5,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100)]",0,"ENSG00000144635"
"1487","LRWD1",0.0557890369610172,6.6374297807187,0.486841287165298,0.637305828594347,0.69872451145301,-7.35867110857165,"NONE",FALSE,"High","Master Protein","Q9UFC0","Leucine-rich repeat and WD repeat-containing protein 1 [OS=Homo sapiens]",0,28.664,4,1,1,2,1,647,70.8,7.21,10.88,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;other biological processes","cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00400, Pf00560","222229","A8K4K2; B2R9G2; hsa:222229; Q8N0T9; Q8WV43; Q96GJ2; Q9UFC0","ENSG00000161036",NA,"Male infertility",1,0,91.5,100.6,101.1,100.8,91.3,122.2,85.5,100.2,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S251(100)]",0,"ENSG00000161036"
"1488","IBTK",0.090489552297548,6.63922999349304,0.486565919036718,0.637493950739515,0.69872451145301,-7.35881508474699,"NONE",FALSE,"High","Master Protein","Q9P2D0","Inhibitor of Bruton tyrosine kinase [OS=Homo sapiens]",0,17.447,3,2,2,2,2,1353,150.4,7.71,5.81,2,"transport;other biological processes","other membranes;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00415, Pf00651, Pf12796","25998","hsa:25998; Q2QKU2; Q2QKU3; Q2QKU4; Q5TFD7; Q5TFD9; Q8IUQ9; Q8IUY7; Q8TAI4; Q9HBI8; Q9P2D0; Q9Y3T8","ENSG00000005700; ENSG00000283068",NA,"Genetic causes of porto-sinusoidal vascular disease",1,0,89.3,92.1,108.8,112.2,75.6,125.3,77.5,112.5,107.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1045(100)]",0,"ENSG00000005700"
"1489","APPL2",-0.058157769367349,6.62221207301178,-0.486556349665665,0.637500488697017,0.69872451145301,-7.35882008669711,"NONE",FALSE,"High","Master Protein","Q8NEU8","DCC-interacting protein 13-beta [OS=Homo sapiens]",0,15.2,3,1,1,1,1,664,74.4,4.94,4.49,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;signal transduction;other biological processes","plasma membrane;other membranes;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf00169, Pf00640, Pf16746","55198","B7Z411; B7Z4B0; F5GZG0; F8W1P5; hsa:55198; Q8N4R7; Q8NEU8; Q9NVL2","ENSG00000136044",NA,NA,0,0,77.7,111.6,92.3,91.2,80.3,100.8,114.2,103.8,112.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T399(100)]",0,"ENSG00000136044"
"1490","BCKDK",0.194367003524365,6.50873886956886,0.484947003206868,0.638600487973818,0.699460400250517,-7.35965996676105,"NONE",FALSE,"High","Master Protein","O14874","Branched-chain alpha-ketoacid dehydrogenase kinase [OS=Homo sapiens]",0,5.258,3,1,2,15,1,412,46.3,8.82,4.32,1,"other metabolic processes;other biological processes","mitochondrion","kinase activity;other molecular function","Pf02518, Pf10436","10295","A8MY43; hsa:10295; O14874; Q6FGL4; Q96G95; Q96IN5","ENSG00000103507","Branched-chain amino acid catabolism","Thiamine metabolic pathways",2,0,116.2,39.9,119.6,76.8,157.4,81.5,105.6,81.7,109.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S31(100)]",0,"ENSG00000103507"
"1491","PRIMPOL",0.0751768479380734,6.63170722900861,0.481766882731772,0.64077684188084,0.701373444634159,-7.36131180602729,"NONE",FALSE,"High","Master Protein","Q96LW4","DNA-directed primase/polymerase protein [OS=Homo sapiens]",0,6.029,3,1,1,2,1,560,64.4,5.3,5.77,1,"cell organization and biogenesis;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;other biological processes","mitochondrion;nucleus;other cell component","other molecular function","Pf01896, Pf03121","201973","A0A0A0MTC0; D3DP55; D6RDM1; hsa:201973; Q5HYJ9; Q96LW4","ENSG00000164306",NA,NA,0,0,82.5,84.8,79.1,101.8,55.4,109.5,127.8,119,137.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S255(100)]",0,"ENSG00000164306"
"1492","SH3PXD2B",0.040942482565292,6.66605870666149,0.479038016417941,0.642647243577526,0.702949263752361,-7.36272099766829,"NONE",FALSE,"High","Master Protein","A1X283","SH3 and PX domain-containing protein 2B [OS=Homo sapiens]",0,48.694,10,5,5,7,5,911,101.5,8.69,20.1,5,"cell organization and biogenesis;other metabolic processes;developmental processes;other biological processes","cytoskeleton;other cell component","enzyme regulator activity;other molecular function","Pf00018, Pf00787, Pf07653","285590","A1X283; B6F0V2; hsa:285590; Q9P2Q1","ENSG00000174705",NA,NA,0,0,89.1,89.3,91.5,96.2,84.2,103.1,106.1,128.6,125.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S291(98.9); S675(100)]",0,"ENSG00000174705"
"1493","DCP1A",-0.0414644389378047,6.62926542008016,-0.473924489179973,0.646159220833877,0.706317380040782,-7.36534108198064,"NONE",FALSE,"High","Master Protein","Q9NPI6","mRNA-decapping enzyme 1A [OS=Homo sapiens]",0,27.577,3,2,2,2,2,582,63.2,6.25,8.81,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;other molecular function","Pf06058, Pf16741","55802","B4DHN9; hsa:55802; Q9NPI6; U3KQM8","ENSG00000272886","Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); mRNA decay by 5' to 3' exoribonuclease; Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA; Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA","TGF-beta signaling pathway",5,0,102.8,111.5,93.8,105,94.4,105.7,94.8,89.8,100.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S525(100)]",0,"ENSG00000272886"
"1494","ARVCF",-0.0838679868297518,6.61123113224582,-0.472091148628863,0.647420604638631,0.707222507878344,-7.36627392158706,"NONE",FALSE,"High","Master Protein","O00192","Splicing regulator ARVCF [OS=Homo sapiens]",0,62.034,6,5,6,14,5,962,104.6,6.81,41.36,5,"cell adhesion;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes","plasma membrane;other membranes;nucleus;other cell component","other molecular function","Pf00514","421","B7WNV2; hsa:421; O00192","ENSG00000099889",NA,"22q11.2 copy number variation syndrome",1,0,117.9,111.5,108.3,119.5,73.3,124.9,94.3,85.1,68.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S203(100); S606(100); T642(100); T872(100)]",0,"ENSG00000099889"
"1495","CEP68",0.0619325459782782,6.66642073264677,0.465544877940951,0.651934197252135,0.711676662150825,-7.36957661728669,"NONE",FALSE,"High","Master Protein","Q76N32","Centrosomal protein of 68 kDa [OS=Homo sapiens]",0,12.242,2,1,1,1,1,757,81.1,5.16,3.71,1,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","other molecular function",NA,"23177","B4DRQ1; D6W5F1; D6W5F2; hsa:23177; O60326; Q76N32; Q9BQ18; Q9UDM9","ENSG00000011523",NA,NA,0,0,82.6,88.9,93.6,89.6,114.6,89.5,135.3,110.8,113.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S478(100)]",0,"ENSG00000011523"
"1496","MECP2",0.0398569059779614,6.6250056162707,0.462401238995868,0.65410700439891,0.713571277526084,-7.37114696872312,"NONE",FALSE,"High","Master Protein","P51608","Methyl-CpG-binding protein 2 [OS=Homo sapiens]",0,46.151,8,3,3,7,3,486,52.4,9.95,30.4,3,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf01429","4204","hsa:4204; O15233; P51608; Q6QHH9; Q7Z384","ENSG00000169057",NA,"Ectoderm differentiation; MECP2 and associated Rett syndrome; Lung fibrosis; Rett syndrome; Transcription co-factors SKI and SKIL protein partners; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Neurogenesis regulation in the olfactory epithelium; ADHD and autism (ASD) linked metabolic pathways and SNP; Sudden infant death syndrome (SIDS) susceptibility pathways",10,0,97,104.2,94.2,109.5,103.1,101,99.1,97.7,89,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S80(100); S350(99.7)]",0,"ENSG00000169057"
"1497","SASH1",0.0458682041946101,6.66454556233825,0.458860194627873,0.656558576854214,0.715767266149684,-7.37290365013321,"NONE",FALSE,"High","Master Protein","O94885","SAM and SH3 domain-containing protein 1 [OS=Homo sapiens]",0,64.291,9,7,7,10,7,1247,136.6,6.09,28.83,7,"protein metabolism;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf00536, Pf07647, Pf07653, Pf12485","23328","hsa:23328; O94885; Q5TGN5; Q8TAI0; Q9H7R7","ENSG00000111961",NA,NA,0,0,92.4,93.4,92.5,98.6,114.3,90.5,112.5,104.7,118.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S355(99.4); S407(100); S442(100); S721(99.3); S813(100); S837(99.6)]",0,"ENSG00000111961"
"1498","KTN1",0.0298479379234378,6.63688962309368,0.456921289571775,0.65790276646543,0.71675388175673,-7.37386004914875,"NONE",FALSE,"High","Master Protein","Q86UP2","Kinectin [OS=Homo sapiens]",0,65.342,4,3,3,8,3,1357,156.2,5.64,35.11,3,"transport;other biological processes","plasma membrane;other membranes;ER/Golgi","cytoskeletal activity","Pf05104","3895","B4DZ88; hsa:3895; Q13999; Q14707; Q15387; Q17RZ5; Q5GGW3; Q86UP2; Q86W57","ENSG00000126777","RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RND2 GTPase cycle; RHOG GTPase cycle; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; RND3 GTPase cycle; RHO GTPases activate KTN1","Glucocorticoid receptor pathway; Nuclear receptors meta-pathway",11,0,97.9,97.6,102.9,103.7,103.4,110,95.1,98.3,93.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); T153(100); S1313(100)]",0,"ENSG00000126777"
"1499","SYMPK",-0.0361897184128717,6.62348668554914,-0.446026753028689,0.665479478470886,0.724524689035681,-7.3791618144783,"NONE",FALSE,"High","Master Protein","Q92797","Symplekin [OS=Homo sapiens]",0,40.615,5,3,3,4,3,1274,141.1,6.13,14.63,3,"cell adhesion;RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf11935, Pf12295","8189","hsa:8189; O00521; O00689; O00733; Q59GT5; Q8N2U5; Q92797","ENSG00000125755","Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs",NA,5,0,103.2,105,103.1,105,103.2,105.5,93.4,97,83,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S501(100); S1243(100); S1259(100)]",0,"ENSG00000125755"
"1500","SP1",0.116622445040196,6.62582491276695,0.44203256281306,0.66826731989723,0.727074844048187,-7.3810748254985,"NONE",FALSE,"High","Master Protein","P08047","Transcription factor Sp1 [OS=Homo sapiens]",0,15.2,4,1,1,1,1,785,80.6,7.34,3.97,1,"stress response;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","6667","E4Z9M7; G5E9M8; hsa:6667; P08047; Q86TN8; Q9H3Q5; Q9NR51; Q9NY21; Q9NYE7","ENSG00000185591","PPARA activates gene expression; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription; RNA polymerase II transcribes snRNA genes; Estrogen-dependent gene expression; Oncogene Induced Senescence; Activation of gene expression by SREBF (SREBP); SARS-CoV-1 targets host intracellular signalling and regulatory pathways; Regulation of CDH11 gene transcription; NFE2L2 regulating tumorigenic genes","Androgen receptor signaling pathway; Sterol regulatory element-binding proteins (SREBP) signaling; Leptin signaling pathway; IL-17 signaling pathway; Androgen receptor network in prostate cancer; AGE/RAGE pathway; Corticotropin-releasing hormone signaling pathway; Adipogenesis; Constitutive androstane receptor pathway; Estrogen receptor pathway; Nuclear receptors meta-pathway; Myometrial relaxation and contraction pathways; Copper homeostasis; Initiation of transcription and translation elongation at the HIV-1 LTR; MECP2 and associated Rett syndrome; TGF-beta signaling pathway; Mitochondrial gene expression; Oxidative stress response; Breast cancer pathway; Ethanol metabolism production of ROS by CYP2E1; Non-genomic actions of 1,25 dihydroxyvitamin D3; EGF/EGFR signaling pathway; Gastrin signaling pathway; IL-18 signaling pathway; Angiotensin II receptor type 1 pathway; Pleural mesothelioma; CCL18 signaling pathway; GDNF signaling; Genetic causes of porto-sinusoidal vascular disease; HDAC6 interactions in the central nervous system; Pathways in cancer; Sudden infant death syndrome (SIDS) susceptibility pathways; Estrogen signaling pathway",42,0,70.8,98.6,96.2,91,144.6,77.2,115.4,82.3,152.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S59(100)]",0,"ENSG00000185591"
"1501","TSC2",0.066790291409232,6.65720942649097,0.438912991396212,0.670448410309733,0.728678327711271,-7.38255744905095,"NONE",FALSE,"High","Master Protein","P49815","Tuberin [OS=Homo sapiens]",0,84.781,7,9,12,20,9,1807,200.5,7.31,41.51,9,"stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf02145, Pf03542, Pf11864","7249","A7E2E2; B4DIL8; B4DIQ7; B4DRN2; B7Z2B8; C9J378; hsa:7249; O75275; P49815; Q4LE71; Q8TAZ1","ENSG00000103197","Constitutive Signaling by AKT1 E17K in Cancer; TP53 Regulates Metabolic Genes; AKT phosphorylates targets in the cytosol; Macroautophagy; Energy dependent regulation of mTOR by LKB1-AMPK; TBC/RABGAPs; Inhibition of TSC complex formation by PKB","AMP-activated protein kinase signaling; Target of rapamycin signaling; Follicle stimulating hormone (FSH) signaling pathway; Glioblastoma signaling pathways; Brain-derived neurotrophic factor (BDNF) signaling pathway; Nanoparticle triggered autophagic cell death; Polycystic kidney disease pathway; Wnt signaling pathway; BDNF-TrkB signaling; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; ATM signaling in development and disease ; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; PI3K/AKT/mTOR - vitamin D3 signaling; PI3K-Akt signaling pathway; Thermogenesis; Synaptic signaling pathways associated with autism spectrum disorder; Fragile X syndrome; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Insulin signaling; p53 transcriptional gene network; Pleural mesothelioma; DYRK1A involvement regarding cell proliferation in brain development; Primary ovarian insufficiency; Monoamine transport",35,0,101.7,99.4,101.7,117.7,77.5,125.2,87.3,111,87.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1097(99.1); S1387(99.1); S1411(100); S1420(100); S1452(100)]",0,"ENSG00000103197"
"1502","SLC12A4",0.0631107033197207,6.67773227659112,0.438647619541807,0.670634098175447,0.728678327711271,-7.38268310563551,"NONE",FALSE,"High","Master Protein","Q9UP95","Solute carrier family 12 member 4 [OS=Homo sapiens]",0,37.006,3,2,4,10,2,1085,120.6,6.44,32.66,2,"cell-cell signaling;cell organization and biogenesis;transport;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522","6560","B4DF69; B4DR04; B4DZ82; B7ZAV0; F5H066; F5H0S9; F5H3C0; hsa:6560; O60632; O75893; Q13953; Q96LD5; Q9UP95","ENSG00000124067","Cation-coupled Chloride cotransporters","Proximal tubule transport",2,0,102.3,103,101.5,117.1,75,131.3,95.4,100.3,94,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100); S967(100)]",0,"ENSG00000124067"
"1503","WTAP",0.0763406379497837,6.62672645174332,0.436064080039529,0.672443091927479,0.729640593374716,-7.38390262535342,"NONE",FALSE,"High","Master Protein","Q15007","Pre-mRNA-splicing regulator WTAP [OS=Homo sapiens]",0,15.2,5,1,1,1,1,396,44.2,5.19,4.52,1,"cell cycle OR cell proliferation;RNA metabolism OR transcription;other metabolic processes;other biological processes","other membranes;nucleus;other cell component","other molecular function","Pf17098","9589","hsa:9589; Q15007; Q5TCL8; Q5TCL9; Q96T28; Q9BYJ7; Q9H4E2","ENSG00000146457","Processing of Capped Intron-Containing Pre-mRNA",NA,1,0,73.5,100.1,92.9,97.6,116,81.6,106,97.4,143,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S306(100)]",0,"ENSG00000146457"
"1504","PPP3CB",-0.0649843377696708,6.5153411820583,-0.43561127274835,0.672760375183739,0.729640593374716,-7.38411565305668,"NONE",FALSE,"High","Master Protein","P16298","Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform [OS=Homo sapiens]",0,2.98,2,1,1,1,1,524,59,5.91,3.02,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf00149","5532","hsa:5532; P16298; P16299; Q5F2F9; Q8N1F0; Q8N3W4","ENSG00000107758","FCERI mediated Ca+2 mobilization; Ca2+ pathway; CLEC7A (Dectin-1) induces NFAT activation; Calcineurin activates NFAT; DARPP-32 events; ROBO receptors bind AKAP5","Physiological and pathological hypertrophy of the heart; Energy metabolism; MicroRNAs in cardiomyocyte hypertrophy; Alzheimer's disease and miRNA effects; Amyotrophic lateral sclerosis (ALS); Initiation of transcription and translation elongation at the HIV-1 LTR; MAPK signaling pathway; Wnt signaling; Alzheimer's disease; Calcium mediated T-cell apoptosis involved in inclusion body myositis",16,0,58.6,66.3,74,53,73.6,59.1,167.6,166.8,214.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S478(100)]",0,"ENSG00000107758"
"1505","SPAG9",-0.0490787387907705,6.66896689929026,-0.435467738916455,0.672860963865776,0.729640593374716,-7.38418313557997,"NONE",FALSE,"High","Master Protein","O60271","C-Jun-amino-terminal kinase-interacting protein 4 [OS=Homo sapiens]",0,87.874,6,5,8,17,5,1321,146.1,5.15,52.1,5,"transport;signal transduction;other biological processes","other membranes;cytosol;cytoskeleton;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf09744, Pf16471, Pf19056","9043","A6H8U5; A8MSX0; B4DHH2; hsa:9043; O60271; O60905; Q3KQU8; Q3MKM7; Q86WC7; Q86WC8; Q8IZX7; Q96II0; Q9H811","ENSG00000008294","Myogenesis",NA,1,0,95.9,97.5,95.3,107.6,73,101.7,112.4,121.4,102.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T217(100); T226(99.6); S730(100)]",0,"ENSG00000008294"
"1506","YRDC",0.032816385540305,6.67173187866193,0.4301610985934,0.676584628518393,0.732720699655358,-7.38666304592702,"NONE",FALSE,"High","Master Protein","Q86U90","Threonylcarbamoyl-AMP synthase [OS=Homo sapiens]",0,10.839,5,1,1,2,1,279,29.3,8.57,6.66,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","plasma membrane;other membranes;mitochondrion;other cell component","nucleic acid binding activity;other molecular function","Pf01300","79693","hsa:79693; Q4W4X8; Q6NVW3; Q7L4E4; Q7Z2I4; Q86U90; Q9H5F8","ENSG00000196449",NA,NA,0,0,94.2,82.6,95.1,99.1,88.9,96.6,116.9,116.7,124.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100)]",0,"ENSG00000196449"
"1507","PTGR2",0.0704584046005543,6.61379936271867,0.430140184042712,0.676599322537147,0.732720699655358,-7.3866727619039,"NONE",FALSE,"High","Master Protein","Q8N8N7","Prostaglandin reductase 2 [OS=Homo sapiens]",0,15.2,5,1,1,3,1,351,38.5,5.41,10.66,1,"other metabolic processes","other cell component","other molecular function","Pf00107, Pf16884","145482","hsa:145482; Q3L8A4; Q6MZH8; Q8N8N7","ENSG00000140043","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Eicosanoid metabolism via cyclooxygenases (COX); Eicosanoid metabolism via lipooxygenases (LOX); Omega-6-fatty acids in senescence",4,0,78.2,63.9,101.4,93.4,63.3,98,131,121.4,145.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S270(100)]",0,"ENSG00000140043"
"1508","SNTB2",-0.0469982695244449,6.63703608580753,-0.42277586344488,0.681782167023355,0.737843830624745,-7.39006562825879,"NONE",FALSE,"High","Master Protein","Q13425","Beta-2-syntrophin [OS=Homo sapiens]",0,70.256,7,4,4,14,4,540,57.9,8.82,43.17,4,NA,"plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf00169, Pf00595, Pf18012","6645","hsa:6645; Q13425; Q9BY09","ENSG00000168807",NA,NA,0,0,101,98.6,97.3,96.4,76.1,121.2,100.2,100.2,103.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S95(100); S110(100); S393(100)]",0,"ENSG00000168807"
"1509","FAM117A",-0.0478440478392086,6.62629691483385,-0.420661800421544,0.683273244833164,0.738967485465688,-7.39102918767127,"NONE",FALSE,"High","Master Protein","Q9C073","Protein FAM117A [OS=Homo sapiens]",0,18.49,6,2,2,4,2,453,48.3,8.31,6.18,2,NA,NA,NA,"Pf15388","81558","B7Z7Q3; hsa:81558; Q9C073","ENSG00000121104",NA,NA,0,0,105.8,97.4,100.7,104,103,96.6,93.6,111.5,84.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S213(100); T299(99.4)]",0,"ENSG00000121104"
"1510","RUFY3",0.0802334443742181,6.59148064196923,0.416081762791619,0.686508535039098,0.741659471737481,-7.39310073213816,"NONE",FALSE,"High","Master Protein","Q7L099","Protein RUFY3 [OS=Homo sapiens]",0,12,6,1,1,1,1,469,52.9,5.49,3.51,1,"cell organization and biogenesis;developmental processes;other biological processes","other membranes;cytosol;other cell component",NA,"Pf02759","22902","B3KM25; B4DYW7; D9N163; hsa:22902; O94948; Q7L099; Q9UI00","ENSG00000018189",NA,NA,0,0,84.4,85.8,98.9,104.8,128.3,72.9,103.2,118.6,85.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S49(99.3)]",0,"ENSG00000018189"
"1511","MTMR2",-0.0416780629531601,6.68060431747528,-0.415851681874349,0.68667123884518,0.741659471737481,-7.39320422056467,"NONE",FALSE,"High","Master Protein","Q13614","Myotubularin-related protein 2 [OS=Homo sapiens]",0,21.85,3,1,1,2,1,643,73.3,7.4,6.98,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf02893, Pf06602","8898","A6NN98; hsa:8898; Q13614; Q9UPS9","ENSG00000087053","Synthesis of PIPs at the plasma membrane; Synthesis of PIPs at the early endosome membrane; Synthesis of PIPs at the late endosome membrane; Synthesis of PIPs at the ER membrane","Intracellular trafficking proteins involved in CMT neuropathy",5,0,86,116.4,109.9,104.9,100.3,105.5,100.1,102.9,100.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S58(100)]",0,"ENSG00000087053"
"1512","RBMX",0.0354658869263567,6.65140109928161,0.414303220650051,0.687766686143092,0.742351343773496,-7.3938992689304,"NONE",FALSE,"High","Master Protein","P38159","RNA-binding motif protein, X chromosome [OS=Homo sapiens]",0,56.289,15,7,9,37,2,391,42.3,10.05,64.51,7,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;other biological processes","non-structural extracellular;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08081","27316","B4E3U4; D3DWH0; E9PG86; hsa:27316; P38159; Q5JQ67; Q8N8Y7; Q969R3","ENSG00000147274","RND2 GTPase cycle; mRNA Splicing - Major Pathway; RND3 GTPase cycle; RND1 GTPase cycle; Processing of Capped Intron-Containing Pre-mRNA; RHOBTB2 GTPase cycle; RHOBTB1 GTPase cycle","mRNA processing",8,0,93,96.2,97.4,95.3,107,104.9,98.7,100.2,115.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S88(100); S189(99.1); S208(100); S326(100); S352(100)]",0,"ENSG00000147274"
"1513","ADAM17",-0.097033025895195,6.59390488424466,-0.409991301063737,0.690821133246936,0.745155379682089,-7.39582154888019,"NONE",FALSE,"High","Master Protein","P78536","Disintegrin and metalloproteinase domain-containing protein 17 [OS=Homo sapiens]",0,11.362,3,2,2,3,2,824,93,5.76,6.98,2,"cell adhesion;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00200, Pf13574, Pf16698","6868","hsa:6868; O60226; P78536","ENSG00000151694","Collagen degradation; Release of Hh-Np from the secreting cell; Activated NOTCH1 Transmits Signal to the Nucleus; Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant; Growth hormone receptor signaling; Nuclear signaling by ERBB4; Signaling by EGFR; TNF signaling; CD163 mediating an anti-inflammatory response; Regulated proteolysis of p75NTR","Alzheimer's disease and miRNA effects; Brain-derived neurotrophic factor (BDNF) signaling pathway; Notch signaling; Copper homeostasis; Ebola virus infection in host; Soluble ACE2-mediated cell entry of SARS-CoV-2; Interactions of natural killer cells in pancreatic cancer; Alzheimer's disease; TROP2 regulatory signaling; Notch signaling pathway",23,0,81.7,85.1,91.5,65.3,124.6,69.8,142.4,94.5,134.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S791(100); S819(100)]",0,"ENSG00000151694"
"1514","BAIAP2",-0.0363363131995076,6.64424625781022,-0.407217114118096,0.692789396196399,0.746575617102959,-7.39704803340681,"NONE",FALSE,"High","Master Protein","Q9UQB8","Brain-specific angiogenesis inhibitor 1-associated protein 2 [OS=Homo sapiens]",0,22.038,6,3,3,3,3,552,60.8,8.9,9.29,3,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cell component","other molecular function","Pf07653, Pf08397","10458","hsa:10458; O43858; Q53HB1; Q86WC1; Q8N5C0; Q96CR7; Q9UBR3; Q9UQ43; Q9UQB8","ENSG00000175866","Regulation of actin dynamics for phagocytic cup formation; FCGR3A-mediated phagocytosis; CDC42 GTPase cycle; RAC1 GTPase cycle; RAC3 GTPase cycle; RHO GTPases Activate WASPs and WAVEs; VEGFA-VEGFR2 Pathway","Regulation of actin cytoskeleton",8,0,90.9,100.1,99.3,100.5,105.1,90,108.7,104.8,103,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100); T340(100); S366(100)]",0,"ENSG00000175866"
"1515","HUWE1",-0.034801505870151,6.63131447934392,-0.406237393612806,0.693485077619865,0.746575617102959,-7.39747925192343,"NONE",FALSE,"High","Master Protein","Q7Z6Z7","E3 ubiquitin-protein ligase HUWE1 [OS=Homo sapiens]",0,98.632,3,6,8,24,6,4374,481.6,5.22,63.6,6,"cell organization and biogenesis;protein metabolism;DNA metabolism;other metabolic processes;stress response;other biological processes","non-structural extracellular;other membranes;cytosol;mitochondrion;ER/Golgi;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00627, Pf00632, Pf02825, Pf06012, Pf06025, Pf14377","10075","hsa:10075; O15029; Q4G2Z2; Q5H961; Q6P4D0; Q7Z6Z7; Q8NG67; Q9BUI0; Q9HCJ4; Q9NSL6; Q9P0A9","ENSG00000086758","Antigen processing: Ubiquitination & Proteasome degradation; Neutrophil degranulation",NA,2,0,103.5,102.8,100.8,99.3,95,115.5,86.6,97.6,99.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1395(100); S1907(100); T2889(100); S2918(99.2); S3816(100)]",0,"ENSG00000086758"
"1516","NOL4L",0.0312926026154763,6.65503426512192,0.406202031344218,0.693510193338288,0.746575617102959,-7.39749479766629,"NONE",FALSE,"High","Master Protein","Q96MY1","Nucleolar protein 4-like [OS=Homo sapiens]",0,21.478,8,2,2,2,2,436,47.2,5.08,7.05,2,NA,"cytosol;nucleus",NA,NA,"140688","hsa:140688; Q5JYB7; Q6P0Y4; Q96MY1; Q9BR34; Q9NQF6","ENSG00000197183",NA,NA,0,0,88.4,86.8,100.2,98.7,99,94.2,109.8,111.8,117.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S130(100)]",0,"ENSG00000197183"
"1517","RAB29",-0.128014263669901,6.64566883120884,-0.400270238873244,0.697728714946177,0.750621794853105,-7.4000839836701,"NONE",FALSE,"High","Master Protein","O14966","Ras-related protein Rab-7L1 [OS=Homo sapiens]",0,6.757,10,1,1,1,1,203,23.1,7.18,2.7,1,"cell organization and biogenesis;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;mitochondrion;ER/Golgi;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf00071","8934","B4E1K3; C9JE77; hsa:8934; O14966","ENSG00000117280","RAB geranylgeranylation",NA,1,0,103,80.2,104.9,83.4,47.7,143.9,146.3,113.6,87.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S177(100)]",0,"ENSG00000117280"
"1518","ATP2B4",0.0718883785044913,6.6435722933876,0.398762292539536,0.698802864977397,0.751282131517201,-7.40073632063758,"NONE",FALSE,"High","Master Protein","P23634","Plasma membrane calcium-transporting ATPase 4 [OS=Homo sapiens]",0,45.601,3,2,2,4,1,1241,137.8,6.6,18.29,2,"stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;cytoskeleton;other cell component","transporter activity;enzyme regulator activity;other molecular function","Pf00122, Pf00689, Pf00690, Pf00702, Pf12424, Pf13246","493","B1APW5; B1APW6; hsa:493; P23634; Q13450; Q13452; Q13455; Q16817; Q7Z3S1","ENSG00000058668","Ion homeostasis; Ion transport by P-type ATPases; Reduction of cytosolic Ca++ levels","Vitamin D-sensitive calcium signaling in depression",4,0,98.2,96.8,100.7,114.9,66.6,135.3,103.2,98.1,86.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S328(100)]",0,"ENSG00000058668"
"1519","RB1CC1",-0.0539987084262057,6.63036430231062,-0.39744919946785,0.69973878762616,0.751793088483142,-7.40130242418886,"NONE",FALSE,"High","Master Protein","Q8TDY2","RB1-inducible coiled-coil protein 1 [OS=Homo sapiens]",0,25.017,2,3,3,4,3,1594,183,5.41,6.83,3,"cell cycle OR cell proliferation;cell organization and biogenesis;other metabolic processes;developmental processes;signal transduction;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","other molecular function","Pf10377","9821","hsa:9821; Q86YR4; Q8TDY2; Q8WVU9; Q92601","ENSG00000023287","Macroautophagy","Alzheimer's disease and miRNA effects; PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer; Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway; Autophagy; Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; Pleural mesothelioma; Alzheimer's disease; Clock-controlled autophagy in bone metabolism; 8q11.23 (RB1CC1) copy number variation; ADHD and autism (ASD) linked metabolic pathways and SNP",11,0,90.4,96.4,96.5,80.4,123.8,89.3,108.9,101.9,113.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S237(100)]",0,"ENSG00000023287"
"1520","TTYH2",-0.0296648129830306,6.60269156037452,-0.389816534468976,0.705189525427012,0.757007532994395,-7.40455724555944,"NONE",FALSE,"High","Master Protein","Q9BSA4","Protein tweety homolog 2 [OS=Homo sapiens]",0,13.606,4,2,3,15,2,534,58.7,5.83,6.06,2,"transport","plasma membrane;other membranes","transporter activity","Pf04906","94015","B3KX97; hsa:94015; Q3B7H8; Q3B7R9; Q6AWB4; Q8NBB7; Q96PK1; Q9BSA4","ENSG00000141540","Stimuli-sensing channels",NA,1,0,99.9,102.7,96.3,95.5,103.8,104.5,88.2,96.5,97.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S444(100); S504(100)]",0,"ENSG00000141540"
"1521","EGFR",0.0353266701851247,6.66201475588436,0.389354724748499,0.705519888287056,0.757007532994395,-7.40475221564423,"NONE",FALSE,"High","Master Protein","P00533","Epidermal growth factor receptor [OS=Homo sapiens]",0,87.014,7,5,7,14,5,1210,134.2,6.68,62.9,5,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;nucleic acid binding activity;kinase activity;other molecular function","Pf00757, Pf01030, Pf07714, Pf14843, Pf21314","1956","hsa:1956; O00688; O00732; P00533; P06268; Q14225; Q68GS5; Q92795; Q9BZS2; Q9GZX1; Q9H2C9; Q9H3C9; Q9UMD7; Q9UMD8; Q9UMG5","ENSG00000146648","HCMV Early Events; NOTCH3 Activation and Transmission of Signal to the Nucleus; PIP3 activates AKT signaling; Respiratory syncytial virus (RSV) attachment and entry; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RAF/MAP kinase cascade; Signaling by ERBB4; SHC1 events in ERBB2 signaling; GRB2 events in ERBB2 signaling; PI3K events in ERBB2 signaling; ERBB2 Regulates Cell Motility; ERBB2 Activates PTK6 Signaling; Downregulation of ERBB2 signaling; Signaling by ERBB2 KD Mutants; Signaling by ERBB2 TMD/JMD mutants; Cargo recognition for clathrin-mediated endocytosis; Signal transduction by L1; GRB2 events in EGFR signaling; GAB1 signalosome; SHC1 events in EGFR signaling; EGFR downregulation; EGFR interacts with phospholipase C-gamma; Inhibition of Signaling by Overexpressed EGFR; Estrogen-dependent nuclear events downstream of ESR-membrane signaling; Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants; PLCG1 events in ERBB2 signaling; EGFR Transactivation by Gastrin; Constitutive Signaling by EGFRvIII; PTK6 promotes HIF1A stabilization; TFAP2 (AP-2) family regulates transcription of growth factors and their receptors; Signaling by ERBB2 ECD mutants","Androgen receptor signaling pathway; Glioblastoma signaling pathways; AGE/RAGE pathway; Gastric cancer network 2; Spinal cord injury; Aryl hydrocarbon receptor pathway; Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); Bladder cancer; TCA cycle nutrient use and invasiveness of ovarian cancer; Extracellular vesicle-mediated signaling in recipient cells; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; Focal adhesion; RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced AP-1 survival signaling; Physico-chemical features and toxicity-associated pathways; MAPK signaling pathway; ERK pathway in Huntington's disease; RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; BMP signaling in eyelid development; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Clear cell renal cell carcinoma pathways; Endometrial cancer; PI3K-Akt signaling pathway; Ebola virus infection in host; Ras signaling; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Extracellular vesicles in the crosstalk of cardiac cells; EGF/EGFR signaling pathway; Relationship between inflammation, COX-2 and EGFR; Regulatory circuits of the STAT3 signaling pathway; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Gastrin signaling pathway; Head and neck squamous cell carcinoma; EGFR tyrosine kinase inhibitor resistance; Pleural mesothelioma; Regulation of actin cytoskeleton; 2q37 copy number variation syndrome; TROP2 regulatory signaling; TAR syndrome; NF1 copy number variation syndrome ; HDAC6 interactions in the central nervous system; ErbB signaling pathway",84,0,93.6,92.3,91.6,91.8,90.1,112.1,103.1,113.8,123.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T693(100); S991(100); S1042(100); S1166(100); S1204(100)]",0,"ENSG00000146648"
"1522","TMEM245",0.0431147791455597,6.63754612724668,0.384213733327475,0.709201924627417,0.760458305513761,-7.40690754979667,"NONE",FALSE,"High","Master Protein","Q9H330","Transmembrane protein 245 [OS=Homo sapiens]",0,60.801,3,1,4,12,1,879,97.3,8.91,47.6,1,NA,"other membranes",NA,"Pf01594","23731","B4DSW7; hsa:23731; Q5JTQ5; Q5SS43; Q6ZME3; Q8NDJ5; Q96CG6; Q9H330","ENSG00000106771",NA,NA,0,0,93.9,96.3,98.6,97.2,84.5,123.9,92.3,102.8,107.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S327(98.8); S332(99.4)]",0,"ENSG00000106771"
"1523","TMEM201",0.0480191190011032,6.62131546495944,0.382973178092485,0.710091613468427,0.760912352712063,-7.4074234866053,"NONE",FALSE,"High","Master Protein","Q5SNT2","Transmembrane protein 201 [OS=Homo sapiens]",0,8.027,2,1,1,2,1,666,72.2,9.22,5.24,1,"cell organization and biogenesis;transport;other biological processes","other membranes;cytoskeleton;nucleus;other cell component","cytoskeletal activity;other molecular function","Pf09779, Pf10476","199953","B9EH90; hsa:199953; Q5SNT2; Q5SNT3","ENSG00000188807",NA,NA,0,0,81.9,84.6,83.9,85.3,90.3,91.7,101.6,145.3,134.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S454(100)]",0,"ENSG00000188807"
"1524","CLIP3",0.0422894045584306,6.6324802939572,0.381242943389511,0.71133325336401,0.761458256564107,-7.40814037460922,"NONE",FALSE,"High","Master Protein","Q96DZ5","CAP-Gly domain-containing linker protein 3 [OS=Homo sapiens]",0,6.905,2,1,1,1,1,547,59.5,7.8,2.56,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;transport;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cytoplasmic organelle;other cell component","cytoskeletal activity;other molecular function","Pf01302, Pf12796","25999","A8K0E4; hsa:25999; Q8WWL1; Q96C99; Q96DZ5; Q9UFT7","ENSG00000105270","Regulation of TNFR1 signaling",NA,1,0,114.1,91,104.7,105.6,98.7,121.2,98.5,90.8,82.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S402(100)]",0,"ENSG00000105270"
"1525","PARD3B",-0.0301286658484257,6.64558030069578,-0.380963016619771,0.711534216458494,0.761458256564107,-7.40825606072313,"NONE",FALSE,"High","Master Protein","Q8TEW8","Partitioning defective 3 homolog B [OS=Homo sapiens]",0,74.058,5,5,5,8,5,1205,132.4,8.37,29.73,5,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00595, Pf12053","117583","E9PE87; hsa:117583; Q8IUC7; Q8IUC9; Q8TEW8; Q96DK9; Q96N09; Q96NX6; Q96NX7; Q96Q29","ENSG00000116117",NA,NA,0,0,101.3,99,100.2,99.2,108.2,99.8,103,94,103.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T133(100); S352(100); S730(100); S746(100)]",0,"ENSG00000116117"
"1526","SON",-0.0568395784508819,6.59669465319957,-0.374510801919044,0.716172779498681,0.765920036790201,-7.41089972656398,"NONE",FALSE,"High","Master Protein","P18583","Protein SON [OS=Homo sapiens]",0,72.935,3,8,13,22,8,2426,263.7,5.64,63.75,8,"cell cycle OR cell proliferation;cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity","Pf01585, Pf14709, Pf17069","6651","D3DSF5; D3DSF6; E7ETE8; E7EU67; E7EVW3; E9PFQ2; hsa:6651; O14487; O95981; P18583; Q14120; Q6PKE0; Q9H7B1; Q9P070; Q9P072; Q9UKP9; Q9UPY0","ENSG00000159140",NA,NA,0,0,114.9,103.4,102.8,113.1,72.9,124.6,85.4,94.7,75.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S283(99.6); S1556(99.6); S1697(100); S1887(100); S1950(100); S1952(99.2); S2009(100); S2013(100); S2031(100)]",0,"ENSG00000159140"
"1527","ZMYND8",0.0373919745522233,6.64587994129567,0.366351442546004,0.722056095051819,0.771511094641088,-7.4141800474573,"NONE",FALSE,"High","Master Protein","Q9ULU4","MYND-type zinc finger-containing chromatin reader ZMYND8 [OS=Homo sapiens]",0,39.29,5,5,5,8,5,1186,131.6,7.2,25.26,5,"cell organization and biogenesis;DNA metabolism;stress response;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00439, Pf00628, Pf00855, Pf12064","23613","B3KVL2; B7Z2A8; B7Z3E0; B7Z680; B7ZM62; E1P5U5; F5H0X3; H7C0U2; hsa:23613; J3KPU3; Q13517; Q2HXV1; Q2HXV2; Q2HXV3; Q2HXV4; Q2HXV7; Q2HXV8; Q2HXV9; Q2HXW0; Q2HXW1; Q2HXW2; Q4JJ94; Q4JJ95; Q5TH09; Q5TH11; Q6MZM1; Q8WXC5; Q9H1F3; Q9H1F4; Q9H1F5; Q9H1L8; Q9H1L9; Q9H2G5; Q9NYN3; Q9UIX6; Q9ULU4","ENSG00000101040",NA,NA,0,0,92,96.4,96.1,95.5,101.1,107.9,108.7,92.3,114.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S425(100); S475(100); S547(100); S652(100); S756(100)]",0,"ENSG00000101040"
"1528","MOCS3",-0.0402462676474133,6.64463237507331,-0.365949836284417,0.722346171943372,0.771511094641088,-7.41433969235535,"NONE",FALSE,"High","Master Protein","O95396","Adenylyltransferase and sulfurtransferase MOCS3 [OS=Homo sapiens]",0,8.145,2,1,1,2,1,460,49.6,6.21,5.59,1,"protein metabolism;RNA metabolism OR transcription;other metabolic processes","cytosol;other cell component","other molecular function","Pf00581, Pf00899","27304","hsa:27304; O95396","ENSG00000124217","Molybdenum cofactor biosynthesis","Metabolic Epileptic Disorders",2,0,97.1,93.8,102.8,97.2,83.6,112.3,90.7,107.9,115.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(100)]",0,"ENSG00000124217"
"1529","SENP3",-0.0462601837604879,6.59173694730973,-0.362626708238614,0.724748217722991,0.773570367118327,-7.41565415385656,"NONE",FALSE,"High","Master Protein","Q9H4L4","Sentrin-specific protease 3 [OS=Homo sapiens]",0,30.401,3,1,2,3,1,574,65,8.56,15.76,1,"protein metabolism;other metabolic processes;other biological processes","nucleus;other cell component","other molecular function","Pf02902, Pf19722","26168","hsa:26168; Q66K15; Q86VS7; Q96PS4; Q9H4L4; Q9Y3W9","ENSG00000161956","Major pathway of rRNA processing in the nucleolus and cytosol",NA,1,0,102.7,101.9,98.2,100.7,112.1,93.7,106.2,85.8,81.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S169(100); S181(100)]",0,"ENSG00000161956"
"1530","ZBTB20",0.039000362424864,6.61067376450025,0.360042064266765,0.726618650117533,0.775059893458702,-7.4166684428943,"NONE",FALSE,"High","Master Protein","Q9HC78","Zinc finger and BTB domain-containing protein 20 [OS=Homo sapiens]",0,75.025,12,4,5,11,4,741,81,6.49,41.39,4,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf00651","26137","Q63HP6; Q8N6R5; Q9HC78; Q9Y410","ENSG00000181722",NA,NA,0,0,103.4,106.3,104.5,99.7,101.7,131.8,83.7,88.1,80.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T211(100); T305(99.6); S353(100); S432(99.2)]",0,"ENSG00000181722"
"1531","FIP1L1",0.0320409402916777,6.64605076236562,0.358595534182725,0.727666291117533,0.77567040307238,-7.41723302131998,"NONE",FALSE,"High","Master Protein","Q6UN15","Pre-mRNA 3'-end-processing factor FIP1 [OS=Homo sapiens]",0,31.07,4,3,3,5,3,594,66.5,5.59,20.46,3,"RNA metabolism OR transcription;other metabolic processes","cytosol;nucleus",NA,"Pf05182","81608","B4DIR3; G3XAD6; hsa:81608; Q0VGE0; Q499Y4; Q49AU3; Q6UN15; Q7Z608; Q8WVN3; Q96F80; Q9H077","ENSG00000145216","Transport of Mature mRNA Derived from an Intronless Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs; Signaling by cytosolic PDGFRA and PDGFRB fusion proteins",NA,6,0,90.9,96.9,104.9,98.7,95.7,116.4,104.4,95.3,101.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S304(100); S492(100)]",0,"ENSG00000145216"
"1532","PUM1",-0.0423609431080578,6.65917124702101,-0.35407898433867,0.730941179008986,0.77865274421845,-7.41898158063632,"NONE",FALSE,"High","Master Protein","Q14671","Pumilio homolog 1 [OS=Homo sapiens]",0,26.059,3,2,2,3,2,1186,126.4,6.84,10.63,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00806","9698","A8K6W4; B4DG92; D3DPN3; E9PCJ0; hsa:9698; Q14671; Q53HH5; Q5VXY7; Q9HAN1","ENSG00000134644","Golgi Associated Vesicle Biogenesis",NA,1,0,84.7,98.6,95.8,92.1,76.5,108.2,100.4,130,122,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S229(98.5); S709(100)]",0,"ENSG00000134644"
"1533","DHCR7",-0.0488711693986446,6.58670254155973,-0.350002740504975,0.733901714157988,0.781296541099697,-7.42054114060712,"NONE",FALSE,"High","Master Protein","Q9UBM7","7-dehydrocholesterol reductase [OS=Homo sapiens]",0,14.413,2,2,2,5,2,475,54.5,8.7,11.14,2,"other metabolic processes","other membranes;ER/Golgi;nucleus","other molecular function","Pf01222","1717","B2R6Z2; hsa:1717; O60492; O60717; Q9UBM7","ENSG00000172893","Activation of gene expression by SREBF (SREBP); Cholesterol biosynthesis via desmosterol; Cholesterol biosynthesis via lathosterol","Vitamin D metabolism; Cholesterol biosynthesis pathway; Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; Cholesterol biosynthesis with skeletal dysplasias; Cholesterol synthesis disorders; Cholesterol metabolism; Enterocyte cholesterol metabolism",10,0,69.9,80.6,80.9,65.7,85.8,70.5,140.9,124.7,176.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S14(100)]",0,"ENSG00000172893"
"1534","SLC12A6",0.0389123720258215,6.63892641158797,0.344916855146319,0.737601999384405,0.784723900257724,-7.42246230098415,"NONE",FALSE,"High","Master Protein","Q9UHW9","Solute carrier family 12 member 6 [OS=Homo sapiens]",0,11.351,2,1,1,1,1,1150,127.5,7.08,3.88,1,"cell-cell signaling;cell organization and biogenesis;stress response;transport;developmental processes;other biological processes","plasma membrane;other membranes;other cell component","transporter activity;other molecular function","Pf00324, Pf03522","9990","A0AV76; hsa:9990; Q2VI00; Q7Z2E7; Q7Z4G5; Q8TDD4; Q9UFR2; Q9UHW9; Q9Y642; Q9Y665","ENSG00000140199","Cation-coupled Chloride cotransporters; Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",NA,2,0,126.9,98.4,101.7,114.5,117.6,111.5,84.8,76.8,94.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1032(100)]",0,"ENSG00000140199"
"1535","CCDC88A",0.022199639232876,6.67831116300618,0.330377877837186,0.748218756776267,0.795500332937373,-7.42780289274922,"NONE",FALSE,"High","Master Protein","Q3V6T2","Girdin [OS=Homo sapiens]",0,78.539,4,6,12,22,6,1871,215.9,6.21,55.13,6,"cell organization and biogenesis;DNA metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","signal transduction activity or receptor binding;enzyme regulator activity;cytoskeletal activity;other molecular function","Pf19047","55704","A1IGE7; B7ZM78; C9JG83; hsa:55704; Q3V6T2; Q53SF1; Q581G3; Q5HYD0; Q7Z339; Q7Z3C5","ENSG00000115355","RND3 GTPase cycle; RND1 GTPase cycle","Mesodermal commitment pathway",3,0,94,95.2,99.4,102.5,92,107.1,106.4,112.2,108.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1417(100); S1653(99.7); T1673(99.5); S1675(99.5); S1701(99.5); S1702(99.7); S1717(100); S1820(99.5)]",0,"ENSG00000115355"
"1536","RBM15B",0.0505776089150451,6.59813464833212,0.328909654053244,0.749294032338037,0.796124909359164,-7.42832972388622,"NONE",FALSE,"High","Master Protein","Q8NDT2","Putative RNA-binding protein 15B [OS=Homo sapiens]",0,25.909,4,4,4,12,4,890,97.1,9.85,10.57,4,"cell organization and biogenesis;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf07744","29890","A4QPG7; hsa:29890; Q6QE19; Q8NDT2; Q9BV96","ENSG00000259956",NA,NA,0,0,109.6,101.8,99.4,107.5,82.5,134.9,87,93.9,72.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S267(99.5); S609(99.7)]",0,"ENSG00000259956"
"1537","NFIB",0.0244268097015059,6.62629368973554,0.31696485427853,0.758062867927428,0.804917762171479,-7.43253046988246,"NONE",FALSE,"High","Master Protein","O00712","Nuclear factor 1 B-type [OS=Homo sapiens]",0,49.271,13,3,5,7,3,420,47.4,8.87,25.18,3,"cell cycle OR cell proliferation;cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;developmental processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00859, Pf03165, Pf10524","4781","G3V1P1; H7BYE8; hsa:4781; O00166; O00712; Q12858; Q5VW29; Q63HM5; Q6ZNF9; Q96J45","ENSG00000147862","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination","Pathways affected in adenoid cystic carcinoma",3,0,102.6,94.5,107.1,102.6,106.7,112.7,89.7,89,97.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S265(100); S295(100); S328(100)]",0,"ENSG00000147862"
"1538","ARHGAP21",-0.0211118197807521,6.63900551371694,-0.315656317249436,0.759025713302582,0.80541610150183,-7.43298141233249,"NONE",FALSE,"High","Master Protein","Q5T5U3","Rho GTPase-activating protein 21 [OS=Homo sapiens]",0,118.085,10,16,17,30,16,1958,217.3,7.8,64.27,16,"cell organization and biogenesis;transport;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","enzyme regulator activity","Pf00169, Pf00620, Pf17820","57584","hsa:57584; Q0VF98; Q5T5U3; Q7Z3P7; Q8N3A2; Q8NI19; Q8TBV5; Q9P2C3","ENSG00000107863","RHOC GTPase cycle; RHOA GTPase cycle; CDC42 GTPase cycle; RAC1 GTPase cycle; RHOQ GTPase cycle; RHOG GTPase cycle; RAC2 GTPase cycle; RAC3 GTPase cycle; RHOB GTPase cycle; RHOD GTPase cycle; RHOJ GTPase cycle; RHOF GTPase cycle; RND3 GTPase cycle",NA,13,0,98.7,101.7,97.3,100.2,101.8,101.8,95.9,100.2,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S36(100); S253(100); S319(98.3); S459(100); S612(100); S954(100); S1099(100); S1433(99.5); S1514(100); S1568(99.8); S1669(100); S1742(100); S1861(99.6)]",0,"ENSG00000107863"
"1539","NHSL1",-0.030607073178194,6.6550599289988,-0.312349427953035,0.761460916753254,0.807475124198382,-7.43411287428924,"NONE",FALSE,"High","Master Protein","Q5SYE7","NHS-like protein 1 [OS=Homo sapiens]",0,52.136,6,5,7,8,5,1610,170.6,6.96,21.07,5,"other biological processes",NA,NA,"Pf15273","57224","hsa:57224; Q3ZCS5; Q5SYE7; Q5SYE8; Q9P2J0","ENSG00000135540",NA,"Thyroid hormones production and peripheral downstream signaling effects",1,0,96.6,94.8,94.6,91,112,92.1,105.5,106.3,119.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S842(100); S851(90.7); S1181(100); S1191(98.1); S1233(100)]",0,"ENSG00000135540"
"1540","SEPTIN2",-0.0270530416946162,6.64545859643875,-0.311642638616768,0.761981756310954,0.80750274435031,-7.43435319010331,"NONE",FALSE,"High","Master Protein","Q15019","Septin-2 [OS=Homo sapiens]",0,112.891,23,7,7,19,7,361,41.5,6.6,80.09,7,"cell cycle OR cell proliferation;cell organization and biogenesis;signal transduction;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;nucleus;other cell component","other molecular function","Pf00735","4735","B4DGE8; hsa:4735; Q14132; Q15019; Q53QU3; Q8IUK9; Q96CB0","ENSG00000168385","Anchoring of the basal body to the plasma membrane","2q37 copy number variation syndrome",2,0,102.9,100,100.9,108.8,83.7,111.4,100.4,98.3,94.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S218(100)]",0,"ENSG00000168385"
"1541","ATF2",0.0791102226976328,6.59661781483182,0.307238442120651,0.765230065380699,0.810293563522723,-7.43583864135782,"NONE",FALSE,"High","Master Protein","P15336","Cyclic AMP-dependent transcription factor ATF-2 [OS=Homo sapiens]",0,24.578,10,3,3,5,3,505,54.5,7.88,8.65,3,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;mitochondrion;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00170","1386","A1L3Z2; A4D7U4; A4D7U5; A4D7V1; D3DPE9; G8JLM5; hsa:1386; P15336; Q13000; Q3B7B7; Q4ZFU9; Q53RY2; Q8TAR1; Q96JT8","ENSG00000115966","NGF-stimulated transcription; Heme signaling; Regulation of PTEN gene transcription; TP53 Regulates Transcription of DNA Repair Genes; Circadian Clock; Transcriptional activation of mitochondrial biogenesis; Estrogen-dependent gene expression; HATs acetylate histones; Activation of the AP-1 family of transcription factors; Response of EIF2AK4 (GCN2) to amino acid deficiency","Energy metabolism; IL-1 signaling pathway; B cell receptor signaling pathway; AGE/RAGE pathway; ATM signaling pathway; Interleukin-1 (IL-1) structural pathway; Myometrial relaxation and contraction pathways; Photodynamic therapy-induced AP-1 survival signaling; TGF-beta signaling pathway; MAPK signaling pathway; ATM signaling in development and disease ; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; IL-4 signaling pathway; DNA IR-double strand breaks and cellular response via ATM; Ethanol effects on histone modifications; p38 MAPK signaling pathway; PI3K-Akt signaling pathway; Thermogenesis; Gastrin signaling pathway; Hepatitis B infection; Thyroid hormones production and peripheral downstream signaling effects; Host-pathogen interaction of human coronaviruses - MAPK signaling; Pleural mesothelioma; 10q11.21q11.23 copy number variation syndrome; T-cell receptor signaling pathway",36,0,100.2,78.7,105.2,105.3,129.4,82.8,134.3,75.3,85.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S112(100); S307(100)]",0,"ENSG00000115966"
"1542","UBXN2B",-0.0362816470754321,6.65999615706753,-0.306726099153449,0.765608256710808,0.810293563522723,-7.436010099044,"NONE",FALSE,"High","Master Protein","Q14CS0","UBX domain-containing protein 2B [OS=Homo sapiens]",0,13.098,6,1,1,2,1,331,37.1,5.64,7.51,1,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;other biological processes","cytosol;cytoskeleton;ER/Golgi;nucleus","other molecular function","Pf00789, Pf08059","137886","B3KWZ3; hsa:137886; Q14CS0","ENSG00000215114",NA,NA,0,0,92.9,105.7,109.1,116.5,86.9,101.4,98.7,108.6,89.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S235(100)]",0,"ENSG00000215114"
"1543","CA14",-0.0233974725039774,6.65728906903101,-0.298521604911629,0.771673279383867,0.816183274111776,-7.43871752541782,"NONE",FALSE,"High","Master Protein","Q9ULX7","Carbonic anhydrase 14 [OS=Homo sapiens]",0,21.129,4,2,2,6,2,337,37.6,6.37,17.86,2,"other metabolic processes","plasma membrane;other membranes","other molecular function","Pf00194","23632","hsa:23632; Q5TB24; Q8NCF4; Q9ULX7","ENSG00000118298","Reversible hydration of carbon dioxide",NA,1,0,93.2,87.1,96.2,97.1,77.7,101.6,110.2,119.1,119.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S325(100)]",0,"ENSG00000118298"
"1544","PPP1R18",0.0221064772696726,6.67695225019513,0.296658592341842,0.773052758914731,0.817112760718162,-7.43932227090782,"NONE",FALSE,"High","Master Protein","Q6NYC8","Phostensin [OS=Homo sapiens]",0,17.773,3,2,2,6,2,613,67.9,5.4,13.44,2,NA,"cytoskeleton;other cell component","cytoskeletal activity;other molecular function","Pf13914, Pf13916","170954","A2AB01; A2AIB8; A4UBI6; A6NCB7; A8MSS7; B7ZCV7; hsa:170954; Q68CK8; Q6NYC8; Q6ZTV1; Q6ZUJ6; Q8NDQ4; Q8TF52; Q9BRL9","ENSG00000146112; ENSG00000206485; ENSG00000225060; ENSG00000229998; ENSG00000230341; ENSG00000234000",NA,"TYROBP causal network in microglia",1,0,93.9,100.5,95.1,106.2,87.8,106.2,107.3,109.5,108.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S145(100); S224(100)]",0,"ENSG00000146112"
"1545","SBF1",-0.0210180831188786,6.64846325686014,-0.292442551707479,0.776177626985187,0.819884716660081,-7.440677098086,"NONE",FALSE,"High","Master Protein","O95248","Myotubularin-related protein 5 [OS=Homo sapiens]",0,34.703,3,3,3,3,3,1868,208.3,6.9,10.64,3,"protein metabolism;other metabolic processes;other biological processes","other membranes;cytosol;ER/Golgi;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00169, Pf02141, Pf02893, Pf03456, Pf06602, Pf12335","6305","A0A024R4Z9; A6PVG9; G5E933; hsa:6305; O60228; O95248; Q5JXD8; Q5PPM2; Q96GR9; Q9UGB8","ENSG00000100241","RAB GEFs exchange GTP for GDP on RABs; Synthesis of PIPs at the ER membrane",NA,2,0,96.3,102.3,98.9,97.3,104.1,103.1,99.3,98.3,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1142(99.6); S1229(100); T1820(100)]",0,"ENSG00000100241"
"1546","REST",0.0300395207376916,6.62121996593456,0.29128013868189,0.777039935044709,0.820264666230896,-7.44104729046835,"NONE",FALSE,"High","Master Protein","Q13127","RE1-silencing transcription factor [OS=Homo sapiens]",0,15.2,2,1,1,1,1,1097,121.8,6.74,4.01,1,"cell organization and biogenesis;stress response;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","5978","A2RUE0; B9EGJ0; hsa:5978; Q12956; Q12957; Q13127; Q13134; Q59ER1; Q8IWI3","ENSG00000084093","HDACs deacetylate histones; Potential therapeutics for SARS; NGF-stimulated transcription; Regulation of PTEN gene transcription; Regulation of NPAS4 gene transcription","MECP2 and associated Rett syndrome; DYRK1A involvement regarding cell proliferation in brain development; 11p11.2 copy number variation syndrome ; Sudden infant death syndrome (SIDS) susceptibility pathways",9,0,96.7,102,83.3,108.5,91.6,93.5,104.6,99.3,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S864(100)]",0,"ENSG00000084093"
"1547","ENGASE",0.0413818807805235,6.58996778075673,0.285438105777963,0.781378523228182,0.82431140911984,-7.4428858566669,"NONE",FALSE,"High","Master Protein","Q8NFI3","Cytosolic endo-beta-N-acetylglucosaminidase [OS=Homo sapiens]",0,7.923,2,1,1,1,1,743,83.9,6.79,2.63,1,"protein metabolism;other metabolic processes","cytosol","other molecular function","Pf03644","64772","hsa:64772; Q659F0; Q8NFI3; Q8TB86; Q9H6U4","ENSG00000167280","N-glycan trimming in the ER and Calnexin/Calreticulin cycle",NA,1,0,107.5,91.5,101.3,105.1,87.4,121.6,99.6,92.9,73.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S66(99.6)]",0,"ENSG00000167280"
"1548","INPP5E",-0.0382844645677407,6.60789219159628,-0.282883553354331,0.783278162846851,0.825781629047843,-7.44367830177059,"NONE",FALSE,"High","Master Protein","Q9NRR6","Phosphatidylinositol polyphosphate 5-phosphatase type IV [OS=Homo sapiens]",0,7.587,2,1,1,1,1,644,70.2,8.95,3.57,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;nucleus;other cell component","other molecular function",NA,"56623","hsa:56623; Q15734; Q6PIV5; Q9NRR6","ENSG00000148384","Synthesis of PIPs at the Golgi membrane; ARL13B-mediated ciliary trafficking of INPP5E","Genes related to primary cilium development (based on CRISPR); Joubert syndrome; Ciliopathies; Bardet-Biedl syndrome",6,0,102.5,99.4,99.7,98.2,119.2,92.8,80.9,93.3,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S99(100)]",0,"ENSG00000148384"
"1549","ATN1",0.0289961736300803,6.6448903285134,0.277114055269592,0.78757404505504,0.829774591045724,-7.44544226634846,"NONE",FALSE,"High","Master Protein","P54259","Atrophin-1 [OS=Homo sapiens]",0,46.212,6,5,6,7,5,1190,125.3,8.98,22.49,5,"developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf03154","1822","hsa:1822; P54259; Q99495; Q99621; Q9UEK7","ENSG00000111676","Regulation of PTEN gene transcription",NA,1,0,93.9,93.8,105.2,104.5,119.2,91.8,103.8,97.1,99.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S34(100); S77(100); S632(100); S645(100); T653(100); S661(100)]",0,"ENSG00000111676"
"1550","MAP2K6",0.0559973336231527,6.37985471380844,0.270214619030268,0.792721137842109,0.834658643198917,-7.44750472554868,"NONE",FALSE,"High","Master Protein","P52564","Dual specificity mitogen-activated protein kinase kinase 6 [OS=Homo sapiens]",0,14.907,5,1,2,3,1,334,37.5,7.39,7.86,1,"other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;nucleus;other cell component","kinase activity;other molecular function","Pf00069","5608","hsa:5608; P52564","ENSG00000108984","PKR-mediated signaling; Interleukin-1 signaling; Oxidative Stress Induced Senescence; Myogenesis; NOD1/2 Signaling Pathway; activated TAK1 mediates p38 MAPK activation; PI5P Regulates TP53 Acetylation","MicroRNAs in cardiomyocyte hypertrophy; Integrin-mediated cell adhesion; IL-1 signaling pathway; RANKL/RANK signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Glioblastoma signaling pathways; B cell receptor signaling pathway; TNF-alpha signaling pathway; Amyotrophic lateral sclerosis (ALS); Interleukin-1 (IL-1) structural pathway; Cardiac hypertrophic response; Photodynamic therapy-induced AP-1 survival signaling; TGF-beta signaling pathway; MAPK signaling pathway; 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression; VEGFA-VEGFR2 signaling; Angiopoietin-like protein 8 regulatory pathway; Embryonic stem cell pluripotency pathways; p38 MAPK signaling pathway; MAPK cascade; Epithelial to mesenchymal transition in colorectal cancer; Vitamin D in inflammatory diseases; Signal transduction through IL1R; Translation inhibitors in chronically activated PDGFRA cells; Hepatitis B infection; Insulin signaling; Host-pathogen interaction of human coronaviruses - MAPK signaling; 16p11.2 proximal deletion syndrome; Angiotensin II receptor type 1 pathway; Pleural mesothelioma; GNAQ pathways in port-wine stain; Interferon type I signaling pathways; Serotonin HTR1 group and FOS pathway; Toll-like receptor signaling pathway",41,0,60,39.1,65.6,55.5,32.4,65.8,165.1,181.2,264.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S207(100)]",0,"ENSG00000108984"
"1551","ANKRD13D",-0.0349516794380742,6.63908045206709,-0.268622676159299,0.793910256956707,0.835371721053092,-7.44797333726004,"NONE",FALSE,"High","Master Protein","Q6ZTN6","Ankyrin repeat domain-containing protein 13D [OS=Homo sapiens]",0,3.763,4,1,1,2,1,605,68.1,5.59,2.35,1,"other biological processes","plasma membrane;other membranes;other cytoplasmic organelle;other cell component","other molecular function","Pf11904, Pf12796","338692","D6RCN6; hsa:338692; Q0VAK0; Q0VGC3; Q6ZTN6; Q6ZVD0; Q86SU1","ENSG00000172932",NA,NA,0,0,99.4,105.9,96.5,90.1,114.8,104.3,85.9,96.7,116,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S552(100); T556(100)]",0,"ENSG00000172932"
"1552","CASK",0.0209913206870578,6.66073504972982,0.265491510636372,0.796250738986925,0.837222129237495,-7.44888708264765,"NONE",FALSE,"High","Master Protein","O14936-4","Isoform 4 of Peripheral plasma membrane protein CASK [OS=Homo sapiens]",0,26.944,2,1,1,4,1,898,102.1,6.4,11.53,1,NA,NA,NA,NA,NA,"O14936-4",NA,NA,NA,0,0,82.2,90.1,92.9,92.2,81.1,101.4,125.3,117.4,123,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S577(99.7)]",0,"ENSG00000147044"
"1553","ZNF768",0.0244112987270473,6.65300619249266,0.264897712200859,0.796694832540336,0.837222129237495,-7.44905917580706,"NONE",FALSE,"High","Master Protein","Q9H5H4","Zinc finger protein 768 [OS=Homo sapiens]",0,19.277,6,3,3,5,3,540,60.2,7.97,14.09,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096, Pf05001","79724","hsa:79724; Q569L7; Q96CX4; Q9H5H4","ENSG00000169957",NA,NA,0,0,95.6,100.3,95.6,102.9,86.8,114.5,99.9,111.6,97,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(100); S125(100); S160(100)]",0,"ENSG00000169957"
"1554","SCD5",0.0400661827844475,6.57235649484014,0.263686490252838,0.797600925777247,0.837532966201104,-7.44940903180061,"NONE",FALSE,"High","Master Protein","Q86SK9","Stearoyl-CoA desaturase 5 [OS=Homo sapiens]",0,9.072,5,1,1,1,1,330,37.6,9.61,2.92,1,"other metabolic processes","other membranes;ER/Golgi","other molecular function","Pf00487","79966","B2RPG0; hsa:79966; Q4W5Q5; Q86SK9; Q8NDS0; Q9H7D1","ENSG00000145284","Fatty acyl-CoA biosynthesis; EGR2 and SOX10-mediated initiation of Schwann cell myelination",NA,2,0,103.6,103.7,106.6,104.9,103.1,125,64,91.5,85.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S27(99.2)]",0,"ENSG00000145284"
"1555","EEPD1",0.0359444781777301,6.64941202251659,0.26313042927439,0.798017011300684,0.837532966201104,-7.4495691182547,"NONE",FALSE,"High","Master Protein","Q7L9B9","Endonuclease/exonuclease/phosphatase family domain-containing protein 1 [OS=Homo sapiens]",0,26.145,8,4,4,10,4,569,62.4,8.41,15.27,4,"DNA metabolism;other metabolic processes;stress response;other biological processes","plasma membrane;other membranes","nucleic acid binding activity","Pf03372, Pf12836","80820","hsa:80820; Q7L9B9; Q96K64; Q9C0F7","ENSG00000122547","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux",NA,1,0,96.8,102.4,98.2,101.1,82.9,126.4,110.4,95.2,89.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100); S25(100); S110(100); S173(100)]",0,"ENSG00000122547"
"1556","MPHOSPH8",-0.024762833190489,6.65053198503307,-0.260718526489665,0.799822544541742,0.838888427180028,-7.45025963375859,"NONE",FALSE,"High","Master Protein","Q99549","M-phase phosphoprotein 8 [OS=Homo sapiens]",0,8.815,2,1,1,1,1,860,97.1,6.06,3.26,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytosol;nucleus;other cell component","other molecular function","Pf00385, Pf12796","54737","B7Z6F9; hsa:54737; Q5JPE5; Q5JTQ0; Q86TK3; Q96MK4; Q99549; Q9BTP1","ENSG00000196199",NA,NA,0,0,105.1,94.6,94.9,99.1,83.6,112.9,104.1,110.9,97.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S51(100)]",0,"ENSG00000196199"
"1557","MAPK8IP3",0.0186019335283181,6.63902424725407,0.259840046316612,0.800480478498918,0.839039268407344,-7.45050958075954,"NONE",FALSE,"High","Master Protein","Q9UPT6","C-Jun-amino-terminal kinase-interacting protein 3 [OS=Homo sapiens]",0,60.769,4,3,7,14,3,1336,147.4,5.4,42.78,3,"cell organization and biogenesis;stress response;transport;developmental processes;signal transduction;other biological processes","other membranes;ER/Golgi;other cell component","cytoskeletal activity;other molecular function","Pf09744, Pf16471, Pf19056","23162","A2A2B3; A7E2B3; hsa:23162; Q96RY4; Q9H4I4; Q9H7P1; Q9NUG0; Q9UPT6","ENSG00000138834",NA,"MAPK signaling pathway",1,0,75.3,79.1,82.8,85.4,73.5,81.9,139.3,137.5,161.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S273(98.9); T275(98.8); S365(100)]",0,"ENSG00000138834"
"1558","KCTD15",-0.0382002444131189,6.66796685755495,-0.255621902189552,0.8036419246035,0.841812336940251,-7.4516981479871,"NONE",FALSE,"High","Master Protein","Q96SI1","BTB/POZ domain-containing protein KCTD15 [OS=Homo sapiens]",0,12.388,7,1,1,2,1,283,31.9,7.44,5.87,1,"cell organization and biogenesis","nucleus","other molecular function","Pf02214, Pf20871","79047","A8K600; hsa:79047; Q96SI1; Q9BVI6","ENSG00000153885","Negative regulation of activity of TFAP2 (AP-2) family transcription factors",NA,1,0,106.3,102.9,109.5,101.1,78.6,136.2,102.5,94.2,88.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S35(100)]",0,"ENSG00000153885"
"1559","H1-2",0.0351896452091838,6.64903213319215,0.252166600788423,0.806234419568857,0.843986255764191,-7.45265746724414,"NONE",FALSE,"High","Master Protein","P16403","Histone H1.2 [OS=Homo sapiens]",0,105.113,42,10,11,19,2,213,21.4,10.93,46.51,10,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00538","3006","A8K4I2; hsa:3006; P16403","ENSG00000187837","Apoptosis induced DNA fragmentation; Formation of Senescence-Associated Heterochromatin Foci (SAHF)",NA,2,0,85.5,81.2,112.2,89.1,102.6,103.8,99,128.1,108.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S2(100); T4(100); S104(100); S113(100); T146(100)]; Met-loss [N-Term]",0,"ENSG00000187837"
"1560","NUP98",0.0208926122381614,6.61657974999642,0.2514545996307,0.80676893948455,0.844004428999222,-7.45285354428611,"NONE",FALSE,"High","Master Protein","P52948","Nuclear pore complex protein Nup98-Nup96 [OS=Homo sapiens]",0,66.832,3,4,4,7,4,1817,197.5,6.4,24.07,4,"cell organization and biogenesis;protein metabolism;transport;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf04096, Pf12110, Pf21240","4928","hsa:4928; P52948; Q8IUT2; Q8WYB0; Q96E54; Q9H3Q4; Q9NT02; Q9UF57; Q9UHX0; Q9Y6J4; Q9Y6J5","ENSG00000110713",NA,"SARS-CoV-2 innate immunity evasion and cell-specific immune response",1,0,93.4,91.7,105.4,99.6,96.1,110.1,92.3,95.9,104.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S612(100); S623(100); S888(100)]",0,"ENSG00000110713"
"1561","C2CD5",-0.0188032042861046,6.65873445660227,-0.25047717728641,0.807502889728819,0.844231080100854,-7.45312182420092,"NONE",FALSE,"High","Master Protein","Q86YS7-3","Isoform 3 of C2 domain-containing protein 5 [OS=Homo sapiens]",0,97.313,12,8,11,18,8,1051,116,5.87,56.55,8,NA,NA,NA,NA,NA,"Q86YS7-3",NA,NA,NA,0,0,98.4,94.6,91.7,99.3,82.5,104.3,106.6,113.1,112.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S260(100); S281(98.1); S295(100); S307(99.5); T339(100); S643(100); S659(99.8); S864(100)]",0,"ENSG00000111731"
"1562","REEP1",0.0217681374884622,6.67032208295001,0.248099023190819,0.809289476936637,0.845510506153844,-7.45377026535629,"NONE",FALSE,"High","Master Protein","Q9H902","Receptor expression-enhancing protein 1 [OS=Homo sapiens]",0,22.138,20,3,4,7,3,201,22.2,9.5,19.13,3,"cell organization and biogenesis","other membranes;cytoskeleton;mitochondrion;ER/Golgi;other cell component","signal transduction activity or receptor binding;cytoskeletal activity","Pf03134","65055","B7Z4D7; B7Z4F2; B7Z5R9; D6W5M2; hsa:65055; Q53TI0; Q9H902","ENSG00000068615","Expression and translocation of olfactory receptors",NA,1,0,94.2,93.4,100.7,93.6,98,113.7,113.2,105.8,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S152(100); S192(99.1)]",0,"ENSG00000068615"
"1563","FGFR3",-0.0318989394250124,6.62544698172,-0.247469208271642,0.809762819312781,0.845510506153844,-7.45394097153531,"NONE",FALSE,"High","Master Protein","P22607","Fibroblast growth factor receptor 3 [OS=Homo sapiens]",0,21.334,4,2,3,4,2,806,87.7,5.9,9.61,2,"cell-cell signaling;cell cycle OR cell proliferation;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cell component","kinase activity;other molecular function","Pf07679, Pf07714, Pf13927, Pf21165","2261","D3DVP9; D3DVQ0; hsa:2261; P22607; Q14308; Q16294; Q16608; Q59FL9","ENSG00000068078","Signaling by activated point mutants of FGFR3; t(4;14) translocations of FGFR3; Signaling by FGFR3 fusions in cancer","Neural crest differentiation; Bladder cancer; NOTCH1 regulation of endothelial cell calcification; MAPK signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Endometrial cancer; PI3K-Akt signaling pathway; Ras signaling; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; Head and neck squamous cell carcinoma; Endochondral ossification; FGFR3 signaling in chondrocyte proliferation and terminal differentiation; Osteoblast differentiation and related diseases; FGF23 signaling in hypophosphatemic rickets and related disorders; EGFR tyrosine kinase inhibitor resistance; Endochondral ossification with skeletal dysplasias; Pleural mesothelioma; Regulation of actin cytoskeleton; 4p16.3 copy number variation",25,0,100.2,110.8,117.3,115.1,88.7,122.2,94.8,75.1,82.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S408(100); S445(99.2)]",0,"ENSG00000068078"
"1564","OSBPL3",0.0227655936228972,6.66175338688699,0.242277396939671,0.81366783304731,0.849044695353715,-7.45533184498161,"NONE",FALSE,"High","Master Protein","Q9H4L5","Oxysterol-binding protein-related protein 3 [OS=Homo sapiens]",0,14.724,2,1,1,2,1,887,101.2,6.87,8.3,1,"other metabolic processes;transport","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","transporter activity;other molecular function","Pf01237, Pf15409","26031","A4D167; A4D168; A4D169; A4D170; A4D171; A4D172; B8ZZ79; B8ZZP0; hsa:26031; O14591; O43357; O43358; Q8N702; Q8N703; Q8N704; Q8NFH0; Q8NFH1; Q8NI12; Q8NI13; Q9BZF4; Q9H4L5; Q9UED6","ENSG00000070882","Synthesis of bile acids and bile salts","Orexin receptor pathway",2,0,91.2,95.6,101.6,107.2,89.7,103,96.3,106,118.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S304(100)]",0,"ENSG00000070882"
"1565","ARHGEF3",0.0865958843602863,6.48271823255048,0.238219678526519,0.816723601691885,0.851171640355112,-7.45639861635703,"NONE",FALSE,"High","Master Protein","Q9NR81","Rho guanine nucleotide exchange factor 3 [OS=Homo sapiens]",0,7.575,2,1,1,1,1,526,59.7,6.43,2.95,1,"signal transduction;other biological processes","cytosol","enzyme regulator activity","Pf00621","50650","A8K5U7; hsa:50650; Q4FZB6; Q4QQI5; Q4QQQ0; Q59F00; Q6NUN3; Q7Z4U2; Q7Z5T2; Q9H7T4; Q9NR81","ENSG00000163947","RHOA GTPase cycle; NRAGE signals death through JNK; G alpha (12/13) signalling events; RHOB GTPase cycle",NA,4,0,40.8,119.9,81.1,80.9,72.1,85,84,191.2,103.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S47(99.6)]",0,"ENSG00000163947"
"1566","C11orf96",0.0248450336148336,6.68316837395014,0.238185628357594,0.816749257840751,0.851171640355112,-7.45640749279965,"NONE",FALSE,"High","Master Protein","Q7Z7L8","Uncharacterized protein C11orf96 [OS=Homo sapiens]",0,33.742,13,4,4,6,4,435,46.1,9.99,17.3,4,NA,NA,NA,"Pf15766","387763","Q7Z7L8",NA,NA,NA,0,0,79.4,98.8,93.5,88.6,97.2,100.5,110,124.3,138.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S385(100); S399(100); S406(100); S425(100)]",0,"ENSG00000187479"
"1567","SEPTIN5",-0.0402756815197511,6.67662653549755,-0.231130463779878,0.822070071066468,0.856169978290029,-7.45821962896862,"NONE",FALSE,"High","Master Protein","Q99719","Septin-5 [OS=Homo sapiens]",0,18,5,1,2,5,1,369,42.8,6.67,9.77,1,"cell-cell signaling;cell cycle OR cell proliferation;transport;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf00735","5413","hsa:5413; O15251; Q96MY5; Q99719","ENSG00000184702",NA,"Parkin-ubiquitin proteasomal system pathway; Parkinson's disease pathway; 22q11.2 copy number variation syndrome",3,0,111.2,97.9,103.5,122.5,71.9,112,102.5,116.1,83.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S327(100)]",0,"ENSG00000184702"
"1568","ANGPT2",-0.063016888416116,6.51756549576239,-0.228906041519519,0.823749660065945,0.857372095170678,-7.45877980646919,"NONE",FALSE,"High","Master Protein","O15123","Angiopoietin-2 [OS=Homo sapiens]",0.006,1.881,2,1,1,1,1,496,56.9,5.58,2.29,1,"other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","non-structural extracellular;extracellular matrix;other cell component","signal transduction activity or receptor binding;other molecular function","Pf00147","285","A0AV38; A8K205; B7ZLM7; hsa:285; O15123; Q9NRR7; Q9P2Y7","ENSG00000091879","Tie2 Signaling","RAC1/PAK1/p38/MMP2 pathway; Photodynamic therapy-induced HIF-1 survival signaling; Hypothesized pathways in pathogenesis of cardiovascular disease; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Pleural mesothelioma",7,0,121.5,94.3,99.4,80.1,66.8,172.8,68.1,77.4,89.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S221(100)]",0,"ENSG00000091879"
"1569","WRNIP1",-0.0289861099198099,6.64123784513486,-0.22544524460701,0.826364660247086,0.859545650429092,-7.45964068653526,"NONE",FALSE,"High","Master Protein","Q96S55","ATPase WRNIP1 [OS=Homo sapiens]",0,35.225,5,3,5,7,3,665,72.1,6.1,15.51,3,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf00004, Pf12002, Pf16193, Pf18279","56897","B2RDB0; hsa:56897; Q53EP6; Q59ET8; Q5W0E2; Q5W0E4; Q8WV26; Q96S55; Q9H681; Q9NRJ6","ENSG00000124535",NA,NA,0,0,87.5,91.6,83.9,88.2,75.8,97.6,100.7,137.4,145.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S75(100); T116(100); S153(99.6)]",0,"ENSG00000124535"
"1570","DCTN4",-0.0449991292985894,6.61337632135996,-0.222508544316135,0.82858540947254,0.860947895196824,-7.46036101879908,"NONE",FALSE,"High","Master Protein","Q9UJW0","Dynactin subunit 4 [OS=Homo sapiens]",0,4.623,3,1,1,1,1,460,52.3,7.34,2.26,1,NA,"cytosol;cytoskeleton;nucleus;other cell component",NA,"Pf05502","51164","B3KWW0; D3DQH0; E5RGT5; hsa:51164; Q8TAN8; Q9UJW0","ENSG00000132912","HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand; MHC class II antigen presentation; COPI-mediated anterograde transport; COPI-independent Golgi-to-ER retrograde traffic","Vasopressin-regulated water reabsorption",5,0,91,106.9,64.2,86.9,59.4,102.2,111,140.8,135.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S196(100)]",0,"ENSG00000132912"
"1571","ARAF",-0.0275679660492454,6.59669352176152,-0.222267370695918,0.828767857447433,0.860947895196824,-7.46041976005682,"NONE",FALSE,"High","Master Protein","P10398","Serine/threonine-protein kinase A-Raf [OS=Homo sapiens]",0,16.676,3,2,2,4,1,606,67.5,9.01,10.7,2,"protein metabolism;other metabolic processes;signal transduction;other biological processes","cytosol;mitochondrion","kinase activity;other molecular function","Pf00130, Pf02196, Pf07714","369","hsa:369; P07557; P10398; Q5H9B2; Q5H9B3","ENSG00000078061","Signaling by BRAF and RAF1 fusions; RAF activation; SHOC2 M1731 mutant abolishes MRAS complex function; Gain-of-function MRAS complexes activate RAF signaling; Signaling by moderate kinase activity BRAF mutants; Paradoxical activation of RAF signaling by kinase inactive BRAF; Signaling downstream of RAS mutants; Signaling by RAF1 mutants; MAP2K and MAPK activation; Negative regulation of MAPK pathway; Signaling by high-kinase activity BRAF mutants","Integrin-mediated cell adhesion; Alzheimer's disease and miRNA effects; Glioblastoma signaling pathways; Common pathways underlying drug addiction; Bladder cancer; MAPK signaling pathway; Embryonic stem cell pluripotency pathways; Endometrial cancer; MET in type 1 papillary renal cell carcinoma; Chromosomal and microsatellite instability in colorectal cancer ; MAPK cascade; Non-small cell lung cancer; Breast cancer pathway; Pancreatic adenocarcinoma pathway; Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; Fragile X syndrome; Hepatitis B infection; Melanoma; EGFR tyrosine kinase inhibitor resistance; Alzheimer's disease; Acute myeloid leukemia; ErbB signaling pathway",33,1,110.4,93.7,106.4,92.4,96.7,124.5,81.8,85.8,98.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S257(100); S582(100)]",0,"ENSG00000078061"
"1572","CRTC3",0.0224975907417173,6.63641065697608,0.221368454897063,0.829447982312572,0.861106302248167,-7.46063814829089,"NONE",FALSE,"High","Master Protein","Q6UUV7","CREB-regulated transcription coactivator 3 [OS=Homo sapiens]",0,65.523,16,5,6,9,5,619,66.9,6.84,32.3,5,"cell organization and biogenesis;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf12884, Pf12885, Pf12886","64784","hsa:64784; Q6DK61; Q6DK62; Q6UUV7; Q8NF38; Q9H6U2","ENSG00000140577","Heme signaling; Circadian Clock; Transcriptional activation of mitochondrial biogenesis",NA,3,0,95.1,111.7,105,101.8,101.2,124.4,82.7,94.6,93.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100); S329(100); S370(99.5); T412(98.8)]",0,"ENSG00000140577"
"1573","SSB",-0.0270100288320689,6.65094633934927,-0.219572641943959,0.830807149454113,0.861969019649786,-7.46107181111994,"NONE",FALSE,"High","Master Protein","P05455","Lupus La protein [OS=Homo sapiens]",0,26.345,5,1,1,5,1,408,46.8,7.12,20.99,1,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity","Pf00076, Pf05383, Pf08777","6741","hsa:6741; P05455; Q15367; Q53XJ4","ENSG00000138385","RNA Polymerase III Abortive And Retractive Initiation; RNA Polymerase III Transcription Termination",NA,2,0,91.1,97.2,98.3,102.2,77,106.1,102,128.7,98.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S366(100)]",0,"ENSG00000138385"
"1574","KLF12",0.0616176744176489,6.57707730136008,0.206283591651378,0.840883018111098,0.871868542285458,-7.46417217954688,"NONE",FALSE,"High","Master Protein","Q9Y4X4","Krueppel-like factor 12 [OS=Homo sapiens]",0,15.2,4,1,1,2,1,402,44.2,9.7,8.51,1,"other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00096","11278","A8K5T2; hsa:11278; L0R3J4; Q5VZM7; Q9UHZ0; Q9Y4X4","ENSG00000118922",NA,NA,0,0,103.2,96.6,94.4,113.9,107.6,96.9,56.9,115.6,111.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S202(100)]",0,"ENSG00000118922"
"1575","RALGAPB",-0.0184218042555031,6.63518194454221,-0.202346524593227,0.843874058184677,0.874378623109505,-7.4650538856902,"NONE",FALSE,"High","Master Protein","Q86X10","Ral GTPase-activating protein subunit beta [OS=Homo sapiens]",0,56.882,6,4,4,5,4,1494,166.7,6.79,19.84,4,"other biological processes",NA,"enzyme regulator activity;other molecular function","Pf20412","57148","A2A2E8; A2A2E9; hsa:57148; Q5TG31; Q86X10; Q8N3D1; Q8WWC0; Q9H3X8; Q9UJR1; Q9ULK1; Q9Y3G9","ENSG00000170471","Translocation of SLC2A4 (GLUT4) to the plasma membrane",NA,1,0,94.9,91.8,106.8,97.5,99.1,104,106.1,103.4,92.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T379(98.9); S479(100); T734(99.1); S1300(100)]",0,"ENSG00000170471"
"1576","IQSEC1",0.0165875777233673,6.64440644974665,0.201686907929642,0.84437543506163,0.874378623109505,-7.46519995938634,"NONE",FALSE,"High","Master Protein","Q6DN90","IQ motif and SEC7 domain-containing protein 1 [OS=Homo sapiens]",0,50.432,9,6,7,12,6,963,108.2,6.93,30.71,6,"cell organization and biogenesis;developmental processes;other biological processes","ER/Golgi;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf01369, Pf16453","9922","A0A087WWK8; hsa:9922; O94863; Q6DN90; Q96D85","ENSG00000144711",NA,"EGF/EGFR signaling pathway",1,0,90.3,94.3,93.6,93,97.2,101.6,99.3,115.4,114.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S89(100); S105(100); S180(100); S198(100); S417(100)]",0,"ENSG00000144711"
"1577","NPAS3",0.015211214603851,6.63158654257723,0.198973886130819,0.846438380998174,0.875959060107178,-7.4657957914126,"NONE",FALSE,"High","Master Protein","Q8IXF0","Neuronal PAS domain-containing protein 3 [OS=Homo sapiens]",0,59.225,6,3,4,9,3,933,100.7,6.62,26.37,3,"other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00989, Pf08447","64067","hsa:64067; Q86US6; Q86US7; Q8IXF0; Q8IXF2; Q9BY81; Q9H323; Q9Y4L8","ENSG00000151322",NA,NA,0,0,97.1,95.8,95.4,101.4,98.2,101.8,93.5,108.1,104.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S622(99.3); S639(99.7)]",0,"ENSG00000151322"
"1578","DMAP1",-0.0242668466307778,6.65263731779795,-0.19568698422853,0.848939337452726,0.877793811606243,-7.46650693689986,"NONE",FALSE,"High","Master Protein","Q9NPF5","DNA methyltransferase 1-associated protein 1 [OS=Homo sapiens]",0,30.401,3,1,1,3,1,467,53,9.5,14.19,1,"cell organization and biogenesis;DNA metabolism;other metabolic processes;stress response;other biological processes","cytosol;nucleus;other cell component","other molecular function","Pf05499, Pf16282","55929","A8K001; D3DPY8; hsa:55929; Q0JSM4; Q5TG41; Q7Z3H7; Q9H0S8; Q9NPF5; Q9P2C2","ENSG00000178028","HATs acetylate histones",NA,1,0,93.1,91.5,105.6,101.8,71.3,118.5,108.9,107.8,101.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T445(99.6)]",0,"ENSG00000178028"
"1579","FAM234A",0.0298375570244813,6.64723870069089,0.195230215037203,0.849287027283246,0.877793811606243,-7.46660483237417,"NONE",FALSE,"High","Master Protein","Q9H0X4","Protein FAM234A [OS=Homo sapiens]",0,21.137,3,2,2,3,2,552,59.6,6.28,12.46,2,NA,"other membranes;other cell component",NA,NA,"83986","D3DU45; hsa:83986; Q7L416; Q96FR1; Q96MC7; Q96S30; Q9H0X4","ENSG00000167930",NA,NA,0,0,76.8,89.1,80.5,96.4,62.7,95.4,149.7,145.4,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100)]",0,"ENSG00000167930"
"1580","NCOR2",-0.012904952422355,6.59268171587846,-0.181588612549958,0.859686311038666,0.88797978456652,-7.46942386032727,"NONE",FALSE,"High","Master Protein","Q9Y618","Nuclear receptor corepressor 2 [OS=Homo sapiens]",0,45.487,2,5,5,10,5,2514,273.5,7.59,23.29,5,"transport;developmental processes;other biological processes","nucleus;other cell component","signal transduction activity or receptor binding;nucleic acid binding activity;other molecular function","Pf00249, Pf15784","9612","hsa:9612; O00613; O15416; O15421; Q13354; Q56D06; Q59GM0; Q9Y5U0; Q9Y618","ENSG00000196498","Constitutive Signaling by NOTCH1 PEST Domain Mutants; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants; NOTCH1 Intracellular Domain Regulates Transcription; Notch-HLH transcription pathway; SUMOylation of transcription cofactors; PPARA activates gene expression; Transcriptional regulation of white adipocyte differentiation; HCMV Early Events; HDACs deacetylate histones; Nuclear Receptor transcription pathway; Cytoprotection by HMOX1; Downregulation of SMAD2/3:SMAD4 transcriptional activity; Loss of MECP2 binding ability to the NCoR/SMRT complex; Regulation of MECP2 expression and activity; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux; NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis","Androgen receptor signaling pathway; Adipogenesis; Aryl hydrocarbon receptor pathway; Notch signaling; Rett syndrome; Notch signaling pathway",23,0,104.8,95.2,93.3,98.4,99.3,102.2,92.9,94.7,96.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S149(100); S152(100); S939(99.2); S1251(100); T1383(100)]",0,"ENSG00000196498"
"1581","MAP2",-0.0129948875047345,6.67670847317402,-0.175160328251866,0.864596693981539,0.892486909916427,-7.47068199583468,"NONE",FALSE,"High","Master Protein","P11137-3","Isoform 3 of Microtubule-associated protein 2 [OS=Homo sapiens]",0,717.957,28,33,51,148,1,1823,199,4.91,546.24,33,NA,NA,NA,NA,NA,"P11137-3",NA,NA,NA,0,34,97,98.9,101.3,109.2,95.3,99,105.2,107.6,104.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S136(97.5); T146(96.6); T423(100); S494(100); S650(99.5); S784(100); S817(100); S829(100); S858(100); S909(100); S1001(100); S1151(99.5); S1176(100); T1250(99.6); S1320(100); S1343(100); S1349(100); S1476(99.8); S1536(100); S1551(100); T1588(98.7); T1601(100); T1612(100); T1627(100); T1645(100); S1649(100); S1675(100); S1778(100); S1786(100)]",0,"ENSG00000078018"
"1582","TTC28",-0.017064562910222,6.63971861362981,-0.1697964100519,0.868698707926236,0.896154419301908,-7.47169733291721,"NONE",FALSE,"High","Master Protein","Q96AY4","Tetratricopeptide repeat protein 28 [OS=Homo sapiens]",0,45.548,2,5,5,8,5,2481,270.7,6.89,24.24,5,"cell cycle OR cell proliferation;other biological processes","cytoskeleton;other cell component","other molecular function","Pf12770, Pf13176, Pf13424","23331","hsa:23331; K7ZRV2; O95928; O95929; Q5W189; Q96AY4; Q9NTE4; Q9UG31; Q9UGG5; Q9UPV8; Q9Y3S5","ENSG00000100154",NA,NA,0,0,98.6,98.1,100.6,101,81.6,118.5,92.9,100.1,106.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S28(100); S2104(99.1); S2108(100); S2117(99.4); S2398(100)]",0,"ENSG00000100154"
"1583","FSBP",-0.0145288962395478,6.61516192534109,-0.159476357716887,0.876602353224487,0.903298604402506,-7.47356250990535,"NONE",FALSE,"High","Master Protein","O95073","Fibrinogen silencer-binding protein [OS=Homo sapiens]",0,4.244,4,1,1,1,1,299,34.7,7.12,2.42,1,NA,"nucleus","other molecular function","Pf13873","100861412; 25788","hsa:100861412; O95073; Q8N4S5","ENSG00000265817",NA,NA,0,0,100.2,108,115.6,108.4,125.3,102.4,84.6,80.2,85.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S193(100)]",0,"ENSG00000265817"
"1584","IRS2",-0.013708156458379,6.659031176795,-0.159308539328733,0.876730998390668,0.903298604402506,-7.47359187948972,"NONE",FALSE,"High","Master Protein","Q9Y4H2","Insulin receptor substrate 2 [OS=Homo sapiens]",0,122.605,11,12,13,28,12,1338,137.2,8.65,75.89,12,"cell cycle OR cell proliferation;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol","signal transduction activity or receptor binding;enzyme regulator activity;other molecular function","Pf00169, Pf02174","8660","hsa:8660; Q96RR2; Q9BZG0; Q9Y4H2; Q9Y6I5","ENSG00000185950","Growth hormone receptor signaling; PIP3 activates AKT signaling; Constitutive Signaling by Aberrant PI3K in Cancer; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; RET signaling; Erythropoietin activates Phosphoinositide-3-kinase (PI3K); RAF/MAP kinase cascade; PI3K Cascade; Interleukin-7 signaling; PI3K/AKT activation; Signaling by Leptin; Erythropoietin activates Phospholipase C gamma (PLCG); Erythropoietin activates STAT5; Erythropoietin activates RAS; SOS-mediated signalling; IRS activation; Signal attenuation","Prolactin signaling pathway; Alzheimer's disease and miRNA effects; Adipogenesis; Brain-derived neurotrophic factor (BDNF) signaling pathway; Alpha 6 beta 4 signaling pathway; Farnesoid X receptor pathway; Nuclear receptors meta-pathway; Transcription factor regulation in adipogenesis; Angiopoietin-like protein 8 regulatory pathway; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Leptin-insulin signaling overlap; IL-4 signaling pathway; Nonalcoholic fatty liver disease; Insulin signaling; FOXA2 pathway; Alzheimer's disease; EPO receptor signaling; Interferon type I signaling pathways",38,0,93.6,88.5,95.8,97.2,99.1,89.8,120,109.6,114.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T350(100); T520(99.6); S560(100); S577(100); S608(100); S620(99.6); S805(99.6); S915(100); S1100(100); S1203(99.3)]",0,"ENSG00000185950"
"1585","PHF2",-0.0164870900823484,6.65093588376016,-0.151885601120821,0.882424961403377,0.908591506000196,-7.47486017753173,"NONE",FALSE,"High","Master Protein","O75151","Lysine-specific demethylase PHF2 [OS=Homo sapiens]",0,23.572,5,3,3,5,3,1096,120.7,9.17,13.9,3,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","nucleus;other cell component","other molecular function","Pf00628, Pf02373, Pf17811","5253","hsa:5253; O75151; Q4VXG0; Q8N3K2; Q9Y6N4","ENSG00000197724","HDMs demethylate histones",NA,1,0,102.7,95.9,100.5,109.4,76.8,114.5,100.4,106.6,95.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S539(99.5); S681(100)]",0,"ENSG00000197724"
"1586","SESN3",-0.0205688600799121,6.68078504283841,-0.14909082532825,0.884570620594415,0.910226515012664,-7.47532209556762,"NONE",FALSE,"High","Master Protein","P58005","Sestrin-3 [OS=Homo sapiens]",0,16.932,4,1,1,4,1,492,57.3,6.25,9.24,1,"stress response;signal transduction;other biological processes","nucleus;other cell component","other molecular function","Pf04636","143686","B7Z7P9; hsa:143686; P58005; Q96AD1","ENSG00000149212","TP53 Regulates Metabolic Genes","Angiopoietin-like protein 8 regulatory pathway; miRNA regulation of p53 pathway in prostate cancer",3,0,83.3,90.9,115.6,85.9,87.4,120.1,114.9,110.1,113.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S7(100)]",0,"ENSG00000149212"
"1587","KHSRP",0.0140530927874041,6.63144069914197,0.144582467335944,0.888033932962996,0.913214479266294,-7.47604923446933,"NONE",FALSE,"High","Master Protein","Q92945","Far upstream element-binding protein 2 [OS=Homo sapiens]",0,16.187,3,2,2,3,2,711,73.1,7.3,10.7,2,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00013, Pf09005","8570","hsa:8570; O00301; Q59EZ9; Q5U4P6; Q92945; Q9UNT5; Q9UQH5","ENSG00000088247","ATF4 activates genes in response to endoplasmic reticulum  stress; KSRP (KHSRP) binds and destabilizes mRNA","Pre-implantation embryo",3,0,98.8,99.3,98.1,102.9,117.2,94.1,91.1,96.4,105.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S181(100); S480(100)]",0,"ENSG00000088247"
"1588","ADCY6",-0.0112229852573202,6.64795798535417,-0.139883073193164,0.891646646583362,0.916352221173833,-7.4767835223759,"NONE",FALSE,"High","Master Protein","O43306","Adenylate cyclase type 6 [OS=Homo sapiens]",0,29.409,2,2,2,3,2,1168,130.5,8.22,10.17,2,"other metabolic processes;signal transduction;other biological processes","plasma membrane;other membranes;other cell component","other molecular function","Pf00211, Pf06327, Pf16214","112","hsa:112; O43306; Q9NR75; Q9UDB0","ENSG00000174233","FCGR3A-mediated IL10 synthesis; G alpha (i) signalling events; G alpha (z) signalling events; Adenylate cyclase inhibitory pathway; G alpha (s) signalling events; GPER1 signaling; ADORA2B mediated anti-inflammatory cytokines production; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion; Adrenaline,noradrenaline inhibits insulin secretion; Vasopressin regulates renal water homeostasis via Aquaporins; PKA activation; PKA activation in glucagon signalling; Adenylate cyclase activating pathway; Hedgehog 'off' state","Myometrial relaxation and contraction pathways; G protein signaling pathways; Chemokine signaling pathway; Phosphodiesterases in neuronal function; Thermogenesis; Envelope proteins and their potential roles in EDMD physiopathology; Ciliopathies; Vasopressin-regulated water reabsorption; Calcium regulation in cardiac cells",24,0,100.6,91.1,101.3,98.4,103.6,100.5,96.3,104.6,110.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S54(100); S576(100)]",0,"ENSG00000174233"
"1589","UBTD1",-0.0155164229355389,6.63805217856789,-0.125831324972211,0.902464369177028,0.926885997795411,-7.47883494546593,"NONE",FALSE,"High","Master Protein","Q9HAC8","Ubiquitin domain-containing protein 1 [OS=Homo sapiens]",0,4.816,7,1,1,1,1,227,25.9,7.83,2.77,1,NA,NA,NA,"Pf00240, Pf16455","80019","D3DR57; hsa:80019; Q53HI3; Q9HAC8","ENSG00000165886",NA,NA,0,0,102.2,95.6,92.7,91.8,95.5,110.4,87.2,115.9,110.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S164(100)]",0,"ENSG00000165886"
"1590","ZNF362",0.0114646863599148,6.58538048103703,0.122744239175549,0.904843867112019,0.928745403224412,-7.47925666040285,"NONE",FALSE,"High","Master Protein","Q5T0B9","Zinc finger protein 362 [OS=Homo sapiens]",0,3.625,2,1,1,1,1,420,45.8,9.64,2.67,1,"other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096","149076","hsa:149076; Q5T0B9; Q8WYU4","ENSG00000160094",NA,NA,0,0,101,101.1,99.3,101.9,111.2,103.2,96.5,86.6,80,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S410(100)]",0,"ENSG00000160094"
"1591","BET1",-0.0173574944894774,6.4080951992605,-0.1176959135033,0.90873720240199,0.932155320125737,-7.47992379143267,"NONE",FALSE,"High","Master Protein","O15155","BET1 homolog [OS=Homo sapiens]",0,7.956,9,1,1,2,1,118,13.3,9.06,6.84,1,"cell organization and biogenesis;transport","other membranes;ER/Golgi","other molecular function",NA,"10282","hsa:10282; O15155; Q96EA0","ENSG00000105829","COPI-mediated anterograde transport; COPII-mediated vesicle transport",NA,2,0,49.2,58.8,58.2,41.9,50.9,58.7,203,165,224.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100)]",0,"ENSG00000105829"
"1592","NUP107",-0.0133024318270696,6.65151158511359,-0.116495343614287,0.909663477311245,0.932519343575346,-7.48007833424603,"NONE",FALSE,"High","Master Protein","P57740","Nuclear pore complex protein Nup107 [OS=Homo sapiens]",0,25.285,4,2,2,4,2,925,106.3,5.43,16.47,2,"cell organization and biogenesis;other metabolic processes;transport;developmental processes","other membranes;cytosol;nucleus;other cell component","other molecular function","Pf04121","57122","B4DZ67; hsa:57122; P57740; Q6PJE1","ENSG00000111581","HCMV Late Events; Separation of Sister Chromatids; Resolution of Sister Chromatid Cohesion; RHO GTPases Activate Formins; HCMV Early Events; EML4 and NUDC in mitotic spindle formation; ISG15 antiviral mechanism; Transport of the SLBP independent Mature mRNA; Transport of the SLBP Dependant Mature mRNA; Transport of Mature mRNA Derived from an Intronless Transcript; Transport of Mature mRNA derived from an Intron-Containing Transcript; Rev-mediated nuclear export of HIV RNA; Transport of Ribonucleoproteins into the Host Nucleus; NS1 Mediated Effects on Host Pathways; Viral Messenger RNA Synthesis; NEP/NS2 Interacts with the Cellular Export Machinery; Regulation of Glucokinase by Glucokinase Regulatory Protein; Nuclear import of Rev protein; Vpr-mediated nuclear import of PICs; snRNP Assembly; SUMOylation of DNA damage response and repair proteins; SUMOylation of ubiquitinylation proteins; Nuclear Pore Complex (NPC) Disassembly; Regulation of HSF1-mediated heat shock response; SUMOylation of SUMOylation proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of DNA replication proteins; Transcriptional regulation by small RNAs; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC); tRNA processing in the nucleus; SARS-CoV-2 activates/modulates innate and adaptive immune responses; Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal; Postmitotic nuclear pore complex (NPC) reformation","Gastric cancer network 1; Primary ovarian insufficiency",37,0,102.7,99.1,88.7,95.7,83.7,114.8,94.6,115.4,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S37(100); S86(99.4)]",0,"ENSG00000111581"
"1593","FGFR1",-0.0314697476640839,6.59625764414897,-0.112051059510311,0.913093604934246,0.935353658836668,-7.48063667112053,"NONE",FALSE,"High","Master Protein","P11362","Fibroblast growth factor receptor 1 [OS=Homo sapiens]",0,5.402,3,1,1,1,1,822,91.8,6.21,2.6,1,"cell-cell signaling;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00047, Pf07679, Pf07714","2260","A8K6T9; A8K8V5; C1KBH8; hsa:2260; P11362; P17049; Q02063; Q02065; Q14306; Q14307; Q53H63; Q59H40; Q5BJG2; Q8N685; Q9UD50; Q9UDF0; Q9UDF1; Q9UDF2","ENSG00000077782","Formation of paraxial mesoderm; Signaling by FGFR1 in disease; Epithelial-Mesenchymal Transition (EMT) during gastrulation; Signaling by activated point mutants of FGFR1; Signaling by plasma membrane FGFR1 fusions","Neural crest differentiation; Glioblastoma signaling pathways; Mesodermal commitment pathway; Mesodermal commitment pathway; MAPK signaling pathway; Embryonic stem cell pluripotency pathways; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; Prion disease pathway; Endometrial cancer; PI3K-Akt signaling pathway; Ras signaling; Breast cancer pathway; Thermogenesis; Hippo signaling regulation pathways; Hippo-Merlin signaling dysregulation; 22q11.2 copy number variation syndrome; Head and neck squamous cell carcinoma; Endochondral ossification; Thyroid hormones production and peripheral downstream signaling effects; Osteoblast differentiation and related diseases; Endochondral ossification with skeletal dysplasias; Kallmann syndrome; Pleural mesothelioma; Regulation of actin cytoskeleton; Macrophage-stimulating protein (MSP) signaling network map",30,0,103.3,49.3,129.1,98.2,63.6,99.5,117.4,115.1,109.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S451(98.2)]",0,"ENSG00000077782"
"1594","MSL3",0.0107159836093444,6.61825131175744,0.110700327739291,0.914136485332543,0.935353658836668,-7.48080207264382,"NONE",FALSE,"High","Master Protein","Q8N5Y2","Male-specific lethal 3 homolog [OS=Homo sapiens]",0,10.091,2,1,1,2,1,521,59.8,8.21,5.14,1,"cell organization and biogenesis;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf05712, Pf11717","10943","A6NCU2; A6NHW8; A8K165; B4DUV8; B7Z227; hsa:10943; Q8N5Y2; Q9UG70; Q9Y5Z8","ENSG00000005302","HATs acetylate histones",NA,1,0,100.7,96.2,107.1,105.6,89,118.9,93.1,96.8,84.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S400(99.6)]",0,"ENSG00000005302"
"1595","SRP72",-0.0119965208944404,6.66548855484188,-0.110685772490338,0.914147724169415,0.935353658836668,-7.4808038440855,"NONE",FALSE,"High","Master Protein","O76094","Signal recognition particle subunit SRP72 [OS=Homo sapiens]",0,30.401,4,1,3,12,1,671,74.6,9.26,59.03,1,"other biological processes","cytosol;ER/Golgi;translational apparatus;other cell component","nucleic acid binding activity;other molecular function","Pf08492, Pf13181, Pf17004","6731","G5E9Z8; hsa:6731; O76094; Q7Z3C0","ENSG00000174780","SRP-dependent cotranslational protein targeting to membrane",NA,1,0,94.2,92.7,107.1,104.4,81.7,111.6,110.2,95.3,111.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S620(99.3); S621(98.9); T624(97.9)]",0,"ENSG00000174780"
"1596","SDE2",-0.016120361351792,6.63817069226727,-0.109814676507711,0.914820377282953,0.93545542338708,-7.48090943748948,"NONE",FALSE,"High","Master Protein","Q6IQ49","Splicing regulator SDE2 [OS=Homo sapiens]",0,15.2,5,1,1,1,1,451,49.7,6.05,5.1,1,"cell cycle OR cell proliferation;protein metabolism;DNA metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;ER/Golgi;nucleus;other cell component","nucleic acid binding activity","Pf13019, Pf13297","163859","A8K4P3; hsa:163859; Q5TD36; Q6IQ49; Q6ZS26; Q8NAG7","ENSG00000143751","mRNA Splicing - Major Pathway",NA,1,0,81.1,110.4,109.2,106.9,117.4,86,100.5,91.5,105.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S278(100)]",0,"ENSG00000143751"
"1597","MCRIP1",-0.0131167591305399,6.63659977407465,-0.103534757340337,0.919671745043521,0.939827356237336,-7.48164605426258,"NONE",FALSE,"High","Master Protein","C9JLW8","Mapk-regulated corepressor-interacting protein 1 [OS=Homo sapiens]",0,15.2,19,1,1,1,1,97,10.9,9.41,4.26,1,"other biological processes","nucleus;other cell component",NA,"Pf14799","348262","C9JLW8; hsa:348262; Q6ZUL0","ENSG00000225663; ENSG00000288213",NA,NA,0,0,96.2,97.4,89.8,86.2,117.3,93.8,100.7,100.4,124.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S21(100)]",0,"ENSG00000225663"
"1598","ZNF521",0.00772445629551477,6.66849336081526,0.10214261724396,0.920747680758268,0.940338056944614,-7.48180348966964,"NONE",FALSE,"High","Master Protein","Q96K83","Zinc finger protein 521 [OS=Homo sapiens]",0,15,2,2,2,2,2,1311,147.8,7.01,4.78,2,"developmental processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00096, Pf12874, Pf13912","25925","A3QVP7; B0YJB7; hsa:25925; Q8IXI0; Q8TES6; Q96K83; Q9C065; Q9HAL5; Q9UFK4","ENSG00000198795","Formation of the anterior neural plate; Formation of the posterior neural plate; RUNX2 regulates osteoblast differentiation",NA,3,0,96.5,104.4,92.7,101.1,96.6,106.7,100.2,109.1,109.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S273(100); S605(100)]",0,"ENSG00000198795"
"1599","ARHGAP23",0.00803801138631144,6.61660875230559,0.0926530055444425,0.928086244277471,0.946657975567484,-7.48281999351903,"NONE",FALSE,"High","Master Protein","Q9P227","Rho GTPase-activating protein 23 [OS=Homo sapiens]",0,27.737,5,5,5,5,5,1491,162.1,9.19,11.61,5,"signal transduction;other biological processes","cytosol","enzyme regulator activity","Pf00620, Pf15410, Pf17820","57636","hsa:57636; Q9P227","ENSG00000273780; ENSG00000275832","RHOA GTPase cycle; RAC1 GTPase cycle","17q12 copy number variation syndrome",3,0,98.5,95.8,107.4,101.5,105.4,109.4,83.6,95.2,99.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S372(100); S598(100); S1393(100)]",0,"ENSG00000275832"
"1600","GTF2F1",0.00980912940875367,6.63227552316833,0.0926403261889185,0.928096054477925,0.946657975567484,-7.48282128557213,"NONE",FALSE,"High","Master Protein","P35269","General transcription factor IIF subunit 1 [OS=Homo sapiens]",0,20.528,5,2,2,4,2,517,58.2,7.49,12.3,2,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus;other cell component","enzyme regulator activity;nucleic acid binding activity;other molecular function","Pf05793","2962","B2RCS0; hsa:2962; P35269; Q9BWN0","ENSG00000125651","Estrogen-dependent gene expression; Viral Messenger RNA Synthesis; Formation of RNA Pol II elongation complex ; Formation of the Early Elongation Complex; Formation of HIV elongation complex in the absence of HIV Tat; Formation of the HIV-1 Early Elongation Complex; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection; Formation of HIV-1 elongation complex containing HIV-1 Tat; Pausing and recovery of Tat-mediated HIV elongation; Abortive elongation of HIV-1 transcript in the absence of Tat; Tat-mediated HIV elongation arrest and recovery; HIV elongation arrest and recovery; Pausing and recovery of HIV elongation; RNA Polymerase II Pre-transcription Events; TP53 Regulates Transcription of DNA Repair Genes; RNA polymerase II transcribes snRNA genes; mRNA Capping; RNA Pol II CTD phosphorylation and interaction with CE; HIV Transcription Initiation; RNA Polymerase II HIV Promoter Escape; RNA Polymerase II Promoter Escape; RNA Polymerase II Transcription Pre-Initiation And Promoter Opening; RNA Polymerase II Transcription Initiation; mRNA Splicing - Major Pathway; FGFR2 alternative splicing; mRNA Splicing - Minor Pathway; Processing of Capped Intron-Containing Pre-mRNA; Signaling by FGFR2 IIIa TM",NA,32,0,92.6,106.4,92.9,103,106.7,95.4,94.6,112.7,94.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T331(100); S385(100)]",0,"ENSG00000125651"
"1601","ZC3H7A",-0.00817737718864198,6.6712570787594,-0.0842678280084603,0.934576670533519,0.952228722098169,-7.48363591477446,"NONE",FALSE,"High","Master Protein","Q8IWR0","Zinc finger CCCH domain-containing protein 7A [OS=Homo sapiens]",0,15.2,2,1,1,1,1,971,110.5,7.3,4.99,1,"RNA metabolism OR transcription;other metabolic processes;other biological processes","nucleus","nucleic acid binding activity;other molecular function","Pf00642","29066","D3DUG5; hsa:29066; Q8IWR0; Q9NPE9","ENSG00000122299",NA,NA,0,0,108.9,96,88.3,103.1,89.5,102.5,106.6,117,102.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T210(100)]",0,"ENSG00000122299"
"1602","ALS2",0.00776678034656442,6.62564788646016,0.0840768984642126,0.934724517647835,0.952228722098169,-7.48365359403351,"NONE",FALSE,"High","Master Protein","Q96Q42","Alsin [OS=Homo sapiens]",0,71.104,4,5,6,16,5,1657,183.5,6.27,52.04,5,"cell-cell signaling;cell organization and biogenesis;other metabolic processes;stress response;transport;developmental processes;other biological processes","cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf00415, Pf00621, Pf02204, Pf02493","57679","hsa:57679; Q53TT1; Q53TV2; Q8N1E0; Q96PC4; Q96Q41; Q96Q42; Q9H973; Q9HCK9","ENSG00000003393","RAC1 GTPase cycle; RAB GEFs exchange GTP for GDP on RABs","Amyotrophic lateral sclerosis (ALS); IL-18 signaling pathway",4,0,102.5,93.4,89.8,92.9,110,96.8,104.1,98.7,106.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S466(99.3); S483(100); S492(100); T510(100); S1464(99.7)]",0,"ENSG00000003393"
"1603","EFR3A",0.0103846853260379,6.62367353604332,0.0827989942397767,0.935714135421065,0.952642213978277,-7.48377089156836,"NONE",FALSE,"High","Master Protein","Q14156","Protein EFR3 homolog A [OS=Homo sapiens]",0,4.393,2,1,1,1,1,821,92.9,6.7,2.32,1,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol",NA,"Pf21052","23167","A7MD19; hsa:23167; Q14156; Q2VPK2; Q63HL7; Q68DX1; Q6IQ18","ENSG00000132294",NA,NA,0,0,98.1,91.1,79,96.2,99.4,83.4,123.8,113.3,104.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S694(100)]",0,"ENSG00000132294"
"1604","ZC3H4",-0.00592691872388063,6.64786249334918,-0.0810387455089595,0.937077472924968,0.95343543379897,-7.4839295255962,"NONE",FALSE,"High","Master Protein","Q9UPT8","Zinc finger CCCH domain-containing protein 4 [OS=Homo sapiens]",0,37.902,4,3,3,4,3,1303,140.2,6.27,14.54,3,"RNA metabolism OR transcription;other metabolic processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00642, Pf14608, Pf18044","23211","hsa:23211; Q9UPT8; Q9Y420","ENSG00000130749",NA,NA,0,0,94.5,99.2,105.5,103.1,99.5,105.6,103,98.6,95.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1114(98.9); S1269(100); S1275(100)]",0,"ENSG00000130749"
"1605","EPHB1",-0.00690150935166223,6.65066929446513,-0.0629484864521165,0.951100241991071,0.967100059146061,-7.48536251444312,"NONE",FALSE,"High","Master Protein","P54762","Ephrin type-B receptor 1 [OS=Homo sapiens]",0,26.991,5,4,4,4,4,984,109.8,6.4,11.01,4,"cell adhesion;cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;ER/Golgi;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00041, Pf00536, Pf01404, Pf07714, Pf14575","2047","A8K593; B3KTB2; B5A969; hsa:2047; O43569; O95142; O95143; P54762; Q0VG87","ENSG00000154928","EPHB-mediated forward signaling; Ephrin signaling; EPH-ephrin mediated repulsion of cells","Neural crest cell migration during development; Neural crest cell migration in cancer",6,0,90.4,91.5,98,87.4,80.4,118.5,113.2,107.5,113.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S570(100); S583(99.6); S774(99.6); S899(99.1)]",0,"ENSG00000154928"
"1606","TTC7B",0.00729977092381429,6.65022226746576,0.0606098397724491,0.952914451731166,0.967889374879697,-7.48552150684379,"NONE",FALSE,"High","Master Protein","Q86TV6","Tetratricopeptide repeat protein 7B [OS=Homo sapiens]",0,47.349,5,3,3,7,3,843,94.1,6.89,18.36,3,"other metabolic processes;other biological processes","plasma membrane;other membranes;cytosol",NA,"Pf12895, Pf13181, Pf13424, Pf19440","145567","hsa:145567; Q86TV6; Q86U24; Q86VT3","ENSG00000165914",NA,NA,0,0,94.7,94.4,93.5,88.2,85,120,110.4,97.8,117.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S630(100)]",0,"ENSG00000165914"
"1607","GSS",-0.00551315863539958,6.66651536864908,-0.0604188332113218,0.953062638132152,0.967889374879697,-7.48553422673448,"NONE",FALSE,"High","Master Protein","P48637","Glutathione synthetase [OS=Homo sapiens]",0,5.067,4,1,1,1,1,474,52.4,5.92,2.5,1,"other metabolic processes;stress response;developmental processes;other biological processes","cytosol","other molecular function","Pf03199, Pf03917","2937","B2R697; B6F210; E1P5P9; hsa:2937; P48637; Q4TTD9","ENSG00000100983","Glutathione synthesis and recycling; Defective GSS causes GSS deficiency","Glutathione metabolism; Trans-sulfuration, one-carbon metabolism and related pathways; Amino acid metabolism; One-carbon metabolism and related pathways; Ferroptosis; Metapathway biotransformation Phase I and II",8,0,100.9,90.8,98.8,93.2,94.1,111.7,103.4,117.3,104.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S415(100)]",0,"ENSG00000100983"
"1608","HYOU1",-0.0136089730350575,6.64659813990336,-0.0579299577551114,0.954993723840772,0.969247361510038,-7.48569630359878,"NONE",FALSE,"High","Master Protein","Q9Y4L1","Hypoxia up-regulated protein 1 [OS=Homo sapiens]",0,60.801,4,2,3,9,2,999,111.3,5.22,32.51,2,"protein metabolism;other metabolic processes;stress response;transport;other biological processes","non-structural extracellular;ER/Golgi;other cell component","other molecular function","Pf00012","10525","A8C1Z0; B7Z909; hsa:10525; Q2I204; Q53H25; Q9Y4L1","ENSG00000149428; ENSG00000280682","XBP1(S) activates chaperone genes; Scavenging by Class F Receptors","VEGFA-VEGFR2 signaling",3,0,104.7,102.6,99.2,125.6,54.6,128.9,104.7,101.9,83.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S567(100)]",0,"ENSG00000149428"
"1609","SRPK2",-0.00491777673237603,6.63505853886964,-0.0528219362764063,0.958957918796628,0.971814599492032,-7.48600760239841,"NONE",FALSE,"High","Master Protein","P78362","SRSF protein kinase 2 [OS=Homo sapiens]",0,11.135,3,2,4,7,2,688,77.5,4.97,8.31,2,"cell organization and biogenesis;protein metabolism;RNA metabolism OR transcription;other metabolic processes;stress response;developmental processes;signal transduction;other biological processes","cytosol;nucleus;other cell component","kinase activity;other molecular function","Pf00069","6733","A8MVX2; hsa:6733; O75220; O75221; P78362; Q6NUL0; Q6V1X2; Q8IYQ3","ENSG00000135250","Maturation of nucleoprotein","mRNA processing",2,0,99,103.8,98.7,100,119.7,96.4,96.8,92.4,100.4,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S497(99.1)]",0,"ENSG00000135250"
"1610","CENPB",0.00726005411897468,6.64213034879826,0.0526639856279957,0.959080519359369,0.971814599492032,-7.48601677099172,"NONE",FALSE,"High","Master Protein","P07199","Major centromere autoantigen B [OS=Homo sapiens]",0,15.2,4,1,1,2,1,599,65.1,4.55,9.61,1,NA,"nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf03184, Pf03221, Pf04218, Pf09026","1059","hsa:1059; P07199; Q96EI4","ENSG00000125817",NA,"IL-18 signaling pathway",1,0,93.1,94.2,85.1,92.8,100.3,91.7,94.2,135,119.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S156(100)]",0,"ENSG00000125817"
"1611","IRF2BPL",0.0044439471676716,6.62756717373425,0.0523688152984799,0.959309632219156,0.971814599492032,-7.48603383124691,"NONE",FALSE,"High","Master Protein","Q9H1B7","Probable E3 ubiquitin-protein ligase IRF2BPL [OS=Homo sapiens]",0,58.917,10,5,7,13,5,796,82.6,8.24,30.92,5,"protein metabolism;other metabolic processes;developmental processes;other biological processes","nucleus","other molecular function","Pf11261","64207","hsa:64207; Q8NDQ2; Q96JG2; Q9H1B7; Q9H3I7","ENSG00000119669",NA,NA,0,0,93.5,91.1,97.3,101.6,101.3,91.7,108.4,98.8,107.5,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S215(100); S334(100); S519(100); S547(100); S659(100)]",0,"ENSG00000119669"
"1612","CTTN",-0.00396796175691705,6.66351002871802,-0.0498666764301086,0.961251961244892,0.972919500478448,-7.48617460039689,"NONE",FALSE,"High","Master Protein","Q14247","Src substrate cortactin [OS=Homo sapiens]",0,103.104,7,5,8,24,5,550,61.5,5.4,77.5,5,"cell adhesion;cell organization and biogenesis;transport;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;ER/Golgi;other cell component","other molecular function","Pf02218, Pf14604","2017","hsa:2017; Q14247; Q8N707; Q96H99","ENSG00000085733; ENSG00000288401","Clathrin-mediated endocytosis; RHO GTPases activate PAKs","Pathogenic Escherichia coli infection; Hepatitis C and hepatocellular carcinoma; ADHD and autism (ASD) linked metabolic pathways and SNP; HDAC6 interactions in the central nervous system",6,0,83,97.1,94.5,95,96.9,92.3,112.4,116.3,124.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S298(100); T401(99.5); S405(100); S418(100)]",0,"ENSG00000085733"
"1613","MARK4",-0.00706980329320039,6.59946065307278,-0.0491155794034745,0.961835066263349,0.972919500478448,-7.48621551282694,"NONE",FALSE,"High","Master Protein","Q96L34","MAP/microtubule affinity-regulating kinase 4 [OS=Homo sapiens]",0,19.779,5,2,2,4,1,752,82.5,9.66,7.17,2,"cell cycle OR cell proliferation;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","cytosol;cytoskeleton;other cell component","cytoskeletal activity;kinase activity;other molecular function","Pf00069, Pf00627, Pf02149","57787","hsa:57787; Q8NG37; Q96JG7; Q96L34; Q96SQ2; Q9BYD8","ENSG00000007047","Anchoring of the basal body to the plasma membrane",NA,1,0,83.4,116.2,107.2,106.1,121.3,92.1,93.5,79.5,95,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T214(100); S438(100)]",0,"ENSG00000007047"
"1614","CASC3",-0.00698105696295048,6.64973198005119,-0.0486599879939172,0.962188770693759,0.972919500478448,-7.48624002661671,"NONE",FALSE,"High","Master Protein","O15234","Protein CASC3 [OS=Homo sapiens]",0,26.745,3,1,1,2,1,703,76.2,6.48,7.32,1,"RNA metabolism OR transcription;other metabolic processes;transport;other biological processes","other membranes;cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf09405","22794","A8K8R0; O15234","ENSG00000108349","Regulation of expression of SLITs and ROBOs; Transport of Mature mRNA derived from an Intron-Containing Transcript; mRNA 3'-end processing; RNA Polymerase II Transcription Termination; mRNA Splicing - Major Pathway; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)",NA,6,0,90.9,102.5,90.6,99.9,118.5,79.8,118.6,99.1,110,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S148(100)]",0,"ENSG00000108349"
"1615","HCFC1",0.00447298434637311,6.64547445637944,0.043276800150394,0.966368713337717,0.976541015583377,-7.48651238810474,"NONE",FALSE,"High","Master Protein","P51610","Host cell factor 1 [OS=Homo sapiens]",0,45.601,3,2,2,5,2,2035,208.6,7.46,27.6,2,"cell cycle OR cell proliferation;cell organization and biogenesis;other biological processes","nucleus;other cell component","other molecular function","Pf01344, Pf13415, Pf13854","3054","hsa:3054; P51610; Q6P4G5","ENSG00000172534","UCH proteinases; Formation of WDR5-containing histone-modifying complexes; Transcriptional activation of mitochondrial biogenesis; HATs acetylate histones","Mitochondrial gene expression; Pleural mesothelioma",6,0,97,85.7,92.3,87.8,80,115.2,109.7,112.5,118.1,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S1507(100)]",0,"ENSG00000172534"
"1616","TNIK",-0.00303251552731076,6.63891110958146,-0.0420233818400039,0.967342127965468,0.976919772796809,-7.48657122862391,"NONE",FALSE,"High","Master Protein","Q9UKE5","TRAF2 and NCK-interacting protein kinase [OS=Homo sapiens]",0,92.248,7,9,10,17,7,1360,154.8,7.17,52.83,9,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","kinase activity;other molecular function","Pf00069, Pf00780","23043","A7E2A3; A8K4U1; D3DNQ6; hsa:23043; O60298; Q8WUY7; Q9UKD8; Q9UKD9; Q9UKE0; Q9UKE1; Q9UKE2; Q9UKE3; Q9UKE4; Q9UKE5","ENSG00000154310","Oxidative Stress Induced Senescence","Hippo-YAP signaling; Pleural mesothelioma",3,2,102.8,99.6,98.2,101.2,110.5,101.3,94.8,99.7,97.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [T181(100); S548(99.6); S570(100); S640(100); S707(100); S769(100)]",0,"ENSG00000154310"
"1617","RPL23A",-0.0050474543255401,6.61915769056304,-0.0346451831309448,0.973073187536049,0.981929672533911,-7.48688255323939,"NONE",FALSE,"High","Master Protein","P62750","Large ribosomal subunit protein uL23 [OS=Homo sapiens]",0,4.345,5,1,1,2,1,156,17.7,10.45,5.64,1,"cell organization and biogenesis;protein metabolism;other metabolic processes","cytosol;translational apparatus;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00276, Pf03939","6147","B2R5B2; hsa:6147; P29316; P39024; P62750; Q92774","ENSG00000198242","Regulation of expression of SLITs and ROBOs; L13a-mediated translational silencing of Ceruloplasmin expression; Formation of a pool of free 40S subunits; GTP hydrolysis and joining of the 60S ribosomal subunit; Major pathway of rRNA processing in the nucleolus and cytosol; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)","Cytoplasmic ribosomal proteins",14,0,88.9,89.4,90.5,82.8,108.5,91.2,108.4,97.1,144.8,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S43(99.6)]",0,"ENSG00000198242"
"1618","KIDINS220",-0.00232756341040918,6.65444208715491,-0.0340877382016364,0.97350625622541,0.981929672533911,-7.48690364079631,"NONE",FALSE,"High","Master Protein","Q9ULH0","Kinase D-interacting substrate of 220 kDa [OS=Homo sapiens]",0,45.176,4,5,6,7,5,1771,196.4,6.62,25.08,5,"cell organization and biogenesis;developmental processes;signal transduction;other biological processes","cytosol;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf07693, Pf12796","57498","A1L4N4; Q4VC08; Q6MZU2; Q9H889; Q9H9E4; Q9NT37; Q9UF42; Q9ULH0","ENSG00000134313","RND2 GTPase cycle; RND1 GTPase cycle; ARMS-mediated activation","Brain-derived neurotrophic factor (BDNF) signaling pathway; Neural crest cell migration in cancer",5,0,95.1,96.7,101.4,102.1,95.1,104.8,105.8,99.9,103.7,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S918(100); S1526(100); S1555(100); S1633(100); S1681(98.8)]",0,"ENSG00000134313"
"1619","RING1",0.0064650613108066,6.60017780241817,0.0330361077934201,0.974323273123602,0.98214674597759,-7.4869424917726,"NONE",FALSE,"High","Master Protein","Q06587","E3 ubiquitin-protein ligase RING1 [OS=Homo sapiens]",0,20.1,4,1,1,3,1,406,42.4,5.62,9.95,1,"cell organization and biogenesis;protein metabolism;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","enzyme regulator activity;other molecular function","Pf00097, Pf16207","6015","A8JZZ0; Q06587; Q5JP96; Q5SQW2; Q86V19","ENSG00000204227; ENSG00000206287; ENSG00000226788; ENSG00000228520; ENSG00000231115; ENSG00000235107","Oxidative Stress Induced Senescence; SUMOylation of DNA damage response and repair proteins; SUMOylation of chromatin organization proteins; SUMOylation of RNA binding proteins; SUMOylation of transcription cofactors; SUMOylation of DNA methylation proteins; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known; Regulation of PTEN gene transcription; Transcriptional Regulation by E2F6","Pleural mesothelioma; Notch signaling pathway",11,0,86.1,83.4,124.9,102.1,104.4,96.3,78.2,92.6,125,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S38(100)]",0,"ENSG00000204227"
"1620","NCKAP5L",0.00517624110742698,6.69523032136144,0.0294422174391804,0.977115614939373,0.984075482057392,-7.48706607595095,"NONE",FALSE,"High","Master Protein","Q9HCH0","Nck-associated protein 5-like [OS=Homo sapiens]",0,14.887,2,1,1,1,1,1334,139.4,8.06,3.79,1,"cell organization and biogenesis","cytoskeleton;other cell component",NA,"Pf15246","57701","hsa:57701; Q2TB26; Q71RH1; Q8N4W1; Q96HX2; Q9HCH0","ENSG00000167566",NA,NA,0,0,95.2,96.8,125.6,111.1,80,131.1,99.4,84.2,112.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S440(100)]",0,"ENSG00000167566"
"1621","TRAPPC14",0.00498053012676003,6.61209850195979,0.0290213727745791,0.977442620352349,0.984075482057392,-7.48707961791441,"NONE",FALSE,"High","Master Protein","Q8WVR3","Trafficking protein particle complex subunit 14 [OS=Homo sapiens]",0,3.65,2,1,1,1,1,580,62.6,8.87,2.17,1,"cell organization and biogenesis;other biological processes","plasma membrane;other membranes;cytoskeleton;ER/Golgi;other cytoplasmic organelle;other cell component","cytoskeletal activity","Pf15806","55262","A4D2A9; D6W5U4; hsa:55262; Q8WVR3; Q9BQJ1; Q9BUB6; Q9NV47","ENSG00000146826",NA,NA,0,0,88.3,104.2,107.7,102.7,75.7,126.6,77,97.9,107,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S517(99.5)]",0,"ENSG00000146826"
"1622","HNRNPD",-0.00729458793079996,6.59695570716331,-0.0277506625368664,0.978430016209583,0.984462260452552,-7.48711932404082,"NONE",FALSE,"High","Master Protein","Q14103","Heterogeneous nuclear ribonucleoprotein D0 [OS=Homo sapiens]",0,43.267,13,4,5,9,4,355,38.4,7.81,27.08,4,"RNA metabolism OR transcription;other metabolic processes;developmental processes;other biological processes","cytosol;nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf08143","3184","A8K9J2; hsa:3184; P07029; Q01858; Q14100; Q14101; Q14102; Q14103; Q4W5A1; Q9UCE8; Q9UCE9","ENSG00000138668","mRNA Splicing - Major Pathway; Processing of Capped Intron-Containing Pre-mRNA","mRNA processing",3,0,87.4,92.2,101.7,80.4,156.4,78.9,100,76.9,139.2,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S83(99.5); S190(100)]",0,"ENSG00000138668"
"1623","FLCN",-0.00220059796116523,6.61741943142917,-0.0212554623958896,0.983477625616498,0.988931290823244,-7.48729452169888,"NONE",FALSE,"High","Master Protein","Q8NFG4","Folliculin [OS=Homo sapiens]",0,30.401,3,1,1,3,1,579,64.4,6.23,17.66,1,"cell cycle OR cell proliferation;cell organization and biogenesis;stress response;developmental processes;signal transduction;other biological processes","plasma membrane;other membranes;cytosol;cytoskeleton;nucleus;other cytoplasmic organelle;other cell component","enzyme regulator activity;other molecular function","Pf11704, Pf16692","201163","A6NJJ8; hsa:201163; Q6ZRX1; Q8NFG4; Q96BD2; Q96BE4","ENSG00000154803","Amino acids regulate mTORC1","Ciliopathies; Bardet-Biedl syndrome; Smith-Magenis and Potocki-Lupski syndrome copy number variation",4,0,94.4,102.8,114.9,107.3,120.8,98.6,82.4,90.2,93,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S62(100)]",0,"ENSG00000154803"
"1624","EPHB2",0.00307466326035843,6.6415704343247,0.0195899615056047,0.984772068266633,0.989102275462024,-7.48733196571705,"NONE",FALSE,"High","Master Protein","P29323","Ephrin type-B receptor 2 [OS=Homo sapiens]",0,16.868,2,2,2,6,2,1055,117.4,6.55,16.59,2,"cell-cell signaling;cell organization and biogenesis;protein metabolism;other metabolic processes;transport;developmental processes;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;cytosol;nucleus;other cell component","signal transduction activity or receptor binding;kinase activity;other molecular function","Pf00041, Pf00536, Pf01404, Pf07699, Pf07714, Pf14575","2048","hsa:2048; O43477; P29323; Q5T0U6; Q5T0U7; Q5T0U8","ENSG00000133216","EPHB-mediated forward signaling; Ephrin signaling; L1CAM interactions; EPH-ephrin mediated repulsion of cells","Microtubule cytoskeleton regulation; Nod-like receptor (NLR) signaling pathway; Transcriptional activation by NRF2 in response to phytochemicals; VEGFA-VEGFR2 signaling; Neovascularization processes; NRF2-ARE regulation; Neural crest cell migration during development; Neural crest cell migration in cancer; Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution",14,0,82.9,85,80.7,103.2,54.6,95.3,129.8,155.6,121.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S575(100)]",0,"ENSG00000133216"
"1625","RPS6",0.00359671563308694,6.53424666855584,0.0188755369115963,0.98532734017354,0.989102275462024,-7.48734709171721,"NONE",FALSE,"High","Master Protein","P62753","Small ribosomal subunit protein eS6 [OS=Homo sapiens]",0,23.26,13,6,8,12,6,249,28.7,10.84,23.04,6,"protein metabolism;RNA metabolism OR transcription;other metabolic processes;signal transduction;other biological processes","cytosol;ER/Golgi;translational apparatus;nucleus;other cell component","other molecular function","Pf01092","6194","hsa:6194; P08227; P10660; P62753; Q4VBY7; Q8N6Z7","ENSG00000137154","Regulation of expression of SLITs and ROBOs; Protein hydroxylation; L13a-mediated translational silencing of Ceruloplasmin expression; Translation initiation complex formation; Formation of a pool of free 40S subunits; Formation of the ternary complex, and subsequently, the 43S complex; Ribosomal scanning and start codon recognition; GTP hydrolysis and joining of the 60S ribosomal subunit; mTORC1-mediated signalling; Major pathway of rRNA processing in the nucleolus and cytosol; rRNA modification in the nucleus and cytosol; SARS-CoV-2 modulates host translation machinery; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC); SRP-dependent cotranslational protein targeting to membrane; Viral mRNA Translation; Response of EIF2AK4 (GCN2) to amino acid deficiency; Peptide chain elongation; Selenocysteine synthesis; Eukaryotic Translation Termination; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC); Nuclear events stimulated by ALK signaling in cancer; SARS-CoV-1 modulates host translation machinery","IL-5 signaling pathway; Thyroid stimulating hormone (TSH) signaling pathway; Leptin signaling pathway; Follicle stimulating hormone (FSH) signaling pathway; Prolactin signaling pathway; Thymic stromal lymphopoietin (TSLP) signaling pathway; Interleukin-11 signaling pathway; Oncostatin M signaling pathway; Brain-derived neurotrophic factor (BDNF) signaling pathway; Kit receptor signaling pathway; MECP2 and associated Rett syndrome; VEGFA-VEGFR2 signaling; Focal adhesion: PI3K-Akt-mTOR-signaling pathway; PI3K-Akt signaling pathway; Hereditary leiomyomatosis and renal cell carcinoma pathway; Thermogenesis; Translation inhibitors in chronically activated PDGFRA cells; Gastrin signaling pathway; Head and neck squamous cell carcinoma; Thyroid hormones production and peripheral downstream signaling effects; Cytoplasmic ribosomal proteins; EGFR tyrosine kinase inhibitor resistance; IL-2 signaling pathway; Pleural mesothelioma; 2q37 copy number variation syndrome; Macrophage-stimulating protein (MSP) signaling network map; Interferon type I signaling pathways",49,0,111.1,109.1,102.9,110.2,168.6,81.8,69.4,68,81.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S236(99.5); S240(100); S244(99.7)]",0,"ENSG00000137154"
"1626","JUND",0.00260327930158244,6.65510548083214,0.0186832344066755,0.985476804788609,0.989102275462024,-7.48735106723267,"NONE",FALSE,"High","Master Protein","P17535","Transcription factor JunD [OS=Homo sapiens]",0,7.345,7,1,1,1,1,347,35.2,7.37,2.62,1,"other metabolic processes;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00170, Pf03957","3727","hsa:3727; P17535; Q53EK9","ENSG00000130522","NGF-stimulated transcription; Estrogen-dependent gene expression","Corticotropin-releasing hormone signaling pathway; Oncostatin M signaling pathway; Apoptosis-related network due to altered Notch3 in ovarian cancer; Aryl hydrocarbon receptor pathway; Nuclear receptors meta-pathway; TGF-beta signaling pathway; MAPK signaling pathway; EGF/EGFR signaling pathway; Angiotensin II receptor type 1 pathway; Hypertrophy model; 10q11.21q11.23 copy number variation syndrome; Osteoarthritic chondrocyte hypertrophy",14,0,102.9,88.1,81.2,100.9,95.8,83.4,103.4,116.4,147,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S90(100)]",0,"ENSG00000130522"
"1627","KRI1",-0.00136768741584437,6.66206969646436,-0.0172764615477307,0.986570218299447,0.989102275462024,-7.48737891166915,"NONE",FALSE,"High","Master Protein","Q8N9T8","Protein KRI1 homolog [OS=Homo sapiens]",0,30.401,7,2,2,7,2,703,82.5,5.14,32.85,2,"RNA metabolism OR transcription;other metabolic processes","nucleus;other cell component",NA,"Pf05178, Pf12936","65095","hsa:65095; Q2M1R5; Q2M1R7; Q7L5J7; Q8N9T8; Q96G92; Q9BU50; Q9H6I1; Q9H978","ENSG00000129347",NA,NA,0,0,87,90.9,99.9,93.5,88.1,103,117.9,109.3,117.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S171(100); S628(99.3)]",0,"ENSG00000129347"
"1628","TGOLN2",-0.00218266718554982,6.64601420432861,-0.0171377863207653,0.986678005179029,0.989102275462024,-7.48738153852878,"NONE",FALSE,"High","Master Protein","O43493","Trans-Golgi network integral membrane protein 2 [OS=Homo sapiens]",0,38.733,8,2,4,6,2,437,45.9,5.63,25.53,2,NA,"plasma membrane;other membranes;ER/Golgi;nucleus;other cytoplasmic organelle",NA,"Pf17818","10618","B2R686; B8ZZ88; D6W5K3; F8W8W7; F8WBK2; hsa:10618; J3KQ45; O15282; O43492; O43493; O43499; O43500; O43501; Q53G68; Q53GV2; Q6MZV1; Q6ZTM7; Q8N6T8; Q92760; Q96QL2","ENSG00000152291; ENSG00000292253","Golgi Associated Vesicle Biogenesis; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs); Post-translational protein phosphorylation; Cargo recognition for clathrin-mediated endocytosis; Retrograde transport at the Trans-Golgi-Network",NA,6,0,92.1,93.2,98.8,105,102,87.5,122.5,102.8,96.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S71(99.6); S298(99.6)]",0,"ENSG00000152291"
"1629","SNX16",-0.00167862835668142,6.63441959771224,-0.0133373063352478,0.989632073248787,0.991454600087182,-7.48744528937033,"NONE",FALSE,"High","Master Protein","P57768","Sorting nexin-16 [OS=Homo sapiens]",0,14.379,6,1,1,1,1,344,39.1,4.65,4.01,1,"transport","other membranes;cytosol;other cytoplasmic organelle;other cell component","other molecular function","Pf00787","64089","A8K4D8; P57768; Q658L0; Q8N4U3","ENSG00000104497",NA,NA,0,0,111.7,98,81.5,107.4,91.8,94.1,109.9,95.2,107.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S286(99.5)]",0,"ENSG00000104497"
"1630","CSTF3",0.00175245872607555,6.6407607562281,0.00997079188238429,0.992248964657388,0.993466448049605,-7.48748848046124,"NONE",FALSE,"High","Master Protein","Q12996","Cleavage stimulation factor subunit 3 [OS=Homo sapiens]",0,8.169,2,1,1,4,1,717,82.9,8.12,6.61,1,"RNA metabolism OR transcription;other metabolic processes","nucleus","nucleic acid binding activity","Pf05843","1479","A8K471; D3DR04; E9PB40; hsa:1479; Q12996; Q32P22; Q96FQ8; Q96QD6; Q96QK4","ENSG00000176102","mRNA 3'-end processing; RNA Polymerase II Transcription Termination; Processing of Intronless Pre-mRNAs","mRNA processing",5,0,93.5,98.5,102.5,111.8,71.4,118.2,101.4,119.7,81.3,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S691(100)]",0,"ENSG00000176102"
"1631","SAFB",-0.000707329988194338,6.6723759400666,-0.00760449992416195,0.994088413485692,0.994697909753924,-7.48751137228795,"NONE",FALSE,"High","Master Protein","Q15424","Scaffold attachment factor B1 [OS=Homo sapiens]",0,88.639,13,7,8,24,4,915,102.6,5.47,64.92,7,"cell organization and biogenesis;signal transduction;other biological processes","nucleus;other cell component","nucleic acid binding activity;other molecular function","Pf00076, Pf02037","6294","A0AV56; B7Z5B6; B7ZLP6; F5H0H3; hsa:6294; O60406; Q15424; Q59HH8","ENSG00000160633","SUMOylation of transcription cofactors","Interleukin-1 (IL-1) structural pathway",2,2,87.9,93.4,93.6,102.1,72.6,104,119.2,116.3,119.9,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S344(100); S589(100); S604(100)]",0,"ENSG00000160633"
"1632","LRPAP1",-7.49783147160343e-05,6.62389861323265,-0.00111457779991802,0.999133540433007,0.999133540433007,-7.48754251969096,"NONE",FALSE,"High","Master Protein","P30533","Alpha-2-macroglobulin receptor-associated protein [OS=Homo sapiens]",0,17.088,7,2,2,4,2,357,41.4,8.78,13.39,2,"transport;signal transduction;other biological processes","non-structural extracellular;plasma membrane;other membranes;ER/Golgi;other cytoplasmic organelle;other cell component","signal transduction activity or receptor binding;other molecular function","Pf06400, Pf06401","4043","D3DVR9; hsa:4043; P30533; Q2M310; Q53HQ3; Q53HS6","ENSG00000163956",NA,"Cholesterol metabolism",1,0,98.6,95.5,101.9,101.3,102.7,103.3,99.1,96,94.6,"High","High","High","High","High","High","High","High","High","High",1,"Phospho [S50(100); S247(100)]",0,"ENSG00000163956"
